0000081362-21-000013.txt : 20210805 0000081362-21-000013.hdr.sgml : 20210805 20210805082129 ACCESSION NUMBER: 0000081362-21-000013 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 109 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210805 DATE AS OF CHANGE: 20210805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUAKER CHEMICAL CORP CENTRAL INDEX KEY: 0000081362 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PRODUCTS OF PETROLEUM & COAL [2990] IRS NUMBER: 230993790 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12019 FILM NUMBER: 211146453 BUSINESS ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR STREET CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 BUSINESS PHONE: 6108324000 MAIL ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR ST CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 10-Q 1 kwr20210630.htm QUAKER CHEMICAL CORPORATION kwr20210630
FALSE --12-31 3 2021 1 30000000 Q2 0000081362 ☒ us-gaap:Assets us-gaap:Liabilities 0000081362 2021-01-01 2021-06-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2021-01-01 2021-06-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2021-01-01 2021-06-30 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2021-01-01 2021-06-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2021-01-01 2021-06-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-06-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-06-30 0000081362 us-gaap:EMEAMember 2021-01-01 2021-06-30 0000081362 srt:AsiaPacificMember 2021-01-01 2021-06-30 0000081362 2021-07-31 0000081362 2020-04-01 2020-06-30 0000081362 2020-01-01 2020-06-30 0000081362 2021-06-30 0000081362 2020-12-31 0000081362 2019-12-31 0000081362 2020-06-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-06-30 0000081362 us-gaap:TransferredOverTimeMember 2020-01-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-06-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2020-04-01 2020-06-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2020-04-01 2020-06-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2020-04-01 2020-06-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2020-01-01 2020-06-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2020-01-01 2020-06-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2020-01-01 2020-06-30 0000081362 us-gaap:RestrictedStockMember 2021-06-30 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-06-30 0000081362 us-gaap:RestrictedStockMember 2021-01-01 2021-06-30 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-06-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-04-01 2021-06-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-04-01 2021-06-30 0000081362 us-gaap:CustomerListsMember 2020-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0000081362 us-gaap:CustomerListsMember 2021-06-30 0000081362 us-gaap:OtherIntangibleAssetsMember 2021-06-30 0000081362 us-gaap:FairValueInputsLevel1Member 2021-06-30 0000081362 us-gaap:FairValueInputsLevel2Member 2021-06-30 0000081362 us-gaap:FairValueInputsLevel3Member 2021-06-30 0000081362 us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 srt:MinimumMember kwr:AcpMember 2021-06-30 0000081362 kwr:AcpMember srt:MaximumMember 2021-06-30 0000081362 kwr:SbDeckingMember 2021-06-30 0000081362 us-gaap:CommonStockMember 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000081362 us-gaap:RetainedEarningsMember 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-12-31 0000081362 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0000081362 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-06-30 0000081362 us-gaap:CommonStockMember 2021-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000081362 us-gaap:RetainedEarningsMember 2021-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-06-30 0000081362 us-gaap:CommonStockMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2019-12-31 0000081362 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0000081362 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-06-30 0000081362 us-gaap:CommonStockMember 2020-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000081362 us-gaap:RetainedEarningsMember 2020-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-04-01 2020-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-04-01 2020-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-04-01 2020-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-06-30 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember 2020-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember 2021-06-30 0000081362 us-gaap:InterestExpenseMember 2020-04-01 2020-06-30 0000081362 us-gaap:InterestExpenseMember 2021-01-01 2021-06-30 0000081362 us-gaap:InterestExpenseMember 2020-01-01 2020-06-30 0000081362 2020-01-01 2020-12-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2020-04-01 2020-06-30 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2020-01-01 2020-06-30 0000081362 kwr:HoughtonCombinationMember 2021-06-30 0000081362 kwr:HoughtonCombinationMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-06-30 0000081362 2021-04-01 2021-06-30 0000081362 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-06-30 0000081362 us-gaap:EmployeeStockOptionMember 2021-06-30 0000081362 srt:MaximumMember kwr:HoughtonEnvironmentalMattersMember 2021-06-30 0000081362 srt:MinimumMember kwr:HoughtonEnvironmentalMattersMember 2021-06-30 0000081362 kwr:DefinedContributionPlanMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-04-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-04-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-04-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-04-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-04-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-04-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-04-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-04-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-04-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-04-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-04-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-04-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-04-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-04-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-04-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-04-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-04-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-04-01 2020-06-30 0000081362 srt:ScenarioPreviouslyReportedMember kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 srt:RestatementAdjustmentMember kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 srt:RestatementAdjustmentMember kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 srt:ScenarioPreviouslyReportedMember kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 kwr:TinplatingsolutionsMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember 2021-02-28 0000081362 us-gaap:CustomerListsMember kwr:TinplatingsolutionsMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:PatentedTechnologyMember 2021-02-28 0000081362 us-gaap:TrademarksMember kwr:TinplatingsolutionsMember 2021-02-28 0000081362 us-gaap:CustomerListsMember kwr:TinplatingsolutionsMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:PatentedTechnologyMember 2021-02-01 2021-02-28 0000081362 us-gaap:TrademarksMember kwr:TinplatingsolutionsMember 2021-02-01 2021-02-28 0000081362 kwr:GrindaixGmbhMember 2021-02-28 0000081362 kwr:GrindaixGmbhMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember 2021-01-01 2021-06-30 0000081362 kwr:CoralChemicalCompanyMember 2021-04-01 2021-06-30 0000081362 kwr:CoralChemicalCompanyMember 2021-01-01 2021-06-30 0000081362 kwr:TelnordicMember 2020-05-01 2020-05-31 0000081362 kwr:TelnordicMember 2020-04-01 2020-06-30 0000081362 kwr:TelnordicMember 2020-06-30 0000081362 kwr:TelnordicMember 2021-01-01 2021-06-30 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-03-31 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-03-01 2020-03-31 0000081362 kwr:NormanHayMember 2019-10-01 2019-10-31 0000081362 kwr:NormanHayMember 2020-01-01 2020-03-31 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2021-04-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2021-04-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2021-04-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-06-30 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2021-04-01 2021-06-30 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2020-04-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2020-04-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2020-04-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-06-30 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2020-04-01 2020-06-30 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-01-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-01-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-01-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0000081362 srt:AmericasMember 2021-04-01 2021-06-30 0000081362 us-gaap:EMEAMember 2021-04-01 2021-06-30 0000081362 srt:AsiaPacificMember 2021-04-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000081362 srt:AmericasMember 2020-04-01 2020-06-30 0000081362 us-gaap:EMEAMember 2020-04-01 2020-06-30 0000081362 srt:AsiaPacificMember 2020-04-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2020-04-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2020-04-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2020-04-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2020-04-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2020-04-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2020-04-01 2020-06-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2020-04-01 2020-06-30 0000081362 us-gaap:TransferredOverTimeMember 2020-04-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2021-04-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2021-04-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2021-04-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2021-04-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2021-04-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2021-04-01 2021-06-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2021-04-01 2021-06-30 0000081362 us-gaap:TransferredOverTimeMember 2021-04-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-06-30 0000081362 srt:AmericasMember 2021-01-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-06-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-06-30 0000081362 us-gaap:TransferredOverTimeMember 2021-01-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-01-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-01-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-01-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-01-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-01-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-01-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-06-30 0000081362 srt:AmericasMember 2020-01-01 2020-06-30 0000081362 us-gaap:EMEAMember 2020-01-01 2020-06-30 0000081362 srt:AsiaPacificMember 2020-01-01 2020-06-30 0000081362 kwr:QhProgramMember 2020-12-31 0000081362 kwr:QhProgramMember 2021-01-01 2021-06-30 0000081362 kwr:QhProgramMember 2021-06-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2021-04-01 2021-06-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2021-04-01 2021-06-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2021-04-01 2021-06-30 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2021-04-01 2021-06-30 0000081362 us-gaap:PerformanceSharesMember 2021-04-01 2021-06-30 0000081362 us-gaap:PerformanceSharesMember 2020-04-01 2020-06-30 0000081362 us-gaap:PerformanceSharesMember 2021-01-01 2021-06-30 0000081362 us-gaap:PerformanceSharesMember 2020-01-01 2020-06-30 0000081362 us-gaap:StockCompensationPlanMember 2021-04-01 2021-06-30 0000081362 us-gaap:StockCompensationPlanMember 2020-04-01 2020-06-30 0000081362 us-gaap:StockCompensationPlanMember 2021-01-01 2021-06-30 0000081362 us-gaap:StockCompensationPlanMember 2020-01-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2020-12-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2020-12-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2020-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-06-30 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2021-06-30 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2020-12-31 0000081362 us-gaap:LineOfCreditMember 2021-06-30 0000081362 us-gaap:DomesticLineOfCreditMember 2021-06-30 0000081362 us-gaap:ForeignLineOfCreditMember 2021-06-30 0000081362 kwr:IndustrialDevelopmentBondsMember 2021-06-30 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2021-06-30 0000081362 us-gaap:LineOfCreditMember 2020-12-31 0000081362 us-gaap:DomesticLineOfCreditMember 2020-12-31 0000081362 us-gaap:ForeignLineOfCreditMember 2020-12-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2020-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2020-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2021-01-01 2021-06-30 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2020-01-01 2020-12-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2021-06-30 0000081362 us-gaap:RevolvingCreditFacilityMember srt:MaximumMember 2021-01-01 2021-06-30 0000081362 us-gaap:RevolvingCreditFacilityMember srt:MinimumMember 2021-01-01 2021-06-30 0000081362 srt:MinimumMember 2021-06-30 0000081362 srt:MaximumMember 2021-06-30 0000081362 kwr:TermLoanMember 2021-01-01 2021-06-30 0000081362 kwr:TermLoanMember 2021-06-30 0000081362 kwr:TermLoanMember 2019-11-30 0000081362 us-gaap:OtherAssetsMember 2021-06-30 0000081362 us-gaap:OtherAssetsMember 2020-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-06-30 0000081362 us-gaap:CorporateBondSecuritiesMember 2020-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-01-01 2021-06-30 0000081362 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0000081362 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0000081362 2020-03-31 0000081362 us-gaap:CommonStockMember 2020-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000081362 us-gaap:RetainedEarningsMember 2020-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-03-31 0000081362 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000081362 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0000081362 us-gaap:CommonStockMember 2021-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000081362 us-gaap:RetainedEarningsMember 2021-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-03-31 0000081362 2021-03-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-04-01 2021-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-04-01 2021-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-04-01 2021-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-04-01 2021-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-04-01 2020-06-30 0000081362 2020-01-01 2020-03-31 0000081362 kwr:ForeignconsumptiontaxMember 2021-06-30 0000081362 srt:MinimumMember kwr:ForeignconsumptiontaxMember 2021-06-30 0000081362 srt:MaximumMember kwr:ForeignconsumptiontaxMember 2021-06-30 0000081362 kwr:ForeignconsumptiontaxMember 2021-01-01 2021-06-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2021-04-01 2021-06-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2021-01-01 2021-06-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2020-04-01 2020-06-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2020-01-01 2020-06-30 0000081362 kwr:DefinedContributionPlanMember 2020-04-01 2020-06-30 0000081362 kwr:DefinedContributionPlanMember 2020-01-01 2020-06-30 0000081362 kwr:DefinedbenefitplansettlementMember 2020-07-01 2020-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-07-01 2020-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-06-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-06-30 0000081362 country:IT 2021-01-01 2021-06-30 0000081362 us-gaap:ForeignCountryMember country:IT kwr:HoughtonMember 2021-06-30 0000081362 country:DE 2021-06-30 0000081362 us-gaap:ForeignCountryMember kwr:NetherlandsAndSpainMember 2021-06-30 0000081362 us-gaap:ForeignCountryMember country:IT 2021-06-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-04-01 2020-06-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-04-01 2020-06-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-06-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-06-30 0000081362 us-gaap:InterestExpenseMember 2021-04-01 2021-06-30 0000081362 kwr:BrazilianIndirectTaxesMember 2021-01-01 2021-06-30 0000081362 us-gaap:InterestRateSwapMember 2019-11-30 0000081362 us-gaap:InterestRateSwapMember 2021-01-01 2021-06-30 0000081362 srt:ScenarioForecastMember 2021-12-31 0000081362 srt:MaximumMember kwr:FacilitiesVehiclesAndMachineryAndEquipmentMember 2021-06-30 0000081362 us-gaap:LandMember srt:MaximumMember 2021-06-30 0000081362 srt:MinimumMember us-gaap:ForeignCountryMember country:IT kwr:HoughtonMember 2021-01-01 2021-06-30 0000081362 srt:MaximumMember us-gaap:ForeignCountryMember country:IT kwr:HoughtonMember 2021-01-01 2021-06-30 0000081362 srt:MinimumMember us-gaap:ForeignCountryMember country:DE kwr:HoughtonMember 2021-01-01 2021-06-30 0000081362 srt:MaximumMember us-gaap:ForeignCountryMember country:DE kwr:HoughtonMember 2021-01-01 2021-06-30 0000081362 srt:SubsidiariesMember country:AR 2021-04-01 2021-06-30 0000081362 srt:SubsidiariesMember country:AR 2021-01-01 2021-06-30 0000081362 srt:SubsidiariesMember country:AR 2020-04-01 2020-06-30 0000081362 srt:SubsidiariesMember country:AR 2020-01-01 2020-06-30 0000081362 kwr:GlobalSpecialtyBusinessesMember kwr:ChemicalMaskantsProductLineMember 2021-01-01 2021-06-30 0000081362 kwr:ForeignconsumptiontaxMember kwr:HoughtonMember 2021-06-30 0000081362 country:DE kwr:HoughtonMember 2021-06-30 0000081362 us-gaap:AssetsTotalMember srt:SubsidiariesMember country:AR us-gaap:GeographicConcentrationRiskMember 2021-04-01 2021-06-30 0000081362 us-gaap:AssetsTotalMember srt:SubsidiariesMember country:AR us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-06-30 0000081362 us-gaap:PerformanceSharesMember 2021-06-30 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:LargestCustomerMember 2020-01-01 2020-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:TopFiveMember 2020-01-01 2020-12-31 0000081362 us-gaap:SalesRevenueNetMember srt:SubsidiariesMember country:AR us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-06-30 0000081362 us-gaap:SalesRevenueNetMember srt:SubsidiariesMember country:AR us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-06-30 0000081362 us-gaap:AssetsTotalMember srt:SubsidiariesMember country:AR us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-06-30 0000081362 us-gaap:SalesRevenueNetMember srt:SubsidiariesMember country:AR us-gaap:GeographicConcentrationRiskMember 2021-04-01 2021-06-30 0000081362 us-gaap:SalesRevenueNetMember srt:SubsidiariesMember country:AR us-gaap:GeographicConcentrationRiskMember 2020-04-01 2020-06-30 0000081362 us-gaap:AssetsTotalMember srt:SubsidiariesMember country:AR us-gaap:GeographicConcentrationRiskMember 2020-04-01 2020-06-30 0000081362 kwr:DefinedContributionPlanMember 2021-04-01 2021-06-30 0000081362 kwr:HoughtonCombinationMember 2021-01-01 2021-03-31 0000081362 kwr:HoughtonCombinationMember 2020-12-31 0000081362 kwr:HoughtonCombinationMember 2021-06-30 0000081362 srt:MaximumMember us-gaap:ForeignCountryMember country:IT 2021-01-01 2021-06-30 0000081362 srt:MinimumMember us-gaap:ForeignCountryMember country:IT 2021-01-01 2021-06-30 0000081362 us-gaap:ForeignCountryMember country:IT 2021-01-01 2021-06-30 0000081362 us-gaap:ForeignCountryMember country:BR 2021-01-01 2021-06-30 0000081362 us-gaap:ForeignCountryMember country:NL 2021-01-01 2021-06-30 0000081362 us-gaap:ForeignCountryMember country:CN 2021-01-01 2021-06-30 0000081362 us-gaap:ForeignCountryMember country:MX 2021-01-01 2021-06-30 0000081362 us-gaap:ForeignCountryMember country:GB 2021-01-01 2021-06-30 0000081362 country:CA us-gaap:StateAndLocalJurisdictionMember 2021-01-01 2021-06-30 0000081362 us-gaap:InternalRevenueServiceIRSMember 2021-01-01 2021-06-30 0000081362 us-gaap:StateAndLocalJurisdictionMember 2021-01-01 2021-06-30 0000081362 us-gaap:ForeignCountryMember country:IN 2021-01-01 2021-06-30 iso4217:BRL iso4217:DKK iso4217:EUR iso4217:GBP iso4217:USD iso4217:ZAR xbrli:pure xbrli:shares iso4217:USD xbrli:shares dummy:People dummy:Segments dummy:Countries
 
 
 
 
 
 
 
 
 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
 
 
 
 
 
 
FORM
10-Q
 
 
 
 
 
 
☒
QUARTERLY
 
REPORT PURSUANT TO SECTION
 
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
 
OF 1934
For the quarterly period ended
June 30, 2021
 
OR
 
☐
TRANSITION REPORT PURSUANT TO
 
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
 
ACT OF 1934
For the transition period from
 
to
 
 
Commission file number
001-12019
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
(Exact name of Registrant as specified in its charter)
 
 
 
 
 
 
Pennsylvania
 
23-0993790
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
901 E. Hector Street
,
Conshohocken
,
Pennsylvania
 
19428 – 2380
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code:
610
-
832-4000
 
Not Applicable
Former name, former address and former fiscal year,
 
if changed since last report.
 
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $1 par value
KWR
New York Stock Exchange
 
Indicate by check mark whether the Registrant (1) has filed all reports
 
required to be filed by Section 13 or 15(d) of the Securities Exchange
 
Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
 
to file such reports), and (2) has been subject to such filing requirements
 
for the past 90
days.
 
Yes
 
☒
 
No
 
☐
 
 
Indicate by check mark whether the Registrant has submitted electronically, every Interactive Data File required
 
to be submitted pursuant to Rule 405 of Regulation S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter
 
period that the registrant was required to submit such files) .
 
Yes
 
☒
 
No
 
☐
 
 
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging
growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company”
 
in Rule 12b-2 of
the Exchange Act.
 
Large accelerated filer
 
☒
Accelerated filer
 
☐
 
Non-accelerated filer
 
☐
 
Smaller reporting
 
company
☐
Emerging growth company
 
☐
 
 
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period
 
for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange
 
Act.
 
☐
 
 
Indicate by check mark whether the Registrant is a shell company (as defined
 
in Rule 12b-2 of the Exchange Act).
 
Yes
 
☐
 
No
 
☒
 
Indicate the number of shares outstanding of each of the issuer’s classes of common
 
stock, as of the latest practicable date.
 
 
 
Number of Shares of Common Stock
Outstanding on July 31, 2021
 
17,878,247
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2
PART
 
I
FINANCIAL INFORMATION
 
Item 1.
 
Financial Statements (Unaudited).
 
Quaker Chemical Corporation
Condensed Consolidated Statements of Operations
(Dollars in thousands, except per share data)
 
Unaudited
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Net sales
$
435,262
$
286,040
$
865,045
$
664,601
Cost of goods sold (
excluding amortization expense - See Note 14
)
 
280,811
 
188,654
 
554,400
 
433,364
Gross profit
 
154,451
 
97,386
 
310,645
 
231,237
Selling, general and administrative expenses
 
108,679
 
86,667
 
212,989
 
185,368
Indefinite-lived intangible asset impairment
—
—
—
38,000
Restructuring and related charges
298
486
1,473
2,202
Combination, integration and other acquisition-related
 
expenses
6,658
7,995
12,473
15,873
Operating income (loss)
 
38,816
2,238
 
83,710
 
(10,206)
Other income (expense), net
 
14,010
 
(993)
 
18,697
 
(22,168)
Interest expense, net
(5,618)
(6,811)
(11,088)
(15,272)
Income (loss) before taxes and equity in net income of
associated companies
 
47,208
 
(5,566)
 
91,319
 
(47,646)
Taxes on income
 
(loss) before equity in net income of associated
companies
 
15,218
 
3,222
 
25,907
 
(9,848)
Income (loss) before equity in net income of associated
companies
 
31,990
 
(8,788)
 
65,412
 
(37,798)
Equity in net income of associated companies
 
1,610
 
1,066
 
6,820
 
1,732
Net income (loss)
33,600
(7,722)
72,232
(36,066)
Less: Net income attributable to noncontrolling interest
30
13
47
50
Net income (loss) attributable to Quaker Chemical Corporation
$
33,570
$
(7,735)
$
72,185
$
(36,116)
Per share data:
 
 
 
 
Net income (loss) attributable to Quaker Chemical Corporation
common shareholders – basic
$
1.88
$
(0.43)
$
4.04
$
(2.03)
Net income (loss) attributable to Quaker Chemical Corporation
 
common shareholders – diluted
$
1.88
$
(0.43)
$
4.03
$
(2.03)
Dividends declared
$
0.395
$
0.385
$
0.790
$
0.770
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3
Quaker Chemical Corporation
Condensed Consolidated Statements of Comprehensive Income (Loss)
 
(Dollars in thousands)
 
Unaudited
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Net income (loss)
 
$
33,600
$
(7,722)
$
72,232
$
(36,066)
Other comprehensive income (loss), net of tax
Currency translation adjustments
16,165
10,551
(9,296)
(44,200)
Defined benefit retirement plans
397
213
1,689
17,170
Current period change in fair value of derivatives
452
(111)
1,014
(4,092)
Unrealized gain (loss) on available-for-sale securities
279
1,608
(2,746)
(103)
Other comprehensive income (loss)
17,293
12,261
(9,339)
(31,225)
Comprehensive income (loss)
50,893
4,539
62,893
(67,291)
Less: Comprehensive (income) loss attributable to
noncontrolling interest
(38)
(14)
(53)
81
Comprehensive income (loss) attributable to Quaker Chemical
Corporation
$
50,855
$
4,525
$
62,840
$
(67,210)
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4
Quaker Chemical Corporation
Condensed Consolidated Balance Sheets
(Dollars in thousands, except par value and share amounts)
 
Unaudited
June 30,
 
December 31,
2021
2020
ASSETS
 
 
 
 
Current assets
 
 
 
 
Cash and cash equivalents
$
145,610
$
181,833
Accounts receivable, net
 
418,642
 
372,974
Inventories
 
 
Raw materials and supplies
 
116,491
 
86,148
Work-in-process
 
and finished goods
 
126,318
 
101,616
Prepaid expenses and other current assets
 
60,844
 
50,156
Total current
 
assets
 
867,905
 
792,727
Property, plant and
 
equipment, at cost
 
424,360
 
423,253
Less accumulated depreciation
 
(229,919)
 
(219,370)
Property, plant and
 
equipment, net
 
194,441
 
203,883
Right of use lease assets
36,160
38,507
Goodwill
 
633,449
 
631,212
Other intangible assets, net
 
1,068,795
 
1,081,358
Investments in associated companies
 
98,013
 
95,785
Deferred tax assets
 
13,392
 
16,566
Other non-current assets
 
32,664
 
31,796
Total assets
$
2,944,819
$
2,891,834
LIABILITIES AND EQUITY
 
 
Current liabilities
 
 
Short-term borrowings and current portion of long-term debt
$
48,079
$
38,967
Accounts and other payables
 
219,617
 
198,872
Accrued compensation
 
33,399
 
43,300
Accrued restructuring
5,278
8,248
Other current liabilities
 
94,061
 
93,573
Total current
 
liabilities
 
400,434
 
382,960
Long-term debt
 
847,154
 
849,068
Long-term lease liabilities
25,668
27,070
Deferred tax liabilities
 
181,264
 
192,763
Other non-current liabilities
 
114,898
 
119,059
Total liabilities
 
1,569,418
 
1,570,920
Commitments and contingencies (Note 19)
Equity
 
 
Common stock $
1
 
par value; authorized
30,000,000
 
shares; issued and
 
 
outstanding 2021 –
17,878,137
 
shares; 2020 –
17,850,616
 
shares
17,878
17,851
Capital in excess of par value
 
910,862
 
905,171
Retained earnings
 
482,001
 
423,940
Accumulated other comprehensive loss
 
(35,943)
 
(26,598)
Total Quaker
 
shareholders’ equity
 
1,374,798
 
1,320,364
Noncontrolling interest
 
603
550
Total equity
1,375,401
1,320,914
Total liabilities and
 
equity
$
2,944,819
$
2,891,834
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5
Quaker Chemical Corporation
Condensed Consolidated Statements of Cash Flows
(Dollars in thousands)
 
Unaudited
Six Months Ended
June 30,
 
2021
2020
Cash flows from operating activities
 
 
 
 
 
Net income (loss)
 
$
72,232
$
(36,066)
Adjustments to reconcile net income (loss) to net cash (used
 
in) provided by operating activities:
 
 
Amortization of debt issuance costs
 
2,375
 
2,375
Depreciation and amortization
 
44,188
 
42,079
Equity in undistributed earnings of associated companies,
 
net of dividends
 
(6,715)
 
3,219
Acquisition-related fair value adjustments related to inventory
801
229
Deferred compensation, deferred taxes and other,
 
net
 
(13,849)
 
(22,033)
Share-based compensation
 
6,134
 
7,673
(Gain) loss on disposal of property,
 
plant, equipment and other assets
 
(5,356)
 
81
Insurance settlement realized
 
—
 
(542)
Indefinite-lived intangible asset impairment
—
38,000
Combination and other acquisition-related expenses, net of
 
payments
(2,305)
1,860
Restructuring and related charges
1,473
2,202
Pension and other postretirement benefits
 
(2,223)
 
18,784
(Decrease) increase in cash from changes in current assets and
 
current
 
 
liabilities, net of acquisitions:
Accounts receivable
 
(47,252)
 
61,659
Inventories
 
(57,020)
 
(3,689)
Prepaid expenses and other current assets
 
(20,111)
 
(2,849)
Change in restructuring liabilities
(4,214)
(9,592)
Accounts payable and accrued liabilities
 
22,274
 
(58,728)
 
Net cash (used in) provided by operating activities
 
(9,568)
 
44,662
Cash flows from investing activities
 
 
Investments in property,
 
plant and equipment
 
(6,974)
 
(7,534)
Payments related to acquisitions, net of cash acquired
 
(29,424)
 
(3,132)
Proceeds from disposition of assets
14,744
11
Insurance settlement interest earned
 
—
 
37
 
Net cash used in investing activities
 
(21,654)
 
(10,618)
Cash flows from financing activities
 
 
Payments of term loan debt
 
(19,065)
 
(18,702)
Borrowings on revolving credit facilities, net
 
29,433
 
205,500
Repayments on other debt, net
(219)
 
(684)
Dividends paid
 
(14,113)
 
(13,662)
Stock options exercised, other
 
(416)
 
(1,923)
Purchase of noncontrolling interest in affiliates
—
(1,047)
Distributions to noncontrolling affiliate shareholders
—
(751)
 
Net cash (used in) provided by financing activities
 
(4,380)
 
168,731
 
Effect of foreign exchange rate changes on
 
cash
 
(683)
 
(4,575)
Net (decrease) increase in cash, cash equivalents and restricted
 
cash
 
(36,285)
 
198,200
Cash, cash equivalents and restricted cash at the beginning
 
of the period
 
181,895
 
143,555
Cash, cash equivalents and restricted cash at the end of
 
the period
$
145,610
$
341,755
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
6
Note 1 – Basis of Presentation and Description of Business
 
Basis of Presentation
As used in these Notes to Condensed Consolidated
 
Financial Statements, the terms “Quaker,”
 
“Quaker Houghton,”
 
the
“Company,”
 
“we,” and “our” refer to Quaker Chemical Corporation (doing
 
business as Quaker Houghton), its subsidiaries, and
associated companies, unless the context otherwise requires.
 
As used in these Notes to Condensed Consolidated
 
Financial Statements,
the term Legacy Quaker refers to the Company prior
 
to the closing of its combination with Houghton International,
 
Inc. (“Houghton”)
(herein referred to as the “Combination”).
 
The condensed consolidated financial statements included herein
 
are unaudited and have
been prepared in accordance with generally accepted
 
accounting principles in the United States (“U.S. GAAP”) for
 
interim financial
reporting and the United States Securities and Exchange Commission
 
(“SEC”) regulations.
 
Certain information and footnote
disclosures normally included in financial statements prepared
 
in accordance with U.S. GAAP have been condensed or
 
omitted
pursuant to such rules and regulations.
 
In the opinion of management, the financial statements reflect all
 
adjustments which are
necessary for a fair statement of the financial position,
 
results of operations and cash flows for the interim periods.
 
The results for the
six months ended June 30, 2021 are not necessarily indicative
 
of the results to be expected for the full year.
 
These financial
statements should be read in conjunction with the Company’s
 
Annual Report filed on Form 10-K for the year
 
ended December 31,
2020 (the “2020 Form 10-K”).
 
Description of Business
The Company was organized in 1918, incorporated
 
as a Pennsylvania business corporation in 1930, and in August
 
2019
completed the Combination with Houghton to form
 
Quaker Houghton.
 
Quaker Houghton is the global leader in industrial process
fluids.
 
With a presence around the world,
 
including operations in over
25
 
countries, the Company’s customers
 
include thousands of
the world’s most advanced
 
and specialized steel, aluminum, automotive, aerospace,
 
offshore, can, mining, and metalworking
companies.
 
Quaker Houghton develops, produces, and markets a broad range
 
of formulated chemical specialty products and offe
 
rs
chemical management services (which the Company refers
 
to as “Fluidcare”) for various heavy industrial and manufacturing
applications throughout its
four
 
segments: Americas; Europe, Middle East and Africa (“EMEA”);
 
Asia/Pacific; and Global Specialty
Businesses.
Hyper-inflationary economies
 
Based on various indices or index compilations being
 
used to monitor inflation in Argentina as well as economic
 
instability,
effective July 1, 2018, Argentina’s
 
economy was considered hyper-inflationary under U.S.
 
GAAP.
 
As of, and for the three and six
months ended June 30, 2021, the Company's Argentine
 
subsidiaries represented less than
1
% of the Company’s consolidated
 
total
assets and net sales, respectively.
 
During the three and six months ended June 30, 2021, the Company
 
recorded $
0.1
 
million and $
0.3
million,
 
respectively, of remeasurement
 
losses associated with the applicable currency conversions related
 
to Argentina.
 
Comparatively,
 
during the three and six months ended June 30, 2020, the
 
Company recorded less than $
0.1
 
million and $
0.1
 
million,
respectively, of
 
remeasurement losses associated with the applicable currency
 
conversions
 
related to Argentina.
 
These losses were
recorded within foreign exchange losses, net, which
 
is a component of other income (expense), net, in the Company’s
 
Condensed
Consolidated Statements of Operations.
COVID-19
Management continues to monitor the impact that the COVID-19
 
pandemic is having on the Company,
 
the overall specialty
chemical industry,
 
and the economies and markets in which the Company operates.
 
The full extent of the COVID-19 pandemic
related business and travel restrictions and changes to
 
business and consumer behavior intended to reduce its spread are
 
uncertain as of
the date of this Quarterly Report on Form 10-Q for the
 
period ended June 30, 2021 (the “Report”) as COVID-19
 
and the responses of
governmental authorities continue to evolve globally.
Further, management continues to
 
evaluate how COVID-19-related circumstances, such as remote
 
work arrangements, affect
financial reporting processes, internal control over financial
 
reporting, and disclosure controls and procedures.
 
While the
circumstances have presented and are expected to continue
 
to present challenges, at this time, Management does not believe that
COVID-19 has had a material impact on financial reporting
 
processes, internal control over financial reporting,
 
and disclosure
controls and procedures.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
7
The Company cannot reasonably estimate the magnitude
 
of the effects these conditions will have on the Company’s
 
operations in
the future as they are subject to significant uncertainties
 
relating to the ultimate geographic spread of the virus,
 
the incidence and
severity of the symptoms, the duration or resurgences
 
of the outbreak including the impact of new variants, the global
 
availability and
acceptance of vaccines as well as their efficacy,
 
the length of the travel restrictions and business closures imposed by
 
governments of
impacted countries, and the economic response by governments
 
of impacted countries, all of which continue to evolve.
To the extent
 
that the Company’s customers and
 
suppliers continue to be significantly and adversely impacted by
 
COVID-19, this
could reduce the availability,
 
or result in delays, of materials or supplies to or from
 
the Company, which in
 
turn could significantly
interrupt the Company’s
 
business operations.
 
Such impacts could grow and become more significant to the
 
Company’s operations
and the Company’s liquidity
 
or financial position.
 
Therefore, given the speed and frequency of continuously
 
evolving developments
with respect to this pandemic, the Company cannot reasonably
 
estimate the magnitude or the full extent to which COVID-19
 
may
impact the Company’s results
 
of operations, liquidity or financial position.
Note 2 – Business Acquisitions
2021 Acquisitions
In June 2021, the Company acquired certain assets for its chemical
 
maskants product line in the Global Specialty Businesses
reportable segment for
2.3
 
million EUR or approximately $
2.8
 
million.
 
The Company accounted for the acquisition using the asset
acquisition method under ASC 805,
Business Combinations
.
 
In February 2021, the Company acquired a tin-plating
 
solutions business for the steel end market for approximately $
25
 
million.
 
This acquisition is part of each of the Company’s
 
geographic reportable segments.
 
The Company allocated $
19.6
 
million of the
purchase price to intangible assets, comprised of $
18.3
 
million of customer relationships, to be amortized over
19 years
; $
0.9
 
million
of existing product technology to be amortized over
14 years
; and $
0.4
 
million of a licensed trademark to be amortized over
3 years
.
 
In addition, the Company recorded $
5.0
 
million of goodwill related to expected value not allocated
 
to other acquired assets, all of
which is expected to be tax deductible.
 
As of June 30, 2021, the allocation of the purchase price has not
 
been finalized and the
one
year
 
measurement period has not ended.
 
Further adjustments may be necessary as a result of the Company’s
 
on-going assessment of
additional information related to the fair value of assets acquired
 
and liabilities assumed.
 
Additionally, in February
 
2021, the Company acquired a
38
% ownership interest in a Germany-based, high-tech
 
provider of
coolant control and delivery systems for approximately
1.4
 
million EUR or approximately $
1.7
 
million.
 
The Company recorded this
investment as an equity method investment within
 
the Condensed Consolidated Financial Statements.
The results of operations of the acquired assets and businesses subsequent
 
to the respective acquisition dates are included in the
Condensed Consolidated Statements of Operations as of June
 
30, 2021.
 
Applicable transaction expenses associated with these
acquisitions are included in Combination, integration
 
and other acquisition-related expenses in the Company’s
 
Condensed
Consolidated Statements of Operations.
 
Certain pro forma and other information is not presented, as the
 
operations of the acquired
assets and businesses are not considered material to the
 
overall operations of the Company for the periods presented.
 
Previous Acquisitions
In December 2020,
 
the Company completed its acquisition of Coral Chemical Company
 
(“Coral”), a privately held, U.S.-based
provider of metal finishing fluid solutions.
 
The acquisition provides technical expertise and product solutions
 
for pre-treatment,
metalworking and wastewater treatment applications
 
to the beverage cans and general industrial end markets.
 
The original purchase
price was approximately $
54.1
 
million, subject to routine and customary post-closing adjustments related
 
to working capital and net
indebtedness levels.
 
The Company anticipates finalizing its post-closing adjustments
 
for the Coral acquisition during 2021 and
currently estimates it will receive approximately $
0.1
 
million to settle such adjustments.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
8
The following table presents the preliminary estimated fair
 
values of Coral net assets acquired:
Measurement
December 22,
December 22,
Period
2020
2020 (1)
Adjustments
(as adjusted)
Cash and cash equivalents
$
958
$
—
$
958
Accounts receivable
8,473
—
8,473
Inventories
4,527
—
4,527
Prepaid expenses and other assets
181
—
181
Property, plant and
 
equipment
10,467
652
11,119
Intangible assets
30,300
(500)
29,800
Goodwill
2,814
270
3,084
Total assets purchased
57,720
422
58,142
Long-term debt including current portions and finance leases
183
556
739
Accounts payable, accrued expenses and other accrued
 
liabilities
3,482
—
3,482
Total liabilities assumed
3,665
556
4,221
Total consideration
 
paid for Coral
54,055
(134)
53,921
Less: estimated purchase price settlement
—
(134)
(134)
Less: cash acquired
958
—
958
Net cash paid for Coral
$
53,097
$
—
$
53,097
(1) As previously disclosed in the Company’s
 
2020 Form 10-K
.
Measurement period adjustments recorded during the first
 
six months of 2021 include certain adjustments related
 
to refining
original estimates for assets and liabilities for certain
 
acquired finance leases, as well the adjustment to reflect the expected
 
settlement
of post-closing working capital and net indebtedness true
 
ups to the original purchase price.
 
As of June 30, 2021,
 
the allocation of the
purchase price for Coral has not been finalized and the
one year
 
measurement period has not ended.
 
Further adjustments may be
necessary as a result of the Company’s
 
on-going assessment of additional information related to the
 
fair value of assets acquired and
liabilities assumed.
 
In May 2020, the Company acquired Tel
 
Nordic ApS (“TEL”), a company that specializes in lubricants and engineering
 
primarily
in high pressure aluminum die casting for its Europe,
 
Middle East and Africa (“EMEA”) reportable segment.
 
Consideration paid was
in the form of a convertible promissory note in the amount
 
of
20.0
 
million DKK, or approximately $
2.9
 
million, which was
subsequently converted into shares of the Company’s
 
common stock.
 
An adjustment to the purchase price of approximately
0.4
million DKK, or less than $
0.1
 
million, was made as a result of finalizing a post-closing
 
settlement in the second quarter of 2020.
 
The
Company allocated approximately $
2.4
 
million of the purchase price to intangible assets to be amortized
 
over
17 years
.
 
In addition,
the Company recorded approximately $
0.5
 
million of goodwill, related to expected value not allocated to
 
other acquired assets, none
of which will be tax deductible.
 
As of June 30, 2021, the allocation of the purchase price of TEL
 
was finalized and the
one year
measurement period ended.
 
In March 2020, the Company acquired the remaining
49
% ownership interest in one of its South African affiliates,
 
Quaker
Chemical South Africa Limited (“QSA”) for
16.7
 
million ZAR, or approximately $
1.0
 
million, from its joint venture partner PQ
Holdings South Africa.
 
QSA is a part of the Company’s
 
Europe, Middle East and Africa (“EMEA”) reportable segment.
 
As this
acquisition was a change in an existing controlling ownership,
 
the Company recorded $
0.7
 
million of excess purchase price over the
carrying value of the noncontrolling interest in Capital in
 
excess of par value.
 
In October 2019, the Company completed its acquisition
 
of the operating divisions of Norman Hay plc (“Norman
 
Hay”), a private
U.K. company that provides specialty chemicals, operating
 
equipment, and services to industrial end markets.
 
The original purchase
price was
80.0
 
million GBP,
 
on a cash-free and debt-free basis, subject to routine
 
and customary post-closing adjustments related to
working capital and net indebtedness levels.
 
The Company finalized its post-closing adjustments for
 
the Norman Hay acquisition and
paid approximately
2.5
 
million GBP during the first quarter of 2020 to settle such adjustments.
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
9
Note 3 – Recently Issued Accounting Standards
 
Recently Issued Accounting Standards
 
Adopted
The Financial Accounting Standards Board (“FASB”)
 
issued Account Standards Update (“ASU”)
 
ASU 2019-12
, Income Taxes
(Topic
 
740): Simplifying the Accounting for Income Taxes
 
in December 2019 to simplify the accounting for income taxes.
 
The
guidance within this accounting standard update
 
removes certain exceptions, including the exception to the
 
incremental approach for
certain intra-period tax allocations, to the requirement
 
to recognize or not recognize certain deferred tax liabilities for
 
equity method
investments and foreign subsidiaries, and to the general
 
methodology for calculating income taxes in an interim period
 
when a year-to-
date loss exceeds the anticipated loss for the year.
 
Further, the guidance simplifies the accounting
 
related to franchise taxes, the step
up in tax basis for goodwill, current and deferred tax
 
expense, and codification improvements for income taxes related
 
to employee
stock ownership plans.
 
The guidance is effective for annual and interim
 
periods beginning after December 15, 2020.
 
The Company
adopted this standard on a prospective basis, effective
 
January 1, 2021.
 
There was no cumulative effect of adoption recorded
 
within
retained earnings on January 1, 2021.
The FASB issued
 
ASU 2020-04,
Reference Rate Reform (Topic
 
848): Facilitation of the Effects of Reference Rate
 
Reform on
Financial Reporting
 
in March 2020.
 
The FASB subsequently
 
issued ASU 2021-01,
Reference Rate Reform (Topic
 
848): Scope
 
in
January 2021 which clarified the guidance but did
 
not materially change the guidance or its applicability to
 
the Company.
 
The
amendments provide temporary optional expedients and
 
exceptions for applying U.S. GAAP to contract modifications,
 
hedging
relationships and other transactions to ease the potential
 
accounting and financial reporting burden associated with transitioning
 
away
from reference rates that are expected to be discontinued,
 
including the London Interbank Offered Rate (“LI
 
BOR”).
 
ASU 2020-04 is
effective for the Company as of March 12,
 
2020 and generally can be applied through December 31, 2022.
 
As of June 30, 2021, the
expedients provided in ASU 2020-04 do not presently
 
impact the Company; however, the Company
 
will continue to monitor for
potential impacts on its consolidated financial statements.
Note 4 – Business Segments
The Company’s operating
 
segments, which are consistent with its reportable segments,
 
reflect the structure of the Company’s
internal organization, the method by which
 
the Company’s resources are allocated
 
and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
 
The Company has
four
 
reportable segments: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
The three geographic segments are composed of the net
 
sales and operations in
each respective region, excluding net sales and operations
 
managed globally by the Global Specialty Businesses segment, which
includes the Company’s
 
container, metal finishing, mining,
 
offshore, specialty coatings, specialty grease and
 
Norman Hay businesses.
Segment operating earnings for each of the Company’s
 
reportable segments are comprised of the segment’s
 
net sales less directly
related cost of goods sold (“COGS”) and selling, general
 
and administrative expenses (“SG&A”).
 
Operating expenses not directly
attributable to the net sales of each respective segment,
 
such as certain corporate and administrative costs, Combination, integration
and other acquisition-related expenses, and Restructuring and related
 
charges, are not included in segment operating
 
earnings.
 
Other
items not specifically identified with the Company’s
 
reportable segments include interest expense, net and other
 
income (expense),
net.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
10
The following table presents information about the performance
 
of the Company’s reportable segments
 
for the three and six
months ended June 30, 2021 and 2020.
 
Certain immaterial reclassifications within the segment disclosures
 
for the three and six
months ended June 30, 2020 have been made to conform
 
with the Company’s current customer
 
industry segmentation.
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Net sales
 
 
 
 
 
 
 
 
 
 
Americas
$
139,673
$
80,576
$
274,544
$
210,472
EMEA
 
123,436
 
77,702
 
243,250
 
182,541
Asia/Pacific
 
91,559
 
68,421
 
188,265
 
141,973
Global Specialty Businesses
 
80,594
 
59,341
 
158,986
 
129,615
Total net sales
$
435,262
$
286,040
$
865,045
$
664,601
Segment operating earnings
Americas
$
33,648
$
10,303
$
65,882
$
39,491
EMEA
23,405
10,471
48,649
28,830
Asia/Pacific
23,227
19,261
50,705
38,802
Global Specialty Businesses
 
24,209
 
16,393
 
48,378
 
36,953
Total segment operating
 
earnings
 
104,489
 
56,428
 
213,614
 
144,076
Combination, integration and other acquisition-related
 
expenses
(6,658)
(7,995)
(12,473)
(15,873)
Restructuring and related charges
(298)
(486)
(1,473)
(2,202)
Fair value step up of acquired inventory sold
 
—
(226)
(801)
(226)
Indefinite-lived intangible asset impairment
—
—
—
(38,000)
Non-operating and administrative expenses
(43,077)
(32,045)
(84,069)
(70,496)
Depreciation
 
of corporate assets and amortization
 
(15,640)
 
(13,438)
 
(31,088)
 
(27,485)
Operating income (loss)
 
38,816
2,238
83,710
(10,206)
Other income (expense), net
14,010
(993)
18,697
(22,168)
Interest expense, net
 
(5,618)
 
(6,811)
 
(11,088)
 
(15,272)
Income (loss) before taxes and equity in net income of
associated companies
$
47,208
$
(5,566)
$
91,319
$
(47,646)
Inter-segment revenues for the three and six months
 
ended June 30, 2021 were $
2.4
 
million and $
5.7
 
million for Americas, $
6.3
million and $
15.1
 
million for EMEA, $
0.4
 
million and $
0.5
 
million for Asia/Pacific, and $
2.1
 
million and $
4.1
 
million for Global
Specialty Businesses, respectively.
 
Inter-segment revenues for the three and six months
 
ended June 30, 2020 were $
2.4
 
million and
$
5.3
 
million for Americas, $
5.3
 
million and $
10.8
 
million for EMEA, $
0.1
 
million and $
0.3
 
million for Asia/Pacific, and $
1.0
 
million
and $
2.3
 
million for Global Specialty Businesses, respectively.
 
However, all inter-segment
 
transactions have been eliminated from
each reportable operating segment’s
 
net sales and earnings for all periods presented in the above
 
tables.
Note 5 – Net Sales and Revenue Recognition
Business Description
The Company develops, produces, and markets a broad
 
range of formulated chemical specialty products and offers
 
chemical
management services (“Fluidcare”) for various heavy
 
industrial and manufacturing applications throughout its four
 
segments.
 
A
significant portion of the Company’s
 
revenues are realized from the sale of process fluids and services
 
made directly to manufacturers
through its own employees and its Fluidcare programs,
 
with the balance being handled through distributors and
 
agents.
As part of the Company’s
 
Fluidcare business, certain third-party product sales to customers are
 
managed by the Company.
 
Where
the Company acts as a principal, revenues are recognized
 
on a gross reporting basis at the selling price negotiated with
 
its customers.
Where the Company acts as an agent, revenue is recognized on
 
a net reporting basis at the amount of the administrative fee earned
 
by
the Company for ordering the goods.
 
The Company transferred third-party products under arrangements recognized
 
on a net reporting
basis of $
16.7
 
million and $
34.5
 
million for the three and six months ended June 30, 2021, respectively,
 
and $
6.2
 
million and $
18.7
million for the three and six months ended June 30,
 
2020, respectively.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
11
As previously disclosed in the Company’s
 
2020 Form 10-K, during 2020, the Company’s
 
five largest customers (each composed
of multiple subsidiaries or divisions with semiautonomous
 
purchasing authority) accounted for approximately
10
% of consolidated net
sales, with its largest customer accounting
 
for approximately
3
% of consolidated net sales.
 
Revenue Recognition Model
The Company applies the five-step model in the FASB’s
 
guidance, which requires the Company to: (i) identify
 
the contract with a
customer; (ii) identify the performance obligations in
 
the contract; (iii) determine the transaction price; (iv) allocate the
 
transaction
price to the performance obligations in the contract; and
 
(v) recognize revenue when, or as, the Company satisfies a performance
obligation.
 
Refer to the Company’s 2020
 
Form 10-K for additional information on the Company’s
 
revenue recognition policies,
including its practical expedients and accounting policy
 
elections.
 
Allowance for Doubtful Accounts
As previously disclosed in the Company’s
 
2020 Form 10-K, during 2020, the Company adopted, as required,
 
an accounting
standard update related to the accounting and disclosure
 
of credit losses effective January 1, 2020.
 
The Company recognizes an
allowance for credit losses, which represents the portion
 
of its trade accounts receivable that the Company does not expect
 
to collect
over the contractual life, considering past events and
 
reasonable and supportable forecasts of future economic conditions.
 
The
Company’s allowance
 
for credit losses on its trade accounts receivables is based on
 
specific collectability facts and circumstances for
each outstanding receivable and customer,
 
the aging of outstanding receivables, and the associated collection
 
risk the Company
estimates for certain past due aging categories, and
 
also, the general risk to all outstanding accounts receivable based on historical
amounts determined to be uncollectible.
 
The Company does not have any off-balance-sheet
 
credit exposure related to its customers.
Contract Assets and Liabilities
The Company recognizes a contract asset or receivable
 
on its Condensed Consolidated Balance Sheet when the Company
performs a service or transfers a good in advance
 
of receiving consideration.
 
A receivable is the Company’s
 
right to consideration that
is unconditional and only the passage of time is required
 
before payment of that consideration is due.
 
A contract asset is the
Company’s right to consideration
 
in exchange for goods or services that the Company has transferred
 
to a customer.
 
The Company
had no material contract assets recorded on its Condensed
 
Consolidated Balance Sheets as of June 30, 2021 or December
 
31, 2020.
A contract liability is recognized when the Company
 
receives consideration, or if it has the unconditional right
 
to receive
consideration, in advance of performance.
 
A contract liability is the Company’s
 
obligation to transfer goods or services to a customer
for which the Company has received consideration,
 
or a specified amount of consideration is due, from the customer.
 
The Company’s
contract liabilities primarily represent deferred revenue
 
recorded for customer payments received by the Company
 
prior to the
Company satisfying the associated performance obligation.
 
Deferred revenues are presented within other current liabilities
 
in the
Company’s Condensed
 
Consolidated Balance Sheets.
 
The Company had approximately $
4.3
 
million and $
4.0
 
million of deferred
revenue as of June 30, 2021 and December 31, 2020,
 
respectively.
 
For the six months ended June 30, 2021, the Company satisfied
 
all
of the associated performance obligations and recognized
 
into revenue the advance payments received and recorded
 
as of December
31, 2020.
Disaggregated Revenue
The following tables disaggregate the Company’s
 
net sales by segment, geographic region, customer industry,
 
and timing of
revenue recognized for the three and six months ended
 
June 30, 2021 and 2020.
Three Months Ended June 30, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
51,799
$
35,634
$
48,207
$
135,640
Metalworking and other
87,874
87,802
43,352
219,028
139,673
123,436
91,559
354,668
Global Specialty Businesses
46,183
21,678
12,733
80,594
$
185,856
$
145,114
$
104,292
$
435,262
Timing of Revenue Recognized
Product sales at a point in time
$
177,227
$
137,838
$
101,264
$
416,329
Services transferred over time
8,629
7,276
3,028
18,933
$
185,856
$
145,114
$
104,292
$
435,262
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
12
 
Three Months Ended June 30, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
32,687
$
24,924
$
35,416
$
93,027
Metalworking and other
47,889
52,778
33,005
133,672
80,576
77,702
68,421
226,699
Global Specialty Businesses
32,294
15,569
11,478
59,341
$
112,870
$
93,271
$
79,899
$
286,040
Timing of Revenue Recognized
Product sales at a point in time
$
108,644
$
87,995
$
78,195
$
274,834
Services transferred over time
4,226
5,276
1,704
11,206
$
112,870
$
93,271
$
79,899
$
286,040
 
Six Months Ended June 30, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
98,592
$
69,908
$
97,950
$
266,450
Metalworking and other
175,952
173,342
90,315
439,609
274,544
243,250
188,265
706,059
Global Specialty Businesses
91,439
41,950
25,597
158,986
$
365,983
$
285,200
$
213,862
$
865,045
Timing of Revenue Recognized
Product sales at a point in time
$
348,821
$
269,000
$
207,663
$
825,484
Services transferred over time
17,162
16,200
6,199
39,561
$
365,983
$
285,200
$
213,862
$
865,045
 
Six Months Ended June 30, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
79,360
$
54,812
$
77,005
$
211,177
Metalworking and other
131,112
127,729
64,968
323,809
210,472
182,541
141,973
534,986
Global Specialty Businesses
76,525
32,174
20,916
129,615
$
286,997
$
214,715
$
162,889
$
664,601
Timing of Revenue Recognized
Product sales at a point in time
$
277,446
$
206,418
$
159,351
$
643,215
Services transferred over time
9,551
8,297
3,538
21,386
$
286,997
$
214,715
$
162,889
$
664,601
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
13
Note 6 – Leases
The Company determines if an arrangement is a lease
 
at its inception.
 
This determination generally depends on whether the
arrangement conveys the right to control the use of an
 
identified fixed asset explicitly or implicitly for a period of
 
time in exchange for
consideration.
 
Control of an underlying asset is conveyed if the Company
 
obtains the rights to direct the use of, and obtains
substantially all of the economic benefits from the use
 
of, the underlying asset.
 
Lease expense for variable leases and short-term
leases is recognized when the obligation is incurred.
 
The Company has operating leases for certain facilities, vehicles
 
and machinery and equipment with remaining lease terms up
 
to
10 years
.
 
In addition, the Company has certain land use leases with remaining
 
lease terms up to
94 years
.
 
The lease term for all of the
Company’s leases includes
 
the non-cancellable period of the lease plus any additional periods
 
covered by an option to extend the lease
that the Company is reasonably certain it will exercise.
 
Operating leases are included in right of use lease assets
, other current
liabilities and long-term lease liabilities
 
on the Condensed Consolidated Balance Sheet.
 
Right of use lease assets and liabilities are
recognized at each lease’s
 
commencement date based on the present value of its lease payments
 
over its respective lease term.
 
The
Company uses the stated borrowing rate for a lease when
 
readily determinable.
 
When a stated borrowing rate is not available in a
lease agreement, the Company uses its incremental borrowing
 
rate based on information available at the lease’s
 
commencement date
to determine the present value of its lease payments.
 
In determining the incremental borrowing rate used to present
 
value each of its
leases, the Company considers certain information
 
including fully secured borrowing rates readily available to the Company
 
and its
subsidiaries.
 
The Company has immaterial finance leases, which are
 
included in property, plant
 
and equipment, current portion of
long-term debt and long-term debt on the Condensed Consolidated
 
Balance Sheet.
Operating lease expense is recognized on a straight-line
 
basis over the lease term.
 
Operating lease expense for the three and six
months ended June 30, 2021 was $
3.6
 
million and $
7.2
 
million, respectively.
 
Comparatively, operating
 
lease expense for the three
and six months ended June 30, 2020 was $
3.5
 
million and $
6.9
 
million, respectively.
 
Short-term lease expense for the three and six
months ended June 30, 2021 was $
0.2
 
million and $
0.5
 
million, respectively.
 
Comparatively, short-term
 
lease expense for the three
and six months ended June 30, 2020 was $
0.4
 
million and $
0.9
 
million, respectively.
 
The Company has
no
 
material variable lease
costs or sublease income for the three or six months ended
 
June 30, 2021 and 2020.
 
Cash paid for operating leases during the six months ended
 
June 30, 2021 and 2020 was $
7.1
 
million and $
6.8
 
million,
respectively.
 
The Company recorded new right of use lease assets and associated lease liabilities
 
of $
3.9
 
million during the six
months ended June 30, 2021.
 
Supplemental balance sheet information related to the Company’s
 
leases is as follows:
June 30,
December 31,
2021
2020
Right of use lease assets
$
36,160
$
38,507
Other current liabilities
10,064
10,901
Long-term lease liabilities
25,668
27,070
Total operating
 
lease liabilities
$
35,732
$
37,971
Weighted average
 
remaining lease term (years)
5.8
6.0
Weighted average
 
discount rate
4.26%
4.20%
Maturities of operating lease liabilities as of June 30,
 
2021 were as follows:
June 30,
2021
For the remainder of 2021
$
6,052
For the year ended December 31, 2022
9,400
For the year ended December 31, 2023
7,234
For the year ended December 31, 2024
5,355
For the year ended December 31, 2025
4,260
For the year ended December 31, 2026 and beyond
8,152
Total lease payments
40,453
Less: imputed interest
(4,721)
Present value of lease liabilities
$
35,732
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
14
Note 7 – Restructuring and Related Activities
The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost
synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated
severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain
manufacturing and non-manufacturing facilities. The exact timing and total costs associated with the QH Program will depend on a
number of factors and is subject to change; however, the Company currently expects reduction in headcount and site closures to
continue to occur throughout 2021 and into 2022 under the QH Program and estimates that anticipated cost synergies realized from the
QH Program will approximate one-times the restructuring costs incurred. Employee separation benefits will vary depending on local
regulations within certain foreign countries and will include severance and other benefits.
All costs incurred to date relate to severance costs to reduce
 
headcount as well as costs to close certain facilities and are
 
recorded
in Restructuring and related charges in the
 
Company’s Condensed Statements
 
of Operations.
 
As described in Note 4 of Notes to
Condensed Consolidated Financial Statements, restructuring
 
and related charges are not included in
 
the Company’s calculation of
reportable segments’ measure of operating earnings
 
and therefore these costs are not reviewed by or recorded to
 
reportable segments.
Activity in the Company’s
 
accrual for restructuring under the QH Program for the six months ended
 
June 30, 2021 is as follows:
QH Program
Accrued restructuring as of December 31,
 
2020
$
8,248
Restructuring and related charges
1,473
Cash payments
(4,214)
Currency translation adjustments
 
(229)
Accrued restructuring as of June 30, 2021
$
5,278
Note 8 – Share-Based Compensation
The Company recognized the following share-based compensation
 
expense in its Condensed Consolidated Statements of
Operations for the three and six months ended June 30, 2021
 
and 2020:
 
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Stock options
$
332
$
353
$
640
$
785
Non-vested stock awards and restricted stock units
1,290
1,259
2,686
2,523
Non-elective and elective 401(k) matching contribution in
 
stock
—
1,162
1,553
1,162
Director stock ownership plan
216
54
419
94
Performance stock units
517
280
836
280
Annual incentive plan
—
(117)
—
2,829
Total share-based
 
compensation expense
$
2,355
$
2,991
$
6,134
$
7,673
Share-based compensation expense is recorded in SG&A,
 
except for $
0.2
 
million and $
0.5
 
million for the three and six months
ended June 30, 2021, respectively,
 
and $
0.3
 
million and $
0.8
 
million for the three and six months ended June 30, 2020, respectively,
recorded within Combination, integration
 
and other acquisition-related expenses.
Stock Options
 
During the first six months of 2021, the Company granted
 
stock options under its long-term incentive plan (“LTIP”)
 
that are
subject only to time-based vesting over a
three
 
year period.
 
For the purposes of determining the fair value of stock
 
option awards, the
Company used a Black-Scholes option pricing model and
 
which primarily used the assumptions set forth in the table below:
Number of options granted
25,250
Dividend yield
0.85
%
Expected volatility
37.33
%
Risk-free interest rate
0.60
%
Expected term (years)
4.0
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
15
The fair value of these options is amortized on a straight
 
-line basis over the vesting period.
 
As of June 30, 2021,
 
unrecognized
compensation expense related to all stock options
 
granted was $
2.4
 
million, to be recognized over a weighted average remaining
period of
2.3
 
years.
 
Restricted Stock Awards
 
and Restricted Stock Units
 
During the six months ended June 30, 2021, the Company
 
granted
17,692
 
non-vested restricted shares and
2,791
 
non-vested
restricted stock units under its LTIP,
 
which are subject to time-based vesting, generally over a
three year
 
period.
 
The fair value of
these grants is based on the trading price of the Company’s
 
common stock on the date of grant.
 
The Company adjusts the grant date
fair value of these awards for expected forfeitures based
 
on historical experience.
 
As of June 30, 2021, unrecognized compensation
expense related to the non-vested restricted shares was $
6.3
 
million, to be recognized over a weighted average remaining
 
period of
1.9
years, and unrecognized compensation expense
 
related to non-vested restricted stock units was $
1.1
 
million, to be recognized over a
weighted average remaining period of
2.1
 
years.
Performance Stock Units
During the first six months of 2021, the Company granted
 
performance-dependent stock awards (“PSUs”) as a component of
 
its
LTIP,
 
which will be settled in a certain number of shares subject to market
 
-based and time-based vesting conditions.
 
The number of
fully vested shares that may ultimately be issued as settlement
 
for each award may range from
0
% up to
200
% of the target award,
subject to the achievement of the Company’s
 
total shareholder return (“TSR”) relative to the performance
 
of the Company’s peer
group, the S&P Midcap 400 Materials group.
 
The service period required for the PSUs is three years and the
 
TSR measurement
period for the PSUs is from January 1 of the year of grant
 
through December 31 of the year prior to issuance of the shares upon
settlement.
Compensation expense for PSUs is measured based on
 
their grant date fair value and is recognized on a straight-line basis over
the
three year
 
vesting period.
 
The grant-date fair value of the PSUs granted during
 
the first six months of 2021 was estimated using a
Monte Carlo simulation on the grant date and using the
 
following assumptions: (i) a risk-free rate of
0.29
%; (ii) an expected term of
3.0
 
years; and (iii) a three year daily historical volatility for each of
 
the companies in the peer group, including Quaker Houghton.
 
As of June 30, 2021, the Company estimates that it will issue
 
approximately
14,698
 
fully vested shares as of the applicable
settlement date of all outstanding PSUs awards based on
 
the conditions of the PSUs and performance to date for
 
each award.
 
As of
June 30, 2021, there was approximately $
4.2
 
million of total unrecognized compensation cost related to PSUs, which
 
the Company
expects to recognize over a weighted-average period
 
of
2.3
 
years.
Annual Incentive Plan
The Company maintains an Annual Incentive Plan
 
(“AIP”), which may be settled in cash or a certain number of
 
shares subject to
performance-based and time-based vesting conditions.
 
As of June 30, 2020, it was the Company’s
 
intention to settle the 2020 AIP in
shares, and therefore, expense associated with the AIP in
 
2020 was recorded as a component of share-based compensation
 
expense.
 
In
the fourth quarter of 2020, the Company determined that it
 
would settle the 2020 AIP in cash.
 
Therefore, the share-based
compensation associated with the AIP during the year
 
ended December 31, 2020 was reclassified from a component
 
of share-based
compensation expense to incentive compensation.
 
This determination and conclusion had no impact on the
 
classification of AIP
expense within the Company’s
 
Condensed Consolidated Statement of Operations for
 
the periods as both are a component of SG&A.
 
As of June 30, 2021, it is the Company’s
 
intention to settle the 2021 AIP in cash.
 
Defined Contribution Plan
 
The Company has a 401(k) plan with an employer
 
match covering a majority of its U.S. employees.
 
The Company matches
50
%
of the first
6
% of compensation that is contributed to the plan, with a maximum
 
matching contribution of
3
% of compensation.
 
Additionally, the
 
plan provides for non-elective nondiscretionary contributions
 
on behalf of participants who have completed one year
of service equal to
3
% of the eligible participants’ compensation.
 
Beginning in April 2020 and continuing through March 2021,
 
the
Company matched both non-elective and elective 401(k)
 
contributions in fully vested shares of the Company’s
 
common stock rather
than cash.
 
For the three months ended June 30, 2021, there were
no
 
matching contributions in stock.
 
For the six months ended June
30, 2021, total contributions were $
1.5
 
million and for both the three and six months ended June 30, 2020,
 
total contributions were
$
1.2
 
million.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
16
Note 9 – Pension and Other Postretirement
 
Benefits
The components of net periodic benefit cost for the
 
three and six months ended June 30, 2021 and 2020 are as follows:
Three Months Ended June 30,
 
Six Months Ended June 30,
 
Other
Other
Postretirement
Postretirement
Pension Benefits
Benefits
Pension Benefits
Benefits
2021
2020
2021
2020
2021
2020
2021
2020
Service cost
$
316
$
1,164
$
2
$
1
$
632
$
2,338
$
3
$
3
Interest cost
1,094
1,486
10
26
2,184
3,255
21
52
Expected return on plan assets
(2,093)
(1,761)
—
—
(4,175)
(3,720)
—
—
Settlement charge
—
—
—
—
—
22,667
—
—
Actuarial loss amortization
857
615
—
16
1,712
1,662
—
31
Prior service cost amortization
3
(41)
—
—
5
(81)
—
—
Net periodic benefit cost
$
177
$
1,463
$
12
$
43
$
358
$
26,121
$
24
$
86
As disclosed in the Company’s
 
2020 Form 10-K, in the fourth quarter of 2018, the
 
Company began the process of terminating its
legacy Quaker non-contributory U.S. pension plan
 
(“Legacy Quaker U.S. Pension Plan”).
 
During the third quarter of 2019, the
Company received a favorable termination determination
 
letter from the Internal Revenue Service (“I.R.S.”) and completed the
Legacy Quaker U.S. Pension Plan termination during the
 
first quarter of 2020.
 
In order to terminate the Legacy Quaker U.S. Pension
Plan in accordance with I.R.S. and Pension Benefit Guaranty Corporation
 
requirements, the Company was required to fully fund the
Legacy Quaker U.S. Pension Plan on a termination basis
 
and the amount necessary to do so was approximately $
1.8
 
million, subject to
final true up adjustments,
 
which were completed in the third quarter of 2020.
 
In addition, the Company recorded a non-cash pension
settlement charge at plan termination of
 
approximately $
22.7
 
million.
 
This settlement charge included the immediate recognition
 
into
expense of the related unrecognized losses within accumulated
 
other comprehensive (loss) income (“AOCI”) on the balance
 
sheet as
of the plan termination date.
 
Employer Contributions
As of June 30, 2021, $
2.1
 
million and $
0.1
 
million of contributions have been made to the Company’s
 
U.S. and foreign pension
plans and its other postretirement benefit plans, respectively
 
.
 
Taking into consideration
 
current minimum cash contribution
requirements, the Company currently expects to make
 
full year cash contributions of approximately $
6
 
million to its U.S. and foreign
pension plans and less than $
1
 
million to its other postretirement benefit plans in 2021
.
Note 10 – Other Income (Expense), Net
 
The components of other income (expense), net, for
 
the three and six months ended June 30, 2021 and 2020 are as follows:
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Income from third party license fees
$
373
$
208
$
712
$
512
Foreign exchange losses, net
(838)
(2,004)
(2,316)
(1,183)
Gain (loss) on disposals of property,
 
plant, equipment and other
assets, net
(54)
(83)
5,356
(81)
Non-income tax refunds and other related credits
14,295
832
14,392
2,131
Pension and postretirement benefit income (costs),
 
non-service components
129
(341)
253
(23,866)
Other non-operating income, net
105
395
300
319
Total other
 
income (expense), net
$
14,010
$
(993)
$
18,697
$
(22,168)
The Gain (loss) on disposals of property,
 
plant, equipment and other assets, net, during the six months
 
ended June 30, 2021,
includes the gain on the sale of certain held-for-sale
 
real property assets related to the Combination.
 
Non-income tax refunds and
other related credits during the three and six months ended
 
June 30, 2021 includes $
13.3
 
million related to certain non-income tax
credits for the Company’s
 
Brazilian subsidiaries described in Note 19 of Notes
 
to Condensed Consolidated Financial Statements.
 
Pension and postretirement benefit costs, non-service components
 
during the six months ended June 30, 2020 includes
 
$
22.7
 
million
related to the Legacy Quaker U.S. Pension Plan non
 
-cash settlement charge described in Note 9 of Notes to
 
Condensed Consolidated
Financial Statements.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
17
Note 11 – Income Taxes
 
and Uncertain Income Tax
 
Positions
The Company’s effective
 
tax rates for the three and six months ended June 30, 2021 were
 
an expense of
32.2
% and
28.4
%,
respectively, compared
 
to an expense of
57.9
% and a benefit of
20.7
% for the three and six months ended June 30, 2020, respectively.
 
The Company’s current
 
year effective tax rates were largely
 
impacted by the sale of certain held-for-sale real
 
property assets related to
the Combination,
 
changes in foreign tax credit valuation allowances, tax law changes
 
in a foreign jurisdiction and the income tax
impacts of certain non-income tax credits recorded
 
by the Company’s Brazilian
 
subsidiaries described in Note 19 of Notes to
Condensed Consolidated Financial Statements.
 
Comparatively, the prior
 
year effective tax rates were impacted by the
 
tax effect of
certain one-time pre-tax losses as well as certain tax charges
 
and benefits in the prior year period including those related
 
to changes in
foreign tax credit valuation allowances, tax law changes in
 
a foreign jurisdiction, changes in uncertain tax positions and
 
the tax
impacts of the Company’s
 
termination of its Legacy Quaker U.S. Pension Plan.
As of December 31, 2020, the Company had a deferred
 
tax liability of $
5.9
 
million, which primarily represents the Company’s
estimate of non-U.S. taxes it will incur to repatriate
 
certain foreign earnings to the U.S.
 
The balance as of June 30, 2021 was $
6.5
million.
 
As of June 30, 2021, the Company’s
 
cumulative liability for gross unrecognized tax benefits was $
24.0
 
million, an increase of
$
1.8
 
million from the cumulative liability accrued as of December 31, 2020.
 
The Company continues to recognize interest and penalties
 
associated with uncertain tax positions as a component of
 
taxes on
income (loss) before equity in net income of associated
 
companies in its Condensed Consolidated Statements of Operations.
 
The
Company recognized an expense for interest of approximately
 
$
0.2
 
million and $
0.2
 
million and a benefit of less than $
0.1
 
million and
$
0.2
 
million for penalties in its Condensed Consolidated Statement of
 
Operations for the three and six months ended June 30, 2021,
respectively, and recognized
 
an expense of $
0.6
 
million and $
0.6
 
million for interest and an expense of $
0.6
 
million and $
0.5
 
million
for penalties in its Condensed Consolidated Statement of
 
Operations for the three and six months ended June 30, 2020
 
,
 
respectively.
 
As of June 30, 2021, the Company had accrued $
3.2
 
million for cumulative interest and $
3.6
 
million for cumulative penalties in its
Condensed Consolidated Balance Sheets, compared
 
to $
3.0
 
million for cumulative interest and $
3.9
 
million for cumulative penalties
accrued at December 31, 2020.
 
During the six months ended June 30, 2021 and 2020, the
 
Company recognized decreases of $
0.8
million and $
1.5
 
million, respectively,
 
in its cumulative liability for gross unrecognized tax benefits
 
due to the expiration of the
applicable statutes of limitations for certain tax years.
The Company estimates that during the year ending December
 
31, 2021 it will reduce its cumulative liability for gross
unrecognized tax benefits by approximately $
1.5
 
million due to the expiration of the statute of limitations with regard
 
to certain tax
positions.
 
This estimated reduction in the cumulative liability for unrecognized
 
tax benefits does not consider any increase in liability
for unrecognized tax benefits with regard to existing tax
 
positions or any increase in cumulative liability for unrecognized
 
tax benefits
with regard to new tax positions for the year ending December
 
31, 2021.
The Company and its subsidiaries are subject to U.S. Federal income
 
tax, as well as the income tax of various state and foreign
tax jurisdictions.
 
Tax years that remain
 
subject to examination by major tax jurisdictions include Italy
 
from
2006
, Brazil from
2011
,
the Netherlands and China from
2015
, Mexico, Spain, Germany and the United Kingdom from
2016
, Canada and the U.S. from
2017
,
India from fiscal year beginning April 1, 2018 and ending
 
March 31,
2019
, and various U.S. state tax jurisdictions from
2011
.
 
As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia
S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under
the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except
2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP
proceedings which the Company has accepted.
 
As of June 30, 2021, the Company has received $
1.6
 
million in refunds from the
Netherlands and Spain and expects to pay $
2.6
 
million due to Italy in the second half of 2021.
 
As of June 30, 2021, the Company
believes it has adequate reserves for the remaining
 
uncertain tax positions related to 2007.
Houghton Italia, S.r.l
 
is also involved in a corporate income tax audit with the Italian tax
 
authorities covering tax years
2014
through
2018
.
 
As of June 30, 2021, the Company has a $
5.6
 
million reserve for uncertain tax positions relating to matters related
 
to
this audit.
 
Since the reserve relates to the tax periods prior to August
 
1, 2019, the tax liability was established through purchase
accounting related to the Combination.
 
The Company has also submitted an indemnification claim against
 
funds held in escrow by
Houghton’s former owners
 
and as a result, a corresponding $
5.6
 
million indemnification receivable has also been established through
purchase accounting.
Houghton Deutschland GmbH is also under audit by
 
the German tax authorities for the tax years
2015
 
through
2017
.
 
Based on
preliminary audit findings, primarily related to
 
transfer pricing, the Company has recorded reserves for $
0.9
 
million as of June 30,
2021.
 
Of this amount, $
0.8
 
million relates to tax periods prior to the Combination and
 
therefore the Company has submitted an
indemnification claim with Houghton’s
 
former owners for any tax liabilities arising pre-Combination.
 
As a result, a corresponding
$
0.8
 
million indemnification receivable has also been established to
 
offset the $
0.8
 
million tax liability.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
18
Note 12 – Earnings Per Share
The following table summarizes earnings per share calculations
 
for the three and six months ended June 30, 2021 and 2020:
Three Months Ended
 
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Basic earnings (loss) per common share
 
 
 
Net income (loss) attributable to Quaker Chemical Corporation
$
 
33,570
$
(7,735)
$
 
72,185
$
(36,116)
Less: (income) loss allocated to participating securities
 
(134)
 
37
 
(287)
 
146
Net income (loss) available to common shareholders
$
 
33,436
$
(7,698)
$
 
71,898
$
(35,970)
Basic weighted average common shares outstanding
17,802,366
17,697,496
17,793,915
17,685,010
Basic earnings (loss) per common share
$
1.88
$
(0.43)
$
4.04
$
(2.03)
Diluted earnings (loss) per common share
Net income (loss) attributable to Quaker Chemical Corporation
$
33,570
$
(7,735)
$
 
72,185
$
(36,116)
Less: (income) loss allocated to participating securities
(134)
 
37
 
(287)
 
146
Net income (loss) available to common shareholders
$
33,436
$
(7,698)
$
71,898
$
(35,970)
Basic weighted average common shares outstanding
17,802,366
17,697,496
17,793,915
17,685,010
Effect of dilutive securities
47,155
—
52,095
—
Diluted weighted average common shares outstanding
17,849,521
17,697,496
17,846,010
17,685,010
Diluted earnings (loss) per common share
$
1.88
$
(0.43)
$
4.03
$
(2.03)
Certain stock options and restricted stock units are not included
 
in the diluted earnings (loss) per share calculation when
 
the effect
would have been anti-dilutive.
 
The calculated amount of anti-diluted shares not included
 
was
6,793
 
and
2,952
 
for the three and six
months ended June 30, 2021,
 
respectively.
 
All of the Company’s potentially
 
dilutive shares for the three and six months ended June
30, 2020 are anti-dilutive and not included in the dilutive
 
loss per share calculations because of the Company’s
 
net loss during the
periods.
Note 13 – Restricted Cash
Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary
of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an
original total value of $35.0 million.
 
The proceeds of both settlements were restricted and could
 
only be used to pay claims and costs
of defense associated with the subsidiary’s
 
asbestos litigation.
 
The proceeds of the settlement and release agreements
 
were deposited
into interest bearing accounts that earned less than
 
$
0.1
 
million offset by $
0.5
 
million of net payments during the six months ended
June 30, 2020.
 
Due to the restricted nature of the proceeds, a corresponding deferred
 
credit was established in other non-current
liabilities for an equal and offsetting amount
 
that continued until the restrictions lapsed.
 
As disclosed in the Company’s
 
2020 Form
10-K, during December 2020, the restrictions ended
 
on these previously received insurance settlements and the
 
Company transferred
the cash into an operating account.
The following table provides a reconciliation of cash,
 
cash equivalents and restricted cash as of June 30, 2021 and 2020
 
,
 
as well
as December 31, 2020 and 2019:
June 30,
 
December 31,
2021
2020
2020
2019
Cash and cash equivalents
$
145,610
$
322,497
$
181,833
$
123,524
Restricted cash included in other current assets
—
85
62
353
Restricted cash included in other assets
—
19,173
—
19,678
Cash, cash equivalents and restricted cash
$
145,610
$
341,755
$
181,895
$
143,555
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
19
Note 14 – Goodwill and Other Intangible Assets
Changes in the carrying amount of goodwill for the
 
six months ended June 30, 2021 were as follows:
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2020
$
213,242
$
140,162
$
158,090
$
119,718
 
$
631,212
Goodwill additions
1,208
2,626
1,308
128
5,270
Currency translation and other adjustments
 
614
(2,633)
1,127
(2,141)
(3,033)
Balance as of June 30, 2021
$
215,064
$
140,155
$
160,525
$
117,705
 
$
633,449
Gross carrying amounts and accumulated amortization
 
for definite-lived intangible assets as of June 30, 2021 and December
 
31,
2020 were as follows:
Gross Carrying
Accumulated
Amount
Amortization
2021
2020
2021
2020
Customer lists and rights to sell
$
858,025
 
$
839,551
 
$
127,883
 
$
99,806
Trademarks, formulations and product
 
technology
 
168,004
 
 
166,448
 
 
34,932
 
 
30,483
Other
 
6,390
 
 
6,372
 
 
5,909
 
 
5,824
Total definite
 
-lived intangible assets
$
1,032,419
 
$
1,012,371
 
$
168,724
 
$
136,113
The Company amortizes definite-lived intangible assets on
 
a straight-line basis over their useful lives.
 
The Company recorded
$
15.0
 
million and $
29.8
 
million of amortization expense for the three and six months
 
ended June 30, 2021, respectively.
 
Comparatively,
 
the Company recorded $
13.7
 
million and $
27.7
 
million of amortization expense for the three and six months ended
June 30, 2020, respectively.
 
Estimated annual aggregate amortization expense for
 
the current year and subsequent five years is as follows:
For the year ended December 31, 2021
$
59,214
For the year ended December 31, 2022
59,564
For the year ended December 31, 2023
59,394
For the year ended December 31, 2024
58,750
For the year ended December 31, 2025
58,037
For the year ended December 31, 2026
57,740
The Company has four indefinite-lived intangible
 
assets totaling $
205.1
 
million as of both June 30, 2021 and December 31, 2020,
including $
204.0
 
million of indefinite-lived intangible assets for trademarks and
 
tradename associated with the Combination.
Goodwill and intangible assets that have indefinite lives are
 
not amortized and are required to be assessed at least annually
 
for
impairment.
 
The Company completes its annual goodwill and indefinite-lived
 
intangible asset impairment test during the fourth
quarter of each year.
 
The Company continuously evaluates if triggering events indicate
 
a possible impairment in one or more of its
reporting units or indefinite-lived or long-lived assets.
The Company previously disclosed in its 2020 Form 10-K
 
that as of March 31, 2020, the Company concluded that the
 
impact of
COVID-19 did not represent a triggering event with
 
regards to the Company’s
 
reporting units or indefinite-lived and long-lived assets,
except for the Company’s
 
Houghton and Fluidcare trademarks and tradename indefinite
 
-lived intangible assets.
 
The determination of
estimated fair value of the Houghton and Fluidcare
 
trademarks and tradename indefinite-lived assets was based on a relief
 
from
royalty valuation method, which requires management’s
 
judgment and often involves the use of significant estimates and assumptions,
including assumptions with respect to the weighted average
 
cost of capital (“WACC”)
 
and royalty rates, as well as revenue growth
rates and terminal growth rates.
 
In the first quarter of 2020, as a result of the impact of
 
COVID-19 driving a decrease in projected
legacy Houghton net sales during that year and the impact
 
of the sales decline on projected future legacy Houghton
 
net sales as well as
an increase in the WACC
 
assumption utilized in the quantitative impairment
 
assessment, the Company concluded that the estimated
fair values of the Houghton and Fluidcare trademarks
 
and tradename intangible assets were less than their carrying values.
 
As a
result, an impairment charge of $
38.0
 
million was recorded in the first quarter of 2020 to write down
 
the carrying values of these
intangible assets to their estimated fair values.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
20
As of June 30, 2021, the Company continued to evaluate all
 
potential triggering events, including the on-going impact
 
of COVID-
19 on the Company’s
 
operations, and the volatility and uncertainty in the economic outlook
 
as a result of COVID-19, to determine if
this indicated it was more likely than not that the carrying
 
value of any of the Company’s
 
reporting units or indefinite-lived or long-
lived intangible assets were not recoverable.
 
The Company concluded that the impact of COVID-19 did not
 
represent a triggering
event as of June 30, 2021.
 
While the Company concluded that the impact of COVID-19 did not
 
represent a triggering event as of June
30, 2021, the Company will continue to evaluate the
 
impact of COVID-19 on the Company’s
 
current and projected results. If the
current economic conditions worsen or projections
 
of the timeline for recovery are significantly extended, then
 
the Company may
conclude in the future that the impact from COVID-19 requires
 
the need to perform further interim quantitative impairment tests,
which could result in additional impairment charges
 
in the future.
Note 15 – Debt
 
Debt as of June 30, 2021 and December 31, 2020
 
includes the following:
As of June 30, 2021
As of December 31, 2020
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.59%
$
189,503
1.65%
$
160,000
U.S. Term Loan
1.59%
555,000
1.65%
570,000
EURO Term Loan
1.50%
148,115
1.50%
157,062
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
2,165
Various
2,072
Total debt
$
904,783
$
899,134
Less: debt issuance costs
(9,550)
(11,099)
Less: short-term and current portion of long-term debts
(48,079)
(38,967)
Total long
 
-term debt
$
847,154
$
849,068
Credit facilities
The Company’s primary
 
credit facility (as amended, the “Credit Facility”) is comprised
 
of a $
400.0
 
million multicurrency
revolver (the “Revolver”), a $
600.0
 
million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower,
 
and a $
150.0
million (as of August 1, 2019) Euro equivalent term loan (the
 
“EURO Term Loan”
 
and together with the “U.S. Term
 
Loan”, the
“Term Loans”)
 
with Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower,
 
each with a
five year
 
term maturing in
August 2024.
 
Subject to the consent of the administrative
 
agent and certain other conditions, the Company may designate additional
borrowers.
 
The maximum amount available under the Credit Facility can be
 
increased by up to $
300.0
 
million at the Company’s
request if there are lenders who agree to accept additional
 
commitments and the Company has satisfied certain other
 
conditions.
 
Borrowings under the Credit Facility bear interest at a base
 
rate or LIBOR plus an applicable margin based upon
 
the Company’s
consolidated net leverage ratio.
 
There are LIBOR replacement provisions that contemplate a further
 
amendment if and when LIBOR
ceases to be reported.
 
The variable interest rate incurred on the outstanding borrowings under
 
the Credit Facility as of and during the
six months ended June 30, 2021 was approximately
1.6
%.
 
In addition to paying interest on outstanding principal under
 
the Credit
Facility, the Company
 
is required to pay a commitment fee ranging from
0.2
% to
0.3
% depending on the Company’s
 
consolidated net
leverage ratio to the lenders under the Revolver in
 
respect of the unutilized commitments thereunder.
 
The Company has unused
capacity under the Revolver of approximately $
206
 
million, net of bank letters of credit of approximately $
4
 
million, as of June 30,
2021.
 
The Credit Facility is subject to certain financial and other covenants. The Company’s initial consolidated net debt to
consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit
Facility.
 
As of June 30, 2021, the consolidated net debt to adjusted
 
EBITDA may not exceed
4.00
 
to 1.
 
The Company’s consolidated
adjusted EBITDA to interest expense ratio cannot
 
be less than
3.0
 
to 1 over the term of the agreement.
 
The Credit Facility also
prohibits the payment of cash dividends if the Company
 
is in default or if the amount of the dividend paid annually
 
exceeds the greater
of $
50.0
 
million and
20
% of consolidated adjusted EBITDA unless the ratio of consolidated
 
net debt to consolidated adjusted
EBITDA is less than
2.0
 
to 1, in which case there is no such limitation on amount.
 
As of June 30, 2021 and December 31, 2020, the
Company was in compliance with all of the Credit Facility covenants.
 
The Term Loans have
 
quarterly principal amortization during
their
five year
 
terms, with
5.0
% amortization of the principal balance due in years
 
1 and 2,
7.5
% in year 3, and
10.0
% in years 4 and 5,
with the remaining principal amount due at maturity.
 
During the six months ended June 30, 2021, the Company made
 
quarterly
amortization payments related to the Term
 
Loans totaling $
19.1
 
million.
 
The Credit Facility is guaranteed by certain of the
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
21
Company’s domestic subsidiaries
 
and is secured by first priority liens on substantially all of
 
the assets of the Company and the
domestic subsidiary guarantors, subject to certain customary exclusions.
 
The obligations of the Dutch borrower are guaranteed only
by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable
 
interest rates on at least
20
% of its total Term Loans.
 
In order to
satisfy this requirement as well as to manage the
 
Company’s exposure to variable
 
interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $
170.0
 
million notional amounts of three year interest rate swaps at a base
 
rate of
1.64
%
plus an applicable margin as provided in the
 
Credit Facility, based on
 
the Company’s consolidated net
 
leverage ratio.
 
At the time the
Company entered into the swaps, and as of June 30,
 
2021, the aggregate interest rate on the swaps, including the
 
fixed base rate plus
an applicable margin, was
3.1
%.
 
See Note 18 of Notes to Condensed Consolidated Financial Statements.
The Company capitalized $
23.7
 
million of certain third-party debt issuance costs in connection
 
with executing the Credit Facility.
 
Approximately $
15.5
 
million of the capitalized costs were attributed to the Term
 
Loans and recorded as a direct reduction of long-
term debt on the Company’s
 
Condensed Consolidated Balance Sheet.
 
Approximately $
8.3
 
million of the capitalized costs were
attributed to the Revolver and recorded within other assets on
 
the Company’s Condensed Consolidated
 
Balance Sheet.
 
These
capitalized costs are being amortized into interest expense
 
over the five year term of the Credit Facility.
 
As of June 30, 2021 and
December 31, 2020, the Company had $
9.6
 
million and $
11.1
 
million, respectively,
 
of debt issuance costs recorded as a reduction of
long-term debt.
 
As of June 30, 2021 and December 31, 2020, the Company
 
had $
5.1
 
million and $
5.9
 
million, respectively, of
 
debt
issuance costs recorded within other assets.
 
Industrial development bonds
As of June 30, 2021 and December 31, 2020, the Company
 
had fixed rate, industrial development authority bonds totaling
 
$
10.0
million in principal amount due in
2028
.
 
These bonds have similar covenants to the Credit Facility noted above.
Bank lines of credit and other
 
debt obligations
The Company has certain unsecured bank lines of credit
 
and discounting facilities in one of its foreign subsidiaries, which
 
are not
collateralized.
 
The Company’s other debt
 
obligations primarily consist of certain domestic and foreign
 
low interest rate or interest-
free municipality-related loans, local credit facilities of
 
certain foreign subsidiaries and capital lease obligations.
 
Total unused
capacity under these arrangements as of June 30, 2021
 
was approximately $
40
 
million.
In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s only other off-balance
sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees
outstanding as of June 30, 2021 were approximately $7 million.
The Company incurred the following debt related expenses
 
included within Interest expense, net, in the Condensed
 
Consolidated
Statements of Operations:
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Interest expense
$
4,813
$
5,951
$
9,463
$
13,663
Amortization of debt issuance costs
1,188
1,188
2,375
2,375
Total
$
6,001
$
7,139
$
11,838
$
16,038
Based on the variable interest rates associated with the Credit
 
Facility, as of June
 
30, 2021 and December 31, 2020, the amounts
at which the Company’s
 
total debt were recorded are not materially different
 
from their fair market value.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
22
Note 16 – Equity
The following tables present the changes in equity,
 
net of tax, for the three and six months ended June 30, 2021
 
and 2020:
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at March 31, 2021
$
17,875
$
908,748
$
455,493
$
(53,228)
$
565
$
1,329,453
Net income
—
—
33,570
—
30
33,600
Amounts reported in other comprehensive
 
income
—
—
—
17,285
8
17,293
Dividends ($
0.395
 
per share)
—
—
(7,062)
—
—
(7,062)
Share issuance and equity-based
compensation plans
3
2,114
—
—
—
2,117
Balance at June 30, 2021
$
17,878
$
910,862
$
482,001
$
(35,943)
$
603
$
1,375,401
Balance at March 31, 2020
$
17,752
$
888,533
$
376,853
$
(121,524)
$
418
$
1,162,032
Net (loss) income
—
—
(7,735)
—
13
(7,722)
Amounts reported in other comprehensive
 
income
—
—
—
12,260
1
12,261
Dividends ($
0.385
 
per share)
—
—
(6,853)
—
—
(6,853)
Share issuance and equity-based
compensation plans
48
7,575
—
—
—
7,623
Balance at June 30, 2020
$
17,800
$
896,108
$
362,265
$
(109,264)
$
432
$
1,167,341
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
23
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at December 31, 2020
$
17,851
$
905,171
$
423,940
$
(26,598)
$
550
$
1,320,914
Net income
—
—
72,185
—
47
72,232
Amounts reported in other comprehensive
 
(loss) income
—
—
—
(9,345)
6
(9,339)
Dividends ($
0.790
 
per share)
—
—
(14,124)
—
—
(14,124)
Share issuance and equity-based
compensation plans
27
5,691
—
—
—
5,718
Balance at June 30, 2021
$
17,878
$
910,862
$
482,001
$
(35,943)
$
603
$
1,375,401
Balance at December 31, 2019
$
17,735
$
888,218
$
412,979
$
(78,170)
$
1,604
$
1,242,366
Cumulative effect of an accounting change
—
—
(911)
—
—
(911)
Balance at January 1, 2020
17,735
888,218
412,068
(78,170)
1,604
1,241,455
Net (loss) income
—
—
(36,116)
—
50
(36,066)
Amounts reported in other comprehensive
 
loss
—
—
—
(31,094)
(131)
(31,225)
Dividends ($
0.770
0 per share)
—
—
(13,687)
—
—
(13,687)
Acquisition of noncontrolling interest
—
(707)
—
—
(340)
(1,047)
Distributions to noncontrolling affiliate
shareholders
—
—
—
—
(751)
(751)
Share issuance and equity-based
compensation plans
65
8,597
—
—
—
8,662
Balance at June 30, 2020
$
17,800
$
896,108
$
362,265
$
(109,264)
$
432
$
1,167,341
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
24
The following tables show the reclassifications from and
 
resulting balances of AOCI for the three and six months ended
 
June 30,
2021 and 2020:
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
 
Translation
Pension
Available-for
 
-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at March 31, 2021
$
(28,334)
$
(22,175)
$
317
$
(3,036)
$
(53,228)
Other comprehensive income (loss) before
 
reclassifications
16,157
(260)
341
586
16,824
Amounts reclassified from AOCI
—
852
2
—
854
Related tax amounts
—
(195)
(64)
(134)
(393)
Balance at June 30, 2021
$
(12,177)
$
(21,778)
$
596
$
(2,584)
$
(35,943)
Balance at March 31, 2020
$
(99,187)
$
(17,576)
$
(460)
$
(4,301)
$
(121,524)
Other comprehensive income (loss) before
reclassifications
10,550
(336)
2,128
(144)
12,198
Amounts reclassified from AOCI
—
600
(93)
—
507
Related tax amounts
—
(51)
(427)
33
(445)
Balance at June 30, 2020
$
(88,637)
$
(17,363)
$
1,148
$
(4,412)
$
(109,264)
 
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
 
Translation
Pension
Available-for
 
-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at December 31, 2020
$
(2,875)
$
(23,467)
$
3,342
$
(3,598)
$
(26,598)
Other comprehensive (loss) income before
reclassifications
(9,302)
521
(404)
1,316
(7,869)
Amounts reclassified from AOCI
—
1,714
(3,083)
—
(1,369)
Related tax amounts
—
(546)
741
(302)
(107)
Balance at June 30, 2021
$
(12,177)
$
(21,778)
$
596
$
(2,584)
$
(35,943)
Balance at December 31, 2019
$
(44,568)
$
(34,533)
$
1,251
$
(320)
$
(78,170)
Other comprehensive (loss) income before
 
reclassifications
(44,069)
492
(8)
(5,315)
(48,900)
Amounts reclassified from AOCI
—
24,966
(125)
—
24,841
Related tax amounts
—
(8,288)
30
1,223
(7,035)
Balance at June 30, 2020
$
(88,637)
$
(17,363)
$
1,148
$
(4,412)
$
(109,264)
All reclassifications related to unrealized gain (loss) in
 
available-for-sale securities relate to the Company’s
 
equity interest in a
captive insurance company and are recorded in equity
 
in net income of associated companies.
 
The amounts reported in other
comprehensive income for noncontrolling interest are
 
related to currency translation adjustments.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
25
Note 17 – Fair Value
 
Measurements
 
The Company has valued its company-owned life insurance
 
policies at fair value.
 
These assets are subject to fair value
measurement as follows:
 
Fair Value
 
Measurements at June 30, 2021
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
$
2,137
$
—
$
2,137
$
—
Total
$
2,137
$
—
$
2,137
$
—
 
Fair Value
 
Measurements at December 31, 2020
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
1,961
$
—
$
1,961
$
—
Total
$
1,961
$
—
$
1,961
$
—
The fair values of Company-owned life insurance assets are based
 
on quotes for like instruments with similar credit ratings and
terms.
 
The Company did not hold any Level 3 investments as of June
 
30, 2021 or December 31, 2020, respectively,
 
so related
disclosures have not been included.
 
Note 18 – Hedging Activities
In order to satisfy certain requirements of the Credit
 
Facility as well as to manage the Company’s
 
exposure to variable interest
rate risk associated with the Credit Facility,
 
in November 2019, the Company entered into $
170.0
 
million notional amounts of
three
year
 
interest rate swaps.
 
See Note 15 of Notes to Condensed Consolidated Financial Statements.
 
These interest rate swaps are
designated as cash flow hedges and, as such, the contracts
 
are marked-to-market at each reporting date and any unrealized gains
 
or
losses are included in AOCI to the extent effective
 
and reclassified to interest expense in the period during which the
 
transaction
affects earnings or it becomes probable that
 
the forecasted transaction will not occur.
 
The balance sheet classification and fair values of the
 
Company’s derivative instruments,
 
which are Level 2 measurements, are as
follows:
Fair Value
Condensed Consolidated
June 30,
 
December 31,
Balance Sheet Location
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
Other non-current liabilities
$
3,356
$
4,672
$
3,356
$
4,672
The following table presents the net unrealized loss deferred to
 
AOCI:
June 30,
 
December 31,
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
2,584
$
3,598
$
2,584
$
3,598
The following table presents the net loss reclassified from
 
AOCI to earnings:
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Amount and location of expense reclassified
from AOCI into expense (effective portion)
Interest expense, net
$
(659)
$
(483)
$
(1,302)
$
(465)
Interest rate swaps are entered into with a limited number
 
of counterparties, each of which allows for net settlement
 
of all
contracts through a single payment in a single currency
 
in the event of a default on or termination of any one
 
contract.
 
As such, in
accordance with the Company’s
 
accounting policy,
 
these derivative instruments are recorded on a net basis within
 
the Condensed
Consolidated Balance Sheets.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
26
Note 19 – Commitments and Contingencies
The Company previously disclosed in its 2020 Form 10-K
 
that AC Products, Inc. (“ACP”), a wholly owned subsidiary,
 
has been
operating a groundwater treatment system to hydraulically
 
contain groundwater contamination emanating from ACP’s
 
site, the
principal contaminant of which is perchloroethylene.
 
As of June 30, 2021, ACP believes it is close to meeting the
 
conditions for
closure of the groundwater treatment system, but continues
 
to operate this system while in discussions with the relevant
 
authorities.
 
As of June 30, 2021, the Company believes that the range
 
of potential-known liabilities associated with the balance
 
of the ACP water
remediation program is approximately $
0.1
 
million to $
1.0
 
million.
 
The low and high ends of the range are based on the length of
operation of the treatment system as determined
 
by groundwater modeling.
 
Costs of operation include the operation and maintenance
of the extraction well, groundwater monitoring and program
 
management.
 
The Company previously disclosed in its 2020 Form 10-K
 
that an inactive subsidiary of the Company that was acquired
 
in 1978
sold certain products containing asbestos, primarily
 
on an installed basis, and is among the defendants in numerous
 
lawsuits alleging
injury due to exposure to asbestos.
 
During the three and six months ended June 30, 2021,
 
there have been no significant changes to
the facts or circumstances of this previously disclosed matter,
 
aside from on-going claims and routine payments associated with
 
this
litigation.
 
Based on a continued analysis of the existing and anticipated
 
future claims against this subsidiary,
 
it is currently projected
that the subsidiary’s total
 
liability over the next 50 years for these claims is approximately
 
$
0.4
 
million (excluding costs of defense).
The Company previously disclosed in its 2020 Form 10-K
 
that it is party to certain environmental matters related to certain
domestic and foreign properties currently or previously
 
owned by Houghton.
 
These environmental matters primarily require the
Company to perform long-term monitoring as well as operating
 
and maintenance at each of the applicable sites.
 
During the three and
six months ended June 30, 2021, there have been no significant
 
changes to the facts or circumstances of these previously
 
disclosed
matters, aside from on-going monitoring and maintenance
 
activities and routine payments associated with each of the
 
sites.
 
The
Company continually evaluates its obligations related to such
 
matters, and based on historical costs incurred and projected
 
costs to be
incurred over the next 28 years, has estimated the present
 
value range of costs for all of the Houghton environmental
 
matters, on a
discounted basis, to be between approximately $
5.5
 
million and $
6.5
 
million as of June 30, 2021, for which $
6.0
 
million was accrued
within other accrued liabilities and other non-current
 
liabilities on the Company’s Condensed
 
Consolidated Balance Sheet as of June
30, 2021.
 
Comparatively, as of December
 
31, 2020, the Company had $
6.0
 
million accrued for with respect to these matters.
The Company believes, although there can be no assurance
 
regarding the outcome of other unrelated environmental matters, that
it has made adequate accruals for costs associated with other
 
environmental problems of which it is aware.
 
Approximately $
0.1
million was accrued as of both June 30, 2021 and December
 
31, 2020,
 
to provide for such anticipated future environmental
assessments and remediation costs.
 
The Company previously disclosed in its 2020 Form 10-K
 
that one of the Company’s subsidiaries
 
received a notice of inspection
from a taxing authority in a country where certain
 
of its subsidiaries operate which related to a non-income (indirect)
 
tax that may be
applicable to certain products the subsidiary sells.
 
To date, the Company
 
has not
 
received any assessment from the authority related to
potential liabilities that may be due from the Company’s
 
subsidiary.
 
Consequently, there is substantial uncertainty
 
with respect to the
Company’s ultimate liability
 
with respect to this indirect tax, as the application of
 
this tax in its given market is ambiguous and
interpreted differently among other peer companies
 
and taxing authorities.
 
The Company, with assistance
 
from independent experts,
has performed an evaluation of the applicability of this
 
indirect tax to the Company’s
 
subsidiaries in this country.
 
During the six
months ended June 30, 2021 and through the date of
 
this Report, there have been no significant changes to
 
the facts or circumstances
of this previously disclosed matter,
 
aside from
 
on-going discussions between the Company and the
 
taxing authority related to this
notice of inspection and independent testing conducted by
 
third-party consultants at the direction of the Company and the taxing
authority to determine if the Company’s
 
products have contents which subject them to this indirect tax.
 
Based on all of the
information available to the Company at this time, as of
 
June 30, 2021, the Company has recorded a liability of $
1.8
 
million in other
accrued liabilities, which reflects the Company’s
 
current best estimate of probable indirect tax owed, including
 
interest and taking into
account applicable statutes of limitations.
 
Because these amounts in part relate to a Houghton entity
 
acquired in the Combination and
for periods prior to the Combination, the Company
 
has submitted an indemnification claim with Houghton’s
 
former owners related to
this potential indirect tax liability.
 
The Company recorded a receivable in other assets for approximately
 
$
1.1
 
million, which reflects
the amount of the initial recorded liability for which
 
the Company anticipates being indemnified.
 
As noted, the Company believes
there is substantial uncertainty with respect to its ultimate liability
 
given the ambiguous application of this indirect tax.
 
At this time,
the Company’s current
 
best estimate of a potential range for possible assessments, including
 
additional amounts that may be assessed
under these indirect tax laws, would be $
0
 
to approximately $
40
 
million, which is net of approximately $
11
 
million of estimated
income tax deductions and approximately $
22
 
million of applicable rights to indemnification from Houghton’s
 
former owners.
During the first six months of 2021, one of the Company’s
 
Brazilian subsidiaries received a notice that it had prevailed
 
on an
existing legal claim in regard to certain non-income
 
(indirect) taxes that had been previously charged and paid.
 
The matter
specifically relates to companies’ rights to exclude the
 
state tax on goods circulation (a valued-added-tax or VAT
 
equivalent, known in
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
27
Brazil as “ICMS”) from
 
the calculation of certain additional indirect taxes (specifically
 
the program of social integration (“PIS”)
and contribution for the financing of social security (“COFINS”))
 
levied by the Brazilian States on the sale of goods.
 
In May 2021,
the Brazilian Supreme Court concluded that ICMS should
 
not be included in the tax base of PIS and COFINS, and confirmed
 
the
methodology for calculating the PIS and COFINS tax credit
 
claims to which taxpayers are entitled.
 
The Company’s Brazilian entities
had previously filed legal or administrative disputes on
 
this matter and are entitled to receive tax credits and interest dating
 
back to
five years preceding the date of their legal claims.
 
As a result of these court rulings in the first six months of 2021,
 
the Company
recognized non-income tax credits of
67.0
 
million BRL or approximately $
13.3
 
million, which includes approximately $
8.4
 
million
for the PIS and COFINS tax credits as well as interest on these
 
tax credits of $
4.9
 
million.
 
The tax credits to which the Company’s
Brazilian subsidiaries are entitled are claimable once registered
 
with the Brazilian tax authorities and the Company anticipates
completing this step during the second half of 2021.
 
These tax credits can be used to offset future Brazilian
 
federal taxes and the
Company currently anticipates using the full amount of
 
credits during the five year period of time permitted.
 
In connection with obtaining regulatory approvals for the
 
Combination, certain steel and aluminum related product lines
 
of
Houghton were divested on August 1, 2019.
 
In July 2021, the entity that acquired these divested product lines
 
submitted an
indemnification claim for certain alleged losses in accordance with
 
the terms of the Asset Purchase Agreement (“APA”)
 
.
 
Under the
terms of the APA,
 
the Company has 45 days to review the claim and respond
 
,
 
and as such, the Company is in the early stages of
evaluating the merits of the alleged losses in the indemnification
 
claim received.
 
As of the date of this Report,
 
the Company does not
believe it is reasonably possible to determine or quantify
 
any possible exposure.
 
The Company is party to other litigation which management
 
currently believes will not have a material adverse
 
effect on the
Company’s results of
 
operations, cash flows or financial condition.
 
In addition, the Company has an immaterial amount of contractual
purchase obligations.
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
28
Item 2.
 
Management’s Discussion and Analysis
 
of Financial Condition and Results of Operations
.
As used in this Report, the terms “Quaker Houghton,”
 
the “Company,”
 
“we” and “our” refer to Quaker Chemical Corporation
(doing business as Quaker Houghton), its subsidiaries, and
 
associated companies, unless the context otherwise requires.
 
As used in
this Report, the term Legacy Quaker refers to the Company
 
prior to the closing of its combination with Houghton International,
 
Inc.
(“Houghton”) (herein referred to as the “Combination”)
 
on August 1, 2019.
 
Throughout the Report, all figures presented, unless
otherwise stated, reflect the results of operations of the
 
combined company for the three months and six months ended
 
June 30,
 
2021
and 2020.
Executive Summary
Quaker Houghton is the global leader in industrial process
 
fluids.
 
With a presence around the world,
 
including operations in over
25 countries, our customers include thousands of the world’s
 
most advanced and specialized steel, aluminum, automotive, aerospace,
offshore, can, mining, and metalworking
 
companies.
 
Our high-performing, innovative and sustainable solutions are
 
backed by best-
in-class technology,
 
deep process knowledge, and customized services.
 
Quaker Houghton is headquartered in Conshohocken,
Pennsylvania, located near Philadelphia in the United States.
The Company had solid second quarter results which reflect
 
the continued COVID-19 recovery in the Company’s
 
end-markets
and customer demand as well as the on-going execution
 
of integration activities and synergy realization,
 
partially offset by raw
material cost headwinds driven by global supply chain pressures.
 
Specifically, net sales of $435.3
 
million in the second quarter of
2021 increased 52% compared to $286.0 million in the second
 
quarter of 2020, primarily due to higher volumes of 40%, including
additional net sales from acquisitions of 5%, the positive
 
impact from foreign currency translation of 8%, and increases
 
in selling price
and product mix of approximately 4%.
 
The significant increase in sales volumes compared to the
 
second quarter of 2020 was
primarily a result of the prior year second quarter being
 
the most severely impacted by COVID-19 globally,
 
while the current quarter
continued to experience end-market improvement and
 
continued market share gains.
 
Gross profit increased significantly quarter-over-
quarter as a result of higher net sales.
 
Despite significant increases in raw material costs, current
 
quarter gross margin of 35.5%
improved as compared to the prior year second quarter,
 
as the prior year was impacted by lower volumes due to COVID-19
 
on fixed
manufacturing costs.
 
Sequentially, the Company
 
experienced lower gross margins compared to the
 
first quarter of 2021 due to
significant raw material cost increases and global supply chain
 
and logistics pressures.
The Company had net income in the second quarter of 2021
 
of $33.6 million, or $1.88 per diluted share, compared
 
to a second
quarter of 2020 net loss of $7.7 million, or $0.43 per
 
diluted share.
 
The current quarter result includes $13.3 million of
 
non-operating
income related to certain non-income tax credits recorded
 
by the Company’s Brazilian subsidiaries.
 
The Company’s prior year
 
second
quarter net loss was dramatically affected
 
by the COVID-19 pandemic and its impact on the global economy,
 
including most of the
Company’s end customers.
 
Excluding non-recurring items including the Brazil non-income
 
tax credits as well as costs associated
with the Combination and other non-core items in each period,
 
the Company’s second quarter of
 
2021 non-GAAP earnings per diluted
share were $1.82 compared to $0.21 in the prior year
 
second quarter.
 
The Company’s current quarter
 
adjusted EBITDA of $70.1
million increased 118% compared
 
to $32.1 million in the second quarter of 2020 primarily due
 
to the significant increase in net sales
quarter-over-quarter as well as higher realized cost synergies
 
from the Combination as compared to the second quarter
 
of 2020,
partially offset by higher raw material costs.
 
The Company estimates that it realized cost synergies associated
 
with the Combination
of approximately $18.5 million during the second quarter
 
of 2021 compared to approximately $12 million during
 
the second quarter of
2020.
 
See the Non-GAAP Measures section of this Item below,
 
as well as other items discussed in the Company’s
 
Consolidated
Operations Review in the Operations section of this Item,
 
below.
The Company’s second
 
quarter of 2021 operating performance in each of its four reportable
 
segments: (i) Americas; (ii) Europe,
Middle East and Africa (“EMEA”); (iii) Asia/Pacific; and (iv)
 
Global Specialty Businesses, reflect similar drivers to that of
 
its
consolidated performance.
 
All four segments had higher net sales compared to the second
 
quarter of 2020 reflecting the negative
impact of COVID-19 on the prior year versus current quarter
 
improvement in the Company’s
 
end markets and overall market share
gains in each segment.
 
All of the Company’s segments
 
benefited from higher sales volumes as compared to
 
the prior year quarter,
additional net sales from acquisitions, the positive impact
 
from foreign currency translation due to the strengthening
 
of most major
currencies against the U.S. dollar, and
 
generally from increases in selling price and product mix.
 
As reported, all of the Company’s
segment operating earnings were higher compared to the
 
second quarter of 2020 which reflects higher current quarter
 
net sales
coupled with a higher gross margin in most segments
 
as compared to the prior year second quarter,
 
partially offset by higher selling,
general and administrative expenses (“SG&A”), which was the
 
result of an increase in direct selling expenses associated with
 
the
significant increase in net sales and, to a lesser extent,
 
the low levels of prior year period SG&A as a result of COVID-19
 
temporary
cost savings measures.
 
Additional details of each segment’s
 
operating performance are further discussed in the Company’s
Reportable Segments Review,
 
in the Operations section of this Item, below.
 
The Company had a net operating cash outflow of $9.6 million
 
in the first six months of 2021 as compared to net operating cash
inflow of $44.7 million in the first six months of 2020.
 
The decrease in net operating cash flow year-over-year was primarily
 
driven
by a significant investment in working capital compared
 
to the prior year, mainly in accounts receivable,
 
due to higher net sales and
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
29
volumes, and inventory,
 
due to higher raw material costs and restocking initiatives as a result
 
of global supply chain and logistics
pressures.
 
The key drivers of the Company’s
 
operating cash flow and working capital are further discussed
 
in the Company’s
Liquidity and Capital Resources section of this Item,
 
below.
Overall, the Company’s
 
second quarter results were strong, despite significant increases
 
in raw material costs and supply chain
issues.
 
Significant improvement over the prior year in
 
all segments was driven by the continued recovery in the
 
Company’s end-
markets and increased customer demand from lower
 
levels experienced during 2020 as a result of COVID-19.
 
While sequential
operating performance as compared to the first quarter
 
of 2021 was slightly lower, continued
 
strong customer demand in the second
quarter of 2021 coupled with on-going market share
 
gains and the execution of integration activities and synergy
 
realization helped
offset the negative impacts from the continued
 
escalation of raw material costs and continued supply chain pressures.
 
As the Company looks forward to the rest of 2021,
 
it expects raw material costs to continue to increase,
 
and it is implementing
additional price increases to help offset them
 
.
 
In addition, while the Company expects customer demand and sales volumes
 
to remain
strong,
 
we anticipate some near-term headwinds in automotive due
 
to the semiconductor shortage and some seasonality trends which
the Company typically experiences in the second half
 
of the year.
 
Despite these near-term headwinds, the Company
 
continues to
expect 2021 will result in a step change in its profitability from
 
2020 as the Company completes its integration cost synergies,
continues to take further share in the marketplace, benefits
 
from projected gradual rebound in demand, and sees the positive
 
impact of
its recent acquisitions.
 
On-going impact of COVID-19
The global outbreak of COVID-19 has negatively impacted
 
all locations where the Company does business.
 
Although the
Company has now operated in this COVID-19 environment
 
for over a year, the full extent
 
of the outbreak and related business
impacts remain uncertain and volatile, and therefore the
 
full extent to which COVID-19 may impact the Company’s
 
future results of
operations or financial condition is uncertain.
 
This outbreak has significantly disrupted the operations of the
 
Company and those of its
suppliers and customers.
 
The Company has experienced volume declines and lower
 
net sales as compared to pre-COVID-19 levels as
a result of the outbreak, as further described in this section.
 
Management continues to monitor the impact that the COVID-19
pandemic is having on the Company,
 
the overall specialty chemical industry and the economies and
 
markets in which the Company
operates.
 
Given the speed and frequency of the continuously evolving developments
 
with respect to this pandemic, the Company
cannot, as of the date of this Report, reasonably estimate
 
the magnitude or the full extent of the impact to its future results
 
of
operations or to the ability of it or its customers to resume
 
more normal operations, even as certain restrictions are lifted.
 
The
prolonged pandemic and resurgences
 
of the outbreak including as new variants emerge
 
,
 
and continued restrictions on day-to-day life
and business operations may result in volume declines
 
and lower net sales in future periods as compared to pre
 
-COVID-19 levels.
 
To
the extent that the Company’s
 
customers and suppliers continue to be significantly and
 
adversely impacted by COVID-19, this could
reduce the availability,
 
or result in delays, of materials or supplies to or from the Company,
 
which in turn could significantly interrupt
the Company’s business operations.
 
Given this ongoing uncertainty,
 
the Company cautions that its future results of operations could
be significantly adversely impacted by COVID-19.
 
Further, management continues to evaluate how
 
COVID-19-related
circumstances, such as remote work arrangements, illness or
 
staffing shortages and travel restrictions have affected
 
financial reporting
processes and systems, internal control over financial reporting,
 
and disclosure controls and procedures.
 
While the circumstances
have presented and are expected to continue to
 
present challenges, and have necessitated additional time and
 
resources to be deployed
to sufficiently address the challenges brought
 
on by the pandemic, at this time, management does not believe that
 
COVID-19 has had
a material impact on financial reporting processes, internal
 
controls over financial reporting, or disclosure controls and
 
procedures.
 
The Company’s top
 
priority, especially during this pandemic,
 
is to protect the health and safety of its employees and
 
customers,
while working to ensure business continuity to meet customers’
 
needs.
 
The Company continues to take steps to protect the health
 
and
wellbeing of its people in affected areas through
 
various actions, including enabling work at home where needed
 
and possible, and
employing social distancing standards, implementing
 
travel restrictions where applicable, enhancing onsite hygiene
 
practices, and
instituting visitation restrictions at the Company’s
 
facilities.
 
The Company has not and does not expect that it will incur
 
material
expenses implementing these health and safety policies.
 
All of the Company’s 31
 
production facilities worldwide are open and
operating and are deemed as essential businesses in the
 
jurisdictions where they are operating.
 
The Company believes that to date it
has been able to meet the needs of all its customers across the
 
globe despite the current economic challenges.
 
The Company’s second
quarter of 2021 showed substantial year-over-year
 
improvement from the prior year second quarter,
 
which was the most severely
impacted by COVID-19, and continued a trend of gradual
 
improvement which began in the second half of 2020.
 
The Company
continues to expect that the impact from COVID-19
 
will gradually improve subject to the effective containment
 
of the virus and its
variants and successful distribution and acceptance
 
of the vaccines that have been developed.
 
However, the incidence of reported
cases of COVID-19 in several geographies where the Company
 
has significant operations remains high and continues to
 
evolve and it
remains highly uncertain as to how long the global pandemic
 
and related economic challenges will last and when our customers’
businesses will recover to pre-COVID-19 levels.
 
The Company took various actions to temporarily conserve
 
cash and reduce costs
during and these temporary initiatives were designed and
 
implemented so that the Company could successfully manage
 
through the
challenging COVID-19 situation while continuing to protect
 
the health of its employees, meet customers’ needs,
 
maintain the
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
30
Company’s long-term
 
competitive advantages
 
and above-market growth, and enable it to continue to effectively
 
integrate Houghton.
 
While the actions taken to date to protect our workforce,
 
to continue to serve our customers with excellence and to conserve
 
cash and
reduce costs, have been effective thus far,
 
further actions to respond to the pandemic and its effects
 
may be necessary as conditions
continue to evolve.
Liquidity and Capital Resources
At June 30, 2021, the Company had cash, cash equivalents and
 
restricted cash of $145.6 million.
 
Total cash, cash
 
equivalents and
restricted cash was $181.9 million at December 31, 2020.
 
The $36.3 million decrease in cash, cash equivalents and restricted
 
cash
was the net result of approximately $21.7 million of cash
 
used in investing activities, $9.6 million of cash used in operating
 
activities,
$4.4 million of cash used in financing activities and a
 
$0.7 million negative impact due to the effect of foreign
 
currency translation.
Net cash flows used in operating activities were $9.6
 
million in the first six months of 2021 compared to net cash
 
flows provided
by operating activities of $44.7 million in the first six
 
months of 2020.
 
The decrease in net operating cash flows of $54.2 million was
primarily driven by a significant change in working
 
capital, partially
 
offset by higher earnings in the current year.
 
The significant
increase in current year net sales resulted in a large
 
increase in accounts receivable in the first six months of 2021 as compared
 
to
accounts receivable being a cash inflow in the prior
 
year as sales significantly declined during the first six months of
 
2020 due to the
initial negative impact from COVID-19.
 
In addition, the Company has experienced an increase in inventory
 
in the first six months of
2021 as a result of rising raw material costs as well as a build
 
in inventory to ensure the Company has appropriate stock
 
to meet
customer demands particularly given the current stress on
 
the global supply chain.
 
In addition, the Company had higher cash
dividends received from its associated companies in
 
the first six months of 2020, primarily due to $5.0 million
 
received from the
Company’s joint venture
 
in Korea with no similar dividend received in the first six months of
 
2021 related to the timing of dividends
received.
Net cash flows used in investing activities were $21.7
 
million in the first six months of 2021 compared to $10.6
 
million in the first
six months of 2020.
 
This increase in cash outflows was driven by higher cash payments related
 
to acquisitions during the first six
months of 2021, including $25.0 million for certain assets related
 
to tin-plating solutions primarily for steel end markets.
 
These higher
cash outflows were partially offset by cash proceeds
 
of approximately $14.7 million from the disposition of assets, which
 
includes the
sale of certain held-for-sale real property
 
assets related to the Combination.
 
Capital expenditures were relatively consistent at $7.0
million in the first six months of 2021 compared to $7.5
 
million in the first six months of 2020.
 
Net cash flows used in financing activities were $4.4
 
million in the first six months of 2021 compared to net cash
 
flows provided
by financing activities of $168.7 million in the first six months
 
of 2020.
 
The decrease of $173.1 million in net cash flows was
primarily related to the prior year borrowings of most of the
 
available liquidity under the Company’s
 
revolving credit facility related
to the economic uncertainty brought on by COVID-19.
 
These additional prior year borrowings were repaid during
 
the third quarter of
2020.
 
In addition, the Company paid $14.1 million of cash dividends
 
during the first six months of 2021, a $0.5 million or 3%
increase in cash dividends compared to the prior year.
 
Finally, during the first six months
 
of 2020, the Company used $1.0 million to
purchase the remaining noncontrolling interest in a
 
South Africa affiliate.
 
Prior to this buyout, this South Africa affiliate made
 
a
distribution to the prior noncontrolling affiliate
 
shareholder of approximately $0.8 million in the first six months
 
of 2020.
 
There were
no similar noncontrolling interest activities in the first six months
 
of 2021.
The Company’s primary
 
credit facility (the “Credit Facility”) is comprised of a $400.0
 
million multicurrency revolver (the
“Revolver”), a $600.0 million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower,
 
and a $150.0 million (as of
August 1, 2019) Euro equivalent term loan (the “Euro
 
Term Loan” and together
 
with the U.S. Term Loan”,
 
the “Term Loans”) with
Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower,
 
each with a five year term maturing in August 2024.
 
Subject
to the consent of the administrative agent and certain other
 
conditions, the Company may designate additional borrowers.
 
The
maximum amount available under the Credit Facility
 
can be increased by up to $300.0 million at the Company’s
 
request if there are
lenders who agree to accept additional commitments and
 
the Company has satisfied certain other conditions.
 
Borrowings under the
Credit Facility bear interest at a base rate or LIBOR plus an
 
applicable margin based on the Company’s
 
consolidated net leverage
ratio.
 
There are LIBOR replacement provisions that contemplate a further
 
amendment if and when LIBOR ceases to be reported.
 
The
weighted average interest rate incurred on the outstanding
 
borrowings under the Credit Facility during both the first six months
 
of
2021 and as of June 30, 2021 was approximately 1.6
 
%.
 
In addition to paying interest on outstanding principal under
 
the Credit
Facility, the Company
 
is required to pay a commitment fee ranging from 0.2% to
 
0.3% depending on the Company’s
 
consolidated net
leverage ratio to the lenders under the Revolver in
 
respect of the unutilized commitments thereunder.
 
The Credit Facility is subject to certain financial and
 
other covenants.
 
The Company’s initial consolidated
 
net debt to
consolidated adjusted EBITDA ratio could not exceed
 
4.25 to 1, with step downs in the permitted ratio over the
 
term of the Credit
Facility.
 
As of June 30, 2021, the consolidated net debt to consolidated
 
adjusted EBITDA ratio may not exceed 4.00 to 1.
 
The
Company’s consolidated
 
adjusted EBITDA to interest expense ratio may not be less than
 
3.0 to 1 over the term of the agreement.
 
The
Credit Facility also prohibits the payment of cash dividends
 
if the Company is in default or if the amount of the dividen
 
ds paid
annually exceeds the greater of $50.0 million and
 
20% of consolidated adjusted EBITDA unless the ratio of
 
consolidated net debt to
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
31
consolidated adjusted EBITDA is less than 2.0 to 1,
 
in which case there is no such limitation on amount.
 
As of June 30, 2021, and
December 31, 2020, the Company was in compliance with
 
all of the Credit Facility covenants.
 
The Term Loans
 
have quarterly
principal amortization during their five year terms,
 
with 5.0% amortization of the principal balance due in years 1 and
 
2, 7.5% in year
3, and 10.0% in years 4 and 5, with the remaining principal
 
amount due at maturity.
 
The Credit Facility is guaranteed by certain of the
Company’s domestic subsidiaries
 
and is secured by first priority liens on substantially all of
 
the assets of the Company and the
domestic subsidiary guarantors, subject to certain customary exclusions.
 
The obligations of the Dutch borrower are guaranteed only
by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable
 
interest rates on at least 20% of its total Term
 
Loans.
 
In order to
satisfy this requirement as well as to manage the
 
Company’s exposure to variable
 
interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $170.0
 
million notional amounts of three year interest rate swaps at a base
 
rate of 1.64%
plus an applicable margin as provided in the
 
Credit Facility, based on
 
the Company’s consolidated net
 
leverage ratio.
 
At the time the
Company entered into the swaps, and as of June 30,
 
2021, the aggregate interest rate on the swaps, including the
 
fixed base rate plus
an applicable margin, was 3.1%.
 
The Company capitalized $23.7 million of certain third-party
 
debt issuance costs in connection with executing
 
the Credit Facility.
 
Approximately $15.5 million of the capitalized costs were attributed
 
to the Term Loans and
 
recorded as a direct reduction of long-
term debt on the Company’s
 
Consolidated Balance Sheet.
 
Approximately $8.3 million of the capitalized costs were
 
attributed to the
Revolver and recorded within other assets on the Company’s
 
Condensed Consolidated Balance Sheet.
 
These capitalized costs are
being amortized into interest expense over the five year
 
term of the Credit Facility.
 
As of June 30, 2021, the Company had Credit Facility borrowings
 
outstanding of $892.6 million.
 
As of December 31, 2020, the
Company had Credit Facility borrowings outstanding
 
of $887.1 million.
 
The Company has unused capacity under the Revolver of
approximately $206 million, net of bank letters of
 
credit of approximately $4 million, as of June 30, 2021.
 
The Company’s other debt
obligations are primarily industrial development bonds,
 
bank lines of credit and municipality-related loans, which
 
totaled $12.2
million and $12.1 million as of June 30, 2021 and
 
December 31, 2020, respectively.
 
Total unused capacity
 
under these arrangements
as of June 30, 2021 was approximately $40 million.
 
The Company’s total net debt
 
as of June 30, 2021 was $759.2 million.
The Company estimates that it realized cost synergies
 
in the first six months of 2021 of approximately $36.5 million
 
compared to
approximately $22 million in the first six months of 2020.
 
The Company continues to expect to realize Combination
 
cost synergies of
approximately $75 million in 2021 and $80 million in
 
2022.
 
The Company continues to expect to incur additional costs
 
and make
associated cash payments to integrate Quaker and Houghton
 
and continue realizing the Combination’s
 
total anticipated cost synergies.
 
The Company expects total cash payments, including
 
those pursuant to the QH Program, described below,
 
but excluding incremental
capital expenditures related to the Combination,
 
will be approximately 1.3 times its total anticipated 2022 cost
 
synergies of $80
million.
 
A significant portion of these costs were already incurred
 
in 2019, 2020 and the first six months of 2021, but the Company
expects to continue to incur such costs throughout
 
the remainder of 2021.
 
The Company incurred $7.6 million of total Combination,
integration and other acquisition-related expenses in the
 
first six months of 2021, which includes $0.5 million of accelerated
depreciation and is net of a $5.4 million gain on the sale of
 
certain held-for-sale real property assets, described in the
 
Non-GAAP
Measures section of this Item below.
 
Comparatively, in the first six months
 
of 2020, the Company incurred $16.5 million of total
Combination, integration and other acquisition-related
 
expenses.
 
The Company had aggregate net cash outflows of
 
approximately
$14.8 million related to the Combination, integration and
 
other acquisition-related expenses during the first six months
 
of 2021 as
compared to $13.8 million during the first six months of
 
2020.
 
Quaker Houghton’s management
 
approved, and the Company initiated, a global restructuring
 
plan (the “QH Program”) in the
third quarter of 2019 as part of its planned cost synergies
 
associated with the Combination.
 
The QH Program includes restructuring
and associated severance costs to reduce total headcount
 
by approximately 400 people globally and plans for the closure
 
of certain
manufacturing and non-manufacturing facilities.
 
In connection with the plans for closure of certain manufacturing
 
and non-
manufacturing facilities, the Company made a decision
 
to make available for sale certain facilities during the second
 
quarter of 2020.
 
During the first quarter of 2021, certain of these facilities were
 
sold and the Company recognized a gain on disposal of $5.4 million
included within other income (expense), net on the Condensed
 
Consolidated Statement of Operations.
 
The exact timing and total
costs associated with the QH Program will depend
 
on a number of factors and is subject to change; however,
 
reductions in headcount
and site closures have continued into 2021.
 
The Company currently expects additional headcount reductions and
 
site closures to occur
into 2022 and estimates that the anticipated cost synergies
 
realized under the QH Program will approximate one-times restructuring
costs incurred.
 
The Company made cash payments related to the settlement of
 
restructuring liabilities under the QH Program during
the first six months of 2021 of approximately $4.2 million
 
compared to $9.6 million in the first six months of 2020.
As of June 30, 2021, the Company’s
 
gross liability for uncertain tax positions, including interest and
 
penalties, was $30.8 million.
 
The Company cannot determine a reliable estimate of
 
the timing of cash flows by period related to its uncertain tax
 
position liability.
 
However, should the entire liability
 
be paid, the amount of the payment may be reduced by up
 
to $7.7 million as a result of offsetting
benefits in other tax jurisdictions.
 
During the fourth quarter of 2020, one of the Company’s
 
subsidiaries received a notice of
inspection from a taxing authority in a country where certain
 
of its subsidiaries operate, which relate to a non-income
 
(indirect) tax
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
32
that may be applicable to certain products the subsidiary
 
sells.
 
To date, the Company
 
has not received any assessment from the
authority related to potential liabilities that may be due
 
from the Company’s subsidiary.
 
Consequently, there is substantial
 
uncertainty
with respect to the Company’s
 
ultimate liability with respect to this indirect tax.
 
During the first six months of 2021, the Company
recorded $13.3 million of non-income tax credits for
 
certain of its Brazilian subsidiaries.
 
The Company expects to utilize these credits
to offset certain Brazilian federal tax payments over
 
approximately the following two years beginning in the second half of 2021.
 
See
Note 19 of Notes to Condensed Consolidated Financial
 
Statements in Item 1 of this Report.
The Company believes that its existing cash, anticipated
 
cash flows from operations and available additional liquidity
 
will be
sufficient to support its operating requirements
 
and fund its business objectives for at least the next twelve
 
months, including but not
limited to, payments of dividends to shareholders, costs related
 
to the Combination and integration, pension plan contributions,
 
capital
expenditures, other business opportunities (including
 
potential acquisitions) and other potential contingencies.
 
The Company’s
liquidity is affected by many factors, some
 
based on normal operations of our business and others related
 
to the impact of the
pandemic on our business and on global economic
 
conditions as well as industry uncertainties, which we cannot
 
predict.
 
We also
cannot predict economic conditions and industry downturns
 
or the timing, strength or duration of recoveries.
 
We may seek,
 
as we
believe appropriate, additional
 
debt or equity financing which would provide capital for
 
corporate purposes, working capital funding,
additional liquidity needs or to fund future growth opportunities, including
 
possible acquisitions and investments.
 
The timing and
amount of potential capital requirements cannot be
 
determined at this time and will depend on a number of factors,
 
including the
actual and projected demand for our products, specialty
 
chemical industry conditions, competitive factors, and the
 
condition of
financial markets, among others.
 
Non-GAAP Measures
The information in this Form 10-Q includes non-GAAP (unaudited)
 
financial information that includes EBITDA, adjusted
EBITDA, adjusted EBITDA margin, non-GAAP operating
 
income, non-GAAP operating margin, non-GAAP
 
net income and non-
GAAP earnings per diluted share.
 
The Company believes these non-GAAP financial measures provide
 
meaningful supplemental
information as they enhance a reader’s understanding
 
of the financial performance of the Company,
 
are indicative of future operating
performance of the Company,
 
and facilitate a comparison among fiscal periods, as the
 
non-GAAP financial measures exclude items
that are not considered indicative of future operating performance
 
or not considered core to the Company’s
 
operations.
 
Non-GAAP
results are presented for supplemental informational
 
purposes only and should not be considered a substitute for the
 
financial
information presented in accordance with GAAP.
 
The Company presents EBITDA which is calculated as net income
 
(loss) attributable to the Company before depreciation and
amortization, interest expense, net, and taxes on income
 
(loss) before equity in net income of associated companies.
 
The Company
also presents adjusted EBITDA which is calculated as EBITDA
 
plus or minus certain items that are not considered indicative of
 
future
operating performance or not considered core to the Company’s
 
operations.
 
In addition, the Company presents non-GAAP operating
income which is calculated as operating income (loss) plus
 
or minus certain items that are not considered indicative
 
of future operating
performance or not considered core to the Company’s
 
operations.
 
Adjusted EBITDA margin and non-GAAP operating
 
margin are
calculated as the percentage of adjusted EBITDA and
 
non-GAAP operating income to consolidated net sales, respectively.
 
The
Company believes these non-GAAP measures provide
 
transparent and useful information and are widely used by analysts, investors,
and competitors in our industry as well as by management
 
in assessing the operating performance of the Company on
 
a consistent
basis.
Additionally, the
 
Company presents non-GAAP net income and non-GAAP earnings
 
per diluted share as additional performance
measures.
 
Non-GAAP net income is calculated as adjusted EBITDA, defined
 
above, less depreciation and amortization, interest
expense, net, and taxes on income before equity in
 
net income of associated companies, in each case adjusted,
 
as applicable, for any
depreciation, amortization, interest or tax impacts resulting
 
from the non-core items identified in the reconciliation
 
of net income
attributable to the Company to adjusted EBITDA.
 
Non-GAAP earnings per diluted share is calculated as non
 
-GAAP net income per
diluted share as accounted for under the “two-class share
 
method.”
 
The Company believes that non-GAAP net income and non-
GAAP earnings per diluted share provide transparent
 
and useful information and are widely used by analysts, investors,
 
and
competitors in our industry as well as by management in
 
assessing the operating performance of the Company on a consistent
 
basis.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
33
The following tables reconcile the Company’s
 
non-GAAP financial measures (unaudited) to their most
 
directly comparable
GAAP (unaudited) financial measures (dollars in thousands unless
 
otherwise noted, except per share amounts):
Non-GAAP Operating Income and Margin Reconciliations
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Operating income (loss)
$
38,816
$
2,238
$
83,710
$
(10,206)
Houghton combination, integration and other
 
 
acquisition-related expenses (a)
6,784
8,253
13,014
16,529
Restructuring and related charges (b)
298
486
1,473
2,202
Fair value step up of acquired inventory sold (c)
—
226
801
226
CEO transition costs (d)
308
—
812
—
Inactive subsidiary's non-operating litigation costs (e)
242
—
293
—
Customer bankruptcy costs (f)
—
—
—
463
Indefinite-lived intangible asset impairment (g)
—
—
—
38,000
Non-GAAP operating income
$
46,448
$
11,203
$
100,103
$
47,214
Non-GAAP operating margin (%) (o)
10.7%
3.9%
11.6%
7.1%
 
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin
and Non-GAAP Net Income Reconciliations
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Net income (loss) attributable to Quaker Chemical Corporation
$
33,570
$
(7,735)
$
72,185
$
(36,116)
Depreciation and amortization (a)(m)
22,344
21,158
44,792
42,742
Interest expense, net
5,618
6,811
11,088
15,272
Taxes on income
 
(loss) before equity in net income
 
of associated companies
15,218
3,222
25,907
(9,848)
EBITDA
76,750
23,456
153,972
12,050
Equity income in a captive insurance company (h)
(883)
(482)
(3,963)
(155)
Houghton combination, integration and other
 
acquisition-related expenses (a)
6,658
7,963
7,085
15,766
Restructuring and related charges (b)
298
486
1,473
2,202
Fair value step up of acquired inventory sold (c)
—
226
801
226
CEO transition costs (d)
308
—
812
—
Inactive subsidiary's non-operating litigation costs (e)
242
—
293
—
Customer bankruptcy costs (f)
—
—
—
463
Indefinite-lived intangible asset impairment (g)
—
—
—
38,000
Pension and postretirement benefit (income) costs,
 
non-service components (i)
(129)
341
(253)
23,866
Brazilian non-income tax credits (j)
(13,293)
—
(13,293)
—
Currency conversion impacts of hyper-inflationary economies (k)
106
73
278
124
Adjusted EBITDA
$
70,057
$
32,063
$
147,205
$
92,542
Adjusted EBITDA margin (%) (o)
16.1%
11.2%
17.0%
13.9%
Adjusted EBITDA
$
70,057
$
32,063
$
147,205
$
92,542
Less: Depreciation and amortization - adjusted (a)
22,218
20,869
44,251
41,980
Less: Interest expense, net
5,618
6,811
11,088
15,272
Less: Taxes on income
 
before equity in net income
 
of associated companies - adjusted (a)(n)
9,773
673
21,512
7,136
Non-GAAP net income
$
32,448
$
3,710
$
70,354
$
28,154
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
34
Non-GAAP Earnings per Diluted Share Reconciliations
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
GAAP earnings (loss) per diluted share attributable to
Quaker Chemical Corporation common shareholders
$
1.88
$
(0.43)
$
4.03
$
(2.03)
Equity income in a captive insurance company
 
per diluted share (h)
(0.05)
(0.03)
(0.22)
(0.01)
Houghton combination, integration and other
 
 
acquisition-related expenses per diluted share (a)
0.28
0.37
0.32
0.73
Restructuring and related charges per diluted
 
share (b)
0.02
0.02
0.07
0.09
Fair value step up of acquired inventory sold per diluted
 
share (c)
—
0.01
0.03
0.01
CEO transition costs per diluted share (d)
0.02
—
0.04
—
Inactive subsidiary's non-operating litigation costs per
 
 
diluted share (e)
0.01
—
0.01
—
Customer bankruptcy costs per diluted share (f)
—
—
—
0.02
Indefinite-lived intangible asset impairment per diluted
 
share (g)
—
—
—
1.65
Pension and postretirement benefit (income) costs,
 
non-service components per diluted share (i)
(0.01)
0.01
(0.01)
0.89
Brazilian non-income tax credits per diluted share (j)
(0.44)
—
(0.44)
—
Currency conversion impacts of hyper-inflationary
 
 
economies per diluted share (k)
0.01
0.01
0.02
0.01
Impact of certain discrete tax items per diluted share (l)
0.10
0.25
0.08
0.23
Non-GAAP earnings per diluted share (p)
$
1.82
$
0.21
$
3.93
$
1.59
(a)
 
Houghton combination, integration and other acquisition-related
 
expenses include certain legal, financial, and other advisory
 
and
consultant costs incurred in connection with post-closing
 
integration activities including internal control readiness and
remediation.
 
These costs are not indicative of the future operating performance
 
of the Company.
 
Approximately $0.4 million
and $0.5 million in the three and six months ended June
 
30, 2021,
 
respectively, of these
 
pre-tax costs were considered non-
deductible for the purpose of determining the Company’s
 
effective tax rate, and, therefore, taxes on income before
 
equity in net
income of associated companies - adjusted reflects the
 
impact of these items.
 
During the three and six months ended June 30,
2021, the Company recorded $0.1 million and $0.5 million,
 
respectively, of
 
accelerated depreciation related to certain of the
Company’s facilities compared
 
to $0.3 million and $0.8 million during the three and
 
six months ended June 30, 2020,
respectively, which
 
is included in the caption “Houghton combination, integration
 
and other acquisition-related expenses” in the
reconciliation of operating income (loss) to non-GAAP
 
operating income and included in the caption “Depreciation
 
and
amortization” in the reconciliation of net income
 
(loss) attributable to the Company to EBITDA, but excluded
 
from the caption
“Depreciation and amortization - adjusted” in the reconciliation
 
of adjusted EBITDA to non-GAAP net income attributable
 
to the
Company.
 
During the six months ended June 30, 2021, the Company recorded
 
a $5.4 million gain on the sale of certain held-for-
sale real property assets related to the Combination
 
which is included in the caption “Houghton combination,
 
integration and
other acquisition-related expenses” in the reconciliation
 
of GAAP earnings (loss) per diluted share attributed
 
to Quaker Chemical
Corporation common shareholders to Non-GAAP earnings
 
per diluted share as well as the reconciliation of net income
 
(loss)
attributable to Quaker Chemical Corporation to Adjusted
 
EBITDA and Non-GAAP net income.
 
See Note 2 of Notes to
Condensed Consolidated Financial Statements, which appears
 
in Item 1 of this Report.
(b)
 
Restructuring and related charges represent
 
the costs incurred by the Company associated with the QH restructuring
 
program
which was initiated in the third quarter of 2019 as part
 
of the Company’s plan
 
to realize cost synergies associated with the
Combination.
 
These costs are not indicative of the future operating performance
 
of the Company.
 
See Note 7 of Notes to
Condensed Consolidated Financial Statements, which appears
 
in Item 1 of this Report.
 
(c)
 
Fair value step up of acquired inventory sold relates
 
to expense associated with selling inventory of acquired
 
businesses which
was adjusted to fair value as a part of purchase accounting.
 
This increase to cost of goods sold (“COGS”) is not indicative
 
of the
future operating performance of the Company.
 
(d)
 
CEO transition costs represent the costs related to the
 
Company’s on-going search
 
for a new CEO in connection with the
previously announced executive transition planned for
 
the end of 2021.
 
These expenses are not indicative of the future operating
performance of the Company.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
35
(e)
 
Inactive subsidiary’s
 
non-operating litigation costs represents the charges
 
incurred by an inactive subsidiary of the Company and
are a result of the termination of restrictions on insurance
 
settlement reserves as previously disclosed in the Company’s
 
2020
Form 10-K.
 
These charges are not indicative of the future operating
 
performance of the Company.
 
See Note 9 of Notes to
Condensed Consolidated Financial Statements, which appears
 
in Item 1 of this Report.
(f)
 
Customer bankruptcy costs represent the cost associated
 
with a specific reserve for trade accounts receivable related
 
to a customer
who filed for bankruptcy protection.
 
These expenses are not indicative of the future operating
 
performance of the Company.
(g)
 
Indefinite-lived intangible asset impairment represents the
 
non-cash charge taken to write down the value
 
of certain indefinite-
lived intangible assets associated with the Houghton
 
Combination.
 
The Company has no prior history of goodwill or intangible
asset impairments and this charge is not indicative
 
of the future operating performance of the Company.
 
See Note 14 of Notes to
Condensed Consolidated Financial Statements, which appears
 
in Item 1 of this Report.
(h)
 
Equity income in a captive insurance company represents the
 
after-tax income attributable to the Company’s
 
interest in Primex,
Ltd. (“Primex”), a captive insurance company.
 
The Company holds a 32% investment in and has significant
 
influence over
Primex, and therefore accounts for this interest under the
 
equity method of accounting.
 
The income attributable to Primex is not
indicative of the future operating performance of the
 
Company and is not considered core to the Company’s
 
operations.
(i)
 
Pension and postretirement benefit (income) costs, non-service
 
components represent the pre-tax, non-service component of
 
the
Company’s pension and
 
postretirement net periodic benefit cost in each period.
 
These costs are not indicative
 
of the future
operating performance of the Company.
 
The amount in the six months ended June 30, 2020 includes the
 
$22.7 million settlement
charge for the Company’s
 
termination of the Legacy Quaker U.S. Pension Plan.
 
See Note 9 of Notes to Condensed Consolidated
Financial Statements, which appears in Item 1 of this Report.
(j)
 
Brazilian non-income tax credits represent indirect tax
 
credits related to certain of the Company’s
 
Brazilian subsidiaries
prevailing in a legal claim as well as the Brazilian Supreme
 
Court ruling on these non-income tax matters.
 
The non-income tax
credit is non-recurring and not indicative of the future
 
operating performance of the Company.
 
See Note 19 of Notes to
Condensed Consolidated Financial Statements, which appears
 
in Item 1 of this Report.
(k)
 
Currency conversion impacts of hyper-inflationary economies represents
 
the foreign currency remeasurement impacts associated
with the Company’s affiliates
 
whose local economies are designated as hyper-inflationary
 
under U.S. GAAP.
 
During the three
and six months ended June 30, 2021 and 2020, the
 
Company incurred non-deductible, pre-tax charges
 
related to the Company’s
Argentine affiliates.
 
These charges related to the immediate recognition
 
of foreign currency remeasurement in the Condensed
Consolidated Statements of Operations associated with
 
these entities are not indicative of the future operating
 
performance of the
Company.
 
See Note 1 of Notes to Condensed Consolidated Financial Statements, which
 
appears in Item 1 of this Report.
(l)
 
The impact of certain discrete tax items includes the impact
 
of changes in certain valuation allowance recorded
 
on certain of the
Company’s foreign
 
tax credits, tax law changes in a foreign jurisdiction, changes in withholding
 
rates, the tax impacts of non-
income tax credits associated with certain of the Company’s
 
Brazilian subsidiaries and the associated impact on previously
accrued for distributions at certain of the Company’s
 
Asia/Pacific subsidiaries, as well as the offsetting
 
impact
 
and amortization
of a deferred tax benefit the Company recorded
 
in the fourth quarters of 2019 and 2020 related to an intercompany
 
intangible
asset transfer.
 
See Note 11 of Notes to Condensed
 
Consolidated Financial Statements, which appears in Item 1
 
of this Report.
 
(m)
 
Depreciation and amortization for the three and six
 
months ended June 30, 2021 includes approximately $0.3
 
million and $0.6
million, respectively,
 
and for the three and six months ended June 30, 2020 includes $0.3
 
million and $0.7 million, respectively,
of amortization expense recorded within equity in
 
net income of associated companies in the Company’s
 
Condensed Consolidated
Statements of Operations, which is attributable to the
 
amortization of the fair value step up for the Company’s
 
50% interest in a
Houghton joint venture in Korea as a result of required
 
purchase accounting.
 
(n)
 
Taxes on income
 
before equity in net income of associated companies – adjusted
 
presents the impact of any current and deferred
income tax expense (benefit), as applicable, of
 
the reconciling items presented in the reconciliation of net income (loss)
attributable to Quaker Chemical Corporation to adjusted
 
EBITDA, and was determined utilizing the applicable rates in the taxing
jurisdictions in which these adjustments occurred, subject
 
to deductibility.
 
Houghton combination, integration and other
acquisition-related expenses described in (a) resulted in
 
incremental taxes of $1.6 million and $1.7 million during the three and
six months ended June 30, 2021,
 
and $1.5 million and $3.4 million during the three and six months ended
 
June 30, 2020,
respectively.
 
Restructuring and related charges described in (b) resulted
 
in incremental taxes of $0.1 million and $0.3 million
during the three and six months ended June 30, 2021,
 
respectively, and $0.1 million
 
and $0.3 million for the three and six months
ended June 30, 2020, respectively.
 
Fair value step up of acquired inventory sold described in (c) resulted
 
in incremental taxes of
$0.2 million during the six months ending June 30, 2021
 
and less than $0.1 million during both the three and six months ended
June 30, 2020.
 
CEO transition expenses described in (d) resulted in incremental
 
taxes of $0.1 million and $0.2 million during the
three and six months ended June 30, 2021, respectively.
 
Inactive subsidiary litigation described in (e) resulted in incremental
taxes of $0.1 million during each of the three and six
 
months ended June 30, 2021.
 
Customer bankruptcy costs described in (f)
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
36
resulted in incremental taxes of $0.1 million during the
 
six months ended June 30, 2020.
 
Indefinite-lived intangible asset
impairment described in (g) resulted in incremental
 
taxes of $8.7 million during the six months ended June 30, 2020.
 
Pension and
postretirement benefit costs, non-service components described
 
in (i) resulted in a tax benefit of less than $0.1 million during each
of the three and six months ended June 30, 2021, and incremental
 
taxes of $0.1 million and $8.0 million for the three and
 
six
months ended June 30, 2020, respectively.
 
Brazilian non-income tax credits described in (j) resulted in
 
incremental taxes of $5.3
million during the three and six months ended June 30,
 
2021.
 
Tax impact of
 
certain discrete items described in (l) above resulted
in an incremental taxes of $1.9 million and $1.5 million
 
during the three and six months ended June 30, 2021,
 
respectively, and
$4.4 million and $4.0 million for the three and six months
 
ended June 30, 2020, respectively.
(o)
 
The Company calculates adjusted EBITDA margin
 
and non-GAAP operating margin as the percentage
 
of adjusted EBITDA and
non-GAAP operating income to consolidated net sales.
(p)
 
The Company calculates non-GAAP earnings per diluted share
 
as non-GAAP net income attributable to the Company
 
per
weighted average diluted shares outstanding using the “two-class share
 
method” to calculate such in each given period.
 
Off-Balance Sheet Arrangements
The Company had no material off-balance
 
sheet items, as defined under Item 303(a)(4) of Regulation S-K as of
 
June 30,
 
2021.
 
The Company’s only
 
off-balance sheet items outstanding as of June 30
 
,
 
2021 represented approximately $7 million of total bank
letters of credit and guarantees.
 
The bank letters of credit and guarantees are not significant to
 
the Company’s liquidity
 
or capital
resources.
 
See Note 15 of Notes to Condensed Consolidated Financial Statements
 
in Item 1 of this Report.
 
Operations
 
Consolidated Operations Review – Comparison of the Second
 
Quarter
 
of 2021 with the Second Quarter of 2020
Net sales were $435.3 million in the second quarter of
 
2021 compared to $286.0 million in the second quarter
 
of 2020.
 
The net
sales increase of approximately $149.2
 
million or 52% quarter-over-quarter
 
was driven by higher sales volumes of 40%, which
includes additional net sales from recent acquisitions of
 
5%, the positive impact of foreign currency translation of
 
8% as well as
increases from selling price and product mix of approximately
 
4%.
 
The significant increase in sales volumes compared to the second
quarter of 2020 was primarily the result of the prior year
 
quarter being the most severely impacted by COVID-19
 
globally as well as
the continued improvement in end market conditions and
 
continued market share gains realized in the current quarter.
 
Sales from
acquisitions includes notably the Company’s
 
acquisition of Coral Chemical Company (“Coral”) in December
 
2020.
 
The positive
impact from foreign currency translation is primarily the
 
result of the strengthening of the euro, Chinese renminbi
 
and Mexican peso
against the U.S. dollar quarter-over-quarter
 
The increase from selling price and product mix includes
 
the benefits of current year
selling price increases implemented to date to help offset
 
the rising raw material costs.
COGS were $280.8 million in the second quarter of 2021
 
compared to $188.7 million in the second quarter of 2020
 
.
 
The increase
in COGS of 49%
 
was driven by the associated COGS on the increase in net
 
sales described above.
Gross profit in the second quarter of 2021 of $154.5
 
million increased $57.1 million or 59% from the second quarter
 
of 2020, due
primarily to the increase in net sales noted above.
 
The Company’s reported
 
gross margin in the second quarter of 2021 was 35.5%
compared to 34.0% in the second quarter of 2020.
 
Excluding one-time increases to COGS including accelerated
 
depreciation in both
periods and the impact of the inventory fair value
 
step up in the prior year quarter, described
 
in the Non-GAAP section of this Item
above, the Company estimates that its gross margins
 
in the second quarters of 2021 and 2020 would have been approximately
 
35.5%
and 34.2%, respectively.
 
While the Company has experienced unprecedented raw material
 
cost increases that began in the fourth
quarter of 2020 and are continuing throughout the first
 
half of 2021, the higher gross margin as compared
 
to the prior year quarter was
primarily driven by the Company’s
 
continued execution of Combination-related logistics, procurement
 
and manufacturing cost
savings initiatives versus the prior year impact of fixed manufacturing
 
costs on the abnormally low volumes due to COVID-19.
 
SG&A in the second quarter of 2021 increased $22.0 million
 
compared to the second quarter of 2020 due primarily to
 
the impact
of sales increases on direct selling costs, additional
 
SG&A from recent acquisitions, higher incentive compensation
 
on improved
operating performance in the current year,
 
and higher SG&A due to foreign currency translation.
 
In addition, SG&A was lower in the
prior year period as a result of certain temporary cost saving measures
 
the Company implemented in response to the onset of COVID-
19.
 
While the Company continues to manage costs during the on
 
-going pandemic, it has incurred higher SG&A as the global
economy continues to gradually rebound.
During the second quarter of 2021, the Company incurred
 
$6.7 million of Combination, integration and other acquisition-related
expenses primarily for professional fees related to Houghton integration
 
and other acquisition-related activities.
 
Comparatively, the
Company incurred $8.0 million of expenses in the prior
 
year second quarter, primarily due
 
to various professional fees related to legal,
financial and other advisory and consulting expenses for
 
integration activities.
 
See the Non-GAAP Measures section of this Item,
above.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
37
The Company initiated a restructuring program during
 
the third quarter of 2019 as part of its global
 
plan to realize cost synergies
associated with the Combination.
 
The Company incurred restructuring and related charges for
 
reductions in headcount and site
closures under this program of $0.3 million and $0.5 million
 
during the second quarters of 2021 and 2020, respectively.
 
See the Non-
GAAP Measures section of this Item, above.
Operating income in the second quarter of 2021 was $38.8
 
million compared to $2.2 million in the second quarter of
 
2020.
 
Excluding Combination, integration and other acquisition
 
-related expenses, restructuring and related charges
 
and other non-core
items, the Company’s
 
current quarter non-GAAP operating income increased 315% to
 
$46.4 million compared to $11.2 million in
 
the
prior year quarter primarily due to the increase in net sales described
 
above and the benefits from cost savings related to the
Combination offset by increases in raw material
 
costs.
The Company had other income, net, of $14.0 million
 
in the second quarter of 2021 compared to other expense,
 
net, of $1.0
million in the second quarter of 2020.
 
The second quarter of 2021 includes $13.3 million related to
 
certain non-income tax credits
recorded by the Company’s
 
Brazilian subsidiaries as well as lower foreign currency transaction
 
losses compared to the prior quarter.
 
See the Non-GAAP Measures section of this Item, above.
Interest expense, net, decreased $1.2 million compared
 
to the second quarter of 2020 driven by lower current quarter
 
borrowings
outstanding as a result of the additional revolver
 
borrowings drawn down in March 2020 at the onset of the
 
pandemic as well as a
decline in overall interest rates quarter-over-quarter.
The Company’s effective
 
tax rates for the second quarters of 2021 and 2020 were 32.2%
 
and 57.9%, respectively.
 
The
Company’s current quarter
 
effective tax rate was impacted by the changes in foreign
 
tax credit valuation allowances, tax law changes
in foreign jurisdictions as well as the tax impacts of
 
certain non-income tax credits recorded by the Company’s
 
Brazilian subsidiaries.
 
Comparatively,
 
the prior year second quarter effective tax rate was impacted
 
by the tax effect of certain one-time pre-tax losses.
 
Excluding the impact
 
of these items as well as all other non-core items in each
 
quarter, described in the Non
 
-GAAP Measures section
of this Item, above, the Company estimates that its second
 
quarters of 2021 and 2020 effective tax rates would
 
have been
approximately 24% and 18%, respectively.
 
The higher estimated current quarter tax rate was driven by the
 
impact of higher pre-tax
income in the current quarter as compared to the prior
 
year quarter on certain tax adjustments as well as increased withholding
 
taxes
on expected current year repatriated earnings.
 
The Company may experience continued volatility in its effective
 
tax rates due to
several factors, including the timing of tax audits and
 
the expiration of applicable statutes of limitations as they relate
 
to uncertain tax
positions, the unpredictability of the timing and
 
amount of certain incentives in various tax jurisdictions, the treatment
 
of certain
acquisition-related costs and the timing and amount
 
of certain share-based compensation-related tax benefits, among
 
other factors.
 
In
addition, the foreign tax credit valuation allowance is based
 
on a number of variables, including forecasted earnings,
 
which may vary.
Equity in net income of associated companies increased $0.5 million
 
in the second quarter of 2021 compared to the second
quarter of 2020, primarily due to higher current year
 
quarter income from the Company’s
 
interest in a captive insurance company
compared to the prior year quarter.
 
See the Non-GAAP Measures section of this Item, above.Net
 
income attributable to
noncontrolling interest was less than $0.1 million
 
in both the second quarters of 2021 and 2020.
Foreign exchange positively impacted the Company’s
 
second quarter results by approximately 10% driven by the positive
 
impact
from foreign currency translation on earnings as well as lower
 
foreign exchange transaction losses in the current
 
year quarter as
compared to the prior year second quarter.
 
Consolidated Operations Review – Comparison of the First Six
 
Months of 2021 with the First Six Months of 2020
Net sales were $865.0 million in the first six months of
 
2021 compared to $664.6 million in the first six months of
 
2020.
 
The net
sales increase of $200.4 million or 30% period-over-period
 
reflects a benefit from higher sales volumes of 22%, which includes
additional net sales from recent acquisitions of 4%,
 
the positive impact from foreign currency translation
 
of 5%, and increases in
selling price and product mix of 3%.
 
The increase in sales volumes compared to the first six months
 
of 2020 was primarily due to
improved end market conditions from the prior year impacts
 
of COVID-19 and continued market share gains.
 
Additional net sales
from acquisitions relate primarily to the acquisitions of
 
a tin-plating solutions business and Coral, acquired in February
 
2021 and
December 2020, respectively.
 
The positive impact from foreign currency translation
 
is primarily the result of the strengthening of the
euro and Chinese Renminbi against the U.S. dollar
 
year-over-year.
 
The increase from selling price and product mix includes the
benefits of current year selling price increases implemented
 
to date to help offset the rising raw material and
 
input costs.
 
COGS were $554.4 million in the first six months of 2021
 
compared to $433.4 million in the first six months of
 
2020.
 
The
increase in COGS of 28% was driven by the associated COGS
 
on the increase in net sales as described above, and to
 
a lesser extent,
an expense of $0.8 million associated with selling acquired
 
Coral inventory in the first six months of 2021 at its fair
 
value described in
the Non-GAAP Measures section of this Item above.
Gross profit in the first six months of 2021 increased $79.4
 
million or 34% from the first six months of 2020, due
 
primarily to the
increase in net sales described above.
 
The Company’s reported gross
 
margin in the first six months of 2021 was 35.9%
 
compared to
34.8% in the first six months of 2020.
 
Excluding one-time increases to COGS including accelerated
 
depreciation and the impact of
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
38
the inventory fair value step up in both periods, described in the
 
Non-GAAP section of this Item above, the Company estimates that
 
its
gross margins in the first six months of
 
2021 and 2020 would have been approximately 36.1% and
 
34.9%, respectively.
 
The
Company’s higher current
 
year gross margin was primarily due to the same
 
impacts described in the second quarter description above.
 
SG&A in the first six months of 2021 increased $27.6
 
million compared to the first six months of 2020 due
 
primarily to the same
drivers described in the second quarter description above.
During the first six months of 2021,
 
the Company incurred $12.5 million of Combination, integration
 
and other acquisition-
related expenses primarily for professional fees related
 
to Houghton integration and other acquisition-related activities.
 
Comparatively,
 
the Company incurred $15.9 million of expenses in the first six
 
months of 2020,
 
primarily due to various professional
fees related to integration activities.
 
See the Non-GAAP Measures section of this Item, above.
As described above, the Company initiated a restructuring
 
program during the third quarter of 2019 as part of its global
 
plan to
realize cost synergies associated with the Combination.
 
The Company recorded restructuring and related charges
 
of $1.5 million
during the first six months of 2021 compared to
 
$2.2 million during the first six months of 2020 under this
 
program.
 
See the Non-
GAAP Measures section of this Item, above.
During the first quarter of 2020, the Company recorded
 
a $38.0 million non-cash impairment charge to write
 
down the value of
certain indefinite-lived intangible assets associated with the
 
Combination.
 
This non-cash impairment charge is related to certain
acquired Houghton trademarks and tradenames and
 
was primarily the result of the projected negative impacts of COVID-19
 
as of
March 31, 2020 on their estimated fair values.
 
There was no similar impairment charges recorded
 
during the first six months of 2021.
 
Operating income in the first six months of 2021 was $83.7
 
million compared to an operating loss of $10.2 million in
 
the first six
months of 2020.
 
Excluding Combination, integration and other acquisition-related
 
expenses, restructuring and related charges, the
non-cash indefinite-lived intangible asset impairment
 
charge, and other non-core items, the Company’s
 
current year non-GAAP
operating income of $100.1 million increased compared
 
to $47.2 million in the prior year period, primarily due to the
 
increase in net
sales described above and the continued benefits from
 
cost savings related to the Combination.
The Company’s other
 
income, net, was $18.7 million in the first six months of 2021 compared
 
to other expense, net of $22.2
million in the prior year period.
 
The year-over-year change was primarily due to other
 
income related to certain non-income tax
credits recorded by the Company’s
 
Brazilian subsidiaries during the second quarter of 2021 as well as the
 
gain on the sale of certain
held-for-sale real property assets during the first
 
quarter of 2021 compared to a first quarter of 2020 pension plan
 
settlement charge
associated with the termination of the Legacy Quaker
 
U.S. Pension Plan.
 
See the Non-GAAP Measures section of this Item, above.
Interest expense, net, decreased $4.2 million in the first
 
six months of 2021 compared to the first six months of 2020
 
driven by
lower current year borrowings outstanding as a result of
 
the additional revolver borrowings drawn down in March 2020
 
at the onset of
the pandemic as well as a decline in overall interest rates year-over-year,
 
as the weighted average interest rate incurred on borrow
 
ings
under the Company’s credit
 
facility was approximately 1.6% during the first six months of
 
2021 compared to approximately 2.5%
during the first six months of 2020.
The Company’s effective
 
tax rates for the first six months of 2021 and 2020 was an expense
 
of 28.4% compared to a benefit of
20.7%, respectively.
 
The Company’s effective
 
tax rate for the six months ended June 30, 2021 was impacted
 
by the sale of certain
held-for-sale real property assets related to the
 
Combination, certain U.S. tax law changes and the tax impact of certain
 
non-income
tax credits recorded by the Company’s
 
Brazilian subsidiaries.
 
Comparatively,
 
the prior year first six months effective tax rate was
impacted by the tax effect of certain one-time
 
pre-tax losses as well as certain tax charges and benefits in
 
the current period including
those related to changes in foreign tax credit valuation allowances,
 
tax law changes in a foreign jurisdiction, and the tax impacts of
 
the
Company’s termination
 
of its Legacy Quaker U.S. Pension Plan and the Houghton
 
indefinite-lived trademarks and tradename
intangible asset impairment.
 
Excluding the impact of these items as well as all other non-core
 
items in each year, described in the
Non-GAAP Measures section of this Item, above,
 
the Company estimates that its first six months of 2021 and 2020
 
effective tax rates
were relatively consistent at approximately 24% and 21%,
 
respectively.
 
The year-over-year increase was largely
 
driven by the impact
of higher pre-tax income in the current year period as compared
 
to the prior year period on certain adjustments as well as increased
withholding tax on expense on current year repatriated
 
earnings.
 
Equity in net income of associated companies increased $5.1 million
 
in the first six months of 2021 compared to the first six
months of 2020, primarily due to higher current year earnings from
 
the Company’s interest in a captive
 
insurance company.
 
See the
Non-GAAP Measures section of this Item, above.
 
In addition, the Company had higher earnings year-over-year
 
from the Company’s
50% interest in its joint venture in Korea.
Net income attributable to noncontrolling interest was less than
 
$0.1 million in both the first six months of 2021 and 2020.
Foreign exchange positively impacted the Company’s
 
first six months of 2021 results by approximately 4% driven by the positive
impact from foreign currency translation on earnings partially
 
offset by higher foreign exchange transaction losses in
 
the current year
as compared to the prior year period.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
39
Reportable Segments Review - Comparison of the Second
 
Quarter of 2021
 
with the Second Quarter of 2020
 
The Company’s reportable
 
segments reflect the structure of the Company’s
 
internal organization, the method by which the
Company’s resources are
 
allocated and the manner by which the chief operating decision
 
maker of the Company assesses its
performance.
 
The Company has four reportable segments: (i) Americas;
 
(ii) EMEA; (iii) Asia/Pacific; and (iv) Global Specialty
Businesses.
 
The three geographic segments are composed of the net
 
sales and operations in each respective region, excluding net
sales and operations managed globally by the Global
 
Specialty Businesses segment, which includes the Company’s
 
container, metal
finishing, mining, offshore, specialty coatings,
 
specialty grease and Norman Hay businesses.
 
Segment operating earnings for the Company’s
 
reportable segments are comprised of net sales less COGS and SG&A directly
related to the respective segment’s
 
product sales.
 
Operating expenses not directly attributable to the net
 
sales of each respective
segment,
 
such as certain corporate and administrative costs, Combination,
 
integration and other acquisition-related expenses,
Restructuring and related charges, and COGS related
 
to acquired inventory sold, which is adjusted to fair value
 
as part of purchase
accounting,
 
are not included in segment operating earnings.
 
Other items not
 
specifically identified with the Company’s
 
reportable
segments include interest expense, net, and other (expense)
 
income, net.
Americas
 
Americas represented approximately 32% of the Company’s
 
consolidated net sales in the second quarter of 2021.
 
The segment’s
net sales were $139.7 million, an increase of $59.1
 
million or 73% compared to the second quarter of 2020.
 
The increase in net sales
reflects the inclusion of additional net sales from acquisitions, primarily
 
Coral.
 
Excluding sales from acquisitions, the segment’s
 
net
sales increase quarter-over-quarter of
 
approximately 65% was driven by higher volumes of 54%,
 
a benefit in selling price and product
mix of 7% and the positive impact of foreign currency
 
translation of 4%.
 
The current quarter volume increase was driven by the
continued economic rebound from the COVID-19
 
slowdown as the pandemic notably impacted this segment during
 
the second quarter
of 2020.
 
The foreign exchange impact was driven by the strengthening
 
of the Mexican peso against the U.S. dollar,
 
as this exchange
rate averaged 20.02 in the second quarter of 2021 compared to
 
23.32 during the second quarter of 2020.
 
This segment’s operating
earnings were $33.6 million, an increase of $23.3
 
million or 227% compared to the second quarter of 2020.
 
The increase in segment
operating earnings reflects the higher net sales describe
 
d
 
above coupled with a higher current quarter gross margin,
 
partially offset by
higher SG&A, including SG&A from acquisitions and
 
an increase in SG&A as the prior year second quarter included temporary
 
cost
savings measures implemented in response to the onset of
 
the COVID-19 pandemic.
EMEA
EMEA represented approximately 28% of the Company’s
 
consolidated net sales in the second quarter of 2021.
 
The segment’s
net sales were $123.4 million, an increase of $45.7
 
million or 59% compared to the second quarter of 2020.
 
The increase in net sales
was driven by increases in volumes of 38%, the positive impact
 
of foreign currency translation of 13%, a benefit from selling
 
price
and product mix of 5%, and additional net sales from acquisitions
 
of 3%.
 
The current quarter volume increase was driven by the
continued economic rebound from the COVID-19
 
slowdown as the pandemic notably impacted this segment during
 
the second quarter
of 2020.
 
The foreign exchange impact was primarily driven by the
 
strengthening of the euro against the U.S. dollar as this exchange
rate averaged 1.20 in the second quarter of 2021 compared
 
to 1.10 in the second quarter of 2020.
 
This segment’s operating earnings
were $23.4 million, an increase of $12.9 million or 124%
 
compared to the second quarter of 2020.
 
The increase in segment operating
earnings reflects the higher net sales described above
 
coupled with a higher current quarter gross margin, partially
 
offset by higher
SG&A as the prior year second quarter included temporary
 
cost savings measures implemented in response to the
 
onset of the
COVID-19 pandemic.
Asia/Pacific
Asia/Pacific represented approximately 21% of the
 
Company’s consolidated net
 
sales in the second quarter of 2021.
 
The
segment’s net sales were $91.6
 
million, an increase of approximately $23.1 million or 34% compared
 
to the second quarter of 2020.
 
The increase in net sales quarter-over-quarter
 
was driven by increases in volumes of 26% and the positive impact
 
of foreign currency
translation of 9% and additional net sales from acquisitions
 
of less than 1%, partially offset by decreases from
 
selling price and
product mix of 2%.
 
The current quarter volume increase was driven by the continued economic
 
rebound from the COVID-19
slowdown.
 
The foreign exchange impact was primarily due to the strengthening
 
of the Chinese renminbi against the U.S. dollar as
this exchange rate averaged 6.46 in the second quarter
 
of 2021 compared to 7.09 in the second quarter of 2020.
 
This segment’s
operating earnings were $23.2 million, an increase of
 
$4.0 million or 21% compared to the second quarter of 2020.
 
The increase in
segment operating earnings reflects the higher net sales descr
 
ibed above partially offset by lower gross margins
 
on rising raw material
costs as well as higher SG&A which includes an increase in
 
direct selling costs associated with higher net sales.
Global Specialty Businesses
Global Specialty Businesses represented approximately
 
19% of the Company’s consolidated
 
net sales in the second quarter of
2021.
 
The segment’s net sales were $80.6
 
million, an increase of $21.3 million or 36% compared to the second
 
quarter of 2020.
 
The
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
40
increase in net sales reflects the inclusion of additional
 
net sales from acquisitions, primarily Coral.
 
Excluding net sales from
acquisitions, the segment’s
 
net sales would have increased 27% quarter-over-quarter
 
driven by increases in selling price and product
mix, including Norman Hay,
 
of 15%, increases in volumes of 7% and the positive impact
 
of foreign currency translation of
approximately 5%.
 
The foreign exchange impact was a result of similar strengthening
 
of certain currencies in EMEA and Americas as
described above.
 
This segment’s operating earnings
 
were $24.2 million, an increase of $7.8 million or 48%
 
compared to the second
quarter of 2020.
 
The increase in segment operating earnings reflects the higher net
 
sales described above coupled with higher gross
margins compared to the second quarter of 2020,
 
partially offset by higher SG&A as the prior
 
year second quarter included temporary
cost savings measures implemented in response to the
 
onset of the COVID-19 pandemic.
 
Reportable Segments Review - Comparison of the First Six
 
months of 2021 with the First Six months of 2020
 
Americas
Americas represented approximately 32% of the Company’s
 
consolidated net sales in the first six months of 2021.
 
The segment’s
net sales were $274.5 million, an increase of $64.0
 
million or 30% compared to the first six months of 2020.
 
The increase in net sales
was due to higher sales volumes of 21%, additional
 
net sales from acquisitions of 6% primarily resulting from
 
Coral, and benefits
from selling price and product mix of 3%.
 
The current year volume increase was driven by the continued
 
economic rebound from the
COVID-19 slowdown as the pandemic began in late
 
March and continued throughout the second quarter of 2020.
 
This segment’s
operating earnings were $65.9 million, an increase of
 
$26.4 million or 67% compared to the first six months of 2020.
 
The increase in
segment operating earnings reflects the higher net sales described
 
above coupled with higher gross margins in the
 
current year period,
partially offset by higher SG&A.
EMEA
EMEA represented approximately 28% of the Company’s
 
consolidated net sales in the first six months of 2021.
 
The segment’s
net sales were $243.3 million, an increase of $60.7
 
million or 33% compared to the first six months of 2020.
 
The increase in net sales
was due to higher sales volumes of 17%, the positive impacts
 
from foreign exchange translation of 10%, increases in
 
selling price and
product mix of 4% and additional net sales from acquisitions
 
of 2%.
 
The current year volume increase was driven by the continued
economic rebound from the COVID-19 slowdown
 
as the pandemic began in late March and continued throughout the
 
second quarter
of 2020.
 
The foreign exchange impact was primarily due to the strengthening
 
of the euro and British pound against the U.S. dollar as
these exchange rates averaged 1.21 and 1.39, respectively,
 
during the first six months of 2021 compared to 1.10
 
and 1.26, respectively,
during the first six months of 2020.
 
This segment’s operating earnings
 
were $48.6 million, an increase of $19.8 million or 69%
compared to the first six months of 2020.
 
The increase in segment operating earnings reflect the higher
 
net sales described above
coupled with improved gross margins in
 
the current year period, partially offset by higher SG&A.
Asia/Pacific
Asia/Pacific represented approximately 22% of the
 
Company’s consolidated net
 
sales in the first six months of 2021.
 
The
segment’s net sales were $188.3
 
million, an increase of $46.3 million or 33% compared to the first
 
six months of 2020.
 
The increase
in net sales was driven by higher sales volumes of
 
approximately 26% and the positive impact of foreign currency
 
translation of 7%.
 
The current year volume increase was driven by
 
the continued gradual economic rebound from the COVID-19 slowdown
 
as the
pandemic notably impacted China during the first quarter of
 
2020 and then the rest of the region during the second quarter
 
of 2020.
 
The foreign exchange impact was primarily due to the
 
strengthening of the Chinese renminbi against the U.S. dollar as
 
this exchange
rate averaged 6.47 during the first six months of 2021 compared
 
to 7.03 during the first six months of 2020.
 
This segment’s operating
earnings were $50.7 million, an increase of $11.9
 
million or 31% compared to the first six months of 2020.
 
The increase in segment
operating earnings were a result of the higher net sales described
 
above partially offset by lower gross margins
 
compared to the first
six months of 2020 driven by increasing raw material
 
costs in the current year, as well as higher
 
SG&A.
Global Specialty Businesses
Global Specialty Businesses represented 18% of the
 
Company’s consolidated net sales in the
 
first six months of 2021.
 
The
segment’s net sales were $159.0
 
million, an increase of $29.4 million or 23% compared to the first
 
six months of 2020.
 
The increase
in net sales was driven by benefits from selling price
 
and product mix, including Norman Hay,
 
of 18%, additional net sales from
acquisitions of 7% primarily driven by Coral, and the
 
positive impact of foreign currency transaction of 4%, partially
 
offset by
decreases in volumes of 6%.
 
The foreign exchange impact was a result of similar strengthening
 
of certain currencies in EMEA and
Americas as described above.
 
Both the changes in selling price and product mix and
 
sales volumes were primarily driven by higher
shipments of a lower priced product in the Company’s
 
mining business in the period year period.
 
This segment’s operating earnings
were $48.4 million, an increase of $11.4
 
million of 31% compared to the first six months of 2020.
 
The increase in segment operating
earnings reflects the higher net sales described above
 
on relatively consistent gross margins period
 
-over-period, partially offset by
slightly higher SG&A in the current year.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
41
Factors That May Affect Our Future Results
(Cautionary Statements Under the Private Securities Litigation
 
Reform Act of 1995)
Certain information included in this Report and other
 
materials filed or to be filed by Quaker Chemical Corporation
 
with the
Securities and Exchange Commission (“SEC”) (as well as information
 
included in oral statements or other written statements made
 
or
to be made by us) contain or may contain forward-looking
 
statements within the meaning of Section 27A of the Securities Act
 
of
1933, as amended, and Section 21E of the Securities Exchange
 
Act of 1934, as amended.
 
These statements can be identified by the
fact that they do not relate strictly to historical or
 
current facts.
 
We have based
 
these forward-looking statements, including statements
regarding the potential effects of the COVID-19
 
pandemic on the Company’s
 
business, results of operations, and financial condition,
our expectation that we will maintain sufficient
 
liquidity and remediate any of our material weaknesses in internal
 
control over
financial reporting, and statements regarding the impact
 
of increased raw material costs and pricing initiative
 
s
 
on our current
expectations about future events.
 
These forward-looking statements include statements with respect
 
to our beliefs, plans, objectives, goals, expectations,
anticipations, intentions, financial condition, results of operations,
 
future performance, and business, including:
 
•
 
the potential benefits of the Combination and other acquisitions;
 
•
 
the impacts on our business as a result of the COVID-19
 
pandemic and any projected global economic rebound
 
or
anticipated positive results due to Company actions taken
 
in response to the pandemic;
•
 
our current and future results and plans; and
 
•
 
statements that include the words “may,”
 
“could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,”
“intend,” “plan” or similar expressions.
Such statements include information relating to current and
 
future business activities, operational matters, capital spending,
 
and
financing sources.
 
From time to time, forward-looking statements are also included in
 
the Company’s other periodic
 
reports on Forms
10-K, 10-Q and 8-K, press releases, and other materials released
 
to, or statements made to, the public.
Any or all of the forward-looking statements in this Report,
 
in the Company’s Annual
 
Report to Shareholders for 2020 and in any
other public statements we make may turn out to be wrong.
 
This can occur as a result of inaccurate assumptions
 
or as a consequence
of known or unknown risks and uncertainties.
 
Many factors discussed in this Report will be important in determining
 
our future
performance.
 
Consequently, actual results may
 
differ materially from those that might be anticipated
 
from our forward-looking
statements.
We undertake
 
no obligation to publicly update any forward-looking statements,
 
whether as a result of new information, future
events or otherwise.
 
However, any further disclosures made
 
on related subjects in the Company’s
 
subsequent reports on Forms 10-K,
10-Q, 8-K and other related filings should be consulted.
 
A major risk is that demand for the Company’s
 
products and services is
largely derived from the demand for our customers’
 
products, which subjects the Company to uncertainties related
 
to downturns in a
customer’s business and unanticipated customer
 
production slowdowns and shutdowns, including as is currently
 
being experienced by
many automotive industry companies.
 
Other major risks and uncertainties include, but are not limited
 
to, the primary and secondary
impacts of the COVID-19 pandemic, including actions
 
taken in response to the pandemic by various governments, which
 
could
exacerbate some or all of the other risks and uncertainties
 
faced by the Company,
 
including the potential for significant increases in
raw material costs, supply chain disruptions, customer
 
financial instability, worldwide
 
economic and political disruptions, foreign
currency fluctuations, significant changes in applicable
 
tax rates and regulations, future terrorist attacks and other acts of
 
violence.
 
Furthermore, the Company is subject to the same business
 
cycles as those experienced by our customers in the
 
steel, automobile,
aircraft, industrial equipment, and durable goods industries.
 
The ultimate impact of COVID-19 on our business will depend
 
on,
among other things, the extent and duration of the pandemic, the
 
severity of the disease and the number of people infected with
 
the
virus including as new variants emerge, the
 
continued uncertainty regarding global availability,
 
administration, acceptance and long-
term efficacy of vaccines, or other treatments for
 
COVID-19 or its variants, the longer-term effects
 
on the economy by the pandemic,
including the resulting market volatility,
 
and by the measures taken by governmental authorities and other
 
third parties restricting day-
to-day life and business operations and the length of time
 
that such measures remain in place, as well as laws and other governmental
programs implemented to address the pandemic
 
or assist impacted businesses, such as fiscal stimulus and other
 
legislation designed to
deliver monetary aid and other relief.
 
Other factors could also adversely affect us, including
 
those related to the Combination and
other acquisitions and the integration of acquired businesses.
 
Our forward-looking statements are subject to risks, uncertainties and
assumptions about the Company and its operations that
 
are subject to change based on various important factors, some
 
of which are
beyond our control.
 
These risks, uncertainties, and possible inaccurate assumptions relevant
 
to our business could cause our actual
results to differ materially from expected
 
and historical results.
 
Therefore, we caution you not to place undue reliance
 
on our forward-looking statements.
 
For more information regarding these
risks and uncertainties as well as certain additional
 
risks that we face, refer to the Risk Factors section, which appears
 
in Item 1A in
our 2020 Form 10-K and in our quarterly and other reports
 
filed from time to time with the SEC.
 
This discussion is provided as
permitted by the Private Securities Litigation Reform Act
 
of 1995.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
 
42
Quaker Houghton on the Internet
 
Financial results, news and other information about
 
Quaker Houghton can be accessed from the Company’s
 
website at
https://www.quakerhoughton.com.
 
This site includes important information on the Company’s
 
locations, products and services,
financial reports, news releases and career opportunities.
 
The Company’s periodic
 
and current reports on Forms 10-K, 10-Q, 8-K, and
other filings, including exhibits and supplemental
 
schedules filed therewith, and amendments to those reports, filed with
 
the SEC are
available on the Company’s
 
website, free of charge, as soon as reasonably
 
practicable after they are electronically filed with or
furnished to the SEC.
 
Information contained on, or that may be accessed through,
 
the Company’s website is not
 
incorporated by
reference in this Report and, accordingly,
 
you should not consider that information part of this Report.
 
43
Item 3.
 
Quantitative and Qualitative Disclosures About Market
 
Risk.
 
We have evaluated
 
the information required under this Item that was disclosed in Part II,
 
Item 7A, of our Annual Report on Form
10-K for the year ended December 31, 2020, and we
 
believe there has been no material change to that information.
 
 
44
Item 4.
 
Controls and Procedures.
 
Evaluation of disclosure controls
 
and procedures.
 
As required by Rule 13a-15(b) under the Securities Exchange
 
Act of 1934, as
amended (the “Exchange Act”), our management,
 
including our principal executive officer and principal financial
 
officer, has
evaluated the effectiveness of our disclosure
 
controls and procedures (as defined in Rule 13a-15(e) under the
 
Exchange Act ) as of the
end of the period covered by this Report.
 
Based on that evaluation, our principal executive officer
 
and our principal financial officer
have concluded that, as of the end of the period covered by
 
this Report, our disclosure controls and procedures (as defined
 
in Rule
13a-15(e) under the Exchange Act) were not effective
 
as of June 30, 2021 because of the material weaknesses in our
 
internal control
over financial reporting, as described below.
As previously disclosed in “Item 9A. Controls and Procedures.”
 
in the Company’s 2020
 
Form 10-K, through the process of
evaluating risks and corresponding changes to the
 
design of existing or the implementation of new controls
 
in light of the significant
non-recurring transactions that occurred during 2019,
 
including the Combination, the Company identified certain deficiencies in
 
its
application of the principles associated with the
Committee of Sponsoring Organizatio
 
n
 
of the Treadway
 
Commission in Internal
Control – Integrated Framework (2013)
 
that management has concluded in the aggregate constitute a material
 
weakness.
 
A material
weakness is a deficiency,
 
or combination of deficiencies, in internal control over financial reporting,
 
such that there is a reasonable
possibility that a material misstatement of annual or interim
 
financial statements will not be prevented or detected on
 
a timely basis.
 
We did not
 
design and maintain effective controls in response to the
 
risks of material misstatement.
 
Specifically, changes to existing
controls or the implementation of new controls were not
 
sufficient to respond to changes to the risks of material
 
misstatement in
financial reporting as a result of becoming a larger,
 
more complex global organization due to the Combination.
 
This material
weakness also contributed to an additional material weakness as we did
 
not design and maintain effective controls
 
over the review of
pricing, quantity and customer data to verify that revenue
 
recognized was complete and accurate.
 
These material weaknesses did not
result in material misstatements to the interim or annual
 
consolidated financial statements.
 
However, these material weaknesses could
result in misstatements to our account balances and disclosures
 
that could result in a material misstatement to the interim
 
or annual
consolidated financial statements that would not be
 
prevented or detected.
Notwithstanding these material weaknesses, the Company
 
has concluded that the unaudited condensed consolidated financial
statements included in this Report present fairly,
 
in all material respects, the financial position of the Company as of
 
June 30, 2021
and December 31, 2020, and that the results of its operations
 
and its cash flows and changes in equity for both the
 
three and six month
periods ended June 30, 2021 and 2020, are in conformity
 
with accounting principles generally accepted in the United States of
America.
 
Progress on Remediation
 
of Material Weaknesses
The Company and its Board of Directors, including the
 
Audit Committee of the Board of Directors, are committed to maintaining
a strong internal control environment.
 
Since identifying the material weaknesses, the Company
 
has dedicated a significant amount of
time and resources to remediate all of the previously identified
 
material weaknesses as quickly and effectively
 
as possible. During
2020 and into 2021,
 
the Company dedicated multiple internal resources and supplemented
 
those internal resources with various third-
party specialists to assist with the formalization of
 
a robust and detailed remediation plan.
 
In undertaking remediation activities, the
Company has hired additional personnel dedicated to
 
financial and information technology compliance to further
 
supplement its
internal resources.
 
In addition, the Company has established a global network
 
of personnel to assist local management in
understanding control performance and documentation
 
requirements.
 
In order to sustain this network, the Company conducts periodic
trainings and hosts discussions to address questions on
 
a current basis.
 
However, the impact of COVID-19,
 
including travel
restrictions and remote work arrangements required
 
the Company to adapt and make changes to its internal controls
 
integration plans
as well as its remediation plans, and has presented and
 
is expected to continue to present challenges with regards to the
 
timing of the
Company’s remediation
 
and integration plan activities.
 
Despite the challenges brought on by COVID-19 and
 
driven by the Company’s
 
priority of creating a long-term sustainable control
structure to ensure stability for a company that has more
 
than doubled in size since August 2019, the Company continues
 
to make
substantial strides towards remediating the underlying
 
causes of the previously disclosed material weaknesses in our
 
risk assessment
process and within our revenue process, as further discussed
 
below.
Risk Assessment –
 
We previously determined
 
that our risk assessment process was not designed adequately
 
to respond to changes
to the risks of material misstatement to financial reporting.
 
In order to remediate this material weakness, we have designed
 
and
implemented an improved risk assessment process, including
 
identifying and assessing those risks attendant to the
 
significant changes
within the Company as a result of becoming a larger,
 
more complex global organization due to the
 
Combination.
 
During 2020, a full
review was performed of our processes and controls across
 
significant locations in order to identify and address potential
 
design gaps.
 
In addition to individual transactional-level control enhancements,
 
this review resulted in (i) an enhanced financial statement
 
risk
assessment, (ii) the standardization of existing legal entity
 
and newly implemented segment quarterly analytics and
 
quarterly closing
packages completed by key financial reporting personnel, (iii) a
 
global account reconciliation review program and (iv)
 
enhancements
to our quarterly identification and reassessment of new and
 
existing business and information technology risks that could
 
affect our
financial reporting.
 
Monitoring is also performed through our enhanced quarterly
 
controls certification process, whereby changes in
business or information technology processes or control
 
owners are identified and addressed timely.
 
Although we have implemented
 
45
and tested the additional controls as noted in our remediation
 
plan and found them to be effective, this material
 
weakness will not be
considered remediated due to the Revenue – Price and
 
Quantity material weakness, discussed below.
 
Once the Revenue – Price and
Quantity material weakness is remediated, we expect
 
the Risk Assessment material weakness will also be remediated.
 
Revenue – Price and Quantity –
We previously
 
determined that we did not design and maintain effective
 
controls over the review
of pricing, quantity and customer data to verify that revenue
 
recognized was complete and accurate.
 
In order to remediate this
material weakness, the Company made significant progress
 
in its redesign of certain aspects of its revenue process and related
controls.
 
The Company has identified and agreed upon design enhancements
 
and requirements for each revenue sub-process.
 
The
design includes enhancements to entity-level and transactional
 
-level manual controls as well as IT general and application
 
controls.
 
During July 2021 and through the date of this Form
 
10-Q filing for the period ended June 30, 2021, the Company has
 
been in the
process of implementing these design changes both
 
centrally and locally.
 
We expect to
 
complete the implementation in the third
quarter of 2021.
 
While the Company believes that the enhancements to these
 
entity-level, transactional and IT general and application
controls will sufficiently address the material weakness
 
previously identified, because the additional controls
 
have not been fully
implemented and tested, this material weakness is not yet remediated.
 
The existing material weakness will not be considered
remediated until the applicable remedial controls have
 
been fully implemented and operate for a sufficient
 
period of time and
management has concluded, through testing, that
 
the controls are operating effectively.
 
Given the significant resources the Company has dedicated
 
to remediation of its material weaknesses, the Company is committed
to remediation and expects that in 2021 it will successfully implement
 
the enhanced design of its revenue processes and have a
sufficient operational effectiveness period
 
to evidence remediation over its price and quantity material weakness
 
and, concurrently,
evidence remediation over its risk assessment material weakness
 
in 2021 as well.
 
 
Changes in internal control over financial
 
reporting.
 
As required by Rule 13a-15(d) under the Exchange Act,
 
our
management, including our principal executive officer
 
and principal financial officer, has evaluated
 
our internal control over
financial reporting to determine whether any changes
 
to our internal control over financial reporting occurred during
 
the
quarter ended June 30, 2021 that have materially affected,
 
or are reasonably likely to materially affect, our
 
internal control
over financial reporting.
 
Based on that evaluation, there were no changes that have materially
 
affected, or are reasonably
likely to materially affect, our internal control
 
over financial reporting during the quarter ended June
 
30, 2021.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
46
PART
 
II.
 
OTHER INFORMATION
Items 3, 4 and 5 of Part II are inapplicable and have been
 
omitted.
Item 1.
 
Legal Proceedings.
 
Incorporated by reference is the information in Note
 
19 of the Notes to the Condensed Consolidated Financial
 
Statements in Part
I, Item 1, of this Report.
Item 1A. Risk Factors.
The Company’s business,
 
financial conditions, results of operations and cash flows are
 
subject to various risks that could cause
actual results to vary materially from recent results or from
 
anticipated future results.
 
In addition to the other information set forth in
this Report, you should carefully consider the risk factors
 
previously disclosed in Part I, Item 1A of our 2020 Form 10-K.
 
There have
been no material changes to the risk factors described therein.
Item 2.
 
Unregistered Sales of Equity Securities and Use of
 
Proceeds.
The following table sets forth information concerning
 
shares of the Company’s
 
common stock acquired by the Company during
the period covered by this Report:
(c)
(d)
Total
 
Number of
Approximate Dollar
(a)
(b)
Shares Purchased
 
Value of
 
Shares that
Total
 
Number
Average
as part of
May Yet
 
be
of Shares
Price Paid
Publicly Announced
Purchased Under the
Period
Purchased (1)
Per Share (2)
Plans or Programs
Plans or Programs (3)
April 1 - April 30
616
 
$
243.71
 
—
$
86,865,026
 
May 1 - May 31
—
$
—
—
$
86,865,026
 
June 1 - June 30
—
$
—
—
$
86,865,026
 
Total
616
 
$
243.71
—
$
86,865,026
 
 
(1)
 
All of these shares were acquired from employees upon
 
their surrender of Quaker Chemical Corporation shares in payment
 
of
the exercise price of employee stock options exercised or
 
for the payment of taxes upon exercise of employee stock
 
options
or the vesting of restricted stock.
 
(2)
 
The price paid for shares acquired from employees pursuant
 
to employee benefit and share-based compensation
 
plans is, in
each case, based on the closing price of the Company’s
 
common stock on the date of exercise or vesting as specified by the
plan pursuant to which the applicable option or restricted
 
stock was granted.
 
(3)
 
On May 6, 2015,
 
the Board of Directors of the Company approved, and the
 
Company announced, a share repurchase
program, pursuant to which the Company is authorized
 
to repurchase up to $100,000,000 of Quaker Chemical Corporation
common stock (the “2015 Share Repurchase Program”),
 
and it has no expiration date.
 
There were no shares acquired by the
Company pursuant to the 2015 Share Repurchase Program
 
during the quarter ended June 30, 2021.
Limitation on the Payment of Dividends
The Credit Facility has certain limitations on the payment
 
of dividends and other so-called restricted payments.
 
See Note 15 of
Notes to Condensed Consolidated Financial Statements, in
 
Part I, Item 1, of this Report.
 
 
 
 
47
Item 6.
 
Exhibits.
 
(a) Exhibits
3.1
–
3.2
–
10.1
–
10.2
–
10.3
–
10.4
–
10.5
–
10.6
–
31.1
–
31.2
–
32.1
–
.**
32.2
–
.**
101.INS
–
Inline XBRL Instance Document*
101.SCH
–
Inline XBRL Taxonomy
 
Extension Schema Document*
101.CAL
–
Inline XBRL Taxonomy
 
Extension Calculation Linkbase Document*
101.DEF
–
Inline XBRL Taxonomy
 
Extension Definition Linkbase Document*
101.LAB
–
Inline XBRL Taxonomy
 
Extension Label Linkbase Document*
101.PRE
–
Inline XBRL Taxonomy
 
Extension Presentation Linkbase Document*
104
–
Cover Page Interactive Data File (formatted as Inline XBRL and
 
contained in Exhibit 101.INS)*
* Filed herewith.
** Furnished herewith.
† Management contract or compensatory plan.
 
*********
 
Pursuant to the requirements of the Securities Exchange Act
 
of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
 
(Registrant)
 
 
 
 
/s/ Shane W.
 
Hostetter
Date: August 5, 2021
 
 
 
Shane W.
 
Hostetter,
 
Senior Vice President, Chief Financial
Officer (officer duly authorized on behalf of,
 
and principal
financial officer of, the Registrant)
 
 EX-10.1 2 exhibit101.htm FORM OF RESTRICTED STOCK AWARD AGREEMENT FOR NON-EMPLOYEE DIRECTORS exhibit101
exhibit101p1i0.gif
 
1
EXHIBIT 10.1
RESTRICTED STOCK AWARD
Pursuant to the current compensation
 
structure for a member of the
 
Board of Directors of Quaker Houghton
 
(the “Board”), First Name
Last Name
 
(the “Grantee”),
 
is hereby
 
issued shares
 
of $1.00
 
par value
 
Common Stock
 
of Quaker
 
Houghton (the
 
“Company”) as
 
a
Restricted Stock
 
Award
 
(the “Award”)
 
under the
 
Quaker Houghton
 
2016 Long-Term
 
Performance Incentive
 
Plan (the
 
“Plan”)
representing a $110,000.00
 
equity award calculated as of MM DD, YYYY (the “Effective
 
Date”) at $XXX.XX per share.
 
This Award
is subject to Grantee’s acceptance
 
of the terms and conditions of this Award
 
set forth in this agreement (the “Agreement”).
 
 
Except as provided herein and in the Plan, shares of
 
Restricted Stock subject to this Award will vest in a single installment on the earlier
of (i) MM
 
DD, YYYY or
 
(ii), if Grantee’s
 
retirement date is
 
the date of
 
the Company’s
 
annual meeting in
 
the next service
 
year (and
Grantee is not
 
up for re-election
 
to serve a
 
new term on
 
the Board), the
 
day before the
 
date of the
 
Company’s annual
 
meeting in that
year.
 
The terms and conditions
 
of this Award
 
are governed by this Agreement
 
and the Plan.
 
Unless otherwise defined herein,
 
terms used in
this Agreement have the meanings assigned to them in the Plan.
 
In the event of any inconsistency between the terms of this Agreement
and the terms of the Plan, the terms of the Plan shall govern.
 
1.
 
As soon as practicable
 
after the Effective
 
Date of this Award,
 
the Company will transfer
 
the number of shares
 
of Common Stock
designated in this Award
 
into a book entry account, opened in Grantee’s
 
name with the Company’s transfer
 
agent.
 
 
2.
 
Shares of Restricted Stock
 
transferred under paragraph 1
 
are subject to certain
 
restrictions for so long
 
as such shares remain
 
unvested
and subject
 
to a risk
 
of forfeiture.
 
Shares of Restricted
 
Stock that
 
have not
 
fully vested
 
under the
 
vesting provisions
 
described
herein, notwithstanding
 
Grantee’s right
 
to vote such
 
stock and receive
 
dividends thereon, may
 
not be sold,
 
assigned, transferred,
exchanged, pledged, hypothecated or
 
otherwise encumbered. Grantee may,
 
however, grant to
 
another person a revocable proxy
 
to
vote unvested shares of Restricted Stock at a Company
 
stockholders’ meeting.
 
3.
 
Grantee (or Grantee’s
 
beneficiary) will have
 
full voting rights
 
with respect to
 
shares of Restricted
 
Stock granted pursuant
 
to this
Award.
 
4.
 
Grantee will be entitled to receive cash dividends on
 
shares of Restricted Stock payable to shareholders of record after
 
the Effective
Date (unless and until such
 
Restricted Stock is forfeited).
 
Cash dividends paid on unvested
 
shares of Restricted Stock will
 
be treated
as ordinary compensation and are
 
subject to withholding.
 
Any stock dividends (or other
 
non-cash dividends) on shares of
 
Restricted
Stock will be subject to the same restrictions as the Restricted
 
Stock.
 
5.
 
Under the Plan,
 
unvested shares of
 
Restricted Stock will
 
be forfeited
 
in the event
 
Grantee’s Board
 
directorship ends prior
 
to the
completion of the
 
vesting period, unless
 
such termination is
 
due to (i) death,
 
(ii) Total
 
Disability or (iii)
 
retirement after attaining
the retirement age under the Board’s
 
retirement policy.
 
6.
 
Shares of
 
Restricted Stock
 
that are
 
no longer
 
subject to
 
forfeiture, will
 
be deposited
 
to Grantee’s
 
stock plan
 
account with
 
the
Company’s third-party administrator as soon as practicable
 
after the date on which
 
they irrevocably vest.
 
Upon the vesting of shares
of Restricted Stock, the
 
prohibition against the
 
sale or transfer of
 
such shares will be
 
lifted and such
 
shares may be treated
 
as any
other shares
 
of Common
 
Stock of
 
the Company,
 
subject to
 
any restrictions
 
on transfer
 
that may
 
be applicable
 
under Federal
securities laws or the Company’s
 
Insider Trading Policy.
 
 
7.
 
Nothing in the Plan
 
or this Agreement will
 
be construed as creating
 
any right in the
 
Grantee to continued
 
employment or service,
or as altering or amending the existing
 
terms and conditions of the Grantee’s
 
employment or service.
 
 
Quaker Chemical Corporation
A Quaker Houghton Company
901 E. Hector Street
Conshohocken, PA 19428-2380
T: 610.832.4000
quakerhoughton.com.
 
 
 
2
8.
 
All notices required
 
to be given
 
hereunder shall
 
be mailed by
 
registered or
 
certified mail to
 
the Company
 
to the attention
 
of its
Secretary, at
 
901 E. Hector
 
Street, Conshohocken, Pennsylvania
 
19428, and to
 
Grantee at Grantee’s
 
address as it
 
appears on the
Company’s books and
 
records unless either of said parties has duly notified the other
 
in writing of a change in address.
 
9.
 
To the
 
extent not preempted
 
by Federal law,
 
this Agreement shall
 
be construed, administered
 
and governed in
 
all respects under
and by the laws of the Commonwealth of Pennsylvania,
 
without giving effect to its conflict of laws principles.
 
10.
 
This Agreement contains all the
 
understandings between the parties
 
hereto pertaining to the
 
matter referred to herein, and
 
supersedes
all undertakings and agreements,
 
whether oral or in
 
writing, previously entered into
 
by them with respect
 
thereto.
 
Grantee represents
that, in
 
executing this Agreement,
 
Grantee has not
 
relied upon any
 
representation or
 
statement not set
 
forth herein
 
made by
 
the
Company with regard to the subject matter of this Agreement.
 
 
QUAKER HOUGHTON
 
 
 
By:
 
 
Robert T. Traub
 
 
 
 
Grantee represents that Grantee is familiar with the terms and provisions of the Plan, and hereby accepts this Award
 
subject to
the terms and
 
provisions of the Plan
 
insofar as they
 
relate to Restricted Stock
 
granted thereunder.
 
Grantee agrees hereby
 
to accept as
binding, conclusive, and final all decisions or interpretations
 
of the Committee upon any questions arising under
 
the Plan or this Grant.
 
Grantee authorizes the
 
Company to withhold
 
in accordance with applicable
 
law from any
 
compensation payable to
 
Grantee any taxes
required to be withheld by Federal, state, or local law as a result of the vesting of this Award
 
.
 
Grantee represents that, in executing this
Agreement, Grantee has
 
not relied upon
 
any representation or
 
statement not set
 
forth herein made
 
by the Company
 
with regard to
 
the
subject matter of this Agreement.
 
 
 
 
 
 
By:
 
 
First Name Last Name
 
 
 
 GRAPHIC 3 exhibit101p1i0.gif LOGO begin 644 exhibit101p1i0.gif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�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end EX-10.2 4 exhibit102.htm FORM OF RESTRICTED STOCK AWARD AGREEMENT FOR EXECUTIVE OFFICERS AND OTHER EMPLOYEES exhibit102

exhibit102p1i0.gif
 
1
EXHIBIT 10.2
 
RESTRICTED STOCK AWARD
 
 
The Compensation
 
and Human
 
Resources Committee
 
(the “Committee”)
 
of the
 
Board of
 
Directors of
 
Quaker Houghton
 
(“the
Company”) has approved the
 
award (the “Award”) to First Name
 
Last Name (the “Grantee”),
 
of XXX shares of
 
$1.00 par value Common
Stock of
 
the Company
 
as a Restricted
 
Stock Award
 
under the
 
Quaker Houghton
 
2016 Long
 
-Term Performance
 
Incentive Plan
 
(the
“Plan”).
 
Subject to Grantee’s
 
acceptance of the terms and conditions
 
of this Award
 
set forth in this agreement (the
 
“Agreement”), this
Award
 
is effective as of MM DD, YYYY (the “Effective
 
Date”).
 
Except as provided herein and in the Plan, shares of Restricted Stock subject to this Award will vest in a single installment on MM DD,
YYYY (the “Vesting
 
Date”) (the period from the Effective
 
Date to the Vesting
 
Date, the “Restriction Period”).
The terms and conditions
 
of this Award
 
are governed by this Agreement
 
and the Plan.
 
Unless otherwise defined herein,
 
terms used in
this Agreement have the meanings assigned to them in the Plan.
 
In the event of any inconsistency between the terms of this Agreement
and the terms of the Plan, the terms of
 
the Plan shall govern.
1.
 
As soon as practicable after the Effective Date of this Award, the Company will transfer the number of shares of Common
Stock designated in this Award
 
into a book entry account, opened
 
in Grantee’s name with
 
the Company’s transfer
 
agent.
 
 
2.
 
Shares of Restricted Stock transferred under
 
paragraph 1 are subject to
 
certain restrictions for so long
 
as such shares remain
unvested and
 
subject to
 
a risk
 
of forfeiture.
 
Shares of
 
Restricted Stock
 
that have
 
not fully
 
vested under
 
the vesting
provisions described herein, notwithstanding Grantee’s right to vote such stock and receive dividends thereon, may not be
sold, assigned, transferred,
 
exchanged, pledged, hypoth
 
ecated or otherwise encumbered.
 
Grantee may,
 
however, grant
 
to
another person a revocable proxy
 
to vote unvested shares of Restricted Stock at
 
a Company stockholders’ meeting.
 
3.
 
Grantee (or Grantee’s
 
beneficiary) will have full voting
 
rights with respect to shares of
 
Restricted Stock granted pursuant
to this Award.
 
 
4.
 
Grantee will be entitled to receive cash dividends on shares of Restricted Stock payable to shareholders of record after the
Effective Date (unless and until such Restricted Stock
 
is forfeited).
 
Cash dividends paid on unvested shares of Restricted
Stock will be
 
treated as ordinary
 
compensation and are
 
subject to withholding.
 
Any stock dividends
 
(or other non
 
-cash
dividends) on shares of Restricted Stock will be
 
subject to the same restrictions as the Restricted Stock.
 
5.
 
Under the Plan, unvested shares
 
of Restricted Stock will be forfeited
 
immediately after Grantee’s
 
Termination
 
of Service
with the Company and its subsidiaries, unless such termination is due to death or Total Disability or on or after attainment
of age 60, in which
 
case the restrictions will
 
lapse on the date
 
of termination on a
 
pro rata basis (based
 
on the number of
full months of active service with the Company
 
or a subsidiary during the Restriction Period over
 
the total number of full
months in the Restriction
 
Period).
 
Restrictions will also lapse
 
prior to the vesting
 
date set forth abo
 
ve upon a Change
 
in
Control which occurs before Grantee’s
 
Termination
 
of Service.
 
Quaker Chemical Corporation
A Quaker Houghton Company
901 E. Hector Street
Conshohocken, PA 19428-2380
T: 610.832.4000
quakerhoughton.com.
 
 
 
2
6.
 
Subject to satisfaction of any tax withholding
 
obligation as described below,
 
shares of Restricted Stock that are no
 
longer
subject to forfeiture will be deposited to Grantee’s stock plan
 
account with the Plan’s third-party
 
administrator, as soon as
practicable after the date
 
on which they irrevocably
 
vest.
 
Upon the vesting of
 
shares of Restricted Stock,
 
the prohibition
against the sale
 
or transfer of
 
such shares will
 
be lifted and
 
such shares may
 
be treated as
 
any other shares
 
of Common
Stock of the
 
Company owned by
 
Grantee,
 
subject to the
 
Company’s stock
 
ownership guidelines and
 
any restrictions on
transfer that may be applicable
 
under Federal securities laws or
 
the Company’s
 
Insider Trading Policy.
 
Delivery of such
shares of Restricted Stock to Grantee or to Grantee’s beneficiary upon vesting will be subject to withholding by the Plan’s
third-party administrator
 
of amounts sufficient
 
to cover the
 
applicable withholding
 
obligations,
 
unless Grantee elects
 
to
make a payment to the Company or to the Plan’s
 
third-party administrator.
 
In the event that any required tax withholding
upon the settlement of such
 
Awards
 
exceeds Grantee’s other compensation due from the
 
Company, Grantee agrees
 
to remit
to the Company,
 
as a condition
 
to the settlement
 
of such
 
Awards,
 
such additional
 
amounts in
 
cash as are
 
necessary to
satisfy such required withholding.
 
Any and all withholding obligations
 
may be settled with shares of Common Stock.
 
 
7.
 
Nothing in the Plan or
 
this Agreement will be construed
 
as creating any right in
 
the Grantee to continued
 
employment or
service,
 
or as altering or amending the existing
 
terms and conditions of the Grantee’s
 
employment or service.
 
8.
 
All notices required to
 
be given hereunder shall be
 
mailed by registered or
 
certified mail to the Company
 
to the attention
of its Secretary,
 
at 901 E.
 
Hector Street, Conshohocken,
 
Pennsylvania 19428,
 
and to Grantee
 
at Grantee’s
 
address as it
appears on the Company’s books and records unless either of said parties has duly notified
 
the other
 
in writing of a change
in address.
 
9.
 
To the extent not preempted
 
by Federal law, this Agreement
 
shall be construed, administered and governed in all respects
under and by the laws of the Commonwealth
 
of Pennsylvania, without giving effect
 
to its conflict of laws principles.
 
10.
 
This Agreement contains all the understandings
 
between the parties hereto pertaining to the matter
 
referred to herein, and
supersedes all
 
undertakings and
 
agreements, whether
 
oral or
 
in writing,
 
previously entered
 
into by
 
them with
 
respect
thereto.
 
Grantee represents
 
that, in executing this Agreement, Grantee has not relied upon any representation or statement
not set forth herein made by the
 
Company with regard to the subject matter
 
of this Agreement.
 
QUAKER HOUGHTON
 
 
BY:
 
 
Michael F. Barry
 
 
 
 
Grantee represents that Grantee is familiar with the terms and provisions of the Plan, and hereby accepts this Award
 
subject to
the terms and
 
provisions of the Plan
 
insofar as they
 
relate to Restricted Stock
 
granted thereunder.
 
Grantee agrees hereby
 
to accept as
binding, conclusive, and final all decisions or interpretations
 
of the Committee upon any questions arising under
 
the Plan or this Grant.
 
Grantee authorizes the
 
Company to withhold
 
in accordance with applicable
 
law from any
 
compensation payable to
 
Grantee any taxes
required to be withheld by Federal, state, or local law as a result of the vesting of this Award.
 
Grantee represents that, in executing this
Agreement, Grantee has
 
not relied upon
 
any representation or
 
statement not set
 
forth herein made
 
by the Company
 
with regard to
 
the
subject matter of this Agreement.
 
 
 
 
 
 
By:
 
 
First Name Last Name
 
 
 GRAPHIC 5 exhibit102p1i0.gif LOGO begin 644 exhibit102p1i0.gif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�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end EX-10.3 6 exhibit103.htm FORM OF INCENTIVE STOCK OPTION AWARD AGREEMENT FOR EXECUTIVE OFFICERS AND OTHER EMPLOYEES exhibit103

exhibit103p1i0.gif
 
 
 
 
1
Exhibit 10.3
INCENTIVE STOCK OPTION AWARD
An Incentive Stock Option (the
 
“Option”) for a total of
 
XXX shares of $1.00 par
 
value per share Common Stock
 
(the “Stock”) of Quaker
Chemical Corporation,
 
also known as Quaker Houghton,
 
a Pennsylvania corporation (the “Company”), is hereby granted
 
as of MM DD,
YEAR (the “Grant Date”) to First Name Last Name (the “Optionee”), subject to the terms and provisions
 
of the Quaker Houghton 2016
Long-Term
 
Performance Incentive Plan
 
(the “Plan”) insofar
 
as the same
 
are applicable to
 
Options granted there
 
under. The
 
terms and
provisions of the Plan are incorporated herein by reference.
 
In the event of any inconsistency between the terms of this Agreement and
the terms of the Plan, the terms of the Plan shall govern.
 
1.
 
The Option Price as determined by the
 
Compensation
 
and Human Resources Committee (the “Committee”) which has
 
the authority
for administering the
 
Plan for the
 
Company is $XXX.XX
 
per share, having
 
been determined pursuant
 
to Section 3.2
 
of the Plan,
which is equal to 100% of the Fair Market Value
 
(as defined in the Plan) of the Stock on the Grant Date.
 
 
2.
 
Subject to the
 
provisions of Paragraphs
 
3 and 4
 
hereof, the Option
 
may be exercised
 
in whole at any
 
time or in part
 
from time to
time on or after the
 
date the Option, or any
 
portion thereof, first becomes exercisable.
 
The Option terminates on
 
the earlier of the
date when fully exercised under the provisions of the Plan, the date fixed pursuant to Section 3.7(a), 3.7(b), or 3.7(c) of the Plan, or
DATE
 
.
 
3.
 
The Option may
 
not be exercised
 
if the issuance
 
of the Stock
 
upon such exercise
 
would constitute a
 
violation of any
 
applicable
Federal or state securities or other law or valid regulation.
 
Further, exercise of an Option
 
granted pursuant to this Agreement shall
be under and subject to Paragraph 3.4 of the Plan.
 
 
4.
 
The Option shall be exercisable in consecutive and near
 
equal installments in accordance with the following Schedule:
 
 
Incentive Stock Options
Exercisable on or After
XXX
VESTING DATE
 
Notwithstanding any provision to
 
the contrary, following
 
termination of Optionee’s
 
employment by the Company
 
or a Subsidiary
of the Company for any reason not
 
specified in Sections 3.7(a) or (b) of the Plan,
 
the Option shall not be or become exercisable
 
as
to any shares other than those shares as to which the Option shall have been exercisable in accordance with the preceding Schedule
on the date of such termination.
 
 
5.
 
The Option may
 
not be transferred
 
in any manner
 
other than by
 
will or the
 
laws of descent
 
or distribution and
 
may be exercised
during the lifetime of the Optionee
 
only by the Optionee,
 
pursuant to the terms of the
 
Plan.
 
The terms of the Option shall
 
be binding
upon the executors, administrators, heirs, successors, and
 
assigns of the Optionee.
 
 
6.
 
The Option may
 
be exercised in
 
accordance with such
 
procedures as the
 
Company may determine
 
,
 
through the Optionee’s
 
stock
plan account with the Plan’s third-party administrator.
 
The Optionee may exercise the Option by logging in to the Optionee’s stock
plan account at
https://shareworks.solium.com
. The Company
 
reserves the right
 
to change the
 
means of exercising
 
options or the
third-party administrator
 
at any time.
 
The third-party administrator,
 
on behalf of
 
the Company,
 
shall be
 
entitled to withhold
 
(or
secure payment from the Optionee in
 
lieu of withholding) the amount
 
of any withholding or other
 
tax required by law to
 
be withheld
or paid by the Company with respect to the Option
 
exercise.
 
7.
 
Optionee shall have
 
none of the rights
 
of a shareholder
 
with respect to any
 
shares of Stock subject
 
to the Option, except
 
as to the
shares with respect to
 
which Optionee has validly
 
exercised the Option granted
 
herein and tendered to
 
the Company the full price
therefor.
 
 
Quaker Chemical Corporation
A Quaker Houghton Company
901 E. Hector Street
Conshohocken, PA 19428-2380
T: 610.832.4000
quakerhoughton.com.
 
 
 
2
8.
 
Nothing in the Plan or this Agreement
 
will be construed as creating any right in the
 
Optionee to continued employment or service,
or as altering or amending the existing terms and conditions
 
of the Optionee’s employment
 
or service.
 
9.
 
All notices required
 
to be given
 
hereunder shall
 
be mailed by
 
registered or
 
certified mail to
 
the Company
 
to the attention
 
of its
Secretary, at 901
 
E. Hector Street, Conshohocken, Pennsylvania 19428,
 
and to Optionee at Optionee’s
 
address as it appears on the
Company’s books and
 
records unless either of said parties has duly notified the other
 
in writing of a change in address.
 
10.
 
To the
 
extent not preempted
 
by Federal law,
 
this Agreement shall
 
be construed, admin
 
istered and governed
 
in all respects
 
under
and by the laws of the Commonwealth of Pennsylvania,
 
without giving effect to its conflict of laws principles.
 
11.
 
This Agreement contains all the
 
understandings between the parties
 
hereto pertaining to the
 
matter referred to herein, and
 
supersedes
all undertakings and
 
agreements, whether oral
 
or in writing, previously
 
entered into by
 
them with respect thereto.
 
You
 
represent
that, in
 
executing this
 
Agreement, you
 
have not
 
relied upon
 
any representation
 
or statement
 
not set
 
forth herein
 
made by
 
the
Company with regard to the subject matter of this Agreement.
 
 
QUAKER HOUGHTON
 
 
 
By:
 
 
Michael F. Barry
 
 
Optionee represents that Optionee is familiar with
 
the terms and provisions of the Plan, and
 
hereby accepts the Option subject
to the terms and provisions of
 
the Plan insofar as they relate
 
to Options granted thereunder.
 
Optionee agrees hereby to accept as
 
binding,
conclusive, and final all decisions or
 
interpretations of the Committee upon
 
any questions arising under the
 
Plan or the Option.
 
Optionee
authorizes the Company to withhold in accordance with
 
applicable law from any compensation payable to Optionee
 
any taxes required
to be
 
withheld by
 
Federal, state,
 
or local
 
law as
 
a result
 
of the
 
exercise of
 
the Option.
 
Optionee represents
 
that, in
 
executing this
Agreement, Optionee has not
 
relied upon any representation or
 
statement not set forth herein made
 
by the Company with regard
 
to the
subject matter of this Agreement.
 
 
OPTIONEE REPRESENTS
 
THAT,
 
AT THE
 
TIME THE
 
OPTION IS
 
GRANTED, OPTIONEE
 
DOES NOT
 
OWN
DIRECTLY OR INDIRECTLY (AS DETERMINED UNDER SECTION 424(d) OF THE INTERNAL REVENUE CODE OF 1986,
AS AMENDED), STOCK POSSESSING MORE THAN 10% OF
 
THE TOTAL COMBINED VOTING POWER OF ALL CLASSES
OF STOCK OF QUAKER CHEMICAL CORPORATION
 
OR ANY OF ITS SUBSIDIARIES.
 
 
 
 
By:
 
 
First Name Last Name
 
 
 
 GRAPHIC 7 exhibit103p1i0.gif LOGO begin 644 exhibit103p1i0.gif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�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end EX-10.4 8 exhibit104.htm FORM OF NON-QUALIFIED STOCK OPTION AWARD AGREEMENT FOR EXECUTIVE OFFICERS AND OTHER EMPLOYEES exhibit104

exhibit104p1i0.gif
 
 
 
 
1
EXHIBIT 10.4
NON-QUALIFIED STOCK OPTION AWARD
A Non-Qualified Stock
 
Option (the “Option”)
 
for a total of
 
XXX shares of $1.00
 
par value per share
 
Common Stock (the
 
“Stock”) of
Quaker Chemical Corporation, also known
 
as Quaker Houghton, a Pennsylvania
 
corporation (the “Company”), is hereby granted
 
as of
MM DD,
 
YEAR (the
 
“Grant Date”)
 
to First
 
Name Last
 
Name (the
 
“Optionee”),
 
subject to
 
the terms
 
and provisions
 
of the
 
Quaker
Houghton 2016 Long-Term
 
Performance Incentive Plan (the “Plan”)
 
insofar as the same are
 
applicable to Options granted
 
thereunder.
The terms and provisions
 
of the Plan are incorporated
 
herein by reference. In
 
the event of any inconsistency
 
between the terms of
 
this
Agreement and the terms of the Plan, the terms of
 
the Plan shall govern.
 
1.
 
The Option Price as determined by the
 
Compensation and Human Resources Committee (the “Committee”) which has
 
the authority
for administering the
 
Plan for the
 
Company is $XXX.XX
 
per share,
 
having been determined
 
pursuant to Section
 
3.2 of the Plan,
which is equal to 100% of the Fair Market Value
 
(as defined in the Plan) of the Stock on the Grant Date.
 
 
2.
 
Subject to the
 
provisions of Paragraphs
 
3 and 4
 
hereof, the Option
 
may be exercised
 
in whole at any
 
time or in part
 
from time to
time on or after the
 
date the Option, or any
 
portion thereof, first becomes exercisable.
 
The Option terminates on
 
the earlier of the
date when fully exercised under the provisions of the Plan, the date fixed pursuant to Section 3.7(a), 3.7(b), or 3.7(c) of the Plan, or
DATE
 
.
 
3.
 
The Option may
 
not be exercised
 
if the issuance
 
of the Stock
 
upon such exercise
 
would constitute a
 
violation of any
 
applicable
Federal or state securities or other law or valid regulation.
 
Further, exercise of an Option
 
granted pursuant to this Agreement shall
be under and subject to Paragraph 3.4 of the Plan.
 
4.
 
The Option shall be exercisable in consecutive and near
 
equal installments in accordance with the following Schedule
 
:
 
 
Non-Qualified Stock Options
Exercisable on or After
X,XXX
VESTING DATE
 
1
X,XXX
VESTING DATE
 
2
X,XXX
VESTING DATE
 
3
 
Notwithstanding any provision to
 
the contrary, following
 
termination of Optionee’s
 
employment by the Company
 
or a Subsidiary
of the Company for any reason not
 
specified in Sections 3.7(a) or (b) of the Plan,
 
the Option shall not be or become exercisable
 
as
to any shares other than those shares as to which the Option shall have been exercisable in accordance with the preceding Schedule
on the date of such termination.
 
 
5.
 
The Option may
 
not be transferred
 
in any manner
 
other than by
 
will or the
 
laws of descent
 
or distribution and
 
may be exercised
during the lifetime of the Optionee
 
only by the Optionee,
 
pursuant to the terms of the
 
Plan.
 
The terms of the Option shall
 
be binding
upon the executors, administrators, heirs, successors, and
 
assigns of the Optionee.
 
 
6.
 
The Option may
 
be exercised in
 
accordance with such
 
procedures as the
 
Company may determine
 
,
 
through
 
the Optionee’s
 
stock
plan account with the Plan’s third-party administrator.
 
The Optionee may exercise the Option by logging in to the Optionee’s stock
plan account at
https://shareworks.solium.com
. The Company
 
reserves the right
 
to change the
 
means of exercising
 
options or the
third-party administrator
 
at any time.
 
The third-party administrator,
 
on behalf of
 
the Company,
 
shall be
 
entitled to withhold
 
(or
secure payment from the Optionee in
 
lieu of withholding) the amount
 
of any withholding or other
 
tax required by law to
 
be withheld
or paid by the Company with respect to the Option
 
exercise.
 
7.
 
Optionee shall have
 
none of the rights
 
of a shareholder
 
with respect to any
 
shares of Stock subject
 
to the Option, except
 
as to the
shares with respect to
 
which Optionee has validly
 
exercised the Option granted
 
herein and tendered to
 
the Company the full price
therefor.
 
 
Quaker Chemical Corporation
A Quaker Houghton Company
901 E. Hector Street
Conshohocken, PA 19428-2380
T: 610.832.4000
quakerhoughton.com.
 
 
 
2
8.
 
Nothing in the Plan or this Agreement
 
will be construed as creating any right in the
 
Optionee to continued employment or service,
or as altering or amending the existing terms and conditions
 
of the Optionee’s employment
 
or service.
 
9.
 
All notices required
 
to be given
 
hereunder shall
 
be mailed by
 
registered or
 
certified mail to
 
the Company
 
to the attention
 
of its
Secretary, at 901
 
E. Hector Street, Conshohocken, Pennsylvania 19428,
 
and to Optionee at Optionee’s
 
address as it appears on the
Company’s books and
 
records unless either of said parties has duly notified the other
 
in writing of a change in address.
 
10.
 
To the
 
extent not preempted
 
by Federal law,
 
this Agreement shall
 
be construed, administered
 
and governed in
 
all respects under
and by the laws of the Commonwealth of Pennsylvania,
 
without giving effect to its conflict of laws principles.
 
11.
 
This Agreement contains all the
 
understandings between the parties
 
hereto pertaining to the
 
matter referred to herein, and
 
supersedes
all undertakings and
 
agreements, whether oral
 
or in writing, previously
 
entered into by
 
them with respect thereto.
 
You
 
represent
that, in
 
executing this
 
Agreement, you
 
have not
 
relied upon
 
any representation
 
or statement
 
not set
 
forth herein
 
made by
 
the
Company with regard to the subject matter of this Agreement.
 
 
 
QUAKER HOUGHTON
 
 
By:
 
 
Michael F. Barry
 
 
Optionee represents that Optionee is familiar with
 
the terms and provisions of the Plan, and
 
hereby accepts the Option subject
to the terms and provisions of
 
the Plan insofar as they relate
 
to Options granted thereunder.
 
Optionee agrees hereby to accept as
 
binding,
conclusive, and final all decisions or
 
interpretations of the Committee upon
 
any questions arising under the
 
Plan or the Option.
 
Optionee
authorizes the Company to withhold in accordance with
 
applicable law from any compensation payable to Optionee
 
any taxes required
to be
 
withheld by
 
Federal, state,
 
or local
 
law as
 
a result
 
of the
 
exercise of
 
the Option.
 
Optionee represents
 
that, in
 
executing this
Agreement, Optionee has not
 
relied upon any representation or
 
statement not set forth herein made
 
by the Company with regard
 
to the
subject matter of this Agreement.
 
 
 
By:
 
 
First Name Last Name
 
 
 
 GRAPHIC 9 exhibit104p1i0.gif LOGO begin 644 exhibit104p1i0.gif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�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end EX-10.5 10 exhibit105.htm FORM OF RESTRICTED STOCK UNIT AWARD AGREEMENT FOR EXECUTIVE OFFICERS AND OTHER EMPLOYEES exhibit105

exhibit105p1i0.gif
 
1
EXHIBIT 10.5
RESTRICTED STOCK UNIT AWARD
The Compensation
 
and Human
 
Resources Committee
 
(the “Committee”)
 
of the
 
Board of
 
Directors of
 
Quaker Houghton
 
(“the
Company”) has approved the
 
award (the “Award”)
 
to First Name Last Name
 
(“the Grantee”), of XX Restricted
 
Stock Units (“RSUs”)
under the Quaker
 
Houghton 2016 Long-Term
 
Performance Incentive Plan
 
(the “Plan”).
 
Each vested RSU
 
entitles Grantee to
 
receive
one share of Common Stock of the
 
Company on the Distribution Date.
 
Subject to Grantee’s acceptance
 
of the terms and conditions of
this Award
 
set forth in this agreement (the “Agreement”), this Award
 
is effective as of MM DD, YYYY (the “Effective
 
Date”).
 
Except as provided herein and in
 
the Plan, RSUs subject to
 
this Award will vest in a single installment
 
on MM DD, YYYY (the
 
“Vesting
Date”) (the period from the Effective Date to
 
the Vesting
 
Date, the “Restriction Period”).
The terms and conditions
 
of this Award
 
are governed by this Agreement
 
and the Plan.
 
Unless otherwise defined herein,
 
terms used in
this Agreement have the meanings assigned to them in the Plan.
 
In the event of any inconsistency between the terms of this Agreement
and the terms of the Plan, the terms of the Plan shall govern.
1.
 
As soon as practicable
 
after the Effective
 
Date of this Award,
 
the RSUs will be
 
credited to a
 
separate account maintained
 
by
the Plan’s third-party administrator
 
on Grantee’s behalf.
2.
 
The RSUs may not be transferred in any manner other than
 
by will or the laws of descent or distribution.
3.
 
The RSUs are not actual shares of Common Stock, and do not
 
have voting rights.
4.
 
Grantee will receive dividend
 
equivalents on RSUs.
 
On each date that
 
the Company pays a
 
cash dividend on a
 
share of Common
Stock, the
 
Company,
 
through the
 
Plan’s third
 
-party administrator,
 
will credit to
 
Grantee’s account
 
an additional
 
number of
RSUs equal to the total number of RSUs credited to Grantee’s
 
account on such date, multiplied by the amount of the per share
cash dividend, and divided by the Fair Market Value of a share of Common Stock on such date. RSUs credited pursuant to this
paragraph will be subject to the same terms and conditions
 
as the RSUs to which the dividend equivalent rights relate.
5.
 
Under the Plan,
 
unvested RSUs will
 
be forfeited immediately
 
after Grantee’s
 
Termination of
 
Service with the
 
Company and
its subsidiaries, unless such termination is due to death or Total Disability or on or after attainment
 
of age 60, in which case the
unvested RSUs will
 
vest on the
 
date of termi
 
nation on a pro
 
rata basis (based
 
on the number
 
of full months
 
of active service
with the Company
 
or a subsidiary
 
during the Vesting
 
Period over the total
 
number of full
 
months in the
 
Vesting
 
Period).
 
In
the event of a
 
Change in Control which
 
occurs before
 
Grantee’s Termination
 
of Service, all unvested
 
RSUs will fully vest
 
as
of the date of such Change in Control.
6.
 
With respect to
 
vested RSUs, a
 
corresponding number of
 
actual shares of Common
 
Stock will be deposited
 
into a stock plan
account established under
 
Grantee’s name
 
by the Plan’s
 
third-party administrator.
 
The date of such
 
transfer shall be referred
to as the “Distribution Date.”
 
7.
 
All distributions to Grantee or to
 
Grantee’s beneficiary
 
upon vesting of the RSUs hereunder
 
will be subject to withholding by
the Plan’s third-party administrator of amounts sufficient to cover the applicable withholding obligations.
 
In the event that any
required tax withholding upon the settlement of such RSUs exceeds your other compensation
 
due from the Company, Grantee
agrees to remit to
 
the Company,
 
as a condition to
 
settlement of such RSUs,
 
such additional amounts
 
in cash as are
 
necessary
to satisfy the required withholding.
 
Any and all withholding obligations may be settled with shares of
 
Common Stock.
 
Quaker Chemical Corporation
A Quaker Houghton Company
901 E. Hector Street
Conshohocken, PA 19428-2380
T: 610.832.4000
quakerhoughton.com.
 
 
 
2
8.
 
Nothing in
 
the Plan
 
or this
 
Agreement will
 
be construed
 
as creating
 
any right
 
in the
 
Grantee to
 
continued employment
 
or
service,
 
or as altering or amending the existing terms and conditions of
 
the Grantee’s employment
 
or service.
9.
 
All notices required to be given hereunder shall be mailed by registered or certified mail to the
 
Company to the attention of its
Secretary, at
 
901 E. Hector
 
Street, Conshohocken,
 
Pennsylvania 19428,
 
and to Grantee
 
at Grantee’s
 
address as it appears
 
on
the Company’s books
 
and records unless either of said parties has
 
duly notified the other in writing
 
of a change in address.
10.
 
To the extent not preempted by Federal
 
law, this Agreement shall be construed, administered
 
and governed in all respects
 
under
and by the laws of the Commonwealth of Pennsylvania,
 
without giving effect to its conflict of laws principles.
11.
 
This Agreement
 
contains all
 
the understandings
 
between the
 
parties hereto
 
pertaining to
 
the matter
 
referred to
 
herein, and
supersedes all undertakings
 
and agreements, whether oral
 
or in writing, previously
 
entered into by them
 
with respect thereto.
 
Grantee represents
 
that, in executing this Agreement, Grantee has not relied upon
 
any representation or statement not set forth
herein made by the Company with regard to the subject
 
matter of this Agreement.
 
QUAKER HOUGHTON
 
 
 
BY:
 
 
Michael F. Barry
 
 
 
Grantee represents that Grantee is familiar with the terms and provisions of the Plan, and hereby accepts this Award
 
subject to
the terms and
 
provisions of the
 
Plan insofar as
 
they relate to
 
RSUs granted thereunder.
 
Grantee agrees
 
hereby to accept
 
as binding,
conclusive, and final all decisions or interpretations of the Committee upon
 
any questions arising under the Plan or this Grant.
 
Grantee
authorizes the Company
 
to withhold in accordance
 
with applicable law from
 
any compensation payable
 
to Grantee any taxes
 
required
to be withheld by
 
Federal, state, or local
 
law as a
 
result of the
 
vesting of this Award.
 
Grantee represents that, in
 
executing this Agreement,
Grantee has not relied upon any representation or statement not set forth herein made by the Company with regard
 
to the subject matter
of this Agreement.
 
 
 
 
 
By:
 
 
First Name Last Name
 
 
 GRAPHIC 11 exhibit105p1i0.gif LOGO begin 644 exhibit105p1i0.gif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�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end EX-10.6 12 exhibit106.htm FORM OF PERFORMANCE STOCK UNIT AWARD AGREEMENT FOR EXECUTIVE OFFICERS AND OTHER EMPLOYEES exhibit106

exhibit106p1i0.gif
 
1
EXHIBIT 10.6
PERFORMANCE STOCK UNIT AWARD
 
The Compensation and Human
 
Resources Committee (the “Committee”)
 
of the Board of Directors
 
of Quaker Houghton
 
has approved
the award (the
 
“Award”)
 
to FIRST NAME
 
LAST NAME
 
(the “Grantee”)
 
,
 
of XXX performance
 
stock units
 
(PSUs) as of
 
MM DD,
YEAR (the “Grant Date”),
 
subject to achieving a
 
pre-determined targeted performance based on
 
the Company’s relative total shareholder
return (“TSR”) as compared to the TSR of the S&P Mid Cap 400
 
(Materials Group) over the three-year period from January
 
1, 2022
 
to
December 31, 202
 
4
 
under the Quaker
 
Houghton 2016 Long
 
-Term Performance
 
Incentive Plan (the “Plan”).
 
This Award
 
is subject to
your acceptance
 
of the terms
 
and conditions
 
of this Award
 
set forth
 
in this agreement
 
(the “Agreement”).
 
The level of
 
payment can
range from 0% to 200% (the “achievement
 
percentage”) of the Target
 
PSU award depending on our TSR performance.
 
The terms and conditions
 
of this Award
 
are governed by this Agreement
 
and the Plan.
 
Unless otherwise defined herein,
 
terms used in
this Agreement have the meanings assigned to them in the Plan.
 
In the event of any inconsistency between the terms of this Agreement
and the terms of the Plan, the terms of
 
the Plan shall govern.
1.
 
PSUs will be
 
paid in the
 
calendar year
 
following the
 
end of the
 
performance period.
 
The number
 
of shares of
 
Quaker
Houghton that will be paid under the PSU award will be equal to (i) the achievement percentage times (ii) the Target
 
PSU
award.
 
 
2.
 
Grantee (or Grantee’s
 
beneficiary) will have no voting
 
rights with respect to the PSUs.
 
 
3.
 
Grantee will not be entitled to receive cash dividends
 
or dividend equivalents on PSUs.
 
4.
 
PSUs may not be transferred in any
 
manner other than by will or the
 
laws of descent or distribution.
 
5.
 
Unvested PSUs will
 
be forfeited
 
in the event
 
Grantee’s employment
 
ends prior to
 
the completion
 
of the vesting
 
period,
unless such termination is due
 
to (i) death, (ii) Total
 
Disability or (iii) retirement on
 
or after attainment of age 60
 
,
 
in each
case, as
 
provided in
 
the Plan.
 
If the
 
Grantee’s termination
 
occurs due
 
to the
 
aforementioned circumstances,
 
then the
Grantee’s PSUs will be prorated
 
based on active service during the performance
 
period, as provided in the Plan.
 
6.
 
All distributions to Grantee or to Grantee’s
 
beneficiary upon vesting of the PSUs hereunder will
 
be subject to withholding
by the Plan’s third-party administrator
 
of amounts sufficient to cover the applicable withholding obligations.
 
In the event
that any
 
required tax
 
withholding upon
 
the settlement
 
of such
 
PSUs exceeds
 
your other
 
compensation due
 
from the
Company, Grantee agrees to
 
remit to the Company, as a condition to settlement of such PSUs, such additional
 
amounts in
cash as are necessary to satisfy the
 
required withholding.
 
Any and all withholding obligations may
 
be settled with shares
of Common Stock.
 
7.
 
Nothing in the Plan or
 
this Agreement will be construed
 
as creating any right in
 
the Grantee to continued
 
employment or
service,
 
or as altering or amending the existing
 
terms and conditions of the Grantee’s
 
employment or service.
 
8.
 
All notices required to
 
be given hereunder shall be
 
mailed by registered or
 
certified mail to the Company
 
to the attention
of its Secretary,
 
at 901 E.
 
Hector Street, Conshohocken,
 
Pennsylvania 19428,
 
and to Grantee
 
at Grantee’s
 
address as it
appears on the Company’s books and records unless either of said parties has duly notified
 
the other in writing of a change
in address.
 
Quaker Chemical Corporation
A Quaker Houghton Company
901 E. Hector Street
Conshohocken, PA 19428-2380
T: 610.832.4000
quakerhoughton.com.
 
 
 
2
9.
 
To the extent not preempted
 
by Federal law, this Agreement
 
shall be construed, administered and governed in all respects
under and by the laws of the Commonwealth
 
of Pennsylvania, without giving effect
 
to its conflict of laws principles.
 
10.
 
This Agreement contains all the understandings
 
between the parties hereto pertaining to the matter
 
referred to herein, and
supersedes all
 
undertakings and
 
agreements, whether
 
oral or
 
in writing,
 
previously entered
 
into by
 
them with
 
respect
thereto.
 
Grantee represents
 
that, in executing this Agreement, Grantee has not relied upon any representation or statement
not set forth herein made by the
 
Company with regard to the subject matter
 
of this Agreement.
 
QUAKER HOUGHTON
 
 
BY:
 
 
Michael F. Barry
 
 
 
Grantee represents that Grantee is familiar with the terms and provisions of the Plan, and hereby accepts this Award
 
subject to
the terms and
 
provisions of the
 
Plan insofar
 
as they relate
 
to PSUs granted
 
thereunder.
 
Grantee agrees
 
hereby to accept
 
as binding,
conclusive, and final all decisions or interpretations of the Committee upon
 
any questions arising under the Plan or this Grant.
 
Grantee
authorizes the Company
 
to withhold in accordance
 
with applicable law from
 
any compensation payable
 
to Grantee any taxes
 
required
to be withheld by
 
Federal, state, or local
 
law as a
 
result of the
 
vesting of this Award.
 
Grantee represents that, in
 
executing this Agreement,
Grantee has not relied upon any representation or statement not set forth herein made by the Company with regard
 
to the subject matter
of this Agreement.
 
 
 
 
BY:
 
First Name Last Name
 
 
 GRAPHIC 13 exhibit106p1i0.gif LOGO begin 644 exhibit106p1i0.gif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�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end EX-31.1 14 exhibit311.htm SECTION 302 CEO CERTIFICATION exhibit311

 
 
1
EXHIBIT 31.1
 
 
CERTIFICATION
 
OF CHIEF EXECUTIVE OFFICER OF THE COMPANY
 
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
I, Michael F.
 
Barry, certify that:
 
1.
I have reviewed this quarterly report on Form 10
 
-Q of Quaker Chemical Corporation;
 
2.
Based on my knowledge, this report does not contain
 
any untrue statement of a material fact or omit to state a material
 
fact
necessary to make the statements made, in light of
 
the circumstances under which such statements were made,
 
not misleading with
respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and
 
other financial information included in this report, fairly
 
present in all
material respects the financial condition, results of operations
 
and cash flows of the registrant as of, and for,
 
the periods presented
in this report;
 
4.
The registrant’s other certifying
 
officer and I are responsible for establishing and
 
maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and
 
15d-15(e)) and internal control over financial reporting (as defined
 
in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant
 
and have:
 
 
(a)
Designed such disclosure controls and procedures, or
 
caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information
 
relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those
 
entities, particularly during the period in which this report
 
is
being prepared;
 
 
(b)
Designed such internal control over financial reporting,
 
or caused such internal control over financial reporting to
 
be
designed under our supervision, to provide reasonable
 
assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes
 
in accordance with generally accepted accounting
principles;
 
 
(c)
Evaluated the effectiveness of the registrant’s
 
disclosure controls and procedures and presented in this report
 
our
conclusions about the effectiveness of the disclosure
 
controls and procedures, as of the end of the period covered
 
by
this report based on such evaluation; and
 
 
(d)
Disclosed in this report any change in the registrant’s
 
internal control over financial reporting that occurred during
the registrant’s most recent
 
fiscal quarter (the registrant’s
 
fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely
 
to materially affect, the registrant’s
 
internal control over financial
reporting; and
 
5.
The registrant’s other certifying
 
officer and I have disclosed, based on our most recent
 
evaluation of internal control over financial
reporting, to the registrant’s
 
auditors and the audit committee of the registrant’s
 
board of directors (or persons performing the
equivalent functions):
 
 
(a)
All significant deficiencies and material weaknesses in the
 
design or operation of internal control over financial
reporting which are reasonably likely to adversely affect
 
the registrant’s ability to record,
 
process, summarize and
report financial information; and
 
 
(b)
Any fraud, whether or not material, that involves management
 
or other employees who have a significant role in the
registrant’s internal control
 
over financial reporting.
Date: August 5, 2021
 
/s/ Michael F. Barry
Michael F. Barry
Chief Executive Officer
 
 EX-31.2 15 exhibit312.htm SECTION 302 CFO CERTIFICATION exhibit312
 
 
1
EXHIBIT 31.2
 
 
CERTIFICATION
 
OF CHIEF FINANCIAL OFFICER OF THE COMPANY
 
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
I, Shane Hostetter, certify that:
 
1.
I have reviewed this quarterly report on Form 10
 
-Q of Quaker Chemical Corporation;
 
2.
Based on my knowledge, this report does not contain
 
any untrue statement of a material fact or omit to state a material
 
fact
necessary to make the statements made, in light of
 
the circumstances under which such statements were made,
 
not misleading with
respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and
 
other financial information included in this report, fairly
 
present in all
material respects the financial condition, results of operations
 
and cash flows of the registrant as of, and for,
 
the periods presented
in this report;
 
4.
The registrant’s other certifying
 
officer and I are responsible for establishing and
 
maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and
 
15d-15(e)) and internal control over financial reporting (as defined
 
in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant
 
and have:
 
 
(a)
Designed such disclosure controls and procedures, or
 
caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information
 
relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those
 
entities, particularly during the period in which this report
 
is
being prepared;
 
 
(b)
Designed such internal control over financial reporting,
 
or caused such internal control over financial reporting to
 
be
designed under our supervision, to provide reasonable
 
assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes
 
in accordance with generally accepted accounting
principles;
 
 
(c)
Evaluated the effectiveness of the registrant’s
 
disclosure controls and procedures and presented in this report
 
our
conclusions about the effectiveness of the disclosure
 
controls and procedures, as of the end of the period covered
 
by
this report based on such evaluation; and
 
 
(d)
Disclosed in this report any change in the registrant’s
 
internal control over financial reporting that occurred during
the registrant’s most recent
 
fiscal quarter (the registrant’s
 
fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely
 
to materially affect, the registrant’s
 
internal control over financial
reporting; and
 
5.
The registrant’s other certifying
 
officer and I have disclosed, based on our most recent
 
evaluation of internal control over financial
reporting, to the registrant’s
 
auditors and the audit committee of the registrant’s
 
board of directors (or persons performing the
equivalent functions):
 
 
(a)
All significant deficiencies and material weaknesses in the
 
design or operation of internal control over financial
reporting which are reasonably likely to adversely affect
 
the registrant’s ability to record,
 
process, summarize and
report financial information; and
 
 
(b)
Any fraud, whether or not material, that involves management
 
or other employees who have a significant role in the
registrant’s internal control
 
over financial reporting.
Date: August 5, 2021
 
/s/ Shane W.
 
Hostetter
Shane W.
 
Hostetter
Chief Financial Officer
 
 EX-32.1 16 exhibit321.htm SECTION 906 CEO CERTIFICATION exhibit321
 
 
1
EXHIBIT 32.1
 
CERTIFICATION
 
PURSUANT TO 18 U.S.C. SECTION 1350
 
The undersigned hereby certifies that the Form 10-Q Quarterly
 
Report of Quaker Chemical Corporation (the “Company”)
 
for the
quarterly period ended June 30, 2021 filed with the Securities and
 
Exchange Commission (the “Report”) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange
 
Act of 1934 and that the information contained
 
in the Report fairly
presents, in all material respects, the financial condition
 
and results of operations of the Company.
 
 
Dated: August 5, 2021
 
 
/s/ Michael F. Barry
 
 
Michael F. Barry
 
 
Chief Executive Officer of Quaker Chemical
 
Corporation
 
 EX-32.2 17 exhibit322.htm SECTION 906 CFO CERTIFICATION exhibit322
 
 
1
EXHIBIT 32.2
 
CERTIFICATION
 
PURSUANT TO 18 U.S.C. SECTION 1350
 
The undersigned hereby certifies that the Form 10-Q Quarterly
 
Report of Quaker Chemical Corporation (the “Company”)
 
for the
quarterly period ended June 30, 2021 filed with the Securities and
 
Exchange Commission (the “Report”) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange
 
Act of 1934 and that the information contained
 
in the Report fairly
presents, in all material respects, the financial condition
 
and results of operations of the Company.
 
 
Dated: August 5, 2021
 
 
/s/ Shane W.
 
Hostetter
 
 
Shane W.
 
Hostetter
 
 
Chief Financial Officer of Quaker Chemical Corporation
 
 EX-101.SCH 18 kwr-20210630.xsd XBRL EXTENSION SCHEMA DOCUMENT 000100 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 000200 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 000400 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 000450 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 000500 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 012410 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 012415 - Disclosure - Hedging Activities link:presentationLink link:definitionLink link:calculationLink 010710 - Disclosure - Share-Based Compensation link:presentationLink link:definitionLink link:calculationLink 011010 - Disclosure - Earnings Per Share link:presentationLink link:definitionLink link:calculationLink 010409 - Disclosure - Business Segments link:presentationLink link:definitionLink link:calculationLink 011510 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:definitionLink link:calculationLink 010750 - Disclosure - Pension and Postretirement Benefits link:presentationLink link:definitionLink link:calculationLink 012510 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 010910 - Disclosure - Income Taxes and Uncertain Income Tax Positions link:presentationLink link:definitionLink link:calculationLink 011910 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 042211 - Disclosure - Equity and Noncontrolling Interest - Changes in Equity (Details) link:presentationLink link:definitionLink link:calculationLink 042212 - Disclosure - Equity and Noncontrolling Interest - Changes in Equity (Parentheticals) (Details) link:presentationLink link:definitionLink link:calculationLink 000300 - Statement - Condensed Consolidated Statements of Comprehensive Income link:presentationLink link:definitionLink link:calculationLink 041010 - Disclosure - Earnings Per Share - Basic (Details) link:presentationLink link:definitionLink link:calculationLink 041020 - Disclosure - Earnings Per Share - Diluted (Details) link:presentationLink link:definitionLink link:calculationLink 041030 - Disclosure - Earnings Per Share - Antidilutive Shares (Details) link:presentationLink link:definitionLink link:calculationLink 042510 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 042520 - Disclosure - Commitments and Contingencies - Operating Leases (Details) link:presentationLink link:definitionLink link:calculationLink 040960 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040970 - Disclosure - Income Taxes - Uncertain Tax Positions - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 042410 - Disclosure - Fair Value - Assets (Details) link:presentationLink link:definitionLink link:calculationLink 042504 - Disclosure - Hedging Activities - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 042505 - Disclosure - Hedging Activities - Table (Details) link:presentationLink link:definitionLink link:calculationLink 041910 - Disclosure - Debt - Table (Details) link:presentationLink link:definitionLink link:calculationLink 041940 - Disclosure - Debt - Maturity Schedules (Details) link:presentationLink link:definitionLink link:calculationLink 041960 - Disclosure - Debt - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040315 - Disclosure - Business Segments - Performance of reportable segments (Details) link:presentationLink link:definitionLink link:calculationLink 041510 - Disclosure - Goodwill and Other Intangible Assets - Goodwill Assets (Details) link:presentationLink link:definitionLink link:calculationLink 041520 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets (Details) link:presentationLink link:definitionLink link:calculationLink 040710 - Disclosure - Share-Based Compensation - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040720 - Disclosure - Share-Based Compensation - Expense Table (Details) link:presentationLink link:definitionLink link:calculationLink 040760 - Disclosure - Share-Based Compensation - Black-Scholes option pricing model (Details) link:presentationLink link:definitionLink link:calculationLink 032410 - Disclosure - Fair Value Measurements (Table) link:presentationLink link:definitionLink link:calculationLink 032411 - Disclosure - Hedging Activities (Tables) link:presentationLink link:definitionLink link:calculationLink 031750 - Disclosure - Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 030710 - Disclosure - Share Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 030410 - Disclosure - Business Segments (Tables) link:presentationLink link:definitionLink link:calculationLink 030303 - Disclosure - Business Acquisitions (Tables) link:presentationLink link:definitionLink link:calculationLink 031510 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 030910 - Disclosure - Taxes on Income and Uncertain Positions (Tables) link:presentationLink link:definitionLink link:calculationLink 030750 - Disclosure - Pension and Other Post Retirement Benefits (Tables) link:presentationLink link:definitionLink link:calculationLink 031010 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 032510 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 040815 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost and Changes in Other Comprehensive Income (Details) link:presentationLink link:definitionLink link:calculationLink 040860 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 042220 - Disclosure - Equity and Noncontrolling Interest - AOCI Reclassifications (Details) link:presentationLink link:definitionLink link:calculationLink 012210 - Disclosure - Equity link:presentationLink link:definitionLink link:calculationLink 032211 - Disclosure - Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 042210 - Disclosure - Equity and Noncontrolling Interest - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 010810 - Disclosure - Other Income (Expense) link:presentationLink link:definitionLink link:calculationLink 030810 - Disclosure - Other Income (Expense) (Tables) link:presentationLink link:definitionLink link:calculationLink 040900 - Disclosure - Other Income (Expense) (Details) link:presentationLink link:definitionLink link:calculationLink 010310 - Disclosure - Recently Issued Accounting Standards link:presentationLink link:definitionLink link:calculationLink 010640 - Disclosure - Restructuring and Related Activities link:presentationLink link:definitionLink link:calculationLink 030610 - Disclosure - Restructuring Activities (Tables) link:presentationLink link:definitionLink link:calculationLink 040650 - Disclosure - Restructuring Activities (Details) link:presentationLink link:definitionLink link:calculationLink 041540 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) link:presentationLink link:definitionLink link:calculationLink 041550 - Disclosure - Intangible Assets - Indefinite Lived (Details) link:presentationLink link:definitionLink link:calculationLink 040640 - Disclosure - Restructuring Activities - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040310 - Disclosure - Recently Issued Accounting Standards - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 010210 - Disclosure - Business Acquisitions link:presentationLink link:definitionLink link:calculationLink 011118 - Disclosure - Restricted Cash link:presentationLink link:definitionLink link:calculationLink 010410 - Disclosure - Net Sales and Revenue Recognition link:presentationLink link:definitionLink link:calculationLink 031110 - Disclosure - Restricted Cash (Tables) link:presentationLink link:definitionLink link:calculationLink 030510 - Disclosure - Net Sales and Revenue Recognition (Tables) link:presentationLink link:definitionLink link:calculationLink 041110 - Disclosure - Restricted Cash (Details) link:presentationLink link:definitionLink link:calculationLink 040412 - Disclosure - Net Sales and Revenue Recognition (Details) link:presentationLink link:definitionLink link:calculationLink 040410 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 010508 - Disclosure - Leases link:presentationLink link:definitionLink link:calculationLink 030609 - Disclosure - Leases (Tables) link:presentationLink link:definitionLink link:calculationLink 040415 - Disclosure - Leases - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040416 - Disclosure - Leases - Supplemental Balance Sheet Information (Details) link:presentationLink link:definitionLink link:calculationLink 040417 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 041950 - Disclosure - Debt - Debt related expenses included within Interest expense (Details) link:presentationLink link:definitionLink link:calculationLink 040214 - Disclosure - Business Acquisitions - Other Acquisitions - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040314 - Disclosure - Business Segments - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040215 - Disclosure - Business Acquisitions - Preliminary Estimated Fair Values of Coral Net Assets Acquired (Details) link:presentationLink link:definitionLink link:calculationLink 040216 - Disclosure - Business Acquisitions - Coral - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 010110 - Disclosure - Basis of Presentation and Description of Business link:presentationLink link:definitionLink link:calculationLink 040010 - Disclosure - Basis of Presentation and Description of Business (Details) link:presentationLink link:definitionLink link:calculationLink 020001 - Disclosure - Basis of Presentation and Description of Business (Policies) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 19 kwr-20210630_cal.xml XBRL CALCULATION LINKBASE DOCUMENT EX-101.DEF 20 kwr-20210630_def.xml XBRL DEFINITION LINKBASE DOCUMENT EX-101.LAB 21 kwr-20210630_lab.xml XBRL LABEL LINKBASE DOCUMENT EX-101.PRE 22 kwr-20210630_pre.xml XBRL PRESENTATION LINKBASE DOCUMENT XML 23 kwr20210630_htm.xml IDEA: XBRL DOCUMENT 0000081362 2021-01-01 2021-06-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2021-01-01 2021-06-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2021-01-01 2021-06-30 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2021-01-01 2021-06-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2021-01-01 2021-06-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-06-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-06-30 0000081362 us-gaap:EMEAMember 2021-01-01 2021-06-30 0000081362 srt:AsiaPacificMember 2021-01-01 2021-06-30 0000081362 2021-07-31 0000081362 2020-04-01 2020-06-30 0000081362 2020-01-01 2020-06-30 0000081362 2021-06-30 0000081362 2020-12-31 0000081362 2019-12-31 0000081362 2020-06-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-06-30 0000081362 us-gaap:TransferredOverTimeMember 2020-01-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-06-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2020-04-01 2020-06-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2020-04-01 2020-06-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2020-04-01 2020-06-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2020-01-01 2020-06-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2020-01-01 2020-06-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2020-01-01 2020-06-30 0000081362 us-gaap:RestrictedStockMember 2021-06-30 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-06-30 0000081362 us-gaap:RestrictedStockMember 2021-01-01 2021-06-30 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-06-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-04-01 2021-06-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-04-01 2021-06-30 0000081362 us-gaap:CustomerListsMember 2020-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0000081362 us-gaap:CustomerListsMember 2021-06-30 0000081362 us-gaap:OtherIntangibleAssetsMember 2021-06-30 0000081362 us-gaap:FairValueInputsLevel1Member 2021-06-30 0000081362 us-gaap:FairValueInputsLevel2Member 2021-06-30 0000081362 us-gaap:FairValueInputsLevel3Member 2021-06-30 0000081362 us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 srt:MinimumMember kwr:AcpMember 2021-06-30 0000081362 srt:MaximumMember kwr:AcpMember 2021-06-30 0000081362 kwr:SbDeckingMember 2021-06-30 0000081362 us-gaap:CommonStockMember 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000081362 us-gaap:RetainedEarningsMember 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-12-31 0000081362 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0000081362 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-06-30 0000081362 us-gaap:CommonStockMember 2021-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000081362 us-gaap:RetainedEarningsMember 2021-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-06-30 0000081362 us-gaap:CommonStockMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2019-12-31 0000081362 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0000081362 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-06-30 0000081362 us-gaap:CommonStockMember 2020-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000081362 us-gaap:RetainedEarningsMember 2020-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-04-01 2020-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-04-01 2020-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-04-01 2020-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-06-30 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember 2020-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember 2021-06-30 0000081362 us-gaap:InterestExpenseMember 2020-04-01 2020-06-30 0000081362 us-gaap:InterestExpenseMember 2021-01-01 2021-06-30 0000081362 us-gaap:InterestExpenseMember 2020-01-01 2020-06-30 0000081362 2020-01-01 2020-12-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2020-04-01 2020-06-30 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2020-01-01 2020-06-30 0000081362 kwr:HoughtonCombinationMember 2021-06-30 0000081362 kwr:HoughtonCombinationMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-06-30 0000081362 2021-04-01 2021-06-30 0000081362 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-06-30 0000081362 us-gaap:EmployeeStockOptionMember 2021-06-30 0000081362 srt:MaximumMember kwr:HoughtonEnvironmentalMattersMember 2021-06-30 0000081362 srt:MinimumMember kwr:HoughtonEnvironmentalMattersMember 2021-06-30 0000081362 kwr:DefinedContributionPlanMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AmericasMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember us-gaap:EMEAMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AsiaPacificMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:GlobalSpecialtyBusinessesMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AmericasMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember us-gaap:EMEAMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AsiaPacificMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:GlobalSpecialtyBusinessesMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2020-04-01 2020-06-30 0000081362 srt:ScenarioPreviouslyReportedMember kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 srt:RestatementAdjustmentMember kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 srt:RestatementAdjustmentMember kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 srt:ScenarioPreviouslyReportedMember kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 kwr:TinplatingsolutionsMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:CustomerListsMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:PatentedTechnologyMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:TrademarksMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:CustomerListsMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:PatentedTechnologyMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:TrademarksMember 2021-02-01 2021-02-28 0000081362 kwr:GrindaixGmbhMember 2021-02-28 0000081362 kwr:GrindaixGmbhMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember 2021-01-01 2021-06-30 0000081362 kwr:CoralChemicalCompanyMember 2021-04-01 2021-06-30 0000081362 kwr:CoralChemicalCompanyMember 2021-01-01 2021-06-30 0000081362 kwr:TelnordicMember 2020-05-01 2020-05-31 0000081362 kwr:TelnordicMember 2020-04-01 2020-06-30 0000081362 kwr:TelnordicMember 2020-06-30 0000081362 kwr:TelnordicMember 2021-01-01 2021-06-30 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-03-31 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-03-01 2020-03-31 0000081362 kwr:NormanHayMember 2019-10-01 2019-10-31 0000081362 kwr:NormanHayMember 2020-01-01 2020-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2021-04-01 2021-06-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2021-01-01 2021-06-30 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2021-04-01 2021-06-30 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2021-01-01 2021-06-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2021-04-01 2021-06-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2021-01-01 2021-06-30 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2021-04-01 2021-06-30 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-06-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2020-04-01 2020-06-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2020-01-01 2020-06-30 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2020-04-01 2020-06-30 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2020-01-01 2020-06-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2020-04-01 2020-06-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2020-01-01 2020-06-30 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2020-04-01 2020-06-30 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AmericasMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember us-gaap:EMEAMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AsiaPacificMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-04-01 2021-06-30 0000081362 srt:AmericasMember 2021-04-01 2021-06-30 0000081362 us-gaap:EMEAMember 2021-04-01 2021-06-30 0000081362 srt:AsiaPacificMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2020-04-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-04-01 2020-06-30 0000081362 srt:AmericasMember 2020-04-01 2020-06-30 0000081362 us-gaap:EMEAMember 2020-04-01 2020-06-30 0000081362 srt:AsiaPacificMember 2020-04-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2020-04-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2020-04-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2020-04-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2020-04-01 2020-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2020-04-01 2020-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2020-04-01 2020-06-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2020-04-01 2020-06-30 0000081362 us-gaap:TransferredOverTimeMember 2020-04-01 2020-06-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2021-04-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2021-04-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2021-04-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2021-04-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2021-04-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2021-04-01 2021-06-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2021-04-01 2021-06-30 0000081362 us-gaap:TransferredOverTimeMember 2021-04-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-06-30 0000081362 srt:AmericasMember 2021-01-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-06-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-06-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-06-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-06-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-06-30 0000081362 us-gaap:TransferredOverTimeMember 2021-01-01 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AmericasMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember us-gaap:EMEAMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AsiaPacificMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-06-30 0000081362 srt:AmericasMember 2020-01-01 2020-06-30 0000081362 us-gaap:EMEAMember 2020-01-01 2020-06-30 0000081362 srt:AsiaPacificMember 2020-01-01 2020-06-30 0000081362 kwr:QhProgramMember 2020-12-31 0000081362 kwr:QhProgramMember 2021-01-01 2021-06-30 0000081362 kwr:QhProgramMember 2021-06-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2021-04-01 2021-06-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2021-04-01 2021-06-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2021-04-01 2021-06-30 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2021-04-01 2021-06-30 0000081362 us-gaap:PerformanceSharesMember 2021-04-01 2021-06-30 0000081362 us-gaap:PerformanceSharesMember 2020-04-01 2020-06-30 0000081362 us-gaap:PerformanceSharesMember 2021-01-01 2021-06-30 0000081362 us-gaap:PerformanceSharesMember 2020-01-01 2020-06-30 0000081362 us-gaap:StockCompensationPlanMember 2021-04-01 2021-06-30 0000081362 us-gaap:StockCompensationPlanMember 2020-04-01 2020-06-30 0000081362 us-gaap:StockCompensationPlanMember 2021-01-01 2021-06-30 0000081362 us-gaap:StockCompensationPlanMember 2020-01-01 2020-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-06-30 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2021-06-30 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2020-12-31 0000081362 us-gaap:LineOfCreditMember 2021-06-30 0000081362 us-gaap:DomesticLineOfCreditMember 2021-06-30 0000081362 us-gaap:ForeignLineOfCreditMember 2021-06-30 0000081362 kwr:IndustrialDevelopmentBondsMember 2021-06-30 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2021-06-30 0000081362 us-gaap:LineOfCreditMember 2020-12-31 0000081362 us-gaap:DomesticLineOfCreditMember 2020-12-31 0000081362 us-gaap:ForeignLineOfCreditMember 2020-12-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2020-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2020-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2021-01-01 2021-06-30 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2020-01-01 2020-12-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2021-06-30 0000081362 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember 2021-01-01 2021-06-30 0000081362 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember 2021-01-01 2021-06-30 0000081362 srt:MinimumMember 2021-06-30 0000081362 srt:MaximumMember 2021-06-30 0000081362 kwr:TermLoanMember 2021-01-01 2021-06-30 0000081362 kwr:TermLoanMember 2021-06-30 0000081362 kwr:TermLoanMember 2019-11-30 0000081362 us-gaap:OtherAssetsMember 2021-06-30 0000081362 us-gaap:OtherAssetsMember 2020-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-06-30 0000081362 us-gaap:CorporateBondSecuritiesMember 2020-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-01-01 2021-06-30 0000081362 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0000081362 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0000081362 2020-03-31 0000081362 us-gaap:CommonStockMember 2020-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000081362 us-gaap:RetainedEarningsMember 2020-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-03-31 0000081362 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000081362 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0000081362 us-gaap:CommonStockMember 2021-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000081362 us-gaap:RetainedEarningsMember 2021-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-03-31 0000081362 2021-03-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:CommonStockMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:NoncontrollingInterestMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:CommonStockMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:RetainedEarningsMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:NoncontrollingInterestMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-04-01 2021-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-04-01 2021-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-04-01 2021-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-04-01 2021-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-04-01 2020-06-30 0000081362 2020-01-01 2020-03-31 0000081362 kwr:ForeignconsumptiontaxMember 2021-06-30 0000081362 srt:MinimumMember kwr:ForeignconsumptiontaxMember 2021-06-30 0000081362 srt:MaximumMember kwr:ForeignconsumptiontaxMember 2021-06-30 0000081362 kwr:ForeignconsumptiontaxMember 2021-01-01 2021-06-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2021-04-01 2021-06-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2021-01-01 2021-06-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2020-04-01 2020-06-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2020-01-01 2020-06-30 0000081362 kwr:DefinedContributionPlanMember 2020-04-01 2020-06-30 0000081362 kwr:DefinedContributionPlanMember 2020-01-01 2020-06-30 0000081362 kwr:DefinedbenefitplansettlementMember 2020-07-01 2020-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-07-01 2020-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-06-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-06-30 0000081362 country:IT 2021-01-01 2021-06-30 0000081362 country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2021-06-30 0000081362 country:DE 2021-06-30 0000081362 kwr:NetherlandsAndSpainMember us-gaap:ForeignCountryMember 2021-06-30 0000081362 country:IT us-gaap:ForeignCountryMember 2021-06-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-04-01 2020-06-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-04-01 2020-06-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-06-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-06-30 0000081362 us-gaap:InterestExpenseMember 2021-04-01 2021-06-30 0000081362 kwr:BrazilianIndirectTaxesMember 2021-01-01 2021-06-30 0000081362 us-gaap:InterestRateSwapMember 2019-11-30 0000081362 us-gaap:InterestRateSwapMember 2021-01-01 2021-06-30 0000081362 srt:ScenarioForecastMember 2021-12-31 0000081362 srt:MaximumMember kwr:FacilitiesVehiclesAndMachineryAndEquipmentMember 2021-06-30 0000081362 srt:MaximumMember us-gaap:LandMember 2021-06-30 0000081362 srt:MinimumMember country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2021-01-01 2021-06-30 0000081362 srt:MaximumMember country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2021-01-01 2021-06-30 0000081362 srt:MinimumMember country:DE kwr:HoughtonMember us-gaap:ForeignCountryMember 2021-01-01 2021-06-30 0000081362 srt:MaximumMember country:DE kwr:HoughtonMember us-gaap:ForeignCountryMember 2021-01-01 2021-06-30 0000081362 srt:SubsidiariesMember country:AR 2021-04-01 2021-06-30 0000081362 srt:SubsidiariesMember country:AR 2021-01-01 2021-06-30 0000081362 srt:SubsidiariesMember country:AR 2020-04-01 2020-06-30 0000081362 srt:SubsidiariesMember country:AR 2020-01-01 2020-06-30 0000081362 kwr:ChemicalMaskantsProductLineMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-06-30 0000081362 kwr:HoughtonMember kwr:ForeignconsumptiontaxMember 2021-06-30 0000081362 country:DE kwr:HoughtonMember 2021-06-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2021-04-01 2021-06-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-06-30 0000081362 us-gaap:PerformanceSharesMember 2021-06-30 0000081362 kwr:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000081362 kwr:TopFiveMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000081362 srt:SubsidiariesMember country:AR us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-06-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-06-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-06-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2021-04-01 2021-06-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2020-04-01 2020-06-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2020-04-01 2020-06-30 0000081362 kwr:DefinedContributionPlanMember 2021-04-01 2021-06-30 0000081362 kwr:HoughtonCombinationMember 2021-01-01 2021-03-31 0000081362 kwr:HoughtonCombinationMember 2020-12-31 0000081362 kwr:HoughtonCombinationMember 2021-06-30 0000081362 srt:MaximumMember country:IT us-gaap:ForeignCountryMember 2021-01-01 2021-06-30 0000081362 srt:MinimumMember country:IT us-gaap:ForeignCountryMember 2021-01-01 2021-06-30 0000081362 country:IT us-gaap:ForeignCountryMember 2021-01-01 2021-06-30 0000081362 country:BR us-gaap:ForeignCountryMember 2021-01-01 2021-06-30 0000081362 country:NL us-gaap:ForeignCountryMember 2021-01-01 2021-06-30 0000081362 country:CN us-gaap:ForeignCountryMember 2021-01-01 2021-06-30 0000081362 country:MX us-gaap:ForeignCountryMember 2021-01-01 2021-06-30 0000081362 country:GB us-gaap:ForeignCountryMember 2021-01-01 2021-06-30 0000081362 country:CA us-gaap:StateAndLocalJurisdictionMember 2021-01-01 2021-06-30 0000081362 us-gaap:InternalRevenueServiceIRSMember 2021-01-01 2021-06-30 0000081362 us-gaap:StateAndLocalJurisdictionMember 2021-01-01 2021-06-30 0000081362 country:IN us-gaap:ForeignCountryMember 2021-01-01 2021-06-30 iso4217:BRL iso4217:DKK iso4217:EUR iso4217:GBP iso4217:USD iso4217:ZAR pure shares iso4217:USD shares dummy:People dummy:Segments dummy:Countries false --12-31 P3Y 2021 1 30000000 Q2 0000081362 false us-gaap:Assets us-gaap:Liabilities 10-Q true 2021-06-30 false 001-12019 QUAKER CHEMICAL CORPORATION PA 23-0993790 901 E. Hector Street Conshohocken PA 19428 – 2380 610 832-4000 Common Stock, $1 par value KWR NYSE Yes Yes Large Accelerated Filer false false 17878247 435262000 286040000 865045000 664601000 280811000 188654000 554400000 433364000 154451000 97386000 310645000 231237000 108679000 86667000 212989000 185368000 0 0 0 38000000 298000 486000 1473000 2202000 6658000 7995000 12473000 15873000 38816000 2238000 83710000 -10206000 14010000 -993000 18697000 -22168000 -5618000 -6811000 -11088000 -15272000 47208000 -5566000 91319000 -47646000 15218000 3222000 25907000 -9848000 31990000 -8788000 65412000 -37798000 1610000 1066000 6820000 1732000 33600000 -7722000 72232000 -36066000 30000 13000 47000 50000 33570000 -7735000 72185000 -36116000 1.88 -0.43 4.04 -2.03 1.88 -0.43 4.03 -2.03 0.395 0.385 0.790 0.770 33600000 -7722000 72232000 -36066000 16165000 10551000 -9296000 -44200000 397000 213000 1689000 17170000 452000 -111000 1014000 -4092000 279000 1608000 -2746000 -103000 17293000 12261000 -9339000 -31225000 50893000 4539000 62893000 -67291000 38000 14000 53000 -81000 50855000 4525000 62840000 -67210000 145610000 181833000 418642000 372974000 116491000 86148000 126318000 101616000 60844000 50156000 867905000 792727000 424360000 423253000 229919000 219370000 194441000 203883000 36160000 38507000 633449000 631212000 1068795000 1081358000 98013000 95785000 13392000 16566000 32664000 31796000 2944819000 2891834000 48079000 38967000 219617000 198872000 33399000 43300000 5278000 8248000 94061000 93573000 400434000 382960000 847154000 849068000 25668000 27070000 181264000 192763000 114898000 119059000 1569418000 1570920000 1 30000000 17878137 17850616 17878000 17851000 910862000 905171000 482001000 423940000 -35943000 -26598000 1374798000 1320364000 603000 550000 1375401000 1320914000 2944819000 2891834000 72232000 -36066000 2375000 2375000 44188000 42079000 6715000 -3219000 801000 229000 -13849000 -22033000 6134000 7673000 5356000 -81000 0 542000 0 38000000 -2305000 1860000 1473000 2202000 -2223000 18784000 47252000 -61659000 57020000 3689000 20111000 2849000 -4214000 -9592000 22274000 -58728000 -9568000 44662000 6974000 7534000 29424000 3132000 14744000 11000 0 37000 -21654000 -10618000 19065000 18702000 29433000 205500000 -219000 -684000 14113000 13662000 -416000 -1923000 0 1047000 0 751000 -4380000 168731000 -683000 -4575000 -36285000 198200000 181895000 143555000 145610000 341755000 <div id="TextBlockContainer4" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:739px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3609" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 1 – Basis of Presentation and Description of Business<div style="display:inline-block;width:4.9px"> </div></div><div id="div_2_XBRL_TS_eb3f996fb8514e3e9a7d1174839ecbb8" style="position:absolute;left:0px;top:20.8px;float:left;"><div id="TextBlockContainer3" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:221px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3630" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Basis of Presentation </div><div id="a3636" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:20.6px;">As used in these Notes to Condensed Consolidated<div style="display:inline-block;width:4.74px"> </div>Financial Statements, the terms “Quaker,”<div style="display:inline-block;width:4.67px"> </div>“Quaker Houghton,”<div style="display:inline-block;width:3.97px"> </div>the </div><div id="a3670" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:35.8px;">“Company,”<div style="display:inline-block;width:4.7px"> </div>“we,” and “our” refer to Quaker Chemical Corporation (doing<div style="display:inline-block;width:4.76px"> </div>business as Quaker Houghton), its subsidiaries, and </div><div id="a3707" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.2px;">associated companies, unless the context otherwise requires.<div style="display:inline-block;width:8.19px"> </div>As used in these Notes to Condensed Consolidated<div style="display:inline-block;width:4.74px"> </div>Financial Statements, </div><div id="a3741" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.6px;">the term Legacy Quaker refers to the Company prior<div style="display:inline-block;width:4.72px"> </div>to the closing of its combination with Houghton International,<div style="display:inline-block;width:4.62px"> </div>Inc. (“Houghton”) </div><div id="a3782" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.9px;">(herein referred to as the “Combination”).<div style="display:inline-block;width:7.75px"> </div>The condensed consolidated financial statements included herein<div style="display:inline-block;width:4.83px"> </div>are unaudited and have </div><div id="a3817" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:97.3px;">been prepared in accordance with generally accepted<div style="display:inline-block;width:4.74px"> </div>accounting principles in the United States (“U.S. GAAP”) for<div style="display:inline-block;width:4.73px"> </div>interim financial </div><div id="a3853" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:112.6px;">reporting and the United States Securities and Exchange Commission<div style="display:inline-block;width:4.92px"> </div>(“SEC”) regulations.<div style="display:inline-block;width:7.15px"> </div>Certain information and footnote </div><div id="a3883" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:127.8px;">disclosures normally included in financial statements prepared<div style="display:inline-block;width:4.81px"> </div>in accordance with U.S. GAAP have been condensed or<div style="display:inline-block;width:4.6px"> </div>omitted </div><div id="a3917" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:143.2px;">pursuant to such rules and regulations.<div style="display:inline-block;width:7.74px"> </div>In the opinion of management, the financial statements reflect all<div style="display:inline-block;width:4.7px"> </div>adjustments which are </div><div id="a3955" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:158.6px;">necessary for a fair statement of the financial position,<div style="display:inline-block;width:4.62px"> </div>results of operations and cash flows for the interim periods.<div style="display:inline-block;width:8.21px"> </div>The results for the </div><div id="a4001" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:173.9px;">six months ended June 30, 2021 are not necessarily indicative<div style="display:inline-block;width:4.79px"> </div>of the results to be expected for the full year.<div style="display:inline-block;width:8.51px"> </div>These financial </div><div id="a4045" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:189.3px;">statements should be read in conjunction with the Company’s<div style="display:inline-block;width:5.45px"> </div>Annual Report filed on Form 10-K for the year<div style="display:inline-block;width:4.74px"> </div>ended December 31, </div><div id="a4090" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:204.7px;">2020 (the “2020 Form 10-K”).</div></div></div><div id="a4090_28_3" style="position:absolute;font-weight:normal;font-style:normal;left:167.813px;top:225.5px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a4105" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:246.1px;">Description of Business </div><div id="a4111" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:266.8px;">The Company was organized in 1918, incorporated<div style="display:inline-block;width:4.89px"> </div>as a Pennsylvania business corporation in 1930, and in August<div style="display:inline-block;width:4.75px"> </div>2019 </div><div id="a4148" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:282.1px;">completed the Combination with Houghton to form<div style="display:inline-block;width:4.79px"> </div>Quaker Houghton.<div style="display:inline-block;width:7.08px"> </div>Quaker Houghton is the global leader in industrial process </div><div id="a4186" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:297.3px;">fluids.<div style="display:inline-block;width:6.94px"> </div>With a presence around the world,<div style="display:inline-block;width:4.71px"> </div>including operations in over </div><div id="a4186_72_2" style="position:absolute;left:385.293px;top:297.3px;">25</div><div id="a4186_74_57" style="position:absolute;font-weight:normal;font-style:normal;left:398.6px;top:297.3px;"><div style="display:inline-block;width:3.36px"> </div>countries, the Company’s customers<div style="display:inline-block;width:4.95px"> </div>include thousands of </div><div id="a4224" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:312.7px;">the world’s most advanced<div style="display:inline-block;width:4.76px"> </div>and specialized steel, aluminum, automotive, aerospace,<div style="display:inline-block;width:4.63px"> </div>offshore, can, mining, and metalworking </div><div id="a4254" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:328px;">companies.<div style="display:inline-block;width:7.12px"> </div>Quaker Houghton develops, produces, and markets a broad range<div style="display:inline-block;width:4.68px"> </div>of formulated chemical specialty products and offe<div style="display:inline-block;width:1.46px"> </div>rs </div><div id="a4289" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:343.4px;">chemical management services (which the Company refers<div style="display:inline-block;width:4.72px"> </div>to as “Fluidcare”) for various heavy industrial and manufacturing </div><div id="a4322" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:358.8px;">applications throughout its </div><div id="a4322_28_4" style="position:absolute;left:150.053px;top:358.8px;">four</div><div id="a4322_32_97" style="position:absolute;font-weight:normal;font-style:normal;left:172.293px;top:358.8px;"><div style="display:inline-block;width:3.36px"> </div>segments: Americas; Europe, Middle East and Africa (“EMEA”);<div style="display:inline-block;width:4.81px"> </div>Asia/Pacific; and Global Specialty </div><div id="a4355" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:374.1px;">Businesses. </div><div id="a4357" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:394.8px;">Hyper-inflationary economies</div><div id="a4362" style="position:absolute;font-weight:normal;font-style:normal;left:164.773px;top:394.8px;"> </div><div id="a4363" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:415.4px;">Based on various indices or index compilations being<div style="display:inline-block;width:4.67px"> </div>used to monitor inflation in Argentina as well as economic<div style="display:inline-block;width:4.99px"> </div>instability, </div><div id="a4401" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:430.8px;">effective July 1, 2018, Argentina’s<div style="display:inline-block;width:5.33px"> </div>economy was considered hyper-inflationary under U.S.<div style="display:inline-block;width:4.55px"> </div>GAAP.<div style="display:inline-block;width:8.23px"> </div>As of, and for the three and six </div><div id="a4444" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:446.1px;">months ended June 30, 2021, the Company's Argentine<div style="display:inline-block;width:4.98px"> </div>subsidiaries represented less than </div><div id="a4444_87_1" style="position:absolute;left:483.24px;top:446.1px;">1</div><div id="a4444_88_38" style="position:absolute;font-weight:normal;font-style:normal;left:489.8px;top:446.1px;">% of the Company’s consolidated<div style="display:inline-block;width:4.95px"> </div>total </div><div id="a4483" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:461.3px;">assets and net sales, respectively.<div style="display:inline-block;width:8.46px"> </div>During the three and six months ended June 30, 2021, the Company<div style="display:inline-block;width:4.74px"> </div>recorded $</div><div id="a4483_112_3" style="position:absolute;left:610.799px;top:461.3px;">0.1</div><div id="a4483_115_14" style="position:absolute;font-weight:normal;font-style:normal;left:627.599px;top:461.3px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a4483_129_3" style="position:absolute;left:701.999px;top:461.3px;">0.3</div><div id="a4483_132_1" style="position:absolute;font-weight:normal;font-style:normal;left:718.639px;top:461.3px;"> </div><div id="a4531" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:476.7px;">million,<div style="display:inline-block;width:3.62px"> </div>respectively, of remeasurement<div style="display:inline-block;width:5.01px"> </div>losses associated with the applicable currency conversions related<div style="display:inline-block;width:4.84px"> </div>to Argentina.<div style="display:inline-block;width:3.93px"> </div></div><div id="a4561" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:492.1px;">Comparatively,<div style="display:inline-block;width:4.73px"> </div>during the three and six months ended June 30, 2020, the<div style="display:inline-block;width:4.74px"> </div>Company recorded less than $</div><div id="a4561_100_3" style="position:absolute;left:559.88px;top:492.1px;">0.1</div><div id="a4561_103_14" style="position:absolute;font-weight:normal;font-style:normal;left:576.56px;top:492.1px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a4561_117_3" style="position:absolute;left:650.959px;top:492.1px;">0.1</div><div id="a4561_120_10" style="position:absolute;font-weight:normal;font-style:normal;left:667.759px;top:492.1px;"><div style="display:inline-block;width:3.36px"> </div>million, </div><div id="a4605" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:507.4px;">respectively, of<div style="display:inline-block;width:4.63px"> </div>remeasurement losses associated with the applicable currency<div style="display:inline-block;width:4.85px"> </div>conversions<div style="display:inline-block;width:3.44px"> </div>related to Argentina.<div style="display:inline-block;width:7.57px"> </div>These losses were </div><div id="a4638" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:522.8px;">recorded within foreign exchange losses, net, which<div style="display:inline-block;width:4.71px"> </div>is a component of other income (expense), net, in the Company’s<div style="display:inline-block;width:5.34px"> </div>Condensed </div><div id="a4678" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:538.1px;">Consolidated Statements of Operations. </div><div id="a4686" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:558.8px;">COVID-19 </div><div id="a4690" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:579.4px;">Management continues to monitor the impact that the COVID-19<div style="display:inline-block;width:4.97px"> </div>pandemic is having on the Company,<div style="display:inline-block;width:5px"> </div>the overall specialty </div><div id="a4728" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:594.8px;">chemical industry,<div style="display:inline-block;width:4.71px"> </div>and the economies and markets in which the Company operates.<div style="display:inline-block;width:8.17px"> </div>The full extent of the COVID-19 pandemic </div><div id="a4768" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:610px;">related business and travel restrictions and changes to<div style="display:inline-block;width:4.77px"> </div>business and consumer behavior intended to reduce its spread are<div style="display:inline-block;width:4.74px"> </div>uncertain as of </div><div id="a4810" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:625.3px;">the date of this Quarterly Report on Form 10-Q for the<div style="display:inline-block;width:4.59px"> </div>period ended June 30, 2021 (the “Report”) as COVID-19<div style="display:inline-block;width:4.71px"> </div>and the responses of </div><div id="a4862" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:640.7px;">governmental authorities continue to evolve globally. </div><div id="a4874" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:661.4px;">Further, management continues to<div style="display:inline-block;width:4.71px"> </div>evaluate how COVID-19-related circumstances, such as remote<div style="display:inline-block;width:4.81px"> </div>work arrangements, affect </div><div id="a4906" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:676.7px;">financial reporting processes, internal control over financial<div style="display:inline-block;width:4.82px"> </div>reporting, and disclosure controls and procedures.<div style="display:inline-block;width:7.87px"> </div>While the </div><div id="a4937" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:692.1px;">circumstances have presented and are expected to continue<div style="display:inline-block;width:4.79px"> </div>to present challenges, at this time, Management does not believe that </div><div id="a4976" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:707.5px;">COVID-19 has had a material impact on financial reporting<div style="display:inline-block;width:4.69px"> </div>processes, internal control over financial reporting,<div style="display:inline-block;width:4.71px"> </div>and disclosure </div><div id="a5012" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:722.8px;">controls and procedures.</div></div><div id="TextBlockContainer6" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:175px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5067" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company cannot reasonably estimate the magnitude<div style="display:inline-block;width:4.81px"> </div>of the effects these conditions will have on the Company’s<div style="display:inline-block;width:5.57px"> </div>operations in </div><div id="a5105" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">the future as they are subject to significant uncertainties<div style="display:inline-block;width:4.71px"> </div>relating to the ultimate geographic spread of the virus,<div style="display:inline-block;width:4.7px"> </div>the incidence and </div><div id="a5147" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">severity of the symptoms, the duration or resurgences<div style="display:inline-block;width:5.04px"> </div>of the outbreak including the impact of new variants, the global<div style="display:inline-block;width:4.71px"> </div>availability and </div><div id="a5189" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">acceptance of vaccines as well as their efficacy,<div style="display:inline-block;width:5.77px"> </div>the length of the travel restrictions and business closures imposed by<div style="display:inline-block;width:4.86px"> </div>governments of </div><div id="a5231" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">impacted countries, and the economic response by governments<div style="display:inline-block;width:4.79px"> </div>of impacted countries, all of which continue to evolve. </div><div id="a5265" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:81.9px;">To the extent<div style="display:inline-block;width:4.81px"> </div>that the Company’s customers and<div style="display:inline-block;width:4.78px"> </div>suppliers continue to be significantly and adversely impacted by<div style="display:inline-block;width:4.81px"> </div>COVID-19, this </div><div id="a5305" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:97.3px;">could reduce the availability,<div style="display:inline-block;width:4.84px"> </div>or result in delays, of materials or supplies to or from<div style="display:inline-block;width:4.71px"> </div>the Company, which in<div style="display:inline-block;width:4.81px"> </div>turn could significantly </div><div id="a5350" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:112.6px;">interrupt the Company’s<div style="display:inline-block;width:4.7px"> </div>business operations.<div style="display:inline-block;width:7.15px"> </div>Such impacts could grow and become more significant to the<div style="display:inline-block;width:4.76px"> </div>Company’s operations </div><div id="a5384" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:128px;">and the Company’s liquidity<div style="display:inline-block;width:4.84px"> </div>or financial position.<div style="display:inline-block;width:7.21px"> </div>Therefore, given the speed and frequency of continuously<div style="display:inline-block;width:4.78px"> </div>evolving developments </div><div id="a5419" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:143.4px;">with respect to this pandemic, the Company cannot reasonably<div style="display:inline-block;width:4.81px"> </div>estimate the magnitude or the full extent to which COVID-19<div style="display:inline-block;width:4.78px"> </div>may </div><div id="a5461" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:158.7px;">impact the Company’s results<div style="display:inline-block;width:4.77px"> </div>of operations, liquidity or financial position.</div></div> <div id="TextBlockContainer3" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:221px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3630" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Basis of Presentation </div><div id="a3636" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:20.6px;">As used in these Notes to Condensed Consolidated<div style="display:inline-block;width:4.74px"> </div>Financial Statements, the terms “Quaker,”<div style="display:inline-block;width:4.67px"> </div>“Quaker Houghton,”<div style="display:inline-block;width:3.97px"> </div>the </div><div id="a3670" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:35.8px;">“Company,”<div style="display:inline-block;width:4.7px"> </div>“we,” and “our” refer to Quaker Chemical Corporation (doing<div style="display:inline-block;width:4.76px"> </div>business as Quaker Houghton), its subsidiaries, and </div><div id="a3707" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.2px;">associated companies, unless the context otherwise requires.<div style="display:inline-block;width:8.19px"> </div>As used in these Notes to Condensed Consolidated<div style="display:inline-block;width:4.74px"> </div>Financial Statements, </div><div id="a3741" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.6px;">the term Legacy Quaker refers to the Company prior<div style="display:inline-block;width:4.72px"> </div>to the closing of its combination with Houghton International,<div style="display:inline-block;width:4.62px"> </div>Inc. (“Houghton”) </div><div id="a3782" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.9px;">(herein referred to as the “Combination”).<div style="display:inline-block;width:7.75px"> </div>The condensed consolidated financial statements included herein<div style="display:inline-block;width:4.83px"> </div>are unaudited and have </div><div id="a3817" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:97.3px;">been prepared in accordance with generally accepted<div style="display:inline-block;width:4.74px"> </div>accounting principles in the United States (“U.S. GAAP”) for<div style="display:inline-block;width:4.73px"> </div>interim financial </div><div id="a3853" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:112.6px;">reporting and the United States Securities and Exchange Commission<div style="display:inline-block;width:4.92px"> </div>(“SEC”) regulations.<div style="display:inline-block;width:7.15px"> </div>Certain information and footnote </div><div id="a3883" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:127.8px;">disclosures normally included in financial statements prepared<div style="display:inline-block;width:4.81px"> </div>in accordance with U.S. GAAP have been condensed or<div style="display:inline-block;width:4.6px"> </div>omitted </div><div id="a3917" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:143.2px;">pursuant to such rules and regulations.<div style="display:inline-block;width:7.74px"> </div>In the opinion of management, the financial statements reflect all<div style="display:inline-block;width:4.7px"> </div>adjustments which are </div><div id="a3955" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:158.6px;">necessary for a fair statement of the financial position,<div style="display:inline-block;width:4.62px"> </div>results of operations and cash flows for the interim periods.<div style="display:inline-block;width:8.21px"> </div>The results for the </div><div id="a4001" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:173.9px;">six months ended June 30, 2021 are not necessarily indicative<div style="display:inline-block;width:4.79px"> </div>of the results to be expected for the full year.<div style="display:inline-block;width:8.51px"> </div>These financial </div><div id="a4045" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:189.3px;">statements should be read in conjunction with the Company’s<div style="display:inline-block;width:5.45px"> </div>Annual Report filed on Form 10-K for the year<div style="display:inline-block;width:4.74px"> </div>ended December 31, </div><div id="a4090" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:204.7px;">2020 (the “2020 Form 10-K”).</div></div> 25 4 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 100000 300000 100000 100000 <div id="TextBlockContainer8" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:726px;height:362px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5482" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 2 – Business Acquisitions </div><div id="a5492" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:23.2px;">2021 Acquisitions </div><div id="a5496" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:46.6px;">In June 2021, the Company acquired certain assets for its chemical<div style="display:inline-block;width:4.94px"> </div>maskants product line in the Global Specialty Businesses </div><div id="a5534" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:62px;">reportable segment for </div><div id="a5534_23_3" style="position:absolute;left:128.613px;top:62px;">2.3</div><div id="a5534_26_31" style="position:absolute;font-weight:normal;font-style:normal;left:145.253px;top:62px;"><div style="display:inline-block;width:3.36px"> </div>million EUR or approximately $</div><div id="a5534_57_3" style="position:absolute;left:321.933px;top:62px;">2.8</div><div id="a5534_60_69" style="position:absolute;font-weight:normal;font-style:normal;left:338.573px;top:62px;"><div style="display:inline-block;width:3.36px"> </div>million.<div style="display:inline-block;width:6.95px"> </div>The Company accounted for the acquisition using the asset </div><div id="a5572" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:77.3px;">acquisition method under ASC 805, </div><div id="a5583" style="position:absolute;font-weight:normal;font-style:italic;left:199.333px;top:77.3px;">Business Combinations</div><div id="a5586" style="position:absolute;font-weight:normal;font-style:normal;left:324.013px;top:77.3px;">.<div style="display:inline-block;width:6.76px"> </div></div><div id="a5589" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:100.5px;">In February 2021, the Company acquired a tin-plating<div style="display:inline-block;width:4.83px"> </div>solutions business for the steel end market for approximately $</div><div id="a5589_116_2" style="position:absolute;left:655.279px;top:100.5px;">25</div><div id="a5589_118_11" style="position:absolute;font-weight:normal;font-style:normal;left:668.559px;top:100.5px;"><div style="display:inline-block;width:3.2px"> </div>million.<div style="display:inline-block;width:3.59px"> </div></div><div id="a5629" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.9px;">This acquisition is part of each of the Company’s<div style="display:inline-block;width:5.35px"> </div>geographic reportable segments.<div style="display:inline-block;width:7.5px"> </div>The Company allocated $</div><div id="a5629_106_4" style="position:absolute;left:587.92px;top:115.9px;">19.6</div><div id="a5629_110_16" style="position:absolute;font-weight:normal;font-style:normal;left:611.28px;top:115.9px;"><div style="display:inline-block;width:3.36px"> </div>million of the </div><div id="a5668" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:131.2px;">purchase price to intangible assets, comprised of $</div><div id="a5668_51_4" style="position:absolute;left:273.453px;top:131.2px;">18.3</div><div id="a5668_55_57" style="position:absolute;font-weight:normal;font-style:normal;left:296.813px;top:131.2px;"><div style="display:inline-block;width:3.36px"> </div>million of customer relationships, to be amortized over </div><div id="a5668_112_8" style="position:absolute;left:596.879px;top:131.2px;">19 years</div><div id="a5668_120_3" style="position:absolute;font-weight:normal;font-style:normal;left:641.679px;top:131.2px;">; $</div><div id="a5668_123_3" style="position:absolute;left:655.279px;top:131.2px;">0.9</div><div id="a5668_126_9" style="position:absolute;font-weight:normal;font-style:normal;left:672.079px;top:131.2px;"><div style="display:inline-block;width:3.36px"> </div>million </div><div id="a5708" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:146.6px;">of existing product technology to be amortized over </div><div id="a5708_52_8" style="position:absolute;left:284.653px;top:146.6px;">14 years</div><div id="a5708_60_7" style="position:absolute;font-weight:normal;font-style:normal;left:329.293px;top:146.6px;">; and $</div><div id="a5708_67_3" style="position:absolute;left:365.613px;top:146.6px;">0.4</div><div id="a5708_70_54" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:146.6px;"><div style="display:inline-block;width:3.36px"> </div>million of a licensed trademark to be amortized over </div><div id="a5708_124_7" style="position:absolute;left:669.039px;top:146.6px;">3 years</div><div id="a5708_131_3" style="position:absolute;font-weight:normal;font-style:normal;left:707.119px;top:146.6px;">.<div style="display:inline-block;width:3.4px"> </div></div><div id="a5755" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:162px;">In addition, the Company recorded $</div><div id="a5755_35_3" style="position:absolute;left:200.773px;top:162px;">5.0</div><div id="a5755_38_94" style="position:absolute;font-weight:normal;font-style:normal;left:217.613px;top:162px;"><div style="display:inline-block;width:3.2px"> </div>million of goodwill related to expected value not allocated<div style="display:inline-block;width:4.72px"> </div>to other acquired assets, all of </div><div id="a5797" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:177.3px;">which is expected to be tax deductible.<div style="display:inline-block;width:7.69px"> </div>As of June 30, 2021, the allocation of the purchase price has not<div style="display:inline-block;width:4.71px"> </div>been finalized and the </div><div id="a5797_130_4" style="position:absolute;left:684.559px;top:177.3px;">one </div><div id="a5848" style="position:absolute;left:4.427px;top:192.5px;">year</div><div id="a5848_4_125" style="position:absolute;font-weight:normal;font-style:normal;left:27.467px;top:192.5px;"><div style="display:inline-block;width:3.36px"> </div>measurement period has not ended.<div style="display:inline-block;width:7.56px"> </div>Further adjustments may be necessary as a result of the Company’s<div style="display:inline-block;width:5.63px"> </div>on-going assessment of </div><div id="a5890" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:207.9px;">additional information related to the fair value of assets acquired<div style="display:inline-block;width:4.92px"> </div>and liabilities assumed. </div><div id="a5916" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:231.2px;"><div style="display:inline-block;width:3.36px"> </div>Additionally, in February<div style="display:inline-block;width:4.89px"> </div>2021, the Company acquired a </div><div id="a5916_56_2" style="position:absolute;left:337.773px;top:231.2px;">38</div><div id="a5916_58_63" style="position:absolute;font-weight:normal;font-style:normal;left:351.053px;top:231.2px;">% ownership interest in a Germany-based, high-tech<div style="display:inline-block;width:4.75px"> </div>provider of </div><div id="a5955" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:246.6px;">coolant control and delivery systems for approximately </div><div id="a5955_55_3" style="position:absolute;left:302.733px;top:246.6px;">1.4</div><div id="a5955_58_31" style="position:absolute;font-weight:normal;font-style:normal;left:319.533px;top:246.6px;"><div style="display:inline-block;width:3.2px"> </div>million EUR or approximately $</div><div id="a5955_89_3" style="position:absolute;left:496.199px;top:246.6px;">1.7</div><div id="a5955_92_37" style="position:absolute;font-weight:normal;font-style:normal;left:512.999px;top:246.6px;"><div style="display:inline-block;width:3.2px"> </div>million.<div style="display:inline-block;width:6.95px"> </div>The Company recorded this </div><div id="a5991" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:262px;">investment as an equity method investment within<div style="display:inline-block;width:4.71px"> </div>the Condensed Consolidated Financial Statements. </div><div id="a6015" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:285.3px;">The results of operations of the acquired assets and businesses subsequent<div style="display:inline-block;width:5.03px"> </div>to the respective acquisition dates are included in the </div><div id="a6055" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:300.5px;">Condensed Consolidated Statements of Operations as of June<div style="display:inline-block;width:4.7px"> </div>30, 2021.<div style="display:inline-block;width:7px"> </div>Applicable transaction expenses associated with these </div><div id="a6087" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:315.9px;">acquisitions are included in Combination, integration<div style="display:inline-block;width:4.76px"> </div>and other acquisition-related expenses in the Company’s<div style="display:inline-block;width:5.31px"> </div>Condensed </div><div id="a6118" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:331.3px;">Consolidated Statements of Operations.<div style="display:inline-block;width:7.82px"> </div>Certain pro forma and other information is not presented, as the<div style="display:inline-block;width:4.73px"> </div>operations of the acquired </div><div id="a6156" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:346.6px;">assets and businesses are not considered material to the<div style="display:inline-block;width:4.76px"> </div>overall operations of the Company for the periods presented.</div></div><div id="TextBlockContainer10" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:720px;height:113px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6193" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Previous Acquisitions </div><div id="a6197" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:20.6px;">In December 2020,<div style="display:inline-block;width:3.96px"> </div>the Company completed its acquisition of Coral Chemical Company<div style="display:inline-block;width:4.73px"> </div>(“Coral”), a privately held, U.S.-based </div><div id="a6237" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:36px;">provider of metal finishing fluid solutions.<div style="display:inline-block;width:7.77px"> </div>The acquisition provides technical expertise and product solutions<div style="display:inline-block;width:4.77px"> </div>for pre-treatment, </div><div id="a6273" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.2px;">metalworking and wastewater treatment applications<div style="display:inline-block;width:4.77px"> </div>to the beverage cans and general industrial end markets.<div style="display:inline-block;width:7.93px"> </div>The original purchase </div><div id="a6309" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.6px;">price was approximately $</div><div id="a6309_25_4" style="position:absolute;left:145.573px;top:66.6px;">54.1</div><div id="a6309_29_103" style="position:absolute;font-weight:normal;font-style:normal;left:168.933px;top:66.6px;"><div style="display:inline-block;width:3.36px"> </div>million, subject to routine and customary post-closing adjustments related<div style="display:inline-block;width:4.92px"> </div>to working capital and net </div><div id="a6349" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.9px;">indebtedness levels.<div style="display:inline-block;width:7.25px"> </div>The Company anticipates finalizing its post-closing adjustments<div style="display:inline-block;width:4.87px"> </div>for the Coral acquisition during 2021 and </div><div id="a6384" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:97.3px;">currently estimates it will receive approximately $</div><div id="a6384_51_3" style="position:absolute;left:272.653px;top:97.3px;">0.1</div><div id="a6384_54_36" style="position:absolute;font-weight:normal;font-style:normal;left:289.453px;top:97.3px;"><div style="display:inline-block;width:3.2px"> </div>million to settle such adjustments.</div></div><div id="TextBlockContainer12" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:519px;height:16px;display:inline-block;"><div id="a6458" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">The following table presents the preliminary estimated fair<div style="display:inline-block;width:4.68px"> </div>values of Coral net assets acquired:</div></div><div id="TextBlockContainer15" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:703px;height:287px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6493" style="position:absolute;font-weight:bold;font-style:normal;left:508.36px;top:0px;">Measurement </div><div id="a6496" style="position:absolute;font-weight:bold;font-style:normal;left:610.64px;top:0px;">December 22, </div><div id="a6502" style="position:absolute;font-weight:bold;font-style:normal;left:406.6px;top:17.6px;">December 22, </div><div id="a6505" style="position:absolute;font-weight:bold;font-style:normal;left:528.68px;top:17.6px;">Period </div><div id="a6508" style="position:absolute;font-weight:bold;font-style:normal;left:636.24px;top:17.6px;">2020 </div><div id="a6514" style="position:absolute;font-weight:bold;font-style:normal;left:422.76px;top:35.2px;">2020 (1) </div><div id="a6517" style="position:absolute;font-weight:bold;font-style:normal;left:511.24px;top:35.2px;">Adjustments </div><div id="a6520" style="position:absolute;font-weight:bold;font-style:normal;left:613.04px;top:35.2px;">(as adjusted) </div><div id="a6524" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:52.3px;">Cash and cash equivalents </div><div id="a6526" style="position:absolute;font-weight:normal;font-style:normal;left:400.52px;top:52.3px;">$ </div><div id="a6528" style="position:absolute;left:466.6px;top:52.3px;">958</div><div id="a6531" style="position:absolute;font-weight:normal;font-style:normal;left:502.6px;top:52.3px;">$ </div><div id="a6533" style="position:absolute;left:575.44px;top:52.3px;">—</div><div id="a6536" style="position:absolute;font-weight:normal;font-style:normal;left:604.56px;top:52.3px;">$ </div><div id="a6538" style="position:absolute;left:670.64px;top:52.3px;">958</div><div id="a6542" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.7px;">Accounts receivable </div><div id="a6545" style="position:absolute;left:456.52px;top:66.7px;">8,473</div><div id="a6549" style="position:absolute;left:575.44px;top:66.7px;">—</div><div id="a6553" style="position:absolute;left:660.56px;top:66.7px;">8,473</div><div id="a6557" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.6px;">Inventories </div><div id="a6561" style="position:absolute;left:456.52px;top:81.6px;">4,527</div><div id="a6565" style="position:absolute;left:575.44px;top:81.6px;">—</div><div id="a6569" style="position:absolute;left:660.56px;top:81.6px;">4,527</div><div id="a6573" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:96.6px;">Prepaid expenses and other assets </div><div id="a6576" style="position:absolute;left:466.6px;top:96.6px;">181</div><div id="a6580" style="position:absolute;left:575.44px;top:96.6px;">—</div><div id="a6584" style="position:absolute;left:670.64px;top:96.6px;">181</div><div id="a6588" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:111.7px;">Property, plant and<div style="display:inline-block;width:4.72px"> </div>equipment </div><div id="a6592" style="position:absolute;left:449.96px;top:111.7px;">10,467</div><div id="a6596" style="position:absolute;left:568.72px;top:111.7px;">652</div><div id="a6600" style="position:absolute;left:654px;top:111.7px;">11,119</div><div id="a6604" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:126.7px;">Intangible assets </div><div id="a6607" style="position:absolute;left:449.96px;top:126.7px;">30,300</div><div id="a6611" style="position:absolute;left:563.76px;top:126.7px;">(500)</div><div id="a6615" style="position:absolute;left:654px;top:126.7px;">29,800</div><div id="a6619" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:141.6px;">Goodwill </div><div id="a6623" style="position:absolute;left:456.52px;top:141.6px;">2,814</div><div id="a6627" style="position:absolute;left:568.72px;top:141.6px;">270</div><div id="a6631" style="position:absolute;left:660.56px;top:141.6px;">3,084</div><div id="a6636" style="position:absolute;font-weight:normal;font-style:normal;left:16.427px;top:157.3px;">Total assets purchased </div><div id="a6639" style="position:absolute;left:449.96px;top:157.3px;">57,720</div><div id="a6643" style="position:absolute;left:568.72px;top:157.3px;">422</div><div id="a6647" style="position:absolute;left:654px;top:157.3px;">58,142</div><div id="a6651" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:171.7px;">Long-term debt including current portions and finance leases </div><div id="a6656" style="position:absolute;left:466.6px;top:171.7px;">183</div><div id="a6660" style="position:absolute;left:568.72px;top:171.7px;">556</div><div id="a6664" style="position:absolute;left:670.64px;top:171.7px;">739</div><div id="a6668" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:186.8px;">Accounts payable, accrued expenses and other accrued<div style="display:inline-block;width:4.7px"> </div>liabilities </div><div id="a6672" style="position:absolute;left:456.52px;top:186.8px;">3,482</div><div id="a6676" style="position:absolute;left:575.44px;top:186.8px;">—</div><div id="a6680" style="position:absolute;left:660.56px;top:186.8px;">3,482</div><div id="a6685" style="position:absolute;font-weight:normal;font-style:normal;left:16.427px;top:203.4px;">Total liabilities assumed </div><div id="a6688" style="position:absolute;left:456.52px;top:203.4px;">3,665</div><div id="a6692" style="position:absolute;left:568.72px;top:203.4px;">556</div><div id="a6696" style="position:absolute;left:660.56px;top:203.4px;">4,221</div><div id="a6701" style="position:absolute;font-weight:normal;font-style:normal;left:16.427px;top:220.4px;">Total consideration<div style="display:inline-block;width:4.76px"> </div>paid for Coral </div><div id="a6704" style="position:absolute;left:449.96px;top:220.4px;">54,055</div><div id="a6708" style="position:absolute;left:563.76px;top:220.4px;">(134)</div><div id="a6712" style="position:absolute;left:654px;top:220.4px;">53,921</div><div id="a6717" style="position:absolute;font-weight:normal;font-style:normal;left:16.427px;top:237.3px;">Less: estimated purchase price settlement </div><div id="a6720" style="position:absolute;left:473.32px;top:237.3px;">—</div><div id="a6724" style="position:absolute;left:563.76px;top:237.3px;">(134)</div><div id="a6728" style="position:absolute;left:665.68px;top:237.3px;">(134)</div><div id="a6733" style="position:absolute;font-weight:normal;font-style:normal;left:16.427px;top:254.3px;">Less: cash acquired </div><div id="a6736" style="position:absolute;left:466.6px;top:254.3px;">958</div><div id="a6740" style="position:absolute;left:575.44px;top:254.3px;">—</div><div id="a6744" style="position:absolute;left:670.64px;top:254.3px;">958</div><div id="a6749" style="position:absolute;font-weight:normal;font-style:normal;left:16.427px;top:271.4px;">Net cash paid for Coral </div><div id="a6751" style="position:absolute;font-weight:normal;font-style:normal;left:400.52px;top:271.4px;">$ </div><div id="a6753" style="position:absolute;left:449.96px;top:271.4px;">53,097</div><div id="a6756" style="position:absolute;font-weight:normal;font-style:normal;left:502.6px;top:271.4px;">$ </div><div id="a6758" style="position:absolute;left:575.44px;top:271.4px;">—</div><div id="a6761" style="position:absolute;font-weight:normal;font-style:normal;left:604.56px;top:271.4px;">$ </div><div id="a6763" style="position:absolute;left:654px;top:271.4px;">53,097</div></div><div id="TextBlockContainer20" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_18_XBRL_TS_4dfca22478d748028f5d6a5c543fe326" style="position:absolute;left:24px;top:0px;float:left;"><div id="TextBlockContainer19" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:351px;height:16px;display:inline-block;"><div id="a6766" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">(1) As previously disclosed in the Company’s<div style="display:inline-block;width:5.2px"> </div>2020 Form 10-K</div></div></div><div id="a6766_59_2" style="position:absolute;font-weight:normal;font-style:normal;left:365.933px;top:0px;">. </div><div id="a6789" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">Measurement period adjustments recorded during the first<div style="display:inline-block;width:4.73px"> </div>six months of 2021 include certain adjustments related<div style="display:inline-block;width:4.7px"> </div>to refining </div><div id="a6823" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">original estimates for assets and liabilities for certain<div style="display:inline-block;width:4.71px"> </div>acquired finance leases, as well the adjustment to reflect the expected<div style="display:inline-block;width:4.74px"> </div>settlement </div><div id="a6863" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:54.1px;">of post-closing working capital and net indebtedness true<div style="display:inline-block;width:4.71px"> </div>ups to the original purchase price.<div style="display:inline-block;width:7.43px"> </div>As of June 30, 2021,<div style="display:inline-block;width:3.88px"> </div>the allocation of the </div><div id="a6915" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.4px;">purchase price for Coral has not been finalized and the </div><div id="a6915_56_8" style="position:absolute;left:299.373px;top:69.4px;">one year</div><div id="a6915_64_63" style="position:absolute;font-weight:normal;font-style:normal;left:344.813px;top:69.4px;"><div style="display:inline-block;width:3.36px"> </div>measurement period has not ended.<div style="display:inline-block;width:7.52px"> </div>Further adjustments may be </div><div id="a6959" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">necessary as a result of the Company’s<div style="display:inline-block;width:5.12px"> </div>on-going assessment of additional information related to the<div style="display:inline-block;width:4.8px"> </div>fair value of assets acquired and </div><div id="a7003" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">liabilities assumed.</div></div><div id="TextBlockContainer22" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:308px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7008" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">In May 2020, the Company acquired Tel<div style="display:inline-block;width:5.47px"> </div>Nordic ApS (“TEL”), a company that specializes in lubricants and engineering<div style="display:inline-block;width:4.89px"> </div>primarily </div><div id="a7046" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">in high pressure aluminum die casting for its Europe,<div style="display:inline-block;width:4.8px"> </div>Middle East and Africa (“EMEA”) reportable segment.<div style="display:inline-block;width:7.78px"> </div>Consideration paid was </div><div id="a7084" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">in the form of a convertible promissory note in the amount<div style="display:inline-block;width:4.8px"> </div>of </div><div id="a7084_62_4" style="position:absolute;left:334.893px;top:30.7px;">20.0</div><div id="a7084_66_32" style="position:absolute;font-weight:normal;font-style:normal;left:358.253px;top:30.7px;"><div style="display:inline-block;width:3.36px"> </div>million DKK, or approximately $</div><div id="a7084_98_3" style="position:absolute;left:540.52px;top:30.7px;">2.9</div><div id="a7084_101_20" style="position:absolute;font-weight:normal;font-style:normal;left:557.16px;top:30.7px;"><div style="display:inline-block;width:3.36px"> </div>million, which was </div><div id="a7126" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">subsequently converted into shares of the Company’s<div style="display:inline-block;width:5.3px"> </div>common stock.<div style="display:inline-block;width:7.17px"> </div>An adjustment to the purchase price of approximately </div><div id="a7126_120_3" style="position:absolute;left:671.44px;top:46.1px;">0.4</div><div id="a7126_123_1" style="position:absolute;font-weight:normal;font-style:normal;left:688.24px;top:46.1px;"> </div><div id="a7163" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">million DKK, or less than $</div><div id="a7163_27_3" style="position:absolute;left:152.773px;top:61.3px;">0.1</div><div id="a7163_30_107" style="position:absolute;font-weight:normal;font-style:normal;left:169.253px;top:61.3px;"><div style="display:inline-block;width:3.36px"> </div>million, was made as a result of finalizing a post-closing<div style="display:inline-block;width:4.82px"> </div>settlement in the second quarter of 2020.<div style="display:inline-block;width:7.57px"> </div>The </div><div id="a7213" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.6px;">Company allocated approximately $</div><div id="a7213_33_3" style="position:absolute;left:198.213px;top:76.6px;">2.4</div><div id="a7213_36_73" style="position:absolute;font-weight:normal;font-style:normal;left:214.853px;top:76.6px;"><div style="display:inline-block;width:3.4px"> </div>million of the purchase price to intangible assets to be amortized<div style="display:inline-block;width:4.74px"> </div>over </div><div id="a7213_109_8" style="position:absolute;left:593.04px;top:76.6px;">17 years</div><div id="a7213_117_16" style="position:absolute;font-weight:normal;font-style:normal;left:637.839px;top:76.6px;">.<div style="display:inline-block;width:6.76px"> </div>In addition, </div><div id="a7253" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92px;">the Company recorded approximately $</div><div id="a7253_36_3" style="position:absolute;left:216.293px;top:92px;">0.5</div><div id="a7253_39_93" style="position:absolute;font-weight:normal;font-style:normal;left:232.973px;top:92px;"><div style="display:inline-block;width:3.36px"> </div>million of goodwill, related to expected value not allocated to<div style="display:inline-block;width:4.71px"> </div>other acquired assets, none </div><div id="a7292" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:107.4px;">of which will be tax deductible.<div style="display:inline-block;width:7.54px"> </div>As of June 30, 2021, the allocation of the purchase price of TEL<div style="display:inline-block;width:4.82px"> </div>was finalized and the </div><div id="a7292_121_8" style="position:absolute;left:642.479px;top:107.4px;">one year</div><div id="a7292_129_1" style="position:absolute;font-weight:normal;font-style:normal;left:688.079px;top:107.4px;"> </div><div id="a7344" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:122.7px;">measurement period ended.<div style="display:inline-block;width:4.04px"> </div></div><div id="a7351" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:145.9px;">In March 2020, the Company acquired the remaining </div><div id="a7351_50_2" style="position:absolute;left:315.693px;top:145.9px;">49</div><div id="a7351_52_68" style="position:absolute;font-weight:normal;font-style:normal;left:328.973px;top:145.9px;">% ownership interest in one of its South African affiliates,<div style="display:inline-block;width:4.76px"> </div>Quaker </div><div id="a7390" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:161.3px;">Chemical South Africa Limited (“QSA”) for </div><div id="a7390_42_4" style="position:absolute;left:245.933px;top:161.3px;">16.7</div><div id="a7390_46_32" style="position:absolute;font-weight:normal;font-style:normal;left:269.293px;top:161.3px;"><div style="display:inline-block;width:3.36px"> </div>million ZAR, or approximately $</div><div id="a7390_78_3" style="position:absolute;left:449.32px;top:161.3px;">1.0</div><div id="a7390_81_44" style="position:absolute;font-weight:normal;font-style:normal;left:466.12px;top:161.3px;"><div style="display:inline-block;width:3.2px"> </div>million, from its joint venture partner PQ </div><div id="a7429" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:176.6px;">Holdings South Africa.<div style="display:inline-block;width:7.34px"> </div>QSA is a part of the Company’s<div style="display:inline-block;width:4.77px"> </div>Europe, Middle East and Africa (“EMEA”) reportable segment.<div style="display:inline-block;width:8.07px"> </div>As this </div><div id="a7469" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:192px;">acquisition was a change in an existing controlling ownership,<div style="display:inline-block;width:4.93px"> </div>the Company recorded $</div><div id="a7469_85_3" style="position:absolute;left:471.72px;top:192px;">0.7</div><div id="a7469_88_43" style="position:absolute;font-weight:normal;font-style:normal;left:488.2px;top:192px;"><div style="display:inline-block;width:3.36px"> </div>million of excess purchase price over the </div><div id="a7510" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:207.4px;">carrying value of the noncontrolling interest in Capital in<div style="display:inline-block;width:4.76px"> </div>excess of par value.<div style="display:inline-block;width:6.99px"> </div></div><div id="a7537" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:230.8px;">In October 2019, the Company completed its acquisition<div style="display:inline-block;width:4.71px"> </div>of the operating divisions of Norman Hay plc (“Norman<div style="display:inline-block;width:4.7px"> </div>Hay”), a private </div><div id="a7577" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:246px;">U.K. company that provides specialty chemicals, operating<div style="display:inline-block;width:4.64px"> </div>equipment, and services to industrial end markets.<div style="display:inline-block;width:8.04px"> </div>The original purchase </div><div id="a7611" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:261.3px;">price was </div><div id="a7611_10_4" style="position:absolute;left:58.539px;top:261.3px;">80.0</div><div id="a7611_14_119" style="position:absolute;font-weight:normal;font-style:normal;left:82.059px;top:261.3px;"><div style="display:inline-block;width:3.2px"> </div>million GBP,<div style="display:inline-block;width:5.02px"> </div>on a cash-free and debt-free basis, subject to routine<div style="display:inline-block;width:4.74px"> </div>and customary post-closing adjustments related to </div><div id="a7657" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:276.7px;">working capital and net indebtedness levels.<div style="display:inline-block;width:7.76px"> </div>The Company finalized its post-closing adjustments for<div style="display:inline-block;width:4.81px"> </div>the Norman Hay acquisition and </div><div id="a7696" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:292px;">paid approximately </div><div id="a7696_19_3" style="position:absolute;left:111.173px;top:292px;">2.5</div><div id="a7696_22_73" style="position:absolute;font-weight:normal;font-style:normal;left:127.973px;top:292px;"><div style="display:inline-block;width:3.2px"> </div>million GBP during the first quarter of 2020 to settle such adjustments.</div></div> 2300000 2800000 25000000 19600000 18300000 P19Y 900000 P14Y 400000 P3Y 5000000.0 P1Y 0.38 1400000 1700000 54100000 100000 <div id="TextBlockContainer16" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:703px;height:287px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_14_XBRL_TS_063f2606415d4b358eb6d37079f1fdf7" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer15" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:703px;height:287px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6493" style="position:absolute;font-weight:bold;font-style:normal;left:508.36px;top:0px;">Measurement </div><div id="a6496" style="position:absolute;font-weight:bold;font-style:normal;left:610.64px;top:0px;">December 22, </div><div id="a6502" style="position:absolute;font-weight:bold;font-style:normal;left:406.6px;top:17.6px;">December 22, </div><div id="a6505" style="position:absolute;font-weight:bold;font-style:normal;left:528.68px;top:17.6px;">Period </div><div id="a6508" style="position:absolute;font-weight:bold;font-style:normal;left:636.24px;top:17.6px;">2020 </div><div id="a6514" style="position:absolute;font-weight:bold;font-style:normal;left:422.76px;top:35.2px;">2020 (1) </div><div id="a6517" style="position:absolute;font-weight:bold;font-style:normal;left:511.24px;top:35.2px;">Adjustments </div><div id="a6520" style="position:absolute;font-weight:bold;font-style:normal;left:613.04px;top:35.2px;">(as adjusted) </div><div id="a6524" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:52.3px;">Cash and cash equivalents </div><div id="a6526" style="position:absolute;font-weight:normal;font-style:normal;left:400.52px;top:52.3px;">$ </div><div id="a6528" style="position:absolute;left:466.6px;top:52.3px;">958</div><div id="a6531" style="position:absolute;font-weight:normal;font-style:normal;left:502.6px;top:52.3px;">$ </div><div id="a6533" style="position:absolute;left:575.44px;top:52.3px;">—</div><div id="a6536" style="position:absolute;font-weight:normal;font-style:normal;left:604.56px;top:52.3px;">$ </div><div id="a6538" style="position:absolute;left:670.64px;top:52.3px;">958</div><div id="a6542" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.7px;">Accounts receivable </div><div id="a6545" style="position:absolute;left:456.52px;top:66.7px;">8,473</div><div id="a6549" style="position:absolute;left:575.44px;top:66.7px;">—</div><div id="a6553" style="position:absolute;left:660.56px;top:66.7px;">8,473</div><div id="a6557" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.6px;">Inventories </div><div id="a6561" style="position:absolute;left:456.52px;top:81.6px;">4,527</div><div id="a6565" style="position:absolute;left:575.44px;top:81.6px;">—</div><div id="a6569" style="position:absolute;left:660.56px;top:81.6px;">4,527</div><div id="a6573" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:96.6px;">Prepaid expenses and other assets </div><div id="a6576" style="position:absolute;left:466.6px;top:96.6px;">181</div><div id="a6580" style="position:absolute;left:575.44px;top:96.6px;">—</div><div id="a6584" style="position:absolute;left:670.64px;top:96.6px;">181</div><div id="a6588" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:111.7px;">Property, plant and<div style="display:inline-block;width:4.72px"> </div>equipment </div><div id="a6592" style="position:absolute;left:449.96px;top:111.7px;">10,467</div><div id="a6596" style="position:absolute;left:568.72px;top:111.7px;">652</div><div id="a6600" style="position:absolute;left:654px;top:111.7px;">11,119</div><div id="a6604" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:126.7px;">Intangible assets </div><div id="a6607" style="position:absolute;left:449.96px;top:126.7px;">30,300</div><div id="a6611" style="position:absolute;left:563.76px;top:126.7px;">(500)</div><div id="a6615" style="position:absolute;left:654px;top:126.7px;">29,800</div><div id="a6619" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:141.6px;">Goodwill </div><div id="a6623" style="position:absolute;left:456.52px;top:141.6px;">2,814</div><div id="a6627" style="position:absolute;left:568.72px;top:141.6px;">270</div><div id="a6631" style="position:absolute;left:660.56px;top:141.6px;">3,084</div><div id="a6636" style="position:absolute;font-weight:normal;font-style:normal;left:16.427px;top:157.3px;">Total assets purchased </div><div id="a6639" style="position:absolute;left:449.96px;top:157.3px;">57,720</div><div id="a6643" style="position:absolute;left:568.72px;top:157.3px;">422</div><div id="a6647" style="position:absolute;left:654px;top:157.3px;">58,142</div><div id="a6651" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:171.7px;">Long-term debt including current portions and finance leases </div><div id="a6656" style="position:absolute;left:466.6px;top:171.7px;">183</div><div id="a6660" style="position:absolute;left:568.72px;top:171.7px;">556</div><div id="a6664" style="position:absolute;left:670.64px;top:171.7px;">739</div><div id="a6668" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:186.8px;">Accounts payable, accrued expenses and other accrued<div style="display:inline-block;width:4.7px"> </div>liabilities </div><div id="a6672" style="position:absolute;left:456.52px;top:186.8px;">3,482</div><div id="a6676" style="position:absolute;left:575.44px;top:186.8px;">—</div><div id="a6680" style="position:absolute;left:660.56px;top:186.8px;">3,482</div><div id="a6685" style="position:absolute;font-weight:normal;font-style:normal;left:16.427px;top:203.4px;">Total liabilities assumed </div><div id="a6688" style="position:absolute;left:456.52px;top:203.4px;">3,665</div><div id="a6692" style="position:absolute;left:568.72px;top:203.4px;">556</div><div id="a6696" style="position:absolute;left:660.56px;top:203.4px;">4,221</div><div id="a6701" style="position:absolute;font-weight:normal;font-style:normal;left:16.427px;top:220.4px;">Total consideration<div style="display:inline-block;width:4.76px"> </div>paid for Coral </div><div id="a6704" style="position:absolute;left:449.96px;top:220.4px;">54,055</div><div id="a6708" style="position:absolute;left:563.76px;top:220.4px;">(134)</div><div id="a6712" style="position:absolute;left:654px;top:220.4px;">53,921</div><div id="a6717" style="position:absolute;font-weight:normal;font-style:normal;left:16.427px;top:237.3px;">Less: estimated purchase price settlement </div><div id="a6720" style="position:absolute;left:473.32px;top:237.3px;">—</div><div id="a6724" style="position:absolute;left:563.76px;top:237.3px;">(134)</div><div id="a6728" style="position:absolute;left:665.68px;top:237.3px;">(134)</div><div id="a6733" style="position:absolute;font-weight:normal;font-style:normal;left:16.427px;top:254.3px;">Less: cash acquired </div><div id="a6736" style="position:absolute;left:466.6px;top:254.3px;">958</div><div id="a6740" style="position:absolute;left:575.44px;top:254.3px;">—</div><div id="a6744" style="position:absolute;left:670.64px;top:254.3px;">958</div><div id="a6749" style="position:absolute;font-weight:normal;font-style:normal;left:16.427px;top:271.4px;">Net cash paid for Coral </div><div id="a6751" style="position:absolute;font-weight:normal;font-style:normal;left:400.52px;top:271.4px;">$ </div><div id="a6753" style="position:absolute;left:449.96px;top:271.4px;">53,097</div><div id="a6756" style="position:absolute;font-weight:normal;font-style:normal;left:502.6px;top:271.4px;">$ </div><div id="a6758" style="position:absolute;left:575.44px;top:271.4px;">—</div><div id="a6761" style="position:absolute;font-weight:normal;font-style:normal;left:604.56px;top:271.4px;">$ </div><div id="a6763" style="position:absolute;left:654px;top:271.4px;">53,097</div></div></div></div><div id="TextBlockContainer19" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:351px;height:16px;display:inline-block;"><div id="a6766" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">(1) As previously disclosed in the Company’s<div style="display:inline-block;width:5.2px"> </div>2020 Form 10-K</div></div> 958000 0 958000 8473000 0 8473000 4527000 0 4527000 181000 0 181000 10467000 652000 11119000 30300000 -500000 29800000 2814000 270000 3084000 57720000 422000 58142000 183000 556000 739000 3482000 0 3482000 3665000 556000 4221000 54055000 -134000 53921000 0 -134000 -134000 958000 0 958000 53097000 0 53097000 P1Y 20000000.0 2900000 400000 100000 2400000 P17Y 500000 P1Y 0.49 16700000 1000000.0 700000 80000000.0 2500000 <div id="TextBlockContainer24" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:346px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7776" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 3 – Recently Issued Accounting Standards<div style="display:inline-block;width:4.46px"> </div></div><div id="a7791" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:24.3px;">Recently Issued Accounting Standards<div style="display:inline-block;width:4.89px"> </div>Adopted </div><div id="a7801" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:46.2px;">The Financial Accounting Standards Board (“FASB”)<div style="display:inline-block;width:5.59px"> </div>issued Account Standards Update (“ASU”)</div><div id="a7822" style="position:absolute;font-size:14.72px;font-weight:normal;font-style:normal;left:550.6px;top:44.9px;"> </div><div id="a7823" style="position:absolute;font-weight:normal;font-style:normal;left:554.28px;top:46.2px;">ASU 2019-12</div><div id="a7828" style="position:absolute;font-weight:normal;font-style:italic;left:629.04px;top:46.2px;">, Income Taxes </div><div id="a7834" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:61.6px;">(Topic<div style="display:inline-block;width:4.82px"> </div>740): Simplifying the Accounting for Income Taxes</div><div id="a7849" style="position:absolute;font-weight:normal;font-style:normal;left:315.373px;top:61.6px;"><div style="display:inline-block;width:3.36px"> </div>in December 2019 to simplify the accounting for income taxes.<div style="display:inline-block;width:8.15px"> </div>The </div><div id="a7872" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:77px;">guidance within this accounting standard update<div style="display:inline-block;width:4.56px"> </div>removes certain exceptions, including the exception to the<div style="display:inline-block;width:4.8px"> </div>incremental approach for </div><div id="a7907" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92.3px;">certain intra-period tax allocations, to the requirement<div style="display:inline-block;width:4.75px"> </div>to recognize or not recognize certain deferred tax liabilities for<div style="display:inline-block;width:4.88px"> </div>equity method </div><div id="a7948" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:107.7px;">investments and foreign subsidiaries, and to the general<div style="display:inline-block;width:4.71px"> </div>methodology for calculating income taxes in an interim period<div style="display:inline-block;width:4.64px"> </div>when a year-to-</div><div id="a7990" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:122.9px;">date loss exceeds the anticipated loss for the year.<div style="display:inline-block;width:8.73px"> </div>Further, the guidance simplifies the accounting<div style="display:inline-block;width:4.76px"> </div>related to franchise taxes, the step </div><div id="a8032" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:138.2px;">up in tax basis for goodwill, current and deferred tax<div style="display:inline-block;width:4.7px"> </div>expense, and codification improvements for income taxes related<div style="display:inline-block;width:4.74px"> </div>to employee </div><div id="a8072" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153.6px;">stock ownership plans.<div style="display:inline-block;width:7.32px"> </div>The guidance is effective for annual and interim<div style="display:inline-block;width:4.59px"> </div>periods beginning after December 15, 2020.<div style="display:inline-block;width:7.82px"> </div>The Company </div><div id="a8110" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:169px;">adopted this standard on a prospective basis, effective<div style="display:inline-block;width:4.86px"> </div>January 1, 2021.<div style="display:inline-block;width:7.1px"> </div>There was no cumulative effect of adoption recorded<div style="display:inline-block;width:4.73px"> </div>within </div><div id="a8152" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:184.3px;">retained earnings on January 1, 2021. </div><div id="a8166" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:207.6px;">The FASB issued<div style="display:inline-block;width:4.75px"> </div>ASU 2020-04, </div><div id="a8178" style="position:absolute;font-weight:normal;font-style:italic;left:207.173px;top:207.6px;">Reference Rate Reform (Topic<div style="display:inline-block;width:5.73px"> </div>848): Facilitation of the Effects of Reference Rate<div style="display:inline-block;width:4.85px"> </div>Reform on </div><div id="a8206" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:222.9px;">Financial Reporting</div><div id="a8210" style="position:absolute;font-weight:normal;font-style:normal;left:113.093px;top:222.9px;"><div style="display:inline-block;width:3.36px"> </div>in March 2020.<div style="display:inline-block;width:6.97px"> </div>The FASB subsequently<div style="display:inline-block;width:4.78px"> </div>issued ASU 2021-01, </div><div id="a8232" style="position:absolute;font-weight:normal;font-style:italic;left:456.52px;top:222.9px;">Reference Rate Reform (Topic<div style="display:inline-block;width:5.57px"> </div>848): Scope</div><div id="a8243" style="position:absolute;font-weight:normal;font-style:normal;left:685.68px;top:222.9px;"><div style="display:inline-block;width:3.36px"> </div>in </div><div id="a8246" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:238.3px;">January 2021 which clarified the guidance but did<div style="display:inline-block;width:4.58px"> </div>not materially change the guidance or its applicability to<div style="display:inline-block;width:4.78px"> </div>the Company.<div style="display:inline-block;width:7.64px"> </div>The </div><div id="a8288" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:253.6px;">amendments provide temporary optional expedients and<div style="display:inline-block;width:4.76px"> </div>exceptions for applying U.S. GAAP to contract modifications,<div style="display:inline-block;width:4.54px"> </div>hedging </div><div id="a8319" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:269px;">relationships and other transactions to ease the potential<div style="display:inline-block;width:4.8px"> </div>accounting and financial reporting burden associated with transitioning<div style="display:inline-block;width:5.11px"> </div>away </div><div id="a8353" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:284.4px;">from reference rates that are expected to be discontinued,<div style="display:inline-block;width:4.84px"> </div>including the London Interbank Offered Rate (“LI<div style="display:inline-block;width:1.49px"> </div>BOR”).<div style="display:inline-block;width:6.74px"> </div>ASU 2020-04 is </div><div id="a8394" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:299.7px;">effective for the Company as of March 12,<div style="display:inline-block;width:4.61px"> </div>2020 and generally can be applied through December 31, 2022.<div style="display:inline-block;width:8.09px"> </div>As of June 30, 2021, the </div><div id="a8442" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:314.9px;">expedients provided in ASU 2020-04 do not presently<div style="display:inline-block;width:4.74px"> </div>impact the Company; however, the Company<div style="display:inline-block;width:4.8px"> </div>will continue to monitor for </div><div id="a8483" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:330.3px;">potential impacts on its consolidated financial statements.</div></div> <div id="TextBlockContainer28" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:213px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8497" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 4 – Business Segments </div><div id="div_26_XBRL_TS_2d4a2c3dfae3439ebf761d2e8084c05f" style="position:absolute;left:0px;top:21.9px;float:left;"><div id="TextBlockContainer27" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:93px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8507" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company’s operating<div style="display:inline-block;width:4.81px"> </div>segments, which are consistent with its reportable segments,<div style="display:inline-block;width:4.7px"> </div>reflect the structure of the Company’s </div><div id="a8541" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">internal organization, the method by which<div style="display:inline-block;width:4.78px"> </div>the Company’s resources are allocated<div style="display:inline-block;width:4.86px"> </div>and the manner by which the chief operating </div><div id="a8579" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">decision maker assesses the Company’s<div style="display:inline-block;width:5.1px"> </div>performance.<div style="display:inline-block;width:7.03px"> </div>The Company has </div><div id="a8579_68_4" style="position:absolute;left:398.28px;top:30.7px;">four</div><div id="a8579_72_53" style="position:absolute;font-weight:normal;font-style:normal;left:420.52px;top:30.7px;"><div style="display:inline-block;width:3.2px"> </div>reportable segments: (i) Americas; (ii) EMEA; (iii) </div><div id="a8615" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">Asia/Pacific; and (iv) Global Specialty Businesses.<div style="display:inline-block;width:7.76px"> </div>The three geographic segments are composed of the net<div style="display:inline-block;width:4.81px"> </div>sales and operations in </div><div id="a8653" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.5px;">each respective region, excluding net sales and operations<div style="display:inline-block;width:4.85px"> </div>managed globally by the Global Specialty Businesses segment, which </div><div id="a8687" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.8px;">includes the Company’s<div style="display:inline-block;width:4.73px"> </div>container, metal finishing, mining,<div style="display:inline-block;width:4.58px"> </div>offshore, specialty coatings, specialty grease and<div style="display:inline-block;width:4.75px"> </div>Norman Hay businesses.</div></div></div><div id="a8687_132_1" style="position:absolute;font-weight:normal;font-style:normal;left:720.4px;top:98.7px;"> </div><div id="a8721" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:120.7px;">Segment operating earnings for each of the Company’s<div style="display:inline-block;width:5.54px"> </div>reportable segments are comprised of the segment’s<div style="display:inline-block;width:5.13px"> </div>net sales less directly </div><div id="a8760" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:136px;">related cost of goods sold (“COGS”) and selling, general<div style="display:inline-block;width:4.74px"> </div>and administrative expenses (“SG&amp;A”).<div style="display:inline-block;width:7.57px"> </div>Operating expenses not directly </div><div id="a8796" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:151.4px;">attributable to the net sales of each respective segment,<div style="display:inline-block;width:4.77px"> </div>such as certain corporate and administrative costs, Combination, integration </div><div id="a8832" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:166.7px;">and other acquisition-related expenses, and Restructuring and related<div style="display:inline-block;width:4.91px"> </div>charges, are not included in segment operating<div style="display:inline-block;width:4.71px"> </div>earnings.<div style="display:inline-block;width:6.73px"> </div>Other </div><div id="a8870" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:181.9px;">items not specifically identified with the Company’s<div style="display:inline-block;width:5.34px"> </div>reportable segments include interest expense, net and other<div style="display:inline-block;width:4.71px"> </div>income (expense), </div><div id="a8904" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:197.3px;">net.</div></div><div id="TextBlockContainer30" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:698px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8957" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The following table presents information about the performance<div style="display:inline-block;width:4.82px"> </div>of the Company’s reportable segments<div style="display:inline-block;width:4.87px"> </div>for the three and six </div><div id="a8993" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">months ended June 30, 2021 and 2020.<div style="display:inline-block;width:7.65px"> </div>Certain immaterial reclassifications within the segment disclosures<div style="display:inline-block;width:4.87px"> </div>for the three and six </div><div id="a9032" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">months ended June 30, 2020 have been made to conform<div style="display:inline-block;width:4.85px"> </div>with the Company’s current customer<div style="display:inline-block;width:4.77px"> </div>industry segmentation.</div></div><div id="TextBlockContainer33" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:475px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9069" style="position:absolute;font-weight:bold;font-style:normal;left:386.733px;top:0px;">Three Months Ended </div><div id="a9072" style="position:absolute;font-weight:bold;font-style:normal;left:581.84px;top:0px;">Six Months Ended </div><div id="a9076" style="position:absolute;font-weight:bold;font-style:normal;left:423.72px;top:17.6px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a9079" style="position:absolute;font-weight:bold;font-style:normal;left:610.8px;top:17.6px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a9083" style="position:absolute;font-weight:bold;font-style:normal;left:386.573px;top:35.5px;">2021 </div><div id="a9086" style="position:absolute;font-weight:bold;font-style:normal;left:481.64px;top:35.5px;">2020 </div><div id="a9089" style="position:absolute;font-weight:bold;font-style:normal;left:574.64px;top:35.5px;">2021 </div><div id="a9092" style="position:absolute;font-weight:bold;font-style:normal;left:667.76px;top:35.5px;">2020 </div><div id="a9094" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.1px;">Net sales </div><div id="a9096" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9099" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9101" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9103" style="position:absolute;font-weight:normal;font-style:normal;left:463.56px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9105" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9107" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9109" style="position:absolute;font-weight:normal;font-style:normal;left:556.52px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9111" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9113" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9115" style="position:absolute;font-weight:normal;font-style:normal;left:649.52px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9118" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:70.4px;">Americas </div><div id="a9120" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:70.4px;">$ </div><div id="a9122" style="position:absolute;left:394.28px;top:70.4px;">139,673</div><div id="a9125" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:70.4px;">$ </div><div id="a9127" style="position:absolute;left:496.04px;top:70.4px;">80,576</div><div id="a9130" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:70.4px;">$ </div><div id="a9132" style="position:absolute;left:582.32px;top:70.4px;">274,544</div><div id="a9135" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:70.4px;">$ </div><div id="a9137" style="position:absolute;left:675.28px;top:70.4px;">210,472</div><div id="a9140" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:88px;">EMEA </div><div id="a9142" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:88px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9144" style="position:absolute;left:394.28px;top:88px;">123,436</div><div id="a9147" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:88px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9149" style="position:absolute;left:496.04px;top:88px;">77,702</div><div id="a9152" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:88px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9154" style="position:absolute;left:582.32px;top:88px;">243,250</div><div id="a9157" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:88px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9159" style="position:absolute;left:675.28px;top:88px;">182,541</div><div id="a9162" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:105.6px;">Asia/Pacific </div><div id="a9164" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:105.6px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9166" style="position:absolute;left:401px;top:105.6px;">91,559</div><div id="a9169" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:105.6px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9171" style="position:absolute;left:496.04px;top:105.6px;">68,421</div><div id="a9174" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:105.6px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9176" style="position:absolute;left:582.32px;top:105.6px;">188,265</div><div id="a9179" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:105.6px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9181" style="position:absolute;left:675.28px;top:105.6px;">141,973</div><div id="a9184" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:123.2px;">Global Specialty Businesses </div><div id="a9186" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:123.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9188" style="position:absolute;left:401px;top:123.2px;">80,594</div><div id="a9191" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:123.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9193" style="position:absolute;left:496.04px;top:123.2px;">59,341</div><div id="a9196" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:123.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9198" style="position:absolute;left:582.32px;top:123.2px;">158,986</div><div id="a9201" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:123.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9203" style="position:absolute;left:675.28px;top:123.2px;">129,615</div><div id="a9205" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:141.4px;">Total net sales </div><div id="a9207" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:141.4px;">$ </div><div id="a9209" style="position:absolute;left:394.28px;top:141.4px;">435,262</div><div id="a9212" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:141.4px;">$ </div><div id="a9214" style="position:absolute;left:489.32px;top:141.4px;">286,040</div><div id="a9217" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:141.4px;">$ </div><div id="a9219" style="position:absolute;left:582.32px;top:141.4px;">865,045</div><div id="a9222" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:141.4px;">$ </div><div id="a9224" style="position:absolute;left:675.28px;top:141.4px;">664,601</div><div id="a9239" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:177.6px;">Segment operating earnings </div><div id="a9253" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:195.2px;">Americas </div><div id="a9255" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:195.2px;">$ </div><div id="a9257" style="position:absolute;left:401px;top:195.2px;">33,648</div><div id="a9260" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:195.2px;">$ </div><div id="a9262" style="position:absolute;left:496.04px;top:195.2px;">10,303</div><div id="a9265" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:195.2px;">$ </div><div id="a9267" style="position:absolute;left:589.04px;top:195.2px;">65,882</div><div id="a9270" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:195.2px;">$ </div><div id="a9272" style="position:absolute;left:682px;top:195.2px;">39,491</div><div id="a9275" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:212.8px;">EMEA </div><div id="a9278" style="position:absolute;left:401px;top:212.8px;">23,405</div><div id="a9282" style="position:absolute;left:496.04px;top:212.8px;">10,471</div><div id="a9286" style="position:absolute;left:589.04px;top:212.8px;">48,649</div><div id="a9290" style="position:absolute;left:682px;top:212.8px;">28,830</div><div id="a9293" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:230.4px;">Asia/Pacific </div><div id="a9296" style="position:absolute;left:401px;top:230.4px;">23,227</div><div id="a9300" style="position:absolute;left:496.04px;top:230.4px;">19,261</div><div id="a9304" style="position:absolute;left:589.04px;top:230.4px;">50,705</div><div id="a9308" style="position:absolute;left:682px;top:230.4px;">38,802</div><div id="a9311" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:248px;">Global Specialty Businesses </div><div id="a9313" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:248px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9315" style="position:absolute;left:401px;top:248px;">24,209</div><div id="a9318" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:248px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9320" style="position:absolute;left:496.04px;top:248px;">16,393</div><div id="a9323" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:248px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9325" style="position:absolute;left:589.04px;top:248px;">48,378</div><div id="a9328" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:248px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9330" style="position:absolute;left:682px;top:248px;">36,953</div><div id="a9332" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:266px;">Total segment operating<div style="display:inline-block;width:4.98px"> </div>earnings </div><div id="a9334" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:266px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9336" style="position:absolute;left:394.28px;top:266px;">104,489</div><div id="a9339" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:266px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9341" style="position:absolute;left:496.04px;top:266px;">56,428</div><div id="a9344" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:266px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9346" style="position:absolute;left:582.32px;top:266px;">213,614</div><div id="a9350" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:266px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9352" style="position:absolute;left:675.28px;top:266px;">144,076</div><div id="a9354" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:283.2px;">Combination, integration and other acquisition-related<div style="display:inline-block;width:4.74px"> </div>expenses </div><div id="a9360" style="position:absolute;left:402.76px;top:283.2px;">(6,658)</div><div id="a9364" style="position:absolute;left:497.8px;top:283.2px;">(7,995)</div><div id="a9368" style="position:absolute;left:584.08px;top:283.2px;">(12,473)</div><div id="a9372" style="position:absolute;left:677.04px;top:283.2px;">(15,873)</div><div id="a9374" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:300.8px;">Restructuring and related charges </div><div id="a9378" style="position:absolute;left:412.68px;top:300.8px;">(298)</div><div id="a9382" style="position:absolute;left:507.72px;top:300.8px;">(486)</div><div id="a9386" style="position:absolute;left:590.8px;top:300.8px;">(1,473)</div><div id="a9390" style="position:absolute;left:683.76px;top:300.8px;">(2,202)</div><div id="a9392" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:318.4px;">Fair value step up of acquired inventory sold<div style="display:inline-block;width:2.19px"> </div></div><div id="a9396" style="position:absolute;left:424.36px;top:318.4px;">—</div><div id="a9400" style="position:absolute;left:507.72px;top:318.4px;">(226)</div><div id="a9404" style="position:absolute;left:600.72px;top:318.4px;">(801)</div><div id="a9408" style="position:absolute;left:693.68px;top:318.4px;">(226)</div><div id="a9410" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:336px;">Indefinite-lived intangible asset impairment </div><div id="a9416" style="position:absolute;left:424.36px;top:336px;">—</div><div id="a9420" style="position:absolute;left:519.4px;top:336px;">—</div><div id="a9424" style="position:absolute;left:612.4px;top:336px;">—</div><div id="a9428" style="position:absolute;left:677.04px;top:336px;">(38,000)</div><div id="a9430" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:353.6px;">Non-operating and administrative expenses </div><div id="a9435" style="position:absolute;left:396.04px;top:353.6px;">(43,077)</div><div id="a9439" style="position:absolute;left:491.08px;top:353.6px;">(32,045)</div><div id="a9443" style="position:absolute;left:584.08px;top:353.6px;">(84,069)</div><div id="a9447" style="position:absolute;left:677.04px;top:353.6px;">(70,496)</div><div id="a9449" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:371.2px;">Depreciation<div style="display:inline-block;width:3.77px"> </div>of corporate assets and amortization </div><div id="a9452" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:371.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9454" style="position:absolute;left:396.04px;top:371.2px;">(15,640)</div><div id="a9457" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:371.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9459" style="position:absolute;left:491.08px;top:371.2px;">(13,438)</div><div id="a9462" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:371.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9464" style="position:absolute;left:584.08px;top:371.2px;">(31,088)</div><div id="a9467" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:371.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9469" style="position:absolute;left:677.04px;top:371.2px;">(27,485)</div><div id="a9471" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:389.2px;">Operating income (loss)<div style="display:inline-block;width:3.85px"> </div></div><div id="a9474" style="position:absolute;left:401px;top:389.2px;">38,816</div><div id="a9479" style="position:absolute;left:502.6px;top:389.2px;">2,238</div><div id="a9483" style="position:absolute;left:589.04px;top:389.2px;">83,710</div><div id="a9487" style="position:absolute;left:677.04px;top:389.2px;">(10,206)</div><div id="a9489" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:406.5px;">Other income (expense), net </div><div id="a9492" style="position:absolute;left:401px;top:406.5px;">14,010</div><div id="a9496" style="position:absolute;left:507.72px;top:406.5px;">(993)</div><div id="a9500" style="position:absolute;left:589.04px;top:406.5px;">18,697</div><div id="a9504" style="position:absolute;left:677.04px;top:406.5px;">(22,168)</div><div id="a9506" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:424.1px;">Interest expense, net </div><div id="a9509" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:424.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9511" style="position:absolute;left:402.76px;top:424.1px;">(5,618)</div><div id="a9514" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:424.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9516" style="position:absolute;left:497.8px;top:424.1px;">(6,811)</div><div id="a9519" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:424.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9521" style="position:absolute;left:584.08px;top:424.1px;">(11,088)</div><div id="a9524" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:424.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9526" style="position:absolute;left:677.04px;top:424.1px;">(15,272)</div><div id="a9528" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:442px;">Income (loss) before taxes and equity in net income of </div><div id="a9542" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:458.9px;">associated companies </div><div id="a9544" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:458.9px;">$ </div><div id="a9546" style="position:absolute;left:401px;top:458.9px;">47,208</div><div id="a9549" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:458.9px;">$ </div><div id="a9551" style="position:absolute;left:497.8px;top:458.9px;">(5,566)</div><div id="a9554" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:458.9px;">$ </div><div id="a9556" style="position:absolute;left:589.04px;top:458.9px;">91,319</div><div id="a9559" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:458.9px;">$ </div><div id="a9561" style="position:absolute;left:677.04px;top:458.9px;">(47,646)</div></div><div id="TextBlockContainer36" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:726px;height:93px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9563" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Inter-segment revenues for the three and six months<div style="display:inline-block;width:4.76px"> </div>ended June 30, 2021 were $</div><div id="a9563_78_3" style="position:absolute;left:458.12px;top:0px;">2.4</div><div id="a9563_81_14" style="position:absolute;font-weight:normal;font-style:normal;left:474.759px;top:0px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a9563_95_3" style="position:absolute;left:549.159px;top:0px;">5.7</div><div id="a9563_98_24" style="position:absolute;font-weight:normal;font-style:normal;left:565.799px;top:0px;"><div style="display:inline-block;width:3.36px"> </div>million for Americas, $</div><div id="a9563_122_3" style="position:absolute;left:694.319px;top:0px;">6.3</div><div id="a9563_125_1" style="position:absolute;font-weight:normal;font-style:normal;left:711.119px;top:0px;"> </div><div id="a9612" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">million and $</div><div id="a9612_13_4" style="position:absolute;left:75.658px;top:15.4px;">15.1</div><div id="a9612_17_20" style="position:absolute;font-weight:normal;font-style:normal;left:99.013px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million for EMEA, $</div><div id="a9612_37_3" style="position:absolute;left:214.213px;top:15.4px;">0.4</div><div id="a9612_40_14" style="position:absolute;font-weight:normal;font-style:normal;left:230.893px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a9612_54_3" style="position:absolute;left:305.453px;top:15.4px;">0.5</div><div id="a9612_57_32" style="position:absolute;font-weight:normal;font-style:normal;left:322.093px;top:15.4px;"><div style="display:inline-block;width:3.2px"> </div>million for Asia/Pacific, and $</div><div id="a9612_89_3" style="position:absolute;left:487.079px;top:15.4px;">2.1</div><div id="a9612_92_14" style="position:absolute;font-weight:normal;font-style:normal;left:503.879px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a9612_106_3" style="position:absolute;left:578.319px;top:15.4px;">4.1</div><div id="a9612_109_20" style="position:absolute;font-weight:normal;font-style:normal;left:594.959px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million for Global </div><div id="a9656" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">Specialty Businesses, respectively.<div style="display:inline-block;width:8.55px"> </div>Inter-segment revenues for the three and six months<div style="display:inline-block;width:4.76px"> </div>ended June 30, 2020 were $</div><div id="a9656_115_3" style="position:absolute;left:626.959px;top:30.6px;">2.4</div><div id="a9656_118_13" style="position:absolute;font-weight:normal;font-style:normal;left:643.599px;top:30.6px;"><div style="display:inline-block;width:3.2px"> </div>million and </div><div id="a9699" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">$</div><div id="a9699_1_3" style="position:absolute;left:11.147px;top:45.9px;">5.3</div><div id="a9699_4_24" style="position:absolute;font-weight:normal;font-style:normal;left:27.947px;top:45.9px;"><div style="display:inline-block;width:3.36px"> </div>million for Americas, $</div><div id="a9699_28_3" style="position:absolute;left:156.453px;top:45.9px;">5.3</div><div id="a9699_31_14" style="position:absolute;font-weight:normal;font-style:normal;left:172.933px;top:45.9px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a9699_45_4" style="position:absolute;left:247.533px;top:45.9px;">10.8</div><div id="a9699_49_20" style="position:absolute;font-weight:normal;font-style:normal;left:270.893px;top:45.9px;"><div style="display:inline-block;width:3.2px"> </div>million for EMEA, $</div><div id="a9699_69_3" style="position:absolute;left:386.093px;top:45.9px;">0.1</div><div id="a9699_72_14" style="position:absolute;font-weight:normal;font-style:normal;left:402.759px;top:45.9px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a9699_86_3" style="position:absolute;left:477.159px;top:45.9px;">0.3</div><div id="a9699_89_32" style="position:absolute;font-weight:normal;font-style:normal;left:493.799px;top:45.9px;"><div style="display:inline-block;width:3.36px"> </div>million for Asia/Pacific, and $</div><div id="a9699_121_3" style="position:absolute;left:658.959px;top:45.9px;">1.0</div><div id="a9699_124_9" style="position:absolute;font-weight:normal;font-style:normal;left:675.759px;top:45.9px;"><div style="display:inline-block;width:3.2px"> </div>million </div><div id="a9748" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">and $</div><div id="a9748_5_3" style="position:absolute;left:33.867px;top:61.3px;">2.3</div><div id="a9748_8_123" style="position:absolute;font-weight:normal;font-style:normal;left:50.539px;top:61.3px;"><div style="display:inline-block;width:3.36px"> </div>million for Global Specialty Businesses, respectively.<div style="display:inline-block;width:8.6px"> </div>However, all inter-segment<div style="display:inline-block;width:4.7px"> </div>transactions have been eliminated from </div><div id="a9783" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.6px;">each reportable operating segment’s<div style="display:inline-block;width:4.97px"> </div>net sales and earnings for all periods presented in the above<div style="display:inline-block;width:4.79px"> </div>tables.</div></div> <div id="TextBlockContainer27" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:93px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8507" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company’s operating<div style="display:inline-block;width:4.81px"> </div>segments, which are consistent with its reportable segments,<div style="display:inline-block;width:4.7px"> </div>reflect the structure of the Company’s </div><div id="a8541" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">internal organization, the method by which<div style="display:inline-block;width:4.78px"> </div>the Company’s resources are allocated<div style="display:inline-block;width:4.86px"> </div>and the manner by which the chief operating </div><div id="a8579" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">decision maker assesses the Company’s<div style="display:inline-block;width:5.1px"> </div>performance.<div style="display:inline-block;width:7.03px"> </div>The Company has </div><div id="a8579_68_4" style="position:absolute;left:398.28px;top:30.7px;">four</div><div id="a8579_72_53" style="position:absolute;font-weight:normal;font-style:normal;left:420.52px;top:30.7px;"><div style="display:inline-block;width:3.2px"> </div>reportable segments: (i) Americas; (ii) EMEA; (iii) </div><div id="a8615" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">Asia/Pacific; and (iv) Global Specialty Businesses.<div style="display:inline-block;width:7.76px"> </div>The three geographic segments are composed of the net<div style="display:inline-block;width:4.81px"> </div>sales and operations in </div><div id="a8653" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.5px;">each respective region, excluding net sales and operations<div style="display:inline-block;width:4.85px"> </div>managed globally by the Global Specialty Businesses segment, which </div><div id="a8687" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.8px;">includes the Company’s<div style="display:inline-block;width:4.73px"> </div>container, metal finishing, mining,<div style="display:inline-block;width:4.58px"> </div>offshore, specialty coatings, specialty grease and<div style="display:inline-block;width:4.75px"> </div>Norman Hay businesses.</div></div> 4 <div id="TextBlockContainer34" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:475px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_32_XBRL_TS_d064a6ad78bf47a78fd8b64142fe0633" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer33" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:475px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9069" style="position:absolute;font-weight:bold;font-style:normal;left:386.733px;top:0px;">Three Months Ended </div><div id="a9072" style="position:absolute;font-weight:bold;font-style:normal;left:581.84px;top:0px;">Six Months Ended </div><div id="a9076" style="position:absolute;font-weight:bold;font-style:normal;left:423.72px;top:17.6px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a9079" style="position:absolute;font-weight:bold;font-style:normal;left:610.8px;top:17.6px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a9083" style="position:absolute;font-weight:bold;font-style:normal;left:386.573px;top:35.5px;">2021 </div><div id="a9086" style="position:absolute;font-weight:bold;font-style:normal;left:481.64px;top:35.5px;">2020 </div><div id="a9089" style="position:absolute;font-weight:bold;font-style:normal;left:574.64px;top:35.5px;">2021 </div><div id="a9092" style="position:absolute;font-weight:bold;font-style:normal;left:667.76px;top:35.5px;">2020 </div><div id="a9094" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.1px;">Net sales </div><div id="a9096" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9099" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9101" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9103" style="position:absolute;font-weight:normal;font-style:normal;left:463.56px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9105" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9107" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9109" style="position:absolute;font-weight:normal;font-style:normal;left:556.52px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9111" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9113" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9115" style="position:absolute;font-weight:normal;font-style:normal;left:649.52px;top:53.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9118" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:70.4px;">Americas </div><div id="a9120" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:70.4px;">$ </div><div id="a9122" style="position:absolute;left:394.28px;top:70.4px;">139,673</div><div id="a9125" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:70.4px;">$ </div><div id="a9127" style="position:absolute;left:496.04px;top:70.4px;">80,576</div><div id="a9130" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:70.4px;">$ </div><div id="a9132" style="position:absolute;left:582.32px;top:70.4px;">274,544</div><div id="a9135" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:70.4px;">$ </div><div id="a9137" style="position:absolute;left:675.28px;top:70.4px;">210,472</div><div id="a9140" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:88px;">EMEA </div><div id="a9142" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:88px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9144" style="position:absolute;left:394.28px;top:88px;">123,436</div><div id="a9147" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:88px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9149" style="position:absolute;left:496.04px;top:88px;">77,702</div><div id="a9152" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:88px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9154" style="position:absolute;left:582.32px;top:88px;">243,250</div><div id="a9157" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:88px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9159" style="position:absolute;left:675.28px;top:88px;">182,541</div><div id="a9162" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:105.6px;">Asia/Pacific </div><div id="a9164" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:105.6px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9166" style="position:absolute;left:401px;top:105.6px;">91,559</div><div id="a9169" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:105.6px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9171" style="position:absolute;left:496.04px;top:105.6px;">68,421</div><div id="a9174" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:105.6px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9176" style="position:absolute;left:582.32px;top:105.6px;">188,265</div><div id="a9179" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:105.6px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9181" style="position:absolute;left:675.28px;top:105.6px;">141,973</div><div id="a9184" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:123.2px;">Global Specialty Businesses </div><div id="a9186" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:123.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9188" style="position:absolute;left:401px;top:123.2px;">80,594</div><div id="a9191" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:123.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9193" style="position:absolute;left:496.04px;top:123.2px;">59,341</div><div id="a9196" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:123.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9198" style="position:absolute;left:582.32px;top:123.2px;">158,986</div><div id="a9201" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:123.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9203" style="position:absolute;left:675.28px;top:123.2px;">129,615</div><div id="a9205" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:141.4px;">Total net sales </div><div id="a9207" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:141.4px;">$ </div><div id="a9209" style="position:absolute;left:394.28px;top:141.4px;">435,262</div><div id="a9212" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:141.4px;">$ </div><div id="a9214" style="position:absolute;left:489.32px;top:141.4px;">286,040</div><div id="a9217" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:141.4px;">$ </div><div id="a9219" style="position:absolute;left:582.32px;top:141.4px;">865,045</div><div id="a9222" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:141.4px;">$ </div><div id="a9224" style="position:absolute;left:675.28px;top:141.4px;">664,601</div><div id="a9239" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:177.6px;">Segment operating earnings </div><div id="a9253" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:195.2px;">Americas </div><div id="a9255" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:195.2px;">$ </div><div id="a9257" style="position:absolute;left:401px;top:195.2px;">33,648</div><div id="a9260" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:195.2px;">$ </div><div id="a9262" style="position:absolute;left:496.04px;top:195.2px;">10,303</div><div id="a9265" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:195.2px;">$ </div><div id="a9267" style="position:absolute;left:589.04px;top:195.2px;">65,882</div><div id="a9270" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:195.2px;">$ </div><div id="a9272" style="position:absolute;left:682px;top:195.2px;">39,491</div><div id="a9275" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:212.8px;">EMEA </div><div id="a9278" style="position:absolute;left:401px;top:212.8px;">23,405</div><div id="a9282" style="position:absolute;left:496.04px;top:212.8px;">10,471</div><div id="a9286" style="position:absolute;left:589.04px;top:212.8px;">48,649</div><div id="a9290" style="position:absolute;left:682px;top:212.8px;">28,830</div><div id="a9293" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:230.4px;">Asia/Pacific </div><div id="a9296" style="position:absolute;left:401px;top:230.4px;">23,227</div><div id="a9300" style="position:absolute;left:496.04px;top:230.4px;">19,261</div><div id="a9304" style="position:absolute;left:589.04px;top:230.4px;">50,705</div><div id="a9308" style="position:absolute;left:682px;top:230.4px;">38,802</div><div id="a9311" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:248px;">Global Specialty Businesses </div><div id="a9313" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:248px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9315" style="position:absolute;left:401px;top:248px;">24,209</div><div id="a9318" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:248px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9320" style="position:absolute;left:496.04px;top:248px;">16,393</div><div id="a9323" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:248px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9325" style="position:absolute;left:589.04px;top:248px;">48,378</div><div id="a9328" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:248px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9330" style="position:absolute;left:682px;top:248px;">36,953</div><div id="a9332" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:266px;">Total segment operating<div style="display:inline-block;width:4.98px"> </div>earnings </div><div id="a9334" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:266px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9336" style="position:absolute;left:394.28px;top:266px;">104,489</div><div id="a9339" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:266px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9341" style="position:absolute;left:496.04px;top:266px;">56,428</div><div id="a9344" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:266px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9346" style="position:absolute;left:582.32px;top:266px;">213,614</div><div id="a9350" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:266px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9352" style="position:absolute;left:675.28px;top:266px;">144,076</div><div id="a9354" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:283.2px;">Combination, integration and other acquisition-related<div style="display:inline-block;width:4.74px"> </div>expenses </div><div id="a9360" style="position:absolute;left:402.76px;top:283.2px;">(6,658)</div><div id="a9364" style="position:absolute;left:497.8px;top:283.2px;">(7,995)</div><div id="a9368" style="position:absolute;left:584.08px;top:283.2px;">(12,473)</div><div id="a9372" style="position:absolute;left:677.04px;top:283.2px;">(15,873)</div><div id="a9374" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:300.8px;">Restructuring and related charges </div><div id="a9378" style="position:absolute;left:412.68px;top:300.8px;">(298)</div><div id="a9382" style="position:absolute;left:507.72px;top:300.8px;">(486)</div><div id="a9386" style="position:absolute;left:590.8px;top:300.8px;">(1,473)</div><div id="a9390" style="position:absolute;left:683.76px;top:300.8px;">(2,202)</div><div id="a9392" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:318.4px;">Fair value step up of acquired inventory sold<div style="display:inline-block;width:2.19px"> </div></div><div id="a9396" style="position:absolute;left:424.36px;top:318.4px;">—</div><div id="a9400" style="position:absolute;left:507.72px;top:318.4px;">(226)</div><div id="a9404" style="position:absolute;left:600.72px;top:318.4px;">(801)</div><div id="a9408" style="position:absolute;left:693.68px;top:318.4px;">(226)</div><div id="a9410" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:336px;">Indefinite-lived intangible asset impairment </div><div id="a9416" style="position:absolute;left:424.36px;top:336px;">—</div><div id="a9420" style="position:absolute;left:519.4px;top:336px;">—</div><div id="a9424" style="position:absolute;left:612.4px;top:336px;">—</div><div id="a9428" style="position:absolute;left:677.04px;top:336px;">(38,000)</div><div id="a9430" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:353.6px;">Non-operating and administrative expenses </div><div id="a9435" style="position:absolute;left:396.04px;top:353.6px;">(43,077)</div><div id="a9439" style="position:absolute;left:491.08px;top:353.6px;">(32,045)</div><div id="a9443" style="position:absolute;left:584.08px;top:353.6px;">(84,069)</div><div id="a9447" style="position:absolute;left:677.04px;top:353.6px;">(70,496)</div><div id="a9449" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:371.2px;">Depreciation<div style="display:inline-block;width:3.77px"> </div>of corporate assets and amortization </div><div id="a9452" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:371.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9454" style="position:absolute;left:396.04px;top:371.2px;">(15,640)</div><div id="a9457" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:371.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9459" style="position:absolute;left:491.08px;top:371.2px;">(13,438)</div><div id="a9462" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:371.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9464" style="position:absolute;left:584.08px;top:371.2px;">(31,088)</div><div id="a9467" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:371.2px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9469" style="position:absolute;left:677.04px;top:371.2px;">(27,485)</div><div id="a9471" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:389.2px;">Operating income (loss)<div style="display:inline-block;width:3.85px"> </div></div><div id="a9474" style="position:absolute;left:401px;top:389.2px;">38,816</div><div id="a9479" style="position:absolute;left:502.6px;top:389.2px;">2,238</div><div id="a9483" style="position:absolute;left:589.04px;top:389.2px;">83,710</div><div id="a9487" style="position:absolute;left:677.04px;top:389.2px;">(10,206)</div><div id="a9489" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:406.5px;">Other income (expense), net </div><div id="a9492" style="position:absolute;left:401px;top:406.5px;">14,010</div><div id="a9496" style="position:absolute;left:507.72px;top:406.5px;">(993)</div><div id="a9500" style="position:absolute;left:589.04px;top:406.5px;">18,697</div><div id="a9504" style="position:absolute;left:677.04px;top:406.5px;">(22,168)</div><div id="a9506" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:424.1px;">Interest expense, net </div><div id="a9509" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:424.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9511" style="position:absolute;left:402.76px;top:424.1px;">(5,618)</div><div id="a9514" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:424.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9516" style="position:absolute;left:497.8px;top:424.1px;">(6,811)</div><div id="a9519" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:424.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9521" style="position:absolute;left:584.08px;top:424.1px;">(11,088)</div><div id="a9524" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:424.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a9526" style="position:absolute;left:677.04px;top:424.1px;">(15,272)</div><div id="a9528" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:442px;">Income (loss) before taxes and equity in net income of </div><div id="a9542" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:458.9px;">associated companies </div><div id="a9544" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:458.9px;">$ </div><div id="a9546" style="position:absolute;left:401px;top:458.9px;">47,208</div><div id="a9549" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:458.9px;">$ </div><div id="a9551" style="position:absolute;left:497.8px;top:458.9px;">(5,566)</div><div id="a9554" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:458.9px;">$ </div><div id="a9556" style="position:absolute;left:589.04px;top:458.9px;">91,319</div><div id="a9559" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:458.9px;">$ </div><div id="a9561" style="position:absolute;left:677.04px;top:458.9px;">(47,646)</div></div></div></div> 139673000 80576000 274544000 210472000 123436000 77702000 243250000 182541000 91559000 68421000 188265000 141973000 80594000 59341000 158986000 129615000 435262000 286040000 865045000 664601000 33648000 10303000 65882000 39491000 23405000 10471000 48649000 28830000 23227000 19261000 50705000 38802000 24209000 16393000 48378000 36953000 104489000 56428000 213614000 144076000 6658000 7995000 12473000 15873000 298000 486000 1473000 2202000 0 226000 801000 226000 0 0 0 38000000 43077000 32045000 84069000 70496000 15640000 13438000 31088000 27485000 38816000 2238000 83710000 -10206000 14010000 -993000 18697000 -22168000 -5618000 -6811000 -11088000 -15272000 47208000 -5566000 91319000 -47646000 2400000 5700000 6300000 15100000 400000 500000 2100000 4100000 2400000 5300000 5300000 10800000 100000 300000 1000000.0 2300000 <div id="TextBlockContainer40" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:213px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9817" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 5 – Net Sales and Revenue Recognition </div><div id="a9833" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:25.6px;">Business Description </div><div id="a9837" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:51.2px;">The Company develops, produces, and markets a broad<div style="display:inline-block;width:4.77px"> </div>range of formulated chemical specialty products and offers<div style="display:inline-block;width:4.85px"> </div>chemical </div><div id="a9871" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.6px;">management services (“Fluidcare”) for various heavy<div style="display:inline-block;width:4.74px"> </div>industrial and manufacturing applications throughout its four<div style="display:inline-block;width:4.89px"> </div>segments.<div style="display:inline-block;width:6.78px"> </div>A </div><div id="a9901" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:82px;">significant portion of the Company’s<div style="display:inline-block;width:5.02px"> </div>revenues are realized from the sale of process fluids and services<div style="display:inline-block;width:4.8px"> </div>made directly to manufacturers </div><div id="a9941" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:97.3px;">through its own employees and its Fluidcare programs,<div style="display:inline-block;width:4.76px"> </div>with the balance being handled through distributors and<div style="display:inline-block;width:4.72px"> </div>agents. </div><div id="div_38_XBRL_TS_d17e07890735413b9ed379261b113b27" style="position:absolute;left:0px;top:120.5px;float:left;"><div id="TextBlockContainer39" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9975" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">As part of the Company’s<div style="display:inline-block;width:4.84px"> </div>Fluidcare business, certain third-party product sales to customers are<div style="display:inline-block;width:4.79px"> </div>managed by the Company.<div style="display:inline-block;width:8.3px"> </div>Where </div><div id="a10015" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">the Company acts as a principal, revenues are recognized<div style="display:inline-block;width:4.67px"> </div>on a gross reporting basis at the selling price negotiated with<div style="display:inline-block;width:4.77px"> </div>its customers. </div><div id="a10060" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Where the Company acts as an agent, revenue is recognized on<div style="display:inline-block;width:4.88px"> </div>a net reporting basis at the amount of the administrative fee earned<div style="display:inline-block;width:4.74px"> </div>by </div><div id="a10108" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">the Company for ordering the goods.</div></div></div><div id="a10108_35_96" style="position:absolute;font-weight:normal;font-style:normal;left:201.573px;top:166.6px;"><div style="display:inline-block;width:6.72px"> </div>The Company transferred third-party products under arrangements recognized<div style="display:inline-block;width:5.01px"> </div>on a net reporting </div><div id="a10146" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:182px;">basis of $</div><div id="a10146_10_4" style="position:absolute;left:55.659px;top:182px;">16.7</div><div id="a10146_14_14" style="position:absolute;font-weight:normal;font-style:normal;left:79.018px;top:182px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a10146_28_4" style="position:absolute;left:153.413px;top:182px;">34.5</div><div id="a10146_32_78" style="position:absolute;font-weight:normal;font-style:normal;left:176.773px;top:182px;"><div style="display:inline-block;width:3.36px"> </div>million for the three and six months ended June 30, 2021, respectively,<div style="display:inline-block;width:5.77px"> </div>and $</div><div id="a10146_110_3" style="position:absolute;left:591.279px;top:182px;">6.2</div><div id="a10146_113_14" style="position:absolute;font-weight:normal;font-style:normal;left:607.919px;top:182px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a10146_127_4" style="position:absolute;left:682.479px;top:182px;">18.7</div><div id="a10146_131_1" style="position:absolute;font-weight:normal;font-style:normal;left:705.839px;top:182px;"> </div><div id="a10199" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:197.3px;">million for the three and six months ended June 30,<div style="display:inline-block;width:4.74px"> </div>2020, respectively.</div></div><div id="TextBlockContainer48" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:544px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10272" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">As previously disclosed in the Company’s<div style="display:inline-block;width:5.29px"> </div>2020 Form 10-K, during 2020, the Company’s<div style="display:inline-block;width:5.04px"> </div>five largest customers (each composed </div><div id="a10310" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">of multiple subsidiaries or divisions with semiautonomous<div style="display:inline-block;width:4.84px"> </div>purchasing authority) accounted for approximately </div><div id="a10310_108_2" style="position:absolute;left:594.16px;top:15.4px;">10</div><div id="a10310_110_22" style="position:absolute;font-weight:normal;font-style:normal;left:607.6px;top:15.4px;">% of consolidated net </div><div id="a10342" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">sales, with its largest customer accounting<div style="display:inline-block;width:4.72px"> </div>for approximately </div><div id="a10342_62_1" style="position:absolute;left:332.333px;top:30.7px;">3</div><div id="a10342_63_28" style="position:absolute;font-weight:normal;font-style:normal;left:339.053px;top:30.7px;">% of consolidated net sales.</div><div id="a10369" style="position:absolute;font-weight:normal;font-style:italic;left:487.56px;top:30.7px;"> </div><div id="a10370" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:51.4px;">Revenue Recognition Model </div><div id="div_42_XBRL_TS_7f1b69d053e84e68863a7323eefc10a6" style="position:absolute;left:0px;top:72px;float:left;"><div id="TextBlockContainer43" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10376" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company applies the five-step model in the FASB’s<div style="display:inline-block;width:6.16px"> </div>guidance, which requires the Company to: (i) identify<div style="display:inline-block;width:4.86px"> </div>the contract with a </div><div id="a10421" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">customer; (ii) identify the performance obligations in<div style="display:inline-block;width:4.78px"> </div>the contract; (iii) determine the transaction price; (iv) allocate the<div style="display:inline-block;width:4.78px"> </div>transaction </div><div id="a10457" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">price to the performance obligations in the contract; and<div style="display:inline-block;width:4.68px"> </div>(v) recognize revenue when, or as, the Company satisfies a performance </div><div id="a10498" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">obligation.<div style="display:inline-block;width:7.02px"> </div>Refer to the Company’s 2020<div style="display:inline-block;width:4.77px"> </div>Form 10-K for additional information on the Company’s<div style="display:inline-block;width:5.34px"> </div>revenue recognition policies, </div><div id="a10534" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">including its practical expedients and accounting policy<div style="display:inline-block;width:4.79px"> </div>elections.</div></div></div><div id="a10534_67_3" style="position:absolute;font-weight:normal;font-style:normal;left:355.533px;top:133.3px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a10551" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:154.1px;">Allowance for Doubtful Accounts </div><div id="div_44_XBRL_TS_bd11708a57654cf7b35168b4331d246b" style="position:absolute;left:0px;top:174.7px;float:left;"><div id="TextBlockContainer45" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:725px;height:123px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10559" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">As previously disclosed in the Company’s<div style="display:inline-block;width:5.29px"> </div>2020 Form 10-K, during 2020, the Company adopted, as required,<div style="display:inline-block;width:4.8px"> </div>an accounting </div><div id="a10597" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.2px;">standard update related to the accounting and disclosure<div style="display:inline-block;width:4.72px"> </div>of credit losses effective January 1, 2020.<div style="display:inline-block;width:7.91px"> </div>The Company recognizes an </div><div id="a10635" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">allowance for credit losses, which represents the portion<div style="display:inline-block;width:4.72px"> </div>of its trade accounts receivable that the Company does not expect<div style="display:inline-block;width:4.76px"> </div>to collect </div><div id="a10678" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46px;">over the contractual life, considering past events and<div style="display:inline-block;width:4.55px"> </div>reasonable and supportable forecasts of future economic conditions.<div style="display:inline-block;width:8.12px"> </div>The </div><div id="a10712" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">Company’s allowance<div style="display:inline-block;width:4.62px"> </div>for credit losses on its trade accounts receivables is based on<div style="display:inline-block;width:4.74px"> </div>specific collectability facts and circumstances for </div><div id="a10751" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.7px;">each outstanding receivable and customer,<div style="display:inline-block;width:4.9px"> </div>the aging of outstanding receivables, and the associated collection<div style="display:inline-block;width:4.89px"> </div>risk the Company </div><div id="a10785" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:91.9px;">estimates for certain past due aging categories, and<div style="display:inline-block;width:4.77px"> </div>also, the general risk to all outstanding accounts receivable based on historical </div><div id="a10825" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:107.2px;">amounts determined to be uncollectible.<div style="display:inline-block;width:7.6px"> </div>The Company does not have any off-balance-sheet<div style="display:inline-block;width:4.74px"> </div>credit exposure related to its customers.</div></div></div><div id="a10825_130_1" style="position:absolute;font-weight:normal;font-style:normal;left:711.12px;top:282px;"> </div><div id="a10865" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:302.8px;">Contract Assets and Liabilities </div><div id="div_46_XBRL_TS_73d9165ef866440885c66ef0f74a09ee" style="position:absolute;left:0px;top:323.4px;float:left;"><div id="TextBlockContainer47" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:221px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10873" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company recognizes a contract asset or receivable<div style="display:inline-block;width:4.63px"> </div>on its Condensed Consolidated Balance Sheet when the Company </div><div id="a10907" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.2px;">performs a service or transfers a good in advance<div style="display:inline-block;width:4.61px"> </div>of receiving consideration.<div style="display:inline-block;width:7.34px"> </div>A receivable is the Company’s<div style="display:inline-block;width:4.72px"> </div>right to consideration that </div><div id="a10949" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">is unconditional and only the passage of time is required<div style="display:inline-block;width:4.71px"> </div>before payment of that consideration is due.<div style="display:inline-block;width:7.88px"> </div>A contract asset is the </div><div id="a10993" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">Company’s right to consideration<div style="display:inline-block;width:4.85px"> </div>in exchange for goods or services that the Company has transferred<div style="display:inline-block;width:4.92px"> </div>to a customer.<div style="display:inline-block;width:7.67px"> </div>The Company </div><div id="a11033" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">had no material contract assets recorded on its Condensed<div style="display:inline-block;width:4.83px"> </div>Consolidated Balance Sheets as of June 30, 2021 or December<div style="display:inline-block;width:4.7px"> </div>31, 2020. </div><div id="a11075" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:81.9px;">A contract liability is recognized when the Company<div style="display:inline-block;width:4.7px"> </div>receives consideration, or if it has the unconditional right<div style="display:inline-block;width:4.72px"> </div>to receive </div><div id="a11113" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:97.3px;">consideration, in advance of performance.<div style="display:inline-block;width:7.82px"> </div>A contract liability is the Company’s<div style="display:inline-block;width:4.98px"> </div>obligation to transfer goods or services to a customer </div><div id="a11153" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:112.7px;">for which the Company has received consideration,<div style="display:inline-block;width:4.73px"> </div>or a specified amount of consideration is due, from the customer.<div style="display:inline-block;width:8.96px"> </div>The Company’s </div><div id="a11193" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:128px;">contract liabilities primarily represent deferred revenue<div style="display:inline-block;width:4.7px"> </div>recorded for customer payments received by the Company<div style="display:inline-block;width:4.73px"> </div>prior to the </div><div id="a11228" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:143.2px;">Company satisfying the associated performance obligation.<div style="display:inline-block;width:8px"> </div>Deferred revenues are presented within other current liabilities<div style="display:inline-block;width:4.71px"> </div>in the </div><div id="a11260" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:158.6px;">Company’s Condensed<div style="display:inline-block;width:4.71px"> </div>Consolidated Balance Sheets.<div style="display:inline-block;width:7.2px"> </div>The Company had approximately $</div><div id="a11260_81_3" style="position:absolute;left:485.64px;top:158.6px;">4.3</div><div id="a11260_84_14" style="position:absolute;font-weight:normal;font-style:normal;left:502.28px;top:158.6px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a11260_98_3" style="position:absolute;left:576.719px;top:158.6px;">4.0</div><div id="a11260_101_21" style="position:absolute;font-weight:normal;font-style:normal;left:593.519px;top:158.6px;"><div style="display:inline-block;width:3.36px"> </div>million of deferred </div><div id="a11294" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:173.9px;">revenue as of June 30, 2021 and December 31, 2020,<div style="display:inline-block;width:4.72px"> </div>respectively.<div style="display:inline-block;width:7.79px"> </div>For the six months ended June 30, 2021, the Company satisfied<div style="display:inline-block;width:4.7px"> </div>all </div><div id="a11340" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:189.3px;">of the associated performance obligations and recognized<div style="display:inline-block;width:4.83px"> </div>into revenue the advance payments received and recorded<div style="display:inline-block;width:4.77px"> </div>as of December </div><div id="a11376" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:204.7px;">31, 2020.</div></div></div></div><div id="TextBlockContainer50" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:701px;height:55px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11380" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Disaggregated Revenue </div><div id="a11384" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.2px;">The following tables disaggregate the Company’s<div style="display:inline-block;width:5.33px"> </div>net sales by segment, geographic region, customer industry,<div style="display:inline-block;width:5.59px"> </div>and timing of </div><div id="a11418" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.6px;">revenue recognized for the three and six months ended<div style="display:inline-block;width:4.7px"> </div>June 30, 2021 and 2020.</div></div><div id="TextBlockContainer54" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_52_XBRL_TS_43f51b4a4250448299c1a96d9b13264b" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer53" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11447" style="position:absolute;font-weight:bold;font-style:normal;left:390.76px;top:0px;">Three Months Ended June 30, 2021 </div><div id="a11458" style="position:absolute;font-weight:bold;font-style:normal;left:630.48px;top:16.8px;">Consolidated </div><div id="a11461" style="position:absolute;font-weight:bold;font-style:normal;left:288.813px;top:31.2px;">Americas </div><div id="a11464" style="position:absolute;font-weight:bold;font-style:normal;left:413.8px;top:31.2px;">EMEA </div><div id="a11467" style="position:absolute;font-weight:bold;font-style:normal;left:518.12px;top:31.2px;">Asia/Pacific </div><div id="a11470" style="position:absolute;font-weight:bold;font-style:normal;left:652.72px;top:31.2px;">Total </div><div id="a11472" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:47.7px;">Customer Industries </div><div id="a11485" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.7px;">Metals </div><div id="a11487" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:65.6px;">$ </div><div id="a11489" style="position:absolute;left:326.413px;top:65.6px;">51,799</div><div id="a11492" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:65.6px;">$ </div><div id="a11494" style="position:absolute;left:444.52px;top:65.6px;">35,634</div><div id="a11497" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:65.6px;">$ </div><div id="a11499" style="position:absolute;left:562.44px;top:65.6px;">48,207</div><div id="a11502" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:65.6px;">$ </div><div id="a11504" style="position:absolute;left:671.76px;top:65.6px;">135,640</div><div id="a11506" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.8px;">Metalworking and other </div><div id="a11509" style="position:absolute;left:326.413px;top:82.6px;">87,874</div><div id="a11513" style="position:absolute;left:444.52px;top:82.6px;">87,802</div><div id="a11517" style="position:absolute;left:562.44px;top:82.6px;">43,352</div><div id="a11521" style="position:absolute;left:671.76px;top:82.6px;">219,028</div><div id="a11525" style="position:absolute;left:319.693px;top:99.6px;">139,673</div><div id="a11529" style="position:absolute;left:437.8px;top:99.6px;">123,436</div><div id="a11533" style="position:absolute;left:562.44px;top:99.6px;">91,559</div><div id="a11537" style="position:absolute;left:671.76px;top:99.6px;">354,668</div><div id="a11539" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:116.5px;">Global Specialty Businesses </div><div id="a11542" style="position:absolute;left:326.413px;top:116.5px;">46,183</div><div id="a11546" style="position:absolute;left:444.52px;top:116.5px;">21,678</div><div id="a11550" style="position:absolute;left:562.44px;top:116.5px;">12,733</div><div id="a11554" style="position:absolute;left:678.48px;top:116.5px;">80,594</div><div id="a11557" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:134.6px;">$ </div><div id="a11559" style="position:absolute;left:319.693px;top:133.6px;">185,856</div><div id="a11562" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:134.6px;">$ </div><div id="a11564" style="position:absolute;left:437.8px;top:133.6px;">145,114</div><div id="a11567" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:134.6px;">$ </div><div id="a11569" style="position:absolute;left:555.72px;top:133.6px;">104,292</div><div id="a11572" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:134.6px;">$ </div><div id="a11574" style="position:absolute;left:671.76px;top:133.6px;">435,262</div><div id="a11588" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:168.7px;">Timing of Revenue Recognized </div><div id="a11601" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:185.8px;">Product sales at a point in time </div><div id="a11603" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:186.6px;">$ </div><div id="a11605" style="position:absolute;left:319.693px;top:186.6px;">177,227</div><div id="a11608" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:186.6px;">$ </div><div id="a11610" style="position:absolute;left:437.8px;top:186.6px;">137,838</div><div id="a11613" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:186.6px;">$ </div><div id="a11615" style="position:absolute;left:555.72px;top:186.6px;">101,264</div><div id="a11618" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:186.6px;">$ </div><div id="a11620" style="position:absolute;left:671.76px;top:186.6px;">416,329</div><div id="a11622" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:202.8px;">Services transferred over time </div><div id="a11625" style="position:absolute;left:332.973px;top:203.6px;">8,629</div><div id="a11629" style="position:absolute;left:451.08px;top:203.6px;">7,276</div><div id="a11633" style="position:absolute;left:569.04px;top:203.6px;">3,028</div><div id="a11637" style="position:absolute;left:678.48px;top:203.6px;">18,933</div><div id="a11640" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:221.6px;">$ </div><div id="a11642" style="position:absolute;left:319.693px;top:220.5px;">185,856</div><div id="a11645" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:221.6px;">$ </div><div id="a11647" style="position:absolute;left:437.8px;top:220.5px;">145,114</div><div id="a11650" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:221.6px;">$ </div><div id="a11652" style="position:absolute;left:555.72px;top:220.5px;">104,292</div><div id="a11655" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:221.6px;">$ </div><div id="a11657" style="position:absolute;left:671.76px;top:220.5px;">435,262</div></div></div></div><div id="TextBlockContainer58" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_56_XBRL_TS_e827bdefc5814e158d311304bd3850f2" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer57" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11710" style="position:absolute;font-weight:bold;font-style:normal;left:390.76px;top:0px;">Three Months Ended June 30, 2020 </div><div id="a11721" style="position:absolute;font-weight:bold;font-style:normal;left:630.48px;top:16.8px;">Consolidated </div><div id="a11724" style="position:absolute;font-weight:bold;font-style:normal;left:288.813px;top:31.2px;">Americas </div><div id="a11727" style="position:absolute;font-weight:bold;font-style:normal;left:413.8px;top:31.2px;">EMEA </div><div id="a11730" style="position:absolute;font-weight:bold;font-style:normal;left:518.12px;top:31.2px;">Asia/Pacific </div><div id="a11733" style="position:absolute;font-weight:bold;font-style:normal;left:652.72px;top:31.2px;">Total </div><div id="a11735" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:47.7px;">Customer Industries </div><div id="a11748" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.6px;">Metals </div><div id="a11750" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:65.6px;">$ </div><div id="a11752" style="position:absolute;left:326.413px;top:65.6px;">32,687</div><div id="a11755" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:65.6px;">$ </div><div id="a11757" style="position:absolute;left:444.52px;top:65.6px;">24,924</div><div id="a11760" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:65.6px;">$ </div><div id="a11762" style="position:absolute;left:562.44px;top:65.6px;">35,416</div><div id="a11765" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:65.6px;">$ </div><div id="a11767" style="position:absolute;left:678.48px;top:65.6px;">93,027</div><div id="a11769" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.8px;">Metalworking and other </div><div id="a11772" style="position:absolute;left:326.413px;top:82.6px;">47,889</div><div id="a11776" style="position:absolute;left:444.52px;top:82.6px;">52,778</div><div id="a11780" style="position:absolute;left:562.44px;top:82.6px;">33,005</div><div id="a11784" style="position:absolute;left:671.76px;top:82.6px;">133,672</div><div id="a11788" style="position:absolute;left:326.413px;top:99.5px;">80,576</div><div id="a11792" style="position:absolute;left:444.52px;top:99.5px;">77,702</div><div id="a11796" style="position:absolute;left:562.44px;top:99.5px;">68,421</div><div id="a11800" style="position:absolute;left:671.76px;top:99.5px;">226,699</div><div id="a11802" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:116.5px;">Global Specialty Businesses </div><div id="a11805" style="position:absolute;left:326.413px;top:116.5px;">32,294</div><div id="a11809" style="position:absolute;left:444.52px;top:116.5px;">15,569</div><div id="a11813" style="position:absolute;left:562.44px;top:116.5px;">11,478</div><div id="a11817" style="position:absolute;left:678.48px;top:116.5px;">59,341</div><div id="a11820" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:134.6px;">$ </div><div id="a11822" style="position:absolute;left:319.693px;top:133.6px;">112,870</div><div id="a11825" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:134.6px;">$ </div><div id="a11827" style="position:absolute;left:444.52px;top:133.6px;">93,271</div><div id="a11830" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:134.6px;">$ </div><div id="a11832" style="position:absolute;left:562.44px;top:133.6px;">79,899</div><div id="a11835" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:134.6px;">$ </div><div id="a11837" style="position:absolute;left:671.76px;top:133.6px;">286,040</div><div id="a11851" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:168.6px;">Timing of Revenue Recognized </div><div id="a11864" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:185.8px;">Product sales at a point in time </div><div id="a11866" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:186.6px;">$ </div><div id="a11868" style="position:absolute;left:319.693px;top:186.6px;">108,644</div><div id="a11871" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:186.6px;">$ </div><div id="a11873" style="position:absolute;left:444.52px;top:186.6px;">87,995</div><div id="a11876" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:186.6px;">$ </div><div id="a11878" style="position:absolute;left:562.44px;top:186.6px;">78,195</div><div id="a11881" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:186.6px;">$ </div><div id="a11883" style="position:absolute;left:671.76px;top:186.6px;">274,834</div><div id="a11885" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:202.8px;">Services transferred over time </div><div id="a11888" style="position:absolute;left:332.973px;top:203.6px;">4,226</div><div id="a11892" style="position:absolute;left:451.08px;top:203.6px;">5,276</div><div id="a11896" style="position:absolute;left:569.04px;top:203.6px;">1,704</div><div id="a11900" style="position:absolute;left:678.48px;top:203.6px;">11,206</div><div id="a11903" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:221.6px;">$ </div><div id="a11905" style="position:absolute;left:319.693px;top:220.5px;">112,870</div><div id="a11908" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:221.6px;">$ </div><div id="a11910" style="position:absolute;left:444.52px;top:220.5px;">93,271</div><div id="a11913" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:221.6px;">$ </div><div id="a11915" style="position:absolute;left:562.44px;top:220.5px;">79,899</div><div id="a11918" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:221.6px;">$ </div><div id="a11920" style="position:absolute;left:671.76px;top:220.5px;">286,040</div></div></div></div><div id="TextBlockContainer62" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_60_XBRL_TS_7fe1438acf704b80a13dec2774db7b64" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer61" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11924" style="position:absolute;font-weight:bold;font-style:normal;left:398.76px;top:0px;">Six Months Ended June 30, 2021 </div><div id="a11936" style="position:absolute;font-weight:bold;font-style:normal;left:630.48px;top:17px;">Consolidated </div><div id="a11939" style="position:absolute;font-weight:bold;font-style:normal;left:288.813px;top:31.2px;">Americas </div><div id="a11942" style="position:absolute;font-weight:bold;font-style:normal;left:413.8px;top:31.2px;">EMEA </div><div id="a11945" style="position:absolute;font-weight:bold;font-style:normal;left:518.12px;top:31.2px;">Asia/Pacific </div><div id="a11948" style="position:absolute;font-weight:bold;font-style:normal;left:652.72px;top:31.2px;">Total </div><div id="a11950" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:47.4px;">Customer Industries </div><div id="a11963" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64px;">Metals </div><div id="a11965" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:65px;">$ </div><div id="a11967" style="position:absolute;left:326.413px;top:65px;">98,592</div><div id="a11970" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:65px;">$ </div><div id="a11972" style="position:absolute;left:444.52px;top:65px;">69,908</div><div id="a11975" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:65px;">$ </div><div id="a11977" style="position:absolute;left:562.44px;top:65px;">97,950</div><div id="a11980" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:65px;">$ </div><div id="a11982" style="position:absolute;left:671.76px;top:65px;">266,450</div><div id="a11984" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.1px;">Metalworking and other </div><div id="a11987" style="position:absolute;left:319.693px;top:81.9px;">175,952</div><div id="a11991" style="position:absolute;left:437.8px;top:81.9px;">173,342</div><div id="a11995" style="position:absolute;left:562.44px;top:81.9px;">90,315</div><div id="a11999" style="position:absolute;left:671.76px;top:81.9px;">439,609</div><div id="a12003" style="position:absolute;left:319.693px;top:98.9px;">274,544</div><div id="a12007" style="position:absolute;left:437.8px;top:98.9px;">243,250</div><div id="a12011" style="position:absolute;left:555.72px;top:98.9px;">188,265</div><div id="a12015" style="position:absolute;left:671.76px;top:98.9px;">706,059</div><div id="a12017" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:115.8px;">Global Specialty Businesses </div><div id="a12020" style="position:absolute;left:326.413px;top:115.8px;">91,439</div><div id="a12024" style="position:absolute;left:444.52px;top:115.8px;">41,950</div><div id="a12028" style="position:absolute;left:562.44px;top:115.8px;">25,597</div><div id="a12032" style="position:absolute;left:671.76px;top:115.8px;">158,986</div><div id="a12035" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:133.9px;">$ </div><div id="a12037" style="position:absolute;left:319.693px;top:133px;">365,983</div><div id="a12040" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:133.9px;">$ </div><div id="a12042" style="position:absolute;left:437.8px;top:133px;">285,200</div><div id="a12045" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:133.9px;">$ </div><div id="a12047" style="position:absolute;left:555.72px;top:133px;">213,862</div><div id="a12050" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:133.9px;">$ </div><div id="a12052" style="position:absolute;left:671.76px;top:133px;">865,045</div><div id="a12066" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:168px;">Timing of Revenue Recognized </div><div id="a12079" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:185.1px;">Product sales at a point in time </div><div id="a12081" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:185.9px;">$ </div><div id="a12083" style="position:absolute;left:319.693px;top:185.9px;">348,821</div><div id="a12086" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:185.9px;">$ </div><div id="a12088" style="position:absolute;left:437.8px;top:185.9px;">269,000</div><div id="a12091" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:185.9px;">$ </div><div id="a12093" style="position:absolute;left:555.72px;top:185.9px;">207,663</div><div id="a12096" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:185.9px;">$ </div><div id="a12098" style="position:absolute;left:671.76px;top:185.9px;">825,484</div><div id="a12100" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:202.1px;">Services transferred over time </div><div id="a12103" style="position:absolute;left:326.413px;top:202.9px;">17,162</div><div id="a12107" style="position:absolute;left:444.52px;top:202.9px;">16,200</div><div id="a12111" style="position:absolute;left:569.04px;top:202.9px;">6,199</div><div id="a12115" style="position:absolute;left:678.48px;top:202.9px;">39,561</div><div id="a12118" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:221px;">$ </div><div id="a12120" style="position:absolute;left:319.693px;top:219.9px;">365,983</div><div id="a12123" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:221px;">$ </div><div id="a12125" style="position:absolute;left:437.8px;top:219.9px;">285,200</div><div id="a12128" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:221px;">$ </div><div id="a12130" style="position:absolute;left:555.72px;top:219.9px;">213,862</div><div id="a12133" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:221px;">$ </div><div id="a12135" style="position:absolute;left:671.76px;top:219.9px;">865,045</div></div></div></div><div id="TextBlockContainer66" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_64_XBRL_TS_c1b98bcf933f4ce6931137ba3813180d" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer65" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12139" style="position:absolute;font-weight:bold;font-style:normal;left:398.76px;top:0px;">Six Months Ended June 30, 2020 </div><div id="a12151" style="position:absolute;font-weight:bold;font-style:normal;left:630.48px;top:17px;">Consolidated </div><div id="a12154" style="position:absolute;font-weight:bold;font-style:normal;left:288.813px;top:31.2px;">Americas </div><div id="a12157" style="position:absolute;font-weight:bold;font-style:normal;left:413.8px;top:31.2px;">EMEA </div><div id="a12160" style="position:absolute;font-weight:bold;font-style:normal;left:518.12px;top:31.2px;">Asia/Pacific </div><div id="a12163" style="position:absolute;font-weight:bold;font-style:normal;left:652.72px;top:31.2px;">Total </div><div id="a12165" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:47.7px;">Customer Industries </div><div id="a12178" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.6px;">Metals </div><div id="a12180" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:65.6px;">$ </div><div id="a12182" style="position:absolute;left:326.413px;top:64.6px;">79,360</div><div id="a12185" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:65.6px;">$ </div><div id="a12187" style="position:absolute;left:444.52px;top:64.6px;">54,812</div><div id="a12190" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:65.6px;">$ </div><div id="a12192" style="position:absolute;left:562.44px;top:64.6px;">77,005</div><div id="a12195" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:65.6px;">$ </div><div id="a12197" style="position:absolute;left:671.76px;top:64.6px;">211,177</div><div id="a12199" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.8px;">Metalworking and other </div><div id="a12202" style="position:absolute;left:319.693px;top:81.8px;">131,112</div><div id="a12206" style="position:absolute;left:437.8px;top:81.8px;">127,729</div><div id="a12210" style="position:absolute;left:562.44px;top:81.8px;">64,968</div><div id="a12214" style="position:absolute;left:671.76px;top:81.8px;">323,809</div><div id="a12218" style="position:absolute;left:319.693px;top:99px;">210,472</div><div id="a12222" style="position:absolute;left:437.8px;top:99px;">182,541</div><div id="a12226" style="position:absolute;left:555.72px;top:99px;">141,973</div><div id="a12230" style="position:absolute;left:671.76px;top:99px;">534,986</div><div id="a12232" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:116.5px;">Global Specialty Businesses </div><div id="a12235" style="position:absolute;left:326.413px;top:115.7px;">76,525</div><div id="a12239" style="position:absolute;left:444.52px;top:115.7px;">32,174</div><div id="a12243" style="position:absolute;left:562.44px;top:115.7px;">20,916</div><div id="a12247" style="position:absolute;left:671.76px;top:115.7px;">129,615</div><div id="a12250" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:134.6px;">$ </div><div id="a12252" style="position:absolute;left:319.693px;top:133.6px;">286,997</div><div id="a12255" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:134.6px;">$ </div><div id="a12257" style="position:absolute;left:437.8px;top:133.6px;">214,715</div><div id="a12260" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:134.6px;">$ </div><div id="a12262" style="position:absolute;left:555.72px;top:133.6px;">162,889</div><div id="a12265" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:134.6px;">$ </div><div id="a12267" style="position:absolute;left:671.76px;top:133.6px;">664,601</div><div id="a12281" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:168.7px;">Timing of Revenue Recognized </div><div id="a12294" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:185.8px;">Product sales at a point in time </div><div id="a12296" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:186.6px;">$ </div><div id="a12298" style="position:absolute;left:319.693px;top:185.8px;">277,446</div><div id="a12301" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:186.6px;">$ </div><div id="a12303" style="position:absolute;left:437.8px;top:185.8px;">206,418</div><div id="a12306" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:186.6px;">$ </div><div id="a12308" style="position:absolute;left:555.72px;top:185.8px;">159,351</div><div id="a12311" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:186.6px;">$ </div><div id="a12313" style="position:absolute;left:671.76px;top:185.8px;">643,215</div><div id="a12315" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:202.8px;">Services transferred over time </div><div id="a12318" style="position:absolute;left:332.973px;top:202.8px;">9,551</div><div id="a12322" style="position:absolute;left:451.08px;top:202.8px;">8,297</div><div id="a12326" style="position:absolute;left:569.04px;top:202.8px;">3,538</div><div id="a12330" style="position:absolute;left:678.48px;top:202.8px;">21,386</div><div id="a12333" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:221.6px;">$ </div><div id="a12335" style="position:absolute;left:319.693px;top:220.5px;">286,997</div><div id="a12338" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:221.6px;">$ </div><div id="a12340" style="position:absolute;left:437.8px;top:220.5px;">214,715</div><div id="a12343" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:221.6px;">$ </div><div id="a12345" style="position:absolute;left:555.72px;top:220.5px;">162,889</div><div id="a12348" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:221.6px;">$ </div><div id="a12350" style="position:absolute;left:671.76px;top:220.5px;">664,601</div></div></div></div> <div id="TextBlockContainer39" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9975" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">As part of the Company’s<div style="display:inline-block;width:4.84px"> </div>Fluidcare business, certain third-party product sales to customers are<div style="display:inline-block;width:4.79px"> </div>managed by the Company.<div style="display:inline-block;width:8.3px"> </div>Where </div><div id="a10015" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">the Company acts as a principal, revenues are recognized<div style="display:inline-block;width:4.67px"> </div>on a gross reporting basis at the selling price negotiated with<div style="display:inline-block;width:4.77px"> </div>its customers. </div><div id="a10060" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Where the Company acts as an agent, revenue is recognized on<div style="display:inline-block;width:4.88px"> </div>a net reporting basis at the amount of the administrative fee earned<div style="display:inline-block;width:4.74px"> </div>by </div><div id="a10108" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">the Company for ordering the goods.</div></div> 16700000 34500000 6200000 18700000 0.10 0.03 <div id="TextBlockContainer43" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10376" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company applies the five-step model in the FASB’s<div style="display:inline-block;width:6.16px"> </div>guidance, which requires the Company to: (i) identify<div style="display:inline-block;width:4.86px"> </div>the contract with a </div><div id="a10421" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">customer; (ii) identify the performance obligations in<div style="display:inline-block;width:4.78px"> </div>the contract; (iii) determine the transaction price; (iv) allocate the<div style="display:inline-block;width:4.78px"> </div>transaction </div><div id="a10457" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">price to the performance obligations in the contract; and<div style="display:inline-block;width:4.68px"> </div>(v) recognize revenue when, or as, the Company satisfies a performance </div><div id="a10498" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">obligation.<div style="display:inline-block;width:7.02px"> </div>Refer to the Company’s 2020<div style="display:inline-block;width:4.77px"> </div>Form 10-K for additional information on the Company’s<div style="display:inline-block;width:5.34px"> </div>revenue recognition policies, </div><div id="a10534" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">including its practical expedients and accounting policy<div style="display:inline-block;width:4.79px"> </div>elections.</div></div><div id="TextBlockContainer47" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:221px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10873" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company recognizes a contract asset or receivable<div style="display:inline-block;width:4.63px"> </div>on its Condensed Consolidated Balance Sheet when the Company </div><div id="a10907" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.2px;">performs a service or transfers a good in advance<div style="display:inline-block;width:4.61px"> </div>of receiving consideration.<div style="display:inline-block;width:7.34px"> </div>A receivable is the Company’s<div style="display:inline-block;width:4.72px"> </div>right to consideration that </div><div id="a10949" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">is unconditional and only the passage of time is required<div style="display:inline-block;width:4.71px"> </div>before payment of that consideration is due.<div style="display:inline-block;width:7.88px"> </div>A contract asset is the </div><div id="a10993" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">Company’s right to consideration<div style="display:inline-block;width:4.85px"> </div>in exchange for goods or services that the Company has transferred<div style="display:inline-block;width:4.92px"> </div>to a customer.<div style="display:inline-block;width:7.67px"> </div>The Company </div><div id="a11033" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">had no material contract assets recorded on its Condensed<div style="display:inline-block;width:4.83px"> </div>Consolidated Balance Sheets as of June 30, 2021 or December<div style="display:inline-block;width:4.7px"> </div>31, 2020. </div><div id="a11075" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:81.9px;">A contract liability is recognized when the Company<div style="display:inline-block;width:4.7px"> </div>receives consideration, or if it has the unconditional right<div style="display:inline-block;width:4.72px"> </div>to receive </div><div id="a11113" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:97.3px;">consideration, in advance of performance.<div style="display:inline-block;width:7.82px"> </div>A contract liability is the Company’s<div style="display:inline-block;width:4.98px"> </div>obligation to transfer goods or services to a customer </div><div id="a11153" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:112.7px;">for which the Company has received consideration,<div style="display:inline-block;width:4.73px"> </div>or a specified amount of consideration is due, from the customer.<div style="display:inline-block;width:8.96px"> </div>The Company’s </div><div id="a11193" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:128px;">contract liabilities primarily represent deferred revenue<div style="display:inline-block;width:4.7px"> </div>recorded for customer payments received by the Company<div style="display:inline-block;width:4.73px"> </div>prior to the </div><div id="a11228" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:143.2px;">Company satisfying the associated performance obligation.<div style="display:inline-block;width:8px"> </div>Deferred revenues are presented within other current liabilities<div style="display:inline-block;width:4.71px"> </div>in the </div><div id="a11260" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:158.6px;">Company’s Condensed<div style="display:inline-block;width:4.71px"> </div>Consolidated Balance Sheets.<div style="display:inline-block;width:7.2px"> </div>The Company had approximately $</div><div id="a11260_81_3" style="position:absolute;left:485.64px;top:158.6px;">4.3</div><div id="a11260_84_14" style="position:absolute;font-weight:normal;font-style:normal;left:502.28px;top:158.6px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a11260_98_3" style="position:absolute;left:576.719px;top:158.6px;">4.0</div><div id="a11260_101_21" style="position:absolute;font-weight:normal;font-style:normal;left:593.519px;top:158.6px;"><div style="display:inline-block;width:3.36px"> </div>million of deferred </div><div id="a11294" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:173.9px;">revenue as of June 30, 2021 and December 31, 2020,<div style="display:inline-block;width:4.72px"> </div>respectively.<div style="display:inline-block;width:7.79px"> </div>For the six months ended June 30, 2021, the Company satisfied<div style="display:inline-block;width:4.7px"> </div>all </div><div id="a11340" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:189.3px;">of the associated performance obligations and recognized<div style="display:inline-block;width:4.83px"> </div>into revenue the advance payments received and recorded<div style="display:inline-block;width:4.77px"> </div>as of December </div><div id="a11376" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:204.7px;">31, 2020.</div></div> <div id="TextBlockContainer45" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:725px;height:123px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10559" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">As previously disclosed in the Company’s<div style="display:inline-block;width:5.29px"> </div>2020 Form 10-K, during 2020, the Company adopted, as required,<div style="display:inline-block;width:4.8px"> </div>an accounting </div><div id="a10597" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.2px;">standard update related to the accounting and disclosure<div style="display:inline-block;width:4.72px"> </div>of credit losses effective January 1, 2020.<div style="display:inline-block;width:7.91px"> </div>The Company recognizes an </div><div id="a10635" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">allowance for credit losses, which represents the portion<div style="display:inline-block;width:4.72px"> </div>of its trade accounts receivable that the Company does not expect<div style="display:inline-block;width:4.76px"> </div>to collect </div><div id="a10678" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46px;">over the contractual life, considering past events and<div style="display:inline-block;width:4.55px"> </div>reasonable and supportable forecasts of future economic conditions.<div style="display:inline-block;width:8.12px"> </div>The </div><div id="a10712" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">Company’s allowance<div style="display:inline-block;width:4.62px"> </div>for credit losses on its trade accounts receivables is based on<div style="display:inline-block;width:4.74px"> </div>specific collectability facts and circumstances for </div><div id="a10751" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.7px;">each outstanding receivable and customer,<div style="display:inline-block;width:4.9px"> </div>the aging of outstanding receivables, and the associated collection<div style="display:inline-block;width:4.89px"> </div>risk the Company </div><div id="a10785" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:91.9px;">estimates for certain past due aging categories, and<div style="display:inline-block;width:4.77px"> </div>also, the general risk to all outstanding accounts receivable based on historical </div><div id="a10825" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:107.2px;">amounts determined to be uncollectible.<div style="display:inline-block;width:7.6px"> </div>The Company does not have any off-balance-sheet<div style="display:inline-block;width:4.74px"> </div>credit exposure related to its customers.</div></div> 4300000 4000000.0 <div id="TextBlockContainer53" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11447" style="position:absolute;font-weight:bold;font-style:normal;left:390.76px;top:0px;">Three Months Ended June 30, 2021 </div><div id="a11458" style="position:absolute;font-weight:bold;font-style:normal;left:630.48px;top:16.8px;">Consolidated </div><div id="a11461" style="position:absolute;font-weight:bold;font-style:normal;left:288.813px;top:31.2px;">Americas </div><div id="a11464" style="position:absolute;font-weight:bold;font-style:normal;left:413.8px;top:31.2px;">EMEA </div><div id="a11467" style="position:absolute;font-weight:bold;font-style:normal;left:518.12px;top:31.2px;">Asia/Pacific </div><div id="a11470" style="position:absolute;font-weight:bold;font-style:normal;left:652.72px;top:31.2px;">Total </div><div id="a11472" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:47.7px;">Customer Industries </div><div id="a11485" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.7px;">Metals </div><div id="a11487" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:65.6px;">$ </div><div id="a11489" style="position:absolute;left:326.413px;top:65.6px;">51,799</div><div id="a11492" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:65.6px;">$ </div><div id="a11494" style="position:absolute;left:444.52px;top:65.6px;">35,634</div><div id="a11497" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:65.6px;">$ </div><div id="a11499" style="position:absolute;left:562.44px;top:65.6px;">48,207</div><div id="a11502" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:65.6px;">$ </div><div id="a11504" style="position:absolute;left:671.76px;top:65.6px;">135,640</div><div id="a11506" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.8px;">Metalworking and other </div><div id="a11509" style="position:absolute;left:326.413px;top:82.6px;">87,874</div><div id="a11513" style="position:absolute;left:444.52px;top:82.6px;">87,802</div><div id="a11517" style="position:absolute;left:562.44px;top:82.6px;">43,352</div><div id="a11521" style="position:absolute;left:671.76px;top:82.6px;">219,028</div><div id="a11525" style="position:absolute;left:319.693px;top:99.6px;">139,673</div><div id="a11529" style="position:absolute;left:437.8px;top:99.6px;">123,436</div><div id="a11533" style="position:absolute;left:562.44px;top:99.6px;">91,559</div><div id="a11537" style="position:absolute;left:671.76px;top:99.6px;">354,668</div><div id="a11539" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:116.5px;">Global Specialty Businesses </div><div id="a11542" style="position:absolute;left:326.413px;top:116.5px;">46,183</div><div id="a11546" style="position:absolute;left:444.52px;top:116.5px;">21,678</div><div id="a11550" style="position:absolute;left:562.44px;top:116.5px;">12,733</div><div id="a11554" style="position:absolute;left:678.48px;top:116.5px;">80,594</div><div id="a11557" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:134.6px;">$ </div><div id="a11559" style="position:absolute;left:319.693px;top:133.6px;">185,856</div><div id="a11562" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:134.6px;">$ </div><div id="a11564" style="position:absolute;left:437.8px;top:133.6px;">145,114</div><div id="a11567" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:134.6px;">$ </div><div id="a11569" style="position:absolute;left:555.72px;top:133.6px;">104,292</div><div id="a11572" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:134.6px;">$ </div><div id="a11574" style="position:absolute;left:671.76px;top:133.6px;">435,262</div><div id="a11588" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:168.7px;">Timing of Revenue Recognized </div><div id="a11601" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:185.8px;">Product sales at a point in time </div><div id="a11603" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:186.6px;">$ </div><div id="a11605" style="position:absolute;left:319.693px;top:186.6px;">177,227</div><div id="a11608" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:186.6px;">$ </div><div id="a11610" style="position:absolute;left:437.8px;top:186.6px;">137,838</div><div id="a11613" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:186.6px;">$ </div><div id="a11615" style="position:absolute;left:555.72px;top:186.6px;">101,264</div><div id="a11618" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:186.6px;">$ </div><div id="a11620" style="position:absolute;left:671.76px;top:186.6px;">416,329</div><div id="a11622" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:202.8px;">Services transferred over time </div><div id="a11625" style="position:absolute;left:332.973px;top:203.6px;">8,629</div><div id="a11629" style="position:absolute;left:451.08px;top:203.6px;">7,276</div><div id="a11633" style="position:absolute;left:569.04px;top:203.6px;">3,028</div><div id="a11637" style="position:absolute;left:678.48px;top:203.6px;">18,933</div><div id="a11640" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:221.6px;">$ </div><div id="a11642" style="position:absolute;left:319.693px;top:220.5px;">185,856</div><div id="a11645" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:221.6px;">$ </div><div id="a11647" style="position:absolute;left:437.8px;top:220.5px;">145,114</div><div id="a11650" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:221.6px;">$ </div><div id="a11652" style="position:absolute;left:555.72px;top:220.5px;">104,292</div><div id="a11655" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:221.6px;">$ </div><div id="a11657" style="position:absolute;left:671.76px;top:220.5px;">435,262</div></div><div id="TextBlockContainer57" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11710" style="position:absolute;font-weight:bold;font-style:normal;left:390.76px;top:0px;">Three Months Ended June 30, 2020 </div><div id="a11721" style="position:absolute;font-weight:bold;font-style:normal;left:630.48px;top:16.8px;">Consolidated </div><div id="a11724" style="position:absolute;font-weight:bold;font-style:normal;left:288.813px;top:31.2px;">Americas </div><div id="a11727" style="position:absolute;font-weight:bold;font-style:normal;left:413.8px;top:31.2px;">EMEA </div><div id="a11730" style="position:absolute;font-weight:bold;font-style:normal;left:518.12px;top:31.2px;">Asia/Pacific </div><div id="a11733" style="position:absolute;font-weight:bold;font-style:normal;left:652.72px;top:31.2px;">Total </div><div id="a11735" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:47.7px;">Customer Industries </div><div id="a11748" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.6px;">Metals </div><div id="a11750" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:65.6px;">$ </div><div id="a11752" style="position:absolute;left:326.413px;top:65.6px;">32,687</div><div id="a11755" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:65.6px;">$ </div><div id="a11757" style="position:absolute;left:444.52px;top:65.6px;">24,924</div><div id="a11760" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:65.6px;">$ </div><div id="a11762" style="position:absolute;left:562.44px;top:65.6px;">35,416</div><div id="a11765" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:65.6px;">$ </div><div id="a11767" style="position:absolute;left:678.48px;top:65.6px;">93,027</div><div id="a11769" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.8px;">Metalworking and other </div><div id="a11772" style="position:absolute;left:326.413px;top:82.6px;">47,889</div><div id="a11776" style="position:absolute;left:444.52px;top:82.6px;">52,778</div><div id="a11780" style="position:absolute;left:562.44px;top:82.6px;">33,005</div><div id="a11784" style="position:absolute;left:671.76px;top:82.6px;">133,672</div><div id="a11788" style="position:absolute;left:326.413px;top:99.5px;">80,576</div><div id="a11792" style="position:absolute;left:444.52px;top:99.5px;">77,702</div><div id="a11796" style="position:absolute;left:562.44px;top:99.5px;">68,421</div><div id="a11800" style="position:absolute;left:671.76px;top:99.5px;">226,699</div><div id="a11802" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:116.5px;">Global Specialty Businesses </div><div id="a11805" style="position:absolute;left:326.413px;top:116.5px;">32,294</div><div id="a11809" style="position:absolute;left:444.52px;top:116.5px;">15,569</div><div id="a11813" style="position:absolute;left:562.44px;top:116.5px;">11,478</div><div id="a11817" style="position:absolute;left:678.48px;top:116.5px;">59,341</div><div id="a11820" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:134.6px;">$ </div><div id="a11822" style="position:absolute;left:319.693px;top:133.6px;">112,870</div><div id="a11825" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:134.6px;">$ </div><div id="a11827" style="position:absolute;left:444.52px;top:133.6px;">93,271</div><div id="a11830" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:134.6px;">$ </div><div id="a11832" style="position:absolute;left:562.44px;top:133.6px;">79,899</div><div id="a11835" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:134.6px;">$ </div><div id="a11837" style="position:absolute;left:671.76px;top:133.6px;">286,040</div><div id="a11851" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:168.6px;">Timing of Revenue Recognized </div><div id="a11864" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:185.8px;">Product sales at a point in time </div><div id="a11866" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:186.6px;">$ </div><div id="a11868" style="position:absolute;left:319.693px;top:186.6px;">108,644</div><div id="a11871" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:186.6px;">$ </div><div id="a11873" style="position:absolute;left:444.52px;top:186.6px;">87,995</div><div id="a11876" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:186.6px;">$ </div><div id="a11878" style="position:absolute;left:562.44px;top:186.6px;">78,195</div><div id="a11881" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:186.6px;">$ </div><div id="a11883" style="position:absolute;left:671.76px;top:186.6px;">274,834</div><div id="a11885" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:202.8px;">Services transferred over time </div><div id="a11888" style="position:absolute;left:332.973px;top:203.6px;">4,226</div><div id="a11892" style="position:absolute;left:451.08px;top:203.6px;">5,276</div><div id="a11896" style="position:absolute;left:569.04px;top:203.6px;">1,704</div><div id="a11900" style="position:absolute;left:678.48px;top:203.6px;">11,206</div><div id="a11903" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:221.6px;">$ </div><div id="a11905" style="position:absolute;left:319.693px;top:220.5px;">112,870</div><div id="a11908" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:221.6px;">$ </div><div id="a11910" style="position:absolute;left:444.52px;top:220.5px;">93,271</div><div id="a11913" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:221.6px;">$ </div><div id="a11915" style="position:absolute;left:562.44px;top:220.5px;">79,899</div><div id="a11918" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:221.6px;">$ </div><div id="a11920" style="position:absolute;left:671.76px;top:220.5px;">286,040</div></div><div id="TextBlockContainer61" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11924" style="position:absolute;font-weight:bold;font-style:normal;left:398.76px;top:0px;">Six Months Ended June 30, 2021 </div><div id="a11936" style="position:absolute;font-weight:bold;font-style:normal;left:630.48px;top:17px;">Consolidated </div><div id="a11939" style="position:absolute;font-weight:bold;font-style:normal;left:288.813px;top:31.2px;">Americas </div><div id="a11942" style="position:absolute;font-weight:bold;font-style:normal;left:413.8px;top:31.2px;">EMEA </div><div id="a11945" style="position:absolute;font-weight:bold;font-style:normal;left:518.12px;top:31.2px;">Asia/Pacific </div><div id="a11948" style="position:absolute;font-weight:bold;font-style:normal;left:652.72px;top:31.2px;">Total </div><div id="a11950" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:47.4px;">Customer Industries </div><div id="a11963" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64px;">Metals </div><div id="a11965" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:65px;">$ </div><div id="a11967" style="position:absolute;left:326.413px;top:65px;">98,592</div><div id="a11970" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:65px;">$ </div><div id="a11972" style="position:absolute;left:444.52px;top:65px;">69,908</div><div id="a11975" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:65px;">$ </div><div id="a11977" style="position:absolute;left:562.44px;top:65px;">97,950</div><div id="a11980" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:65px;">$ </div><div id="a11982" style="position:absolute;left:671.76px;top:65px;">266,450</div><div id="a11984" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.1px;">Metalworking and other </div><div id="a11987" style="position:absolute;left:319.693px;top:81.9px;">175,952</div><div id="a11991" style="position:absolute;left:437.8px;top:81.9px;">173,342</div><div id="a11995" style="position:absolute;left:562.44px;top:81.9px;">90,315</div><div id="a11999" style="position:absolute;left:671.76px;top:81.9px;">439,609</div><div id="a12003" style="position:absolute;left:319.693px;top:98.9px;">274,544</div><div id="a12007" style="position:absolute;left:437.8px;top:98.9px;">243,250</div><div id="a12011" style="position:absolute;left:555.72px;top:98.9px;">188,265</div><div id="a12015" style="position:absolute;left:671.76px;top:98.9px;">706,059</div><div id="a12017" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:115.8px;">Global Specialty Businesses </div><div id="a12020" style="position:absolute;left:326.413px;top:115.8px;">91,439</div><div id="a12024" style="position:absolute;left:444.52px;top:115.8px;">41,950</div><div id="a12028" style="position:absolute;left:562.44px;top:115.8px;">25,597</div><div id="a12032" style="position:absolute;left:671.76px;top:115.8px;">158,986</div><div id="a12035" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:133.9px;">$ </div><div id="a12037" style="position:absolute;left:319.693px;top:133px;">365,983</div><div id="a12040" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:133.9px;">$ </div><div id="a12042" style="position:absolute;left:437.8px;top:133px;">285,200</div><div id="a12045" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:133.9px;">$ </div><div id="a12047" style="position:absolute;left:555.72px;top:133px;">213,862</div><div id="a12050" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:133.9px;">$ </div><div id="a12052" style="position:absolute;left:671.76px;top:133px;">865,045</div><div id="a12066" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:168px;">Timing of Revenue Recognized </div><div id="a12079" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:185.1px;">Product sales at a point in time </div><div id="a12081" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:185.9px;">$ </div><div id="a12083" style="position:absolute;left:319.693px;top:185.9px;">348,821</div><div id="a12086" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:185.9px;">$ </div><div id="a12088" style="position:absolute;left:437.8px;top:185.9px;">269,000</div><div id="a12091" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:185.9px;">$ </div><div id="a12093" style="position:absolute;left:555.72px;top:185.9px;">207,663</div><div id="a12096" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:185.9px;">$ </div><div id="a12098" style="position:absolute;left:671.76px;top:185.9px;">825,484</div><div id="a12100" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:202.1px;">Services transferred over time </div><div id="a12103" style="position:absolute;left:326.413px;top:202.9px;">17,162</div><div id="a12107" style="position:absolute;left:444.52px;top:202.9px;">16,200</div><div id="a12111" style="position:absolute;left:569.04px;top:202.9px;">6,199</div><div id="a12115" style="position:absolute;left:678.48px;top:202.9px;">39,561</div><div id="a12118" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:221px;">$ </div><div id="a12120" style="position:absolute;left:319.693px;top:219.9px;">365,983</div><div id="a12123" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:221px;">$ </div><div id="a12125" style="position:absolute;left:437.8px;top:219.9px;">285,200</div><div id="a12128" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:221px;">$ </div><div id="a12130" style="position:absolute;left:555.72px;top:219.9px;">213,862</div><div id="a12133" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:221px;">$ </div><div id="a12135" style="position:absolute;left:671.76px;top:219.9px;">865,045</div></div><div id="TextBlockContainer65" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12139" style="position:absolute;font-weight:bold;font-style:normal;left:398.76px;top:0px;">Six Months Ended June 30, 2020 </div><div id="a12151" style="position:absolute;font-weight:bold;font-style:normal;left:630.48px;top:17px;">Consolidated </div><div id="a12154" style="position:absolute;font-weight:bold;font-style:normal;left:288.813px;top:31.2px;">Americas </div><div id="a12157" style="position:absolute;font-weight:bold;font-style:normal;left:413.8px;top:31.2px;">EMEA </div><div id="a12160" style="position:absolute;font-weight:bold;font-style:normal;left:518.12px;top:31.2px;">Asia/Pacific </div><div id="a12163" style="position:absolute;font-weight:bold;font-style:normal;left:652.72px;top:31.2px;">Total </div><div id="a12165" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:47.7px;">Customer Industries </div><div id="a12178" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.6px;">Metals </div><div id="a12180" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:65.6px;">$ </div><div id="a12182" style="position:absolute;left:326.413px;top:64.6px;">79,360</div><div id="a12185" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:65.6px;">$ </div><div id="a12187" style="position:absolute;left:444.52px;top:64.6px;">54,812</div><div id="a12190" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:65.6px;">$ </div><div id="a12192" style="position:absolute;left:562.44px;top:64.6px;">77,005</div><div id="a12195" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:65.6px;">$ </div><div id="a12197" style="position:absolute;left:671.76px;top:64.6px;">211,177</div><div id="a12199" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.8px;">Metalworking and other </div><div id="a12202" style="position:absolute;left:319.693px;top:81.8px;">131,112</div><div id="a12206" style="position:absolute;left:437.8px;top:81.8px;">127,729</div><div id="a12210" style="position:absolute;left:562.44px;top:81.8px;">64,968</div><div id="a12214" style="position:absolute;left:671.76px;top:81.8px;">323,809</div><div id="a12218" style="position:absolute;left:319.693px;top:99px;">210,472</div><div id="a12222" style="position:absolute;left:437.8px;top:99px;">182,541</div><div id="a12226" style="position:absolute;left:555.72px;top:99px;">141,973</div><div id="a12230" style="position:absolute;left:671.76px;top:99px;">534,986</div><div id="a12232" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:116.5px;">Global Specialty Businesses </div><div id="a12235" style="position:absolute;left:326.413px;top:115.7px;">76,525</div><div id="a12239" style="position:absolute;left:444.52px;top:115.7px;">32,174</div><div id="a12243" style="position:absolute;left:562.44px;top:115.7px;">20,916</div><div id="a12247" style="position:absolute;left:671.76px;top:115.7px;">129,615</div><div id="a12250" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:134.6px;">$ </div><div id="a12252" style="position:absolute;left:319.693px;top:133.6px;">286,997</div><div id="a12255" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:134.6px;">$ </div><div id="a12257" style="position:absolute;left:437.8px;top:133.6px;">214,715</div><div id="a12260" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:134.6px;">$ </div><div id="a12262" style="position:absolute;left:555.72px;top:133.6px;">162,889</div><div id="a12265" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:134.6px;">$ </div><div id="a12267" style="position:absolute;left:671.76px;top:133.6px;">664,601</div><div id="a12281" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:168.7px;">Timing of Revenue Recognized </div><div id="a12294" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:185.8px;">Product sales at a point in time </div><div id="a12296" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:186.6px;">$ </div><div id="a12298" style="position:absolute;left:319.693px;top:185.8px;">277,446</div><div id="a12301" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:186.6px;">$ </div><div id="a12303" style="position:absolute;left:437.8px;top:185.8px;">206,418</div><div id="a12306" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:186.6px;">$ </div><div id="a12308" style="position:absolute;left:555.72px;top:185.8px;">159,351</div><div id="a12311" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:186.6px;">$ </div><div id="a12313" style="position:absolute;left:671.76px;top:185.8px;">643,215</div><div id="a12315" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:202.8px;">Services transferred over time </div><div id="a12318" style="position:absolute;left:332.973px;top:202.8px;">9,551</div><div id="a12322" style="position:absolute;left:451.08px;top:202.8px;">8,297</div><div id="a12326" style="position:absolute;left:569.04px;top:202.8px;">3,538</div><div id="a12330" style="position:absolute;left:678.48px;top:202.8px;">21,386</div><div id="a12333" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:221.6px;">$ </div><div id="a12335" style="position:absolute;left:319.693px;top:220.5px;">286,997</div><div id="a12338" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:221.6px;">$ </div><div id="a12340" style="position:absolute;left:437.8px;top:220.5px;">214,715</div><div id="a12343" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:221.6px;">$ </div><div id="a12345" style="position:absolute;left:555.72px;top:220.5px;">162,889</div><div id="a12348" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:221.6px;">$ </div><div id="a12350" style="position:absolute;left:671.76px;top:220.5px;">664,601</div></div> 51799000 35634000 48207000 135640000 87874000 87802000 43352000 219028000 139673000 123436000 91559000 354668000 46183000 21678000 12733000 80594000 185856000 145114000 104292000 435262000 177227000 137838000 101264000 416329000 8629000 7276000 3028000 18933000 185856000 145114000 104292000 435262000 32687000 24924000 35416000 93027000 47889000 52778000 33005000 133672000 80576000 77702000 68421000 226699000 32294000 15569000 11478000 59341000 112870000 93271000 79899000 286040000 108644000 87995000 78195000 274834000 4226000 5276000 1704000 11206000 112870000 93271000 79899000 286040000 98592000 69908000 97950000 266450000 175952000 173342000 90315000 439609000 274544000 243250000 188265000 706059000 91439000 41950000 25597000 158986000 365983000 285200000 213862000 865045000 348821000 269000000 207663000 825484000 17162000 16200000 6199000 39561000 365983000 285200000 213862000 865045000 79360000 54812000 77005000 211177000 131112000 127729000 64968000 323809000 210472000 182541000 141973000 534986000 76525000 32174000 20916000 129615000 286997000 214715000 162889000 664601000 277446000 206418000 159351000 643215000 9551000 8297000 3538000 21386000 286997000 214715000 162889000 664601000 <div id="TextBlockContainer70" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:292px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12401" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 6 – Leases </div><div id="div_68_XBRL_TS_8c06c8e1621448c4813235577e1c3604" style="position:absolute;left:0px;top:23.4px;float:left;"><div id="TextBlockContainer69" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12409" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company determines if an arrangement is a lease<div style="display:inline-block;width:4.74px"> </div>at its inception.<div style="display:inline-block;width:7.16px"> </div>This determination generally depends on whether the </div><div id="a12447" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">arrangement conveys the right to control the use of an<div style="display:inline-block;width:4.74px"> </div>identified fixed asset explicitly or implicitly for a period of<div style="display:inline-block;width:4.73px"> </div>time in exchange for </div><div id="a12496" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">consideration.<div style="display:inline-block;width:7.09px"> </div>Control of an underlying asset is conveyed if the Company<div style="display:inline-block;width:4.54px"> </div>obtains the rights to direct the use of, and obtains </div><div id="a12539" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">substantially all of the economic benefits from the use<div style="display:inline-block;width:4.73px"> </div>of, the underlying asset.<div style="display:inline-block;width:7.19px"> </div>Lease expense for variable leases and short-term </div><div id="a12581" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">leases is recognized when the obligation is incurred.</div></div></div><div id="a12581_53_1" style="position:absolute;font-weight:normal;font-style:normal;left:283.213px;top:84.6px;"> </div><div id="a12597" style="position:absolute;font-weight:bold;font-style:normal;left:286.413px;top:84.6px;"> </div><div id="a12598" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:108px;">The Company has operating leases for certain facilities, vehicles<div style="display:inline-block;width:4.7px"> </div>and machinery and equipment with remaining lease terms up<div style="display:inline-block;width:4.76px"> </div>to </div><div id="a12636" style="position:absolute;left:4.427px;top:123.4px;">10 years</div><div id="a12636_8_89" style="position:absolute;font-weight:normal;font-style:normal;left:49.387px;top:123.4px;">.<div style="display:inline-block;width:6.63px"> </div>In addition, the Company has certain land use leases with remaining<div style="display:inline-block;width:4.9px"> </div>lease terms up to </div><div id="a12636_97_8" style="position:absolute;left:520.04px;top:123.4px;">94 years</div><div id="a12636_105_33" style="position:absolute;font-weight:normal;font-style:normal;left:564.839px;top:123.4px;">.<div style="display:inline-block;width:6.8px"> </div>The lease term for all of the </div><div id="a12688" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:138.7px;">Company’s leases includes<div style="display:inline-block;width:4.76px"> </div>the non-cancellable period of the lease plus any additional periods<div style="display:inline-block;width:4.8px"> </div>covered by an option to extend the lease </div><div id="a12732" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153.9px;">that the Company is reasonably certain it will exercise.<div style="display:inline-block;width:8.05px"> </div></div><div id="a12732_58_58" style="position:absolute;left:304.173px;top:153.9px;-sec-ix-hidden:ID_1151;">Operating leases are included in right of use lease assets</div><div id="a12732_116_16" style="position:absolute;font-weight:normal;font-style:normal;left:603.439px;top:153.9px;">, other current </div><div id="a12774" style="position:absolute;left:4.427px;top:169.3px;-sec-ix-hidden:ID_1152;">liabilities and long-term lease liabilities</div><div id="a12774_43_93" style="position:absolute;font-weight:normal;font-style:normal;left:215.333px;top:169.3px;"><div style="display:inline-block;width:3.4px"> </div>on the Condensed Consolidated Balance Sheet.<div style="display:inline-block;width:8.12px"> </div>Right of use lease assets and liabilities are </div><div id="a12814" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:184.6px;">recognized at each lease’s<div style="display:inline-block;width:4.75px"> </div>commencement date based on the present value of its lease payments<div style="display:inline-block;width:4.79px"> </div>over its respective lease term.<div style="display:inline-block;width:7.55px"> </div>The </div><div id="a12857" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:200px;">Company uses the stated borrowing rate for a lease when<div style="display:inline-block;width:4.73px"> </div>readily determinable.<div style="display:inline-block;width:7.2px"> </div>When a stated borrowing rate is not available in a </div><div id="a12901" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:215.4px;">lease agreement, the Company uses its incremental borrowing<div style="display:inline-block;width:4.78px"> </div>rate based on information available at the lease’s<div style="display:inline-block;width:5.1px"> </div>commencement date </div><div id="a12938" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:230.8px;">to determine the present value of its lease payments.<div style="display:inline-block;width:7.99px"> </div>In determining the incremental borrowing rate used to present<div style="display:inline-block;width:4.73px"> </div>value each of its </div><div id="a12982" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:246px;">leases, the Company considers certain information<div style="display:inline-block;width:4.71px"> </div>including fully secured borrowing rates readily available to the Company<div style="display:inline-block;width:4.92px"> </div>and its </div><div id="a13018" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:261.3px;">subsidiaries.<div style="display:inline-block;width:6.97px"> </div>The Company has immaterial finance leases, which are<div style="display:inline-block;width:4.75px"> </div>included in property, plant<div style="display:inline-block;width:4.81px"> </div>and equipment, current portion of </div><div id="a13057" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:276.7px;">long-term debt and long-term debt on the Condensed Consolidated<div style="display:inline-block;width:4.95px"> </div>Balance Sheet.</div></div><div id="TextBlockContainer72" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:719px;height:170px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13083" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Operating lease expense is recognized on a straight-line<div style="display:inline-block;width:4.76px"> </div>basis over the lease term.<div style="display:inline-block;width:7.13px"> </div>Operating lease expense for the three and six </div><div id="a13128" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">months ended June 30, 2021 was $</div><div id="a13128_32_3" style="position:absolute;left:190.693px;top:15.4px;">3.6</div><div id="a13128_35_14" style="position:absolute;font-weight:normal;font-style:normal;left:207.493px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a13128_49_3" style="position:absolute;left:281.933px;top:15.4px;">7.2</div><div id="a13128_52_78" style="position:absolute;font-weight:normal;font-style:normal;left:298.733px;top:15.4px;"><div style="display:inline-block;width:3.2px"> </div>million, respectively.<div style="display:inline-block;width:8.08px"> </div>Comparatively, operating<div style="display:inline-block;width:4.83px"> </div>lease expense for the three </div><div id="a13171" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">and six months ended June 30, 2020 was $</div><div id="a13171_40_3" style="position:absolute;left:232.333px;top:30.6px;">3.5</div><div id="a13171_43_14" style="position:absolute;font-weight:normal;font-style:normal;left:248.973px;top:30.6px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a13171_57_3" style="position:absolute;left:323.533px;top:30.6px;">6.9</div><div id="a13171_60_72" style="position:absolute;font-weight:normal;font-style:normal;left:340.173px;top:30.6px;"><div style="display:inline-block;width:3.36px"> </div>million, respectively.<div style="display:inline-block;width:8.08px"> </div>Short-term lease expense for the three and six </div><div id="a13220" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">months ended June 30, 2021 was $</div><div id="a13220_32_3" style="position:absolute;left:190.693px;top:45.9px;">0.2</div><div id="a13220_35_14" style="position:absolute;font-weight:normal;font-style:normal;left:207.493px;top:45.9px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a13220_49_3" style="position:absolute;left:281.933px;top:45.9px;">0.5</div><div id="a13220_52_79" style="position:absolute;font-weight:normal;font-style:normal;left:298.733px;top:45.9px;"><div style="display:inline-block;width:3.2px"> </div>million, respectively.<div style="display:inline-block;width:8.08px"> </div>Comparatively, short-term<div style="display:inline-block;width:4.78px"> </div>lease expense for the three </div><div id="a13265" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">and six months ended June 30, 2020 was $</div><div id="a13265_40_3" style="position:absolute;left:232.333px;top:61.3px;">0.4</div><div id="a13265_43_14" style="position:absolute;font-weight:normal;font-style:normal;left:248.973px;top:61.3px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a13265_57_3" style="position:absolute;left:323.533px;top:61.3px;">0.9</div><div id="a13265_60_41" style="position:absolute;font-weight:normal;font-style:normal;left:340.173px;top:61.3px;"><div style="display:inline-block;width:3.36px"> </div>million, respectively.<div style="display:inline-block;width:8.08px"> </div>The Company has </div><div id="a13265_101_2" style="position:absolute;left:563.559px;top:61.3px;">no</div><div id="a13265_103_25" style="position:absolute;font-weight:normal;font-style:normal;left:576.879px;top:61.3px;"><div style="display:inline-block;width:3.36px"> </div>material variable lease </div><div id="a13308" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.6px;">costs or sublease income for the three or six months ended<div style="display:inline-block;width:4.74px"> </div>June 30, 2021 and 2020.<div style="display:inline-block;width:7.15px"> </div></div><div id="a13342" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:100px;">Cash paid for operating leases during the six months ended<div style="display:inline-block;width:4.77px"> </div>June 30, 2021 and 2020 was $</div><div id="a13342_87_3" style="position:absolute;left:508.199px;top:100px;">7.1</div><div id="a13342_90_14" style="position:absolute;font-weight:normal;font-style:normal;left:524.839px;top:100px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a13342_104_3" style="position:absolute;left:599.279px;top:100px;">6.8</div><div id="a13342_107_10" style="position:absolute;font-weight:normal;font-style:normal;left:616.079px;top:100px;"><div style="display:inline-block;width:3.36px"> </div>million, </div><div id="a13385" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">respectively.<div style="display:inline-block;width:7.98px"> </div>The Company recorded new right of use lease assets and associated lease liabilities<div style="display:inline-block;width:4.84px"> </div>of $</div><div id="a13385_103_3" style="position:absolute;left:546.919px;top:115.4px;">3.9</div><div id="a13385_106_24" style="position:absolute;font-weight:normal;font-style:normal;left:563.719px;top:115.4px;"><div style="display:inline-block;width:3.2px"> </div>million during the six </div><div id="a13429" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.7px;">months ended June 30, 2021.<div style="display:inline-block;width:7.35px"> </div></div><div id="a13441" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:153.9px;">Supplemental balance sheet information related to the Company’s<div style="display:inline-block;width:5.61px"> </div>leases is as follows:</div></div><div id="TextBlockContainer75" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:169px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13468" style="position:absolute;font-weight:bold;font-style:normal;left:493.32px;top:0px;">June 30, </div><div id="a13472" style="position:absolute;font-weight:bold;font-style:normal;left:577.2px;top:0px;">December 31, </div><div id="a13476" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:17px;">2021 </div><div id="a13479" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:17px;">2020 </div><div id="a13482" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:33.9px;">Right of use lease assets </div><div id="a13484" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:33.9px;">$ </div><div id="a13486" style="position:absolute;left:518.92px;top:33.9px;">36,160</div><div id="a13489" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:33.9px;">$ </div><div id="a13491" style="position:absolute;left:618px;top:33.9px;">38,507</div><div id="a13501" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">Other current liabilities </div><div id="a13504" style="position:absolute;left:518.92px;top:68px;">10,064</div><div id="a13508" style="position:absolute;left:618px;top:68px;">10,901</div><div id="a13511" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:85px;">Long-term lease liabilities </div><div id="a13516" style="position:absolute;left:518.92px;top:85px;">25,668</div><div id="a13520" style="position:absolute;left:618px;top:85px;">27,070</div><div id="a13523" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:101.9px;">Total operating<div style="display:inline-block;width:4.74px"> </div>lease liabilities </div><div id="a13526" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:101.9px;">$ </div><div id="a13528" style="position:absolute;left:518.92px;top:101.9px;">35,732</div><div id="a13531" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:101.9px;">$ </div><div id="a13533" style="position:absolute;left:618px;top:101.9px;">37,971</div><div id="a13544" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:136px;">Weighted average<div style="display:inline-block;width:4.84px"> </div>remaining lease term (years) </div><div id="a13547" style="position:absolute;left:538.96px;top:136px;">5.8</div><div id="a13551" style="position:absolute;left:638px;top:136px;">6.0</div><div id="a13554" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153px;">Weighted average<div style="display:inline-block;width:4.84px"> </div>discount rate </div><div id="a13557" style="position:absolute;left:525.16px;top:153px;display:flex;">4.26%</div><div id="a13561" style="position:absolute;left:624.24px;top:153px;display:flex;">4.20%</div></div><div id="TextBlockContainer78" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:417px;height:16px;display:inline-block;"><div id="a13563" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">Maturities of operating lease liabilities as of June 30,<div style="display:inline-block;width:4.6px"> </div>2021 were as follows:</div></div><div id="TextBlockContainer82" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:184px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_80_XBRL_TS_0d579ae1d84049168fd116dbaa5385b9" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer81" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:184px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13592" style="position:absolute;font-weight:bold;font-style:normal;left:592.4px;top:0px;">June 30, </div><div id="a13596" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:17.1px;">2021 </div><div id="a13599" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:33.1px;">For the remainder of 2021 </div><div id="a13601" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:33.1px;">$ </div><div id="a13603" style="position:absolute;left:624.56px;top:33.1px;">6,052</div><div id="a13606" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:49.1px;">For the year ended December 31, 2022 </div><div id="a13609" style="position:absolute;left:624.56px;top:49.1px;">9,400</div><div id="a13612" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.1px;">For the year ended December 31, 2023 </div><div id="a13615" style="position:absolute;left:624.56px;top:66.1px;">7,234</div><div id="a13618" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:83px;">For the year ended December 31, 2024 </div><div id="a13621" style="position:absolute;left:624.56px;top:83px;">5,355</div><div id="a13624" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">For the year ended December 31, 2025 </div><div id="a13627" style="position:absolute;left:624.56px;top:100px;">4,260</div><div id="a13630" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:117.1px;">For the year ended December 31, 2026 and beyond </div><div id="a13634" style="position:absolute;left:624.56px;top:117.1px;">8,152</div><div id="a13637" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:134.1px;">Total lease payments </div><div id="a13640" style="position:absolute;left:618px;top:134.1px;">40,453</div><div id="a13643" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:151px;">Less: imputed interest </div><div id="a13646" style="position:absolute;left:619.76px;top:151px;">(4,721)</div><div id="a13649" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:168px;">Present value of lease liabilities </div><div id="a13651" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:168px;">$ </div><div id="a13653" style="position:absolute;left:618px;top:168px;">35,732</div></div></div></div> <div id="TextBlockContainer69" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12409" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company determines if an arrangement is a lease<div style="display:inline-block;width:4.74px"> </div>at its inception.<div style="display:inline-block;width:7.16px"> </div>This determination generally depends on whether the </div><div id="a12447" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">arrangement conveys the right to control the use of an<div style="display:inline-block;width:4.74px"> </div>identified fixed asset explicitly or implicitly for a period of<div style="display:inline-block;width:4.73px"> </div>time in exchange for </div><div id="a12496" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">consideration.<div style="display:inline-block;width:7.09px"> </div>Control of an underlying asset is conveyed if the Company<div style="display:inline-block;width:4.54px"> </div>obtains the rights to direct the use of, and obtains </div><div id="a12539" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">substantially all of the economic benefits from the use<div style="display:inline-block;width:4.73px"> </div>of, the underlying asset.<div style="display:inline-block;width:7.19px"> </div>Lease expense for variable leases and short-term </div><div id="a12581" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">leases is recognized when the obligation is incurred.</div></div> P10Y P94Y 3600000 7200000 3500000 6900000 200000 500000 400000 900000 0 0 0 0 0 0 0 0 7100000 6800000 3900000 <div id="TextBlockContainer76" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:169px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_74_XBRL_TS_28a22557745b422a8997cc4e07903877" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer75" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:169px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13468" style="position:absolute;font-weight:bold;font-style:normal;left:493.32px;top:0px;">June 30, </div><div id="a13472" style="position:absolute;font-weight:bold;font-style:normal;left:577.2px;top:0px;">December 31, </div><div id="a13476" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:17px;">2021 </div><div id="a13479" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:17px;">2020 </div><div id="a13482" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:33.9px;">Right of use lease assets </div><div id="a13484" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:33.9px;">$ </div><div id="a13486" style="position:absolute;left:518.92px;top:33.9px;">36,160</div><div id="a13489" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:33.9px;">$ </div><div id="a13491" style="position:absolute;left:618px;top:33.9px;">38,507</div><div id="a13501" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">Other current liabilities </div><div id="a13504" style="position:absolute;left:518.92px;top:68px;">10,064</div><div id="a13508" style="position:absolute;left:618px;top:68px;">10,901</div><div id="a13511" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:85px;">Long-term lease liabilities </div><div id="a13516" style="position:absolute;left:518.92px;top:85px;">25,668</div><div id="a13520" style="position:absolute;left:618px;top:85px;">27,070</div><div id="a13523" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:101.9px;">Total operating<div style="display:inline-block;width:4.74px"> </div>lease liabilities </div><div id="a13526" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:101.9px;">$ </div><div id="a13528" style="position:absolute;left:518.92px;top:101.9px;">35,732</div><div id="a13531" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:101.9px;">$ </div><div id="a13533" style="position:absolute;left:618px;top:101.9px;">37,971</div><div id="a13544" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:136px;">Weighted average<div style="display:inline-block;width:4.84px"> </div>remaining lease term (years) </div><div id="a13547" style="position:absolute;left:538.96px;top:136px;">5.8</div><div id="a13551" style="position:absolute;left:638px;top:136px;">6.0</div><div id="a13554" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153px;">Weighted average<div style="display:inline-block;width:4.84px"> </div>discount rate </div><div id="a13557" style="position:absolute;left:525.16px;top:153px;display:flex;">4.26%</div><div id="a13561" style="position:absolute;left:624.24px;top:153px;display:flex;">4.20%</div></div></div></div> 36160000 38507000 10064000 10901000 25668000 27070000 35732000 37971000 P5Y9M18D P6Y 4.26 4.20 <div id="TextBlockContainer81" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:184px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13592" style="position:absolute;font-weight:bold;font-style:normal;left:592.4px;top:0px;">June 30, </div><div id="a13596" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:17.1px;">2021 </div><div id="a13599" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:33.1px;">For the remainder of 2021 </div><div id="a13601" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:33.1px;">$ </div><div id="a13603" style="position:absolute;left:624.56px;top:33.1px;">6,052</div><div id="a13606" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:49.1px;">For the year ended December 31, 2022 </div><div id="a13609" style="position:absolute;left:624.56px;top:49.1px;">9,400</div><div id="a13612" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.1px;">For the year ended December 31, 2023 </div><div id="a13615" style="position:absolute;left:624.56px;top:66.1px;">7,234</div><div id="a13618" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:83px;">For the year ended December 31, 2024 </div><div id="a13621" style="position:absolute;left:624.56px;top:83px;">5,355</div><div id="a13624" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">For the year ended December 31, 2025 </div><div id="a13627" style="position:absolute;left:624.56px;top:100px;">4,260</div><div id="a13630" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:117.1px;">For the year ended December 31, 2026 and beyond </div><div id="a13634" style="position:absolute;left:624.56px;top:117.1px;">8,152</div><div id="a13637" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:134.1px;">Total lease payments </div><div id="a13640" style="position:absolute;left:618px;top:134.1px;">40,453</div><div id="a13643" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:151px;">Less: imputed interest </div><div id="a13646" style="position:absolute;left:619.76px;top:151px;">(4,721)</div><div id="a13649" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:168px;">Present value of lease liabilities </div><div id="a13651" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:168px;">$ </div><div id="a13653" style="position:absolute;left:618px;top:168px;">35,732</div></div> 6052000 9400000 7234000 5355000 4260000 8152000 40453000 4721000 35732000 <div id="TextBlockContainer84" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:216px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13704" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 7 – Restructuring and Related Activities </div><div id="a13718" style="position:absolute;left:28.427px;top:23.4px;">The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost </div><div id="a13758" style="position:absolute;left:4.427px;top:38.7px;">synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated </div><div id="a13795" style="position:absolute;left:4.427px;top:53.9px;">severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain </div><div id="a13836" style="position:absolute;left:4.427px;top:69.3px;">manufacturing and non-manufacturing facilities. The exact timing and total costs associated with the QH Program will depend on a </div><div id="a13876" style="position:absolute;left:4.427px;top:84.6px;">number of factors and is subject to change; however, the Company currently expects reduction in headcount and site closures to </div><div id="a13917" style="position:absolute;left:4.427px;top:100px;">continue to occur throughout 2021 and into 2022 under the QH Program and estimates that anticipated cost synergies realized from the </div><div id="a13959" style="position:absolute;left:4.427px;top:115.4px;">QH Program will approximate one-times the restructuring costs incurred. Employee separation benefits will vary depending on local </div><div id="a13995" style="position:absolute;left:4.427px;top:130.7px;">regulations within certain foreign countries and will include severance and other benefits.</div><div id="a13995_91_1" style="position:absolute;font-weight:normal;font-style:normal;left:482.12px;top:130.7px;"> </div><div id="a14020" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:153.9px;">All costs incurred to date relate to severance costs to reduce<div style="display:inline-block;width:4.78px"> </div>headcount as well as costs to close certain facilities and are<div style="display:inline-block;width:4.78px"> </div>recorded </div><div id="a14066" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:169.3px;">in Restructuring and related charges in the<div style="display:inline-block;width:4.8px"> </div>Company’s Condensed Statements<div style="display:inline-block;width:4.72px"> </div>of Operations.<div style="display:inline-block;width:7.07px"> </div>As described in Note 4 of Notes to </div><div id="a14108" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:184.6px;">Condensed Consolidated Financial Statements, restructuring<div style="display:inline-block;width:4.74px"> </div>and related charges are not included in<div style="display:inline-block;width:4.7px"> </div>the Company’s calculation of </div><div id="a14141" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:200px;">reportable segments’ measure of operating earnings<div style="display:inline-block;width:4.71px"> </div>and therefore these costs are not reviewed by or recorded to<div style="display:inline-block;width:4.72px"> </div>reportable segments.</div></div><div id="TextBlockContainer86" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:699px;height:16px;display:inline-block;"><div id="a14179" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">Activity in the Company’s<div style="display:inline-block;width:4.77px"> </div>accrual for restructuring under the QH Program for the six months ended<div style="display:inline-block;width:4.96px"> </div>June 30, 2021 is as follows:</div></div><div id="TextBlockContainer90" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:664px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_88_XBRL_TS_98558c94639649bc8d7319250ef31c9e" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer89" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:664px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14226" style="position:absolute;font-weight:bold;font-style:normal;left:576.72px;top:0px;">QH Program </div><div id="a14229" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:16.2px;">Accrued restructuring as of December 31,<div style="display:inline-block;width:7.72px"> </div>2020 </div><div id="a14232" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:16.6px;">$ </div><div id="a14234" style="position:absolute;left:622.16px;top:16.6px;">8,248</div><div id="a14238" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:33.6px;">Restructuring and related charges </div><div id="a14241" style="position:absolute;left:621.04px;top:33.6px;">1,473</div><div id="a14245" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:50.6px;">Cash payments </div><div id="a14248" style="position:absolute;left:616.24px;top:50.6px;">(4,214)</div><div id="a14252" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:67.5px;">Currency translation adjustments </div><div id="a14254" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:67.5px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a14256" style="position:absolute;left:626.16px;top:67.5px;">(229)</div><div id="a14259" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">Accrued restructuring as of June 30, 2021 </div><div id="a14261" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:85.6px;">$ </div><div id="a14263" style="position:absolute;left:621.04px;top:85.6px;">5,278</div></div></div></div> The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain manufacturing and non-manufacturing facilities. The exact timing and total costs associated with the QH Program will depend on a number of factors and is subject to change; however, the Company currently expects reduction in headcount and site closures to continue to occur throughout 2021 and into 2022 under the QH Program and estimates that anticipated cost synergies realized from the QH Program will approximate one-times the restructuring costs incurred. Employee separation benefits will vary depending on local regulations within certain foreign countries and will include severance and other benefits. 400 <div id="TextBlockContainer89" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:664px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14226" style="position:absolute;font-weight:bold;font-style:normal;left:576.72px;top:0px;">QH Program </div><div id="a14229" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:16.2px;">Accrued restructuring as of December 31,<div style="display:inline-block;width:7.72px"> </div>2020 </div><div id="a14232" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:16.6px;">$ </div><div id="a14234" style="position:absolute;left:622.16px;top:16.6px;">8,248</div><div id="a14238" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:33.6px;">Restructuring and related charges </div><div id="a14241" style="position:absolute;left:621.04px;top:33.6px;">1,473</div><div id="a14245" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:50.6px;">Cash payments </div><div id="a14248" style="position:absolute;left:616.24px;top:50.6px;">(4,214)</div><div id="a14252" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:67.5px;">Currency translation adjustments </div><div id="a14254" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:67.5px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a14256" style="position:absolute;left:626.16px;top:67.5px;">(229)</div><div id="a14259" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">Accrued restructuring as of June 30, 2021 </div><div id="a14261" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:85.6px;">$ </div><div id="a14263" style="position:absolute;left:621.04px;top:85.6px;">5,278</div></div> 8248000 1473000 4214000 229000 5278000 <div id="TextBlockContainer92" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:682px;height:54px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14265" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 8 – Share-Based Compensation </div><div id="a14277" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.2px;">The Company recognized the following share-based compensation<div style="display:inline-block;width:4.83px"> </div>expense in its Condensed Consolidated Statements of </div><div id="a14308" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.6px;">Operations for the three and six months ended June 30, 2021<div style="display:inline-block;width:4.72px"> </div>and 2020:</div></div><div id="TextBlockContainer96" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:727px;height:170px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_94_XBRL_TS_0ff0571e7d5d412983e1d5ea6802dcea" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer95" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:727px;height:170px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14337" style="position:absolute;font-weight:bold;font-style:normal;left:386.733px;top:0px;">Three Months Ended </div><div id="a14341" style="position:absolute;font-weight:bold;font-style:normal;left:581.84px;top:0px;">Six Months Ended </div><div id="a14345" style="position:absolute;font-weight:bold;font-style:normal;left:423.72px;top:17.1px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a14348" style="position:absolute;font-weight:bold;font-style:normal;left:610.8px;top:17.1px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a14352" style="position:absolute;font-weight:bold;font-style:normal;left:386.573px;top:34.1px;">2021 </div><div id="a14355" style="position:absolute;font-weight:bold;font-style:normal;left:481.64px;top:34.1px;">2020 </div><div id="a14358" style="position:absolute;font-weight:bold;font-style:normal;left:574.64px;top:34.1px;">2021 </div><div id="a14361" style="position:absolute;font-weight:bold;font-style:normal;left:667.76px;top:34.1px;">2020 </div><div id="a14363" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.1px;">Stock options </div><div id="a14365" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:51.1px;">$ </div><div id="a14367" style="position:absolute;left:417.64px;top:51.1px;">332</div><div id="a14370" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:51.1px;">$ </div><div id="a14372" style="position:absolute;left:512.68px;top:51.1px;">353</div><div id="a14375" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:51.1px;">$ </div><div id="a14377" style="position:absolute;left:605.68px;top:51.1px;">640</div><div id="a14380" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:51.1px;">$ </div><div id="a14382" style="position:absolute;left:698.64px;top:51.1px;">785</div><div id="a14384" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">Non-vested stock awards and restricted stock units </div><div id="a14389" style="position:absolute;left:407.56px;top:68px;">1,290</div><div id="a14393" style="position:absolute;left:502.6px;top:68px;">1,259</div><div id="a14397" style="position:absolute;left:595.6px;top:68px;">2,686</div><div id="a14401" style="position:absolute;left:688.56px;top:68px;">2,523</div><div id="a14403" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:85.1px;">Non-elective and elective 401(k) matching contribution in<div style="display:inline-block;width:4.73px"> </div>stock </div><div id="a14408" style="position:absolute;left:424.36px;top:85.1px;">—</div><div id="a14412" style="position:absolute;left:502.6px;top:85.1px;">1,162</div><div id="a14416" style="position:absolute;left:595.6px;top:85.1px;">1,553</div><div id="a14420" style="position:absolute;left:688.56px;top:85.1px;">1,162</div><div id="a14422" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:102.1px;">Director stock ownership plan </div><div id="a14425" style="position:absolute;left:417.64px;top:102.1px;">216</div><div id="a14429" style="position:absolute;left:519.4px;top:102.1px;">54</div><div id="a14433" style="position:absolute;left:605.68px;top:102.1px;">419</div><div id="a14437" style="position:absolute;left:705.36px;top:102.1px;">94</div><div id="a14439" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:119.1px;">Performance stock units </div><div id="a14442" style="position:absolute;left:417.64px;top:119.1px;">517</div><div id="a14446" style="position:absolute;left:512.68px;top:119.1px;">280</div><div id="a14450" style="position:absolute;left:605.68px;top:119.1px;">836</div><div id="a14454" style="position:absolute;left:698.64px;top:119.1px;">280</div><div id="a14456" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:136px;">Annual incentive plan </div><div id="a14459" style="position:absolute;left:424.36px;top:136px;">—</div><div id="a14463" style="position:absolute;left:507.72px;top:136px;">(117)</div><div id="a14467" style="position:absolute;left:612.4px;top:136px;">—</div><div id="a14471" style="position:absolute;left:688.56px;top:136px;">2,829</div><div id="a14473" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:154.1px;">Total share-based<div style="display:inline-block;width:4.86px"> </div>compensation expense </div><div id="a14477" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:154.1px;">$ </div><div id="a14479" style="position:absolute;left:407.56px;top:154.1px;">2,355</div><div id="a14482" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:154.1px;">$ </div><div id="a14484" style="position:absolute;left:502.6px;top:154.1px;">2,991</div><div id="a14487" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:154.1px;">$ </div><div id="a14489" style="position:absolute;left:595.6px;top:154.1px;">6,134</div><div id="a14492" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:154.1px;">$ </div><div id="a14494" style="position:absolute;left:688.56px;top:154.1px;">7,673</div></div></div></div><div id="TextBlockContainer98" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:124px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14496" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Share-based compensation expense is recorded in SG&amp;A,<div style="display:inline-block;width:4.71px"> </div>except for $</div><div id="a14496_66_3" style="position:absolute;left:404.04px;top:0px;">0.2</div><div id="a14496_69_14" style="position:absolute;font-weight:normal;font-style:normal;left:420.68px;top:0px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a14496_83_3" style="position:absolute;left:495.079px;top:0px;">0.5</div><div id="a14496_86_38" style="position:absolute;font-weight:normal;font-style:normal;left:511.72px;top:0px;"><div style="display:inline-block;width:3.36px"> </div>million for the three and six months </div><div id="a14538" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">ended June 30, 2021, respectively,<div style="display:inline-block;width:5.12px"> </div>and $</div><div id="a14538_40_3" style="position:absolute;left:221.253px;top:15.4px;">0.3</div><div id="a14538_43_14" style="position:absolute;font-weight:normal;font-style:normal;left:237.933px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a14538_57_3" style="position:absolute;left:312.333px;top:15.4px;">0.8</div><div id="a14538_60_73" style="position:absolute;font-weight:normal;font-style:normal;left:328.973px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million for the three and six months ended June 30, 2020, respectively, </div><div id="a14585" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">recorded within Combination, integration<div style="display:inline-block;width:4.48px"> </div>and other acquisition-related expenses. </div><div id="a14604" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:54.1px;">Stock Options</div><div id="a14607" style="position:absolute;font-weight:normal;font-style:normal;left:78.859px;top:54.1px;"> </div><div id="a14608" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:77.5px;">During the first six months of 2021, the Company granted<div style="display:inline-block;width:4.84px"> </div>stock options under its long-term incentive plan (“LTIP”)<div style="display:inline-block;width:5.63px"> </div>that are </div><div id="a14650" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92.8px;">subject only to time-based vesting over a </div><div id="a14650_42_5" style="position:absolute;left:226.413px;top:92.8px;-sec-ix-hidden:ID_444;">three</div><div id="a14650_47_90" style="position:absolute;font-weight:normal;font-style:normal;left:253.133px;top:92.8px;"><div style="display:inline-block;width:3.2px"> </div>year period.<div style="display:inline-block;width:6.82px"> </div>For the purposes of determining the fair value of stock<div style="display:inline-block;width:4.65px"> </div>option awards, the </div><div id="a14699" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:108.2px;">Company used a Black-Scholes option pricing model and<div style="display:inline-block;width:4.72px"> </div>which primarily used the assumptions set forth in the table below:</div></div><div id="TextBlockContainer101" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:436px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14740" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">Number of options granted </div><div id="a14742" style="position:absolute;left:373.933px;top:0px;">25,250</div><div id="a14747" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:17.1px;">Dividend yield </div><div id="a14749" style="position:absolute;left:388.333px;top:17.1px;">0.85</div><div id="a14751" style="position:absolute;font-weight:normal;font-style:normal;left:416.493px;top:17.1px;">% </div><div id="a14755" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:34.1px;">Expected volatility </div><div id="a14757" style="position:absolute;left:381.613px;top:34.1px;">37.33</div><div id="a14759" style="position:absolute;font-weight:normal;font-style:normal;left:416.493px;top:34.1px;">% </div><div id="a14763" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51px;">Risk-free interest rate </div><div id="a14767" style="position:absolute;left:388.333px;top:51px;">0.60</div><div id="a14769" style="position:absolute;font-weight:normal;font-style:normal;left:416.493px;top:51px;">% </div><div id="a14773" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">Expected term (years) </div><div id="a14775" style="position:absolute;left:395.053px;top:68px;">4.0</div></div><div id="TextBlockContainer104" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:714px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14828" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The fair value of these options is amortized on a straight<div style="display:inline-block;width:1.42px"> </div>-line basis over the vesting period.<div style="display:inline-block;width:7.34px"> </div>As of June 30, 2021,<div style="display:inline-block;width:3.88px"> </div>unrecognized </div><div id="a14875" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">compensation expense related to all stock options<div style="display:inline-block;width:4.59px"> </div>granted was $</div><div id="a14875_63_3" style="position:absolute;left:346.413px;top:15.4px;">2.4</div><div id="a14875_66_61" style="position:absolute;font-weight:normal;font-style:normal;left:363.213px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million, to be recognized over a weighted average remaining </div><div id="a14913" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">period of </div><div id="a14913_10_3" style="position:absolute;left:56.459px;top:30.7px;">2.3</div><div id="a14913_13_7" style="position:absolute;font-weight:normal;font-style:normal;left:73.098px;top:30.7px;"><div style="display:inline-block;width:3.36px"> </div>years.</div></div><div id="TextBlockContainer106" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:131px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14922" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Restricted Stock Awards<div style="display:inline-block;width:5.03px"> </div>and Restricted Stock Units</div><div id="a14935" style="position:absolute;font-weight:normal;font-style:normal;left:280.013px;top:0px;"> </div><div id="a14936" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.2px;">During the six months ended June 30, 2021, the Company<div style="display:inline-block;width:4.78px"> </div>granted </div><div id="a14936_63_6" style="position:absolute;left:385.293px;top:23.2px;">17,692</div><div id="a14936_69_34" style="position:absolute;font-weight:normal;font-style:normal;left:421.96px;top:23.2px;"><div style="display:inline-block;width:3.36px"> </div>non-vested restricted shares and </div><div id="a14936_103_5" style="position:absolute;left:599.44px;top:23.2px;">2,791</div><div id="a14936_108_12" style="position:absolute;font-weight:normal;font-style:normal;left:629.36px;top:23.2px;"><div style="display:inline-block;width:3.36px"> </div>non-vested </div><div id="a14981" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.6px;">restricted stock units under its LTIP,<div style="display:inline-block;width:6.96px"> </div>which are subject to time-based vesting, generally over a </div><div id="a14981_97_10" style="position:absolute;left:509.32px;top:38.6px;">three year</div><div id="a14981_107_28" style="position:absolute;font-weight:normal;font-style:normal;left:562.279px;top:38.6px;"><div style="display:inline-block;width:3.36px"> </div>period.<div style="display:inline-block;width:6.79px"> </div>The fair value of </div><div id="a15028" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.9px;">these grants is based on the trading price of the Company’s<div style="display:inline-block;width:5.47px"> </div>common stock on the date of grant.<div style="display:inline-block;width:7.35px"> </div>The Company adjusts the grant date </div><div id="a15077" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">fair value of these awards for expected forfeitures based<div style="display:inline-block;width:4.71px"> </div>on historical experience.<div style="display:inline-block;width:7.31px"> </div>As of June 30, 2021, unrecognized compensation </div><div id="a15115" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">expense related to the non-vested restricted shares was $</div><div id="a15115_57_3" style="position:absolute;left:305.933px;top:84.6px;">6.3</div><div id="a15115_60_71" style="position:absolute;font-weight:normal;font-style:normal;left:322.733px;top:84.6px;"><div style="display:inline-block;width:3.2px"> </div>million, to be recognized over a weighted average remaining<div style="display:inline-block;width:4.78px"> </div>period of </div><div id="a15115_131_3" style="position:absolute;left:705.359px;top:84.6px;">1.9</div><div id="a15115_134_1" style="position:absolute;font-weight:normal;font-style:normal;left:721.999px;top:84.6px;"> </div><div id="a15159" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:99.8px;">years, and unrecognized compensation expense<div style="display:inline-block;width:4.69px"> </div>related to non-vested restricted stock units was $</div><div id="a15159_95_3" style="position:absolute;left:520.36px;top:99.8px;">1.1</div><div id="a15159_98_34" style="position:absolute;font-weight:normal;font-style:normal;left:537.16px;top:99.8px;"><div style="display:inline-block;width:3.36px"> </div>million, to be recognized over a </div><div id="a15199" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.2px;">weighted average remaining period of </div><div id="a15199_37_3" style="position:absolute;left:210.853px;top:115.2px;">2.1</div><div id="a15199_40_7" style="position:absolute;font-weight:normal;font-style:normal;left:227.533px;top:115.2px;"><div style="display:inline-block;width:3.36px"> </div>years.</div></div><div id="TextBlockContainer108" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:721px;height:131px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15214" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Performance Stock Units </div><div id="a15220" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">During the first six months of 2021, the Company granted<div style="display:inline-block;width:4.68px"> </div>performance-dependent stock awards (“PSUs”) as a component of<div style="display:inline-block;width:4.87px"> </div>its </div><div id="a15260" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.8px;">LTIP,<div style="display:inline-block;width:6.22px"> </div>which will be settled in a certain number of shares subject to market<div style="display:inline-block;width:1.64px"> </div>-based and time-based vesting conditions.<div style="display:inline-block;width:7.73px"> </div>The number of </div><div id="a15308" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:54.1px;">fully vested shares that may ultimately be issued as settlement<div style="display:inline-block;width:4.87px"> </div>for each award may range from </div><div id="a15308_94_1" style="position:absolute;left:510.599px;top:54.1px;">0</div><div id="a15308_95_8" style="position:absolute;font-weight:normal;font-style:normal;left:517.319px;top:54.1px;">% up to </div><div id="a15308_103_3" style="position:absolute;left:562.119px;top:54.1px;">200</div><div id="a15308_106_23" style="position:absolute;font-weight:normal;font-style:normal;left:582.119px;top:54.1px;">% of the target award, </div><div id="a15356" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">subject to the achievement of the Company’s<div style="display:inline-block;width:5.25px"> </div>total shareholder return (“TSR”) relative to the performance<div style="display:inline-block;width:4.8px"> </div>of the Company’s peer </div><div id="a15395" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.7px;">group, the S&amp;P Midcap 400 Materials group.<div style="display:inline-block;width:7.74px"> </div>The service period required for the PSUs is three years and the<div style="display:inline-block;width:4.83px"> </div>TSR measurement </div><div id="a15437" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">period for the PSUs is from January 1 of the year of grant<div style="display:inline-block;width:4.85px"> </div>through December 31 of the year prior to issuance of the shares upon </div><div id="a15490" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">settlement.</div></div><div id="TextBlockContainer110" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:726px;height:131px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15492" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Compensation expense for PSUs is measured based on<div style="display:inline-block;width:4.74px"> </div>their grant date fair value and is recognized on a straight-line basis over </div><div id="a15536" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.2px;">the </div><div id="a15536_4_10" style="position:absolute;left:24.107px;top:15.2px;">three year</div><div id="a15536_14_122" style="position:absolute;font-weight:normal;font-style:normal;left:77.099px;top:15.2px;"><div style="display:inline-block;width:3.36px"> </div>vesting period.<div style="display:inline-block;width:6.83px"> </div>The grant-date fair value of the PSUs granted during<div style="display:inline-block;width:4.7px"> </div>the first six months of 2021 was estimated using a </div><div id="a15586" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">Monte Carlo simulation on the grant date and using the<div style="display:inline-block;width:4.78px"> </div>following assumptions: (i) a risk-free rate of </div><div id="a15586_102_4" style="position:absolute;left:541.799px;top:30.6px;">0.29</div><div id="a15586_106_28" style="position:absolute;font-weight:normal;font-style:normal;left:565.319px;top:30.6px;">%; (ii) an expected term of </div><div id="a15634" style="position:absolute;left:4.427px;top:45.9px;">3.0</div><div id="a15634_3_132" style="position:absolute;font-weight:normal;font-style:normal;left:21.227px;top:45.9px;"><div style="display:inline-block;width:3.36px"> </div>years; and (iii) a three year daily historical volatility for each of<div style="display:inline-block;width:4.75px"> </div>the companies in the peer group, including Quaker Houghton.<div style="display:inline-block;width:4.7px"> </div></div><div id="a15680" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:69.3px;">As of June 30, 2021, the Company estimates that it will issue<div style="display:inline-block;width:4.71px"> </div>approximately </div><div id="a15680_76_6" style="position:absolute;left:438.6px;top:69.3px;">14,698</div><div id="a15680_82_42" style="position:absolute;font-weight:normal;font-style:normal;left:475.24px;top:69.3px;"><div style="display:inline-block;width:3.36px"> </div>fully vested shares as of the applicable </div><div id="a15723" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">settlement date of all outstanding PSUs awards based on<div style="display:inline-block;width:4.81px"> </div>the conditions of the PSUs and performance to date for<div style="display:inline-block;width:4.73px"> </div>each award.<div style="display:inline-block;width:6.84px"> </div>As of </div><div id="a15770" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">June 30, 2021, there was approximately $</div><div id="a15770_40_3" style="position:absolute;left:226.733px;top:100px;">4.2</div><div id="a15770_43_84" style="position:absolute;font-weight:normal;font-style:normal;left:243.533px;top:100px;"><div style="display:inline-block;width:3.36px"> </div>million of total unrecognized compensation cost related to PSUs, which<div style="display:inline-block;width:4.79px"> </div>the Company </div><div id="a15808" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">expects to recognize over a weighted-average period<div style="display:inline-block;width:4.59px"> </div>of </div><div id="a15808_55_3" style="position:absolute;left:303.053px;top:115.4px;">2.3</div><div id="a15808_58_7" style="position:absolute;font-weight:normal;font-style:normal;left:319.693px;top:115.4px;"><div style="display:inline-block;width:3.2px"> </div>years.</div></div><div id="TextBlockContainer112" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:147px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15830" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Annual Incentive Plan </div><div id="a15836" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The Company maintains an Annual Incentive Plan<div style="display:inline-block;width:4.7px"> </div>(“AIP”), which may be settled in cash or a certain number of<div style="display:inline-block;width:4.72px"> </div>shares subject to </div><div id="a15880" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">performance-based and time-based vesting conditions.<div style="display:inline-block;width:8.02px"> </div>As of June 30, 2020, it was the Company’s<div style="display:inline-block;width:5.03px"> </div>intention to settle the 2020 AIP in </div><div id="a15926" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:54.1px;">shares, and therefore, expense associated with the AIP in<div style="display:inline-block;width:4.72px"> </div>2020 was recorded as a component of share-based compensation<div style="display:inline-block;width:4.86px"> </div>expense.<div style="display:inline-block;width:7.03px"> </div>In </div><div id="a15969" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.4px;">the fourth quarter of 2020, the Company determined that it<div style="display:inline-block;width:4.55px"> </div>would settle the 2020 AIP in cash.<div style="display:inline-block;width:7.53px"> </div>Therefore, the share-based </div><div id="a16011" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">compensation associated with the AIP during the year<div style="display:inline-block;width:4.72px"> </div>ended December 31, 2020 was reclassified from a component<div style="display:inline-block;width:4.72px"> </div>of share-based </div><div id="a16052" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">compensation expense to incentive compensation.<div style="display:inline-block;width:7.93px"> </div>This determination and conclusion had no impact on the<div style="display:inline-block;width:4.7px"> </div>classification of AIP </div><div id="a16086" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">expense within the Company’s<div style="display:inline-block;width:4.79px"> </div>Condensed Consolidated Statement of Operations for<div style="display:inline-block;width:4.77px"> </div>the periods as both are a component of SG&amp;A.<div style="display:inline-block;width:4.38px"> </div></div><div id="a16124" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.7px;">As of June 30, 2021, it is the Company’s<div style="display:inline-block;width:5.18px"> </div>intention to settle the 2021 AIP in cash.</div></div><div id="TextBlockContainer114" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:730px;height:147px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a16159" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Defined Contribution Plan<div style="display:inline-block;width:3.88px"> </div></div><div id="a16166" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.2px;">The Company has a 401(k) plan with an employer<div style="display:inline-block;width:4.58px"> </div>match covering a majority of its U.S. employees.<div style="display:inline-block;width:7.97px"> </div>The Company matches </div><div id="a16166_117_2" style="position:absolute;left:694.479px;top:23.2px;">50</div><div id="a16166_119_2" style="position:absolute;font-weight:normal;font-style:normal;left:707.919px;top:23.2px;">% </div><div id="a16208" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.6px;">of the first </div><div id="a16208_13_1" style="position:absolute;left:63.499px;top:38.6px;">6</div><div id="a16208_14_91" style="position:absolute;font-weight:normal;font-style:normal;left:70.219px;top:38.6px;">% of compensation that is contributed to the plan, with a maximum<div style="display:inline-block;width:4.71px"> </div>matching contribution of </div><div id="a16208_105_1" style="position:absolute;left:568.52px;top:38.6px;">3</div><div id="a16208_106_20" style="position:absolute;font-weight:normal;font-style:normal;left:575.239px;top:38.6px;">% of compensation.<div style="display:inline-block;width:3.64px"> </div></div><div id="a16250" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:54px;">Additionally, the<div style="display:inline-block;width:4.65px"> </div>plan provides for non-elective nondiscretionary contributions<div style="display:inline-block;width:4.83px"> </div>on behalf of participants who have completed one year </div><div id="a16287" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">of service equal to </div><div id="a16287_20_1" style="position:absolute;left:106.053px;top:69.3px;">3</div><div id="a16287_21_110" style="position:absolute;font-weight:normal;font-style:normal;left:112.773px;top:69.3px;">% of the eligible participants’ compensation.<div style="display:inline-block;width:7.57px"> </div>Beginning in April 2020 and continuing through March 2021,<div style="display:inline-block;width:4.71px"> </div>the </div><div id="a16327" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.7px;">Company matched both non-elective and elective 401(k)<div style="display:inline-block;width:4.82px"> </div>contributions in fully vested shares of the Company’s<div style="display:inline-block;width:5.23px"> </div>common stock rather </div><div id="a16366" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">than cash.<div style="display:inline-block;width:7.09px"> </div>For the three months ended June 30, 2021, there were </div><div id="a16366_65_2" style="position:absolute;left:354.093px;top:100px;">no</div><div id="a16366_67_65" style="position:absolute;font-weight:normal;font-style:normal;left:367.533px;top:100px;"><div style="display:inline-block;width:3.36px"> </div>matching contributions in stock.<div style="display:inline-block;width:7.44px"> </div>For the six months ended June </div><div id="a16414" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.2px;">30, 2021, total contributions were $</div><div id="a16414_36_3" style="position:absolute;left:194.533px;top:115.2px;">1.5</div><div id="a16414_39_93" style="position:absolute;font-weight:normal;font-style:normal;left:211.173px;top:115.2px;"><div style="display:inline-block;width:3.36px"> </div>million and for both the three and six months ended June 30, 2020,<div style="display:inline-block;width:4.88px"> </div>total contributions were </div><div id="a16462" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.6px;">$</div><div id="a16462_1_3" style="position:absolute;left:11.147px;top:130.6px;">1.2</div><div id="a16462_4_9" style="position:absolute;font-weight:normal;font-style:normal;left:27.947px;top:130.6px;"><div style="display:inline-block;width:3.36px"> </div>million.</div></div> <div id="TextBlockContainer95" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:727px;height:170px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14337" style="position:absolute;font-weight:bold;font-style:normal;left:386.733px;top:0px;">Three Months Ended </div><div id="a14341" style="position:absolute;font-weight:bold;font-style:normal;left:581.84px;top:0px;">Six Months Ended </div><div id="a14345" style="position:absolute;font-weight:bold;font-style:normal;left:423.72px;top:17.1px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a14348" style="position:absolute;font-weight:bold;font-style:normal;left:610.8px;top:17.1px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a14352" style="position:absolute;font-weight:bold;font-style:normal;left:386.573px;top:34.1px;">2021 </div><div id="a14355" style="position:absolute;font-weight:bold;font-style:normal;left:481.64px;top:34.1px;">2020 </div><div id="a14358" style="position:absolute;font-weight:bold;font-style:normal;left:574.64px;top:34.1px;">2021 </div><div id="a14361" style="position:absolute;font-weight:bold;font-style:normal;left:667.76px;top:34.1px;">2020 </div><div id="a14363" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.1px;">Stock options </div><div id="a14365" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:51.1px;">$ </div><div id="a14367" style="position:absolute;left:417.64px;top:51.1px;">332</div><div id="a14370" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:51.1px;">$ </div><div id="a14372" style="position:absolute;left:512.68px;top:51.1px;">353</div><div id="a14375" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:51.1px;">$ </div><div id="a14377" style="position:absolute;left:605.68px;top:51.1px;">640</div><div id="a14380" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:51.1px;">$ </div><div id="a14382" style="position:absolute;left:698.64px;top:51.1px;">785</div><div id="a14384" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">Non-vested stock awards and restricted stock units </div><div id="a14389" style="position:absolute;left:407.56px;top:68px;">1,290</div><div id="a14393" style="position:absolute;left:502.6px;top:68px;">1,259</div><div id="a14397" style="position:absolute;left:595.6px;top:68px;">2,686</div><div id="a14401" style="position:absolute;left:688.56px;top:68px;">2,523</div><div id="a14403" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:85.1px;">Non-elective and elective 401(k) matching contribution in<div style="display:inline-block;width:4.73px"> </div>stock </div><div id="a14408" style="position:absolute;left:424.36px;top:85.1px;">—</div><div id="a14412" style="position:absolute;left:502.6px;top:85.1px;">1,162</div><div id="a14416" style="position:absolute;left:595.6px;top:85.1px;">1,553</div><div id="a14420" style="position:absolute;left:688.56px;top:85.1px;">1,162</div><div id="a14422" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:102.1px;">Director stock ownership plan </div><div id="a14425" style="position:absolute;left:417.64px;top:102.1px;">216</div><div id="a14429" style="position:absolute;left:519.4px;top:102.1px;">54</div><div id="a14433" style="position:absolute;left:605.68px;top:102.1px;">419</div><div id="a14437" style="position:absolute;left:705.36px;top:102.1px;">94</div><div id="a14439" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:119.1px;">Performance stock units </div><div id="a14442" style="position:absolute;left:417.64px;top:119.1px;">517</div><div id="a14446" style="position:absolute;left:512.68px;top:119.1px;">280</div><div id="a14450" style="position:absolute;left:605.68px;top:119.1px;">836</div><div id="a14454" style="position:absolute;left:698.64px;top:119.1px;">280</div><div id="a14456" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:136px;">Annual incentive plan </div><div id="a14459" style="position:absolute;left:424.36px;top:136px;">—</div><div id="a14463" style="position:absolute;left:507.72px;top:136px;">(117)</div><div id="a14467" style="position:absolute;left:612.4px;top:136px;">—</div><div id="a14471" style="position:absolute;left:688.56px;top:136px;">2,829</div><div id="a14473" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:154.1px;">Total share-based<div style="display:inline-block;width:4.86px"> </div>compensation expense </div><div id="a14477" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:154.1px;">$ </div><div id="a14479" style="position:absolute;left:407.56px;top:154.1px;">2,355</div><div id="a14482" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:154.1px;">$ </div><div id="a14484" style="position:absolute;left:502.6px;top:154.1px;">2,991</div><div id="a14487" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:154.1px;">$ </div><div id="a14489" style="position:absolute;left:595.6px;top:154.1px;">6,134</div><div id="a14492" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:154.1px;">$ </div><div id="a14494" style="position:absolute;left:688.56px;top:154.1px;">7,673</div></div> 332000 353000 640000 785000 1290000 1259000 2686000 2523000 0 1162000 1553000 1162000 216000 54000 419000 94000 517000 280000 836000 280000 0 -117000 0 2829000 2355000 2991000 6134000 7673000 200000 500000 300000 800000 <div id="TextBlockContainer102" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:436px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_100_XBRL_TS_cd75c0bafa2e4402a459e4591de4676c" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer101" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:436px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14740" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">Number of options granted </div><div id="a14742" style="position:absolute;left:373.933px;top:0px;">25,250</div><div id="a14747" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:17.1px;">Dividend yield </div><div id="a14749" style="position:absolute;left:388.333px;top:17.1px;">0.85</div><div id="a14751" style="position:absolute;font-weight:normal;font-style:normal;left:416.493px;top:17.1px;">% </div><div id="a14755" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:34.1px;">Expected volatility </div><div id="a14757" style="position:absolute;left:381.613px;top:34.1px;">37.33</div><div id="a14759" style="position:absolute;font-weight:normal;font-style:normal;left:416.493px;top:34.1px;">% </div><div id="a14763" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51px;">Risk-free interest rate </div><div id="a14767" style="position:absolute;left:388.333px;top:51px;">0.60</div><div id="a14769" style="position:absolute;font-weight:normal;font-style:normal;left:416.493px;top:51px;">% </div><div id="a14773" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">Expected term (years) </div><div id="a14775" style="position:absolute;left:395.053px;top:68px;">4.0</div></div></div></div> 25250 0.0085 0.3733 0.0060 P4Y 2400000 P2Y3M18D 17692 2791 P3Y 6300000 P1Y10M24D 1100000 P2Y1M6D 0 2 P3Y 0.0029 P3Y 14698 4200000 P2Y3M18D 0.50 0.06 0.03 0.03 0 1500000 1200000 1200000 <div id="TextBlockContainer116" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:671px;height:35px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a16516" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 9 – Pension and Other Postretirement<div style="display:inline-block;width:5.03px"> </div>Benefits </div><div id="a16532" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:19.4px;">The components of net periodic benefit cost for the<div style="display:inline-block;width:4.72px"> </div>three and six months ended June 30, 2021 and 2020 are as follows:</div></div><div id="TextBlockContainer119" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:727px;height:204px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a16578" style="position:absolute;font-weight:bold;font-style:normal;left:222.253px;top:0px;">Three Months Ended June 30,<div style="display:inline-block;width:4.23px"> </div></div><div id="a16581" style="position:absolute;font-weight:bold;font-style:normal;left:510.44px;top:0px;">Six Months Ended June 30,<div style="display:inline-block;width:4.05px"> </div></div><div id="a16591" style="position:absolute;font-weight:bold;font-style:normal;left:361.453px;top:17px;">Other </div><div id="a16600" style="position:absolute;font-weight:bold;font-style:normal;left:641.52px;top:17px;">Other </div><div id="a16610" style="position:absolute;font-weight:bold;font-style:normal;left:335.853px;top:34.1px;">Postretirement </div><div id="a16619" style="position:absolute;font-weight:bold;font-style:normal;left:615.92px;top:34.1px;">Postretirement </div><div id="a16623" style="position:absolute;font-weight:bold;font-style:normal;left:191.493px;top:51px;">Pension Benefits </div><div id="a16626" style="position:absolute;font-weight:bold;font-style:normal;left:355.533px;top:51px;">Benefits </div><div id="a16629" style="position:absolute;font-weight:bold;font-style:normal;left:471.56px;top:51px;">Pension Benefits </div><div id="a16632" style="position:absolute;font-weight:bold;font-style:normal;left:635.6px;top:51px;">Benefits </div><div id="a16637" style="position:absolute;font-weight:bold;font-style:normal;left:195.173px;top:68px;">2021 </div><div id="a16641" style="position:absolute;font-weight:bold;font-style:normal;left:265.133px;top:68px;">2020 </div><div id="a16645" style="position:absolute;font-weight:bold;font-style:normal;left:335.213px;top:68px;">2021 </div><div id="a16649" style="position:absolute;font-weight:bold;font-style:normal;left:405.16px;top:68px;">2020 </div><div id="a16653" style="position:absolute;font-weight:bold;font-style:normal;left:475.24px;top:68px;">2021 </div><div id="a16657" style="position:absolute;font-weight:bold;font-style:normal;left:545.16px;top:68px;">2020 </div><div id="a16661" style="position:absolute;font-weight:bold;font-style:normal;left:615.28px;top:68px;">2021 </div><div id="a16665" style="position:absolute;font-weight:bold;font-style:normal;left:685.2px;top:68px;">2020 </div><div id="a16667" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:85px;">Service cost </div><div id="a16669" style="position:absolute;font-weight:normal;font-style:normal;left:174.373px;top:85px;">$ </div><div id="a16671" style="position:absolute;left:208.613px;top:85px;">316</div><div id="a16674" style="position:absolute;font-weight:normal;font-style:normal;left:244.493px;top:85px;">$ </div><div id="a16676" style="position:absolute;left:268.493px;top:85px;">1,164</div><div id="a16679" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:85px;">$ </div><div id="a16681" style="position:absolute;left:361.933px;top:85px;">2</div><div id="a16684" style="position:absolute;font-weight:normal;font-style:normal;left:384.493px;top:85px;">$ </div><div id="a16686" style="position:absolute;left:431.88px;top:85px;">1</div><div id="a16689" style="position:absolute;font-weight:normal;font-style:normal;left:454.44px;top:85px;">$ </div><div id="a16691" style="position:absolute;left:488.68px;top:85px;">632</div><div id="a16694" style="position:absolute;font-weight:normal;font-style:normal;left:524.52px;top:85px;">$ </div><div id="a16696" style="position:absolute;left:548.52px;top:85px;">2,338</div><div id="a16699" style="position:absolute;font-weight:normal;font-style:normal;left:594.48px;top:85px;">$ </div><div id="a16701" style="position:absolute;left:642px;top:85px;">3</div><div id="a16704" style="position:absolute;font-weight:normal;font-style:normal;left:664.56px;top:85px;">$ </div><div id="a16706" style="position:absolute;left:711.92px;top:85px;">3</div><div id="a16708" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:102.1px;">Interest cost </div><div id="a16711" style="position:absolute;left:198.533px;top:102.1px;">1,094</div><div id="a16715" style="position:absolute;left:268.493px;top:102.1px;">1,486</div><div id="a16719" style="position:absolute;left:355.373px;top:102.1px;">10</div><div id="a16723" style="position:absolute;left:425.32px;top:102.1px;">26</div><div id="a16727" style="position:absolute;left:478.6px;top:102.1px;">2,184</div><div id="a16731" style="position:absolute;left:548.52px;top:102.1px;">3,255</div><div id="a16735" style="position:absolute;left:635.44px;top:102.1px;">21</div><div id="a16739" style="position:absolute;left:705.36px;top:102.1px;">52</div><div id="a16741" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:119px;">Expected return on plan assets </div><div id="a16744" style="position:absolute;left:193.733px;top:119px;">(2,093)</div><div id="a16748" style="position:absolute;left:263.693px;top:119px;">(1,761)</div><div id="a16752" style="position:absolute;left:355.373px;top:119px;">—</div><div id="a16756" style="position:absolute;left:425.32px;top:119px;">—</div><div id="a16760" style="position:absolute;left:473.8px;top:119px;">(4,175)</div><div id="a16764" style="position:absolute;left:543.72px;top:119px;">(3,720)</div><div id="a16768" style="position:absolute;left:635.44px;top:119px;">—</div><div id="a16772" style="position:absolute;left:705.36px;top:119px;">—</div><div id="a16774" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:136px;">Settlement charge </div><div id="a16777" style="position:absolute;left:215.373px;top:136px;">—</div><div id="a16781" style="position:absolute;left:285.293px;top:136px;">—</div><div id="a16785" style="position:absolute;left:355.373px;top:136px;">—</div><div id="a16789" style="position:absolute;left:425.32px;top:136px;">—</div><div id="a16793" style="position:absolute;left:495.4px;top:136px;">—</div><div id="a16797" style="position:absolute;left:541.96px;top:136px;">22,667</div><div id="a16801" style="position:absolute;left:635.44px;top:136px;">—</div><div id="a16805" style="position:absolute;left:705.36px;top:136px;">—</div><div id="a16807" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153px;">Actuarial loss amortization </div><div id="a16810" style="position:absolute;left:208.613px;top:153px;">857</div><div id="a16814" style="position:absolute;left:278.573px;top:153px;">615</div><div id="a16818" style="position:absolute;left:355.373px;top:153px;">—</div><div id="a16822" style="position:absolute;left:425.32px;top:153px;">16</div><div id="a16826" style="position:absolute;left:478.6px;top:153px;">1,712</div><div id="a16830" style="position:absolute;left:548.52px;top:153px;">1,662</div><div id="a16834" style="position:absolute;left:635.44px;top:153px;">—</div><div id="a16838" style="position:absolute;left:705.36px;top:153px;">31</div><div id="a16840" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:170.1px;">Prior service cost amortization </div><div id="a16843" style="position:absolute;left:221.933px;top:170.1px;">3</div><div id="a16847" style="position:absolute;left:280.333px;top:170.1px;">(41)</div><div id="a16851" style="position:absolute;left:355.373px;top:170.1px;">—</div><div id="a16855" style="position:absolute;left:425.32px;top:170.1px;">—</div><div id="a16859" style="position:absolute;left:501.96px;top:170.1px;">5</div><div id="a16863" style="position:absolute;left:560.36px;top:170.1px;">(81)</div><div id="a16867" style="position:absolute;left:635.44px;top:170.1px;">—</div><div id="a16871" style="position:absolute;left:705.36px;top:170.1px;">—</div><div id="a16873" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:188.7px;">Net periodic benefit cost </div><div id="a16875" style="position:absolute;font-weight:normal;font-style:normal;left:174.373px;top:188.7px;">$ </div><div id="a16877" style="position:absolute;left:208.613px;top:188.7px;">177</div><div id="a16880" style="position:absolute;font-weight:normal;font-style:normal;left:244.493px;top:188.7px;">$ </div><div id="a16882" style="position:absolute;left:268.493px;top:188.7px;">1,463</div><div id="a16885" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:188.7px;">$ </div><div id="a16887" style="position:absolute;left:355.373px;top:188.7px;">12</div><div id="a16890" style="position:absolute;font-weight:normal;font-style:normal;left:384.493px;top:188.7px;">$ </div><div id="a16892" style="position:absolute;left:425.32px;top:188.7px;">43</div><div id="a16895" style="position:absolute;font-weight:normal;font-style:normal;left:454.44px;top:188.7px;">$ </div><div id="a16897" style="position:absolute;left:488.68px;top:188.7px;">358</div><div id="a16900" style="position:absolute;font-weight:normal;font-style:normal;left:524.52px;top:188.7px;">$ </div><div id="a16902" style="position:absolute;left:541.96px;top:188.7px;">26,121</div><div id="a16905" style="position:absolute;font-weight:normal;font-style:normal;left:594.48px;top:188.7px;">$ </div><div id="a16907" style="position:absolute;left:635.44px;top:188.7px;">24</div><div id="a16910" style="position:absolute;font-weight:normal;font-style:normal;left:664.56px;top:188.7px;">$ </div><div id="a16912" style="position:absolute;left:705.36px;top:188.7px;">86</div></div><div id="TextBlockContainer122" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:154px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a16914" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">As disclosed in the Company’s<div style="display:inline-block;width:4.79px"> </div>2020 Form 10-K, in the fourth quarter of 2018, the<div style="display:inline-block;width:4.7px"> </div>Company began the process of terminating its </div><div id="a16960" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">legacy Quaker non-contributory U.S. pension plan<div style="display:inline-block;width:4.59px"> </div>(“Legacy Quaker U.S. Pension Plan”).<div style="display:inline-block;width:7.51px"> </div>During the third quarter of 2019, the </div><div id="a17001" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Company received a favorable termination determination<div style="display:inline-block;width:4.81px"> </div>letter from the Internal Revenue Service (“I.R.S.”) and completed the </div><div id="a17033" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">Legacy Quaker U.S. Pension Plan termination during the<div style="display:inline-block;width:4.79px"> </div>first quarter of 2020.<div style="display:inline-block;width:7.09px"> </div>In order to terminate the Legacy Quaker U.S. Pension </div><div id="a17075" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">Plan in accordance with I.R.S. and Pension Benefit Guaranty Corporation<div style="display:inline-block;width:5.06px"> </div>requirements, the Company was required to fully fund the </div><div id="a17113" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.6px;">Legacy Quaker U.S. Pension Plan on a termination basis<div style="display:inline-block;width:4.71px"> </div>and the amount necessary to do so was approximately $</div><div id="a17113_108_3" style="position:absolute;left:607.44px;top:76.6px;">1.8</div><div id="a17113_111_21" style="position:absolute;font-weight:normal;font-style:normal;left:624.24px;top:76.6px;"><div style="display:inline-block;width:3.36px"> </div>million, subject to </div><div id="a17159" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92px;">final true up adjustments,<div style="display:inline-block;width:4.08px"> </div>which were completed in the third quarter of 2020.<div style="display:inline-block;width:7.84px"> </div>In addition, the Company recorded a non-cash pension </div><div id="a17206" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:107.4px;">settlement charge at plan termination of<div style="display:inline-block;width:4.69px"> </div>approximately $</div><div id="a17206_56_4" style="position:absolute;left:307.053px;top:107.4px;">22.7</div><div id="a17206_60_74" style="position:absolute;font-weight:normal;font-style:normal;left:330.413px;top:107.4px;"><div style="display:inline-block;width:3.36px"> </div>million.<div style="display:inline-block;width:6.95px"> </div>This settlement charge included the immediate recognition<div style="display:inline-block;width:4.97px"> </div>into </div><div id="a17242" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:122.7px;">expense of the related unrecognized losses within accumulated<div style="display:inline-block;width:4.91px"> </div>other comprehensive (loss) income (“AOCI”) on the balance<div style="display:inline-block;width:4.77px"> </div>sheet as </div><div id="a17279" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:138.1px;">of the plan termination date.</div></div><div id="TextBlockContainer124" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:725px;height:83px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17291" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Employer Contributions </div><div id="a17295" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:20.6px;">As of June 30, 2021, $</div><div id="a17295_22_3" style="position:absolute;left:148.933px;top:20.6px;">2.1</div><div id="a17295_25_14" style="position:absolute;font-weight:normal;font-style:normal;left:165.573px;top:20.6px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a17295_39_3" style="position:absolute;left:240.173px;top:20.6px;">0.1</div><div id="a17295_42_83" style="position:absolute;font-weight:normal;font-style:normal;left:256.813px;top:20.6px;"><div style="display:inline-block;width:3.36px"> </div>million of contributions have been made to the Company’s<div style="display:inline-block;width:5.48px"> </div>U.S. and foreign pension </div><div id="a17340" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:36px;">plans and its other postretirement benefit plans, respectively<div style="display:inline-block;width:1.5px"> </div>.<div style="display:inline-block;width:6.6px"> </div>Taking into consideration<div style="display:inline-block;width:4.98px"> </div>current minimum cash contribution </div><div id="a17372" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.2px;">requirements, the Company currently expects to make<div style="display:inline-block;width:4.64px"> </div>full year cash contributions of approximately $</div><div id="a17372_99_1" style="position:absolute;left:546.759px;top:51.2px;">6</div><div id="a17372_100_33" style="position:absolute;font-weight:normal;font-style:normal;left:553.48px;top:51.2px;"><div style="display:inline-block;width:3.2px"> </div>million to its U.S. and foreign </div><div id="a17412" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.6px;">pension plans and less than $</div><div id="a17412_29_1" style="position:absolute;left:159.813px;top:66.6px;">1</div><div id="a17412_30_58" style="position:absolute;font-weight:normal;font-style:normal;left:166.373px;top:66.6px;"><div style="display:inline-block;width:3.36px"> </div>million to its other postretirement benefit plans in 2021</div></div> <div id="TextBlockContainer120" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:727px;height:204px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_118_XBRL_TS_538c7687e35a42a7ae9d6c4ac3774b02" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer119" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:727px;height:204px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a16578" style="position:absolute;font-weight:bold;font-style:normal;left:222.253px;top:0px;">Three Months Ended June 30,<div style="display:inline-block;width:4.23px"> </div></div><div id="a16581" style="position:absolute;font-weight:bold;font-style:normal;left:510.44px;top:0px;">Six Months Ended June 30,<div style="display:inline-block;width:4.05px"> </div></div><div id="a16591" style="position:absolute;font-weight:bold;font-style:normal;left:361.453px;top:17px;">Other </div><div id="a16600" style="position:absolute;font-weight:bold;font-style:normal;left:641.52px;top:17px;">Other </div><div id="a16610" style="position:absolute;font-weight:bold;font-style:normal;left:335.853px;top:34.1px;">Postretirement </div><div id="a16619" style="position:absolute;font-weight:bold;font-style:normal;left:615.92px;top:34.1px;">Postretirement </div><div id="a16623" style="position:absolute;font-weight:bold;font-style:normal;left:191.493px;top:51px;">Pension Benefits </div><div id="a16626" style="position:absolute;font-weight:bold;font-style:normal;left:355.533px;top:51px;">Benefits </div><div id="a16629" style="position:absolute;font-weight:bold;font-style:normal;left:471.56px;top:51px;">Pension Benefits </div><div id="a16632" style="position:absolute;font-weight:bold;font-style:normal;left:635.6px;top:51px;">Benefits </div><div id="a16637" style="position:absolute;font-weight:bold;font-style:normal;left:195.173px;top:68px;">2021 </div><div id="a16641" style="position:absolute;font-weight:bold;font-style:normal;left:265.133px;top:68px;">2020 </div><div id="a16645" style="position:absolute;font-weight:bold;font-style:normal;left:335.213px;top:68px;">2021 </div><div id="a16649" style="position:absolute;font-weight:bold;font-style:normal;left:405.16px;top:68px;">2020 </div><div id="a16653" style="position:absolute;font-weight:bold;font-style:normal;left:475.24px;top:68px;">2021 </div><div id="a16657" style="position:absolute;font-weight:bold;font-style:normal;left:545.16px;top:68px;">2020 </div><div id="a16661" style="position:absolute;font-weight:bold;font-style:normal;left:615.28px;top:68px;">2021 </div><div id="a16665" style="position:absolute;font-weight:bold;font-style:normal;left:685.2px;top:68px;">2020 </div><div id="a16667" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:85px;">Service cost </div><div id="a16669" style="position:absolute;font-weight:normal;font-style:normal;left:174.373px;top:85px;">$ </div><div id="a16671" style="position:absolute;left:208.613px;top:85px;">316</div><div id="a16674" style="position:absolute;font-weight:normal;font-style:normal;left:244.493px;top:85px;">$ </div><div id="a16676" style="position:absolute;left:268.493px;top:85px;">1,164</div><div id="a16679" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:85px;">$ </div><div id="a16681" style="position:absolute;left:361.933px;top:85px;">2</div><div id="a16684" style="position:absolute;font-weight:normal;font-style:normal;left:384.493px;top:85px;">$ </div><div id="a16686" style="position:absolute;left:431.88px;top:85px;">1</div><div id="a16689" style="position:absolute;font-weight:normal;font-style:normal;left:454.44px;top:85px;">$ </div><div id="a16691" style="position:absolute;left:488.68px;top:85px;">632</div><div id="a16694" style="position:absolute;font-weight:normal;font-style:normal;left:524.52px;top:85px;">$ </div><div id="a16696" style="position:absolute;left:548.52px;top:85px;">2,338</div><div id="a16699" style="position:absolute;font-weight:normal;font-style:normal;left:594.48px;top:85px;">$ </div><div id="a16701" style="position:absolute;left:642px;top:85px;">3</div><div id="a16704" style="position:absolute;font-weight:normal;font-style:normal;left:664.56px;top:85px;">$ </div><div id="a16706" style="position:absolute;left:711.92px;top:85px;">3</div><div id="a16708" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:102.1px;">Interest cost </div><div id="a16711" style="position:absolute;left:198.533px;top:102.1px;">1,094</div><div id="a16715" style="position:absolute;left:268.493px;top:102.1px;">1,486</div><div id="a16719" style="position:absolute;left:355.373px;top:102.1px;">10</div><div id="a16723" style="position:absolute;left:425.32px;top:102.1px;">26</div><div id="a16727" style="position:absolute;left:478.6px;top:102.1px;">2,184</div><div id="a16731" style="position:absolute;left:548.52px;top:102.1px;">3,255</div><div id="a16735" style="position:absolute;left:635.44px;top:102.1px;">21</div><div id="a16739" style="position:absolute;left:705.36px;top:102.1px;">52</div><div id="a16741" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:119px;">Expected return on plan assets </div><div id="a16744" style="position:absolute;left:193.733px;top:119px;">(2,093)</div><div id="a16748" style="position:absolute;left:263.693px;top:119px;">(1,761)</div><div id="a16752" style="position:absolute;left:355.373px;top:119px;">—</div><div id="a16756" style="position:absolute;left:425.32px;top:119px;">—</div><div id="a16760" style="position:absolute;left:473.8px;top:119px;">(4,175)</div><div id="a16764" style="position:absolute;left:543.72px;top:119px;">(3,720)</div><div id="a16768" style="position:absolute;left:635.44px;top:119px;">—</div><div id="a16772" style="position:absolute;left:705.36px;top:119px;">—</div><div id="a16774" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:136px;">Settlement charge </div><div id="a16777" style="position:absolute;left:215.373px;top:136px;">—</div><div id="a16781" style="position:absolute;left:285.293px;top:136px;">—</div><div id="a16785" style="position:absolute;left:355.373px;top:136px;">—</div><div id="a16789" style="position:absolute;left:425.32px;top:136px;">—</div><div id="a16793" style="position:absolute;left:495.4px;top:136px;">—</div><div id="a16797" style="position:absolute;left:541.96px;top:136px;">22,667</div><div id="a16801" style="position:absolute;left:635.44px;top:136px;">—</div><div id="a16805" style="position:absolute;left:705.36px;top:136px;">—</div><div id="a16807" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153px;">Actuarial loss amortization </div><div id="a16810" style="position:absolute;left:208.613px;top:153px;">857</div><div id="a16814" style="position:absolute;left:278.573px;top:153px;">615</div><div id="a16818" style="position:absolute;left:355.373px;top:153px;">—</div><div id="a16822" style="position:absolute;left:425.32px;top:153px;">16</div><div id="a16826" style="position:absolute;left:478.6px;top:153px;">1,712</div><div id="a16830" style="position:absolute;left:548.52px;top:153px;">1,662</div><div id="a16834" style="position:absolute;left:635.44px;top:153px;">—</div><div id="a16838" style="position:absolute;left:705.36px;top:153px;">31</div><div id="a16840" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:170.1px;">Prior service cost amortization </div><div id="a16843" style="position:absolute;left:221.933px;top:170.1px;">3</div><div id="a16847" style="position:absolute;left:280.333px;top:170.1px;">(41)</div><div id="a16851" style="position:absolute;left:355.373px;top:170.1px;">—</div><div id="a16855" style="position:absolute;left:425.32px;top:170.1px;">—</div><div id="a16859" style="position:absolute;left:501.96px;top:170.1px;">5</div><div id="a16863" style="position:absolute;left:560.36px;top:170.1px;">(81)</div><div id="a16867" style="position:absolute;left:635.44px;top:170.1px;">—</div><div id="a16871" style="position:absolute;left:705.36px;top:170.1px;">—</div><div id="a16873" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:188.7px;">Net periodic benefit cost </div><div id="a16875" style="position:absolute;font-weight:normal;font-style:normal;left:174.373px;top:188.7px;">$ </div><div id="a16877" style="position:absolute;left:208.613px;top:188.7px;">177</div><div id="a16880" style="position:absolute;font-weight:normal;font-style:normal;left:244.493px;top:188.7px;">$ </div><div id="a16882" style="position:absolute;left:268.493px;top:188.7px;">1,463</div><div id="a16885" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:188.7px;">$ </div><div id="a16887" style="position:absolute;left:355.373px;top:188.7px;">12</div><div id="a16890" style="position:absolute;font-weight:normal;font-style:normal;left:384.493px;top:188.7px;">$ </div><div id="a16892" style="position:absolute;left:425.32px;top:188.7px;">43</div><div id="a16895" style="position:absolute;font-weight:normal;font-style:normal;left:454.44px;top:188.7px;">$ </div><div id="a16897" style="position:absolute;left:488.68px;top:188.7px;">358</div><div id="a16900" style="position:absolute;font-weight:normal;font-style:normal;left:524.52px;top:188.7px;">$ </div><div id="a16902" style="position:absolute;left:541.96px;top:188.7px;">26,121</div><div id="a16905" style="position:absolute;font-weight:normal;font-style:normal;left:594.48px;top:188.7px;">$ </div><div id="a16907" style="position:absolute;left:635.44px;top:188.7px;">24</div><div id="a16910" style="position:absolute;font-weight:normal;font-style:normal;left:664.56px;top:188.7px;">$ </div><div id="a16912" style="position:absolute;left:705.36px;top:188.7px;">86</div></div></div></div> 316000 1164000 2000 1000 632000 2338000 3000 3000 1094000 1486000 10000 26000 2184000 3255000 21000 52000 2093000 1761000 0 0 4175000 3720000 0 0 0 0 0 0 0 -22667000 0 0 -857000 -615000 0 -16000 -1712000 -1662000 0 -31000 3000 -41000 0 0 5000 -81000 0 0 177000 1463000 12000 43000 358000 26121000 24000 86000 1800000 22700000 2100000 100000 6000000 1000000 <div id="TextBlockContainer126" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:694px;height:36px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17443" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 10 – Other Income (Expense), Net</div><div id="a17456" style="position:absolute;font-weight:normal;font-style:normal;left:227.053px;top:0px;"> </div><div id="a17457" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:20.6px;">The components of other income (expense), net, for<div style="display:inline-block;width:4.76px"> </div>the three and six months ended June 30, 2021 and 2020 are as follows:</div></div><div id="TextBlockContainer130" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:210px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_128_XBRL_TS_0140e58fa29b426da51e6803a5fe8267" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer129" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:210px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17503" style="position:absolute;font-weight:bold;font-style:normal;left:388.013px;top:0px;">Three Months Ended </div><div id="a17506" style="position:absolute;font-weight:bold;font-style:normal;left:583.12px;top:0px;">Six Months Ended </div><div id="a17510" style="position:absolute;font-weight:bold;font-style:normal;left:425px;top:17.6px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a17513" style="position:absolute;font-weight:bold;font-style:normal;left:612.08px;top:17.6px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a17517" style="position:absolute;font-weight:bold;font-style:normal;left:387.853px;top:35.2px;">2021 </div><div id="a17520" style="position:absolute;font-weight:bold;font-style:normal;left:482.92px;top:35.2px;">2020 </div><div id="a17523" style="position:absolute;font-weight:bold;font-style:normal;left:575.92px;top:35.2px;">2021 </div><div id="a17526" style="position:absolute;font-weight:bold;font-style:normal;left:668.88px;top:35.2px;">2020 </div><div id="a17528" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:52.8px;">Income from third party license fees </div><div id="a17530" style="position:absolute;font-weight:normal;font-style:normal;left:361.453px;top:52.8px;">$ </div><div id="a17532" style="position:absolute;left:417px;top:52.8px;">373</div><div id="a17535" style="position:absolute;font-weight:normal;font-style:normal;left:456.52px;top:52.8px;">$ </div><div id="a17537" style="position:absolute;left:512.04px;top:52.8px;">208</div><div id="a17540" style="position:absolute;font-weight:normal;font-style:normal;left:549.48px;top:52.8px;">$ </div><div id="a17542" style="position:absolute;left:605.04px;top:52.8px;">712</div><div id="a17545" style="position:absolute;font-weight:normal;font-style:normal;left:642.48px;top:52.8px;">$ </div><div id="a17547" style="position:absolute;left:698.16px;top:52.8px;">512</div><div id="a17549" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:70.4px;">Foreign exchange losses, net </div><div id="a17552" style="position:absolute;left:412.04px;top:70.4px;">(838)</div><div id="a17556" style="position:absolute;left:497.16px;top:70.4px;">(2,004)</div><div id="a17560" style="position:absolute;left:590.16px;top:70.4px;">(2,316)</div><div id="a17564" style="position:absolute;left:683.28px;top:70.4px;">(1,183)</div><div id="a17566" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:89.6px;">Gain (loss) on disposals of property,<div style="display:inline-block;width:5.22px"> </div>plant, equipment and other </div><div id="a17581" style="position:absolute;font-weight:normal;font-style:normal;left:13.387px;top:106.6px;">assets, net </div><div id="a17584" style="position:absolute;left:418.76px;top:106.6px;">(54)</div><div id="a17588" style="position:absolute;left:513.8px;top:106.6px;">(83)</div><div id="a17592" style="position:absolute;left:594.96px;top:106.6px;">5,356</div><div id="a17596" style="position:absolute;left:699.92px;top:106.6px;">(81)</div><div id="a17598" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:124.2px;">Non-income tax refunds and other related credits </div><div id="a17604" style="position:absolute;left:400.36px;top:124.2px;">14,295</div><div id="a17608" style="position:absolute;left:512.04px;top:124.2px;">832</div><div id="a17612" style="position:absolute;left:588.4px;top:124.2px;">14,392</div><div id="a17616" style="position:absolute;left:688.08px;top:124.2px;">2,131</div><div id="a17618" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:141.8px;">Pension and postretirement benefit income (costs),<div style="display:inline-block;width:4.61px"> </div></div><div id="a17631" style="position:absolute;font-weight:normal;font-style:normal;left:13.387px;top:159.4px;">non-service components </div><div id="a17636" style="position:absolute;left:417px;top:159.4px;">129</div><div id="a17640" style="position:absolute;left:507.08px;top:159.4px;">(341)</div><div id="a17644" style="position:absolute;left:605.04px;top:159.4px;">253</div><div id="a17648" style="position:absolute;left:676.56px;top:159.4px;">(23,866)</div><div id="a17650" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:177px;">Other non-operating income, net </div><div id="a17655" style="position:absolute;left:417px;top:177px;">105</div><div id="a17659" style="position:absolute;left:512.04px;top:177px;">395</div><div id="a17663" style="position:absolute;left:605.04px;top:177px;">300</div><div id="a17667" style="position:absolute;left:698.16px;top:177px;">319</div><div id="a17669" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:194px;">Total other<div style="display:inline-block;width:4.7px"> </div>income (expense), net </div><div id="a17672" style="position:absolute;font-weight:normal;font-style:normal;left:361.453px;top:194px;">$ </div><div id="a17674" style="position:absolute;left:400.36px;top:194px;">14,010</div><div id="a17677" style="position:absolute;font-weight:normal;font-style:normal;left:456.52px;top:194px;">$ </div><div id="a17679" style="position:absolute;left:507.08px;top:194px;">(993)</div><div id="a17682" style="position:absolute;font-weight:normal;font-style:normal;left:549.48px;top:194px;">$ </div><div id="a17684" style="position:absolute;left:588.4px;top:194px;">18,697</div><div id="a17687" style="position:absolute;font-weight:normal;font-style:normal;left:642.48px;top:194px;">$ </div><div id="a17689" style="position:absolute;left:676.56px;top:194px;">(22,168)</div></div></div></div><div id="TextBlockContainer132" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:723px;height:108px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17691" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Gain (loss) on disposals of property,<div style="display:inline-block;width:5.29px"> </div>plant, equipment and other assets, net, during the six months<div style="display:inline-block;width:4.85px"> </div>ended June 30, 2021, </div><div id="a17734" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">includes the gain on the sale of certain held-for-sale<div style="display:inline-block;width:4.77px"> </div>real property assets related to the Combination.<div style="display:inline-block;width:7.77px"> </div>Non-income tax refunds and </div><div id="a17780" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">other related credits during the three and six months ended<div style="display:inline-block;width:4.93px"> </div>June 30, 2021 includes $</div><div id="a17780_84_4" style="position:absolute;left:453.16px;top:30.7px;">13.3</div><div id="a17780_88_43" style="position:absolute;font-weight:normal;font-style:normal;left:476.52px;top:30.7px;"><div style="display:inline-block;width:3.2px"> </div>million related to certain non-income tax </div><div id="a17826" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">credits for the Company’s<div style="display:inline-block;width:4.7px"> </div>Brazilian subsidiaries described in Note 19 of Notes<div style="display:inline-block;width:4.7px"> </div>to Condensed Consolidated Financial Statements.<div style="display:inline-block;width:4.32px"> </div></div><div id="a17862" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.4px;">Pension and postretirement benefit costs, non-service components<div style="display:inline-block;width:4.86px"> </div>during the six months ended June 30, 2020 includes<div style="display:inline-block;width:4.7px"> </div>$</div><div id="a17862_117_4" style="position:absolute;left:646.8px;top:61.4px;">22.7</div><div id="a17862_121_9" style="position:absolute;font-weight:normal;font-style:normal;left:670.16px;top:61.4px;"><div style="display:inline-block;width:3.36px"> </div>million </div><div id="a17902" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.8px;">related to the Legacy Quaker U.S. Pension Plan non<div style="display:inline-block;width:1.39px"> </div>-cash settlement charge described in Note 9 of Notes to<div style="display:inline-block;width:4.8px"> </div>Condensed Consolidated </div><div id="a17946" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92.2px;">Financial Statements.</div></div> <div id="TextBlockContainer129" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:210px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17503" style="position:absolute;font-weight:bold;font-style:normal;left:388.013px;top:0px;">Three Months Ended </div><div id="a17506" style="position:absolute;font-weight:bold;font-style:normal;left:583.12px;top:0px;">Six Months Ended </div><div id="a17510" style="position:absolute;font-weight:bold;font-style:normal;left:425px;top:17.6px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a17513" style="position:absolute;font-weight:bold;font-style:normal;left:612.08px;top:17.6px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a17517" style="position:absolute;font-weight:bold;font-style:normal;left:387.853px;top:35.2px;">2021 </div><div id="a17520" style="position:absolute;font-weight:bold;font-style:normal;left:482.92px;top:35.2px;">2020 </div><div id="a17523" style="position:absolute;font-weight:bold;font-style:normal;left:575.92px;top:35.2px;">2021 </div><div id="a17526" style="position:absolute;font-weight:bold;font-style:normal;left:668.88px;top:35.2px;">2020 </div><div id="a17528" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:52.8px;">Income from third party license fees </div><div id="a17530" style="position:absolute;font-weight:normal;font-style:normal;left:361.453px;top:52.8px;">$ </div><div id="a17532" style="position:absolute;left:417px;top:52.8px;">373</div><div id="a17535" style="position:absolute;font-weight:normal;font-style:normal;left:456.52px;top:52.8px;">$ </div><div id="a17537" style="position:absolute;left:512.04px;top:52.8px;">208</div><div id="a17540" style="position:absolute;font-weight:normal;font-style:normal;left:549.48px;top:52.8px;">$ </div><div id="a17542" style="position:absolute;left:605.04px;top:52.8px;">712</div><div id="a17545" style="position:absolute;font-weight:normal;font-style:normal;left:642.48px;top:52.8px;">$ </div><div id="a17547" style="position:absolute;left:698.16px;top:52.8px;">512</div><div id="a17549" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:70.4px;">Foreign exchange losses, net </div><div id="a17552" style="position:absolute;left:412.04px;top:70.4px;">(838)</div><div id="a17556" style="position:absolute;left:497.16px;top:70.4px;">(2,004)</div><div id="a17560" style="position:absolute;left:590.16px;top:70.4px;">(2,316)</div><div id="a17564" style="position:absolute;left:683.28px;top:70.4px;">(1,183)</div><div id="a17566" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:89.6px;">Gain (loss) on disposals of property,<div style="display:inline-block;width:5.22px"> </div>plant, equipment and other </div><div id="a17581" style="position:absolute;font-weight:normal;font-style:normal;left:13.387px;top:106.6px;">assets, net </div><div id="a17584" style="position:absolute;left:418.76px;top:106.6px;">(54)</div><div id="a17588" style="position:absolute;left:513.8px;top:106.6px;">(83)</div><div id="a17592" style="position:absolute;left:594.96px;top:106.6px;">5,356</div><div id="a17596" style="position:absolute;left:699.92px;top:106.6px;">(81)</div><div id="a17598" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:124.2px;">Non-income tax refunds and other related credits </div><div id="a17604" style="position:absolute;left:400.36px;top:124.2px;">14,295</div><div id="a17608" style="position:absolute;left:512.04px;top:124.2px;">832</div><div id="a17612" style="position:absolute;left:588.4px;top:124.2px;">14,392</div><div id="a17616" style="position:absolute;left:688.08px;top:124.2px;">2,131</div><div id="a17618" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:141.8px;">Pension and postretirement benefit income (costs),<div style="display:inline-block;width:4.61px"> </div></div><div id="a17631" style="position:absolute;font-weight:normal;font-style:normal;left:13.387px;top:159.4px;">non-service components </div><div id="a17636" style="position:absolute;left:417px;top:159.4px;">129</div><div id="a17640" style="position:absolute;left:507.08px;top:159.4px;">(341)</div><div id="a17644" style="position:absolute;left:605.04px;top:159.4px;">253</div><div id="a17648" style="position:absolute;left:676.56px;top:159.4px;">(23,866)</div><div id="a17650" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:177px;">Other non-operating income, net </div><div id="a17655" style="position:absolute;left:417px;top:177px;">105</div><div id="a17659" style="position:absolute;left:512.04px;top:177px;">395</div><div id="a17663" style="position:absolute;left:605.04px;top:177px;">300</div><div id="a17667" style="position:absolute;left:698.16px;top:177px;">319</div><div id="a17669" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:194px;">Total other<div style="display:inline-block;width:4.7px"> </div>income (expense), net </div><div id="a17672" style="position:absolute;font-weight:normal;font-style:normal;left:361.453px;top:194px;">$ </div><div id="a17674" style="position:absolute;left:400.36px;top:194px;">14,010</div><div id="a17677" style="position:absolute;font-weight:normal;font-style:normal;left:456.52px;top:194px;">$ </div><div id="a17679" style="position:absolute;left:507.08px;top:194px;">(993)</div><div id="a17682" style="position:absolute;font-weight:normal;font-style:normal;left:549.48px;top:194px;">$ </div><div id="a17684" style="position:absolute;left:588.4px;top:194px;">18,697</div><div id="a17687" style="position:absolute;font-weight:normal;font-style:normal;left:642.48px;top:194px;">$ </div><div id="a17689" style="position:absolute;left:676.56px;top:194px;">(22,168)</div></div> 373000 208000 712000 512000 -838000 -2004000 -2316000 -1183000 -54000 -83000 5356000 -81000 14295000 832000 14392000 2131000 129000 -341000 253000 -23866000 105000 395000 300000 319000 14010000 -993000 18697000 -22168000 13300000 22700000 <div id="TextBlockContainer134" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:864px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17999" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 11 – Income Taxes<div style="display:inline-block;width:6.03px"> </div>and Uncertain Income Tax<div style="display:inline-block;width:5.07px"> </div>Positions </div><div id="a18019" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The Company’s effective<div style="display:inline-block;width:5.08px"> </div>tax rates for the three and six months ended June 30, 2021 were<div style="display:inline-block;width:4.77px"> </div>an expense of </div><div id="a18019_102_4" style="position:absolute;left:587.119px;top:23.4px;">32.2</div><div id="a18019_106_6" style="position:absolute;font-weight:normal;font-style:normal;left:610.479px;top:23.4px;">% and </div><div id="a18019_112_4" style="position:absolute;left:647.439px;top:23.4px;">28.4</div><div id="a18019_116_3" style="position:absolute;font-weight:normal;font-style:normal;left:670.639px;top:23.4px;">%, </div><div id="a18063" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">respectively, compared<div style="display:inline-block;width:4.94px"> </div>to an expense of </div><div id="a18063_40_4" style="position:absolute;left:221.933px;top:38.7px;">57.9</div><div id="a18063_44_19" style="position:absolute;font-weight:normal;font-style:normal;left:245.293px;top:38.7px;">% and a benefit of </div><div id="a18063_63_4" style="position:absolute;left:346.413px;top:38.7px;">20.7</div><div id="a18063_67_67" style="position:absolute;font-weight:normal;font-style:normal;left:369.773px;top:38.7px;">% for the three and six months ended June 30, 2020, respectively.<div style="display:inline-block;width:5.71px"> </div></div><div id="a18111" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.9px;">The Company’s current<div style="display:inline-block;width:4.72px"> </div>year effective tax rates were largely<div style="display:inline-block;width:4.58px"> </div>impacted by the sale of certain held-for-sale real<div style="display:inline-block;width:4.78px"> </div>property assets related to </div><div id="a18158" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">the Combination,<div style="display:inline-block;width:3.97px"> </div>changes in foreign tax credit valuation allowances, tax law changes<div style="display:inline-block;width:4.78px"> </div>in a foreign jurisdiction and the income tax </div><div id="a18200" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">impacts of certain non-income tax credits recorded<div style="display:inline-block;width:4.55px"> </div>by the Company’s Brazilian<div style="display:inline-block;width:4.83px"> </div>subsidiaries described in Note 19 of Notes to </div><div id="a18240" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">Condensed Consolidated Financial Statements.<div style="display:inline-block;width:7.76px"> </div>Comparatively, the prior<div style="display:inline-block;width:4.85px"> </div>year effective tax rates were impacted by the<div style="display:inline-block;width:4.72px"> </div>tax effect of </div><div id="a18277" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">certain one-time pre-tax losses as well as certain tax charges<div style="display:inline-block;width:5px"> </div>and benefits in the prior year period including those related<div style="display:inline-block;width:4.87px"> </div>to changes in </div><div id="a18327" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.7px;">foreign tax credit valuation allowances, tax law changes in<div style="display:inline-block;width:4.79px"> </div>a foreign jurisdiction, changes in uncertain tax positions and<div style="display:inline-block;width:4.7px"> </div>the tax </div><div id="a18368" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:146.1px;">impacts of the Company’s<div style="display:inline-block;width:4.82px"> </div>termination of its Legacy Quaker U.S. Pension Plan. </div><div id="a18392" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:166.7px;">As of December 31, 2020, the Company had a deferred<div style="display:inline-block;width:4.72px"> </div>tax liability of $</div><div id="a18392_70_3" style="position:absolute;left:412.519px;top:166.7px;">5.9</div><div id="a18392_73_51" style="position:absolute;font-weight:normal;font-style:normal;left:429.319px;top:166.7px;"><div style="display:inline-block;width:3.36px"> </div>million, which primarily represents the Company’s </div><div id="a18432" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:181.9px;">estimate of non-U.S. taxes it will incur to repatriate<div style="display:inline-block;width:4.77px"> </div>certain foreign earnings to the U.S.<div style="display:inline-block;width:7.4px"> </div>The balance as of June 30, 2021 was $</div><div id="a18432_130_3" style="position:absolute;left:681.199px;top:181.9px;">6.5</div><div id="a18432_133_1" style="position:absolute;font-weight:normal;font-style:normal;left:697.999px;top:181.9px;"> </div><div id="a18484" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:197.3px;">million.<div style="display:inline-block;width:3.46px"> </div></div><div id="a18487" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:218px;">As of June 30, 2021, the Company’s<div style="display:inline-block;width:5.02px"> </div>cumulative liability for gross unrecognized tax benefits was $</div><div id="a18487_97_4" style="position:absolute;left:555.24px;top:218px;">24.0</div><div id="a18487_101_25" style="position:absolute;font-weight:normal;font-style:normal;left:578.8px;top:218px;"><div style="display:inline-block;width:3.36px"> </div>million, an increase of </div><div id="a18529" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:233.3px;">$</div><div id="a18529_1_3" style="position:absolute;left:11.147px;top:233.3px;">1.8</div><div id="a18529_4_73" style="position:absolute;font-weight:normal;font-style:normal;left:27.946px;top:233.3px;"><div style="display:inline-block;width:3.36px"> </div>million from the cumulative liability accrued as of December 31, 2020.<div style="display:inline-block;width:4.61px"> </div></div><div id="a18557" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:254px;">The Company continues to recognize interest and penalties<div style="display:inline-block;width:4.8px"> </div>associated with uncertain tax positions as a component of<div style="display:inline-block;width:4.78px"> </div>taxes on </div><div id="a18595" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:269.3px;">income (loss) before equity in net income of associated<div style="display:inline-block;width:4.77px"> </div>companies in its Condensed Consolidated Statements of Operations.<div style="display:inline-block;width:8.18px"> </div>The </div><div id="a18631" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:284.7px;">Company recognized an expense for interest of approximately<div style="display:inline-block;width:4.81px"> </div>$</div><div id="a18631_61_3" style="position:absolute;left:346.733px;top:284.7px;">0.2</div><div id="a18631_64_14" style="position:absolute;font-weight:normal;font-style:normal;left:363.373px;top:284.7px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a18631_78_3" style="position:absolute;left:437.8px;top:284.7px;">0.2</div><div id="a18631_81_37" style="position:absolute;font-weight:normal;font-style:normal;left:454.6px;top:284.7px;"><div style="display:inline-block;width:3.36px"> </div>million and a benefit of less than $</div><div id="a18631_118_3" style="position:absolute;left:642.64px;top:284.7px;">0.1</div><div id="a18631_121_13" style="position:absolute;font-weight:normal;font-style:normal;left:659.28px;top:284.7px;"><div style="display:inline-block;width:3.36px"> </div>million and </div><div id="a18678" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:300px;">$</div><div id="a18678_1_3" style="position:absolute;left:11.147px;top:300px;">0.2</div><div id="a18678_4_127" style="position:absolute;font-weight:normal;font-style:normal;left:27.947px;top:300px;"><div style="display:inline-block;width:3.36px"> </div>million for penalties in its Condensed Consolidated Statement of<div style="display:inline-block;width:4.79px"> </div>Operations for the three and six months ended June 30, 2021, </div><div id="a18723" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:315.4px;">respectively, and recognized<div style="display:inline-block;width:5.03px"> </div>an expense of $</div><div id="a18723_44_3" style="position:absolute;left:243.373px;top:315.4px;">0.6</div><div id="a18723_47_14" style="position:absolute;font-weight:normal;font-style:normal;left:260.173px;top:315.4px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a18723_61_3" style="position:absolute;left:334.413px;top:315.4px;">0.6</div><div id="a18723_64_41" style="position:absolute;font-weight:normal;font-style:normal;left:351.213px;top:315.4px;"><div style="display:inline-block;width:3.36px"> </div>million for interest and an expense of $</div><div id="a18723_105_3" style="position:absolute;left:563.719px;top:315.4px;">0.6</div><div id="a18723_108_14" style="position:absolute;font-weight:normal;font-style:normal;left:580.559px;top:315.4px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a18723_122_3" style="position:absolute;left:654.799px;top:315.4px;">0.5</div><div id="a18723_125_9" style="position:absolute;font-weight:normal;font-style:normal;left:671.599px;top:315.4px;"><div style="display:inline-block;width:3.36px"> </div>million </div><div id="a18769" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:330.6px;">for penalties in its Condensed Consolidated Statement of<div style="display:inline-block;width:4.72px"> </div>Operations for the three and six months ended June 30, 2020<div style="display:inline-block;width:1.36px"> </div>,<div style="display:inline-block;width:3.4px"> </div>respectively.<div style="display:inline-block;width:3.56px"> </div></div><div id="a18811" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:346px;">As of June 30, 2021, the Company had accrued $</div><div id="a18811_46_3" style="position:absolute;left:267.053px;top:346px;">3.2</div><div id="a18811_49_38" style="position:absolute;font-weight:normal;font-style:normal;left:283.853px;top:346px;"><div style="display:inline-block;width:3.2px"> </div>million for cumulative interest and $</div><div id="a18811_87_3" style="position:absolute;left:482.279px;top:346px;">3.6</div><div id="a18811_90_41" style="position:absolute;font-weight:normal;font-style:normal;left:498.919px;top:346px;"><div style="display:inline-block;width:3.36px"> </div>million for cumulative penalties in its </div><div id="a18862" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:361.3px;">Condensed Consolidated Balance Sheets, compared<div style="display:inline-block;width:4.74px"> </div>to $</div><div id="a18862_52_3" style="position:absolute;left:304.973px;top:361.3px;">3.0</div><div id="a18862_55_38" style="position:absolute;font-weight:normal;font-style:normal;left:321.613px;top:361.3px;"><div style="display:inline-block;width:3.2px"> </div>million for cumulative interest and $</div><div id="a18862_93_3" style="position:absolute;left:520.04px;top:361.3px;">3.9</div><div id="a18862_96_34" style="position:absolute;font-weight:normal;font-style:normal;left:536.84px;top:361.3px;"><div style="display:inline-block;width:3.36px"> </div>million for cumulative penalties </div><div id="a18896" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:376.7px;">accrued at December 31, 2020.<div style="display:inline-block;width:7.48px"> </div>During the six months ended June 30, 2021 and 2020, the<div style="display:inline-block;width:4.65px"> </div>Company recognized decreases of $</div><div id="a18896_120_3" style="position:absolute;left:680.559px;top:376.7px;">0.8</div><div id="a18896_123_1" style="position:absolute;font-weight:normal;font-style:normal;left:697.199px;top:376.7px;"> </div><div id="a18942" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:392px;">million and $</div><div id="a18942_13_3" style="position:absolute;left:75.658px;top:392px;">1.5</div><div id="a18942_16_117" style="position:absolute;font-weight:normal;font-style:normal;left:92.293px;top:392px;"><div style="display:inline-block;width:3.36px"> </div>million, respectively,<div style="display:inline-block;width:4.7px"> </div>in its cumulative liability for gross unrecognized tax benefits<div style="display:inline-block;width:4.84px"> </div>due to the expiration of the </div><div id="a18985" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:407.4px;">applicable statutes of limitations for certain tax years. </div><div id="a19001" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:428px;">The Company estimates that during the year ending December<div style="display:inline-block;width:4.88px"> </div>31, 2021 it will reduce its cumulative liability for gross </div><div id="a19039" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:443.4px;">unrecognized tax benefits by approximately $</div><div id="a19039_44_3" style="position:absolute;left:248.653px;top:443.4px;">1.5</div><div id="a19039_47_88" style="position:absolute;font-weight:normal;font-style:normal;left:265.293px;top:443.4px;"><div style="display:inline-block;width:3.36px"> </div>million due to the expiration of the statute of limitations with regard<div style="display:inline-block;width:4.82px"> </div>to certain tax </div><div id="a19082" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:458.6px;">positions.<div style="display:inline-block;width:6.99px"> </div>This estimated reduction in the cumulative liability for unrecognized<div style="display:inline-block;width:4.89px"> </div>tax benefits does not consider any increase in liability </div><div id="a19120" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:474px;">for unrecognized tax benefits with regard to existing tax<div style="display:inline-block;width:4.66px"> </div>positions or any increase in cumulative liability for unrecognized<div style="display:inline-block;width:4.71px"> </div>tax benefits </div><div id="a19160" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:489.3px;">with regard to new tax positions for the year ending December<div style="display:inline-block;width:4.88px"> </div>31, 2021. </div><div id="a19186" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:510px;">The Company and its subsidiaries are subject to U.S. Federal income<div style="display:inline-block;width:5.02px"> </div>tax, as well as the income tax of various state and foreign </div><div id="a19232" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:525.3px;">tax jurisdictions.<div style="display:inline-block;width:7.18px"> </div>Tax years that remain<div style="display:inline-block;width:4.76px"> </div>subject to examination by major tax jurisdictions include Italy<div style="display:inline-block;width:4.56px"> </div>from </div><div id="a19232_111_4" style="position:absolute;left:582.96px;top:525.3px;">2006</div><div id="a19232_115_14" style="position:absolute;font-weight:normal;font-style:normal;left:609.68px;top:525.3px;">, Brazil from </div><div id="a19232_129_4" style="position:absolute;left:681.36px;top:525.3px;">2011</div><div id="a19232_133_2" style="position:absolute;font-weight:normal;font-style:normal;left:708.08px;top:525.3px;">, </div><div id="a19272" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:540.7px;">the Netherlands and China from </div><div id="a19272_31_4" style="position:absolute;left:178.853px;top:540.7px;">2015</div><div id="a19272_35_53" style="position:absolute;font-weight:normal;font-style:normal;left:205.573px;top:540.7px;">, Mexico, Spain, Germany and the United Kingdom from </div><div id="a19272_88_4" style="position:absolute;left:514.6px;top:540.7px;">2016</div><div id="a19272_92_27" style="position:absolute;font-weight:normal;font-style:normal;left:541.32px;top:540.7px;">, Canada and the U.S. from </div><div id="a19272_119_4" style="position:absolute;left:689.84px;top:540.7px;">2017</div><div id="a19272_123_2" style="position:absolute;font-weight:normal;font-style:normal;left:716.4px;top:540.7px;">, </div><div id="a19314" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:556.1px;">India from fiscal year beginning April 1, 2018 and ending<div style="display:inline-block;width:4.65px"> </div>March 31, </div><div id="a19314_68_4" style="position:absolute;left:374.893px;top:556.1px;">2019</div><div id="a19314_72_48" style="position:absolute;font-weight:normal;font-style:normal;left:401.613px;top:556.1px;">, and various U.S. state tax jurisdictions from </div><div id="a19314_120_4" style="position:absolute;left:646.32px;top:556.1px;">2011</div><div id="a19314_124_4" style="position:absolute;font-weight:normal;font-style:normal;left:673.04px;top:556.1px;">.<div style="display:inline-block;width:6.6px"> </div></div><div id="a19358" style="position:absolute;left:28.427px;top:576.7px;">As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia </div><div id="a19394" style="position:absolute;left:4.427px;top:592.1px;">S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under </div><div id="a19437" style="position:absolute;left:4.427px;top:607.3px;">the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except </div><div id="a19473" style="position:absolute;left:4.427px;top:622.6px;">2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP </div><div id="a19514" style="position:absolute;left:4.427px;top:638px;">proceedings which the Company has accepted.</div><div id="a19514_43_49" style="position:absolute;font-weight:normal;font-style:normal;left:254.093px;top:638px;"><div style="display:inline-block;width:6.72px"> </div>As of June 30, 2021, the Company has received $</div><div id="a19514_92_3" style="position:absolute;left:525.64px;top:638px;">1.6</div><div id="a19514_95_29" style="position:absolute;font-weight:normal;font-style:normal;left:542.28px;top:638px;"><div style="display:inline-block;width:3.36px"> </div>million in refunds from the </div><div id="a19559" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:653.3px;">Netherlands and Spain and expects to pay $</div><div id="a19559_42_3" style="position:absolute;left:237.453px;top:653.3px;">2.6</div><div id="a19559_45_84" style="position:absolute;font-weight:normal;font-style:normal;left:254.253px;top:653.3px;"><div style="display:inline-block;width:3.2px"> </div>million due to Italy in the second half of 2021.<div style="display:inline-block;width:7.96px"> </div>As of June 30, 2021, the Company </div><div id="a19613" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:668.7px;">believes it has adequate reserves for the remaining<div style="display:inline-block;width:4.64px"> </div>uncertain tax positions related to 2007. </div><div id="a19641" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:689.4px;">Houghton Italia, S.r.l<div style="display:inline-block;width:4.74px"> </div>is also involved in a corporate income tax audit with the Italian tax<div style="display:inline-block;width:4.82px"> </div>authorities covering tax years </div><div id="a19641_124_4" style="position:absolute;left:665.2px;top:689.4px;">2014</div><div id="a19641_128_1" style="position:absolute;font-weight:normal;font-style:normal;left:691.92px;top:689.4px;"> </div><div id="a19684" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:704.7px;">through </div><div id="a19684_8_4" style="position:absolute;left:49.419px;top:704.7px;">2018</div><div id="a19684_12_43" style="position:absolute;font-weight:normal;font-style:normal;left:76.139px;top:704.7px;">.<div style="display:inline-block;width:6.6px"> </div>As of June 30, 2021, the Company has a $</div><div id="a19684_55_3" style="position:absolute;left:311.693px;top:704.7px;">5.6</div><div id="a19684_58_76" style="position:absolute;font-weight:normal;font-style:normal;left:328.333px;top:704.7px;"><div style="display:inline-block;width:3.36px"> </div>million reserve for uncertain tax positions relating to matters related<div style="display:inline-block;width:4.86px"> </div>to </div><div id="a19733" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:720.1px;">this audit.<div style="display:inline-block;width:7.01px"> </div>Since the reserve relates to the tax periods prior to August<div style="display:inline-block;width:4.7px"> </div>1, 2019, the tax liability was established through purchase </div><div id="a19777" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:735.3px;">accounting related to the Combination.<div style="display:inline-block;width:7.74px"> </div>The Company has also submitted an indemnification claim against<div style="display:inline-block;width:4.73px"> </div>funds held in escrow by </div><div id="a19816" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:750.7px;">Houghton’s former owners<div style="display:inline-block;width:4.76px"> </div>and as a result, a corresponding $</div><div id="a19816_59_3" style="position:absolute;left:330.413px;top:750.7px;">5.6</div><div id="a19816_62_70" style="position:absolute;font-weight:normal;font-style:normal;left:347.213px;top:750.7px;"><div style="display:inline-block;width:3.36px"> </div>million indemnification receivable has also been established through </div><div id="a19853" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:766px;">purchase accounting. </div><div id="a19857" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:786.7px;">Houghton Deutschland GmbH is also under audit by<div style="display:inline-block;width:4.7px"> </div>the German tax authorities for the tax years </div><div id="a19857_94_4" style="position:absolute;left:546.919px;top:786.7px;">2015</div><div id="a19857_98_9" style="position:absolute;font-weight:normal;font-style:normal;left:573.679px;top:786.7px;"><div style="display:inline-block;width:3.36px"> </div>through </div><div id="a19857_107_4" style="position:absolute;left:621.839px;top:786.7px;">2017</div><div id="a19857_111_12" style="position:absolute;font-weight:normal;font-style:normal;left:648.559px;top:786.7px;">.<div style="display:inline-block;width:6.6px"> </div>Based on </div><div id="a19901" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:802px;">preliminary audit findings, primarily related to<div style="display:inline-block;width:4.72px"> </div>transfer pricing, the Company has recorded reserves for $</div><div id="a19901_106_3" style="position:absolute;left:563.879px;top:802px;">0.9</div><div id="a19901_109_24" style="position:absolute;font-weight:normal;font-style:normal;left:580.56px;top:802px;"><div style="display:inline-block;width:3.36px"> </div>million as of June 30, </div><div id="a19943" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:817.4px;">2021.<div style="display:inline-block;width:6.95px"> </div>Of this amount, $</div><div id="a19943_24_3" style="position:absolute;left:134.533px;top:817.4px;">0.8</div><div id="a19943_27_100" style="position:absolute;font-weight:normal;font-style:normal;left:151.333px;top:817.4px;"><div style="display:inline-block;width:3.2px"> </div>million relates to tax periods prior to the Combination and<div style="display:inline-block;width:4.71px"> </div>therefore the Company has submitted an </div><div id="a19986" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:832.7px;">indemnification claim with Houghton’s<div style="display:inline-block;width:5.18px"> </div>former owners for any tax liabilities arising pre-Combination.<div style="display:inline-block;width:7.96px"> </div>As a result, a corresponding </div><div id="a20022" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:848.1px;">$</div><div id="a20022_1_3" style="position:absolute;left:11.147px;top:848.1px;">0.8</div><div id="a20022_4_77" style="position:absolute;font-weight:normal;font-style:normal;left:27.947px;top:848.1px;"><div style="display:inline-block;width:3.36px"> </div>million indemnification receivable has also been established to<div style="display:inline-block;width:4.72px"> </div>offset the $</div><div id="a20022_81_3" style="position:absolute;left:429.8px;top:848.1px;">0.8</div><div id="a20022_84_23" style="position:absolute;font-weight:normal;font-style:normal;left:446.44px;top:848.1px;"><div style="display:inline-block;width:3.36px"> </div>million tax liability.</div></div> 0.322 0.284 0.579 -0.207 5900000 6500000 24000000.0 1800000 200000 200000 -100000 200000 600000 600000 600000 500000 3200000 3600000 3000000.0 3900000 800000 1500000 1500000 2006 2011 2015 2015 2016 2016 2017 2017 2019 2011 As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except 2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP proceedings which the Company has accepted. 2007 2015 -1600000 2600000 2014 2018 5600000 5600000 2015 2017 900000 800000 800000 800000 <div id="TextBlockContainer136" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:699px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a20102" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 12 – Earnings Per Share </div><div id="a20114" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The following table summarizes earnings per share calculations<div style="display:inline-block;width:4.95px"> </div>for the three and six months ended June 30, 2021 and 2020:</div></div><div id="TextBlockContainer140" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:307px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_138_XBRL_TS_4cf63bc0fd11463a81eb486457c9ef6b" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer139" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:307px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a20156" style="position:absolute;font-weight:bold;font-style:normal;left:387.853px;top:0px;">Three Months Ended<div style="display:inline-block;width:4.06px"> </div></div><div id="a20159" style="position:absolute;font-weight:bold;font-style:normal;left:582.96px;top:0px;">Six Months Ended </div><div id="a20163" style="position:absolute;font-weight:bold;font-style:normal;left:424.84px;top:17px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a20166" style="position:absolute;font-weight:bold;font-style:normal;left:611.92px;top:17px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a20170" style="position:absolute;font-weight:bold;font-style:normal;left:387.693px;top:34.2px;">2021 </div><div id="a20173" style="position:absolute;font-weight:bold;font-style:normal;left:482.6px;top:34.2px;">2020 </div><div id="a20176" style="position:absolute;font-weight:bold;font-style:normal;left:575.76px;top:34.2px;">2021 </div><div id="a20179" style="position:absolute;font-weight:bold;font-style:normal;left:668.72px;top:34.2px;">2020 </div><div id="a20181" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:51.8px;">Basic earnings (loss) per common share </div><div id="a20184" style="position:absolute;font-weight:normal;font-style:normal;left:368.493px;top:51.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a20188" style="position:absolute;font-weight:normal;font-style:normal;left:463.56px;top:51.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a20192" style="position:absolute;font-weight:normal;font-style:normal;left:556.52px;top:51.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a20198" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:69.8px;">Net income (loss) attributable to Quaker Chemical Corporation </div><div id="a20201" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:68.5px;">$<div style="display:inline-block;width:3.44px"> </div></div><div id="a20203" style="position:absolute;left:402.92px;top:69.8px;">33,570</div><div id="a20206" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:68.5px;">$ </div><div id="a20208" style="position:absolute;left:499.72px;top:69.8px;">(7,735)</div><div id="a20211" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:68.5px;">$<div style="display:inline-block;width:3.44px"> </div></div><div id="a20213" style="position:absolute;left:590.96px;top:69.8px;">72,185</div><div id="a20216" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:68.5px;">$ </div><div id="a20218" style="position:absolute;left:678.96px;top:69.8px;">(36,116)</div><div id="a20221" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:86.9px;">Less: (income) loss allocated to participating securities </div><div id="a20223" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:85.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20225" style="position:absolute;left:414.6px;top:86.9px;">(134)</div><div id="a20228" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:85.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20230" style="position:absolute;left:521.32px;top:86.9px;">37</div><div id="a20233" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:85.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20235" style="position:absolute;left:602.64px;top:86.9px;">(287)</div><div id="a20238" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:85.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20240" style="position:absolute;left:700.56px;top:86.9px;">146</div><div id="a20243" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:103.8px;">Net income (loss) available to common shareholders </div><div id="a20245" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:103.4px;">$<div style="display:inline-block;width:3.44px"> </div></div><div id="a20247" style="position:absolute;left:402.92px;top:103.8px;">33,436</div><div id="a20250" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:103.4px;">$ </div><div id="a20252" style="position:absolute;left:499.72px;top:103.8px;">(7,698)</div><div id="a20255" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:103.4px;">$<div style="display:inline-block;width:3.44px"> </div></div><div id="a20257" style="position:absolute;left:590.96px;top:103.8px;">71,898</div><div id="a20260" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:103.4px;">$ </div><div id="a20262" style="position:absolute;left:678.96px;top:103.8px;">(35,970)</div><div id="a20265" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:120.8px;">Basic weighted average common shares outstanding </div><div id="a20268" style="position:absolute;left:380.493px;top:120.8px;">17,802,366</div><div id="a20272" style="position:absolute;left:475.56px;top:120.8px;">17,697,496</div><div id="a20276" style="position:absolute;left:568.52px;top:120.8px;">17,793,915</div><div id="a20281" style="position:absolute;left:661.52px;top:120.8px;">17,685,010</div><div id="a20283" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:137.8px;">Basic earnings (loss) per common share </div><div id="a20285" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:137px;">$ </div><div id="a20287" style="position:absolute;left:416.2px;top:137.8px;">1.88</div><div id="a20290" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:137px;">$ </div><div id="a20292" style="position:absolute;left:506.44px;top:137.8px;">(0.43)</div><div id="a20295" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:137px;">$ </div><div id="a20297" style="position:absolute;left:604.24px;top:137.8px;">4.04</div><div id="a20300" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:137px;">$ </div><div id="a20302" style="position:absolute;left:692.4px;top:137.8px;">(2.03)</div><div id="a20317" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:171.9px;">Diluted earnings (loss) per common share </div><div id="a20332" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:188.8px;">Net income (loss) attributable to Quaker Chemical Corporation </div><div id="a20334" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:188px;">$ </div><div id="a20336" style="position:absolute;left:402.92px;top:188.8px;">33,570</div><div id="a20339" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:188px;">$ </div><div id="a20341" style="position:absolute;left:499.72px;top:188.8px;">(7,735)</div><div id="a20344" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:188px;">$<div style="display:inline-block;width:3.44px"> </div></div><div id="a20346" style="position:absolute;left:590.96px;top:188.8px;">72,185</div><div id="a20349" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:188px;">$ </div><div id="a20351" style="position:absolute;left:678.96px;top:188.8px;">(36,116)</div><div id="a20354" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:205.8px;">Less: (income) loss allocated to participating securities </div><div id="a20357" style="position:absolute;left:414.6px;top:205.8px;">(134)</div><div id="a20360" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:205px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20362" style="position:absolute;left:521.32px;top:205.8px;">37</div><div id="a20365" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:205px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20367" style="position:absolute;left:602.64px;top:205.8px;">(287)</div><div id="a20370" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:205px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20372" style="position:absolute;left:700.56px;top:205.8px;">146</div><div id="a20375" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:222.9px;">Net income (loss) available to common shareholders </div><div id="a20377" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:222.3px;">$ </div><div id="a20379" style="position:absolute;left:402.92px;top:222.9px;">33,436</div><div id="a20382" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:222.3px;">$ </div><div id="a20384" style="position:absolute;left:499.72px;top:222.9px;">(7,698)</div><div id="a20387" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:222.3px;">$ </div><div id="a20389" style="position:absolute;left:590.96px;top:222.9px;">71,898</div><div id="a20392" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:222.3px;">$ </div><div id="a20394" style="position:absolute;left:678.96px;top:222.9px;">(35,970)</div><div id="a20397" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:239.1px;">Basic weighted average common shares outstanding </div><div id="a20400" style="position:absolute;left:380.493px;top:239.9px;">17,802,366</div><div id="a20404" style="position:absolute;left:475.56px;top:239.9px;">17,697,496</div><div id="a20408" style="position:absolute;left:568.52px;top:239.9px;">17,793,915</div><div id="a20412" style="position:absolute;left:661.52px;top:239.9px;">17,685,010</div><div id="a20415" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:256px;">Effect of dilutive securities </div><div id="a20418" style="position:absolute;left:402.92px;top:256px;">47,155</div><div id="a20422" style="position:absolute;left:521.32px;top:256px;">—</div><div id="a20426" style="position:absolute;left:590.96px;top:256px;">52,095</div><div id="a20430" style="position:absolute;left:707.28px;top:256px;">—</div><div id="a20433" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:273.3px;">Diluted weighted average common shares outstanding </div><div id="a20436" style="position:absolute;left:380.493px;top:273.3px;">17,849,521</div><div id="a20440" style="position:absolute;left:475.56px;top:273.3px;">17,697,496</div><div id="a20444" style="position:absolute;left:568.52px;top:273.3px;">17,846,010</div><div id="a20448" style="position:absolute;left:661.52px;top:273.3px;">17,685,010</div><div id="a20450" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:290.9px;">Diluted earnings (loss) per common share </div><div id="a20452" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:290px;">$ </div><div id="a20454" style="position:absolute;left:416.2px;top:290.9px;">1.88</div><div id="a20457" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:290px;">$ </div><div id="a20459" style="position:absolute;left:506.44px;top:290.9px;">(0.43)</div><div id="a20462" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:290px;">$ </div><div id="a20464" style="position:absolute;left:604.24px;top:290.9px;">4.03</div><div id="a20467" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:290px;">$ </div><div id="a20469" style="position:absolute;left:692.4px;top:290.9px;">(2.03)</div></div></div></div><div id="TextBlockContainer142" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a20471" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Certain stock options and restricted stock units are not included<div style="display:inline-block;width:4.85px"> </div>in the diluted earnings (loss) per share calculation when<div style="display:inline-block;width:4.69px"> </div>the effect </div><div id="a20513" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">would have been anti-dilutive.<div style="display:inline-block;width:7.46px"> </div>The calculated amount of anti-diluted shares not included<div style="display:inline-block;width:4.6px"> </div>was </div><div id="a20513_94_5" style="position:absolute;left:507.72px;top:15.4px;">6,793</div><div id="a20513_99_5" style="position:absolute;font-weight:normal;font-style:normal;left:537.96px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>and </div><div id="a20513_104_5" style="position:absolute;left:563.879px;top:15.4px;">2,952</div><div id="a20513_109_23" style="position:absolute;font-weight:normal;font-style:normal;left:593.839px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>for the three and six </div><div id="a20559" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">months ended June 30, 2021,<div style="display:inline-block;width:4.15px"> </div>respectively.<div style="display:inline-block;width:6.96px"> </div>All of the Company’s potentially<div style="display:inline-block;width:4.71px"> </div>dilutive shares for the three and six months ended June </div><div id="a20603" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">30, 2020 are anti-dilutive and not included in the dilutive<div style="display:inline-block;width:4.75px"> </div>loss per share calculations because of the Company’s<div style="display:inline-block;width:5.31px"> </div>net loss during the </div><div id="a20650" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.4px;">periods.</div></div> <div id="TextBlockContainer139" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:307px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a20156" style="position:absolute;font-weight:bold;font-style:normal;left:387.853px;top:0px;">Three Months Ended<div style="display:inline-block;width:4.06px"> </div></div><div id="a20159" style="position:absolute;font-weight:bold;font-style:normal;left:582.96px;top:0px;">Six Months Ended </div><div id="a20163" style="position:absolute;font-weight:bold;font-style:normal;left:424.84px;top:17px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a20166" style="position:absolute;font-weight:bold;font-style:normal;left:611.92px;top:17px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a20170" style="position:absolute;font-weight:bold;font-style:normal;left:387.693px;top:34.2px;">2021 </div><div id="a20173" style="position:absolute;font-weight:bold;font-style:normal;left:482.6px;top:34.2px;">2020 </div><div id="a20176" style="position:absolute;font-weight:bold;font-style:normal;left:575.76px;top:34.2px;">2021 </div><div id="a20179" style="position:absolute;font-weight:bold;font-style:normal;left:668.72px;top:34.2px;">2020 </div><div id="a20181" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:51.8px;">Basic earnings (loss) per common share </div><div id="a20184" style="position:absolute;font-weight:normal;font-style:normal;left:368.493px;top:51.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a20188" style="position:absolute;font-weight:normal;font-style:normal;left:463.56px;top:51.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a20192" style="position:absolute;font-weight:normal;font-style:normal;left:556.52px;top:51.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a20198" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:69.8px;">Net income (loss) attributable to Quaker Chemical Corporation </div><div id="a20201" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:68.5px;">$<div style="display:inline-block;width:3.44px"> </div></div><div id="a20203" style="position:absolute;left:402.92px;top:69.8px;">33,570</div><div id="a20206" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:68.5px;">$ </div><div id="a20208" style="position:absolute;left:499.72px;top:69.8px;">(7,735)</div><div id="a20211" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:68.5px;">$<div style="display:inline-block;width:3.44px"> </div></div><div id="a20213" style="position:absolute;left:590.96px;top:69.8px;">72,185</div><div id="a20216" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:68.5px;">$ </div><div id="a20218" style="position:absolute;left:678.96px;top:69.8px;">(36,116)</div><div id="a20221" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:86.9px;">Less: (income) loss allocated to participating securities </div><div id="a20223" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:85.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20225" style="position:absolute;left:414.6px;top:86.9px;">(134)</div><div id="a20228" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:85.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20230" style="position:absolute;left:521.32px;top:86.9px;">37</div><div id="a20233" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:85.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20235" style="position:absolute;left:602.64px;top:86.9px;">(287)</div><div id="a20238" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:85.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20240" style="position:absolute;left:700.56px;top:86.9px;">146</div><div id="a20243" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:103.8px;">Net income (loss) available to common shareholders </div><div id="a20245" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:103.4px;">$<div style="display:inline-block;width:3.44px"> </div></div><div id="a20247" style="position:absolute;left:402.92px;top:103.8px;">33,436</div><div id="a20250" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:103.4px;">$ </div><div id="a20252" style="position:absolute;left:499.72px;top:103.8px;">(7,698)</div><div id="a20255" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:103.4px;">$<div style="display:inline-block;width:3.44px"> </div></div><div id="a20257" style="position:absolute;left:590.96px;top:103.8px;">71,898</div><div id="a20260" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:103.4px;">$ </div><div id="a20262" style="position:absolute;left:678.96px;top:103.8px;">(35,970)</div><div id="a20265" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:120.8px;">Basic weighted average common shares outstanding </div><div id="a20268" style="position:absolute;left:380.493px;top:120.8px;">17,802,366</div><div id="a20272" style="position:absolute;left:475.56px;top:120.8px;">17,697,496</div><div id="a20276" style="position:absolute;left:568.52px;top:120.8px;">17,793,915</div><div id="a20281" style="position:absolute;left:661.52px;top:120.8px;">17,685,010</div><div id="a20283" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:137.8px;">Basic earnings (loss) per common share </div><div id="a20285" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:137px;">$ </div><div id="a20287" style="position:absolute;left:416.2px;top:137.8px;">1.88</div><div id="a20290" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:137px;">$ </div><div id="a20292" style="position:absolute;left:506.44px;top:137.8px;">(0.43)</div><div id="a20295" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:137px;">$ </div><div id="a20297" style="position:absolute;left:604.24px;top:137.8px;">4.04</div><div id="a20300" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:137px;">$ </div><div id="a20302" style="position:absolute;left:692.4px;top:137.8px;">(2.03)</div><div id="a20317" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:171.9px;">Diluted earnings (loss) per common share </div><div id="a20332" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:188.8px;">Net income (loss) attributable to Quaker Chemical Corporation </div><div id="a20334" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:188px;">$ </div><div id="a20336" style="position:absolute;left:402.92px;top:188.8px;">33,570</div><div id="a20339" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:188px;">$ </div><div id="a20341" style="position:absolute;left:499.72px;top:188.8px;">(7,735)</div><div id="a20344" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:188px;">$<div style="display:inline-block;width:3.44px"> </div></div><div id="a20346" style="position:absolute;left:590.96px;top:188.8px;">72,185</div><div id="a20349" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:188px;">$ </div><div id="a20351" style="position:absolute;left:678.96px;top:188.8px;">(36,116)</div><div id="a20354" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:205.8px;">Less: (income) loss allocated to participating securities </div><div id="a20357" style="position:absolute;left:414.6px;top:205.8px;">(134)</div><div id="a20360" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:205px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20362" style="position:absolute;left:521.32px;top:205.8px;">37</div><div id="a20365" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:205px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20367" style="position:absolute;left:602.64px;top:205.8px;">(287)</div><div id="a20370" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:205px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a20372" style="position:absolute;left:700.56px;top:205.8px;">146</div><div id="a20375" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:222.9px;">Net income (loss) available to common shareholders </div><div id="a20377" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:222.3px;">$ </div><div id="a20379" style="position:absolute;left:402.92px;top:222.9px;">33,436</div><div id="a20382" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:222.3px;">$ </div><div id="a20384" style="position:absolute;left:499.72px;top:222.9px;">(7,698)</div><div id="a20387" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:222.3px;">$ </div><div id="a20389" style="position:absolute;left:590.96px;top:222.9px;">71,898</div><div id="a20392" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:222.3px;">$ </div><div id="a20394" style="position:absolute;left:678.96px;top:222.9px;">(35,970)</div><div id="a20397" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:239.1px;">Basic weighted average common shares outstanding </div><div id="a20400" style="position:absolute;left:380.493px;top:239.9px;">17,802,366</div><div id="a20404" style="position:absolute;left:475.56px;top:239.9px;">17,697,496</div><div id="a20408" style="position:absolute;left:568.52px;top:239.9px;">17,793,915</div><div id="a20412" style="position:absolute;left:661.52px;top:239.9px;">17,685,010</div><div id="a20415" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:256px;">Effect of dilutive securities </div><div id="a20418" style="position:absolute;left:402.92px;top:256px;">47,155</div><div id="a20422" style="position:absolute;left:521.32px;top:256px;">—</div><div id="a20426" style="position:absolute;left:590.96px;top:256px;">52,095</div><div id="a20430" style="position:absolute;left:707.28px;top:256px;">—</div><div id="a20433" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:273.3px;">Diluted weighted average common shares outstanding </div><div id="a20436" style="position:absolute;left:380.493px;top:273.3px;">17,849,521</div><div id="a20440" style="position:absolute;left:475.56px;top:273.3px;">17,697,496</div><div id="a20444" style="position:absolute;left:568.52px;top:273.3px;">17,846,010</div><div id="a20448" style="position:absolute;left:661.52px;top:273.3px;">17,685,010</div><div id="a20450" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:290.9px;">Diluted earnings (loss) per common share </div><div id="a20452" style="position:absolute;font-weight:normal;font-style:normal;left:358.573px;top:290px;">$ </div><div id="a20454" style="position:absolute;left:416.2px;top:290.9px;">1.88</div><div id="a20457" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:290px;">$ </div><div id="a20459" style="position:absolute;left:506.44px;top:290.9px;">(0.43)</div><div id="a20462" style="position:absolute;font-weight:normal;font-style:normal;left:546.6px;top:290px;">$ </div><div id="a20464" style="position:absolute;left:604.24px;top:290.9px;">4.03</div><div id="a20467" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:290px;">$ </div><div id="a20469" style="position:absolute;left:692.4px;top:290.9px;">(2.03)</div></div> 33570000 -7735000 72185000 -36116000 134000 -37000 287000 -146000 33436000 -7698000 71898000 -35970000 17802366 17697496 17793915 17685010 1.88 -0.43 4.04 -2.03 33570000 -7735000 72185000 -36116000 134000 -37000 287000 -146000 33436000 -7698000 71898000 -35970000 17802366 17697496 17793915 17685010 47155 0 52095 0 17849521 17697496 17846010 17685010 1.88 -0.43 4.03 -2.03 6793 2952 <div id="TextBlockContainer144" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:162px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a20652" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 13 – Restricted Cash </div><div id="a20662" style="position:absolute;left:28.427px;top:23.2px;">Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary </div><div id="a20704" style="position:absolute;left:4.427px;top:38.6px;">of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an </div><div id="a20743" style="position:absolute;left:4.427px;top:53.9px;">original total value of $35.0 million.</div><div id="a20743_38_98" style="position:absolute;font-weight:normal;font-style:normal;left:198.213px;top:53.9px;"><div style="display:inline-block;width:6.72px"> </div>The proceeds of both settlements were restricted and could<div style="display:inline-block;width:4.8px"> </div>only be used to pay claims and costs </div><div id="a20790" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">of defense associated with the subsidiary’s<div style="display:inline-block;width:5.2px"> </div>asbestos litigation.<div style="display:inline-block;width:7.07px"> </div>The proceeds of the settlement and release agreements<div style="display:inline-block;width:4.7px"> </div>were deposited </div><div id="a20827" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">into interest bearing accounts that earned less than<div style="display:inline-block;width:4.56px"> </div>$</div><div id="a20827_54_3" style="position:absolute;left:283.053px;top:84.6px;">0.1</div><div id="a20827_57_20" style="position:absolute;font-weight:normal;font-style:normal;left:299.693px;top:84.6px;"><div style="display:inline-block;width:3.36px"> </div>million offset by $</div><div id="a20827_77_3" style="position:absolute;left:401.96px;top:84.6px;">0.5</div><div id="a20827_80_53" style="position:absolute;font-weight:normal;font-style:normal;left:418.76px;top:84.6px;"><div style="display:inline-block;width:3.2px"> </div>million of net payments during the six months ended </div><div id="a20874" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:99.8px;">June 30, 2020.<div style="display:inline-block;width:7.21px"> </div>Due to the restricted nature of the proceeds, a corresponding deferred<div style="display:inline-block;width:4.82px"> </div>credit was established in other non-current </div><div id="a20918" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.2px;">liabilities for an equal and offsetting amount<div style="display:inline-block;width:4.76px"> </div>that continued until the restrictions lapsed.<div style="display:inline-block;width:7.6px"> </div>As disclosed in the Company’s<div style="display:inline-block;width:4.8px"> </div>2020 Form </div><div id="a20960" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.6px;">10-K, during December 2020, the restrictions ended<div style="display:inline-block;width:4.6px"> </div>on these previously received insurance settlements and the<div style="display:inline-block;width:4.72px"> </div>Company transferred </div><div id="a20997" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:145.9px;">the cash into an operating account.</div></div><div id="TextBlockContainer146" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:719px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21009" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The following table provides a reconciliation of cash,<div style="display:inline-block;width:4.76px"> </div>cash equivalents and restricted cash as of June 30, 2021 and 2020<div style="display:inline-block;width:1.37px"> </div>,<div style="display:inline-block;width:3.24px"> </div>as well </div><div id="a21054" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">as December 31, 2020 and 2019:</div></div><div id="TextBlockContainer149" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:727px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21068" style="position:absolute;font-weight:bold;font-style:normal;left:423.72px;top:0px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a21071" style="position:absolute;font-weight:bold;font-style:normal;left:595.6px;top:0px;">December 31, </div><div id="a21074" style="position:absolute;font-weight:bold;font-style:normal;left:386.573px;top:17.6px;">2021 </div><div id="a21077" style="position:absolute;font-weight:bold;font-style:normal;left:481.64px;top:17.6px;">2020 </div><div id="a21080" style="position:absolute;font-weight:bold;font-style:normal;left:574.64px;top:17.6px;">2020 </div><div id="a21083" style="position:absolute;font-weight:bold;font-style:normal;left:667.76px;top:17.6px;">2019 </div><div id="a21085" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:35.2px;">Cash and cash equivalents </div><div id="a21087" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:35.2px;">$ </div><div id="a21089" style="position:absolute;left:394.28px;top:35.2px;">145,610</div><div id="a21092" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:35.2px;">$ </div><div id="a21094" style="position:absolute;left:489.32px;top:35.2px;">322,497</div><div id="a21097" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:35.2px;">$ </div><div id="a21099" style="position:absolute;left:582.32px;top:35.2px;">181,833</div><div id="a21102" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:35.2px;">$ </div><div id="a21104" style="position:absolute;left:675.28px;top:35.2px;">123,524</div><div id="a21106" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:52.8px;">Restricted cash included in other current assets </div><div id="a21109" style="position:absolute;left:424.36px;top:52.8px;">—</div><div id="a21113" style="position:absolute;left:519.4px;top:52.8px;">85</div><div id="a21117" style="position:absolute;left:612.4px;top:52.8px;">62</div><div id="a21121" style="position:absolute;left:698.64px;top:52.8px;">353</div><div id="a21123" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:70.4px;">Restricted cash included in other assets </div><div id="a21126" style="position:absolute;left:424.36px;top:70.4px;">—</div><div id="a21130" style="position:absolute;left:496.04px;top:70.4px;">19,173</div><div id="a21134" style="position:absolute;left:612.4px;top:70.4px;">—</div><div id="a21138" style="position:absolute;left:682px;top:70.4px;">19,678</div><div id="a21140" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:88.8px;">Cash, cash equivalents and restricted cash </div><div id="a21143" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:88.8px;">$ </div><div id="a21145" style="position:absolute;left:394.28px;top:88.8px;">145,610</div><div id="a21148" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:88.8px;">$ </div><div id="a21150" style="position:absolute;left:489.32px;top:88.8px;">341,755</div><div id="a21153" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:88.8px;">$ </div><div id="a21155" style="position:absolute;left:582.32px;top:88.8px;">181,895</div><div id="a21158" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:88.8px;">$ </div><div id="a21160" style="position:absolute;left:675.28px;top:88.8px;">143,555</div></div> Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an original total value of $35.0 million. 35000000.0 100000 500000 <div id="TextBlockContainer150" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:727px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_148_XBRL_TS_017fb2abe70047849a324fdf1864768e" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer149" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:727px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21068" style="position:absolute;font-weight:bold;font-style:normal;left:423.72px;top:0px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a21071" style="position:absolute;font-weight:bold;font-style:normal;left:595.6px;top:0px;">December 31, </div><div id="a21074" style="position:absolute;font-weight:bold;font-style:normal;left:386.573px;top:17.6px;">2021 </div><div id="a21077" style="position:absolute;font-weight:bold;font-style:normal;left:481.64px;top:17.6px;">2020 </div><div id="a21080" style="position:absolute;font-weight:bold;font-style:normal;left:574.64px;top:17.6px;">2020 </div><div id="a21083" style="position:absolute;font-weight:bold;font-style:normal;left:667.76px;top:17.6px;">2019 </div><div id="a21085" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:35.2px;">Cash and cash equivalents </div><div id="a21087" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:35.2px;">$ </div><div id="a21089" style="position:absolute;left:394.28px;top:35.2px;">145,610</div><div id="a21092" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:35.2px;">$ </div><div id="a21094" style="position:absolute;left:489.32px;top:35.2px;">322,497</div><div id="a21097" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:35.2px;">$ </div><div id="a21099" style="position:absolute;left:582.32px;top:35.2px;">181,833</div><div id="a21102" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:35.2px;">$ </div><div id="a21104" style="position:absolute;left:675.28px;top:35.2px;">123,524</div><div id="a21106" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:52.8px;">Restricted cash included in other current assets </div><div id="a21109" style="position:absolute;left:424.36px;top:52.8px;">—</div><div id="a21113" style="position:absolute;left:519.4px;top:52.8px;">85</div><div id="a21117" style="position:absolute;left:612.4px;top:52.8px;">62</div><div id="a21121" style="position:absolute;left:698.64px;top:52.8px;">353</div><div id="a21123" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:70.4px;">Restricted cash included in other assets </div><div id="a21126" style="position:absolute;left:424.36px;top:70.4px;">—</div><div id="a21130" style="position:absolute;left:496.04px;top:70.4px;">19,173</div><div id="a21134" style="position:absolute;left:612.4px;top:70.4px;">—</div><div id="a21138" style="position:absolute;left:682px;top:70.4px;">19,678</div><div id="a21140" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:88.8px;">Cash, cash equivalents and restricted cash </div><div id="a21143" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:88.8px;">$ </div><div id="a21145" style="position:absolute;left:394.28px;top:88.8px;">145,610</div><div id="a21148" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:88.8px;">$ </div><div id="a21150" style="position:absolute;left:489.32px;top:88.8px;">341,755</div><div id="a21153" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:88.8px;">$ </div><div id="a21155" style="position:absolute;left:582.32px;top:88.8px;">181,895</div><div id="a21158" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:88.8px;">$ </div><div id="a21160" style="position:absolute;left:675.28px;top:88.8px;">143,555</div></div></div></div> 145610000 322497000 181833000 123524000 0 85000 62000 353000 0 19173000 0 19678000 145610000 341755000 181895000 143555000 <div id="TextBlockContainer152" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:577px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21211" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 14 – Goodwill and Other Intangible Assets </div><div id="a21227" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">Changes in the carrying amount of goodwill for the<div style="display:inline-block;width:4.75px"> </div>six months ended June 30, 2021 were as follows:</div></div><div id="TextBlockContainer155" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21274" style="position:absolute;font-weight:bold;font-style:normal;left:568.68px;top:0px;">Global </div><div id="a21289" style="position:absolute;font-weight:bold;font-style:normal;left:562.12px;top:16.3px;">Specialty </div><div id="a21296" style="position:absolute;font-weight:bold;font-style:normal;left:278.093px;top:31.2px;">Americas </div><div id="a21299" style="position:absolute;font-weight:bold;font-style:normal;left:380.013px;top:31.2px;">EMEA </div><div id="a21302" style="position:absolute;font-weight:bold;font-style:normal;left:461.32px;top:31.2px;">Asia/Pacific </div><div id="a21305" style="position:absolute;font-weight:bold;font-style:normal;left:557.96px;top:31.2px;">Businesses </div><div id="a21308" style="position:absolute;font-weight:bold;font-style:normal;left:666px;top:31.2px;">Total </div><div id="a21310" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:47.8px;">Balance as of December 31, 2020 </div><div id="a21312" style="position:absolute;font-weight:normal;font-style:normal;left:263.533px;top:47.8px;">$ </div><div id="a21314" style="position:absolute;left:299.213px;top:47.8px;">213,242</div><div id="a21317" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:47.8px;">$ </div><div id="a21319" style="position:absolute;left:394.28px;top:47.8px;">140,162</div><div id="a21322" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:47.8px;">$ </div><div id="a21324" style="position:absolute;left:489.32px;top:47.8px;">158,090</div><div id="a21328" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:47.8px;">$ </div><div id="a21330" style="position:absolute;left:582.32px;top:47.8px;">119,718</div><div id="a21332" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:47.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21334" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:47.8px;">$ </div><div id="a21336" style="position:absolute;left:675.28px;top:47.8px;">631,212</div><div id="a21339" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:65px;">Goodwill additions </div><div id="a21342" style="position:absolute;left:312.493px;top:65px;">1,208</div><div id="a21346" style="position:absolute;left:407.56px;top:65px;">2,626</div><div id="a21350" style="position:absolute;left:502.6px;top:65px;">1,308</div><div id="a21354" style="position:absolute;left:605.68px;top:65px;">128</div><div id="a21358" style="position:absolute;left:688.56px;top:65px;">5,270</div><div id="a21361" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:81.9px;">Currency translation and other adjustments </div><div id="a21363" style="position:absolute;font-weight:normal;font-style:normal;left:263.533px;top:81.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21365" style="position:absolute;left:322.573px;top:81.9px;">614</div><div id="a21369" style="position:absolute;left:402.76px;top:81.9px;">(2,633)</div><div id="a21373" style="position:absolute;left:502.6px;top:81.9px;">1,127</div><div id="a21377" style="position:absolute;left:590.8px;top:81.9px;">(2,141)</div><div id="a21381" style="position:absolute;left:683.76px;top:81.9px;">(3,033)</div><div id="a21383" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:99.8px;">Balance as of June 30, 2021 </div><div id="a21385" style="position:absolute;font-weight:normal;font-style:normal;left:263.533px;top:99.8px;">$ </div><div id="a21387" style="position:absolute;left:299.213px;top:99.8px;">215,064</div><div id="a21390" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:99.8px;">$ </div><div id="a21392" style="position:absolute;left:394.28px;top:99.8px;">140,155</div><div id="a21395" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:99.8px;">$ </div><div id="a21397" style="position:absolute;left:489.32px;top:99.8px;">160,525</div><div id="a21400" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:99.8px;">$ </div><div id="a21402" style="position:absolute;left:582.32px;top:99.8px;">117,705</div><div id="a21404" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:99.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21406" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:99.8px;">$ </div><div id="a21408" style="position:absolute;left:675.28px;top:99.8px;">633,449</div></div><div id="TextBlockContainer158" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:721px;height:32px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21410" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Gross carrying amounts and accumulated amortization<div style="display:inline-block;width:4.73px"> </div>for definite-lived intangible assets as of June 30, 2021 and December<div style="display:inline-block;width:4.88px"> </div>31, </div><div id="a21448" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.5px;">2020 were as follows:</div></div><div id="TextBlockContainer161" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:118px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21458" style="position:absolute;font-weight:bold;font-style:normal;left:402.76px;top:0px;">Gross Carrying </div><div id="a21461" style="position:absolute;font-weight:bold;font-style:normal;left:596.72px;top:0px;">Accumulated </div><div id="a21465" style="position:absolute;font-weight:bold;font-style:normal;left:424.04px;top:15.1px;">Amount </div><div id="a21468" style="position:absolute;font-weight:bold;font-style:normal;left:596.4px;top:15.1px;">Amortization </div><div id="a21472" style="position:absolute;font-weight:bold;font-style:normal;left:386.573px;top:31.6px;">2021 </div><div id="a21475" style="position:absolute;font-weight:bold;font-style:normal;left:481.64px;top:31.6px;">2020 </div><div id="a21478" style="position:absolute;font-weight:bold;font-style:normal;left:574.64px;top:31.6px;">2021 </div><div id="a21481" style="position:absolute;font-weight:bold;font-style:normal;left:667.76px;top:31.6px;">2020 </div><div id="a21483" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:49.2px;">Customer lists and rights to sell </div><div id="a21485" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:49.2px;">$ </div><div id="a21487" style="position:absolute;left:395.24px;top:49.2px;">858,025</div><div id="a21489" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:49.2px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21491" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:49.2px;">$ </div><div id="a21493" style="position:absolute;left:490.28px;top:49.2px;">839,551</div><div id="a21495" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:49.2px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21497" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:49.2px;">$ </div><div id="a21499" style="position:absolute;left:583.28px;top:49.2px;">127,883</div><div id="a21501" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:49.2px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21503" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:49.2px;">$ </div><div id="a21505" style="position:absolute;left:682.96px;top:49.2px;">99,806</div><div id="a21507" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.4px;">Trademarks, formulations and product<div style="display:inline-block;width:4.8px"> </div>technology </div><div id="a21509" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:66.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21511" style="position:absolute;left:395.24px;top:66.4px;">168,004</div><div id="a21513" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:66.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21515" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:66.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21517" style="position:absolute;left:490.28px;top:66.4px;">166,448</div><div id="a21519" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:66.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21521" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:66.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21523" style="position:absolute;left:590px;top:66.4px;">34,932</div><div id="a21525" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:66.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21527" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:66.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21529" style="position:absolute;left:682.96px;top:66.4px;">30,483</div><div id="a21531" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84px;">Other </div><div id="a21533" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:84px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21535" style="position:absolute;left:408.52px;top:84px;">6,390</div><div id="a21537" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:84px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21539" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:84px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21541" style="position:absolute;left:503.56px;top:84px;">6,372</div><div id="a21543" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:84px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21545" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:84px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21547" style="position:absolute;left:596.56px;top:84px;">5,909</div><div id="a21549" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:84px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21551" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:84px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21553" style="position:absolute;left:689.52px;top:84px;">5,824</div><div id="a21555" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:102.4px;">Total definite<div style="display:inline-block;width:1.37px"> </div>-lived intangible assets </div><div id="a21559" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:102.4px;">$ </div><div id="a21561" style="position:absolute;left:385.293px;top:102.4px;">1,032,419</div><div id="a21563" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:102.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21565" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:102.4px;">$ </div><div id="a21567" style="position:absolute;left:480.36px;top:102.4px;">1,012,371</div><div id="a21569" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:102.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21571" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:102.4px;">$ </div><div id="a21573" style="position:absolute;left:583.28px;top:102.4px;">168,724</div><div id="a21575" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:102.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21577" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:102.4px;">$ </div><div id="a21579" style="position:absolute;left:676.24px;top:102.4px;">136,113</div></div><div id="TextBlockContainer164" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:714px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21581" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company amortizes definite-lived intangible assets on<div style="display:inline-block;width:4.77px"> </div>a straight-line basis over their useful lives.<div style="display:inline-block;width:7.53px"> </div>The Company recorded </div><div id="a21619" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.2px;">$</div><div id="a21619_1_4" style="position:absolute;left:11.147px;top:15.2px;">15.0</div><div id="a21619_5_14" style="position:absolute;font-weight:normal;font-style:normal;left:34.507px;top:15.2px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a21619_19_4" style="position:absolute;left:108.933px;top:15.2px;">29.8</div><div id="a21619_23_98" style="position:absolute;font-weight:normal;font-style:normal;left:132.293px;top:15.2px;"><div style="display:inline-block;width:3.36px"> </div>million of amortization expense for the three and six months<div style="display:inline-block;width:4.76px"> </div>ended June 30, 2021, respectively.<div style="display:inline-block;width:4.97px"> </div></div><div id="a21658" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">Comparatively,<div style="display:inline-block;width:4.73px"> </div>the Company recorded $</div><div id="a21658_37_4" style="position:absolute;left:222.053px;top:30.6px;">13.7</div><div id="a21658_41_14" style="position:absolute;font-weight:normal;font-style:normal;left:245.453px;top:30.6px;"><div style="display:inline-block;width:3.2px"> </div>million and $</div><div id="a21658_55_4" style="position:absolute;left:319.853px;top:30.6px;">27.7</div><div id="a21658_59_68" style="position:absolute;font-weight:normal;font-style:normal;left:343.213px;top:30.6px;"><div style="display:inline-block;width:3.36px"> </div>million of amortization expense for the three and six months ended </div><div id="a21696" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">June 30, 2020, respectively.</div></div><div id="TextBlockContainer166" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:598px;height:16px;display:inline-block;"><div id="a21706" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">Estimated annual aggregate amortization expense for<div style="display:inline-block;width:4.7px"> </div>the current year and subsequent five years is as follows:</div></div><div id="TextBlockContainer170" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:366px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_168_XBRL_TS_a365e22f30ed407c9cd8c1d17986a8f3" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer169" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:366px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21739" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0.8px;">For the year ended December 31, 2021 </div><div id="a21741" style="position:absolute;font-weight:normal;font-style:normal;left:275.533px;top:0.8px;">$ </div><div id="a21743" style="position:absolute;left:320.973px;top:0px;">59,214</div><div id="a21747" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:17.8px;">For the year ended December 31, 2022 </div><div id="a21750" style="position:absolute;left:320.973px;top:17px;">59,564</div><div id="a21754" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:34.9px;">For the year ended December 31, 2023 </div><div id="a21757" style="position:absolute;left:320.973px;top:33.9px;">59,394</div><div id="a21761" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.9px;">For the year ended December 31, 2024 </div><div id="a21764" style="position:absolute;left:320.973px;top:51.1px;">58,750</div><div id="a21768" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68.8px;">For the year ended December 31, 2025 </div><div id="a21771" style="position:absolute;left:320.973px;top:68px;">58,037</div><div id="a21775" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:85.8px;">For the year ended December 31, 2026 </div><div id="a21778" style="position:absolute;left:320.973px;top:85px;">57,740</div></div></div></div><div id="TextBlockContainer174" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:316px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21781" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company has four indefinite-lived intangible<div style="display:inline-block;width:4.7px"> </div>assets totaling $</div><div id="a21781_66_5" style="position:absolute;left:381.933px;top:0px;">205.1</div><div id="a21781_71_57" style="position:absolute;font-weight:normal;font-style:normal;left:411.88px;top:0px;"><div style="display:inline-block;width:3.36px"> </div>million as of both June 30, 2021 and December 31, 2020, </div><div id="a21823" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">including $</div><div id="a21823_11_5" style="position:absolute;left:64.939px;top:15.4px;">204.0</div><div id="a21823_16_109" style="position:absolute;font-weight:normal;font-style:normal;left:95.013px;top:15.4px;"><div style="display:inline-block;width:3.2px"> </div>million of indefinite-lived intangible assets for trademarks and<div style="display:inline-block;width:4.75px"> </div>tradename associated with the Combination. </div><div id="div_172_XBRL_TS_de5984e19ad942cf99354fda61402a5d" style="position:absolute;left:0px;top:38.7px;float:left;"><div id="TextBlockContainer173" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:714px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21855" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Goodwill and intangible assets that have indefinite lives are<div style="display:inline-block;width:4.67px"> </div>not amortized and are required to be assessed at least annually<div style="display:inline-block;width:4.87px"> </div>for </div><div id="a21897" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">impairment.<div style="display:inline-block;width:7.17px"> </div>The Company completes its annual goodwill and indefinite-lived<div style="display:inline-block;width:4.73px"> </div>intangible asset impairment test during the fourth </div><div id="a21931" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">quarter of each year.<div style="display:inline-block;width:7.96px"> </div>The Company continuously evaluates if triggering events indicate<div style="display:inline-block;width:4.81px"> </div>a possible impairment in one or more of its </div><div id="a21973" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">reporting units or indefinite-lived or long-lived assets.</div></div></div><div id="a21973_57_1" style="position:absolute;font-weight:normal;font-style:normal;left:292.973px;top:84.8px;"> </div><div id="a21991" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:108px;">The Company previously disclosed in its 2020 Form 10-K<div style="display:inline-block;width:4.78px"> </div>that as of March 31, 2020, the Company concluded that the<div style="display:inline-block;width:4.79px"> </div>impact of </div><div id="a22037" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:123.4px;">COVID-19 did not represent a triggering event with<div style="display:inline-block;width:4.64px"> </div>regards to the Company’s<div style="display:inline-block;width:4.73px"> </div>reporting units or indefinite-lived and long-lived assets, </div><div id="a22082" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:138.8px;">except for the Company’s<div style="display:inline-block;width:4.81px"> </div>Houghton and Fluidcare trademarks and tradename indefinite<div style="display:inline-block;width:1.34px"> </div>-lived intangible assets.<div style="display:inline-block;width:7.01px"> </div>The determination of </div><div id="a22116" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:154.1px;">estimated fair value of the Houghton and Fluidcare<div style="display:inline-block;width:4.7px"> </div>trademarks and tradename indefinite-lived assets was based on a relief<div style="display:inline-block;width:4.83px"> </div>from </div><div id="a22156" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:169.3px;">royalty valuation method, which requires management’s<div style="display:inline-block;width:5.51px"> </div>judgment and often involves the use of significant estimates and assumptions, </div><div id="a22190" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:184.7px;">including assumptions with respect to the weighted average<div style="display:inline-block;width:4.71px"> </div>cost of capital (“WACC”)<div style="display:inline-block;width:5.3px"> </div>and royalty rates, as well as revenue growth </div><div id="a22230" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:200px;">rates and terminal growth rates.<div style="display:inline-block;width:7.44px"> </div>In the first quarter of 2020, as a result of the impact of<div style="display:inline-block;width:4.7px"> </div>COVID-19 driving a decrease in projected </div><div id="a22280" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:215.4px;">legacy Houghton net sales during that year and the impact<div style="display:inline-block;width:4.68px"> </div>of the sales decline on projected future legacy Houghton<div style="display:inline-block;width:4.7px"> </div>net sales as well as </div><div id="a22329" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:230.8px;">an increase in the WACC<div style="display:inline-block;width:5.31px"> </div>assumption utilized in the quantitative impairment<div style="display:inline-block;width:4.84px"> </div>assessment, the Company concluded that the estimated </div><div id="a22365" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:246.1px;">fair values of the Houghton and Fluidcare trademarks<div style="display:inline-block;width:4.71px"> </div>and tradename intangible assets were less than their carrying values.<div style="display:inline-block;width:8.09px"> </div>As a </div><div id="a22406" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:261.3px;">result, an impairment charge of $</div><div id="a22406_33_4" style="position:absolute;left:181.573px;top:261.3px;">38.0</div><div id="a22406_37_94" style="position:absolute;font-weight:normal;font-style:normal;left:204.933px;top:261.3px;"><div style="display:inline-block;width:3.36px"> </div>million was recorded in the first quarter of 2020 to write down<div style="display:inline-block;width:4.74px"> </div>the carrying values of these </div><div id="a22452" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:276.7px;">intangible assets to their estimated fair values. </div><div id="a22466" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:300px;"><div style="display:inline-block;width:192.03px"> </div></div></div><div id="TextBlockContainer176" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:139px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a22517" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">As of June 30, 2021, the Company continued to evaluate all<div style="display:inline-block;width:4.71px"> </div>potential triggering events, including the on-going impact<div style="display:inline-block;width:4.79px"> </div>of COVID-</div><div id="a22559" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">19 on the Company’s<div style="display:inline-block;width:4.7px"> </div>operations, and the volatility and uncertainty in the economic outlook<div style="display:inline-block;width:4.78px"> </div>as a result of COVID-19, to determine if </div><div id="a22605" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">this indicated it was more likely than not that the carrying<div style="display:inline-block;width:4.75px"> </div>value of any of the Company’s<div style="display:inline-block;width:4.81px"> </div>reporting units or indefinite-lived or long-</div><div id="a22653" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">lived intangible assets were not recoverable.<div style="display:inline-block;width:7.85px"> </div>The Company concluded that the impact of COVID-19 did not<div style="display:inline-block;width:4.7px"> </div>represent a triggering </div><div id="a22694" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">event as of June 30, 2021.<div style="display:inline-block;width:7.48px"> </div>While the Company concluded that the impact of COVID-19 did not<div style="display:inline-block;width:4.87px"> </div>represent a triggering event as of June </div><div id="a22744" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.6px;">30, 2021, the Company will continue to evaluate the<div style="display:inline-block;width:4.7px"> </div>impact of COVID-19 on the Company’s<div style="display:inline-block;width:4.71px"> </div>current and projected results. If the </div><div id="a22788" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92px;">current economic conditions worsen or projections<div style="display:inline-block;width:4.72px"> </div>of the timeline for recovery are significantly extended, then<div style="display:inline-block;width:4.7px"> </div>the Company may </div><div id="a22824" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:107.4px;">conclude in the future that the impact from COVID-19 requires<div style="display:inline-block;width:4.82px"> </div>the need to perform further interim quantitative impairment tests, </div><div id="a22864" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:122.7px;">which could result in additional impairment charges<div style="display:inline-block;width:4.84px"> </div>in the future.</div></div> <div id="TextBlockContainer156" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_154_XBRL_TS_52b60c3f2caf4e6da6d400c2e629a373" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer155" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21274" style="position:absolute;font-weight:bold;font-style:normal;left:568.68px;top:0px;">Global </div><div id="a21289" style="position:absolute;font-weight:bold;font-style:normal;left:562.12px;top:16.3px;">Specialty </div><div id="a21296" style="position:absolute;font-weight:bold;font-style:normal;left:278.093px;top:31.2px;">Americas </div><div id="a21299" style="position:absolute;font-weight:bold;font-style:normal;left:380.013px;top:31.2px;">EMEA </div><div id="a21302" style="position:absolute;font-weight:bold;font-style:normal;left:461.32px;top:31.2px;">Asia/Pacific </div><div id="a21305" style="position:absolute;font-weight:bold;font-style:normal;left:557.96px;top:31.2px;">Businesses </div><div id="a21308" style="position:absolute;font-weight:bold;font-style:normal;left:666px;top:31.2px;">Total </div><div id="a21310" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:47.8px;">Balance as of December 31, 2020 </div><div id="a21312" style="position:absolute;font-weight:normal;font-style:normal;left:263.533px;top:47.8px;">$ </div><div id="a21314" style="position:absolute;left:299.213px;top:47.8px;">213,242</div><div id="a21317" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:47.8px;">$ </div><div id="a21319" style="position:absolute;left:394.28px;top:47.8px;">140,162</div><div id="a21322" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:47.8px;">$ </div><div id="a21324" style="position:absolute;left:489.32px;top:47.8px;">158,090</div><div id="a21328" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:47.8px;">$ </div><div id="a21330" style="position:absolute;left:582.32px;top:47.8px;">119,718</div><div id="a21332" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:47.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21334" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:47.8px;">$ </div><div id="a21336" style="position:absolute;left:675.28px;top:47.8px;">631,212</div><div id="a21339" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:65px;">Goodwill additions </div><div id="a21342" style="position:absolute;left:312.493px;top:65px;">1,208</div><div id="a21346" style="position:absolute;left:407.56px;top:65px;">2,626</div><div id="a21350" style="position:absolute;left:502.6px;top:65px;">1,308</div><div id="a21354" style="position:absolute;left:605.68px;top:65px;">128</div><div id="a21358" style="position:absolute;left:688.56px;top:65px;">5,270</div><div id="a21361" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:81.9px;">Currency translation and other adjustments </div><div id="a21363" style="position:absolute;font-weight:normal;font-style:normal;left:263.533px;top:81.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21365" style="position:absolute;left:322.573px;top:81.9px;">614</div><div id="a21369" style="position:absolute;left:402.76px;top:81.9px;">(2,633)</div><div id="a21373" style="position:absolute;left:502.6px;top:81.9px;">1,127</div><div id="a21377" style="position:absolute;left:590.8px;top:81.9px;">(2,141)</div><div id="a21381" style="position:absolute;left:683.76px;top:81.9px;">(3,033)</div><div id="a21383" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:99.8px;">Balance as of June 30, 2021 </div><div id="a21385" style="position:absolute;font-weight:normal;font-style:normal;left:263.533px;top:99.8px;">$ </div><div id="a21387" style="position:absolute;left:299.213px;top:99.8px;">215,064</div><div id="a21390" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:99.8px;">$ </div><div id="a21392" style="position:absolute;left:394.28px;top:99.8px;">140,155</div><div id="a21395" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:99.8px;">$ </div><div id="a21397" style="position:absolute;left:489.32px;top:99.8px;">160,525</div><div id="a21400" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:99.8px;">$ </div><div id="a21402" style="position:absolute;left:582.32px;top:99.8px;">117,705</div><div id="a21404" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:99.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21406" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:99.8px;">$ </div><div id="a21408" style="position:absolute;left:675.28px;top:99.8px;">633,449</div></div></div></div> 213242000 140162000 158090000 119718000 631212000 1208000 2626000 1308000 128000 5270000 614000 -2633000 1127000 -2141000 -3033000 215064000 140155000 160525000 117705000 633449000 <div id="TextBlockContainer162" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:118px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_160_XBRL_TS_06f89985a76745be86842dc0628bee1a" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer161" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:118px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21458" style="position:absolute;font-weight:bold;font-style:normal;left:402.76px;top:0px;">Gross Carrying </div><div id="a21461" style="position:absolute;font-weight:bold;font-style:normal;left:596.72px;top:0px;">Accumulated </div><div id="a21465" style="position:absolute;font-weight:bold;font-style:normal;left:424.04px;top:15.1px;">Amount </div><div id="a21468" style="position:absolute;font-weight:bold;font-style:normal;left:596.4px;top:15.1px;">Amortization </div><div id="a21472" style="position:absolute;font-weight:bold;font-style:normal;left:386.573px;top:31.6px;">2021 </div><div id="a21475" style="position:absolute;font-weight:bold;font-style:normal;left:481.64px;top:31.6px;">2020 </div><div id="a21478" style="position:absolute;font-weight:bold;font-style:normal;left:574.64px;top:31.6px;">2021 </div><div id="a21481" style="position:absolute;font-weight:bold;font-style:normal;left:667.76px;top:31.6px;">2020 </div><div id="a21483" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:49.2px;">Customer lists and rights to sell </div><div id="a21485" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:49.2px;">$ </div><div id="a21487" style="position:absolute;left:395.24px;top:49.2px;">858,025</div><div id="a21489" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:49.2px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21491" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:49.2px;">$ </div><div id="a21493" style="position:absolute;left:490.28px;top:49.2px;">839,551</div><div id="a21495" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:49.2px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21497" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:49.2px;">$ </div><div id="a21499" style="position:absolute;left:583.28px;top:49.2px;">127,883</div><div id="a21501" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:49.2px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21503" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:49.2px;">$ </div><div id="a21505" style="position:absolute;left:682.96px;top:49.2px;">99,806</div><div id="a21507" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.4px;">Trademarks, formulations and product<div style="display:inline-block;width:4.8px"> </div>technology </div><div id="a21509" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:66.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21511" style="position:absolute;left:395.24px;top:66.4px;">168,004</div><div id="a21513" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:66.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21515" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:66.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21517" style="position:absolute;left:490.28px;top:66.4px;">166,448</div><div id="a21519" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:66.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21521" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:66.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21523" style="position:absolute;left:590px;top:66.4px;">34,932</div><div id="a21525" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:66.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21527" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:66.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21529" style="position:absolute;left:682.96px;top:66.4px;">30,483</div><div id="a21531" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84px;">Other </div><div id="a21533" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:84px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21535" style="position:absolute;left:408.52px;top:84px;">6,390</div><div id="a21537" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:84px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21539" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:84px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21541" style="position:absolute;left:503.56px;top:84px;">6,372</div><div id="a21543" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:84px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21545" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:84px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21547" style="position:absolute;left:596.56px;top:84px;">5,909</div><div id="a21549" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:84px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21551" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:84px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a21553" style="position:absolute;left:689.52px;top:84px;">5,824</div><div id="a21555" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:102.4px;">Total definite<div style="display:inline-block;width:1.37px"> </div>-lived intangible assets </div><div id="a21559" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:102.4px;">$ </div><div id="a21561" style="position:absolute;left:385.293px;top:102.4px;">1,032,419</div><div id="a21563" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:102.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21565" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:102.4px;">$ </div><div id="a21567" style="position:absolute;left:480.36px;top:102.4px;">1,012,371</div><div id="a21569" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:102.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21571" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:102.4px;">$ </div><div id="a21573" style="position:absolute;left:583.28px;top:102.4px;">168,724</div><div id="a21575" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:102.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21577" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:102.4px;">$ </div><div id="a21579" style="position:absolute;left:676.24px;top:102.4px;">136,113</div></div></div></div> 858025000 839551000 127883000 99806000 168004000 166448000 34932000 30483000 6390000 6372000 5909000 5824000 1032419000 1012371000 168724000 136113000 15000000.0 29800000 13700000 27700000 <div id="TextBlockContainer169" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:366px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21739" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0.8px;">For the year ended December 31, 2021 </div><div id="a21741" style="position:absolute;font-weight:normal;font-style:normal;left:275.533px;top:0.8px;">$ </div><div id="a21743" style="position:absolute;left:320.973px;top:0px;">59,214</div><div id="a21747" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:17.8px;">For the year ended December 31, 2022 </div><div id="a21750" style="position:absolute;left:320.973px;top:17px;">59,564</div><div id="a21754" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:34.9px;">For the year ended December 31, 2023 </div><div id="a21757" style="position:absolute;left:320.973px;top:33.9px;">59,394</div><div id="a21761" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.9px;">For the year ended December 31, 2024 </div><div id="a21764" style="position:absolute;left:320.973px;top:51.1px;">58,750</div><div id="a21768" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68.8px;">For the year ended December 31, 2025 </div><div id="a21771" style="position:absolute;left:320.973px;top:68px;">58,037</div><div id="a21775" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:85.8px;">For the year ended December 31, 2026 </div><div id="a21778" style="position:absolute;left:320.973px;top:85px;">57,740</div></div> 59214000 59564000 59394000 58750000 58037000 57740000 205100000 205100000 204000000.0 204000000.0 <div id="TextBlockContainer173" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:714px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21855" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Goodwill and intangible assets that have indefinite lives are<div style="display:inline-block;width:4.67px"> </div>not amortized and are required to be assessed at least annually<div style="display:inline-block;width:4.87px"> </div>for </div><div id="a21897" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">impairment.<div style="display:inline-block;width:7.17px"> </div>The Company completes its annual goodwill and indefinite-lived<div style="display:inline-block;width:4.73px"> </div>intangible asset impairment test during the fourth </div><div id="a21931" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">quarter of each year.<div style="display:inline-block;width:7.96px"> </div>The Company continuously evaluates if triggering events indicate<div style="display:inline-block;width:4.81px"> </div>a possible impairment in one or more of its </div><div id="a21973" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">reporting units or indefinite-lived or long-lived assets.</div></div> 38000000.0 38000000.0 <div id="TextBlockContainer178" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:427px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a22885" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 15 – Debt<div style="display:inline-block;width:3.67px"> </div></div><div id="a22894" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">Debt as of June 30, 2021 and December 31, 2020<div style="display:inline-block;width:4.73px"> </div>includes the following:</div></div><div id="TextBlockContainer182" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:685px;height:223px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_180_XBRL_TS_a1ea4a4dd4b147d5bfada4e8581daa8f" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer181" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:685px;height:223px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a22924" style="position:absolute;font-weight:bold;font-style:normal;left:345.133px;top:0px;">As of June 30, 2021 </div><div id="a22927" style="position:absolute;font-weight:bold;font-style:normal;left:521.16px;top:0px;">As of December 31, 2020 </div><div id="a22933" style="position:absolute;font-weight:bold;font-style:normal;left:316.973px;top:17.3px;">Interest </div><div id="a22936" style="position:absolute;font-weight:bold;font-style:normal;left:402.28px;top:17.3px;">Outstanding<div style="display:inline-block;width:3.55px"> </div></div><div id="a22939" style="position:absolute;font-weight:bold;font-style:normal;left:514.12px;top:17.3px;">Interest </div><div id="a22941" style="position:absolute;font-weight:bold;font-style:normal;left:588.4px;top:17.3px;">Outstanding<div style="display:inline-block;width:3.55px"> </div></div><div id="a22947" style="position:absolute;font-weight:bold;font-style:normal;left:325.933px;top:31.6px;">Rate </div><div id="a22950" style="position:absolute;font-weight:bold;font-style:normal;left:415.24px;top:31.6px;">Balance </div><div id="a22953" style="position:absolute;font-weight:bold;font-style:normal;left:523.08px;top:31.6px;">Rate </div><div id="a22955" style="position:absolute;font-weight:bold;font-style:normal;left:601.36px;top:31.6px;">Balance </div><div id="a22959" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:48px;">Credit Facilities: </div><div id="a22975" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:65.8px;">Revolver </div><div id="a22978" style="position:absolute;left:327.053px;top:65.8px;display:flex;">1.59%</div><div id="a22981" style="position:absolute;font-weight:normal;font-style:normal;left:384.52px;top:65.8px;">$ </div><div id="a22983" style="position:absolute;left:443.88px;top:65.8px;">189,503</div><div id="a22986" style="position:absolute;left:514.12px;top:65.8px;display:flex;">1.65%</div><div id="a22989" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:65.8px;">$ </div><div id="a22991" style="position:absolute;left:629.84px;top:65.8px;">160,000</div><div id="a22996" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:83.4px;">U.S. Term Loan </div><div id="a22999" style="position:absolute;left:327.053px;top:83.4px;display:flex;">1.59%</div><div id="a23003" style="position:absolute;left:443.88px;top:83.4px;">555,000</div><div id="a23006" style="position:absolute;left:514.12px;top:83.4px;display:flex;">1.65%</div><div id="a23010" style="position:absolute;left:628.88px;top:83.4px;">570,000</div><div id="a23015" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:101px;">EURO Term Loan </div><div id="a23018" style="position:absolute;left:327.053px;top:101px;display:flex;">1.50%</div><div id="a23022" style="position:absolute;left:443.88px;top:101px;">148,115</div><div id="a23025" style="position:absolute;left:514.12px;top:101px;display:flex;">1.50%</div><div id="a23029" style="position:absolute;left:628.88px;top:101px;">157,062</div><div id="a23033" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:117.5px;">Industrial development bonds </div><div id="a23036" style="position:absolute;left:327.053px;top:118.6px;display:flex;">5.26%</div><div id="a23040" style="position:absolute;left:450.6px;top:118.6px;">10,000</div><div id="a23043" style="position:absolute;left:514.12px;top:118.6px;display:flex;">5.26%</div><div id="a23047" style="position:absolute;left:635.6px;top:118.6px;">10,000</div><div id="a23051" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:135.1px;">Bank lines of credit and other debt obligations </div><div id="a23054" style="position:absolute;left:323.213px;top:136.2px;">Various</div><div id="a23058" style="position:absolute;left:457.16px;top:136.2px;">2,165</div><div id="a23061" style="position:absolute;left:510.28px;top:136.2px;">Various</div><div id="a23065" style="position:absolute;left:642.16px;top:136.2px;">2,072</div><div id="a23069" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153px;">Total debt </div><div id="a23074" style="position:absolute;font-weight:normal;font-style:normal;left:384.52px;top:153.8px;">$ </div><div id="a23076" style="position:absolute;left:443.88px;top:153.8px;">904,783</div><div id="a23081" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:153.8px;">$ </div><div id="a23083" style="position:absolute;left:628.88px;top:153.8px;">899,134</div><div id="a23087" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:170.3px;">Less: debt issuance costs </div><div id="a23093" style="position:absolute;left:452.36px;top:171.4px;">(9,550)</div><div id="a23099" style="position:absolute;left:630.64px;top:171.4px;">(11,099)</div><div id="a23103" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:187.9px;">Less: short-term and current portion of long-term debts </div><div id="a23113" style="position:absolute;left:445.64px;top:189px;">(48,079)</div><div id="a23119" style="position:absolute;left:630.64px;top:189px;">(38,967)</div><div id="a23123" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:206.3px;">Total long<div style="display:inline-block;width:1.36px"> </div>-term debt </div><div id="a23130" style="position:absolute;font-weight:normal;font-style:normal;left:384.52px;top:207.4px;">$ </div><div id="a23132" style="position:absolute;left:444.84px;top:207.4px;">847,154</div><div id="a23137" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:207.4px;">$ </div><div id="a23139" style="position:absolute;left:629.84px;top:207.4px;">849,068</div></div></div></div><div id="TextBlockContainer184" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:431px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a23142" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Credit facilities </div><div id="a23146" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The Company’s primary<div style="display:inline-block;width:4.76px"> </div>credit facility (as amended, the “Credit Facility”) is comprised<div style="display:inline-block;width:4.71px"> </div>of a $</div><div id="a23146_93_5" style="position:absolute;left:529.639px;top:23.4px;">400.0</div><div id="a23146_98_23" style="position:absolute;font-weight:normal;font-style:normal;left:559.719px;top:23.4px;"><div style="display:inline-block;width:3.36px"> </div>million multicurrency </div><div id="a23180" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">revolver (the “Revolver”), a $</div><div id="a23180_30_5" style="position:absolute;left:163.973px;top:38.7px;">600.0</div><div id="a23180_35_85" style="position:absolute;font-weight:normal;font-style:normal;left:194.053px;top:38.7px;"><div style="display:inline-block;width:3.36px"> </div>million term loan (the “U.S. Term<div style="display:inline-block;width:5px"> </div>Loan”), each with the Company as borrower,<div style="display:inline-block;width:5.06px"> </div>and a $</div><div id="a23180_120_5" style="position:absolute;left:665.199px;top:38.7px;">150.0</div><div id="a23180_125_1" style="position:absolute;font-weight:normal;font-style:normal;left:695.279px;top:38.7px;"> </div><div id="a23222" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.9px;">million (as of August 1, 2019) Euro equivalent term loan (the<div style="display:inline-block;width:4.71px"> </div>“EURO Term Loan”<div style="display:inline-block;width:4.89px"> </div>and together with the “U.S. Term<div style="display:inline-block;width:5.02px"> </div>Loan”, the </div><div id="a23266" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">“Term Loans”)<div style="display:inline-block;width:4.86px"> </div>with Quaker Chemical B.V.,<div style="display:inline-block;width:5.48px"> </div>a Dutch subsidiary of the Company as borrower,<div style="display:inline-block;width:4.96px"> </div>each with a </div><div id="a23266_100_9" style="position:absolute;left:571.44px;top:69.3px;">five year</div><div id="a23266_109_18" style="position:absolute;font-weight:normal;font-style:normal;left:618.48px;top:69.3px;"><div style="display:inline-block;width:3.36px"> </div>term maturing in </div><div id="a23310" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.7px;">August 2024.<div style="display:inline-block;width:7.18px"> </div>Subject to the consent of the administrative<div style="display:inline-block;width:4.3px"> </div>agent and certain other conditions, the Company may designate additional </div><div id="a23349" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">borrowers.<div style="display:inline-block;width:7.03px"> </div>The maximum amount available under the Credit Facility can be<div style="display:inline-block;width:4.73px"> </div>increased by up to $</div><div id="a23349_94_5" style="position:absolute;left:524.04px;top:100px;">300.0</div><div id="a23349_99_26" style="position:absolute;font-weight:normal;font-style:normal;left:554.12px;top:100px;"><div style="display:inline-block;width:3.36px"> </div>million at the Company’s </div><div id="a23389" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">request if there are lenders who agree to accept additional<div style="display:inline-block;width:4.87px"> </div>commitments and the Company has satisfied certain other<div style="display:inline-block;width:4.76px"> </div>conditions.<div style="display:inline-block;width:3.43px"> </div></div><div id="a23428" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.6px;">Borrowings under the Credit Facility bear interest at a base<div style="display:inline-block;width:4.8px"> </div>rate or LIBOR plus an applicable margin based upon<div style="display:inline-block;width:4.89px"> </div>the Company’s </div><div id="a23470" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:145.9px;">consolidated net leverage ratio.<div style="display:inline-block;width:7.38px"> </div>There are LIBOR replacement provisions that contemplate a further<div style="display:inline-block;width:4.88px"> </div>amendment if and when LIBOR </div><div id="a23507" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:161.3px;">ceases to be reported.<div style="display:inline-block;width:7.33px"> </div>The variable interest rate incurred on the outstanding borrowings under<div style="display:inline-block;width:4.86px"> </div>the Credit Facility as of and during the </div><div id="a23551" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:176.7px;">six months ended June 30, 2021 was approximately </div><div id="a23551_49_3" style="position:absolute;left:283.373px;top:176.7px;">1.6</div><div id="a23551_52_77" style="position:absolute;font-weight:normal;font-style:normal;left:300.173px;top:176.7px;">%.<div style="display:inline-block;width:6.74px"> </div>In addition to paying interest on outstanding principal under<div style="display:inline-block;width:4.83px"> </div>the Credit </div><div id="a23594" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:192px;">Facility, the Company<div style="display:inline-block;width:4.89px"> </div>is required to pay a commitment fee ranging from </div><div id="a23594_71_3" style="position:absolute;left:396.04px;top:192px;">0.2</div><div id="a23594_74_5" style="position:absolute;font-weight:normal;font-style:normal;left:412.84px;top:192px;">% to </div><div id="a23594_79_3" style="position:absolute;left:440.84px;top:192px;">0.3</div><div id="a23594_82_46" style="position:absolute;font-weight:normal;font-style:normal;left:457.64px;top:192px;">% depending on the Company’s<div style="display:inline-block;width:4.78px"> </div>consolidated net </div><div id="a23636" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:207.4px;">leverage ratio to the lenders under the Revolver in<div style="display:inline-block;width:4.55px"> </div>respect of the unutilized commitments thereunder.<div style="display:inline-block;width:8.65px"> </div>The Company has unused </div><div id="a23674" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:222.6px;">capacity under the Revolver of approximately $</div><div id="a23674_46_3" style="position:absolute;left:259.373px;top:222.6px;">206</div><div id="a23674_49_58" style="position:absolute;font-weight:normal;font-style:normal;left:279.373px;top:222.6px;"><div style="display:inline-block;width:3.36px"> </div>million, net of bank letters of credit of approximately $</div><div id="a23674_107_1" style="position:absolute;left:576.88px;top:222.6px;">4</div><div id="a23674_108_25" style="position:absolute;font-weight:normal;font-style:normal;left:583.44px;top:222.6px;"><div style="display:inline-block;width:3.36px"> </div>million, as of June 30, </div><div id="a23719" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:237.9px;">2021.<div style="display:inline-block;width:6.79px"> </div></div><div id="a23722" style="position:absolute;left:28.427px;top:261.3px;">The Credit Facility is subject to certain financial and other covenants. The Company’s initial consolidated net debt to </div><div id="a23759" style="position:absolute;left:4.427px;top:276.7px;">consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit </div><div id="a23805" style="position:absolute;left:4.427px;top:292.1px;">Facility.</div><div id="a23805_9_83" style="position:absolute;font-weight:normal;font-style:normal;left:48.459px;top:292.1px;"><div style="display:inline-block;width:6.72px"> </div>As of June 30, 2021, the consolidated net debt to adjusted<div style="display:inline-block;width:4.69px"> </div>EBITDA may not exceed </div><div id="a23805_92_4" style="position:absolute;left:505.959px;top:292.1px;">4.00</div><div id="a23805_96_35" style="position:absolute;font-weight:normal;font-style:normal;left:529.319px;top:292.1px;"><div style="display:inline-block;width:3.36px"> </div>to 1.<div style="display:inline-block;width:6.79px"> </div>The Company’s consolidated </div><div id="a23850" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:307.4px;">adjusted EBITDA to interest expense ratio cannot<div style="display:inline-block;width:4.56px"> </div>be less than </div><div id="a23850_62_3" style="position:absolute;left:339.373px;top:307.4px;">3.0</div><div id="a23850_65_64" style="position:absolute;font-weight:normal;font-style:normal;left:356.173px;top:307.4px;"><div style="display:inline-block;width:3.36px"> </div>to 1 over the term of the agreement.<div style="display:inline-block;width:7.36px"> </div>The Credit Facility also </div><div id="a23896" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:322.6px;">prohibits the payment of cash dividends if the Company<div style="display:inline-block;width:4.78px"> </div>is in default or if the amount of the dividend paid annually<div style="display:inline-block;width:4.79px"> </div>exceeds the greater </div><div id="a23944" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:338px;">of $</div><div id="a23944_4_4" style="position:absolute;left:25.707px;top:338px;">50.0</div><div id="a23944_8_13" style="position:absolute;font-weight:normal;font-style:normal;left:49.099px;top:338px;"><div style="display:inline-block;width:3.2px"> </div>million and </div><div id="a23944_21_2" style="position:absolute;left:116.773px;top:338px;">20</div><div id="a23944_23_101" style="position:absolute;font-weight:normal;font-style:normal;left:130.213px;top:338px;">% of consolidated adjusted EBITDA unless the ratio of consolidated<div style="display:inline-block;width:4.7px"> </div>net debt to consolidated adjusted </div><div id="a23982" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:353.3px;">EBITDA is less than </div><div id="a23982_20_3" style="position:absolute;left:118.533px;top:353.3px;">2.0</div><div id="a23982_23_61" style="position:absolute;font-weight:normal;font-style:normal;left:135.333px;top:353.3px;"><div style="display:inline-block;width:3.36px"> </div>to 1, in which case there is no such limitation on amount.<div style="display:inline-block;width:8.05px"> </div></div><div id="a23982_84_47" style="position:absolute;left:450.279px;top:353.3px;">As of June 30, 2021 and December 31, 2020, the </div><div id="a24037" style="position:absolute;left:4.427px;top:368.7px;">Company was in compliance with all of the Credit Facility covenants.</div><div id="a24037_68_62" style="position:absolute;font-weight:normal;font-style:normal;left:377.613px;top:368.7px;"><div style="display:inline-block;width:6.72px"> </div>The Term Loans have<div style="display:inline-block;width:4.71px"> </div>quarterly principal amortization during </div><div id="a24075" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:384.1px;">their </div><div id="a24075_6_9" style="position:absolute;left:32.267px;top:384.1px;">five year</div><div id="a24075_15_13" style="position:absolute;font-weight:normal;font-style:normal;left:79.338px;top:384.1px;"><div style="display:inline-block;width:3.36px"> </div>terms, with </div><div id="a24075_28_3" style="position:absolute;left:146.053px;top:384.1px;">5.0</div><div id="a24075_31_62" style="position:absolute;font-weight:normal;font-style:normal;left:162.533px;top:384.1px;">% amortization of the principal balance due in years<div style="display:inline-block;width:4.54px"> </div>1 and 2, </div><div id="a24075_93_3" style="position:absolute;left:490.279px;top:384.1px;">7.5</div><div id="a24075_96_17" style="position:absolute;font-weight:normal;font-style:normal;left:507.079px;top:384.1px;">% in year 3, and </div><div id="a24075_113_4" style="position:absolute;left:597.359px;top:384.1px;">10.0</div><div id="a24075_117_20" style="position:absolute;font-weight:normal;font-style:normal;left:620.879px;top:384.1px;">% in years 4 and 5, </div><div id="a24131" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:399.3px;">with the remaining principal amount due at maturity.<div style="display:inline-block;width:8.87px"> </div>During the six months ended June 30, 2021, the Company made<div style="display:inline-block;width:4.7px"> </div>quarterly </div><div id="a24171" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:414.6px;">amortization payments related to the Term<div style="display:inline-block;width:5.35px"> </div>Loans totaling $</div><div id="a24171_58_4" style="position:absolute;left:321.613px;top:414.6px;">19.1</div><div id="a24171_62_63" style="position:absolute;font-weight:normal;font-style:normal;left:344.973px;top:414.6px;"><div style="display:inline-block;width:3.36px"> </div>million.<div style="display:inline-block;width:6.82px"> </div>The Credit Facility is guaranteed by certain of the </div></div><div id="TextBlockContainer186" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:734px;height:277px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a24258" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">Company’s domestic subsidiaries<div style="display:inline-block;width:4.8px"> </div>and is secured by first priority liens on substantially all of<div style="display:inline-block;width:4.83px"> </div>the assets of the Company and the </div><div id="a24301" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">domestic subsidiary guarantors, subject to certain customary exclusions.<div style="display:inline-block;width:8.33px"> </div>The obligations of the Dutch borrower are guaranteed only </div><div id="a24335" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">by certain foreign subsidiaries on an unsecured basis. </div><div id="a24351" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:53.9px;">The Credit Facility required the Company to fix its variable<div style="display:inline-block;width:4.87px"> </div>interest rates on at least </div><div id="a24351_88_2" style="position:absolute;left:478.439px;top:53.9px;">20</div><div id="a24351_90_40" style="position:absolute;font-weight:normal;font-style:normal;left:491.879px;top:53.9px;">% of its total Term Loans.<div style="display:inline-block;width:8.28px"> </div>In order to </div><div id="a24399" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">satisfy this requirement as well as to manage the<div style="display:inline-block;width:4.74px"> </div>Company’s exposure to variable<div style="display:inline-block;width:4.69px"> </div>interest rate risk associated with the Credit Facility, </div><div id="a24441" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">in November 2019, the Company entered into $</div><div id="a24441_44_5" style="position:absolute;left:259.373px;top:84.6px;">170.0</div><div id="a24441_49_78" style="position:absolute;font-weight:normal;font-style:normal;left:289.453px;top:84.6px;"><div style="display:inline-block;width:3.36px"> </div>million notional amounts of three year interest rate swaps at a base<div style="display:inline-block;width:4.72px"> </div>rate of </div><div id="a24441_127_4" style="position:absolute;left:689.679px;top:84.6px;">1.64</div><div id="a24441_131_2" style="position:absolute;font-weight:normal;font-style:normal;left:713.199px;top:84.6px;">% </div><div id="a24487" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">plus an applicable margin as provided in the<div style="display:inline-block;width:4.75px"> </div>Credit Facility, based on<div style="display:inline-block;width:4.7px"> </div>the Company’s consolidated net<div style="display:inline-block;width:4.72px"> </div>leverage ratio.<div style="display:inline-block;width:6.97px"> </div>At the time the </div><div id="a24532" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">Company entered into the swaps, and as of June 30,<div style="display:inline-block;width:4.73px"> </div>2021, the aggregate interest rate on the swaps, including the<div style="display:inline-block;width:4.53px"> </div>fixed base rate plus </div><div id="a24580" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.7px;">an applicable margin, was </div><div id="a24580_26_3" style="position:absolute;left:147.013px;top:130.7px;">3.1</div><div id="a24580_29_73" style="position:absolute;font-weight:normal;font-style:normal;left:163.653px;top:130.7px;">%.<div style="display:inline-block;width:6.74px"> </div>See Note 18 of Notes to Condensed Consolidated Financial Statements. </div><div id="a24610" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:153.9px;">The Company capitalized $</div><div id="a24610_25_4" style="position:absolute;left:175.493px;top:153.9px;">23.7</div><div id="a24610_29_103" style="position:absolute;font-weight:normal;font-style:normal;left:198.853px;top:153.9px;"><div style="display:inline-block;width:3.36px"> </div>million of certain third-party debt issuance costs in connection<div style="display:inline-block;width:4.8px"> </div>with executing the Credit Facility.<div style="display:inline-block;width:4.84px"> </div></div><div id="a24648" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:169.3px;">Approximately $</div><div id="a24648_15_4" style="position:absolute;left:95.339px;top:169.3px;">15.5</div><div id="a24648_19_111" style="position:absolute;font-weight:normal;font-style:normal;left:118.693px;top:169.3px;"><div style="display:inline-block;width:3.36px"> </div>million of the capitalized costs were attributed to the Term<div style="display:inline-block;width:5.55px"> </div>Loans and recorded as a direct reduction of long-</div><div id="a24690" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:184.6px;">term debt on the Company’s<div style="display:inline-block;width:4.74px"> </div>Condensed Consolidated Balance Sheet.<div style="display:inline-block;width:7.79px"> </div>Approximately $</div><div id="a24690_81_3" style="position:absolute;left:472.84px;top:184.6px;">8.3</div><div id="a24690_84_39" style="position:absolute;font-weight:normal;font-style:normal;left:489.48px;top:184.6px;"><div style="display:inline-block;width:3.36px"> </div>million of the capitalized costs were </div><div id="a24725" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:200px;">attributed to the Revolver and recorded within other assets on<div style="display:inline-block;width:4.8px"> </div>the Company’s Condensed Consolidated<div style="display:inline-block;width:4.89px"> </div>Balance Sheet.<div style="display:inline-block;width:7.05px"> </div>These </div><div id="a24759" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:215.4px;">capitalized costs are being amortized into interest expense<div style="display:inline-block;width:4.87px"> </div>over the five year term of the Credit Facility.<div style="display:inline-block;width:8.54px"> </div>As of June 30, 2021 and </div><div id="a24807" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:230.8px;">December 31, 2020, the Company had $</div><div id="a24807_36_3" style="position:absolute;left:220.133px;top:230.8px;">9.6</div><div id="a24807_39_14" style="position:absolute;font-weight:normal;font-style:normal;left:236.813px;top:230.8px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a24807_53_4" style="position:absolute;left:311.213px;top:230.8px;">11.1</div><div id="a24807_57_74" style="position:absolute;font-weight:normal;font-style:normal;left:334.573px;top:230.8px;"><div style="display:inline-block;width:3.36px"> </div>million, respectively,<div style="display:inline-block;width:4.72px"> </div>of debt issuance costs recorded as a reduction of </div><div id="a24849" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:246px;">long-term debt.<div style="display:inline-block;width:7.11px"> </div>As of June 30, 2021 and December 31, 2020, the Company<div style="display:inline-block;width:4.82px"> </div>had $</div><div id="a24849_77_3" style="position:absolute;left:441.959px;top:246px;">5.1</div><div id="a24849_80_14" style="position:absolute;font-weight:normal;font-style:normal;left:458.759px;top:246px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a24849_94_3" style="position:absolute;left:533.159px;top:246px;">5.9</div><div id="a24849_97_32" style="position:absolute;font-weight:normal;font-style:normal;left:549.799px;top:246px;"><div style="display:inline-block;width:3.36px"> </div>million, respectively, of<div style="display:inline-block;width:4.6px"> </div>debt </div><div id="a24897" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:261.3px;">issuance costs recorded within other assets.</div></div><div id="TextBlockContainer188" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:240px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a24911" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Industrial development bonds </div><div id="a24917" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">As of June 30, 2021 and December 31, 2020, the Company<div style="display:inline-block;width:4.66px"> </div>had fixed rate, industrial development authority bonds totaling<div style="display:inline-block;width:4.94px"> </div>$</div><div id="a24917_120_4" style="position:absolute;left:691.279px;top:23.4px;">10.0</div><div id="a24917_124_1" style="position:absolute;font-weight:normal;font-style:normal;left:714.639px;top:23.4px;"> </div><div id="a24960" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">million in principal amount due in </div><div id="a24960_35_4" style="position:absolute;left:190.373px;top:38.7px;">2028</div><div id="a24960_39_74" style="position:absolute;font-weight:normal;font-style:normal;left:217.093px;top:38.7px;">.<div style="display:inline-block;width:6.8px"> </div>These bonds have similar covenants to the Credit Facility noted above. </div><div id="a24997" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:62.1px;">Bank lines of credit and other<div style="display:inline-block;width:4.53px"> </div>debt obligations </div><div id="a25013" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:85.3px;">The Company has certain unsecured bank lines of credit<div style="display:inline-block;width:4.89px"> </div>and discounting facilities in one of its foreign subsidiaries, which<div style="display:inline-block;width:4.74px"> </div>are not </div><div id="a25056" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100.6px;">collateralized.<div style="display:inline-block;width:7.12px"> </div>The Company’s other debt<div style="display:inline-block;width:4.7px"> </div>obligations primarily consist of certain domestic and foreign<div style="display:inline-block;width:4.88px"> </div>low interest rate or interest-</div><div id="a25092" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:116px;">free municipality-related loans, local credit facilities of<div style="display:inline-block;width:4.79px"> </div>certain foreign subsidiaries and capital lease obligations.<div style="display:inline-block;width:7.84px"> </div>Total unused </div><div id="a25127" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:131.4px;">capacity under these arrangements as of June 30, 2021<div style="display:inline-block;width:4.83px"> </div>was approximately $</div><div id="a25127_73_2" style="position:absolute;left:409.8px;top:131.4px;">40</div><div id="a25127_75_10" style="position:absolute;font-weight:normal;font-style:normal;left:423.08px;top:131.4px;"><div style="display:inline-block;width:3.36px"> </div>million. </div><div id="a25156" style="position:absolute;left:28.427px;top:154.7px;">In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s only other off-balance </div><div id="a25198" style="position:absolute;left:4.427px;top:169.9px;">sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees </div><div id="a25233" style="position:absolute;left:4.427px;top:185.3px;">outstanding as of June 30, 2021 were approximately $7 million.</div><div id="a25233_62_1" style="position:absolute;font-weight:normal;font-style:normal;left:344.813px;top:185.3px;"> </div><div id="a25256" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:208.7px;">The Company incurred the following debt related expenses<div style="display:inline-block;width:4.7px"> </div>included within Interest expense, net, in the Condensed<div style="display:inline-block;width:4.86px"> </div>Consolidated </div><div id="a25291" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:224px;">Statements of Operations:</div></div><div id="TextBlockContainer191" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:722px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25299" style="position:absolute;font-weight:bold;font-style:normal;left:384.013px;top:0px;">Three Months Ended </div><div id="a25302" style="position:absolute;font-weight:bold;font-style:normal;left:578.16px;top:0px;">Six Months Ended </div><div id="a25305" style="position:absolute;font-weight:bold;font-style:normal;left:421px;top:17px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a25308" style="position:absolute;font-weight:bold;font-style:normal;left:607.12px;top:17px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a25311" style="position:absolute;font-weight:bold;font-style:normal;left:384.813px;top:34.1px;">2021 </div><div id="a25314" style="position:absolute;font-weight:bold;font-style:normal;left:477.8px;top:34.1px;">2020 </div><div id="a25317" style="position:absolute;font-weight:bold;font-style:normal;left:570.96px;top:34.1px;">2021 </div><div id="a25320" style="position:absolute;font-weight:bold;font-style:normal;left:663.92px;top:34.1px;">2020 </div><div id="a25322" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51px;">Interest expense </div><div id="a25324" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:51px;">$ </div><div id="a25326" style="position:absolute;left:404.04px;top:51px;">4,813</div><div id="a25329" style="position:absolute;font-weight:normal;font-style:normal;left:451.4px;top:51px;">$ </div><div id="a25331" style="position:absolute;left:497px;top:51px;">5,951</div><div id="a25334" style="position:absolute;font-weight:normal;font-style:normal;left:544.52px;top:51px;">$ </div><div id="a25336" style="position:absolute;left:590px;top:51px;">9,463</div><div id="a25339" style="position:absolute;font-weight:normal;font-style:normal;left:637.52px;top:51px;">$ </div><div id="a25341" style="position:absolute;left:676.4px;top:51px;">13,663</div><div id="a25343" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">Amortization of debt issuance costs </div><div id="a25346" style="position:absolute;left:404.04px;top:68px;">1,188</div><div id="a25350" style="position:absolute;left:497px;top:68px;">1,188</div><div id="a25354" style="position:absolute;left:590px;top:68px;">2,375</div><div id="a25358" style="position:absolute;left:682.96px;top:68px;">2,375</div><div id="a25360" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:86.1px;">Total </div><div id="a25362" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:86.1px;">$ </div><div id="a25364" style="position:absolute;left:404.04px;top:86.1px;">6,001</div><div id="a25367" style="position:absolute;font-weight:normal;font-style:normal;left:451.4px;top:86.1px;">$ </div><div id="a25369" style="position:absolute;left:497px;top:86.1px;">7,139</div><div id="a25372" style="position:absolute;font-weight:normal;font-style:normal;left:544.52px;top:86.1px;">$ </div><div id="a25374" style="position:absolute;left:583.44px;top:86.1px;">11,838</div><div id="a25377" style="position:absolute;font-weight:normal;font-style:normal;left:637.52px;top:86.1px;">$ </div><div id="a25379" style="position:absolute;left:676.4px;top:86.1px;">16,038</div></div><div id="TextBlockContainer194" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:721px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25381" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Based on the variable interest rates associated with the Credit<div style="display:inline-block;width:4.75px"> </div>Facility, as of June<div style="display:inline-block;width:4.73px"> </div>30, 2021 and December 31, 2020, the amounts </div><div id="a25425" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">at which the Company’s<div style="display:inline-block;width:4.75px"> </div>total debt were recorded are not materially different<div style="display:inline-block;width:4.66px"> </div>from their fair market value.</div></div> <div id="TextBlockContainer181" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:685px;height:223px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a22924" style="position:absolute;font-weight:bold;font-style:normal;left:345.133px;top:0px;">As of June 30, 2021 </div><div id="a22927" style="position:absolute;font-weight:bold;font-style:normal;left:521.16px;top:0px;">As of December 31, 2020 </div><div id="a22933" style="position:absolute;font-weight:bold;font-style:normal;left:316.973px;top:17.3px;">Interest </div><div id="a22936" style="position:absolute;font-weight:bold;font-style:normal;left:402.28px;top:17.3px;">Outstanding<div style="display:inline-block;width:3.55px"> </div></div><div id="a22939" style="position:absolute;font-weight:bold;font-style:normal;left:514.12px;top:17.3px;">Interest </div><div id="a22941" style="position:absolute;font-weight:bold;font-style:normal;left:588.4px;top:17.3px;">Outstanding<div style="display:inline-block;width:3.55px"> </div></div><div id="a22947" style="position:absolute;font-weight:bold;font-style:normal;left:325.933px;top:31.6px;">Rate </div><div id="a22950" style="position:absolute;font-weight:bold;font-style:normal;left:415.24px;top:31.6px;">Balance </div><div id="a22953" style="position:absolute;font-weight:bold;font-style:normal;left:523.08px;top:31.6px;">Rate </div><div id="a22955" style="position:absolute;font-weight:bold;font-style:normal;left:601.36px;top:31.6px;">Balance </div><div id="a22959" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:48px;">Credit Facilities: </div><div id="a22975" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:65.8px;">Revolver </div><div id="a22978" style="position:absolute;left:327.053px;top:65.8px;display:flex;">1.59%</div><div id="a22981" style="position:absolute;font-weight:normal;font-style:normal;left:384.52px;top:65.8px;">$ </div><div id="a22983" style="position:absolute;left:443.88px;top:65.8px;">189,503</div><div id="a22986" style="position:absolute;left:514.12px;top:65.8px;display:flex;">1.65%</div><div id="a22989" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:65.8px;">$ </div><div id="a22991" style="position:absolute;left:629.84px;top:65.8px;">160,000</div><div id="a22996" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:83.4px;">U.S. Term Loan </div><div id="a22999" style="position:absolute;left:327.053px;top:83.4px;display:flex;">1.59%</div><div id="a23003" style="position:absolute;left:443.88px;top:83.4px;">555,000</div><div id="a23006" style="position:absolute;left:514.12px;top:83.4px;display:flex;">1.65%</div><div id="a23010" style="position:absolute;left:628.88px;top:83.4px;">570,000</div><div id="a23015" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:101px;">EURO Term Loan </div><div id="a23018" style="position:absolute;left:327.053px;top:101px;display:flex;">1.50%</div><div id="a23022" style="position:absolute;left:443.88px;top:101px;">148,115</div><div id="a23025" style="position:absolute;left:514.12px;top:101px;display:flex;">1.50%</div><div id="a23029" style="position:absolute;left:628.88px;top:101px;">157,062</div><div id="a23033" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:117.5px;">Industrial development bonds </div><div id="a23036" style="position:absolute;left:327.053px;top:118.6px;display:flex;">5.26%</div><div id="a23040" style="position:absolute;left:450.6px;top:118.6px;">10,000</div><div id="a23043" style="position:absolute;left:514.12px;top:118.6px;display:flex;">5.26%</div><div id="a23047" style="position:absolute;left:635.6px;top:118.6px;">10,000</div><div id="a23051" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:135.1px;">Bank lines of credit and other debt obligations </div><div id="a23054" style="position:absolute;left:323.213px;top:136.2px;">Various</div><div id="a23058" style="position:absolute;left:457.16px;top:136.2px;">2,165</div><div id="a23061" style="position:absolute;left:510.28px;top:136.2px;">Various</div><div id="a23065" style="position:absolute;left:642.16px;top:136.2px;">2,072</div><div id="a23069" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153px;">Total debt </div><div id="a23074" style="position:absolute;font-weight:normal;font-style:normal;left:384.52px;top:153.8px;">$ </div><div id="a23076" style="position:absolute;left:443.88px;top:153.8px;">904,783</div><div id="a23081" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:153.8px;">$ </div><div id="a23083" style="position:absolute;left:628.88px;top:153.8px;">899,134</div><div id="a23087" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:170.3px;">Less: debt issuance costs </div><div id="a23093" style="position:absolute;left:452.36px;top:171.4px;">(9,550)</div><div id="a23099" style="position:absolute;left:630.64px;top:171.4px;">(11,099)</div><div id="a23103" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:187.9px;">Less: short-term and current portion of long-term debts </div><div id="a23113" style="position:absolute;left:445.64px;top:189px;">(48,079)</div><div id="a23119" style="position:absolute;left:630.64px;top:189px;">(38,967)</div><div id="a23123" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:206.3px;">Total long<div style="display:inline-block;width:1.36px"> </div>-term debt </div><div id="a23130" style="position:absolute;font-weight:normal;font-style:normal;left:384.52px;top:207.4px;">$ </div><div id="a23132" style="position:absolute;left:444.84px;top:207.4px;">847,154</div><div id="a23137" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:207.4px;">$ </div><div id="a23139" style="position:absolute;left:629.84px;top:207.4px;">849,068</div></div> 1.59 189503000 1.65 160000000 1.59 555000000 1.65 570000000 1.50 148115000 1.50 157062000 5.26 10000000 5.26 10000000 Various 2165000 Various 2072000 904783000 899134000 9550000 11099000 48079000 38967000 847154000 847154000 849068000 849068000 400000000.0 600000000.0 150000000.0 P5Y 300000000.0 0.016 0.002 0.003 206000000 4000000 The Credit Facility is subject to certain financial and other covenants. The Company’s initial consolidated net debt to consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit Facility. 4.25 4.00 3.0 50000000.0 0.20 2.0 As of June 30, 2021 and December 31, 2020, the Company was in compliance with all of the Credit Facility covenants. P5Y 0.050 0.075 0.100 19100000 0.20 170000000.0 0.0164 0.031 23700000 15500000 8300000 9600000 11100000 5100000 5900000 10000000.0 10000000.0 2028 40000000 In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s only other off-balance sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees outstanding as of June 30, 2021 were approximately $7 million. 7000000 <div id="TextBlockContainer192" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:722px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_190_XBRL_TS_207f68d821cb4a09ac6e703a54e25dd0" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer191" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:722px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25299" style="position:absolute;font-weight:bold;font-style:normal;left:384.013px;top:0px;">Three Months Ended </div><div id="a25302" style="position:absolute;font-weight:bold;font-style:normal;left:578.16px;top:0px;">Six Months Ended </div><div id="a25305" style="position:absolute;font-weight:bold;font-style:normal;left:421px;top:17px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a25308" style="position:absolute;font-weight:bold;font-style:normal;left:607.12px;top:17px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a25311" style="position:absolute;font-weight:bold;font-style:normal;left:384.813px;top:34.1px;">2021 </div><div id="a25314" style="position:absolute;font-weight:bold;font-style:normal;left:477.8px;top:34.1px;">2020 </div><div id="a25317" style="position:absolute;font-weight:bold;font-style:normal;left:570.96px;top:34.1px;">2021 </div><div id="a25320" style="position:absolute;font-weight:bold;font-style:normal;left:663.92px;top:34.1px;">2020 </div><div id="a25322" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51px;">Interest expense </div><div id="a25324" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:51px;">$ </div><div id="a25326" style="position:absolute;left:404.04px;top:51px;">4,813</div><div id="a25329" style="position:absolute;font-weight:normal;font-style:normal;left:451.4px;top:51px;">$ </div><div id="a25331" style="position:absolute;left:497px;top:51px;">5,951</div><div id="a25334" style="position:absolute;font-weight:normal;font-style:normal;left:544.52px;top:51px;">$ </div><div id="a25336" style="position:absolute;left:590px;top:51px;">9,463</div><div id="a25339" style="position:absolute;font-weight:normal;font-style:normal;left:637.52px;top:51px;">$ </div><div id="a25341" style="position:absolute;left:676.4px;top:51px;">13,663</div><div id="a25343" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">Amortization of debt issuance costs </div><div id="a25346" style="position:absolute;left:404.04px;top:68px;">1,188</div><div id="a25350" style="position:absolute;left:497px;top:68px;">1,188</div><div id="a25354" style="position:absolute;left:590px;top:68px;">2,375</div><div id="a25358" style="position:absolute;left:682.96px;top:68px;">2,375</div><div id="a25360" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:86.1px;">Total </div><div id="a25362" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:86.1px;">$ </div><div id="a25364" style="position:absolute;left:404.04px;top:86.1px;">6,001</div><div id="a25367" style="position:absolute;font-weight:normal;font-style:normal;left:451.4px;top:86.1px;">$ </div><div id="a25369" style="position:absolute;left:497px;top:86.1px;">7,139</div><div id="a25372" style="position:absolute;font-weight:normal;font-style:normal;left:544.52px;top:86.1px;">$ </div><div id="a25374" style="position:absolute;left:583.44px;top:86.1px;">11,838</div><div id="a25377" style="position:absolute;font-weight:normal;font-style:normal;left:637.52px;top:86.1px;">$ </div><div id="a25379" style="position:absolute;left:676.4px;top:86.1px;">16,038</div></div></div></div> 4813000 5951000 9463000 13663000 1188000 1188000 2375000 2375000 6001000 7139000 11838000 16038000 <div id="TextBlockContainer196" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:688px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25508" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 16 – Equity </div><div id="a25516" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The following tables present the changes in equity,<div style="display:inline-block;width:5.44px"> </div>net of tax, for the three and six months ended June 30, 2021<div style="display:inline-block;width:4.72px"> </div>and 2020:</div></div><div id="TextBlockContainer199" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:730px;height:362px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25575" style="position:absolute;font-weight:bold;font-style:normal;left:463.72px;top:0px;">Accumulated </div><div id="a25589" style="position:absolute;font-weight:bold;font-style:normal;left:317.773px;top:14.9px;">Capital in </div><div id="a25595" style="position:absolute;font-weight:bold;font-style:normal;left:484.52px;top:14.9px;">Other </div><div id="a25606" style="position:absolute;font-weight:bold;font-style:normal;left:255.053px;top:29.9px;">Common </div><div id="a25609" style="position:absolute;font-weight:bold;font-style:normal;left:320.013px;top:29.9px;">Excess of </div><div id="a25612" style="position:absolute;font-weight:bold;font-style:normal;left:391.053px;top:29.9px;">Retained </div><div id="a25615" style="position:absolute;font-weight:bold;font-style:normal;left:457px;top:29.9px;">Comprehensive </div><div id="a25618" style="position:absolute;font-weight:bold;font-style:normal;left:555.08px;top:29.9px;">Noncontrolling </div><div id="a25626" style="position:absolute;font-weight:bold;font-style:normal;left:265.453px;top:45px;">Stock </div><div id="a25629" style="position:absolute;font-weight:bold;font-style:normal;left:317.293px;top:45px;">Par Value </div><div id="a25632" style="position:absolute;font-weight:bold;font-style:normal;left:390.573px;top:45px;">Earnings </div><div id="a25635" style="position:absolute;font-weight:bold;font-style:normal;left:488.52px;top:45px;">Loss </div><div id="a25638" style="position:absolute;font-weight:bold;font-style:normal;left:575.76px;top:45px;">Interest </div><div id="a25641" style="position:absolute;font-weight:bold;font-style:normal;left:669.84px;top:45px;">Total </div><div id="a25643" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:62.2px;">Balance at March 31, 2021 </div><div id="a25645" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:62.2px;">$ </div><div id="a25647" style="position:absolute;left:267.853px;top:62.2px;">17,875</div><div id="a25650" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:62.2px;">$ </div><div id="a25652" style="position:absolute;left:329.293px;top:62.2px;">908,748</div><div id="a25655" style="position:absolute;font-weight:normal;font-style:normal;left:383.533px;top:62.2px;">$ </div><div id="a25657" style="position:absolute;left:402.28px;top:62.2px;">455,493</div><div id="a25660" style="position:absolute;font-weight:normal;font-style:normal;left:456.52px;top:62.2px;">$ </div><div id="a25662" style="position:absolute;left:501px;top:62.2px;">(53,228)</div><div id="a25665" style="position:absolute;font-weight:normal;font-style:normal;left:553.48px;top:62.2px;">$ </div><div id="a25667" style="position:absolute;left:618.64px;top:62.2px;">565</div><div id="a25670" style="position:absolute;font-weight:normal;font-style:normal;left:649.52px;top:62.2px;">$ </div><div id="a25672" style="position:absolute;left:663.44px;top:62.2px;">1,329,453</div><div id="a25675" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:79.8px;">Net income </div><div id="a25678" style="position:absolute;left:291.213px;top:79.8px;">—</div><div id="a25682" style="position:absolute;left:359.373px;top:79.8px;">—</div><div id="a25686" style="position:absolute;left:409px;top:79.8px;">33,570</div><div id="a25690" style="position:absolute;left:529.32px;top:79.8px;">—</div><div id="a25694" style="position:absolute;left:625.36px;top:79.8px;">30</div><div id="a25698" style="position:absolute;left:680.08px;top:79.8px;">33,600</div><div id="a25701" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:97.4px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4.32px"> </div></div><div id="a25722" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:115px;">income </div><div id="a25725" style="position:absolute;left:291.213px;top:115px;">—</div><div id="a25729" style="position:absolute;left:359.373px;top:115px;">—</div><div id="a25733" style="position:absolute;left:432.36px;top:115px;">—</div><div id="a25737" style="position:absolute;left:505.96px;top:115px;">17,285</div><div id="a25741" style="position:absolute;left:631.92px;top:115px;">8</div><div id="a25745" style="position:absolute;left:680.08px;top:115px;">17,293</div><div id="a25748" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:132.6px;">Dividends ($</div><div id="a25748_12_5" style="position:absolute;left:83.786px;top:132.6px;">0.395</div><div id="a25748_17_12" style="position:absolute;font-weight:normal;font-style:normal;left:113.706px;top:132.6px;"><div style="display:inline-block;width:3.36px"> </div>per share) </div><div id="a25751" style="position:absolute;left:291.213px;top:132.6px;">—</div><div id="a25755" style="position:absolute;left:359.373px;top:132.6px;">—</div><div id="a25759" style="position:absolute;left:410.76px;top:132.6px;">(7,062)</div><div id="a25763" style="position:absolute;left:529.32px;top:132.6px;">—</div><div id="a25767" style="position:absolute;left:625.36px;top:132.6px;">—</div><div id="a25771" style="position:absolute;left:681.84px;top:132.6px;">(7,062)</div><div id="a25774" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:150.2px;">Share issuance and equity-based </div><div id="a25797" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:167.9px;">compensation plans </div><div id="a25800" style="position:absolute;left:297.773px;top:167.9px;">3</div><div id="a25804" style="position:absolute;left:342.573px;top:167.9px;">2,114</div><div id="a25808" style="position:absolute;left:432.36px;top:167.9px;">—</div><div id="a25812" style="position:absolute;left:529.32px;top:167.9px;">—</div><div id="a25816" style="position:absolute;left:625.36px;top:167.9px;">—</div><div id="a25820" style="position:absolute;left:686.64px;top:167.9px;">2,117</div><div id="a25822" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:186.3px;">Balance at June 30, 2021 </div><div id="a25824" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:186.3px;">$ </div><div id="a25826" style="position:absolute;left:267.853px;top:186.3px;">17,878</div><div id="a25829" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:186.3px;">$ </div><div id="a25831" style="position:absolute;left:329.293px;top:186.3px;">910,862</div><div id="a25834" style="position:absolute;font-weight:normal;font-style:normal;left:383.533px;top:186.3px;">$ </div><div id="a25836" style="position:absolute;left:402.28px;top:186.3px;">482,001</div><div id="a25839" style="position:absolute;font-weight:normal;font-style:normal;left:456.52px;top:186.3px;">$ </div><div id="a25841" style="position:absolute;left:501px;top:186.3px;">(35,943)</div><div id="a25844" style="position:absolute;font-weight:normal;font-style:normal;left:553.48px;top:186.3px;">$ </div><div id="a25846" style="position:absolute;left:618.64px;top:186.3px;">603</div><div id="a25849" style="position:absolute;font-weight:normal;font-style:normal;left:649.52px;top:186.3px;">$ </div><div id="a25851" style="position:absolute;left:663.44px;top:186.3px;">1,375,401</div><div id="a25873" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:222.3px;">Balance at March 31, 2020 </div><div id="a25875" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:222.3px;">$ </div><div id="a25877" style="position:absolute;left:267.853px;top:222.3px;">17,752</div><div id="a25880" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:222.3px;">$ </div><div id="a25882" style="position:absolute;left:329.293px;top:222.3px;">888,533</div><div id="a25885" style="position:absolute;font-weight:normal;font-style:normal;left:383.533px;top:222.3px;">$ </div><div id="a25887" style="position:absolute;left:402.28px;top:222.3px;">376,853</div><div id="a25890" style="position:absolute;font-weight:normal;font-style:normal;left:456.52px;top:222.3px;">$ </div><div id="a25892" style="position:absolute;left:494.44px;top:222.3px;">(121,524)</div><div id="a25895" style="position:absolute;font-weight:normal;font-style:normal;left:553.48px;top:222.3px;">$ </div><div id="a25897" style="position:absolute;left:618.64px;top:222.3px;">418</div><div id="a25900" style="position:absolute;font-weight:normal;font-style:normal;left:649.52px;top:222.3px;">$ </div><div id="a25902" style="position:absolute;left:663.44px;top:222.3px;">1,162,032</div><div id="a25905" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:239.9px;">Net (loss) income </div><div id="a25908" style="position:absolute;left:291.213px;top:239.9px;">—</div><div id="a25912" style="position:absolute;left:359.373px;top:239.9px;">—</div><div id="a25916" style="position:absolute;left:410.76px;top:239.9px;">(7,735)</div><div id="a25920" style="position:absolute;left:529.32px;top:239.9px;">—</div><div id="a25924" style="position:absolute;left:625.36px;top:239.9px;">13</div><div id="a25928" style="position:absolute;left:681.84px;top:239.9px;">(7,722)</div><div id="a25931" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:257.5px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4.32px"> </div></div><div id="a25952" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:275.1px;">income </div><div id="a25955" style="position:absolute;left:291.213px;top:275.1px;">—</div><div id="a25959" style="position:absolute;left:359.373px;top:275.1px;">—</div><div id="a25963" style="position:absolute;left:432.36px;top:275.1px;">—</div><div id="a25967" style="position:absolute;left:505.96px;top:275.1px;">12,260</div><div id="a25971" style="position:absolute;left:631.92px;top:275.1px;">1</div><div id="a25975" style="position:absolute;left:680.08px;top:275.1px;">12,261</div><div id="a25978" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:292.7px;">Dividends ($</div><div id="a25978_12_5" style="position:absolute;left:83.786px;top:292.7px;">0.385</div><div id="a25978_17_12" style="position:absolute;font-weight:normal;font-style:normal;left:113.706px;top:292.7px;"><div style="display:inline-block;width:3.36px"> </div>per share) </div><div id="a25981" style="position:absolute;left:291.213px;top:292.7px;">—</div><div id="a25985" style="position:absolute;left:359.373px;top:292.7px;">—</div><div id="a25989" style="position:absolute;left:410.76px;top:292.7px;">(6,853)</div><div id="a25993" style="position:absolute;left:529.32px;top:292.7px;">—</div><div id="a25997" style="position:absolute;left:625.36px;top:292.7px;">—</div><div id="a26001" style="position:absolute;left:681.84px;top:292.7px;">(6,853)</div><div id="a26004" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:310.3px;">Share issuance and equity-based </div><div id="a26027" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:327.9px;">compensation plans </div><div id="a26030" style="position:absolute;left:291.213px;top:327.9px;">48</div><div id="a26034" style="position:absolute;left:342.573px;top:327.9px;">7,575</div><div id="a26038" style="position:absolute;left:432.36px;top:327.9px;">—</div><div id="a26042" style="position:absolute;left:529.32px;top:327.9px;">—</div><div id="a26046" style="position:absolute;left:625.36px;top:327.9px;">—</div><div id="a26050" style="position:absolute;left:686.64px;top:327.9px;">7,623</div><div id="a26052" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:346.3px;">Balance at June 30, 2020 </div><div id="a26054" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:346.3px;">$ </div><div id="a26056" style="position:absolute;left:267.853px;top:346.3px;">17,800</div><div id="a26059" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:345px;">$ </div><div id="a26061" style="position:absolute;left:329.293px;top:346.3px;">896,108</div><div id="a26064" style="position:absolute;font-weight:normal;font-style:normal;left:383.533px;top:346.3px;">$ </div><div id="a26066" style="position:absolute;left:402.28px;top:346.3px;">362,265</div><div id="a26069" style="position:absolute;font-weight:normal;font-style:normal;left:456.52px;top:346.3px;">$ </div><div id="a26071" style="position:absolute;left:494.44px;top:346.3px;">(109,264)</div><div id="a26074" style="position:absolute;font-weight:normal;font-style:normal;left:553.48px;top:346.3px;">$ </div><div id="a26076" style="position:absolute;left:618.64px;top:346.3px;">432</div><div id="a26079" style="position:absolute;font-weight:normal;font-style:normal;left:649.52px;top:346.3px;">$ </div><div id="a26081" style="position:absolute;left:663.44px;top:346.3px;">1,167,341</div></div><div id="TextBlockContainer203" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:742px;height:450px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a26145" style="position:absolute;font-weight:bold;font-style:normal;left:475.72px;top:0px;">Accumulated </div><div id="a26159" style="position:absolute;font-weight:bold;font-style:normal;left:323.693px;top:15px;">Capital in </div><div id="a26165" style="position:absolute;font-weight:bold;font-style:normal;left:496.52px;top:15px;">Other </div><div id="a26176" style="position:absolute;font-weight:bold;font-style:normal;left:255.053px;top:29.9px;">Common </div><div id="a26179" style="position:absolute;font-weight:bold;font-style:normal;left:325.933px;top:29.9px;">Excess of </div><div id="a26182" style="position:absolute;font-weight:bold;font-style:normal;left:403.08px;top:29.9px;">Retained </div><div id="a26185" style="position:absolute;font-weight:bold;font-style:normal;left:469px;top:29.9px;">Comprehensive </div><div id="a26188" style="position:absolute;font-weight:bold;font-style:normal;left:567.08px;top:29.9px;">Noncontrolling </div><div id="a26196" style="position:absolute;font-weight:bold;font-style:normal;left:265.453px;top:45px;">Stock </div><div id="a26199" style="position:absolute;font-weight:bold;font-style:normal;left:323.373px;top:45px;">Par Value </div><div id="a26202" style="position:absolute;font-weight:bold;font-style:normal;left:402.6px;top:45px;">Earnings </div><div id="a26205" style="position:absolute;font-weight:bold;font-style:normal;left:500.52px;top:45px;">Loss </div><div id="a26208" style="position:absolute;font-weight:bold;font-style:normal;left:587.76px;top:45px;">Interest </div><div id="a26211" style="position:absolute;font-weight:bold;font-style:normal;left:681.84px;top:45px;">Total </div><div id="a26213" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:62.2px;">Balance at December 31, 2020 </div><div id="a26215" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:62.2px;">$ </div><div id="a26217" style="position:absolute;left:267.853px;top:62.2px;">17,851</div><div id="a26220" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:62.2px;">$ </div><div id="a26222" style="position:absolute;left:341.293px;top:62.2px;">905,171</div><div id="a26225" style="position:absolute;font-weight:normal;font-style:normal;left:395.56px;top:62.2px;">$ </div><div id="a26227" style="position:absolute;left:414.28px;top:62.2px;">423,940</div><div id="a26230" style="position:absolute;font-weight:normal;font-style:normal;left:468.52px;top:62.2px;">$ </div><div id="a26232" style="position:absolute;left:513px;top:62.2px;">(26,598)</div><div id="a26235" style="position:absolute;font-weight:normal;font-style:normal;left:565.48px;top:62.2px;">$ </div><div id="a26237" style="position:absolute;left:630.64px;top:62.2px;">550</div><div id="a26240" style="position:absolute;font-weight:normal;font-style:normal;left:661.52px;top:62.2px;">$ </div><div id="a26242" style="position:absolute;left:675.44px;top:62.2px;">1,320,914</div><div id="a26245" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:79.8px;">Net income </div><div id="a26248" style="position:absolute;left:291.213px;top:79.8px;">—</div><div id="a26252" style="position:absolute;left:371.373px;top:79.8px;">—</div><div id="a26256" style="position:absolute;left:421px;top:79.8px;">72,185</div><div id="a26260" style="position:absolute;left:541.32px;top:79.8px;">—</div><div id="a26264" style="position:absolute;left:637.36px;top:79.8px;">47</div><div id="a26268" style="position:absolute;left:692.08px;top:79.8px;">72,232</div><div id="a26271" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:97.4px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4.32px"> </div></div><div id="a26292" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:115px;">(loss) income </div><div id="a26295" style="position:absolute;left:291.213px;top:115px;">—</div><div id="a26299" style="position:absolute;left:371.373px;top:115px;">—</div><div id="a26303" style="position:absolute;left:444.36px;top:115px;">—</div><div id="a26307" style="position:absolute;left:519.72px;top:115px;">(9,345)</div><div id="a26311" style="position:absolute;left:643.92px;top:115px;">6</div><div id="a26315" style="position:absolute;left:693.84px;top:115px;">(9,339)</div><div id="a26318" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:132.6px;">Dividends ($</div><div id="a26318_12_5" style="position:absolute;left:83.786px;top:132.6px;">0.790</div><div id="a26318_17_12" style="position:absolute;font-weight:normal;font-style:normal;left:113.706px;top:132.6px;"><div style="display:inline-block;width:3.36px"> </div>per share) </div><div id="a26321" style="position:absolute;left:291.213px;top:132.6px;">—</div><div id="a26325" style="position:absolute;left:371.373px;top:132.6px;">—</div><div id="a26329" style="position:absolute;left:416.04px;top:132.6px;">(14,124)</div><div id="a26333" style="position:absolute;left:541.32px;top:132.6px;">—</div><div id="a26337" style="position:absolute;left:637.36px;top:132.6px;">—</div><div id="a26341" style="position:absolute;left:687.12px;top:132.6px;">(14,124)</div><div id="a26344" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:150.2px;">Share issuance and equity-based </div><div id="a26367" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:167.8px;">compensation plans </div><div id="a26370" style="position:absolute;left:291.213px;top:167.8px;">27</div><div id="a26374" style="position:absolute;left:354.573px;top:167.8px;">5,691</div><div id="a26378" style="position:absolute;left:444.36px;top:167.8px;">—</div><div id="a26382" style="position:absolute;left:541.32px;top:167.8px;">—</div><div id="a26386" style="position:absolute;left:637.36px;top:167.8px;">—</div><div id="a26390" style="position:absolute;left:698.64px;top:167.8px;">5,718</div><div id="a26392" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:186.2px;">Balance at June 30, 2021 </div><div id="a26394" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:186.2px;">$ </div><div id="a26396" style="position:absolute;left:267.853px;top:186.2px;">17,878</div><div id="a26399" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:186.2px;">$ </div><div id="a26401" style="position:absolute;left:341.293px;top:186.2px;">910,862</div><div id="a26404" style="position:absolute;font-weight:normal;font-style:normal;left:395.56px;top:186.2px;">$ </div><div id="a26406" style="position:absolute;left:414.28px;top:186.2px;">482,001</div><div id="a26409" style="position:absolute;font-weight:normal;font-style:normal;left:468.52px;top:186.2px;">$ </div><div id="a26411" style="position:absolute;left:513px;top:186.2px;">(35,943)</div><div id="a26414" style="position:absolute;font-weight:normal;font-style:normal;left:565.48px;top:186.2px;">$ </div><div id="a26416" style="position:absolute;left:630.64px;top:186.2px;">603</div><div id="a26419" style="position:absolute;font-weight:normal;font-style:normal;left:661.52px;top:186.2px;">$ </div><div id="a26421" style="position:absolute;left:675.44px;top:186.2px;">1,375,401</div><div id="a26444" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:222.3px;">Balance at December 31, 2019 </div><div id="a26446" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:222.3px;">$ </div><div id="a26448" style="position:absolute;left:267.853px;top:222.3px;">17,735</div><div id="a26451" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:222.3px;">$ </div><div id="a26453" style="position:absolute;left:341.293px;top:222.3px;">888,218</div><div id="a26456" style="position:absolute;font-weight:normal;font-style:normal;left:395.56px;top:222.3px;">$ </div><div id="a26458" style="position:absolute;left:414.28px;top:222.3px;">412,979</div><div id="a26461" style="position:absolute;font-weight:normal;font-style:normal;left:468.52px;top:222.3px;">$ </div><div id="a26463" style="position:absolute;left:513px;top:222.3px;">(78,170)</div><div id="a26466" style="position:absolute;font-weight:normal;font-style:normal;left:565.48px;top:222.3px;">$ </div><div id="a26468" style="position:absolute;left:620.56px;top:222.3px;">1,604</div><div id="a26471" style="position:absolute;font-weight:normal;font-style:normal;left:661.52px;top:222.3px;">$ </div><div id="a26473" style="position:absolute;left:675.44px;top:222.3px;">1,242,366</div><div id="a26476" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:239.9px;">Cumulative effect of an accounting change </div><div id="a26479" style="position:absolute;left:291.213px;top:239.9px;">—</div><div id="a26483" style="position:absolute;left:371.373px;top:239.9px;">—</div><div id="a26487" style="position:absolute;left:432.68px;top:239.9px;">(911)</div><div id="a26491" style="position:absolute;left:541.32px;top:239.9px;">—</div><div id="a26495" style="position:absolute;left:637.36px;top:239.9px;">—</div><div id="a26499" style="position:absolute;left:703.76px;top:239.9px;">(911)</div><div id="a26501" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:257.5px;">Balance at January 1, 2020 </div><div id="a26504" style="position:absolute;left:267.853px;top:257.5px;">17,735</div><div id="a26508" style="position:absolute;left:341.293px;top:257.5px;">888,218</div><div id="a26512" style="position:absolute;left:414.28px;top:257.5px;">412,068</div><div id="a26516" style="position:absolute;left:513px;top:257.5px;">(78,170)</div><div id="a26520" style="position:absolute;left:620.56px;top:257.5px;">1,604</div><div id="a26524" style="position:absolute;left:675.44px;top:257.5px;">1,241,455</div><div id="a26527" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:275.1px;">Net (loss) income </div><div id="a26530" style="position:absolute;left:291.213px;top:275.1px;">—</div><div id="a26534" style="position:absolute;left:371.373px;top:275.1px;">—</div><div id="a26538" style="position:absolute;left:416.04px;top:275.1px;">(36,116)</div><div id="a26542" style="position:absolute;left:541.32px;top:275.1px;">—</div><div id="a26546" style="position:absolute;left:637.36px;top:275.1px;">50</div><div id="a26550" style="position:absolute;left:687.12px;top:275.1px;">(36,066)</div><div id="a26553" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:292.7px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4.32px"> </div></div><div id="a26574" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:310.3px;">loss </div><div id="a26577" style="position:absolute;left:291.213px;top:310.3px;">—</div><div id="a26581" style="position:absolute;left:371.373px;top:310.3px;">—</div><div id="a26585" style="position:absolute;left:444.36px;top:310.3px;">—</div><div id="a26589" style="position:absolute;left:513px;top:310.3px;">(31,094)</div><div id="a26593" style="position:absolute;left:625.68px;top:310.3px;">(131)</div><div id="a26597" style="position:absolute;left:687.12px;top:310.3px;">(31,225)</div><div id="a26600" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:327.9px;">Dividends ($</div><div id="a26600_12_5" style="position:absolute;left:83.786px;top:327.9px;">0.770</div><div id="a26600_17_13" style="position:absolute;font-weight:normal;font-style:normal;left:113.706px;top:327.9px;">0 per share) </div><div id="a26603" style="position:absolute;left:291.213px;top:327.9px;">—</div><div id="a26607" style="position:absolute;left:371.373px;top:327.9px;">—</div><div id="a26611" style="position:absolute;left:416.04px;top:327.9px;">(13,687)</div><div id="a26615" style="position:absolute;left:541.32px;top:327.9px;">—</div><div id="a26619" style="position:absolute;left:637.36px;top:327.9px;">—</div><div id="a26623" style="position:absolute;left:687.12px;top:327.9px;">(13,687)</div><div id="a26626" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:345.5px;">Acquisition of noncontrolling interest </div><div id="a26629" style="position:absolute;left:291.213px;top:345.5px;">—</div><div id="a26633" style="position:absolute;left:359.693px;top:345.5px;">(707)</div><div id="a26637" style="position:absolute;left:444.36px;top:345.5px;">—</div><div id="a26641" style="position:absolute;left:541.32px;top:345.5px;">—</div><div id="a26645" style="position:absolute;left:625.68px;top:345.5px;">(340)</div><div id="a26649" style="position:absolute;left:693.84px;top:345.5px;">(1,047)</div><div id="a26652" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:363.1px;">Distributions to noncontrolling affiliate </div><div id="a26673" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:380.7px;">shareholders </div><div id="a26676" style="position:absolute;left:291.213px;top:380.7px;">—</div><div id="a26680" style="position:absolute;left:371.373px;top:380.7px;">—</div><div id="a26684" style="position:absolute;left:444.36px;top:380.7px;">—</div><div id="a26688" style="position:absolute;left:541.32px;top:380.7px;">—</div><div id="a26692" style="position:absolute;left:625.68px;top:380.7px;">(751)</div><div id="a26696" style="position:absolute;left:703.76px;top:380.7px;">(751)</div><div id="a26699" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:398.3px;">Share issuance and equity-based </div><div id="a26722" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:415.9px;">compensation plans </div><div id="a26725" style="position:absolute;left:291.213px;top:415.9px;">65</div><div id="a26729" style="position:absolute;left:354.573px;top:415.9px;">8,597</div><div id="a26733" style="position:absolute;left:444.36px;top:415.9px;">—</div><div id="a26737" style="position:absolute;left:541.32px;top:415.9px;">—</div><div id="a26741" style="position:absolute;left:637.36px;top:415.9px;">—</div><div id="a26745" style="position:absolute;left:698.64px;top:415.9px;">8,662</div><div id="a26747" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:434.3px;">Balance at June 30, 2020 </div><div id="a26749" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:434.3px;">$ </div><div id="a26751" style="position:absolute;left:267.853px;top:434.3px;">17,800</div><div id="a26754" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:434.3px;">$ </div><div id="a26756" style="position:absolute;left:341.293px;top:434.3px;">896,108</div><div id="a26759" style="position:absolute;font-weight:normal;font-style:normal;left:395.56px;top:434.3px;">$ </div><div id="a26761" style="position:absolute;left:414.28px;top:434.3px;">362,265</div><div id="a26764" style="position:absolute;font-weight:normal;font-style:normal;left:468.52px;top:434.3px;">$ </div><div id="a26766" style="position:absolute;left:506.44px;top:434.3px;">(109,264)</div><div id="a26769" style="position:absolute;font-weight:normal;font-style:normal;left:565.48px;top:434.3px;">$ </div><div id="a26771" style="position:absolute;left:630.64px;top:434.3px;">432</div><div id="a26774" style="position:absolute;font-weight:normal;font-style:normal;left:661.52px;top:434.3px;">$ </div><div id="a26776" style="position:absolute;left:675.44px;top:434.3px;">1,167,341</div></div><div id="TextBlockContainer206" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:725px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a26827" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The following tables show the reclassifications from and<div style="display:inline-block;width:4.68px"> </div>resulting balances of AOCI for the three and six months ended<div style="display:inline-block;width:5.02px"> </div>June 30, </div><div id="a26869" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">2021 and 2020:</div></div><div id="TextBlockContainer209" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:288px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a26882" style="position:absolute;font-weight:bold;font-style:normal;left:413.32px;top:0px;">Defined </div><div id="a26885" style="position:absolute;font-weight:bold;font-style:normal;left:491.4px;top:0px;">Unrealized </div><div id="a26897" style="position:absolute;font-weight:bold;font-style:normal;left:324.973px;top:17px;">Currency </div><div id="a26901" style="position:absolute;font-weight:bold;font-style:normal;left:415.08px;top:17px;">Benefit </div><div id="a26904" style="position:absolute;font-weight:bold;font-style:normal;left:482.28px;top:17px;">Gain (Loss) in<div style="display:inline-block;width:3.72px"> </div></div><div id="a26916" style="position:absolute;font-weight:bold;font-style:normal;left:319.053px;top:34.1px;">Translation </div><div id="a26919" style="position:absolute;font-weight:bold;font-style:normal;left:413.32px;top:34.1px;">Pension </div><div id="a26922" style="position:absolute;font-weight:bold;font-style:normal;left:482.6px;top:34.1px;">Available-for<div style="display:inline-block;width:1.37px"> </div>- </div><div id="a26928" style="position:absolute;font-weight:bold;font-style:normal;left:580.08px;top:34.1px;">Derivative </div><div id="a26937" style="position:absolute;font-weight:bold;font-style:normal;left:316.173px;top:51px;">Adjustments </div><div id="a26940" style="position:absolute;font-weight:bold;font-style:normal;left:419.88px;top:51px;">Plans </div><div id="a26942" style="position:absolute;font-weight:bold;font-style:normal;left:481.32px;top:51px;">Sale Securities </div><div id="a26944" style="position:absolute;font-weight:bold;font-style:normal;left:574.8px;top:51px;">Instruments </div><div id="a26947" style="position:absolute;font-weight:bold;font-style:normal;left:673.36px;top:51px;">Total </div><div id="a26949" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:68px;">Balance at March 31, 2021 </div><div id="a26952" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:68px;">$ </div><div id="a26954" style="position:absolute;left:344.973px;top:68px;">(28,334)</div><div id="a26957" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:68px;">$ </div><div id="a26959" style="position:absolute;left:428.04px;top:68px;">(22,175)</div><div id="a26962" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:68px;">$ </div><div id="a26964" style="position:absolute;left:540.68px;top:68px;">317</div><div id="a26967" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:68px;">$ </div><div id="a26969" style="position:absolute;left:608.88px;top:68px;">(3,036)</div><div id="a26972" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:68px;">$ </div><div id="a26974" style="position:absolute;left:677.04px;top:68px;">(53,228)</div><div id="a26977" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:85px;">Other comprehensive income (loss) before<div style="display:inline-block;width:4.37px"> </div></div><div id="a26996" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:102.1px;">reclassifications </div><div id="a27000" style="position:absolute;left:349.933px;top:102.1px;">16,157</div><div id="a27004" style="position:absolute;left:444.68px;top:102.1px;">(260)</div><div id="a27008" style="position:absolute;left:540.68px;top:102.1px;">341</div><div id="a27012" style="position:absolute;left:623.76px;top:102.1px;">586</div><div id="a27016" style="position:absolute;left:682px;top:102.1px;">16,824</div><div id="a27019" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:119px;">Amounts reclassified from AOCI </div><div id="a27023" style="position:absolute;left:373.293px;top:119px;">—</div><div id="a27027" style="position:absolute;left:449.64px;top:119px;">852</div><div id="a27031" style="position:absolute;left:553.96px;top:119px;">2</div><div id="a27035" style="position:absolute;left:630.48px;top:119px;">—</div><div id="a27039" style="position:absolute;left:698.64px;top:119px;">854</div><div id="a27042" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:136px;">Related tax amounts </div><div id="a27046" style="position:absolute;left:373.293px;top:136px;">—</div><div id="a27050" style="position:absolute;left:444.68px;top:136px;">(195)</div><div id="a27054" style="position:absolute;left:542.44px;top:136px;">(64)</div><div id="a27058" style="position:absolute;left:618.8px;top:136px;">(134)</div><div id="a27062" style="position:absolute;left:693.68px;top:136px;">(393)</div><div id="a27064" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:153px;">Balance at June 30, 2021 </div><div id="a27067" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:153px;">$ </div><div id="a27069" style="position:absolute;left:344.973px;top:153px;">(12,177)</div><div id="a27072" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:153px;">$ </div><div id="a27074" style="position:absolute;left:428.04px;top:153px;">(21,778)</div><div id="a27077" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:153px;">$ </div><div id="a27079" style="position:absolute;left:540.68px;top:153px;">596</div><div id="a27082" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:153px;">$ </div><div id="a27084" style="position:absolute;left:608.88px;top:153px;">(2,584)</div><div id="a27087" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:153px;">$ </div><div id="a27089" style="position:absolute;left:677.04px;top:153px;">(35,943)</div><div id="a27109" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:187.1px;">Balance at March 31, 2020 </div><div id="a27113" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:187.1px;">$ </div><div id="a27115" style="position:absolute;left:344.973px;top:187.1px;">(99,187)</div><div id="a27118" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:187.1px;">$ </div><div id="a27120" style="position:absolute;left:428.04px;top:187.1px;">(17,576)</div><div id="a27123" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:187.1px;">$ </div><div id="a27125" style="position:absolute;left:535.72px;top:187.1px;">(460)</div><div id="a27128" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:187.1px;">$ </div><div id="a27130" style="position:absolute;left:608.88px;top:187.1px;">(4,301)</div><div id="a27133" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:187.1px;">$ </div><div id="a27135" style="position:absolute;left:670.48px;top:187.1px;">(121,524)</div><div id="a27138" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:204px;">Other comprehensive income (loss) before </div><div id="a27157" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:221px;">reclassifications </div><div id="a27161" style="position:absolute;left:349.933px;top:221px;">10,550</div><div id="a27165" style="position:absolute;left:444.68px;top:221px;">(336)</div><div id="a27169" style="position:absolute;left:530.6px;top:221px;">2,128</div><div id="a27173" style="position:absolute;left:618.8px;top:221px;">(144)</div><div id="a27177" style="position:absolute;left:682px;top:221px;">12,198</div><div id="a27180" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:238.1px;">Amounts reclassified from AOCI </div><div id="a27184" style="position:absolute;left:373.293px;top:238.1px;">—</div><div id="a27188" style="position:absolute;left:449.64px;top:238.1px;">600</div><div id="a27192" style="position:absolute;left:542.44px;top:238.1px;">(93)</div><div id="a27196" style="position:absolute;left:630.48px;top:238.1px;">—</div><div id="a27200" style="position:absolute;left:698.64px;top:238.1px;">507</div><div id="a27203" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:255.1px;">Related tax amounts </div><div id="a27207" style="position:absolute;left:373.293px;top:255.1px;">—</div><div id="a27211" style="position:absolute;left:451.4px;top:255.1px;">(51)</div><div id="a27215" style="position:absolute;left:535.72px;top:255.1px;">(427)</div><div id="a27219" style="position:absolute;left:630.48px;top:255.1px;">33</div><div id="a27223" style="position:absolute;left:693.68px;top:255.1px;">(445)</div><div id="a27225" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:272px;">Balance at June 30, 2020 </div><div id="a27228" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:272px;">$ </div><div id="a27230" style="position:absolute;left:344.973px;top:272px;">(88,637)</div><div id="a27233" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:272px;">$ </div><div id="a27235" style="position:absolute;left:428.04px;top:272px;">(17,363)</div><div id="a27238" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:272px;">$ </div><div id="a27240" style="position:absolute;left:530.6px;top:272px;">1,148</div><div id="a27243" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:272px;">$ </div><div id="a27245" style="position:absolute;left:608.88px;top:272px;">(4,412)</div><div id="a27248" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:272px;">$ </div><div id="a27250" style="position:absolute;left:670.48px;top:272px;">(109,264)</div></div><div id="TextBlockContainer214" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:288px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_212_XBRL_TS_8fcb8910a7f549fb9c5a68afd7060296" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer213" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:288px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a27260" style="position:absolute;font-weight:bold;font-style:normal;left:413.32px;top:0px;">Defined </div><div id="a27263" style="position:absolute;font-weight:bold;font-style:normal;left:491.4px;top:0px;">Unrealized </div><div id="a27274" style="position:absolute;font-weight:bold;font-style:normal;left:324.973px;top:17.1px;">Currency </div><div id="a27277" style="position:absolute;font-weight:bold;font-style:normal;left:415.08px;top:17.1px;">Benefit </div><div id="a27280" style="position:absolute;font-weight:bold;font-style:normal;left:482.28px;top:17.1px;">Gain (Loss) in<div style="display:inline-block;width:3.72px"> </div></div><div id="a27291" style="position:absolute;font-weight:bold;font-style:normal;left:319.053px;top:34.1px;">Translation </div><div id="a27294" style="position:absolute;font-weight:bold;font-style:normal;left:413.32px;top:34.1px;">Pension </div><div id="a27297" style="position:absolute;font-weight:bold;font-style:normal;left:482.6px;top:34.1px;">Available-for<div style="display:inline-block;width:1.37px"> </div>- </div><div id="a27303" style="position:absolute;font-weight:bold;font-style:normal;left:580.08px;top:34.1px;">Derivative </div><div id="a27312" style="position:absolute;font-weight:bold;font-style:normal;left:316.173px;top:51px;">Adjustments </div><div id="a27315" style="position:absolute;font-weight:bold;font-style:normal;left:419.88px;top:51px;">Plans </div><div id="a27317" style="position:absolute;font-weight:bold;font-style:normal;left:481.32px;top:51px;">Sale Securities </div><div id="a27319" style="position:absolute;font-weight:bold;font-style:normal;left:574.8px;top:51px;">Instruments </div><div id="a27322" style="position:absolute;font-weight:bold;font-style:normal;left:673.36px;top:51px;">Total </div><div id="a27324" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:68px;">Balance at December 31, 2020 </div><div id="a27327" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:68px;">$ </div><div id="a27329" style="position:absolute;left:351.693px;top:68px;">(2,875)</div><div id="a27332" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:68px;">$ </div><div id="a27334" style="position:absolute;left:428.04px;top:68px;">(23,467)</div><div id="a27337" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:68px;">$ </div><div id="a27339" style="position:absolute;left:530.6px;top:68px;">3,342</div><div id="a27342" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:68px;">$ </div><div id="a27344" style="position:absolute;left:608.88px;top:68px;">(3,598)</div><div id="a27347" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:68px;">$ </div><div id="a27349" style="position:absolute;left:677.04px;top:68px;">(26,598)</div><div id="a27352" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:85.1px;">Other comprehensive (loss) income before </div><div id="a27371" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:102.1px;">reclassifications </div><div id="a27375" style="position:absolute;left:351.693px;top:102.1px;">(9,302)</div><div id="a27379" style="position:absolute;left:449.64px;top:102.1px;">521</div><div id="a27383" style="position:absolute;left:535.72px;top:102.1px;">(404)</div><div id="a27387" style="position:absolute;left:613.68px;top:102.1px;">1,316</div><div id="a27391" style="position:absolute;left:683.76px;top:102.1px;">(7,869)</div><div id="a27394" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:119.1px;">Amounts reclassified from AOCI </div><div id="a27398" style="position:absolute;left:373.293px;top:119.1px;">—</div><div id="a27402" style="position:absolute;left:439.56px;top:119.1px;">1,714</div><div id="a27406" style="position:absolute;left:525.8px;top:119.1px;">(3,083)</div><div id="a27410" style="position:absolute;left:630.48px;top:119.1px;">—</div><div id="a27414" style="position:absolute;left:683.76px;top:119.1px;">(1,369)</div><div id="a27417" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:136px;">Related tax amounts </div><div id="a27421" style="position:absolute;left:373.293px;top:136px;">—</div><div id="a27425" style="position:absolute;left:444.68px;top:136px;">(546)</div><div id="a27429" style="position:absolute;left:540.68px;top:136px;">741</div><div id="a27433" style="position:absolute;left:618.8px;top:136px;">(302)</div><div id="a27437" style="position:absolute;left:693.68px;top:136px;">(107)</div><div id="a27439" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:153.1px;">Balance at June 30, 2021 </div><div id="a27442" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:153.1px;">$ </div><div id="a27444" style="position:absolute;left:344.973px;top:153.1px;">(12,177)</div><div id="a27447" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:153.1px;">$ </div><div id="a27449" style="position:absolute;left:428.04px;top:153.1px;">(21,778)</div><div id="a27452" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:153.1px;">$ </div><div id="a27454" style="position:absolute;left:540.68px;top:153.1px;">596</div><div id="a27457" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:153.1px;">$ </div><div id="a27459" style="position:absolute;left:608.88px;top:153.1px;">(2,584)</div><div id="a27462" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:153.1px;">$ </div><div id="a27464" style="position:absolute;left:677.04px;top:153.1px;">(35,943)</div><div id="a27484" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:187.1px;">Balance at December 31, 2019 </div><div id="a27488" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:187.1px;">$ </div><div id="a27490" style="position:absolute;left:344.973px;top:187.1px;">(44,568)</div><div id="a27493" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:187.1px;">$ </div><div id="a27495" style="position:absolute;left:428.04px;top:187.1px;">(34,533)</div><div id="a27498" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:187.1px;">$ </div><div id="a27500" style="position:absolute;left:530.6px;top:187.1px;">1,251</div><div id="a27503" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:187.1px;">$ </div><div id="a27505" style="position:absolute;left:618.8px;top:187.1px;">(320)</div><div id="a27508" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:187.1px;">$ </div><div id="a27510" style="position:absolute;left:677.04px;top:187.1px;">(78,170)</div><div id="a27513" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:204px;">Other comprehensive (loss) income before<div style="display:inline-block;width:4.37px"> </div></div><div id="a27532" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:221.1px;">reclassifications </div><div id="a27536" style="position:absolute;left:344.973px;top:221.1px;">(44,069)</div><div id="a27540" style="position:absolute;left:449.64px;top:221.1px;">492</div><div id="a27544" style="position:absolute;left:549.16px;top:221.1px;">(8)</div><div id="a27548" style="position:absolute;left:608.88px;top:221.1px;">(5,315)</div><div id="a27552" style="position:absolute;left:677.04px;top:221.1px;">(48,900)</div><div id="a27555" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:238.1px;">Amounts reclassified from AOCI </div><div id="a27559" style="position:absolute;left:373.293px;top:238.1px;">—</div><div id="a27563" style="position:absolute;left:433px;top:238.1px;">24,966</div><div id="a27567" style="position:absolute;left:535.72px;top:238.1px;">(125)</div><div id="a27571" style="position:absolute;left:630.48px;top:238.1px;">—</div><div id="a27575" style="position:absolute;left:682px;top:238.1px;">24,841</div><div id="a27578" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:255.1px;">Related tax amounts </div><div id="a27582" style="position:absolute;left:373.293px;top:255.1px;">—</div><div id="a27586" style="position:absolute;left:434.76px;top:255.1px;">(8,288)</div><div id="a27590" style="position:absolute;left:547.4px;top:255.1px;">30</div><div id="a27594" style="position:absolute;left:613.68px;top:255.1px;">1,223</div><div id="a27598" style="position:absolute;left:683.76px;top:255.1px;">(7,035)</div><div id="a27600" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:272px;">Balance at June 30, 2020 </div><div id="a27603" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:272px;">$ </div><div id="a27605" style="position:absolute;left:344.973px;top:272px;">(88,637)</div><div id="a27608" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:272px;">$ </div><div id="a27610" style="position:absolute;left:428.04px;top:272px;">(17,363)</div><div id="a27613" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:272px;">$ </div><div id="a27615" style="position:absolute;left:530.6px;top:272px;">1,148</div><div id="a27618" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:272px;">$ </div><div id="a27620" style="position:absolute;left:608.88px;top:272px;">(4,412)</div><div id="a27623" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:272px;">$ </div><div id="a27625" style="position:absolute;left:670.48px;top:272px;">(109,264)</div></div></div></div><div id="TextBlockContainer216" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:712px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a27627" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">All reclassifications related to unrealized gain (loss) in<div style="display:inline-block;width:4.73px"> </div>available-for-sale securities relate to the Company’s<div style="display:inline-block;width:5.42px"> </div>equity interest in a </div><div id="a27667" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">captive insurance company and are recorded in equity<div style="display:inline-block;width:4.77px"> </div>in net income of associated companies.<div style="display:inline-block;width:7.56px"> </div>The amounts reported in other </div><div id="a27705" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.8px;">comprehensive income for noncontrolling interest are<div style="display:inline-block;width:4.77px"> </div>related to currency translation adjustments.</div></div> <div id="TextBlockContainer200" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:730px;height:362px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_198_XBRL_TS_3efaa2dc8927451d9e517a9c7c4efd92" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer199" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:730px;height:362px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25575" style="position:absolute;font-weight:bold;font-style:normal;left:463.72px;top:0px;">Accumulated </div><div id="a25589" style="position:absolute;font-weight:bold;font-style:normal;left:317.773px;top:14.9px;">Capital in </div><div id="a25595" style="position:absolute;font-weight:bold;font-style:normal;left:484.52px;top:14.9px;">Other </div><div id="a25606" style="position:absolute;font-weight:bold;font-style:normal;left:255.053px;top:29.9px;">Common </div><div id="a25609" style="position:absolute;font-weight:bold;font-style:normal;left:320.013px;top:29.9px;">Excess of </div><div id="a25612" style="position:absolute;font-weight:bold;font-style:normal;left:391.053px;top:29.9px;">Retained </div><div id="a25615" style="position:absolute;font-weight:bold;font-style:normal;left:457px;top:29.9px;">Comprehensive </div><div id="a25618" style="position:absolute;font-weight:bold;font-style:normal;left:555.08px;top:29.9px;">Noncontrolling </div><div id="a25626" style="position:absolute;font-weight:bold;font-style:normal;left:265.453px;top:45px;">Stock </div><div id="a25629" style="position:absolute;font-weight:bold;font-style:normal;left:317.293px;top:45px;">Par Value </div><div id="a25632" style="position:absolute;font-weight:bold;font-style:normal;left:390.573px;top:45px;">Earnings </div><div id="a25635" style="position:absolute;font-weight:bold;font-style:normal;left:488.52px;top:45px;">Loss </div><div id="a25638" style="position:absolute;font-weight:bold;font-style:normal;left:575.76px;top:45px;">Interest </div><div id="a25641" style="position:absolute;font-weight:bold;font-style:normal;left:669.84px;top:45px;">Total </div><div id="a25643" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:62.2px;">Balance at March 31, 2021 </div><div id="a25645" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:62.2px;">$ </div><div id="a25647" style="position:absolute;left:267.853px;top:62.2px;">17,875</div><div id="a25650" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:62.2px;">$ </div><div id="a25652" style="position:absolute;left:329.293px;top:62.2px;">908,748</div><div id="a25655" style="position:absolute;font-weight:normal;font-style:normal;left:383.533px;top:62.2px;">$ </div><div id="a25657" style="position:absolute;left:402.28px;top:62.2px;">455,493</div><div id="a25660" style="position:absolute;font-weight:normal;font-style:normal;left:456.52px;top:62.2px;">$ </div><div id="a25662" style="position:absolute;left:501px;top:62.2px;">(53,228)</div><div id="a25665" style="position:absolute;font-weight:normal;font-style:normal;left:553.48px;top:62.2px;">$ </div><div id="a25667" style="position:absolute;left:618.64px;top:62.2px;">565</div><div id="a25670" style="position:absolute;font-weight:normal;font-style:normal;left:649.52px;top:62.2px;">$ </div><div id="a25672" style="position:absolute;left:663.44px;top:62.2px;">1,329,453</div><div id="a25675" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:79.8px;">Net income </div><div id="a25678" style="position:absolute;left:291.213px;top:79.8px;">—</div><div id="a25682" style="position:absolute;left:359.373px;top:79.8px;">—</div><div id="a25686" style="position:absolute;left:409px;top:79.8px;">33,570</div><div id="a25690" style="position:absolute;left:529.32px;top:79.8px;">—</div><div id="a25694" style="position:absolute;left:625.36px;top:79.8px;">30</div><div id="a25698" style="position:absolute;left:680.08px;top:79.8px;">33,600</div><div id="a25701" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:97.4px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4.32px"> </div></div><div id="a25722" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:115px;">income </div><div id="a25725" style="position:absolute;left:291.213px;top:115px;">—</div><div id="a25729" style="position:absolute;left:359.373px;top:115px;">—</div><div id="a25733" style="position:absolute;left:432.36px;top:115px;">—</div><div id="a25737" style="position:absolute;left:505.96px;top:115px;">17,285</div><div id="a25741" style="position:absolute;left:631.92px;top:115px;">8</div><div id="a25745" style="position:absolute;left:680.08px;top:115px;">17,293</div><div id="a25748" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:132.6px;">Dividends ($</div><div id="a25748_12_5" style="position:absolute;left:83.786px;top:132.6px;">0.395</div><div id="a25748_17_12" style="position:absolute;font-weight:normal;font-style:normal;left:113.706px;top:132.6px;"><div style="display:inline-block;width:3.36px"> </div>per share) </div><div id="a25751" style="position:absolute;left:291.213px;top:132.6px;">—</div><div id="a25755" style="position:absolute;left:359.373px;top:132.6px;">—</div><div id="a25759" style="position:absolute;left:410.76px;top:132.6px;">(7,062)</div><div id="a25763" style="position:absolute;left:529.32px;top:132.6px;">—</div><div id="a25767" style="position:absolute;left:625.36px;top:132.6px;">—</div><div id="a25771" style="position:absolute;left:681.84px;top:132.6px;">(7,062)</div><div id="a25774" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:150.2px;">Share issuance and equity-based </div><div id="a25797" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:167.9px;">compensation plans </div><div id="a25800" style="position:absolute;left:297.773px;top:167.9px;">3</div><div id="a25804" style="position:absolute;left:342.573px;top:167.9px;">2,114</div><div id="a25808" style="position:absolute;left:432.36px;top:167.9px;">—</div><div id="a25812" style="position:absolute;left:529.32px;top:167.9px;">—</div><div id="a25816" style="position:absolute;left:625.36px;top:167.9px;">—</div><div id="a25820" style="position:absolute;left:686.64px;top:167.9px;">2,117</div><div id="a25822" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:186.3px;">Balance at June 30, 2021 </div><div id="a25824" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:186.3px;">$ </div><div id="a25826" style="position:absolute;left:267.853px;top:186.3px;">17,878</div><div id="a25829" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:186.3px;">$ </div><div id="a25831" style="position:absolute;left:329.293px;top:186.3px;">910,862</div><div id="a25834" style="position:absolute;font-weight:normal;font-style:normal;left:383.533px;top:186.3px;">$ </div><div id="a25836" style="position:absolute;left:402.28px;top:186.3px;">482,001</div><div id="a25839" style="position:absolute;font-weight:normal;font-style:normal;left:456.52px;top:186.3px;">$ </div><div id="a25841" style="position:absolute;left:501px;top:186.3px;">(35,943)</div><div id="a25844" style="position:absolute;font-weight:normal;font-style:normal;left:553.48px;top:186.3px;">$ </div><div id="a25846" style="position:absolute;left:618.64px;top:186.3px;">603</div><div id="a25849" style="position:absolute;font-weight:normal;font-style:normal;left:649.52px;top:186.3px;">$ </div><div id="a25851" style="position:absolute;left:663.44px;top:186.3px;">1,375,401</div><div id="a25873" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:222.3px;">Balance at March 31, 2020 </div><div id="a25875" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:222.3px;">$ </div><div id="a25877" style="position:absolute;left:267.853px;top:222.3px;">17,752</div><div id="a25880" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:222.3px;">$ </div><div id="a25882" style="position:absolute;left:329.293px;top:222.3px;">888,533</div><div id="a25885" style="position:absolute;font-weight:normal;font-style:normal;left:383.533px;top:222.3px;">$ </div><div id="a25887" style="position:absolute;left:402.28px;top:222.3px;">376,853</div><div id="a25890" style="position:absolute;font-weight:normal;font-style:normal;left:456.52px;top:222.3px;">$ </div><div id="a25892" style="position:absolute;left:494.44px;top:222.3px;">(121,524)</div><div id="a25895" style="position:absolute;font-weight:normal;font-style:normal;left:553.48px;top:222.3px;">$ </div><div id="a25897" style="position:absolute;left:618.64px;top:222.3px;">418</div><div id="a25900" style="position:absolute;font-weight:normal;font-style:normal;left:649.52px;top:222.3px;">$ </div><div id="a25902" style="position:absolute;left:663.44px;top:222.3px;">1,162,032</div><div id="a25905" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:239.9px;">Net (loss) income </div><div id="a25908" style="position:absolute;left:291.213px;top:239.9px;">—</div><div id="a25912" style="position:absolute;left:359.373px;top:239.9px;">—</div><div id="a25916" style="position:absolute;left:410.76px;top:239.9px;">(7,735)</div><div id="a25920" style="position:absolute;left:529.32px;top:239.9px;">—</div><div id="a25924" style="position:absolute;left:625.36px;top:239.9px;">13</div><div id="a25928" style="position:absolute;left:681.84px;top:239.9px;">(7,722)</div><div id="a25931" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:257.5px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4.32px"> </div></div><div id="a25952" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:275.1px;">income </div><div id="a25955" style="position:absolute;left:291.213px;top:275.1px;">—</div><div id="a25959" style="position:absolute;left:359.373px;top:275.1px;">—</div><div id="a25963" style="position:absolute;left:432.36px;top:275.1px;">—</div><div id="a25967" style="position:absolute;left:505.96px;top:275.1px;">12,260</div><div id="a25971" style="position:absolute;left:631.92px;top:275.1px;">1</div><div id="a25975" style="position:absolute;left:680.08px;top:275.1px;">12,261</div><div id="a25978" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:292.7px;">Dividends ($</div><div id="a25978_12_5" style="position:absolute;left:83.786px;top:292.7px;">0.385</div><div id="a25978_17_12" style="position:absolute;font-weight:normal;font-style:normal;left:113.706px;top:292.7px;"><div style="display:inline-block;width:3.36px"> </div>per share) </div><div id="a25981" style="position:absolute;left:291.213px;top:292.7px;">—</div><div id="a25985" style="position:absolute;left:359.373px;top:292.7px;">—</div><div id="a25989" style="position:absolute;left:410.76px;top:292.7px;">(6,853)</div><div id="a25993" style="position:absolute;left:529.32px;top:292.7px;">—</div><div id="a25997" style="position:absolute;left:625.36px;top:292.7px;">—</div><div id="a26001" style="position:absolute;left:681.84px;top:292.7px;">(6,853)</div><div id="a26004" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:310.3px;">Share issuance and equity-based </div><div id="a26027" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:327.9px;">compensation plans </div><div id="a26030" style="position:absolute;left:291.213px;top:327.9px;">48</div><div id="a26034" style="position:absolute;left:342.573px;top:327.9px;">7,575</div><div id="a26038" style="position:absolute;left:432.36px;top:327.9px;">—</div><div id="a26042" style="position:absolute;left:529.32px;top:327.9px;">—</div><div id="a26046" style="position:absolute;left:625.36px;top:327.9px;">—</div><div id="a26050" style="position:absolute;left:686.64px;top:327.9px;">7,623</div><div id="a26052" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:346.3px;">Balance at June 30, 2020 </div><div id="a26054" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:346.3px;">$ </div><div id="a26056" style="position:absolute;left:267.853px;top:346.3px;">17,800</div><div id="a26059" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:345px;">$ </div><div id="a26061" style="position:absolute;left:329.293px;top:346.3px;">896,108</div><div id="a26064" style="position:absolute;font-weight:normal;font-style:normal;left:383.533px;top:346.3px;">$ </div><div id="a26066" style="position:absolute;left:402.28px;top:346.3px;">362,265</div><div id="a26069" style="position:absolute;font-weight:normal;font-style:normal;left:456.52px;top:346.3px;">$ </div><div id="a26071" style="position:absolute;left:494.44px;top:346.3px;">(109,264)</div><div id="a26074" style="position:absolute;font-weight:normal;font-style:normal;left:553.48px;top:346.3px;">$ </div><div id="a26076" style="position:absolute;left:618.64px;top:346.3px;">432</div><div id="a26079" style="position:absolute;font-weight:normal;font-style:normal;left:649.52px;top:346.3px;">$ </div><div id="a26081" style="position:absolute;left:663.44px;top:346.3px;">1,167,341</div></div></div></div><div id="TextBlockContainer204" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:742px;height:450px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_202_XBRL_TS_3181580e616744a6bfc9c398aebcaeae" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer203" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:742px;height:450px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a26145" style="position:absolute;font-weight:bold;font-style:normal;left:475.72px;top:0px;">Accumulated </div><div id="a26159" style="position:absolute;font-weight:bold;font-style:normal;left:323.693px;top:15px;">Capital in </div><div id="a26165" style="position:absolute;font-weight:bold;font-style:normal;left:496.52px;top:15px;">Other </div><div id="a26176" style="position:absolute;font-weight:bold;font-style:normal;left:255.053px;top:29.9px;">Common </div><div id="a26179" style="position:absolute;font-weight:bold;font-style:normal;left:325.933px;top:29.9px;">Excess of </div><div id="a26182" style="position:absolute;font-weight:bold;font-style:normal;left:403.08px;top:29.9px;">Retained </div><div id="a26185" style="position:absolute;font-weight:bold;font-style:normal;left:469px;top:29.9px;">Comprehensive </div><div id="a26188" style="position:absolute;font-weight:bold;font-style:normal;left:567.08px;top:29.9px;">Noncontrolling </div><div id="a26196" style="position:absolute;font-weight:bold;font-style:normal;left:265.453px;top:45px;">Stock </div><div id="a26199" style="position:absolute;font-weight:bold;font-style:normal;left:323.373px;top:45px;">Par Value </div><div id="a26202" style="position:absolute;font-weight:bold;font-style:normal;left:402.6px;top:45px;">Earnings </div><div id="a26205" style="position:absolute;font-weight:bold;font-style:normal;left:500.52px;top:45px;">Loss </div><div id="a26208" style="position:absolute;font-weight:bold;font-style:normal;left:587.76px;top:45px;">Interest </div><div id="a26211" style="position:absolute;font-weight:bold;font-style:normal;left:681.84px;top:45px;">Total </div><div id="a26213" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:62.2px;">Balance at December 31, 2020 </div><div id="a26215" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:62.2px;">$ </div><div id="a26217" style="position:absolute;left:267.853px;top:62.2px;">17,851</div><div id="a26220" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:62.2px;">$ </div><div id="a26222" style="position:absolute;left:341.293px;top:62.2px;">905,171</div><div id="a26225" style="position:absolute;font-weight:normal;font-style:normal;left:395.56px;top:62.2px;">$ </div><div id="a26227" style="position:absolute;left:414.28px;top:62.2px;">423,940</div><div id="a26230" style="position:absolute;font-weight:normal;font-style:normal;left:468.52px;top:62.2px;">$ </div><div id="a26232" style="position:absolute;left:513px;top:62.2px;">(26,598)</div><div id="a26235" style="position:absolute;font-weight:normal;font-style:normal;left:565.48px;top:62.2px;">$ </div><div id="a26237" style="position:absolute;left:630.64px;top:62.2px;">550</div><div id="a26240" style="position:absolute;font-weight:normal;font-style:normal;left:661.52px;top:62.2px;">$ </div><div id="a26242" style="position:absolute;left:675.44px;top:62.2px;">1,320,914</div><div id="a26245" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:79.8px;">Net income </div><div id="a26248" style="position:absolute;left:291.213px;top:79.8px;">—</div><div id="a26252" style="position:absolute;left:371.373px;top:79.8px;">—</div><div id="a26256" style="position:absolute;left:421px;top:79.8px;">72,185</div><div id="a26260" style="position:absolute;left:541.32px;top:79.8px;">—</div><div id="a26264" style="position:absolute;left:637.36px;top:79.8px;">47</div><div id="a26268" style="position:absolute;left:692.08px;top:79.8px;">72,232</div><div id="a26271" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:97.4px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4.32px"> </div></div><div id="a26292" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:115px;">(loss) income </div><div id="a26295" style="position:absolute;left:291.213px;top:115px;">—</div><div id="a26299" style="position:absolute;left:371.373px;top:115px;">—</div><div id="a26303" style="position:absolute;left:444.36px;top:115px;">—</div><div id="a26307" style="position:absolute;left:519.72px;top:115px;">(9,345)</div><div id="a26311" style="position:absolute;left:643.92px;top:115px;">6</div><div id="a26315" style="position:absolute;left:693.84px;top:115px;">(9,339)</div><div id="a26318" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:132.6px;">Dividends ($</div><div id="a26318_12_5" style="position:absolute;left:83.786px;top:132.6px;">0.790</div><div id="a26318_17_12" style="position:absolute;font-weight:normal;font-style:normal;left:113.706px;top:132.6px;"><div style="display:inline-block;width:3.36px"> </div>per share) </div><div id="a26321" style="position:absolute;left:291.213px;top:132.6px;">—</div><div id="a26325" style="position:absolute;left:371.373px;top:132.6px;">—</div><div id="a26329" style="position:absolute;left:416.04px;top:132.6px;">(14,124)</div><div id="a26333" style="position:absolute;left:541.32px;top:132.6px;">—</div><div id="a26337" style="position:absolute;left:637.36px;top:132.6px;">—</div><div id="a26341" style="position:absolute;left:687.12px;top:132.6px;">(14,124)</div><div id="a26344" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:150.2px;">Share issuance and equity-based </div><div id="a26367" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:167.8px;">compensation plans </div><div id="a26370" style="position:absolute;left:291.213px;top:167.8px;">27</div><div id="a26374" style="position:absolute;left:354.573px;top:167.8px;">5,691</div><div id="a26378" style="position:absolute;left:444.36px;top:167.8px;">—</div><div id="a26382" style="position:absolute;left:541.32px;top:167.8px;">—</div><div id="a26386" style="position:absolute;left:637.36px;top:167.8px;">—</div><div id="a26390" style="position:absolute;left:698.64px;top:167.8px;">5,718</div><div id="a26392" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:186.2px;">Balance at June 30, 2021 </div><div id="a26394" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:186.2px;">$ </div><div id="a26396" style="position:absolute;left:267.853px;top:186.2px;">17,878</div><div id="a26399" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:186.2px;">$ </div><div id="a26401" style="position:absolute;left:341.293px;top:186.2px;">910,862</div><div id="a26404" style="position:absolute;font-weight:normal;font-style:normal;left:395.56px;top:186.2px;">$ </div><div id="a26406" style="position:absolute;left:414.28px;top:186.2px;">482,001</div><div id="a26409" style="position:absolute;font-weight:normal;font-style:normal;left:468.52px;top:186.2px;">$ </div><div id="a26411" style="position:absolute;left:513px;top:186.2px;">(35,943)</div><div id="a26414" style="position:absolute;font-weight:normal;font-style:normal;left:565.48px;top:186.2px;">$ </div><div id="a26416" style="position:absolute;left:630.64px;top:186.2px;">603</div><div id="a26419" style="position:absolute;font-weight:normal;font-style:normal;left:661.52px;top:186.2px;">$ </div><div id="a26421" style="position:absolute;left:675.44px;top:186.2px;">1,375,401</div><div id="a26444" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:222.3px;">Balance at December 31, 2019 </div><div id="a26446" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:222.3px;">$ </div><div id="a26448" style="position:absolute;left:267.853px;top:222.3px;">17,735</div><div id="a26451" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:222.3px;">$ </div><div id="a26453" style="position:absolute;left:341.293px;top:222.3px;">888,218</div><div id="a26456" style="position:absolute;font-weight:normal;font-style:normal;left:395.56px;top:222.3px;">$ </div><div id="a26458" style="position:absolute;left:414.28px;top:222.3px;">412,979</div><div id="a26461" style="position:absolute;font-weight:normal;font-style:normal;left:468.52px;top:222.3px;">$ </div><div id="a26463" style="position:absolute;left:513px;top:222.3px;">(78,170)</div><div id="a26466" style="position:absolute;font-weight:normal;font-style:normal;left:565.48px;top:222.3px;">$ </div><div id="a26468" style="position:absolute;left:620.56px;top:222.3px;">1,604</div><div id="a26471" style="position:absolute;font-weight:normal;font-style:normal;left:661.52px;top:222.3px;">$ </div><div id="a26473" style="position:absolute;left:675.44px;top:222.3px;">1,242,366</div><div id="a26476" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:239.9px;">Cumulative effect of an accounting change </div><div id="a26479" style="position:absolute;left:291.213px;top:239.9px;">—</div><div id="a26483" style="position:absolute;left:371.373px;top:239.9px;">—</div><div id="a26487" style="position:absolute;left:432.68px;top:239.9px;">(911)</div><div id="a26491" style="position:absolute;left:541.32px;top:239.9px;">—</div><div id="a26495" style="position:absolute;left:637.36px;top:239.9px;">—</div><div id="a26499" style="position:absolute;left:703.76px;top:239.9px;">(911)</div><div id="a26501" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:257.5px;">Balance at January 1, 2020 </div><div id="a26504" style="position:absolute;left:267.853px;top:257.5px;">17,735</div><div id="a26508" style="position:absolute;left:341.293px;top:257.5px;">888,218</div><div id="a26512" style="position:absolute;left:414.28px;top:257.5px;">412,068</div><div id="a26516" style="position:absolute;left:513px;top:257.5px;">(78,170)</div><div id="a26520" style="position:absolute;left:620.56px;top:257.5px;">1,604</div><div id="a26524" style="position:absolute;left:675.44px;top:257.5px;">1,241,455</div><div id="a26527" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:275.1px;">Net (loss) income </div><div id="a26530" style="position:absolute;left:291.213px;top:275.1px;">—</div><div id="a26534" style="position:absolute;left:371.373px;top:275.1px;">—</div><div id="a26538" style="position:absolute;left:416.04px;top:275.1px;">(36,116)</div><div id="a26542" style="position:absolute;left:541.32px;top:275.1px;">—</div><div id="a26546" style="position:absolute;left:637.36px;top:275.1px;">50</div><div id="a26550" style="position:absolute;left:687.12px;top:275.1px;">(36,066)</div><div id="a26553" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:292.7px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4.32px"> </div></div><div id="a26574" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:310.3px;">loss </div><div id="a26577" style="position:absolute;left:291.213px;top:310.3px;">—</div><div id="a26581" style="position:absolute;left:371.373px;top:310.3px;">—</div><div id="a26585" style="position:absolute;left:444.36px;top:310.3px;">—</div><div id="a26589" style="position:absolute;left:513px;top:310.3px;">(31,094)</div><div id="a26593" style="position:absolute;left:625.68px;top:310.3px;">(131)</div><div id="a26597" style="position:absolute;left:687.12px;top:310.3px;">(31,225)</div><div id="a26600" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:327.9px;">Dividends ($</div><div id="a26600_12_5" style="position:absolute;left:83.786px;top:327.9px;">0.770</div><div id="a26600_17_13" style="position:absolute;font-weight:normal;font-style:normal;left:113.706px;top:327.9px;">0 per share) </div><div id="a26603" style="position:absolute;left:291.213px;top:327.9px;">—</div><div id="a26607" style="position:absolute;left:371.373px;top:327.9px;">—</div><div id="a26611" style="position:absolute;left:416.04px;top:327.9px;">(13,687)</div><div id="a26615" style="position:absolute;left:541.32px;top:327.9px;">—</div><div id="a26619" style="position:absolute;left:637.36px;top:327.9px;">—</div><div id="a26623" style="position:absolute;left:687.12px;top:327.9px;">(13,687)</div><div id="a26626" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:345.5px;">Acquisition of noncontrolling interest </div><div id="a26629" style="position:absolute;left:291.213px;top:345.5px;">—</div><div id="a26633" style="position:absolute;left:359.693px;top:345.5px;">(707)</div><div id="a26637" style="position:absolute;left:444.36px;top:345.5px;">—</div><div id="a26641" style="position:absolute;left:541.32px;top:345.5px;">—</div><div id="a26645" style="position:absolute;left:625.68px;top:345.5px;">(340)</div><div id="a26649" style="position:absolute;left:693.84px;top:345.5px;">(1,047)</div><div id="a26652" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:363.1px;">Distributions to noncontrolling affiliate </div><div id="a26673" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:380.7px;">shareholders </div><div id="a26676" style="position:absolute;left:291.213px;top:380.7px;">—</div><div id="a26680" style="position:absolute;left:371.373px;top:380.7px;">—</div><div id="a26684" style="position:absolute;left:444.36px;top:380.7px;">—</div><div id="a26688" style="position:absolute;left:541.32px;top:380.7px;">—</div><div id="a26692" style="position:absolute;left:625.68px;top:380.7px;">(751)</div><div id="a26696" style="position:absolute;left:703.76px;top:380.7px;">(751)</div><div id="a26699" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:398.3px;">Share issuance and equity-based </div><div id="a26722" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:415.9px;">compensation plans </div><div id="a26725" style="position:absolute;left:291.213px;top:415.9px;">65</div><div id="a26729" style="position:absolute;left:354.573px;top:415.9px;">8,597</div><div id="a26733" style="position:absolute;left:444.36px;top:415.9px;">—</div><div id="a26737" style="position:absolute;left:541.32px;top:415.9px;">—</div><div id="a26741" style="position:absolute;left:637.36px;top:415.9px;">—</div><div id="a26745" style="position:absolute;left:698.64px;top:415.9px;">8,662</div><div id="a26747" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:434.3px;">Balance at June 30, 2020 </div><div id="a26749" style="position:absolute;font-weight:normal;font-style:normal;left:254.413px;top:434.3px;">$ </div><div id="a26751" style="position:absolute;left:267.853px;top:434.3px;">17,800</div><div id="a26754" style="position:absolute;font-weight:normal;font-style:normal;left:315.533px;top:434.3px;">$ </div><div id="a26756" style="position:absolute;left:341.293px;top:434.3px;">896,108</div><div id="a26759" style="position:absolute;font-weight:normal;font-style:normal;left:395.56px;top:434.3px;">$ </div><div id="a26761" style="position:absolute;left:414.28px;top:434.3px;">362,265</div><div id="a26764" style="position:absolute;font-weight:normal;font-style:normal;left:468.52px;top:434.3px;">$ </div><div id="a26766" style="position:absolute;left:506.44px;top:434.3px;">(109,264)</div><div id="a26769" style="position:absolute;font-weight:normal;font-style:normal;left:565.48px;top:434.3px;">$ </div><div id="a26771" style="position:absolute;left:630.64px;top:434.3px;">432</div><div id="a26774" style="position:absolute;font-weight:normal;font-style:normal;left:661.52px;top:434.3px;">$ </div><div id="a26776" style="position:absolute;left:675.44px;top:434.3px;">1,167,341</div></div></div></div> 17875000 908748000 455493000 -53228000 565000 1329453000 0 0 33570000 0 30000 33600000 0 0 0 17285000 8000 17293000 0.395 0 0 7062000 0 0 7062000 3000 2114000 0 0 0 2117000 17878000 910862000 482001000 -35943000 603000 1375401000 17752000 888533000 376853000 -121524000 418000 1162032000 0 0 -7735000 0 13000 -7722000 0 0 0 12260000 1000 12261000 0.385 0 0 6853000 0 0 6853000 48000 7575000 0 0 0 7623000 17800000 896108000 362265000 -109264000 432000 1167341000 17851000 905171000 423940000 -26598000 550000 1320914000 0 0 72185000 0 47000 72232000 0 0 0 -9345000 6000 -9339000 0.790 0 0 14124000 0 0 14124000 27000 5691000 0 0 0 5718000 17878000 910862000 482001000 -35943000 603000 1375401000 17735000 888218000 412979000 -78170000 1604000 1242366000 0 0 -911000 0 0 -911000 17735000 888218000 412068000 -78170000 1604000 1241455000 0 0 -36116000 0 50000 -36066000 0 0 0 -31094000 -131000 -31225000 0.770 0 0 13687000 0 0 13687000 0 707000 0 0 340000 1047000 0 0 0 0 751000 751000 65000 8597000 0 0 0 8662000 17800000 896108000 362265000 -109264000 432000 1167341000 <div id="TextBlockContainer210" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:288px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_208_XBRL_TS_505debe442ea4bc9b875682f085f413f" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer209" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:288px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a26882" style="position:absolute;font-weight:bold;font-style:normal;left:413.32px;top:0px;">Defined </div><div id="a26885" style="position:absolute;font-weight:bold;font-style:normal;left:491.4px;top:0px;">Unrealized </div><div id="a26897" style="position:absolute;font-weight:bold;font-style:normal;left:324.973px;top:17px;">Currency </div><div id="a26901" style="position:absolute;font-weight:bold;font-style:normal;left:415.08px;top:17px;">Benefit </div><div id="a26904" style="position:absolute;font-weight:bold;font-style:normal;left:482.28px;top:17px;">Gain (Loss) in<div style="display:inline-block;width:3.72px"> </div></div><div id="a26916" style="position:absolute;font-weight:bold;font-style:normal;left:319.053px;top:34.1px;">Translation </div><div id="a26919" style="position:absolute;font-weight:bold;font-style:normal;left:413.32px;top:34.1px;">Pension </div><div id="a26922" style="position:absolute;font-weight:bold;font-style:normal;left:482.6px;top:34.1px;">Available-for<div style="display:inline-block;width:1.37px"> </div>- </div><div id="a26928" style="position:absolute;font-weight:bold;font-style:normal;left:580.08px;top:34.1px;">Derivative </div><div id="a26937" style="position:absolute;font-weight:bold;font-style:normal;left:316.173px;top:51px;">Adjustments </div><div id="a26940" style="position:absolute;font-weight:bold;font-style:normal;left:419.88px;top:51px;">Plans </div><div id="a26942" style="position:absolute;font-weight:bold;font-style:normal;left:481.32px;top:51px;">Sale Securities </div><div id="a26944" style="position:absolute;font-weight:bold;font-style:normal;left:574.8px;top:51px;">Instruments </div><div id="a26947" style="position:absolute;font-weight:bold;font-style:normal;left:673.36px;top:51px;">Total </div><div id="a26949" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:68px;">Balance at March 31, 2021 </div><div id="a26952" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:68px;">$ </div><div id="a26954" style="position:absolute;left:344.973px;top:68px;">(28,334)</div><div id="a26957" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:68px;">$ </div><div id="a26959" style="position:absolute;left:428.04px;top:68px;">(22,175)</div><div id="a26962" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:68px;">$ </div><div id="a26964" style="position:absolute;left:540.68px;top:68px;">317</div><div id="a26967" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:68px;">$ </div><div id="a26969" style="position:absolute;left:608.88px;top:68px;">(3,036)</div><div id="a26972" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:68px;">$ </div><div id="a26974" style="position:absolute;left:677.04px;top:68px;">(53,228)</div><div id="a26977" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:85px;">Other comprehensive income (loss) before<div style="display:inline-block;width:4.37px"> </div></div><div id="a26996" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:102.1px;">reclassifications </div><div id="a27000" style="position:absolute;left:349.933px;top:102.1px;">16,157</div><div id="a27004" style="position:absolute;left:444.68px;top:102.1px;">(260)</div><div id="a27008" style="position:absolute;left:540.68px;top:102.1px;">341</div><div id="a27012" style="position:absolute;left:623.76px;top:102.1px;">586</div><div id="a27016" style="position:absolute;left:682px;top:102.1px;">16,824</div><div id="a27019" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:119px;">Amounts reclassified from AOCI </div><div id="a27023" style="position:absolute;left:373.293px;top:119px;">—</div><div id="a27027" style="position:absolute;left:449.64px;top:119px;">852</div><div id="a27031" style="position:absolute;left:553.96px;top:119px;">2</div><div id="a27035" style="position:absolute;left:630.48px;top:119px;">—</div><div id="a27039" style="position:absolute;left:698.64px;top:119px;">854</div><div id="a27042" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:136px;">Related tax amounts </div><div id="a27046" style="position:absolute;left:373.293px;top:136px;">—</div><div id="a27050" style="position:absolute;left:444.68px;top:136px;">(195)</div><div id="a27054" style="position:absolute;left:542.44px;top:136px;">(64)</div><div id="a27058" style="position:absolute;left:618.8px;top:136px;">(134)</div><div id="a27062" style="position:absolute;left:693.68px;top:136px;">(393)</div><div id="a27064" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:153px;">Balance at June 30, 2021 </div><div id="a27067" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:153px;">$ </div><div id="a27069" style="position:absolute;left:344.973px;top:153px;">(12,177)</div><div id="a27072" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:153px;">$ </div><div id="a27074" style="position:absolute;left:428.04px;top:153px;">(21,778)</div><div id="a27077" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:153px;">$ </div><div id="a27079" style="position:absolute;left:540.68px;top:153px;">596</div><div id="a27082" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:153px;">$ </div><div id="a27084" style="position:absolute;left:608.88px;top:153px;">(2,584)</div><div id="a27087" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:153px;">$ </div><div id="a27089" style="position:absolute;left:677.04px;top:153px;">(35,943)</div><div id="a27109" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:187.1px;">Balance at March 31, 2020 </div><div id="a27113" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:187.1px;">$ </div><div id="a27115" style="position:absolute;left:344.973px;top:187.1px;">(99,187)</div><div id="a27118" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:187.1px;">$ </div><div id="a27120" style="position:absolute;left:428.04px;top:187.1px;">(17,576)</div><div id="a27123" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:187.1px;">$ </div><div id="a27125" style="position:absolute;left:535.72px;top:187.1px;">(460)</div><div id="a27128" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:187.1px;">$ </div><div id="a27130" style="position:absolute;left:608.88px;top:187.1px;">(4,301)</div><div id="a27133" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:187.1px;">$ </div><div id="a27135" style="position:absolute;left:670.48px;top:187.1px;">(121,524)</div><div id="a27138" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:204px;">Other comprehensive income (loss) before </div><div id="a27157" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:221px;">reclassifications </div><div id="a27161" style="position:absolute;left:349.933px;top:221px;">10,550</div><div id="a27165" style="position:absolute;left:444.68px;top:221px;">(336)</div><div id="a27169" style="position:absolute;left:530.6px;top:221px;">2,128</div><div id="a27173" style="position:absolute;left:618.8px;top:221px;">(144)</div><div id="a27177" style="position:absolute;left:682px;top:221px;">12,198</div><div id="a27180" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:238.1px;">Amounts reclassified from AOCI </div><div id="a27184" style="position:absolute;left:373.293px;top:238.1px;">—</div><div id="a27188" style="position:absolute;left:449.64px;top:238.1px;">600</div><div id="a27192" style="position:absolute;left:542.44px;top:238.1px;">(93)</div><div id="a27196" style="position:absolute;left:630.48px;top:238.1px;">—</div><div id="a27200" style="position:absolute;left:698.64px;top:238.1px;">507</div><div id="a27203" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:255.1px;">Related tax amounts </div><div id="a27207" style="position:absolute;left:373.293px;top:255.1px;">—</div><div id="a27211" style="position:absolute;left:451.4px;top:255.1px;">(51)</div><div id="a27215" style="position:absolute;left:535.72px;top:255.1px;">(427)</div><div id="a27219" style="position:absolute;left:630.48px;top:255.1px;">33</div><div id="a27223" style="position:absolute;left:693.68px;top:255.1px;">(445)</div><div id="a27225" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:272px;">Balance at June 30, 2020 </div><div id="a27228" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:272px;">$ </div><div id="a27230" style="position:absolute;left:344.973px;top:272px;">(88,637)</div><div id="a27233" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:272px;">$ </div><div id="a27235" style="position:absolute;left:428.04px;top:272px;">(17,363)</div><div id="a27238" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:272px;">$ </div><div id="a27240" style="position:absolute;left:530.6px;top:272px;">1,148</div><div id="a27243" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:272px;">$ </div><div id="a27245" style="position:absolute;left:608.88px;top:272px;">(4,412)</div><div id="a27248" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:272px;">$ </div><div id="a27250" style="position:absolute;left:670.48px;top:272px;">(109,264)</div></div></div></div><div id="TextBlockContainer213" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:288px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a27260" style="position:absolute;font-weight:bold;font-style:normal;left:413.32px;top:0px;">Defined </div><div id="a27263" style="position:absolute;font-weight:bold;font-style:normal;left:491.4px;top:0px;">Unrealized </div><div id="a27274" style="position:absolute;font-weight:bold;font-style:normal;left:324.973px;top:17.1px;">Currency </div><div id="a27277" style="position:absolute;font-weight:bold;font-style:normal;left:415.08px;top:17.1px;">Benefit </div><div id="a27280" style="position:absolute;font-weight:bold;font-style:normal;left:482.28px;top:17.1px;">Gain (Loss) in<div style="display:inline-block;width:3.72px"> </div></div><div id="a27291" style="position:absolute;font-weight:bold;font-style:normal;left:319.053px;top:34.1px;">Translation </div><div id="a27294" style="position:absolute;font-weight:bold;font-style:normal;left:413.32px;top:34.1px;">Pension </div><div id="a27297" style="position:absolute;font-weight:bold;font-style:normal;left:482.6px;top:34.1px;">Available-for<div style="display:inline-block;width:1.37px"> </div>- </div><div id="a27303" style="position:absolute;font-weight:bold;font-style:normal;left:580.08px;top:34.1px;">Derivative </div><div id="a27312" style="position:absolute;font-weight:bold;font-style:normal;left:316.173px;top:51px;">Adjustments </div><div id="a27315" style="position:absolute;font-weight:bold;font-style:normal;left:419.88px;top:51px;">Plans </div><div id="a27317" style="position:absolute;font-weight:bold;font-style:normal;left:481.32px;top:51px;">Sale Securities </div><div id="a27319" style="position:absolute;font-weight:bold;font-style:normal;left:574.8px;top:51px;">Instruments </div><div id="a27322" style="position:absolute;font-weight:bold;font-style:normal;left:673.36px;top:51px;">Total </div><div id="a27324" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:68px;">Balance at December 31, 2020 </div><div id="a27327" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:68px;">$ </div><div id="a27329" style="position:absolute;left:351.693px;top:68px;">(2,875)</div><div id="a27332" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:68px;">$ </div><div id="a27334" style="position:absolute;left:428.04px;top:68px;">(23,467)</div><div id="a27337" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:68px;">$ </div><div id="a27339" style="position:absolute;left:530.6px;top:68px;">3,342</div><div id="a27342" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:68px;">$ </div><div id="a27344" style="position:absolute;left:608.88px;top:68px;">(3,598)</div><div id="a27347" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:68px;">$ </div><div id="a27349" style="position:absolute;left:677.04px;top:68px;">(26,598)</div><div id="a27352" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:85.1px;">Other comprehensive (loss) income before </div><div id="a27371" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:102.1px;">reclassifications </div><div id="a27375" style="position:absolute;left:351.693px;top:102.1px;">(9,302)</div><div id="a27379" style="position:absolute;left:449.64px;top:102.1px;">521</div><div id="a27383" style="position:absolute;left:535.72px;top:102.1px;">(404)</div><div id="a27387" style="position:absolute;left:613.68px;top:102.1px;">1,316</div><div id="a27391" style="position:absolute;left:683.76px;top:102.1px;">(7,869)</div><div id="a27394" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:119.1px;">Amounts reclassified from AOCI </div><div id="a27398" style="position:absolute;left:373.293px;top:119.1px;">—</div><div id="a27402" style="position:absolute;left:439.56px;top:119.1px;">1,714</div><div id="a27406" style="position:absolute;left:525.8px;top:119.1px;">(3,083)</div><div id="a27410" style="position:absolute;left:630.48px;top:119.1px;">—</div><div id="a27414" style="position:absolute;left:683.76px;top:119.1px;">(1,369)</div><div id="a27417" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:136px;">Related tax amounts </div><div id="a27421" style="position:absolute;left:373.293px;top:136px;">—</div><div id="a27425" style="position:absolute;left:444.68px;top:136px;">(546)</div><div id="a27429" style="position:absolute;left:540.68px;top:136px;">741</div><div id="a27433" style="position:absolute;left:618.8px;top:136px;">(302)</div><div id="a27437" style="position:absolute;left:693.68px;top:136px;">(107)</div><div id="a27439" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:153.1px;">Balance at June 30, 2021 </div><div id="a27442" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:153.1px;">$ </div><div id="a27444" style="position:absolute;left:344.973px;top:153.1px;">(12,177)</div><div id="a27447" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:153.1px;">$ </div><div id="a27449" style="position:absolute;left:428.04px;top:153.1px;">(21,778)</div><div id="a27452" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:153.1px;">$ </div><div id="a27454" style="position:absolute;left:540.68px;top:153.1px;">596</div><div id="a27457" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:153.1px;">$ </div><div id="a27459" style="position:absolute;left:608.88px;top:153.1px;">(2,584)</div><div id="a27462" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:153.1px;">$ </div><div id="a27464" style="position:absolute;left:677.04px;top:153.1px;">(35,943)</div><div id="a27484" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:187.1px;">Balance at December 31, 2019 </div><div id="a27488" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:187.1px;">$ </div><div id="a27490" style="position:absolute;left:344.973px;top:187.1px;">(44,568)</div><div id="a27493" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:187.1px;">$ </div><div id="a27495" style="position:absolute;left:428.04px;top:187.1px;">(34,533)</div><div id="a27498" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:187.1px;">$ </div><div id="a27500" style="position:absolute;left:530.6px;top:187.1px;">1,251</div><div id="a27503" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:187.1px;">$ </div><div id="a27505" style="position:absolute;left:618.8px;top:187.1px;">(320)</div><div id="a27508" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:187.1px;">$ </div><div id="a27510" style="position:absolute;left:677.04px;top:187.1px;">(78,170)</div><div id="a27513" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:204px;">Other comprehensive (loss) income before<div style="display:inline-block;width:4.37px"> </div></div><div id="a27532" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:221.1px;">reclassifications </div><div id="a27536" style="position:absolute;left:344.973px;top:221.1px;">(44,069)</div><div id="a27540" style="position:absolute;left:449.64px;top:221.1px;">492</div><div id="a27544" style="position:absolute;left:549.16px;top:221.1px;">(8)</div><div id="a27548" style="position:absolute;left:608.88px;top:221.1px;">(5,315)</div><div id="a27552" style="position:absolute;left:677.04px;top:221.1px;">(48,900)</div><div id="a27555" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:238.1px;">Amounts reclassified from AOCI </div><div id="a27559" style="position:absolute;left:373.293px;top:238.1px;">—</div><div id="a27563" style="position:absolute;left:433px;top:238.1px;">24,966</div><div id="a27567" style="position:absolute;left:535.72px;top:238.1px;">(125)</div><div id="a27571" style="position:absolute;left:630.48px;top:238.1px;">—</div><div id="a27575" style="position:absolute;left:682px;top:238.1px;">24,841</div><div id="a27578" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:255.1px;">Related tax amounts </div><div id="a27582" style="position:absolute;left:373.293px;top:255.1px;">—</div><div id="a27586" style="position:absolute;left:434.76px;top:255.1px;">(8,288)</div><div id="a27590" style="position:absolute;left:547.4px;top:255.1px;">30</div><div id="a27594" style="position:absolute;left:613.68px;top:255.1px;">1,223</div><div id="a27598" style="position:absolute;left:683.76px;top:255.1px;">(7,035)</div><div id="a27600" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:272px;">Balance at June 30, 2020 </div><div id="a27603" style="position:absolute;font-weight:normal;font-style:normal;left:314.413px;top:272px;">$ </div><div id="a27605" style="position:absolute;left:344.973px;top:272px;">(88,637)</div><div id="a27608" style="position:absolute;font-weight:normal;font-style:normal;left:397.48px;top:272px;">$ </div><div id="a27610" style="position:absolute;left:428.04px;top:272px;">(17,363)</div><div id="a27613" style="position:absolute;font-weight:normal;font-style:normal;left:480.52px;top:272px;">$ </div><div id="a27615" style="position:absolute;left:530.6px;top:272px;">1,148</div><div id="a27618" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:272px;">$ </div><div id="a27620" style="position:absolute;left:608.88px;top:272px;">(4,412)</div><div id="a27623" style="position:absolute;font-weight:normal;font-style:normal;left:654.48px;top:272px;">$ </div><div id="a27625" style="position:absolute;left:670.48px;top:272px;">(109,264)</div></div> -28334000 -22175000 317000 -3036000 -53228000 16157000 -260000 341000 586000 16824000 0 852000 2000 0 854000 0 -195000 -64000 -134000 -393000 -12177000 -21778000 596000 -2584000 -35943000 -99187000 -17576000 -460000 -4301000 -121524000 10550000 -336000 2128000 -144000 12198000 0 600000 -93000 0 507000 0 -51000 -427000 33000 -445000 -88637000 -17363000 1148000 -4412000 -109264000 -2875000 -23467000 3342000 -3598000 -26598000 -9302000 521000 -404000 1316000 -7869000 0 1714000 -3083000 0 -1369000 0 -546000 741000 -302000 -107000 -12177000 -21778000 596000 -2584000 -35943000 -44568000 -34533000 1251000 -320000 -78170000 -44069000 492000 -8000 -5315000 -48900000 0 24966000 -125000 0 24841000 0 -8288000 30000 1223000 -7035000 -88637000 -17363000 1148000 -4412000 -109264000 <div id="TextBlockContainer218" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:674px;height:55px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a27776" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 17 – Fair Value<div style="display:inline-block;width:5.24px"> </div>Measurements</div><div id="a27787" style="position:absolute;font-weight:normal;font-style:normal;left:209.253px;top:0px;"> </div><div id="a27788" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The Company has valued its company-owned life insurance<div style="display:inline-block;width:4.69px"> </div>policies at fair value.<div style="display:inline-block;width:7.23px"> </div>These assets are subject to fair value </div><div id="a27829" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">measurement as follows:</div></div><div id="TextBlockContainer221" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a27840" style="position:absolute;font-weight:bold;font-style:normal;left:452.2px;top:0px;">Fair Value<div style="display:inline-block;width:4.84px"> </div>Measurements at June 30, 2021 </div><div id="a27845" style="position:absolute;font-weight:bold;font-style:normal;left:365.453px;top:15px;">Total </div><div id="a27848" style="position:absolute;font-weight:bold;font-style:normal;left:499.24px;top:15px;">Using Fair Value<div style="display:inline-block;width:4.89px"> </div>Hierarchy </div><div id="a27850" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Assets </div><div id="a27852" style="position:absolute;font-weight:bold;font-style:normal;left:350.093px;top:30.7px;">Fair Value </div><div id="a27855" style="position:absolute;font-weight:bold;font-style:normal;left:460.2px;top:30.7px;">Level 1 </div><div id="a27858" style="position:absolute;font-weight:bold;font-style:normal;left:558.28px;top:30.7px;">Level 2 </div><div id="a27861" style="position:absolute;font-weight:bold;font-style:normal;left:656.24px;top:30.7px;">Level 3 </div><div id="a27863" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.6px;">Company-owned life insurance </div><div id="a27867" style="position:absolute;font-weight:normal;font-style:normal;left:338.413px;top:46.6px;">$ </div><div id="a27869" style="position:absolute;left:393.16px;top:46.6px;">2,137</div><div id="a27872" style="position:absolute;font-weight:normal;font-style:normal;left:438.44px;top:46.6px;">$ </div><div id="a27874" style="position:absolute;left:509.96px;top:46.6px;">—</div><div id="a27877" style="position:absolute;font-weight:normal;font-style:normal;left:536.52px;top:46.6px;">$ </div><div id="a27879" style="position:absolute;left:591.12px;top:46.6px;">2,137</div><div id="a27882" style="position:absolute;font-weight:normal;font-style:normal;left:634.48px;top:46.6px;">$ </div><div id="a27884" style="position:absolute;left:706px;top:46.6px;">—</div><div id="a27886" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.5px;">Total </div><div id="a27888" style="position:absolute;font-weight:normal;font-style:normal;left:338.413px;top:64.5px;">$ </div><div id="a27890" style="position:absolute;left:393.16px;top:64.5px;">2,137</div><div id="a27893" style="position:absolute;font-weight:normal;font-style:normal;left:438.44px;top:64.5px;">$ </div><div id="a27895" style="position:absolute;left:509.96px;top:64.5px;">—</div><div id="a27898" style="position:absolute;font-weight:normal;font-style:normal;left:536.52px;top:64.5px;">$ </div><div id="a27900" style="position:absolute;left:591.12px;top:64.5px;">2,137</div><div id="a27903" style="position:absolute;font-weight:normal;font-style:normal;left:634.48px;top:64.5px;">$ </div><div id="a27905" style="position:absolute;left:706px;top:64.5px;">—</div></div><div id="TextBlockContainer225" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a27913" style="position:absolute;font-weight:bold;font-style:normal;left:438.76px;top:0px;">Fair Value<div style="display:inline-block;width:4.84px"> </div>Measurements at December 31, 2020 </div><div id="a27918" style="position:absolute;font-weight:bold;font-style:normal;left:367.213px;top:15px;">Total </div><div id="a27921" style="position:absolute;font-weight:bold;font-style:normal;left:501px;top:15px;">Using Fair Value<div style="display:inline-block;width:4.89px"> </div>Hierarchy </div><div id="a27923" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Assets </div><div id="a27925" style="position:absolute;font-weight:bold;font-style:normal;left:351.853px;top:30.7px;">Fair Value </div><div id="a27929" style="position:absolute;font-weight:bold;font-style:normal;left:461.96px;top:30.7px;">Level 1 </div><div id="a27932" style="position:absolute;font-weight:bold;font-style:normal;left:560.04px;top:30.7px;">Level 2 </div><div id="a27935" style="position:absolute;font-weight:bold;font-style:normal;left:658px;top:30.7px;">Level 3 </div><div id="a27937" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.6px;">Company-owned life insurance<div style="display:inline-block;width:4.06px"> </div></div><div id="a27941" style="position:absolute;font-weight:normal;font-style:normal;left:338.413px;top:46.6px;">$ </div><div id="a27943" style="position:absolute;left:393.64px;top:46.6px;">1,961</div><div id="a27946" style="position:absolute;font-weight:normal;font-style:normal;left:438.44px;top:46.6px;">$ </div><div id="a27948" style="position:absolute;left:510.44px;top:46.6px;">—</div><div id="a27951" style="position:absolute;font-weight:normal;font-style:normal;left:536.52px;top:46.6px;">$ </div><div id="a27953" style="position:absolute;left:591.6px;top:46.6px;">1,961</div><div id="a27956" style="position:absolute;font-weight:normal;font-style:normal;left:634.48px;top:46.6px;">$ </div><div id="a27958" style="position:absolute;left:706.48px;top:46.6px;">—</div><div id="a27960" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.5px;">Total </div><div id="a27962" style="position:absolute;font-weight:normal;font-style:normal;left:338.413px;top:64.5px;">$ </div><div id="a27964" style="position:absolute;left:393.64px;top:64.5px;">1,961</div><div id="a27967" style="position:absolute;font-weight:normal;font-style:normal;left:438.44px;top:64.5px;">$ </div><div id="a27969" style="position:absolute;left:510.44px;top:64.5px;">—</div><div id="a27972" style="position:absolute;font-weight:normal;font-style:normal;left:536.52px;top:64.5px;">$ </div><div id="a27974" style="position:absolute;left:591.6px;top:64.5px;">1,961</div><div id="a27977" style="position:absolute;font-weight:normal;font-style:normal;left:634.48px;top:64.5px;">$ </div><div id="a27979" style="position:absolute;left:706.48px;top:64.5px;">—</div></div><div id="TextBlockContainer228" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:716px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a27981" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The fair values of Company-owned life insurance assets are based<div style="display:inline-block;width:4.81px"> </div>on quotes for like instruments with similar credit ratings and </div><div id="a28023" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">terms.<div style="display:inline-block;width:6.89px"> </div>The Company did not hold any Level 3 investments as of June<div style="display:inline-block;width:4.84px"> </div>30, 2021 or December 31, 2020, respectively,<div style="display:inline-block;width:5.31px"> </div>so related </div><div id="a28067" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">disclosures have not been included.</div></div> <div id="TextBlockContainer222" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_220_XBRL_TS_006574e538454c048d2a7c64fc5e6b4e" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer221" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a27840" style="position:absolute;font-weight:bold;font-style:normal;left:452.2px;top:0px;">Fair Value<div style="display:inline-block;width:4.84px"> </div>Measurements at June 30, 2021 </div><div id="a27845" style="position:absolute;font-weight:bold;font-style:normal;left:365.453px;top:15px;">Total </div><div id="a27848" style="position:absolute;font-weight:bold;font-style:normal;left:499.24px;top:15px;">Using Fair Value<div style="display:inline-block;width:4.89px"> </div>Hierarchy </div><div id="a27850" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Assets </div><div id="a27852" style="position:absolute;font-weight:bold;font-style:normal;left:350.093px;top:30.7px;">Fair Value </div><div id="a27855" style="position:absolute;font-weight:bold;font-style:normal;left:460.2px;top:30.7px;">Level 1 </div><div id="a27858" style="position:absolute;font-weight:bold;font-style:normal;left:558.28px;top:30.7px;">Level 2 </div><div id="a27861" style="position:absolute;font-weight:bold;font-style:normal;left:656.24px;top:30.7px;">Level 3 </div><div id="a27863" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.6px;">Company-owned life insurance </div><div id="a27867" style="position:absolute;font-weight:normal;font-style:normal;left:338.413px;top:46.6px;">$ </div><div id="a27869" style="position:absolute;left:393.16px;top:46.6px;">2,137</div><div id="a27872" style="position:absolute;font-weight:normal;font-style:normal;left:438.44px;top:46.6px;">$ </div><div id="a27874" style="position:absolute;left:509.96px;top:46.6px;">—</div><div id="a27877" style="position:absolute;font-weight:normal;font-style:normal;left:536.52px;top:46.6px;">$ </div><div id="a27879" style="position:absolute;left:591.12px;top:46.6px;">2,137</div><div id="a27882" style="position:absolute;font-weight:normal;font-style:normal;left:634.48px;top:46.6px;">$ </div><div id="a27884" style="position:absolute;left:706px;top:46.6px;">—</div><div id="a27886" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.5px;">Total </div><div id="a27888" style="position:absolute;font-weight:normal;font-style:normal;left:338.413px;top:64.5px;">$ </div><div id="a27890" style="position:absolute;left:393.16px;top:64.5px;">2,137</div><div id="a27893" style="position:absolute;font-weight:normal;font-style:normal;left:438.44px;top:64.5px;">$ </div><div id="a27895" style="position:absolute;left:509.96px;top:64.5px;">—</div><div id="a27898" style="position:absolute;font-weight:normal;font-style:normal;left:536.52px;top:64.5px;">$ </div><div id="a27900" style="position:absolute;left:591.12px;top:64.5px;">2,137</div><div id="a27903" style="position:absolute;font-weight:normal;font-style:normal;left:634.48px;top:64.5px;">$ </div><div id="a27905" style="position:absolute;left:706px;top:64.5px;">—</div></div></div></div><div id="TextBlockContainer226" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_224_XBRL_TS_dce88a0cef5d4629bfa17876059d510d" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer225" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a27913" style="position:absolute;font-weight:bold;font-style:normal;left:438.76px;top:0px;">Fair Value<div style="display:inline-block;width:4.84px"> </div>Measurements at December 31, 2020 </div><div id="a27918" style="position:absolute;font-weight:bold;font-style:normal;left:367.213px;top:15px;">Total </div><div id="a27921" style="position:absolute;font-weight:bold;font-style:normal;left:501px;top:15px;">Using Fair Value<div style="display:inline-block;width:4.89px"> </div>Hierarchy </div><div id="a27923" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Assets </div><div id="a27925" style="position:absolute;font-weight:bold;font-style:normal;left:351.853px;top:30.7px;">Fair Value </div><div id="a27929" style="position:absolute;font-weight:bold;font-style:normal;left:461.96px;top:30.7px;">Level 1 </div><div id="a27932" style="position:absolute;font-weight:bold;font-style:normal;left:560.04px;top:30.7px;">Level 2 </div><div id="a27935" style="position:absolute;font-weight:bold;font-style:normal;left:658px;top:30.7px;">Level 3 </div><div id="a27937" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.6px;">Company-owned life insurance<div style="display:inline-block;width:4.06px"> </div></div><div id="a27941" style="position:absolute;font-weight:normal;font-style:normal;left:338.413px;top:46.6px;">$ </div><div id="a27943" style="position:absolute;left:393.64px;top:46.6px;">1,961</div><div id="a27946" style="position:absolute;font-weight:normal;font-style:normal;left:438.44px;top:46.6px;">$ </div><div id="a27948" style="position:absolute;left:510.44px;top:46.6px;">—</div><div id="a27951" style="position:absolute;font-weight:normal;font-style:normal;left:536.52px;top:46.6px;">$ </div><div id="a27953" style="position:absolute;left:591.6px;top:46.6px;">1,961</div><div id="a27956" style="position:absolute;font-weight:normal;font-style:normal;left:634.48px;top:46.6px;">$ </div><div id="a27958" style="position:absolute;left:706.48px;top:46.6px;">—</div><div id="a27960" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.5px;">Total </div><div id="a27962" style="position:absolute;font-weight:normal;font-style:normal;left:338.413px;top:64.5px;">$ </div><div id="a27964" style="position:absolute;left:393.64px;top:64.5px;">1,961</div><div id="a27967" style="position:absolute;font-weight:normal;font-style:normal;left:438.44px;top:64.5px;">$ </div><div id="a27969" style="position:absolute;left:510.44px;top:64.5px;">—</div><div id="a27972" style="position:absolute;font-weight:normal;font-style:normal;left:536.52px;top:64.5px;">$ </div><div id="a27974" style="position:absolute;left:591.6px;top:64.5px;">1,961</div><div id="a27977" style="position:absolute;font-weight:normal;font-style:normal;left:634.48px;top:64.5px;">$ </div><div id="a27979" style="position:absolute;left:706.48px;top:64.5px;">—</div></div></div></div> 2137000 0 2137000 0 2137000 0 2137000 0 1961000 0 1961000 0 1961000 0 1961000 0 <div id="TextBlockContainer230" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:155px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a28077" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 18 – Hedging Activities </div><div id="a28087" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">In order to satisfy certain requirements of the Credit<div style="display:inline-block;width:4.78px"> </div>Facility as well as to manage the Company’s<div style="display:inline-block;width:4.96px"> </div>exposure to variable interest </div><div id="a28129" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">rate risk associated with the Credit Facility,<div style="display:inline-block;width:5.22px"> </div>in November 2019, the Company entered into $</div><div id="a28129_91_5" style="position:absolute;left:494.759px;top:38.7px;">170.0</div><div id="a28129_96_29" style="position:absolute;font-weight:normal;font-style:normal;left:524.839px;top:38.7px;"><div style="display:inline-block;width:3.36px"> </div>million notional amounts of </div><div id="a28129_125_6" style="position:absolute;left:680.079px;top:38.7px;">three </div><div id="a28169" style="position:absolute;left:4.427px;top:53.9px;">year</div><div id="a28169_4_123" style="position:absolute;font-weight:normal;font-style:normal;left:27.467px;top:53.9px;"><div style="display:inline-block;width:3.36px"> </div>interest rate swaps.<div style="display:inline-block;width:7.1px"> </div>See Note 15 of Notes to Condensed Consolidated Financial Statements.<div style="display:inline-block;width:8.23px"> </div>These interest rate swaps are </div><div id="a28208" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">designated as cash flow hedges and, as such, the contracts<div style="display:inline-block;width:4.78px"> </div>are marked-to-market at each reporting date and any unrealized gains<div style="display:inline-block;width:4.85px"> </div>or </div><div id="a28254" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">losses are included in AOCI to the extent effective<div style="display:inline-block;width:4.97px"> </div>and reclassified to interest expense in the period during which the<div style="display:inline-block;width:4.81px"> </div>transaction </div><div id="a28296" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">affects earnings or it becomes probable that<div style="display:inline-block;width:4.74px"> </div>the forecasted transaction will not occur.<div style="display:inline-block;width:8.19px"> </div></div><div id="a28325" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:123.4px;">The balance sheet classification and fair values of the<div style="display:inline-block;width:4.79px"> </div>Company’s derivative instruments,<div style="display:inline-block;width:4.74px"> </div>which are Level 2 measurements, are as </div><div id="a28363" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:138.7px;">follows:</div></div><div id="TextBlockContainer234" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:709px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_232_XBRL_TS_369daa2b27cf4699a00469a07da0f518" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer233" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:709px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a28371" style="position:absolute;font-weight:bold;font-style:normal;left:567.6px;top:0px;">Fair Value </div><div id="a28377" style="position:absolute;font-weight:bold;font-style:normal;left:319.053px;top:17.3px;">Condensed Consolidated </div><div id="a28380" style="position:absolute;font-weight:bold;font-style:normal;left:519.4px;top:17.3px;">June 30,<div style="display:inline-block;width:3.53px"> </div></div><div id="a28383" style="position:absolute;font-weight:bold;font-style:normal;left:614.32px;top:17.3px;">December 31, </div><div id="a28389" style="position:absolute;font-weight:bold;font-style:normal;left:322.893px;top:33.9px;">Balance Sheet Location </div><div id="a28393" style="position:absolute;font-weight:bold;font-style:normal;left:529.8px;top:33.9px;">2021 </div><div id="a28396" style="position:absolute;font-weight:bold;font-style:normal;left:639.76px;top:33.9px;">2020 </div><div id="a28400" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:51.2px;">Derivatives designated as cash flow hedges: </div><div id="a28413" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:68px;">Interest rate swaps </div><div id="a28415" style="position:absolute;font-weight:normal;font-style:normal;left:295.533px;top:68px;">Other non-current liabilities </div><div id="a28420" style="position:absolute;font-weight:normal;font-style:normal;left:493.64px;top:68px;">$ </div><div id="a28422" style="position:absolute;left:559.6px;top:68px;">3,356</div><div id="a28425" style="position:absolute;font-weight:normal;font-style:normal;left:603.6px;top:68px;">$ </div><div id="a28427" style="position:absolute;left:669.68px;top:68px;">4,672</div><div id="a28436" style="position:absolute;font-weight:normal;font-style:normal;left:493.64px;top:85.8px;">$ </div><div id="a28438" style="position:absolute;left:559.6px;top:85.8px;">3,356</div><div id="a28441" style="position:absolute;font-weight:normal;font-style:normal;left:603.6px;top:85.8px;">$ </div><div id="a28443" style="position:absolute;left:669.68px;top:85.8px;">4,672</div></div></div></div><div id="TextBlockContainer236" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:389px;height:16px;display:inline-block;"><div id="a28446" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">The following table presents the net unrealized loss deferred to<div style="display:inline-block;width:4.8px"> </div>AOCI:</div></div><div id="TextBlockContainer240" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:709px;height:85px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_238_XBRL_TS_3dbe44086adb4cc0bd73a1b46021f473" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer239" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:709px;height:85px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a28475" style="position:absolute;font-weight:bold;font-style:normal;left:518.28px;top:0px;">June 30,<div style="display:inline-block;width:3.53px"> </div></div><div id="a28478" style="position:absolute;font-weight:bold;font-style:normal;left:614.32px;top:0px;">December 31, </div><div id="a28487" style="position:absolute;font-weight:bold;font-style:normal;left:528.68px;top:17px;">2021 </div><div id="a28490" style="position:absolute;font-weight:bold;font-style:normal;left:639.76px;top:17px;">2020 </div><div id="a28494" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:34.2px;">Derivatives designated as cash flow hedges: </div><div id="a28507" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:51px;">Interest rate swaps </div><div id="a28510" style="position:absolute;font-weight:normal;font-style:normal;left:322.573px;top:51px;">AOCI </div><div id="a28513" style="position:absolute;font-weight:normal;font-style:normal;left:493.96px;top:51px;">$ </div><div id="a28515" style="position:absolute;left:558.6px;top:51px;">2,584</div><div id="a28518" style="position:absolute;font-weight:normal;font-style:normal;left:605.04px;top:51px;">$ </div><div id="a28520" style="position:absolute;left:669.68px;top:51px;">3,598</div><div id="a28529" style="position:absolute;font-weight:normal;font-style:normal;left:493.96px;top:68.8px;">$ </div><div id="a28531" style="position:absolute;left:558.6px;top:68.8px;">2,584</div><div id="a28534" style="position:absolute;font-weight:normal;font-style:normal;left:605.04px;top:68.8px;">$ </div><div id="a28536" style="position:absolute;left:669.68px;top:68.8px;">3,598</div></div></div></div><div id="TextBlockContainer242" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:424px;height:16px;display:inline-block;"><div id="a28539" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">The following table presents the net loss reclassified from<div style="display:inline-block;width:4.82px"> </div>AOCI to earnings:</div></div><div id="TextBlockContainer246" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:717px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_244_XBRL_TS_4845fb53e79a471baceca67139779eb7" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer245" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:717px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a28568" style="position:absolute;font-weight:bold;font-style:normal;left:419.88px;top:0px;">Three Months Ended </div><div id="a28571" style="position:absolute;font-weight:bold;font-style:normal;left:581.84px;top:0px;">Six Months Ended </div><div id="a28578" style="position:absolute;font-weight:bold;font-style:normal;left:456.84px;top:17px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a28581" style="position:absolute;font-weight:bold;font-style:normal;left:610.8px;top:17px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a28588" style="position:absolute;font-weight:bold;font-style:normal;left:428.68px;top:34.4px;">2021 </div><div id="a28591" style="position:absolute;font-weight:bold;font-style:normal;left:505.64px;top:34.4px;">2020 </div><div id="a28594" style="position:absolute;font-weight:bold;font-style:normal;left:582.64px;top:34.4px;">2021 </div><div id="a28597" style="position:absolute;font-weight:bold;font-style:normal;left:659.76px;top:34.4px;">2020 </div><div id="a28601" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.4px;">Amount and location of expense reclassified </div><div id="a28618" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">from AOCI into expense (effective portion) </div><div id="a28621" style="position:absolute;font-weight:normal;font-style:normal;left:277.453px;top:68px;">Interest expense, net </div><div id="a28623" style="position:absolute;font-weight:normal;font-style:normal;left:407.56px;top:68px;">$ </div><div id="a28625" style="position:absolute;left:447.72px;top:68px;">(659)</div><div id="a28628" style="position:absolute;font-weight:normal;font-style:normal;left:484.52px;top:68px;">$ </div><div id="a28630" style="position:absolute;left:524.68px;top:68px;">(483)</div><div id="a28633" style="position:absolute;font-weight:normal;font-style:normal;left:561.48px;top:68px;">$ </div><div id="a28635" style="position:absolute;left:591.92px;top:68px;">(1,302)</div><div id="a28638" style="position:absolute;font-weight:normal;font-style:normal;left:638.64px;top:68px;">$ </div><div id="a28640" style="position:absolute;left:678.8px;top:68px;">(465)</div></div></div></div><div id="TextBlockContainer248" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:709px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a28643" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Interest rate swaps are entered into with a limited number<div style="display:inline-block;width:4.77px"> </div>of counterparties, each of which allows for net settlement<div style="display:inline-block;width:4.71px"> </div>of all </div><div id="a28685" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">contracts through a single payment in a single currency<div style="display:inline-block;width:4.77px"> </div>in the event of a default on or termination of any one<div style="display:inline-block;width:4.72px"> </div>contract.<div style="display:inline-block;width:6.88px"> </div>As such, in </div><div id="a28735" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">accordance with the Company’s<div style="display:inline-block;width:4.75px"> </div>accounting policy,<div style="display:inline-block;width:4.73px"> </div>these derivative instruments are recorded on a net basis within<div style="display:inline-block;width:4.8px"> </div>the Condensed </div><div id="a28771" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">Consolidated Balance Sheets.</div></div> 170000000.0 P3Y <div id="TextBlockContainer233" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:709px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a28371" style="position:absolute;font-weight:bold;font-style:normal;left:567.6px;top:0px;">Fair Value </div><div id="a28377" style="position:absolute;font-weight:bold;font-style:normal;left:319.053px;top:17.3px;">Condensed Consolidated </div><div id="a28380" style="position:absolute;font-weight:bold;font-style:normal;left:519.4px;top:17.3px;">June 30,<div style="display:inline-block;width:3.53px"> </div></div><div id="a28383" style="position:absolute;font-weight:bold;font-style:normal;left:614.32px;top:17.3px;">December 31, </div><div id="a28389" style="position:absolute;font-weight:bold;font-style:normal;left:322.893px;top:33.9px;">Balance Sheet Location </div><div id="a28393" style="position:absolute;font-weight:bold;font-style:normal;left:529.8px;top:33.9px;">2021 </div><div id="a28396" style="position:absolute;font-weight:bold;font-style:normal;left:639.76px;top:33.9px;">2020 </div><div id="a28400" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:51.2px;">Derivatives designated as cash flow hedges: </div><div id="a28413" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:68px;">Interest rate swaps </div><div id="a28415" style="position:absolute;font-weight:normal;font-style:normal;left:295.533px;top:68px;">Other non-current liabilities </div><div id="a28420" style="position:absolute;font-weight:normal;font-style:normal;left:493.64px;top:68px;">$ </div><div id="a28422" style="position:absolute;left:559.6px;top:68px;">3,356</div><div id="a28425" style="position:absolute;font-weight:normal;font-style:normal;left:603.6px;top:68px;">$ </div><div id="a28427" style="position:absolute;left:669.68px;top:68px;">4,672</div><div id="a28436" style="position:absolute;font-weight:normal;font-style:normal;left:493.64px;top:85.8px;">$ </div><div id="a28438" style="position:absolute;left:559.6px;top:85.8px;">3,356</div><div id="a28441" style="position:absolute;font-weight:normal;font-style:normal;left:603.6px;top:85.8px;">$ </div><div id="a28443" style="position:absolute;left:669.68px;top:85.8px;">4,672</div></div><div id="TextBlockContainer239" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:709px;height:85px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a28475" style="position:absolute;font-weight:bold;font-style:normal;left:518.28px;top:0px;">June 30,<div style="display:inline-block;width:3.53px"> </div></div><div id="a28478" style="position:absolute;font-weight:bold;font-style:normal;left:614.32px;top:0px;">December 31, </div><div id="a28487" style="position:absolute;font-weight:bold;font-style:normal;left:528.68px;top:17px;">2021 </div><div id="a28490" style="position:absolute;font-weight:bold;font-style:normal;left:639.76px;top:17px;">2020 </div><div id="a28494" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:34.2px;">Derivatives designated as cash flow hedges: </div><div id="a28507" style="position:absolute;font-weight:normal;font-style:normal;left:14.507px;top:51px;">Interest rate swaps </div><div id="a28510" style="position:absolute;font-weight:normal;font-style:normal;left:322.573px;top:51px;">AOCI </div><div id="a28513" style="position:absolute;font-weight:normal;font-style:normal;left:493.96px;top:51px;">$ </div><div id="a28515" style="position:absolute;left:558.6px;top:51px;">2,584</div><div id="a28518" style="position:absolute;font-weight:normal;font-style:normal;left:605.04px;top:51px;">$ </div><div id="a28520" style="position:absolute;left:669.68px;top:51px;">3,598</div><div id="a28529" style="position:absolute;font-weight:normal;font-style:normal;left:493.96px;top:68.8px;">$ </div><div id="a28531" style="position:absolute;left:558.6px;top:68.8px;">2,584</div><div id="a28534" style="position:absolute;font-weight:normal;font-style:normal;left:605.04px;top:68.8px;">$ </div><div id="a28536" style="position:absolute;left:669.68px;top:68.8px;">3,598</div></div><div id="TextBlockContainer245" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:717px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a28568" style="position:absolute;font-weight:bold;font-style:normal;left:419.88px;top:0px;">Three Months Ended </div><div id="a28571" style="position:absolute;font-weight:bold;font-style:normal;left:581.84px;top:0px;">Six Months Ended </div><div id="a28578" style="position:absolute;font-weight:bold;font-style:normal;left:456.84px;top:17px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a28581" style="position:absolute;font-weight:bold;font-style:normal;left:610.8px;top:17px;">June 30,<div style="display:inline-block;width:3.49px"> </div></div><div id="a28588" style="position:absolute;font-weight:bold;font-style:normal;left:428.68px;top:34.4px;">2021 </div><div id="a28591" style="position:absolute;font-weight:bold;font-style:normal;left:505.64px;top:34.4px;">2020 </div><div id="a28594" style="position:absolute;font-weight:bold;font-style:normal;left:582.64px;top:34.4px;">2021 </div><div id="a28597" style="position:absolute;font-weight:bold;font-style:normal;left:659.76px;top:34.4px;">2020 </div><div id="a28601" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.4px;">Amount and location of expense reclassified </div><div id="a28618" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">from AOCI into expense (effective portion) </div><div id="a28621" style="position:absolute;font-weight:normal;font-style:normal;left:277.453px;top:68px;">Interest expense, net </div><div id="a28623" style="position:absolute;font-weight:normal;font-style:normal;left:407.56px;top:68px;">$ </div><div id="a28625" style="position:absolute;left:447.72px;top:68px;">(659)</div><div id="a28628" style="position:absolute;font-weight:normal;font-style:normal;left:484.52px;top:68px;">$ </div><div id="a28630" style="position:absolute;left:524.68px;top:68px;">(483)</div><div id="a28633" style="position:absolute;font-weight:normal;font-style:normal;left:561.48px;top:68px;">$ </div><div id="a28635" style="position:absolute;left:591.92px;top:68px;">(1,302)</div><div id="a28638" style="position:absolute;font-weight:normal;font-style:normal;left:638.64px;top:68px;">$ </div><div id="a28640" style="position:absolute;left:678.8px;top:68px;">(465)</div></div> 3356000 4672000 3356000 4672000 2584000 3598000 2584000 3598000 -659000 -483000 -1302000 -465000 <div id="TextBlockContainer250" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:861px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a28826" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 19 – Commitments and Contingencies </div><div id="a28840" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The Company previously disclosed in its 2020 Form 10-K<div style="display:inline-block;width:4.78px"> </div>that AC Products, Inc. (“ACP”), a wholly owned subsidiary,<div style="display:inline-block;width:5.48px"> </div>has been </div><div id="a28882" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">operating a groundwater treatment system to hydraulically<div style="display:inline-block;width:4.76px"> </div>contain groundwater contamination emanating from ACP’s<div style="display:inline-block;width:5.16px"> </div>site, the </div><div id="a28913" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.9px;">principal contaminant of which is perchloroethylene.<div style="display:inline-block;width:8.03px"> </div>As of June 30, 2021, ACP believes it is close to meeting the<div style="display:inline-block;width:4.75px"> </div>conditions for </div><div id="a28955" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">closure of the groundwater treatment system, but continues<div style="display:inline-block;width:4.74px"> </div>to operate this system while in discussions with the relevant<div style="display:inline-block;width:4.81px"> </div>authorities.<div style="display:inline-block;width:3.5px"> </div></div><div id="a28994" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">As of June 30, 2021, the Company believes that the range<div style="display:inline-block;width:4.74px"> </div>of potential-known liabilities associated with the balance<div style="display:inline-block;width:4.71px"> </div>of the ACP water </div><div id="a29040" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">remediation program is approximately $</div><div id="a29040_38_3" style="position:absolute;left:219.333px;top:100px;">0.1</div><div id="a29040_41_13" style="position:absolute;font-weight:normal;font-style:normal;left:236.013px;top:100px;"><div style="display:inline-block;width:3.36px"> </div>million to $</div><div id="a29040_54_3" style="position:absolute;left:301.613px;top:100px;">1.0</div><div id="a29040_57_73" style="position:absolute;font-weight:normal;font-style:normal;left:318.253px;top:100px;"><div style="display:inline-block;width:3.2px"> </div>million.<div style="display:inline-block;width:6.95px"> </div>The low and high ends of the range are based on the length of </div><div id="a29087" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">operation of the treatment system as determined<div style="display:inline-block;width:4.56px"> </div>by groundwater modeling.<div style="display:inline-block;width:7.35px"> </div>Costs of operation include the operation and maintenance </div><div id="a29123" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.7px;">of the extraction well, groundwater monitoring and program<div style="display:inline-block;width:4.77px"> </div>management. </div><div id="a29141" style="position:absolute;font-weight:bold;font-style:normal;left:404.04px;top:130.7px;"> </div><div id="a29142" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:153.9px;">The Company previously disclosed in its 2020 Form 10-K<div style="display:inline-block;width:4.78px"> </div>that an inactive subsidiary of the Company that was acquired<div style="display:inline-block;width:4.71px"> </div>in 1978 </div><div id="a29186" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:169.3px;">sold certain products containing asbestos, primarily<div style="display:inline-block;width:4.65px"> </div>on an installed basis, and is among the defendants in numerous<div style="display:inline-block;width:4.91px"> </div>lawsuits alleging </div><div id="a29225" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:184.6px;">injury due to exposure to asbestos.<div style="display:inline-block;width:7.39px"> </div>During the three and six months ended June 30, 2021,<div style="display:inline-block;width:4.69px"> </div>there have been no significant changes to </div><div id="a29273" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:200px;">the facts or circumstances of this previously disclosed matter,<div style="display:inline-block;width:5.33px"> </div>aside from on-going claims and routine payments associated with<div style="display:inline-block;width:4.72px"> </div>this </div><div id="a29313" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:215.4px;">litigation.<div style="display:inline-block;width:7px"> </div>Based on a continued analysis of the existing and anticipated<div style="display:inline-block;width:4.77px"> </div>future claims against this subsidiary,<div style="display:inline-block;width:4.96px"> </div>it is currently projected </div><div id="a29353" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:230.8px;">that the subsidiary’s total<div style="display:inline-block;width:4.8px"> </div>liability over the next 50 years for these claims is approximately<div style="display:inline-block;width:4.65px"> </div>$</div><div id="a29353_96_3" style="position:absolute;left:495.239px;top:230.8px;">0.4</div><div id="a29353_99_39" style="position:absolute;font-weight:normal;font-style:normal;left:512.039px;top:230.8px;"><div style="display:inline-block;width:3.36px"> </div>million (excluding costs of defense). </div><div id="a29395" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:254px;">The Company previously disclosed in its 2020 Form 10-K<div style="display:inline-block;width:4.78px"> </div>that it is party to certain environmental matters related to certain </div><div id="a29437" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:269.3px;">domestic and foreign properties currently or previously<div style="display:inline-block;width:4.6px"> </div>owned by Houghton.<div style="display:inline-block;width:7.14px"> </div>These environmental matters primarily require the </div><div id="a29470" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:284.7px;">Company to perform long-term monitoring as well as operating<div style="display:inline-block;width:4.96px"> </div>and maintenance at each of the applicable sites.<div style="display:inline-block;width:7.7px"> </div>During the three and </div><div id="a29514" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:300px;">six months ended June 30, 2021, there have been no significant<div style="display:inline-block;width:4.84px"> </div>changes to the facts or circumstances of these previously<div style="display:inline-block;width:4.66px"> </div>disclosed </div><div id="a29557" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:315.4px;">matters, aside from on-going monitoring and maintenance<div style="display:inline-block;width:4.83px"> </div>activities and routine payments associated with each of the<div style="display:inline-block;width:4.73px"> </div>sites.<div style="display:inline-block;width:6.51px"> </div>The </div><div id="a29595" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:330.6px;">Company continually evaluates its obligations related to such<div style="display:inline-block;width:4.71px"> </div>matters, and based on historical costs incurred and projected<div style="display:inline-block;width:4.73px"> </div>costs to be </div><div id="a29636" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:346px;">incurred over the next 28 years, has estimated the present<div style="display:inline-block;width:4.76px"> </div>value range of costs for all of the Houghton environmental<div style="display:inline-block;width:4.77px"> </div>matters, on a </div><div id="a29682" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:361.3px;">discounted basis, to be between approximately $</div><div id="a29682_47_3" style="position:absolute;left:263.373px;top:361.3px;">5.5</div><div id="a29682_50_14" style="position:absolute;font-weight:normal;font-style:normal;left:280.013px;top:361.3px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a29682_64_3" style="position:absolute;left:354.573px;top:361.3px;">6.5</div><div id="a29682_67_41" style="position:absolute;font-weight:normal;font-style:normal;left:371.213px;top:361.3px;"><div style="display:inline-block;width:3.36px"> </div>million as of June 30, 2021, for which $</div><div id="a29682_108_3" style="position:absolute;left:587.919px;top:361.3px;">6.0</div><div id="a29682_111_21" style="position:absolute;font-weight:normal;font-style:normal;left:604.559px;top:361.3px;"><div style="display:inline-block;width:3.36px"> </div>million was accrued </div><div id="a29726" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:376.7px;">within other accrued liabilities and other non-current<div style="display:inline-block;width:4.77px"> </div>liabilities on the Company’s Condensed<div style="display:inline-block;width:4.79px"> </div>Consolidated Balance Sheet as of June </div><div id="a29764" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:392px;">30, 2021.<div style="display:inline-block;width:7.03px"> </div>Comparatively, as of December<div style="display:inline-block;width:4.81px"> </div>31, 2020, the Company had $</div><div id="a29764_68_3" style="position:absolute;left:391.533px;top:392px;">6.0</div><div id="a29764_71_52" style="position:absolute;font-weight:normal;font-style:normal;left:408.36px;top:392px;"><div style="display:inline-block;width:3.2px"> </div>million accrued for with respect to these matters. </div><div id="a29804" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:415.4px;">The Company believes, although there can be no assurance<div style="display:inline-block;width:4.72px"> </div>regarding the outcome of other unrelated environmental matters, that </div><div id="a29840" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:430.6px;">it has made adequate accruals for costs associated with other<div style="display:inline-block;width:4.71px"> </div>environmental problems of which it is aware.<div style="display:inline-block;width:7.73px"> </div>Approximately $</div><div id="a29840_123_3" style="position:absolute;left:670.319px;top:430.6px;">0.1</div><div id="a29840_126_1" style="position:absolute;font-weight:normal;font-style:normal;left:686.959px;top:430.6px;"> </div><div id="a29878" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:446px;">million was accrued as of both June 30, 2021 and December<div style="display:inline-block;width:4.72px"> </div>31, 2020,<div style="display:inline-block;width:3.64px"> </div>to provide for such anticipated future environmental </div><div id="a29919" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:461.3px;">assessments and remediation costs.<div style="display:inline-block;width:7.49px"> </div></div><div id="a29928" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:484.7px;">The Company previously disclosed in its 2020 Form 10-K<div style="display:inline-block;width:4.78px"> </div>that one of the Company’s subsidiaries<div style="display:inline-block;width:4.73px"> </div>received a notice of inspection </div><div id="a29971" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:500.1px;">from a taxing authority in a country where certain<div style="display:inline-block;width:4.58px"> </div>of its subsidiaries operate which related to a non-income (indirect)<div style="display:inline-block;width:4.92px"> </div>tax that may be </div><div id="a30019" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:515.4px;">applicable to certain products the subsidiary sells.<div style="display:inline-block;width:7.81px"> </div>To date, the Company<div style="display:inline-block;width:4.86px"> </div>has not<div style="display:inline-block;width:3.45px"> </div>received any assessment from the authority related to </div><div id="a30063" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:530.6px;">potential liabilities that may be due from the Company’s<div style="display:inline-block;width:5.39px"> </div>subsidiary.<div style="display:inline-block;width:7.91px"> </div>Consequently, there is substantial uncertainty<div style="display:inline-block;width:5.12px"> </div>with respect to the </div><div id="a30102" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:546px;">Company’s ultimate liability<div style="display:inline-block;width:4.7px"> </div>with respect to this indirect tax, as the application of<div style="display:inline-block;width:4.72px"> </div>this tax in its given market is ambiguous and </div><div id="a30146" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:561.3px;">interpreted differently among other peer companies<div style="display:inline-block;width:4.83px"> </div>and taxing authorities.<div style="display:inline-block;width:7.24px"> </div>The Company, with assistance<div style="display:inline-block;width:4.7px"> </div>from independent experts, </div><div id="a30179" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:576.7px;">has performed an evaluation of the applicability of this<div style="display:inline-block;width:4.74px"> </div>indirect tax to the Company’s<div style="display:inline-block;width:4.83px"> </div>subsidiaries in this country.<div style="display:inline-block;width:8.12px"> </div>During the six </div><div id="a30221" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:592.1px;">months ended June 30, 2021 and through the date of<div style="display:inline-block;width:4.7px"> </div>this Report, there have been no significant changes to<div style="display:inline-block;width:4.7px"> </div>the facts or circumstances </div><div id="a30267" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:607.3px;">of this previously disclosed matter,<div style="display:inline-block;width:4.7px"> </div>aside from<div style="display:inline-block;width:3.62px"> </div>on-going discussions between the Company and the<div style="display:inline-block;width:4.78px"> </div>taxing authority related to this </div><div id="a30308" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:622.6px;">notice of inspection and independent testing conducted by<div style="display:inline-block;width:4.83px"> </div>third-party consultants at the direction of the Company and the taxing </div><div id="a30348" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:638px;">authority to determine if the Company’s<div style="display:inline-block;width:5.02px"> </div>products have contents which subject them to this indirect tax.<div style="display:inline-block;width:8.2px"> </div>Based on all of the </div><div id="a30391" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:653.3px;">information available to the Company at this time, as of<div style="display:inline-block;width:4.83px"> </div>June 30, 2021, the Company has recorded a liability of $</div><div id="a30391_113_3" style="position:absolute;left:607.919px;top:653.3px;">1.8</div><div id="a30391_116_18" style="position:absolute;font-weight:normal;font-style:normal;left:624.559px;top:653.3px;"><div style="display:inline-block;width:3.36px"> </div>million in other </div><div id="a30441" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:668.7px;">accrued liabilities, which reflects the Company’s<div style="display:inline-block;width:5.35px"> </div>current best estimate of probable indirect tax owed, including<div style="display:inline-block;width:4.75px"> </div>interest and taking into </div><div id="a30479" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:684.1px;">account applicable statutes of limitations.<div style="display:inline-block;width:7.58px"> </div>Because these amounts in part relate to a Houghton entity<div style="display:inline-block;width:4.77px"> </div>acquired in the Combination and </div><div id="a30520" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:699.3px;">for periods prior to the Combination, the Company<div style="display:inline-block;width:4.54px"> </div>has submitted an indemnification claim with Houghton’s<div style="display:inline-block;width:5.4px"> </div>former owners related to </div><div id="a30559" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:714.7px;">this potential indirect tax liability.<div style="display:inline-block;width:8.38px"> </div>The Company recorded a receivable in other assets for approximately<div style="display:inline-block;width:4.94px"> </div>$</div><div id="a30559_109_3" style="position:absolute;left:573.799px;top:714.7px;">1.1</div><div id="a30559_112_25" style="position:absolute;font-weight:normal;font-style:normal;left:590.479px;top:714.7px;"><div style="display:inline-block;width:3.36px"> </div>million, which reflects </div><div id="a30598" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:730px;">the amount of the initial recorded liability for which<div style="display:inline-block;width:4.76px"> </div>the Company anticipates being indemnified.<div style="display:inline-block;width:7.66px"> </div>As noted, the Company believes </div><div id="a30638" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:745.4px;">there is substantial uncertainty with respect to its ultimate liability<div style="display:inline-block;width:4.85px"> </div>given the ambiguous application of this indirect tax.<div style="display:inline-block;width:7.94px"> </div>At this time, </div><div id="a30681" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:760.7px;">the Company’s current<div style="display:inline-block;width:4.66px"> </div>best estimate of a potential range for possible assessments, including<div style="display:inline-block;width:5.03px"> </div>additional amounts that may be assessed </div><div id="a30720" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:776.1px;">under these indirect tax laws, would be $</div><div id="a30720_41_1" style="position:absolute;left:223.053px;top:776.1px;">0</div><div id="a30720_42_19" style="position:absolute;font-weight:normal;font-style:normal;left:229.773px;top:776.1px;"><div style="display:inline-block;width:3.36px"> </div>to approximately $</div><div id="a30720_61_2" style="position:absolute;left:333.773px;top:776.1px;">40</div><div id="a30720_63_41" style="position:absolute;font-weight:normal;font-style:normal;left:347.213px;top:776.1px;"><div style="display:inline-block;width:3.36px"> </div>million, which is net of approximately $</div><div id="a30720_104_2" style="position:absolute;left:565px;top:776.1px;">11</div><div id="a30720_106_22" style="position:absolute;font-weight:normal;font-style:normal;left:578.32px;top:776.1px;"><div style="display:inline-block;width:3.36px"> </div>million of estimated </div><div id="a30765" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:791.5px;">income tax deductions and approximately $</div><div id="a30765_41_2" style="position:absolute;left:237.613px;top:791.5px;">22</div><div id="a30765_43_80" style="position:absolute;font-weight:normal;font-style:normal;left:250.893px;top:791.5px;"><div style="display:inline-block;width:3.36px"> </div>million of applicable rights to indemnification from Houghton’s<div style="display:inline-block;width:5.5px"> </div>former owners. </div><div id="a30798" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:814.7px;">During the first six months of 2021, one of the Company’s<div style="display:inline-block;width:5.44px"> </div>Brazilian subsidiaries received a notice that it had prevailed<div style="display:inline-block;width:4.71px"> </div>on an </div><div id="a30842" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:830px;">existing legal claim in regard to certain non-income<div style="display:inline-block;width:4.7px"> </div>(indirect) taxes that had been previously charged and paid.<div style="display:inline-block;width:8.17px"> </div>The matter </div><div id="a30884" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:845.4px;">specifically relates to companies’ rights to exclude the<div style="display:inline-block;width:4.77px"> </div>state tax on goods circulation (a valued-added-tax or VAT<div style="display:inline-block;width:7.89px"> </div>equivalent, known in </div></div><div id="TextBlockContainer252" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:323px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a30977" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">Brazil as “ICMS”) from<div style="display:inline-block;width:4.06px"> </div>the calculation of certain additional indirect taxes (specifically<div style="display:inline-block;width:4.74px"> </div>the program of social integration (“PIS”) </div><div id="a31014" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">and contribution for the financing of social security (“COFINS”))<div style="display:inline-block;width:4.79px"> </div>levied by the Brazilian States on the sale of goods.<div style="display:inline-block;width:7.9px"> </div>In May 2021, </div><div id="a31059" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">the Brazilian Supreme Court concluded that ICMS should<div style="display:inline-block;width:4.9px"> </div>not be included in the tax base of PIS and COFINS, and confirmed<div style="display:inline-block;width:4.89px"> </div>the </div><div id="a31104" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">methodology for calculating the PIS and COFINS tax credit<div style="display:inline-block;width:4.77px"> </div>claims to which taxpayers are entitled.<div style="display:inline-block;width:7.58px"> </div>The Company’s Brazilian entities </div><div id="a31143" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">had previously filed legal or administrative disputes on<div style="display:inline-block;width:4.72px"> </div>this matter and are entitled to receive tax credits and interest dating<div style="display:inline-block;width:4.77px"> </div>back to </div><div id="a31188" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.6px;">five years preceding the date of their legal claims.<div style="display:inline-block;width:7.91px"> </div>As a result of these court rulings in the first six months of 2021,<div style="display:inline-block;width:4.73px"> </div>the Company </div><div id="a31239" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92px;">recognized non-income tax credits of </div><div id="a31239_37_4" style="position:absolute;left:206.373px;top:92px;">67.0</div><div id="a31239_41_31" style="position:absolute;font-weight:normal;font-style:normal;left:229.773px;top:92px;"><div style="display:inline-block;width:3.36px"> </div>million BRL or approximately $</div><div id="a31239_72_4" style="position:absolute;left:405.8px;top:92px;">13.3</div><div id="a31239_76_40" style="position:absolute;font-weight:normal;font-style:normal;left:429.16px;top:92px;"><div style="display:inline-block;width:3.2px"> </div>million, which includes approximately $</div><div id="a31239_116_3" style="position:absolute;left:648.239px;top:92px;">8.4</div><div id="a31239_119_9" style="position:absolute;font-weight:normal;font-style:normal;left:665.039px;top:92px;"><div style="display:inline-block;width:3.36px"> </div>million </div><div id="a31282" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:107.4px;">for the PIS and COFINS tax credits as well as interest on these<div style="display:inline-block;width:4.73px"> </div>tax credits of $</div><div id="a31282_80_3" style="position:absolute;left:422.28px;top:107.4px;">4.9</div><div id="a31282_83_50" style="position:absolute;font-weight:normal;font-style:normal;left:439.08px;top:107.4px;"><div style="display:inline-block;width:3.36px"> </div>million.<div style="display:inline-block;width:6.63px"> </div>The tax credits to which the Company’s </div><div id="a31334" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:122.7px;">Brazilian subsidiaries are entitled are claimable once registered<div style="display:inline-block;width:4.8px"> </div>with the Brazilian tax authorities and the Company anticipates </div><div id="a31368" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:137.9px;">completing this step during the second half of 2021.<div style="display:inline-block;width:7.98px"> </div>These tax credits can be used to offset future Brazilian<div style="display:inline-block;width:4.76px"> </div>federal taxes and the </div><div id="a31416" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153.3px;">Company currently anticipates using the full amount of<div style="display:inline-block;width:4.85px"> </div>credits during the five year period of time permitted.<div style="display:inline-block;width:4.27px"> </div></div><div id="a31452" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:176.6px;">In connection with obtaining regulatory approvals for the<div style="display:inline-block;width:4.78px"> </div>Combination, certain steel and aluminum related product lines<div style="display:inline-block;width:4.58px"> </div>of </div><div id="a31486" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:192px;">Houghton were divested on August 1, 2019.<div style="display:inline-block;width:7.88px"> </div>In July 2021, the entity that acquired these divested product lines<div style="display:inline-block;width:4.74px"> </div>submitted an </div><div id="a31526" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:207.4px;">indemnification claim for certain alleged losses in accordance with<div style="display:inline-block;width:4.76px"> </div>the terms of the Asset Purchase Agreement (“APA”)<div style="display:inline-block;width:2.35px"> </div>.<div style="display:inline-block;width:6.76px"> </div>Under the </div><div id="a31567" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:222.8px;">terms of the APA,<div style="display:inline-block;width:5.09px"> </div>the Company has 45 days to review the claim and respond<div style="display:inline-block;width:1.48px"> </div>,<div style="display:inline-block;width:3.4px"> </div>and as such, the Company is in the early stages of </div><div id="a31620" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:238px;">evaluating the merits of the alleged losses in the indemnification<div style="display:inline-block;width:4.82px"> </div>claim received.<div style="display:inline-block;width:7.08px"> </div>As of the date of this Report,<div style="display:inline-block;width:4px"> </div>the Company does not </div><div id="a31670" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:253.3px;">believe it is reasonably possible to determine or quantify<div style="display:inline-block;width:4.73px"> </div>any possible exposure.<div style="display:inline-block;width:3.74px"> </div></div><div id="a31695" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:276.7px;">The Company is party to other litigation which management<div style="display:inline-block;width:4.81px"> </div>currently believes will not have a material adverse<div style="display:inline-block;width:4.74px"> </div>effect on the </div><div id="a31735" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:292px;">Company’s results of<div style="display:inline-block;width:4.59px"> </div>operations, cash flows or financial condition.<div style="display:inline-block;width:7.89px"> </div>In addition, the Company has an immaterial amount of contractual </div><div id="a31773" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:307.4px;">purchase obligations.</div></div> 100000 1000000.0 400000 5500000 6500000 6000000.0 6000000.0 100000 100000 1800000 1100000 0 40000000 11000000 22000000 67000000.0 13300000 -8400000 4900000 XML 24 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2021
Jul. 31, 2021
Document and Entity Information [Abstract]    
Document Type 10-Q  
Document Period Focus Q2  
Document quarterly report true  
Document Fiscal Year Focus 2021  
Document period end date Jun. 30, 2021  
Current fiscal year end date --12-31  
Document Transition Report false  
Amendment flag false  
Entity File Number 001-12019  
Entity registrant name QUAKER CHEMICAL CORPORATION  
Entity Incorporation State Country Code PA  
Entity Tax Identification Number 23-0993790  
Entity central index key 0000081362  
Entity Address Address Line 901 E. Hector Street  
Entity Address City Or Town Conshohocken  
Entity Address State Or Province PA  
Entity Address Postal Zip Code 19428 – 2380  
City Area Code 610  
Local Phone Number 832-4000  
Entity current reporting status Yes  
Entity Interactive Data Current Yes  
Entity filer category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Security 12(b) Title Common Stock, $1 par value  
Trading Symbol KWR  
Entity common stock shares outstanding   17,878,247
Security Exchange Name NYSE  
XML 25 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Net sales $ 435,262 $ 286,040 $ 865,045 $ 664,601
Cost of goods sold (excluding amortization expense - See Note 14) 280,811 188,654 554,400 433,364
Gross profit 154,451 97,386 310,645 231,237
Selling, general and administrative expenses 108,679 86,667 212,989 185,368
Indefinite-lived intangible asset impairment 0 0 0 38,000
Restructuring and related charges 298 486 1,473 2,202
Combination, integration and other acquisition-related expenses 6,658 7,995 12,473 15,873
Operating income (loss) 38,816 2,238 83,710 (10,206)
Other income (expense), net 14,010 (993) 18,697 (22,168)
Interest expense, net (5,618) (6,811) (11,088) (15,272)
Income (loss) before taxes and equity in net income of associated companies 47,208 (5,566) 91,319 (47,646)
Taxes on income (loss) before equity in net income of associated companies 15,218 3,222 25,907 (9,848)
Income (loss) before equity in net income of associated companies 31,990 (8,788) 65,412 (37,798)
Equity in net income of associated companies 1,610 1,066 6,820 1,732
Net income (loss) 33,600 (7,722) 72,232 (36,066)
Less: Net income attributable to noncontrolling interest 30 13 47 50
Net income (loss) attributable to Quaker Chemical Corporation $ 33,570 $ (7,735) $ 72,185 $ (36,116)
Per share data:        
Net income (loss) attributable to Quaker Chemical Corporation common shareholders - basic $ 1.88 $ (0.43) $ 4.04 $ (2.03)
Net income (loss) attributable to Quaker Chemical Corporation common shareholders - diluted 1.88 (0.43) 4.03 (2.03)
Dividends declared $ 0.395 $ 0.385 $ 0.790 $ 0.770
XML 26 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Statement Of Comprehensive Income [Abstract]        
Net income (loss) $ 33,600 $ (7,722) $ 72,232 $ (36,066)
Currency translation adjustments 16,165 10,551 (9,296) (44,200)
Defined Benefit Plans [Abstract]        
Defined Benefit Retirement Plans 397 213 1,689 17,170
Current period change in fair value of derivatives 452 (111) 1,014 (4,092)
Unrealized gain (loss) on available-for-sale securities 279 1,608 (2,746) (103)
Other comprehensive income (loss) 17,293 12,261 (9,339) (31,225)
Comprehensive income (loss) 50,893 4,539 62,893 (67,291)
Less: (income) loss attributable to noncontrolling interest (38) (14) (53) 81
Comprehensive income (loss) attributable to Quaker Chemical Corporation $ 50,855 $ 4,525 $ 62,840 $ (67,210)
XML 27 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 145,610 $ 181,833
Accounts receivable, net 418,642 372,974
Inventories    
Raw materials and supplies 116,491 86,148
Work-in-process and finished goods 126,318 101,616
Prepaid expenses and other current assets 60,844 50,156
Total current assets 867,905 792,727
Property, Plant and Equipment, at Cost 424,360 423,253
Less: Accumulated Depreciation (229,919) (219,370)
Property, Plant and Equipment, net 194,441 203,883
Right of use lease assets 36,160 38,507
Goodwill 633,449 631,212
Other intangible assets, net 1,068,795 1,081,358
Investments in associated companies 98,013 95,785
Deferred tax assets 13,392 16,566
Other non-current assets 32,664 31,796
Total assets 2,944,819 2,891,834
Current liabilities    
Short-term borrowings and current portion of long-term debt 48,079 38,967
Accounts and Other Payables 219,617 198,872
Accrued compensation 33,399 43,300
Accrued restructuring 5,278 8,248
Other accrued liabilities 94,061 93,573
Total current liabilities 400,434 382,960
Long-term debt 847,154 849,068
Long-term lease liabilities 25,668 27,070
Deferred tax liabilities 181,264 192,763
Other non-current liabilities 114,898 119,059
Total liabilities 1,569,418 1,570,920
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]    
Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2021 -17,878,137 shares; 2020 - 17,850,616 shares 17,878 17,851
Capital in excess of par value 910,862 905,171
Retained earnings 482,001 423,940
Accumulated other comprehensive loss (35,943) (26,598)
Total Quaker shareholders' equity 1,374,798 1,320,364
Noncontrolling interest 603 550
Total equity 1,375,401 1,320,914
Total liabilities and equity $ 2,944,819 $ 2,891,834
XML 28 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Jun. 30, 2021
Dec. 31, 2020
Statement Of Financial Position [Abstract]    
Common Stock Par Value $ 1 $ 1
Common Stock Shares Authorized 30,000,000 30,000,000
Common Stock Shares, Issued 17,878,137 17,850,616
XML 29 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities    
Net income (loss) $ 72,232 $ (36,066)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Amortization of debt issuance costs 2,375 2,375
Depreciation and amortization 44,188 42,079
Equity in undistributed earnings of associated companies, net of dividends (6,715) 3,219
Acquisition-related fair value adjustments related to inventory 801 229
Deferred compensation, deferred taxes and other, net (13,849) (22,033)
Share-based compensation 6,134 7,673
(Gain) loss on disposal of property, plant, equipment and other assets (5,356) 81
Insurance settlement realized 0 (542)
Indefinite-lived intangible asset impairment 0 38,000
Combination and other acquisition-related expenses, net of payments (2,305) 1,860
Restructuring and related charges 1,473 2,202
Pension And Other Postretirement Benefit Expense (2,223) 18,784
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:    
Accounts receivable (47,252) 61,659
Inventories (57,020) (3,689)
Prepaid expenses and other current assets (20,111) (2,849)
Change in restructuring liabilities (4,214) (9,592)
Accounts payable and accrued liabilities 22,274 (58,728)
Net cash (used in) provided by operating activities (9,568) 44,662
Cash flows from investing activities    
Investments in property, plant and equipment (6,974) (7,534)
Payments related to acquisitions, net of cash acquired (29,424) (3,132)
Proceeds from disposition of assets 14,744 11
Insurance settlement interest earned 0 37
Net cash used in investing activities (21,654) (10,618)
Cash flows from financing activities    
Payments of term loan debt 19,065 18,702
Borrowings on revolving credit facilities, net 29,433 205,500
Repayments on other debt, net (219) (684)
Dividends paid (14,113) (13,662)
Stock options exercised, other (416) (1,923)
Purchase of noncontrolling interest in affiliates, net 0 (1,047)
Distributions to noncontrolling affiliate shareholders 0 (751)
Net cash (used in) provided by financing activities (4,380) 168,731
Effect of foreign exchange rate changes on cash (683) (4,575)
Net (decrease) increase in cash, cash equivalents and restricted cash (36,285) 198,200
Cash, Cash Equivalents and Restricted Cash at the beginning of the period 181,895 143,555
Cash, Cash Equivalents and Restricted Cash at the end of the period $ 145,610 $ 341,755
XML 30 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Basis of Presentation and Description of Business
 6 Months Ended
Jun. 30, 2021
Basis of Presentation and Description of Business [Abstract]  
Basis of Presentation and Description of Business [Text Block]
Note 1 – Basis of Presentation and Description of Business
 
Basis of Presentation
As used in these Notes to Condensed Consolidated
 
Financial Statements, the terms “Quaker,”
 
“Quaker Houghton,”
 
the
“Company,”
 
“we,” and “our” refer to Quaker Chemical Corporation (doing
 
business as Quaker Houghton), its subsidiaries, and
associated companies, unless the context otherwise requires.
 
As used in these Notes to Condensed Consolidated
 
Financial Statements,
the term Legacy Quaker refers to the Company prior
 
to the closing of its combination with Houghton International,
 
Inc. (“Houghton”)
(herein referred to as the “Combination”).
 
The condensed consolidated financial statements included herein
 
are unaudited and have
been prepared in accordance with generally accepted
 
accounting principles in the United States (“U.S. GAAP”) for
 
interim financial
reporting and the United States Securities and Exchange Commission
 
(“SEC”) regulations.
 
Certain information and footnote
disclosures normally included in financial statements prepared
 
in accordance with U.S. GAAP have been condensed or
 
omitted
pursuant to such rules and regulations.
 
In the opinion of management, the financial statements reflect all
 
adjustments which are
necessary for a fair statement of the financial position,
 
results of operations and cash flows for the interim periods.
 
The results for the
six months ended June 30, 2021 are not necessarily indicative
 
of the results to be expected for the full year.
 
These financial
statements should be read in conjunction with the Company’s
 
Annual Report filed on Form 10-K for the year
 
ended December 31,
2020 (the “2020 Form 10-K”).
 
Description of Business
The Company was organized in 1918, incorporated
 
as a Pennsylvania business corporation in 1930, and in August
 
2019
completed the Combination with Houghton to form
 
Quaker Houghton.
 
Quaker Houghton is the global leader in industrial process
fluids.
 
With a presence around the world,
 
including operations in over
25
 
countries, the Company’s customers
 
include thousands of
the world’s most advanced
 
and specialized steel, aluminum, automotive, aerospace,
 
offshore, can, mining, and metalworking
companies.
 
Quaker Houghton develops, produces, and markets a broad range
 
of formulated chemical specialty products and offe
 
rs
chemical management services (which the Company refers
 
to as “Fluidcare”) for various heavy industrial and manufacturing
applications throughout its
four
 
segments: Americas; Europe, Middle East and Africa (“EMEA”);
 
Asia/Pacific; and Global Specialty
Businesses.
Hyper-inflationary economies
 
Based on various indices or index compilations being
 
used to monitor inflation in Argentina as well as economic
 
instability,
effective July 1, 2018, Argentina’s
 
economy was considered hyper-inflationary under U.S.
 
GAAP.
 
As of, and for the three and six
months ended June 30, 2021, the Company's Argentine
 
subsidiaries represented less than
1
% of the Company’s consolidated
 
total
assets and net sales, respectively.
 
During the three and six months ended June 30, 2021, the Company
 
recorded $
0.1
 
million and $
0.3
million,
 
respectively, of remeasurement
 
losses associated with the applicable currency conversions related
 
to Argentina.
 
Comparatively,
 
during the three and six months ended June 30, 2020, the
 
Company recorded less than $
0.1
 
million and $
0.1
 
million,
respectively, of
 
remeasurement losses associated with the applicable currency
 
conversions
 
related to Argentina.
 
These losses were
recorded within foreign exchange losses, net, which
 
is a component of other income (expense), net, in the Company’s
 
Condensed
Consolidated Statements of Operations.
COVID-19
Management continues to monitor the impact that the COVID-19
 
pandemic is having on the Company,
 
the overall specialty
chemical industry,
 
and the economies and markets in which the Company operates.
 
The full extent of the COVID-19 pandemic
related business and travel restrictions and changes to
 
business and consumer behavior intended to reduce its spread are
 
uncertain as of
the date of this Quarterly Report on Form 10-Q for the
 
period ended June 30, 2021 (the “Report”) as COVID-19
 
and the responses of
governmental authorities continue to evolve globally.
Further, management continues to
 
evaluate how COVID-19-related circumstances, such as remote
 
work arrangements, affect
financial reporting processes, internal control over financial
 
reporting, and disclosure controls and procedures.
 
While the
circumstances have presented and are expected to continue
 
to present challenges, at this time, Management does not believe that
COVID-19 has had a material impact on financial reporting
 
processes, internal control over financial reporting,
 
and disclosure
controls and procedures.
The Company cannot reasonably estimate the magnitude
 
of the effects these conditions will have on the Company’s
 
operations in
the future as they are subject to significant uncertainties
 
relating to the ultimate geographic spread of the virus,
 
the incidence and
severity of the symptoms, the duration or resurgences
 
of the outbreak including the impact of new variants, the global
 
availability and
acceptance of vaccines as well as their efficacy,
 
the length of the travel restrictions and business closures imposed by
 
governments of
impacted countries, and the economic response by governments
 
of impacted countries, all of which continue to evolve.
To the extent
 
that the Company’s customers and
 
suppliers continue to be significantly and adversely impacted by
 
COVID-19, this
could reduce the availability,
 
or result in delays, of materials or supplies to or from
 
the Company, which in
 
turn could significantly
interrupt the Company’s
 
business operations.
 
Such impacts could grow and become more significant to the
 
Company’s operations
and the Company’s liquidity
 
or financial position.
 
Therefore, given the speed and frequency of continuously
 
evolving developments
with respect to this pandemic, the Company cannot reasonably
 
estimate the magnitude or the full extent to which COVID-19
 
may
impact the Company’s results
 
of operations, liquidity or financial position.
XML 31 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Business Acquisitions
 6 Months Ended
Jun. 30, 2021
Business Acquisitions [Abstract]  
Business acquisitions disclosure [Text Block]
Note 2 – Business Acquisitions
2021 Acquisitions
In June 2021, the Company acquired certain assets for its chemical
 
maskants product line in the Global Specialty Businesses
reportable segment for
2.3
 
million EUR or approximately $
2.8
 
million.
 
The Company accounted for the acquisition using the asset
acquisition method under ASC 805,
Business Combinations
.
 
In February 2021, the Company acquired a tin-plating
 
solutions business for the steel end market for approximately $
25
 
million.
 
This acquisition is part of each of the Company’s
 
geographic reportable segments.
 
The Company allocated $
19.6
 
million of the
purchase price to intangible assets, comprised of $
18.3
 
million of customer relationships, to be amortized over
19 years
; $
0.9
 
million
of existing product technology to be amortized over
14 years
; and $
0.4
 
million of a licensed trademark to be amortized over
3 years
.
 
In addition, the Company recorded $
5.0
 
million of goodwill related to expected value not allocated
 
to other acquired assets, all of
which is expected to be tax deductible.
 
As of June 30, 2021, the allocation of the purchase price has not
 
been finalized and the
one
year
 
measurement period has not ended.
 
Further adjustments may be necessary as a result of the Company’s
 
on-going assessment of
additional information related to the fair value of assets acquired
 
and liabilities assumed.
 
Additionally, in February
 
2021, the Company acquired a
38
% ownership interest in a Germany-based, high-tech
 
provider of
coolant control and delivery systems for approximately
1.4
 
million EUR or approximately $
1.7
 
million.
 
The Company recorded this
investment as an equity method investment within
 
the Condensed Consolidated Financial Statements.
The results of operations of the acquired assets and businesses subsequent
 
to the respective acquisition dates are included in the
Condensed Consolidated Statements of Operations as of June
 
30, 2021.
 
Applicable transaction expenses associated with these
acquisitions are included in Combination, integration
 
and other acquisition-related expenses in the Company’s
 
Condensed
Consolidated Statements of Operations.
 
Certain pro forma and other information is not presented, as the
 
operations of the acquired
assets and businesses are not considered material to the
 
overall operations of the Company for the periods presented.
Previous Acquisitions
In December 2020,
 
the Company completed its acquisition of Coral Chemical Company
 
(“Coral”), a privately held, U.S.-based
provider of metal finishing fluid solutions.
 
The acquisition provides technical expertise and product solutions
 
for pre-treatment,
metalworking and wastewater treatment applications
 
to the beverage cans and general industrial end markets.
 
The original purchase
price was approximately $
54.1
 
million, subject to routine and customary post-closing adjustments related
 
to working capital and net
indebtedness levels.
 
The Company anticipates finalizing its post-closing adjustments
 
for the Coral acquisition during 2021 and
currently estimates it will receive approximately $
0.1
 
million to settle such adjustments.
The following table presents the preliminary estimated fair
 
values of Coral net assets acquired:
Measurement
December 22,
December 22,
Period
2020
2020 (1)
Adjustments
(as adjusted)
Cash and cash equivalents
$
958
$
—
$
958
Accounts receivable
8,473
—
8,473
Inventories
4,527
—
4,527
Prepaid expenses and other assets
181
—
181
Property, plant and
 
equipment
10,467
652
11,119
Intangible assets
30,300
(500)
29,800
Goodwill
2,814
270
3,084
Total assets purchased
57,720
422
58,142
Long-term debt including current portions and finance leases
183
556
739
Accounts payable, accrued expenses and other accrued
 
liabilities
3,482
—
3,482
Total liabilities assumed
3,665
556
4,221
Total consideration
 
paid for Coral
54,055
(134)
53,921
Less: estimated purchase price settlement
—
(134)
(134)
Less: cash acquired
958
—
958
Net cash paid for Coral
$
53,097
$
—
$
53,097
(1) As previously disclosed in the Company’s
 
2020 Form 10-K
.
Measurement period adjustments recorded during the first
 
six months of 2021 include certain adjustments related
 
to refining
original estimates for assets and liabilities for certain
 
acquired finance leases, as well the adjustment to reflect the expected
 
settlement
of post-closing working capital and net indebtedness true
 
ups to the original purchase price.
 
As of June 30, 2021,
 
the allocation of the
purchase price for Coral has not been finalized and the
one year
 
measurement period has not ended.
 
Further adjustments may be
necessary as a result of the Company’s
 
on-going assessment of additional information related to the
 
fair value of assets acquired and
liabilities assumed.
In May 2020, the Company acquired Tel
 
Nordic ApS (“TEL”), a company that specializes in lubricants and engineering
 
primarily
in high pressure aluminum die casting for its Europe,
 
Middle East and Africa (“EMEA”) reportable segment.
 
Consideration paid was
in the form of a convertible promissory note in the amount
 
of
20.0
 
million DKK, or approximately $
2.9
 
million, which was
subsequently converted into shares of the Company’s
 
common stock.
 
An adjustment to the purchase price of approximately
0.4
million DKK, or less than $
0.1
 
million, was made as a result of finalizing a post-closing
 
settlement in the second quarter of 2020.
 
The
Company allocated approximately $
2.4
 
million of the purchase price to intangible assets to be amortized
 
over
17 years
.
 
In addition,
the Company recorded approximately $
0.5
 
million of goodwill, related to expected value not allocated to
 
other acquired assets, none
of which will be tax deductible.
 
As of June 30, 2021, the allocation of the purchase price of TEL
 
was finalized and the
one year
measurement period ended.
 
In March 2020, the Company acquired the remaining
49
% ownership interest in one of its South African affiliates,
 
Quaker
Chemical South Africa Limited (“QSA”) for
16.7
 
million ZAR, or approximately $
1.0
 
million, from its joint venture partner PQ
Holdings South Africa.
 
QSA is a part of the Company’s
 
Europe, Middle East and Africa (“EMEA”) reportable segment.
 
As this
acquisition was a change in an existing controlling ownership,
 
the Company recorded $
0.7
 
million of excess purchase price over the
carrying value of the noncontrolling interest in Capital in
 
excess of par value.
 
In October 2019, the Company completed its acquisition
 
of the operating divisions of Norman Hay plc (“Norman
 
Hay”), a private
U.K. company that provides specialty chemicals, operating
 
equipment, and services to industrial end markets.
 
The original purchase
price was
80.0
 
million GBP,
 
on a cash-free and debt-free basis, subject to routine
 
and customary post-closing adjustments related to
working capital and net indebtedness levels.
 
The Company finalized its post-closing adjustments for
 
the Norman Hay acquisition and
paid approximately
2.5
 
million GBP during the first quarter of 2020 to settle such adjustments.
XML 32 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Recently Issued Accounting Standards
 6 Months Ended
Jun. 30, 2021
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]  
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]
Note 3 – Recently Issued Accounting Standards
 
Recently Issued Accounting Standards
 
Adopted
The Financial Accounting Standards Board (“FASB”)
 
issued Account Standards Update (“ASU”)
 
ASU 2019-12
, Income Taxes
(Topic
 
740): Simplifying the Accounting for Income Taxes
 
in December 2019 to simplify the accounting for income taxes.
 
The
guidance within this accounting standard update
 
removes certain exceptions, including the exception to the
 
incremental approach for
certain intra-period tax allocations, to the requirement
 
to recognize or not recognize certain deferred tax liabilities for
 
equity method
investments and foreign subsidiaries, and to the general
 
methodology for calculating income taxes in an interim period
 
when a year-to-
date loss exceeds the anticipated loss for the year.
 
Further, the guidance simplifies the accounting
 
related to franchise taxes, the step
up in tax basis for goodwill, current and deferred tax
 
expense, and codification improvements for income taxes related
 
to employee
stock ownership plans.
 
The guidance is effective for annual and interim
 
periods beginning after December 15, 2020.
 
The Company
adopted this standard on a prospective basis, effective
 
January 1, 2021.
 
There was no cumulative effect of adoption recorded
 
within
retained earnings on January 1, 2021.
The FASB issued
 
ASU 2020-04,
Reference Rate Reform (Topic
 
848): Facilitation of the Effects of Reference Rate
 
Reform on
Financial Reporting
 
in March 2020.
 
The FASB subsequently
 
issued ASU 2021-01,
Reference Rate Reform (Topic
 
848): Scope
 
in
January 2021 which clarified the guidance but did
 
not materially change the guidance or its applicability to
 
the Company.
 
The
amendments provide temporary optional expedients and
 
exceptions for applying U.S. GAAP to contract modifications,
 
hedging
relationships and other transactions to ease the potential
 
accounting and financial reporting burden associated with transitioning
 
away
from reference rates that are expected to be discontinued,
 
including the London Interbank Offered Rate (“LI
 
BOR”).
 
ASU 2020-04 is
effective for the Company as of March 12,
 
2020 and generally can be applied through December 31, 2022.
 
As of June 30, 2021, the
expedients provided in ASU 2020-04 do not presently
 
impact the Company; however, the Company
 
will continue to monitor for
potential impacts on its consolidated financial statements.
XML 33 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments
 6 Months Ended
Jun. 30, 2021
Business Segment Disclosures [Abstract]  
Segment Reporting Disclosure [Text Block]
Note 4 – Business Segments
The Company’s operating
 
segments, which are consistent with its reportable segments,
 
reflect the structure of the Company’s
internal organization, the method by which
 
the Company’s resources are allocated
 
and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
 
The Company has
four
 
reportable segments: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
The three geographic segments are composed of the net
 
sales and operations in
each respective region, excluding net sales and operations
 
managed globally by the Global Specialty Businesses segment, which
includes the Company’s
 
container, metal finishing, mining,
 
offshore, specialty coatings, specialty grease and
 
Norman Hay businesses.
Segment operating earnings for each of the Company’s
 
reportable segments are comprised of the segment’s
 
net sales less directly
related cost of goods sold (“COGS”) and selling, general
 
and administrative expenses (“SG&A”).
 
Operating expenses not directly
attributable to the net sales of each respective segment,
 
such as certain corporate and administrative costs, Combination, integration
and other acquisition-related expenses, and Restructuring and related
 
charges, are not included in segment operating
 
earnings.
 
Other
items not specifically identified with the Company’s
 
reportable segments include interest expense, net and other
 
income (expense),
net.
The following table presents information about the performance
 
of the Company’s reportable segments
 
for the three and six
months ended June 30, 2021 and 2020.
 
Certain immaterial reclassifications within the segment disclosures
 
for the three and six
months ended June 30, 2020 have been made to conform
 
with the Company’s current customer
 
industry segmentation.
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Net sales
 
 
 
 
 
 
 
 
 
 
Americas
$
139,673
$
80,576
$
274,544
$
210,472
EMEA
 
123,436
 
77,702
 
243,250
 
182,541
Asia/Pacific
 
91,559
 
68,421
 
188,265
 
141,973
Global Specialty Businesses
 
80,594
 
59,341
 
158,986
 
129,615
Total net sales
$
435,262
$
286,040
$
865,045
$
664,601
Segment operating earnings
Americas
$
33,648
$
10,303
$
65,882
$
39,491
EMEA
23,405
10,471
48,649
28,830
Asia/Pacific
23,227
19,261
50,705
38,802
Global Specialty Businesses
 
24,209
 
16,393
 
48,378
 
36,953
Total segment operating
 
earnings
 
104,489
 
56,428
 
213,614
 
144,076
Combination, integration and other acquisition-related
 
expenses
(6,658)
(7,995)
(12,473)
(15,873)
Restructuring and related charges
(298)
(486)
(1,473)
(2,202)
Fair value step up of acquired inventory sold
 
—
(226)
(801)
(226)
Indefinite-lived intangible asset impairment
—
—
—
(38,000)
Non-operating and administrative expenses
(43,077)
(32,045)
(84,069)
(70,496)
Depreciation
 
of corporate assets and amortization
 
(15,640)
 
(13,438)
 
(31,088)
 
(27,485)
Operating income (loss)
 
38,816
2,238
83,710
(10,206)
Other income (expense), net
14,010
(993)
18,697
(22,168)
Interest expense, net
 
(5,618)
 
(6,811)
 
(11,088)
 
(15,272)
Income (loss) before taxes and equity in net income of
associated companies
$
47,208
$
(5,566)
$
91,319
$
(47,646)
Inter-segment revenues for the three and six months
 
ended June 30, 2021 were $
2.4
 
million and $
5.7
 
million for Americas, $
6.3
million and $
15.1
 
million for EMEA, $
0.4
 
million and $
0.5
 
million for Asia/Pacific, and $
2.1
 
million and $
4.1
 
million for Global
Specialty Businesses, respectively.
 
Inter-segment revenues for the three and six months
 
ended June 30, 2020 were $
2.4
 
million and
$
5.3
 
million for Americas, $
5.3
 
million and $
10.8
 
million for EMEA, $
0.1
 
million and $
0.3
 
million for Asia/Pacific, and $
1.0
 
million
and $
2.3
 
million for Global Specialty Businesses, respectively.
 
However, all inter-segment
 
transactions have been eliminated from
each reportable operating segment’s
 
net sales and earnings for all periods presented in the above
 
tables.
XML 34 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Net Sales and Revenue Recognition
 6 Months Ended
Jun. 30, 2021
Revenue From Contract With Customer [Abstract]  
Revenue From Contract With Customer [TextBlock]
Note 5 – Net Sales and Revenue Recognition
Business Description
The Company develops, produces, and markets a broad
 
range of formulated chemical specialty products and offers
 
chemical
management services (“Fluidcare”) for various heavy
 
industrial and manufacturing applications throughout its four
 
segments.
 
A
significant portion of the Company’s
 
revenues are realized from the sale of process fluids and services
 
made directly to manufacturers
through its own employees and its Fluidcare programs,
 
with the balance being handled through distributors and
 
agents.
As part of the Company’s
 
Fluidcare business, certain third-party product sales to customers are
 
managed by the Company.
 
Where
the Company acts as a principal, revenues are recognized
 
on a gross reporting basis at the selling price negotiated with
 
its customers.
Where the Company acts as an agent, revenue is recognized on
 
a net reporting basis at the amount of the administrative fee earned
 
by
the Company for ordering the goods.
 
The Company transferred third-party products under arrangements recognized
 
on a net reporting
basis of $
16.7
 
million and $
34.5
 
million for the three and six months ended June 30, 2021, respectively,
 
and $
6.2
 
million and $
18.7
million for the three and six months ended June 30,
 
2020, respectively.
As previously disclosed in the Company’s
 
2020 Form 10-K, during 2020, the Company’s
 
five largest customers (each composed
of multiple subsidiaries or divisions with semiautonomous
 
purchasing authority) accounted for approximately
10
% of consolidated net
sales, with its largest customer accounting
 
for approximately
3
% of consolidated net sales.
 
Revenue Recognition Model
The Company applies the five-step model in the FASB’s
 
guidance, which requires the Company to: (i) identify
 
the contract with a
customer; (ii) identify the performance obligations in
 
the contract; (iii) determine the transaction price; (iv) allocate the
 
transaction
price to the performance obligations in the contract; and
 
(v) recognize revenue when, or as, the Company satisfies a performance
obligation.
 
Refer to the Company’s 2020
 
Form 10-K for additional information on the Company’s
 
revenue recognition policies,
including its practical expedients and accounting policy
 
elections.
 
Allowance for Doubtful Accounts
As previously disclosed in the Company’s
 
2020 Form 10-K, during 2020, the Company adopted, as required,
 
an accounting
standard update related to the accounting and disclosure
 
of credit losses effective January 1, 2020.
 
The Company recognizes an
allowance for credit losses, which represents the portion
 
of its trade accounts receivable that the Company does not expect
 
to collect
over the contractual life, considering past events and
 
reasonable and supportable forecasts of future economic conditions.
 
The
Company’s allowance
 
for credit losses on its trade accounts receivables is based on
 
specific collectability facts and circumstances for
each outstanding receivable and customer,
 
the aging of outstanding receivables, and the associated collection
 
risk the Company
estimates for certain past due aging categories, and
 
also, the general risk to all outstanding accounts receivable based on historical
amounts determined to be uncollectible.
 
The Company does not have any off-balance-sheet
 
credit exposure related to its customers.
Contract Assets and Liabilities
The Company recognizes a contract asset or receivable
 
on its Condensed Consolidated Balance Sheet when the Company
performs a service or transfers a good in advance
 
of receiving consideration.
 
A receivable is the Company’s
 
right to consideration that
is unconditional and only the passage of time is required
 
before payment of that consideration is due.
 
A contract asset is the
Company’s right to consideration
 
in exchange for goods or services that the Company has transferred
 
to a customer.
 
The Company
had no material contract assets recorded on its Condensed
 
Consolidated Balance Sheets as of June 30, 2021 or December
 
31, 2020.
A contract liability is recognized when the Company
 
receives consideration, or if it has the unconditional right
 
to receive
consideration, in advance of performance.
 
A contract liability is the Company’s
 
obligation to transfer goods or services to a customer
for which the Company has received consideration,
 
or a specified amount of consideration is due, from the customer.
 
The Company’s
contract liabilities primarily represent deferred revenue
 
recorded for customer payments received by the Company
 
prior to the
Company satisfying the associated performance obligation.
 
Deferred revenues are presented within other current liabilities
 
in the
Company’s Condensed
 
Consolidated Balance Sheets.
 
The Company had approximately $
4.3
 
million and $
4.0
 
million of deferred
revenue as of June 30, 2021 and December 31, 2020,
 
respectively.
 
For the six months ended June 30, 2021, the Company satisfied
 
all
of the associated performance obligations and recognized
 
into revenue the advance payments received and recorded
 
as of December
31, 2020.
Disaggregated Revenue
The following tables disaggregate the Company’s
 
net sales by segment, geographic region, customer industry,
 
and timing of
revenue recognized for the three and six months ended
 
June 30, 2021 and 2020.
Three Months Ended June 30, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
51,799
$
35,634
$
48,207
$
135,640
Metalworking and other
87,874
87,802
43,352
219,028
139,673
123,436
91,559
354,668
Global Specialty Businesses
46,183
21,678
12,733
80,594
$
185,856
$
145,114
$
104,292
$
435,262
Timing of Revenue Recognized
Product sales at a point in time
$
177,227
$
137,838
$
101,264
$
416,329
Services transferred over time
8,629
7,276
3,028
18,933
$
185,856
$
145,114
$
104,292
$
435,262
Three Months Ended June 30, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
32,687
$
24,924
$
35,416
$
93,027
Metalworking and other
47,889
52,778
33,005
133,672
80,576
77,702
68,421
226,699
Global Specialty Businesses
32,294
15,569
11,478
59,341
$
112,870
$
93,271
$
79,899
$
286,040
Timing of Revenue Recognized
Product sales at a point in time
$
108,644
$
87,995
$
78,195
$
274,834
Services transferred over time
4,226
5,276
1,704
11,206
$
112,870
$
93,271
$
79,899
$
286,040
Six Months Ended June 30, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
98,592
$
69,908
$
97,950
$
266,450
Metalworking and other
175,952
173,342
90,315
439,609
274,544
243,250
188,265
706,059
Global Specialty Businesses
91,439
41,950
25,597
158,986
$
365,983
$
285,200
$
213,862
$
865,045
Timing of Revenue Recognized
Product sales at a point in time
$
348,821
$
269,000
$
207,663
$
825,484
Services transferred over time
17,162
16,200
6,199
39,561
$
365,983
$
285,200
$
213,862
$
865,045
Six Months Ended June 30, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
79,360
$
54,812
$
77,005
$
211,177
Metalworking and other
131,112
127,729
64,968
323,809
210,472
182,541
141,973
534,986
Global Specialty Businesses
76,525
32,174
20,916
129,615
$
286,997
$
214,715
$
162,889
$
664,601
Timing of Revenue Recognized
Product sales at a point in time
$
277,446
$
206,418
$
159,351
$
643,215
Services transferred over time
9,551
8,297
3,538
21,386
$
286,997
$
214,715
$
162,889
$
664,601
XML 35 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Leases
 6 Months Ended
Jun. 30, 2021
Leases [Abstract]  
Leases Disclosure [TextBlock]
Note 6 – Leases
The Company determines if an arrangement is a lease
 
at its inception.
 
This determination generally depends on whether the
arrangement conveys the right to control the use of an
 
identified fixed asset explicitly or implicitly for a period of
 
time in exchange for
consideration.
 
Control of an underlying asset is conveyed if the Company
 
obtains the rights to direct the use of, and obtains
substantially all of the economic benefits from the use
 
of, the underlying asset.
 
Lease expense for variable leases and short-term
leases is recognized when the obligation is incurred.
 
The Company has operating leases for certain facilities, vehicles
 
and machinery and equipment with remaining lease terms up
 
to
10 years
.
 
In addition, the Company has certain land use leases with remaining
 
lease terms up to
94 years
.
 
The lease term for all of the
Company’s leases includes
 
the non-cancellable period of the lease plus any additional periods
 
covered by an option to extend the lease
that the Company is reasonably certain it will exercise.
 
Operating leases are included in right of use lease assets
, other current
liabilities and long-term lease liabilities
 
on the Condensed Consolidated Balance Sheet.
 
Right of use lease assets and liabilities are
recognized at each lease’s
 
commencement date based on the present value of its lease payments
 
over its respective lease term.
 
The
Company uses the stated borrowing rate for a lease when
 
readily determinable.
 
When a stated borrowing rate is not available in a
lease agreement, the Company uses its incremental borrowing
 
rate based on information available at the lease’s
 
commencement date
to determine the present value of its lease payments.
 
In determining the incremental borrowing rate used to present
 
value each of its
leases, the Company considers certain information
 
including fully secured borrowing rates readily available to the Company
 
and its
subsidiaries.
 
The Company has immaterial finance leases, which are
 
included in property, plant
 
and equipment, current portion of
long-term debt and long-term debt on the Condensed Consolidated
 
Balance Sheet.
Operating lease expense is recognized on a straight-line
 
basis over the lease term.
 
Operating lease expense for the three and six
months ended June 30, 2021 was $
3.6
 
million and $
7.2
 
million, respectively.
 
Comparatively, operating
 
lease expense for the three
and six months ended June 30, 2020 was $
3.5
 
million and $
6.9
 
million, respectively.
 
Short-term lease expense for the three and six
months ended June 30, 2021 was $
0.2
 
million and $
0.5
 
million, respectively.
 
Comparatively, short-term
 
lease expense for the three
and six months ended June 30, 2020 was $
0.4
 
million and $
0.9
 
million, respectively.
 
The Company has
no
 
material variable lease
costs or sublease income for the three or six months ended
 
June 30, 2021 and 2020.
 
Cash paid for operating leases during the six months ended
 
June 30, 2021 and 2020 was $
7.1
 
million and $
6.8
 
million,
respectively.
 
The Company recorded new right of use lease assets and associated lease liabilities
 
of $
3.9
 
million during the six
months ended June 30, 2021.
 
Supplemental balance sheet information related to the Company’s
 
leases is as follows:
June 30,
December 31,
2021
2020
Right of use lease assets
$
36,160
$
38,507
Other current liabilities
10,064
10,901
Long-term lease liabilities
25,668
27,070
Total operating
 
lease liabilities
$
35,732
$
37,971
Weighted average
 
remaining lease term (years)
5.8
6.0
Weighted average
 
discount rate
4.26%
4.20%
Maturities of operating lease liabilities as of June 30,
 
2021 were as follows:
June 30,
2021
For the remainder of 2021
$
6,052
For the year ended December 31, 2022
9,400
For the year ended December 31, 2023
7,234
For the year ended December 31, 2024
5,355
For the year ended December 31, 2025
4,260
For the year ended December 31, 2026 and beyond
8,152
Total lease payments
40,453
Less: imputed interest
(4,721)
Present value of lease liabilities
$
35,732
XML 36 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Restructuring and Related Activities
 6 Months Ended
Jun. 30, 2021
Restructuring And Related Activities [Abstract]  
Restructuring And Related Activities Disclosure [Text Block]
Note 7 – Restructuring and Related Activities
The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost
synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated
severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain
manufacturing and non-manufacturing facilities. The exact timing and total costs associated with the QH Program will depend on a
number of factors and is subject to change; however, the Company currently expects reduction in headcount and site closures to
continue to occur throughout 2021 and into 2022 under the QH Program and estimates that anticipated cost synergies realized from the
QH Program will approximate one-times the restructuring costs incurred. Employee separation benefits will vary depending on local
regulations within certain foreign countries and will include severance and other benefits.
All costs incurred to date relate to severance costs to reduce
 
headcount as well as costs to close certain facilities and are
 
recorded
in Restructuring and related charges in the
 
Company’s Condensed Statements
 
of Operations.
 
As described in Note 4 of Notes to
Condensed Consolidated Financial Statements, restructuring
 
and related charges are not included in
 
the Company’s calculation of
reportable segments’ measure of operating earnings
 
and therefore these costs are not reviewed by or recorded to
 
reportable segments.
Activity in the Company’s
 
accrual for restructuring under the QH Program for the six months ended
 
June 30, 2021 is as follows:
QH Program
Accrued restructuring as of December 31,
 
2020
$
8,248
Restructuring and related charges
1,473
Cash payments
(4,214)
Currency translation adjustments
 
(229)
Accrued restructuring as of June 30, 2021
$
5,278
XML 37 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation
 6 Months Ended
Jun. 30, 2021
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note 8 – Share-Based Compensation
The Company recognized the following share-based compensation
 
expense in its Condensed Consolidated Statements of
Operations for the three and six months ended June 30, 2021
 
and 2020:
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Stock options
$
332
$
353
$
640
$
785
Non-vested stock awards and restricted stock units
1,290
1,259
2,686
2,523
Non-elective and elective 401(k) matching contribution in
 
stock
—
1,162
1,553
1,162
Director stock ownership plan
216
54
419
94
Performance stock units
517
280
836
280
Annual incentive plan
—
(117)
—
2,829
Total share-based
 
compensation expense
$
2,355
$
2,991
$
6,134
$
7,673
Share-based compensation expense is recorded in SG&A,
 
except for $
0.2
 
million and $
0.5
 
million for the three and six months
ended June 30, 2021, respectively,
 
and $
0.3
 
million and $
0.8
 
million for the three and six months ended June 30, 2020, respectively,
recorded within Combination, integration
 
and other acquisition-related expenses.
Stock Options
 
During the first six months of 2021, the Company granted
 
stock options under its long-term incentive plan (“LTIP”)
 
that are
subject only to time-based vesting over a
three
 
year period.
 
For the purposes of determining the fair value of stock
 
option awards, the
Company used a Black-Scholes option pricing model and
 
which primarily used the assumptions set forth in the table below:
Number of options granted
25,250
Dividend yield
0.85
%
Expected volatility
37.33
%
Risk-free interest rate
0.60
%
Expected term (years)
4.0
The fair value of these options is amortized on a straight
 
-line basis over the vesting period.
 
As of June 30, 2021,
 
unrecognized
compensation expense related to all stock options
 
granted was $
2.4
 
million, to be recognized over a weighted average remaining
period of
2.3
 
years.
Restricted Stock Awards
 
and Restricted Stock Units
 
During the six months ended June 30, 2021, the Company
 
granted
17,692
 
non-vested restricted shares and
2,791
 
non-vested
restricted stock units under its LTIP,
 
which are subject to time-based vesting, generally over a
three year
 
period.
 
The fair value of
these grants is based on the trading price of the Company’s
 
common stock on the date of grant.
 
The Company adjusts the grant date
fair value of these awards for expected forfeitures based
 
on historical experience.
 
As of June 30, 2021, unrecognized compensation
expense related to the non-vested restricted shares was $
6.3
 
million, to be recognized over a weighted average remaining
 
period of
1.9
years, and unrecognized compensation expense
 
related to non-vested restricted stock units was $
1.1
 
million, to be recognized over a
weighted average remaining period of
2.1
 
years.
Performance Stock Units
During the first six months of 2021, the Company granted
 
performance-dependent stock awards (“PSUs”) as a component of
 
its
LTIP,
 
which will be settled in a certain number of shares subject to market
 
-based and time-based vesting conditions.
 
The number of
fully vested shares that may ultimately be issued as settlement
 
for each award may range from
0
% up to
200
% of the target award,
subject to the achievement of the Company’s
 
total shareholder return (“TSR”) relative to the performance
 
of the Company’s peer
group, the S&P Midcap 400 Materials group.
 
The service period required for the PSUs is three years and the
 
TSR measurement
period for the PSUs is from January 1 of the year of grant
 
through December 31 of the year prior to issuance of the shares upon
settlement.
Compensation expense for PSUs is measured based on
 
their grant date fair value and is recognized on a straight-line basis over
the
three year
 
vesting period.
 
The grant-date fair value of the PSUs granted during
 
the first six months of 2021 was estimated using a
Monte Carlo simulation on the grant date and using the
 
following assumptions: (i) a risk-free rate of
0.29
%; (ii) an expected term of
3.0
 
years; and (iii) a three year daily historical volatility for each of
 
the companies in the peer group, including Quaker Houghton.
 
As of June 30, 2021, the Company estimates that it will issue
 
approximately
14,698
 
fully vested shares as of the applicable
settlement date of all outstanding PSUs awards based on
 
the conditions of the PSUs and performance to date for
 
each award.
 
As of
June 30, 2021, there was approximately $
4.2
 
million of total unrecognized compensation cost related to PSUs, which
 
the Company
expects to recognize over a weighted-average period
 
of
2.3
 
years.
Annual Incentive Plan
The Company maintains an Annual Incentive Plan
 
(“AIP”), which may be settled in cash or a certain number of
 
shares subject to
performance-based and time-based vesting conditions.
 
As of June 30, 2020, it was the Company’s
 
intention to settle the 2020 AIP in
shares, and therefore, expense associated with the AIP in
 
2020 was recorded as a component of share-based compensation
 
expense.
 
In
the fourth quarter of 2020, the Company determined that it
 
would settle the 2020 AIP in cash.
 
Therefore, the share-based
compensation associated with the AIP during the year
 
ended December 31, 2020 was reclassified from a component
 
of share-based
compensation expense to incentive compensation.
 
This determination and conclusion had no impact on the
 
classification of AIP
expense within the Company’s
 
Condensed Consolidated Statement of Operations for
 
the periods as both are a component of SG&A.
 
As of June 30, 2021, it is the Company’s
 
intention to settle the 2021 AIP in cash.
Defined Contribution Plan
 
The Company has a 401(k) plan with an employer
 
match covering a majority of its U.S. employees.
 
The Company matches
50
%
of the first
6
% of compensation that is contributed to the plan, with a maximum
 
matching contribution of
3
% of compensation.
 
Additionally, the
 
plan provides for non-elective nondiscretionary contributions
 
on behalf of participants who have completed one year
of service equal to
3
% of the eligible participants’ compensation.
 
Beginning in April 2020 and continuing through March 2021,
 
the
Company matched both non-elective and elective 401(k)
 
contributions in fully vested shares of the Company’s
 
common stock rather
than cash.
 
For the three months ended June 30, 2021, there were
no
 
matching contributions in stock.
 
For the six months ended June
30, 2021, total contributions were $
1.5
 
million and for both the three and six months ended June 30, 2020,
 
total contributions were
$
1.2
 
million.
XML 38 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Pension and Postretirement Benefits
 6 Months Ended
Jun. 30, 2021
Pension and Other Postretirement Benefits [Abstract]  
Pension And Other Postretirement Benefits Disclosure [Text Block]
Note 9 – Pension and Other Postretirement
 
Benefits
The components of net periodic benefit cost for the
 
three and six months ended June 30, 2021 and 2020 are as follows:
Three Months Ended June 30,
 
Six Months Ended June 30,
 
Other
Other
Postretirement
Postretirement
Pension Benefits
Benefits
Pension Benefits
Benefits
2021
2020
2021
2020
2021
2020
2021
2020
Service cost
$
316
$
1,164
$
2
$
1
$
632
$
2,338
$
3
$
3
Interest cost
1,094
1,486
10
26
2,184
3,255
21
52
Expected return on plan assets
(2,093)
(1,761)
—
—
(4,175)
(3,720)
—
—
Settlement charge
—
—
—
—
—
22,667
—
—
Actuarial loss amortization
857
615
—
16
1,712
1,662
—
31
Prior service cost amortization
3
(41)
—
—
5
(81)
—
—
Net periodic benefit cost
$
177
$
1,463
$
12
$
43
$
358
$
26,121
$
24
$
86
As disclosed in the Company’s
 
2020 Form 10-K, in the fourth quarter of 2018, the
 
Company began the process of terminating its
legacy Quaker non-contributory U.S. pension plan
 
(“Legacy Quaker U.S. Pension Plan”).
 
During the third quarter of 2019, the
Company received a favorable termination determination
 
letter from the Internal Revenue Service (“I.R.S.”) and completed the
Legacy Quaker U.S. Pension Plan termination during the
 
first quarter of 2020.
 
In order to terminate the Legacy Quaker U.S. Pension
Plan in accordance with I.R.S. and Pension Benefit Guaranty Corporation
 
requirements, the Company was required to fully fund the
Legacy Quaker U.S. Pension Plan on a termination basis
 
and the amount necessary to do so was approximately $
1.8
 
million, subject to
final true up adjustments,
 
which were completed in the third quarter of 2020.
 
In addition, the Company recorded a non-cash pension
settlement charge at plan termination of
 
approximately $
22.7
 
million.
 
This settlement charge included the immediate recognition
 
into
expense of the related unrecognized losses within accumulated
 
other comprehensive (loss) income (“AOCI”) on the balance
 
sheet as
of the plan termination date.
Employer Contributions
As of June 30, 2021, $
2.1
 
million and $
0.1
 
million of contributions have been made to the Company’s
 
U.S. and foreign pension
plans and its other postretirement benefit plans, respectively
 
.
 
Taking into consideration
 
current minimum cash contribution
requirements, the Company currently expects to make
 
full year cash contributions of approximately $
6
 
million to its U.S. and foreign
pension plans and less than $
1
 
million to its other postretirement benefit plans in 2021
XML 39 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Other Income (Expense)
 6 Months Ended
Jun. 30, 2021
Other Income and Expenses [Abstract]  
Other Income and Other Expense Disclosure [Text Block]
Note 10 – Other Income (Expense), Net
 
The components of other income (expense), net, for
 
the three and six months ended June 30, 2021 and 2020 are as follows:
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Income from third party license fees
$
373
$
208
$
712
$
512
Foreign exchange losses, net
(838)
(2,004)
(2,316)
(1,183)
Gain (loss) on disposals of property,
 
plant, equipment and other
assets, net
(54)
(83)
5,356
(81)
Non-income tax refunds and other related credits
14,295
832
14,392
2,131
Pension and postretirement benefit income (costs),
 
non-service components
129
(341)
253
(23,866)
Other non-operating income, net
105
395
300
319
Total other
 
income (expense), net
$
14,010
$
(993)
$
18,697
$
(22,168)
The Gain (loss) on disposals of property,
 
plant, equipment and other assets, net, during the six months
 
ended June 30, 2021,
includes the gain on the sale of certain held-for-sale
 
real property assets related to the Combination.
 
Non-income tax refunds and
other related credits during the three and six months ended
 
June 30, 2021 includes $
13.3
 
million related to certain non-income tax
credits for the Company’s
 
Brazilian subsidiaries described in Note 19 of Notes
 
to Condensed Consolidated Financial Statements.
 
Pension and postretirement benefit costs, non-service components
 
during the six months ended June 30, 2020 includes
 
$
22.7
 
million
related to the Legacy Quaker U.S. Pension Plan non
 
-cash settlement charge described in Note 9 of Notes to
 
Condensed Consolidated
Financial Statements.
XML 40 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes and Uncertain Income Tax Positions
 6 Months Ended
Jun. 30, 2021
Taxes on Income and Uncertain Tax Positions [Abstract]  
Taxes on Income [Text Block]
Note 11 – Income Taxes
 
and Uncertain Income Tax
 
Positions
The Company’s effective
 
tax rates for the three and six months ended June 30, 2021 were
 
an expense of
32.2
% and
28.4
%,
respectively, compared
 
to an expense of
57.9
% and a benefit of
20.7
% for the three and six months ended June 30, 2020, respectively.
 
The Company’s current
 
year effective tax rates were largely
 
impacted by the sale of certain held-for-sale real
 
property assets related to
the Combination,
 
changes in foreign tax credit valuation allowances, tax law changes
 
in a foreign jurisdiction and the income tax
impacts of certain non-income tax credits recorded
 
by the Company’s Brazilian
 
subsidiaries described in Note 19 of Notes to
Condensed Consolidated Financial Statements.
 
Comparatively, the prior
 
year effective tax rates were impacted by the
 
tax effect of
certain one-time pre-tax losses as well as certain tax charges
 
and benefits in the prior year period including those related
 
to changes in
foreign tax credit valuation allowances, tax law changes in
 
a foreign jurisdiction, changes in uncertain tax positions and
 
the tax
impacts of the Company’s
 
termination of its Legacy Quaker U.S. Pension Plan.
As of December 31, 2020, the Company had a deferred
 
tax liability of $
5.9
 
million, which primarily represents the Company’s
estimate of non-U.S. taxes it will incur to repatriate
 
certain foreign earnings to the U.S.
 
The balance as of June 30, 2021 was $
6.5
million.
 
As of June 30, 2021, the Company’s
 
cumulative liability for gross unrecognized tax benefits was $
24.0
 
million, an increase of
$
1.8
 
million from the cumulative liability accrued as of December 31, 2020.
 
The Company continues to recognize interest and penalties
 
associated with uncertain tax positions as a component of
 
taxes on
income (loss) before equity in net income of associated
 
companies in its Condensed Consolidated Statements of Operations.
 
The
Company recognized an expense for interest of approximately
 
$
0.2
 
million and $
0.2
 
million and a benefit of less than $
0.1
 
million and
$
0.2
 
million for penalties in its Condensed Consolidated Statement of
 
Operations for the three and six months ended June 30, 2021,
respectively, and recognized
 
an expense of $
0.6
 
million and $
0.6
 
million for interest and an expense of $
0.6
 
million and $
0.5
 
million
for penalties in its Condensed Consolidated Statement of
 
Operations for the three and six months ended June 30, 2020
 
,
 
respectively.
 
As of June 30, 2021, the Company had accrued $
3.2
 
million for cumulative interest and $
3.6
 
million for cumulative penalties in its
Condensed Consolidated Balance Sheets, compared
 
to $
3.0
 
million for cumulative interest and $
3.9
 
million for cumulative penalties
accrued at December 31, 2020.
 
During the six months ended June 30, 2021 and 2020, the
 
Company recognized decreases of $
0.8
million and $
1.5
 
million, respectively,
 
in its cumulative liability for gross unrecognized tax benefits
 
due to the expiration of the
applicable statutes of limitations for certain tax years.
The Company estimates that during the year ending December
 
31, 2021 it will reduce its cumulative liability for gross
unrecognized tax benefits by approximately $
1.5
 
million due to the expiration of the statute of limitations with regard
 
to certain tax
positions.
 
This estimated reduction in the cumulative liability for unrecognized
 
tax benefits does not consider any increase in liability
for unrecognized tax benefits with regard to existing tax
 
positions or any increase in cumulative liability for unrecognized
 
tax benefits
with regard to new tax positions for the year ending December
 
31, 2021.
The Company and its subsidiaries are subject to U.S. Federal income
 
tax, as well as the income tax of various state and foreign
tax jurisdictions.
 
Tax years that remain
 
subject to examination by major tax jurisdictions include Italy
 
from
2006
, Brazil from
2011
,
the Netherlands and China from
2015
, Mexico, Spain, Germany and the United Kingdom from
2016
, Canada and the U.S. from
2017
,
India from fiscal year beginning April 1, 2018 and ending
 
March 31,
2019
, and various U.S. state tax jurisdictions from
2011
.
 
As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia
S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under
the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except
2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP
proceedings which the Company has accepted.
 
As of June 30, 2021, the Company has received $
1.6
 
million in refunds from the
Netherlands and Spain and expects to pay $
2.6
 
million due to Italy in the second half of 2021.
 
As of June 30, 2021, the Company
believes it has adequate reserves for the remaining
 
uncertain tax positions related to 2007.
Houghton Italia, S.r.l
 
is also involved in a corporate income tax audit with the Italian tax
 
authorities covering tax years
2014
through
2018
.
 
As of June 30, 2021, the Company has a $
5.6
 
million reserve for uncertain tax positions relating to matters related
 
to
this audit.
 
Since the reserve relates to the tax periods prior to August
 
1, 2019, the tax liability was established through purchase
accounting related to the Combination.
 
The Company has also submitted an indemnification claim against
 
funds held in escrow by
Houghton’s former owners
 
and as a result, a corresponding $
5.6
 
million indemnification receivable has also been established through
purchase accounting.
Houghton Deutschland GmbH is also under audit by
 
the German tax authorities for the tax years
2015
 
through
2017
.
 
Based on
preliminary audit findings, primarily related to
 
transfer pricing, the Company has recorded reserves for $
0.9
 
million as of June 30,
2021.
 
Of this amount, $
0.8
 
million relates to tax periods prior to the Combination and
 
therefore the Company has submitted an
indemnification claim with Houghton’s
 
former owners for any tax liabilities arising pre-Combination.
 
As a result, a corresponding
$
0.8
 
million indemnification receivable has also been established to
 
offset the $
0.8
 
million tax liability.
XML 41 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share
 6 Months Ended
Jun. 30, 2021
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
Note 12 – Earnings Per Share
The following table summarizes earnings per share calculations
 
for the three and six months ended June 30, 2021 and 2020:
Three Months Ended
 
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Basic earnings (loss) per common share
 
 
 
Net income (loss) attributable to Quaker Chemical Corporation
$
 
33,570
$
(7,735)
$
 
72,185
$
(36,116)
Less: (income) loss allocated to participating securities
 
(134)
 
37
 
(287)
 
146
Net income (loss) available to common shareholders
$
 
33,436
$
(7,698)
$
 
71,898
$
(35,970)
Basic weighted average common shares outstanding
17,802,366
17,697,496
17,793,915
17,685,010
Basic earnings (loss) per common share
$
1.88
$
(0.43)
$
4.04
$
(2.03)
Diluted earnings (loss) per common share
Net income (loss) attributable to Quaker Chemical Corporation
$
33,570
$
(7,735)
$
 
72,185
$
(36,116)
Less: (income) loss allocated to participating securities
(134)
 
37
 
(287)
 
146
Net income (loss) available to common shareholders
$
33,436
$
(7,698)
$
71,898
$
(35,970)
Basic weighted average common shares outstanding
17,802,366
17,697,496
17,793,915
17,685,010
Effect of dilutive securities
47,155
—
52,095
—
Diluted weighted average common shares outstanding
17,849,521
17,697,496
17,846,010
17,685,010
Diluted earnings (loss) per common share
$
1.88
$
(0.43)
$
4.03
$
(2.03)
Certain stock options and restricted stock units are not included
 
in the diluted earnings (loss) per share calculation when
 
the effect
would have been anti-dilutive.
 
The calculated amount of anti-diluted shares not included
 
was
6,793
 
and
2,952
 
for the three and six
months ended June 30, 2021,
 
respectively.
 
All of the Company’s potentially
 
dilutive shares for the three and six months ended June
30, 2020 are anti-dilutive and not included in the dilutive
 
loss per share calculations because of the Company’s
 
net loss during the
periods.
XML 42 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Restricted Cash
 6 Months Ended
Jun. 30, 2021
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]  
Cash And Cash Equivalents Disclosure [Text Block]
Note 13 – Restricted Cash
Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary
of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an
original total value of $35.0 million.
 
The proceeds of both settlements were restricted and could
 
only be used to pay claims and costs
of defense associated with the subsidiary’s
 
asbestos litigation.
 
The proceeds of the settlement and release agreements
 
were deposited
into interest bearing accounts that earned less than
 
$
0.1
 
million offset by $
0.5
 
million of net payments during the six months ended
June 30, 2020.
 
Due to the restricted nature of the proceeds, a corresponding deferred
 
credit was established in other non-current
liabilities for an equal and offsetting amount
 
that continued until the restrictions lapsed.
 
As disclosed in the Company’s
 
2020 Form
10-K, during December 2020, the restrictions ended
 
on these previously received insurance settlements and the
 
Company transferred
the cash into an operating account.
The following table provides a reconciliation of cash,
 
cash equivalents and restricted cash as of June 30, 2021 and 2020
 
,
 
as well
as December 31, 2020 and 2019:
June 30,
 
December 31,
2021
2020
2020
2019
Cash and cash equivalents
$
145,610
$
322,497
$
181,833
$
123,524
Restricted cash included in other current assets
—
85
62
353
Restricted cash included in other assets
—
19,173
—
19,678
Cash, cash equivalents and restricted cash
$
145,610
$
341,755
$
181,895
$
143,555
XML 43 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill and Intangible Assets
 6 Months Ended
Jun. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]  
Goodwill And Intangible Assets Disclosure [Text Block]
Note 14 – Goodwill and Other Intangible Assets
Changes in the carrying amount of goodwill for the
 
six months ended June 30, 2021 were as follows:
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2020
$
213,242
$
140,162
$
158,090
$
119,718
 
$
631,212
Goodwill additions
1,208
2,626
1,308
128
5,270
Currency translation and other adjustments
 
614
(2,633)
1,127
(2,141)
(3,033)
Balance as of June 30, 2021
$
215,064
$
140,155
$
160,525
$
117,705
 
$
633,449
Gross carrying amounts and accumulated amortization
 
for definite-lived intangible assets as of June 30, 2021 and December
 
31,
2020 were as follows:
Gross Carrying
Accumulated
Amount
Amortization
2021
2020
2021
2020
Customer lists and rights to sell
$
858,025
 
$
839,551
 
$
127,883
 
$
99,806
Trademarks, formulations and product
 
technology
 
168,004
 
 
166,448
 
 
34,932
 
 
30,483
Other
 
6,390
 
 
6,372
 
 
5,909
 
 
5,824
Total definite
 
-lived intangible assets
$
1,032,419
 
$
1,012,371
 
$
168,724
 
$
136,113
The Company amortizes definite-lived intangible assets on
 
a straight-line basis over their useful lives.
 
The Company recorded
$
15.0
 
million and $
29.8
 
million of amortization expense for the three and six months
 
ended June 30, 2021, respectively.
 
Comparatively,
 
the Company recorded $
13.7
 
million and $
27.7
 
million of amortization expense for the three and six months ended
June 30, 2020, respectively.
Estimated annual aggregate amortization expense for
 
the current year and subsequent five years is as follows:
For the year ended December 31, 2021
$
59,214
For the year ended December 31, 2022
59,564
For the year ended December 31, 2023
59,394
For the year ended December 31, 2024
58,750
For the year ended December 31, 2025
58,037
For the year ended December 31, 2026
57,740
The Company has four indefinite-lived intangible
 
assets totaling $
205.1
 
million as of both June 30, 2021 and December 31, 2020,
including $
204.0
 
million of indefinite-lived intangible assets for trademarks and
 
tradename associated with the Combination.
Goodwill and intangible assets that have indefinite lives are
 
not amortized and are required to be assessed at least annually
 
for
impairment.
 
The Company completes its annual goodwill and indefinite-lived
 
intangible asset impairment test during the fourth
quarter of each year.
 
The Company continuously evaluates if triggering events indicate
 
a possible impairment in one or more of its
reporting units or indefinite-lived or long-lived assets.
The Company previously disclosed in its 2020 Form 10-K
 
that as of March 31, 2020, the Company concluded that the
 
impact of
COVID-19 did not represent a triggering event with
 
regards to the Company’s
 
reporting units or indefinite-lived and long-lived assets,
except for the Company’s
 
Houghton and Fluidcare trademarks and tradename indefinite
 
-lived intangible assets.
 
The determination of
estimated fair value of the Houghton and Fluidcare
 
trademarks and tradename indefinite-lived assets was based on a relief
 
from
royalty valuation method, which requires management’s
 
judgment and often involves the use of significant estimates and assumptions,
including assumptions with respect to the weighted average
 
cost of capital (“WACC”)
 
and royalty rates, as well as revenue growth
rates and terminal growth rates.
 
In the first quarter of 2020, as a result of the impact of
 
COVID-19 driving a decrease in projected
legacy Houghton net sales during that year and the impact
 
of the sales decline on projected future legacy Houghton
 
net sales as well as
an increase in the WACC
 
assumption utilized in the quantitative impairment
 
assessment, the Company concluded that the estimated
fair values of the Houghton and Fluidcare trademarks
 
and tradename intangible assets were less than their carrying values.
 
As a
result, an impairment charge of $
38.0
 
million was recorded in the first quarter of 2020 to write down
 
the carrying values of these
intangible assets to their estimated fair values.
 
As of June 30, 2021, the Company continued to evaluate all
 
potential triggering events, including the on-going impact
 
of COVID-
19 on the Company’s
 
operations, and the volatility and uncertainty in the economic outlook
 
as a result of COVID-19, to determine if
this indicated it was more likely than not that the carrying
 
value of any of the Company’s
 
reporting units or indefinite-lived or long-
lived intangible assets were not recoverable.
 
The Company concluded that the impact of COVID-19 did not
 
represent a triggering
event as of June 30, 2021.
 
While the Company concluded that the impact of COVID-19 did not
 
represent a triggering event as of June
30, 2021, the Company will continue to evaluate the
 
impact of COVID-19 on the Company’s
 
current and projected results. If the
current economic conditions worsen or projections
 
of the timeline for recovery are significantly extended, then
 
the Company may
conclude in the future that the impact from COVID-19 requires
 
the need to perform further interim quantitative impairment tests,
which could result in additional impairment charges
 
in the future.
XML 44 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Debt
 6 Months Ended
Jun. 30, 2021
Debt [Abstract]  
Debt [Text Block]
Note 15 – Debt
 
Debt as of June 30, 2021 and December 31, 2020
 
includes the following:
As of June 30, 2021
As of December 31, 2020
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.59%
$
189,503
1.65%
$
160,000
U.S. Term Loan
1.59%
555,000
1.65%
570,000
EURO Term Loan
1.50%
148,115
1.50%
157,062
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
2,165
Various
2,072
Total debt
$
904,783
$
899,134
Less: debt issuance costs
(9,550)
(11,099)
Less: short-term and current portion of long-term debts
(48,079)
(38,967)
Total long
 
-term debt
$
847,154
$
849,068
Credit facilities
The Company’s primary
 
credit facility (as amended, the “Credit Facility”) is comprised
 
of a $
400.0
 
million multicurrency
revolver (the “Revolver”), a $
600.0
 
million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower,
 
and a $
150.0
million (as of August 1, 2019) Euro equivalent term loan (the
 
“EURO Term Loan”
 
and together with the “U.S. Term
 
Loan”, the
“Term Loans”)
 
with Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower,
 
each with a
five year
 
term maturing in
August 2024.
 
Subject to the consent of the administrative
 
agent and certain other conditions, the Company may designate additional
borrowers.
 
The maximum amount available under the Credit Facility can be
 
increased by up to $
300.0
 
million at the Company’s
request if there are lenders who agree to accept additional
 
commitments and the Company has satisfied certain other
 
conditions.
 
Borrowings under the Credit Facility bear interest at a base
 
rate or LIBOR plus an applicable margin based upon
 
the Company’s
consolidated net leverage ratio.
 
There are LIBOR replacement provisions that contemplate a further
 
amendment if and when LIBOR
ceases to be reported.
 
The variable interest rate incurred on the outstanding borrowings under
 
the Credit Facility as of and during the
six months ended June 30, 2021 was approximately
1.6
%.
 
In addition to paying interest on outstanding principal under
 
the Credit
Facility, the Company
 
is required to pay a commitment fee ranging from
0.2
% to
0.3
% depending on the Company’s
 
consolidated net
leverage ratio to the lenders under the Revolver in
 
respect of the unutilized commitments thereunder.
 
The Company has unused
capacity under the Revolver of approximately $
206
 
million, net of bank letters of credit of approximately $
4
 
million, as of June 30,
2021.
 
The Credit Facility is subject to certain financial and other covenants. The Company’s initial consolidated net debt to
consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit
Facility.
 
As of June 30, 2021, the consolidated net debt to adjusted
 
EBITDA may not exceed
4.00
 
to 1.
 
The Company’s consolidated
adjusted EBITDA to interest expense ratio cannot
 
be less than
3.0
 
to 1 over the term of the agreement.
 
The Credit Facility also
prohibits the payment of cash dividends if the Company
 
is in default or if the amount of the dividend paid annually
 
exceeds the greater
of $
50.0
 
million and
20
% of consolidated adjusted EBITDA unless the ratio of consolidated
 
net debt to consolidated adjusted
EBITDA is less than
2.0
 
to 1, in which case there is no such limitation on amount.
 
As of June 30, 2021 and December 31, 2020, the
Company was in compliance with all of the Credit Facility covenants.
 
The Term Loans have
 
quarterly principal amortization during
their
five year
 
terms, with
5.0
% amortization of the principal balance due in years
 
1 and 2,
7.5
% in year 3, and
10.0
% in years 4 and 5,
with the remaining principal amount due at maturity.
 
During the six months ended June 30, 2021, the Company made
 
quarterly
amortization payments related to the Term
 
Loans totaling $
19.1
 
million.
 
The Credit Facility is guaranteed by certain of the
Company’s domestic subsidiaries
 
and is secured by first priority liens on substantially all of
 
the assets of the Company and the
domestic subsidiary guarantors, subject to certain customary exclusions.
 
The obligations of the Dutch borrower are guaranteed only
by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable
 
interest rates on at least
20
% of its total Term Loans.
 
In order to
satisfy this requirement as well as to manage the
 
Company’s exposure to variable
 
interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $
170.0
 
million notional amounts of three year interest rate swaps at a base
 
rate of
1.64
%
plus an applicable margin as provided in the
 
Credit Facility, based on
 
the Company’s consolidated net
 
leverage ratio.
 
At the time the
Company entered into the swaps, and as of June 30,
 
2021, the aggregate interest rate on the swaps, including the
 
fixed base rate plus
an applicable margin, was
3.1
%.
 
See Note 18 of Notes to Condensed Consolidated Financial Statements.
The Company capitalized $
23.7
 
million of certain third-party debt issuance costs in connection
 
with executing the Credit Facility.
 
Approximately $
15.5
 
million of the capitalized costs were attributed to the Term
 
Loans and recorded as a direct reduction of long-
term debt on the Company’s
 
Condensed Consolidated Balance Sheet.
 
Approximately $
8.3
 
million of the capitalized costs were
attributed to the Revolver and recorded within other assets on
 
the Company’s Condensed Consolidated
 
Balance Sheet.
 
These
capitalized costs are being amortized into interest expense
 
over the five year term of the Credit Facility.
 
As of June 30, 2021 and
December 31, 2020, the Company had $
9.6
 
million and $
11.1
 
million, respectively,
 
of debt issuance costs recorded as a reduction of
long-term debt.
 
As of June 30, 2021 and December 31, 2020, the Company
 
had $
5.1
 
million and $
5.9
 
million, respectively, of
 
debt
issuance costs recorded within other assets.
Industrial development bonds
As of June 30, 2021 and December 31, 2020, the Company
 
had fixed rate, industrial development authority bonds totaling
 
$
10.0
million in principal amount due in
2028
.
 
These bonds have similar covenants to the Credit Facility noted above.
Bank lines of credit and other
 
debt obligations
The Company has certain unsecured bank lines of credit
 
and discounting facilities in one of its foreign subsidiaries, which
 
are not
collateralized.
 
The Company’s other debt
 
obligations primarily consist of certain domestic and foreign
 
low interest rate or interest-
free municipality-related loans, local credit facilities of
 
certain foreign subsidiaries and capital lease obligations.
 
Total unused
capacity under these arrangements as of June 30, 2021
 
was approximately $
40
 
million.
In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s only other off-balance
sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees
outstanding as of June 30, 2021 were approximately $7 million.
The Company incurred the following debt related expenses
 
included within Interest expense, net, in the Condensed
 
Consolidated
Statements of Operations:
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Interest expense
$
4,813
$
5,951
$
9,463
$
13,663
Amortization of debt issuance costs
1,188
1,188
2,375
2,375
Total
$
6,001
$
7,139
$
11,838
$
16,038
Based on the variable interest rates associated with the Credit
 
Facility, as of June
 
30, 2021 and December 31, 2020, the amounts
at which the Company’s
 
total debt were recorded are not materially different
 
from their fair market value.
XML 45 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Equity
 6 Months Ended
Jun. 30, 2021
Equity [Abstract]  
Equity [Text Block]
Note 16 – Equity
The following tables present the changes in equity,
 
net of tax, for the three and six months ended June 30, 2021
 
and 2020:
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at March 31, 2021
$
17,875
$
908,748
$
455,493
$
(53,228)
$
565
$
1,329,453
Net income
—
—
33,570
—
30
33,600
Amounts reported in other comprehensive
 
income
—
—
—
17,285
8
17,293
Dividends ($
0.395
 
per share)
—
—
(7,062)
—
—
(7,062)
Share issuance and equity-based
compensation plans
3
2,114
—
—
—
2,117
Balance at June 30, 2021
$
17,878
$
910,862
$
482,001
$
(35,943)
$
603
$
1,375,401
Balance at March 31, 2020
$
17,752
$
888,533
$
376,853
$
(121,524)
$
418
$
1,162,032
Net (loss) income
—
—
(7,735)
—
13
(7,722)
Amounts reported in other comprehensive
 
income
—
—
—
12,260
1
12,261
Dividends ($
0.385
 
per share)
—
—
(6,853)
—
—
(6,853)
Share issuance and equity-based
compensation plans
48
7,575
—
—
—
7,623
Balance at June 30, 2020
$
17,800
$
896,108
$
362,265
$
(109,264)
$
432
$
1,167,341
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at December 31, 2020
$
17,851
$
905,171
$
423,940
$
(26,598)
$
550
$
1,320,914
Net income
—
—
72,185
—
47
72,232
Amounts reported in other comprehensive
 
(loss) income
—
—
—
(9,345)
6
(9,339)
Dividends ($
0.790
 
per share)
—
—
(14,124)
—
—
(14,124)
Share issuance and equity-based
compensation plans
27
5,691
—
—
—
5,718
Balance at June 30, 2021
$
17,878
$
910,862
$
482,001
$
(35,943)
$
603
$
1,375,401
Balance at December 31, 2019
$
17,735
$
888,218
$
412,979
$
(78,170)
$
1,604
$
1,242,366
Cumulative effect of an accounting change
—
—
(911)
—
—
(911)
Balance at January 1, 2020
17,735
888,218
412,068
(78,170)
1,604
1,241,455
Net (loss) income
—
—
(36,116)
—
50
(36,066)
Amounts reported in other comprehensive
 
loss
—
—
—
(31,094)
(131)
(31,225)
Dividends ($
0.770
0 per share)
—
—
(13,687)
—
—
(13,687)
Acquisition of noncontrolling interest
—
(707)
—
—
(340)
(1,047)
Distributions to noncontrolling affiliate
shareholders
—
—
—
—
(751)
(751)
Share issuance and equity-based
compensation plans
65
8,597
—
—
—
8,662
Balance at June 30, 2020
$
17,800
$
896,108
$
362,265
$
(109,264)
$
432
$
1,167,341
The following tables show the reclassifications from and
 
resulting balances of AOCI for the three and six months ended
 
June 30,
2021 and 2020:
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
 
Translation
Pension
Available-for
 
-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at March 31, 2021
$
(28,334)
$
(22,175)
$
317
$
(3,036)
$
(53,228)
Other comprehensive income (loss) before
 
reclassifications
16,157
(260)
341
586
16,824
Amounts reclassified from AOCI
—
852
2
—
854
Related tax amounts
—
(195)
(64)
(134)
(393)
Balance at June 30, 2021
$
(12,177)
$
(21,778)
$
596
$
(2,584)
$
(35,943)
Balance at March 31, 2020
$
(99,187)
$
(17,576)
$
(460)
$
(4,301)
$
(121,524)
Other comprehensive income (loss) before
reclassifications
10,550
(336)
2,128
(144)
12,198
Amounts reclassified from AOCI
—
600
(93)
—
507
Related tax amounts
—
(51)
(427)
33
(445)
Balance at June 30, 2020
$
(88,637)
$
(17,363)
$
1,148
$
(4,412)
$
(109,264)
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
 
Translation
Pension
Available-for
 
-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at December 31, 2020
$
(2,875)
$
(23,467)
$
3,342
$
(3,598)
$
(26,598)
Other comprehensive (loss) income before
reclassifications
(9,302)
521
(404)
1,316
(7,869)
Amounts reclassified from AOCI
—
1,714
(3,083)
—
(1,369)
Related tax amounts
—
(546)
741
(302)
(107)
Balance at June 30, 2021
$
(12,177)
$
(21,778)
$
596
$
(2,584)
$
(35,943)
Balance at December 31, 2019
$
(44,568)
$
(34,533)
$
1,251
$
(320)
$
(78,170)
Other comprehensive (loss) income before
 
reclassifications
(44,069)
492
(8)
(5,315)
(48,900)
Amounts reclassified from AOCI
—
24,966
(125)
—
24,841
Related tax amounts
—
(8,288)
30
1,223
(7,035)
Balance at June 30, 2020
$
(88,637)
$
(17,363)
$
1,148
$
(4,412)
$
(109,264)
All reclassifications related to unrealized gain (loss) in
 
available-for-sale securities relate to the Company’s
 
equity interest in a
captive insurance company and are recorded in equity
 
in net income of associated companies.
 
The amounts reported in other
comprehensive income for noncontrolling interest are
 
related to currency translation adjustments.
XML 46 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements
 6 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
Note 17 – Fair Value
 
Measurements
 
The Company has valued its company-owned life insurance
 
policies at fair value.
 
These assets are subject to fair value
measurement as follows:
Fair Value
 
Measurements at June 30, 2021
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
$
2,137
$
—
$
2,137
$
—
Total
$
2,137
$
—
$
2,137
$
—
Fair Value
 
Measurements at December 31, 2020
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
1,961
$
—
$
1,961
$
—
Total
$
1,961
$
—
$
1,961
$
—
The fair values of Company-owned life insurance assets are based
 
on quotes for like instruments with similar credit ratings and
terms.
 
The Company did not hold any Level 3 investments as of June
 
30, 2021 or December 31, 2020, respectively,
 
so related
disclosures have not been included.
XML 47 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Hedging Activities
 6 Months Ended
Jun. 30, 2021
General Discussion Of Derivative Instruments And Hedging Activities [Abstract]  
Derivative Instruments And Hedging Activities Disclosure [Text Block]
Note 18 – Hedging Activities
In order to satisfy certain requirements of the Credit
 
Facility as well as to manage the Company’s
 
exposure to variable interest
rate risk associated with the Credit Facility,
 
in November 2019, the Company entered into $
170.0
 
million notional amounts of
three
year
 
interest rate swaps.
 
See Note 15 of Notes to Condensed Consolidated Financial Statements.
 
These interest rate swaps are
designated as cash flow hedges and, as such, the contracts
 
are marked-to-market at each reporting date and any unrealized gains
 
or
losses are included in AOCI to the extent effective
 
and reclassified to interest expense in the period during which the
 
transaction
affects earnings or it becomes probable that
 
the forecasted transaction will not occur.
 
The balance sheet classification and fair values of the
 
Company’s derivative instruments,
 
which are Level 2 measurements, are as
follows:
Fair Value
Condensed Consolidated
June 30,
 
December 31,
Balance Sheet Location
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
Other non-current liabilities
$
3,356
$
4,672
$
3,356
$
4,672
The following table presents the net unrealized loss deferred to
 
AOCI:
June 30,
 
December 31,
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
2,584
$
3,598
$
2,584
$
3,598
The following table presents the net loss reclassified from
 
AOCI to earnings:
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Amount and location of expense reclassified
from AOCI into expense (effective portion)
Interest expense, net
$
(659)
$
(483)
$
(1,302)
$
(465)
Interest rate swaps are entered into with a limited number
 
of counterparties, each of which allows for net settlement
 
of all
contracts through a single payment in a single currency
 
in the event of a default on or termination of any one
 
contract.
 
As such, in
accordance with the Company’s
 
accounting policy,
 
these derivative instruments are recorded on a net basis within
 
the Condensed
Consolidated Balance Sheets.
XML 48 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments And Contingencies Disclosure [Text Block]
Note 19 – Commitments and Contingencies
The Company previously disclosed in its 2020 Form 10-K
 
that AC Products, Inc. (“ACP”), a wholly owned subsidiary,
 
has been
operating a groundwater treatment system to hydraulically
 
contain groundwater contamination emanating from ACP’s
 
site, the
principal contaminant of which is perchloroethylene.
 
As of June 30, 2021, ACP believes it is close to meeting the
 
conditions for
closure of the groundwater treatment system, but continues
 
to operate this system while in discussions with the relevant
 
authorities.
 
As of June 30, 2021, the Company believes that the range
 
of potential-known liabilities associated with the balance
 
of the ACP water
remediation program is approximately $
0.1
 
million to $
1.0
 
million.
 
The low and high ends of the range are based on the length of
operation of the treatment system as determined
 
by groundwater modeling.
 
Costs of operation include the operation and maintenance
of the extraction well, groundwater monitoring and program
 
management.
 
The Company previously disclosed in its 2020 Form 10-K
 
that an inactive subsidiary of the Company that was acquired
 
in 1978
sold certain products containing asbestos, primarily
 
on an installed basis, and is among the defendants in numerous
 
lawsuits alleging
injury due to exposure to asbestos.
 
During the three and six months ended June 30, 2021,
 
there have been no significant changes to
the facts or circumstances of this previously disclosed matter,
 
aside from on-going claims and routine payments associated with
 
this
litigation.
 
Based on a continued analysis of the existing and anticipated
 
future claims against this subsidiary,
 
it is currently projected
that the subsidiary’s total
 
liability over the next 50 years for these claims is approximately
 
$
0.4
 
million (excluding costs of defense).
The Company previously disclosed in its 2020 Form 10-K
 
that it is party to certain environmental matters related to certain
domestic and foreign properties currently or previously
 
owned by Houghton.
 
These environmental matters primarily require the
Company to perform long-term monitoring as well as operating
 
and maintenance at each of the applicable sites.
 
During the three and
six months ended June 30, 2021, there have been no significant
 
changes to the facts or circumstances of these previously
 
disclosed
matters, aside from on-going monitoring and maintenance
 
activities and routine payments associated with each of the
 
sites.
 
The
Company continually evaluates its obligations related to such
 
matters, and based on historical costs incurred and projected
 
costs to be
incurred over the next 28 years, has estimated the present
 
value range of costs for all of the Houghton environmental
 
matters, on a
discounted basis, to be between approximately $
5.5
 
million and $
6.5
 
million as of June 30, 2021, for which $
6.0
 
million was accrued
within other accrued liabilities and other non-current
 
liabilities on the Company’s Condensed
 
Consolidated Balance Sheet as of June
30, 2021.
 
Comparatively, as of December
 
31, 2020, the Company had $
6.0
 
million accrued for with respect to these matters.
The Company believes, although there can be no assurance
 
regarding the outcome of other unrelated environmental matters, that
it has made adequate accruals for costs associated with other
 
environmental problems of which it is aware.
 
Approximately $
0.1
million was accrued as of both June 30, 2021 and December
 
31, 2020,
 
to provide for such anticipated future environmental
assessments and remediation costs.
 
The Company previously disclosed in its 2020 Form 10-K
 
that one of the Company’s subsidiaries
 
received a notice of inspection
from a taxing authority in a country where certain
 
of its subsidiaries operate which related to a non-income (indirect)
 
tax that may be
applicable to certain products the subsidiary sells.
 
To date, the Company
 
has not
 
received any assessment from the authority related to
potential liabilities that may be due from the Company’s
 
subsidiary.
 
Consequently, there is substantial uncertainty
 
with respect to the
Company’s ultimate liability
 
with respect to this indirect tax, as the application of
 
this tax in its given market is ambiguous and
interpreted differently among other peer companies
 
and taxing authorities.
 
The Company, with assistance
 
from independent experts,
has performed an evaluation of the applicability of this
 
indirect tax to the Company’s
 
subsidiaries in this country.
 
During the six
months ended June 30, 2021 and through the date of
 
this Report, there have been no significant changes to
 
the facts or circumstances
of this previously disclosed matter,
 
aside from
 
on-going discussions between the Company and the
 
taxing authority related to this
notice of inspection and independent testing conducted by
 
third-party consultants at the direction of the Company and the taxing
authority to determine if the Company’s
 
products have contents which subject them to this indirect tax.
 
Based on all of the
information available to the Company at this time, as of
 
June 30, 2021, the Company has recorded a liability of $
1.8
 
million in other
accrued liabilities, which reflects the Company’s
 
current best estimate of probable indirect tax owed, including
 
interest and taking into
account applicable statutes of limitations.
 
Because these amounts in part relate to a Houghton entity
 
acquired in the Combination and
for periods prior to the Combination, the Company
 
has submitted an indemnification claim with Houghton’s
 
former owners related to
this potential indirect tax liability.
 
The Company recorded a receivable in other assets for approximately
 
$
1.1
 
million, which reflects
the amount of the initial recorded liability for which
 
the Company anticipates being indemnified.
 
As noted, the Company believes
there is substantial uncertainty with respect to its ultimate liability
 
given the ambiguous application of this indirect tax.
 
At this time,
the Company’s current
 
best estimate of a potential range for possible assessments, including
 
additional amounts that may be assessed
under these indirect tax laws, would be $
0
 
to approximately $
40
 
million, which is net of approximately $
11
 
million of estimated
income tax deductions and approximately $
22
 
million of applicable rights to indemnification from Houghton’s
 
former owners.
During the first six months of 2021, one of the Company’s
 
Brazilian subsidiaries received a notice that it had prevailed
 
on an
existing legal claim in regard to certain non-income
 
(indirect) taxes that had been previously charged and paid.
 
The matter
specifically relates to companies’ rights to exclude the
 
state tax on goods circulation (a valued-added-tax or VAT
 
equivalent, known in
Brazil as “ICMS”) from
 
the calculation of certain additional indirect taxes (specifically
 
the program of social integration (“PIS”)
and contribution for the financing of social security (“COFINS”))
 
levied by the Brazilian States on the sale of goods.
 
In May 2021,
the Brazilian Supreme Court concluded that ICMS should
 
not be included in the tax base of PIS and COFINS, and confirmed
 
the
methodology for calculating the PIS and COFINS tax credit
 
claims to which taxpayers are entitled.
 
The Company’s Brazilian entities
had previously filed legal or administrative disputes on
 
this matter and are entitled to receive tax credits and interest dating
 
back to
five years preceding the date of their legal claims.
 
As a result of these court rulings in the first six months of 2021,
 
the Company
recognized non-income tax credits of
67.0
 
million BRL or approximately $
13.3
 
million, which includes approximately $
8.4
 
million
for the PIS and COFINS tax credits as well as interest on these
 
tax credits of $
4.9
 
million.
 
The tax credits to which the Company’s
Brazilian subsidiaries are entitled are claimable once registered
 
with the Brazilian tax authorities and the Company anticipates
completing this step during the second half of 2021.
 
These tax credits can be used to offset future Brazilian
 
federal taxes and the
Company currently anticipates using the full amount of
 
credits during the five year period of time permitted.
 
In connection with obtaining regulatory approvals for the
 
Combination, certain steel and aluminum related product lines
 
of
Houghton were divested on August 1, 2019.
 
In July 2021, the entity that acquired these divested product lines
 
submitted an
indemnification claim for certain alleged losses in accordance with
 
the terms of the Asset Purchase Agreement (“APA”)
 
.
 
Under the
terms of the APA,
 
the Company has 45 days to review the claim and respond
 
,
 
and as such, the Company is in the early stages of
evaluating the merits of the alleged losses in the indemnification
 
claim received.
 
As of the date of this Report,
 
the Company does not
believe it is reasonably possible to determine or quantify
 
any possible exposure.
 
The Company is party to other litigation which management
 
currently believes will not have a material adverse
 
effect on the
Company’s results of
 
operations, cash flows or financial condition.
 
In addition, the Company has an immaterial amount of contractual
purchase obligations.
XML 49 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Basis of Presentation and Description of Business (Policies)
 6 Months Ended
Jun. 30, 2021
Basis of Presentation and Description of Business [Abstract]  
Basis Of Accounting Policy [Policy Text Block]
Basis of Presentation
As used in these Notes to Condensed Consolidated
 
Financial Statements, the terms “Quaker,”
 
“Quaker Houghton,”
 
the
“Company,”
 
“we,” and “our” refer to Quaker Chemical Corporation (doing
 
business as Quaker Houghton), its subsidiaries, and
associated companies, unless the context otherwise requires.
 
As used in these Notes to Condensed Consolidated
 
Financial Statements,
the term Legacy Quaker refers to the Company prior
 
to the closing of its combination with Houghton International,
 
Inc. (“Houghton”)
(herein referred to as the “Combination”).
 
The condensed consolidated financial statements included herein
 
are unaudited and have
been prepared in accordance with generally accepted
 
accounting principles in the United States (“U.S. GAAP”) for
 
interim financial
reporting and the United States Securities and Exchange Commission
 
(“SEC”) regulations.
 
Certain information and footnote
disclosures normally included in financial statements prepared
 
in accordance with U.S. GAAP have been condensed or
 
omitted
pursuant to such rules and regulations.
 
In the opinion of management, the financial statements reflect all
 
adjustments which are
necessary for a fair statement of the financial position,
 
results of operations and cash flows for the interim periods.
 
The results for the
six months ended June 30, 2021 are not necessarily indicative
 
of the results to be expected for the full year.
 
These financial
statements should be read in conjunction with the Company’s
 
Annual Report filed on Form 10-K for the year
 
ended December 31,
2020 (the “2020 Form 10-K”).
Segments [Policy Text Block]
The Company’s operating
 
segments, which are consistent with its reportable segments,
 
reflect the structure of the Company’s
internal organization, the method by which
 
the Company’s resources are allocated
 
and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
 
The Company has
four
 
reportable segments: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
The three geographic segments are composed of the net
 
sales and operations in
each respective region, excluding net sales and operations
 
managed globally by the Global Specialty Businesses segment, which
includes the Company’s
 
container, metal finishing, mining,
 
offshore, specialty coatings, specialty grease and
 
Norman Hay businesses.
Revenue Recognition [Policy Text Block]
The Company applies the five-step model in the FASB’s
 
guidance, which requires the Company to: (i) identify
 
the contract with a
customer; (ii) identify the performance obligations in
 
the contract; (iii) determine the transaction price; (iv) allocate the
 
transaction
price to the performance obligations in the contract; and
 
(v) recognize revenue when, or as, the Company satisfies a performance
obligation.
 
Refer to the Company’s 2020
 
Form 10-K for additional information on the Company’s
 
revenue recognition policies,
including its practical expedients and accounting policy
 
elections.
The Company recognizes a contract asset or receivable
 
on its Condensed Consolidated Balance Sheet when the Company
performs a service or transfers a good in advance
 
of receiving consideration.
 
A receivable is the Company’s
 
right to consideration that
is unconditional and only the passage of time is required
 
before payment of that consideration is due.
 
A contract asset is the
Company’s right to consideration
 
in exchange for goods or services that the Company has transferred
 
to a customer.
 
The Company
had no material contract assets recorded on its Condensed
 
Consolidated Balance Sheets as of June 30, 2021 or December
 
31, 2020.
A contract liability is recognized when the Company
 
receives consideration, or if it has the unconditional right
 
to receive
consideration, in advance of performance.
 
A contract liability is the Company’s
 
obligation to transfer goods or services to a customer
for which the Company has received consideration,
 
or a specified amount of consideration is due, from the customer.
 
The Company’s
contract liabilities primarily represent deferred revenue
 
recorded for customer payments received by the Company
 
prior to the
Company satisfying the associated performance obligation.
 
Deferred revenues are presented within other current liabilities
 
in the
Company’s Condensed
 
Consolidated Balance Sheets.
 
The Company had approximately $
4.3
 
million and $
4.0
 
million of deferred
revenue as of June 30, 2021 and December 31, 2020,
 
respectively.
 
For the six months ended June 30, 2021, the Company satisfied
 
all
of the associated performance obligations and recognized
 
into revenue the advance payments received and recorded
 
as of December
31, 2020.
Revenue From Contract With Customer [Policy Text Block]
As part of the Company’s
 
Fluidcare business, certain third-party product sales to customers are
 
managed by the Company.
 
Where
the Company acts as a principal, revenues are recognized
 
on a gross reporting basis at the selling price negotiated with
 
its customers.
Where the Company acts as an agent, revenue is recognized on
 
a net reporting basis at the amount of the administrative fee earned
 
by
the Company for ordering the goods.
Goodwill And Intangible Assets, Goodwill, Policy [Policy Text Block]
Goodwill and intangible assets that have indefinite lives are
 
not amortized and are required to be assessed at least annually
 
for
impairment.
 
The Company completes its annual goodwill and indefinite-lived
 
intangible asset impairment test during the fourth
quarter of each year.
 
The Company continuously evaluates if triggering events indicate
 
a possible impairment in one or more of its
reporting units or indefinite-lived or long-lived assets.
Lessee Leases [Policy Text Block]
The Company determines if an arrangement is a lease
 
at its inception.
 
This determination generally depends on whether the
arrangement conveys the right to control the use of an
 
identified fixed asset explicitly or implicitly for a period of
 
time in exchange for
consideration.
 
Control of an underlying asset is conveyed if the Company
 
obtains the rights to direct the use of, and obtains
substantially all of the economic benefits from the use
 
of, the underlying asset.
 
Lease expense for variable leases and short-term
leases is recognized when the obligation is incurred.
Credit Loss Financial Instrument [Policy Text Block]
As previously disclosed in the Company’s
 
2020 Form 10-K, during 2020, the Company adopted, as required,
 
an accounting
standard update related to the accounting and disclosure
 
of credit losses effective January 1, 2020.
 
The Company recognizes an
allowance for credit losses, which represents the portion
 
of its trade accounts receivable that the Company does not expect
 
to collect
over the contractual life, considering past events and
 
reasonable and supportable forecasts of future economic conditions.
 
The
Company’s allowance
 
for credit losses on its trade accounts receivables is based on
 
specific collectability facts and circumstances for
each outstanding receivable and customer,
 
the aging of outstanding receivables, and the associated collection
 
risk the Company
estimates for certain past due aging categories, and
 
also, the general risk to all outstanding accounts receivable based on historical
amounts determined to be uncollectible.
 
The Company does not have any off-balance-sheet
 
credit exposure related to its customers.
XML 50 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Business Acquisitions (Tables)
 6 Months Ended
Jun. 30, 2021
Business Acquisition [Line Items]  
Schedule of estimated fair values of net assets acquired [Table Text Block]
Measurement
December 22,
December 22,
Period
2020
2020 (1)
Adjustments
(as adjusted)
Cash and cash equivalents
$
958
$
—
$
958
Accounts receivable
8,473
—
8,473
Inventories
4,527
—
4,527
Prepaid expenses and other assets
181
—
181
Property, plant and
 
equipment
10,467
652
11,119
Intangible assets
30,300
(500)
29,800
Goodwill
2,814
270
3,084
Total assets purchased
57,720
422
58,142
Long-term debt including current portions and finance leases
183
556
739
Accounts payable, accrued expenses and other accrued
 
liabilities
3,482
—
3,482
Total liabilities assumed
3,665
556
4,221
Total consideration
 
paid for Coral
54,055
(134)
53,921
Less: estimated purchase price settlement
—
(134)
(134)
Less: cash acquired
958
—
958
Net cash paid for Coral
$
53,097
$
—
$
53,097
(1) As previously disclosed in the Company’s
 
2020 Form 10-K
XML 51 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments (Tables)
 6 Months Ended
Jun. 30, 2021
Business Segment Disclosures [Abstract]  
Schedule of information about the performance of the Company's reportable segments, sales and total assets [Table Text Block]
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Net sales
 
 
 
 
 
 
 
 
 
 
Americas
$
139,673
$
80,576
$
274,544
$
210,472
EMEA
 
123,436
 
77,702
 
243,250
 
182,541
Asia/Pacific
 
91,559
 
68,421
 
188,265
 
141,973
Global Specialty Businesses
 
80,594
 
59,341
 
158,986
 
129,615
Total net sales
$
435,262
$
286,040
$
865,045
$
664,601
Segment operating earnings
Americas
$
33,648
$
10,303
$
65,882
$
39,491
EMEA
23,405
10,471
48,649
28,830
Asia/Pacific
23,227
19,261
50,705
38,802
Global Specialty Businesses
 
24,209
 
16,393
 
48,378
 
36,953
Total segment operating
 
earnings
 
104,489
 
56,428
 
213,614
 
144,076
Combination, integration and other acquisition-related
 
expenses
(6,658)
(7,995)
(12,473)
(15,873)
Restructuring and related charges
(298)
(486)
(1,473)
(2,202)
Fair value step up of acquired inventory sold
 
—
(226)
(801)
(226)
Indefinite-lived intangible asset impairment
—
—
—
(38,000)
Non-operating and administrative expenses
(43,077)
(32,045)
(84,069)
(70,496)
Depreciation
 
of corporate assets and amortization
 
(15,640)
 
(13,438)
 
(31,088)
 
(27,485)
Operating income (loss)
 
38,816
2,238
83,710
(10,206)
Other income (expense), net
14,010
(993)
18,697
(22,168)
Interest expense, net
 
(5,618)
 
(6,811)
 
(11,088)
 
(15,272)
Income (loss) before taxes and equity in net income of
associated companies
$
47,208
$
(5,566)
$
91,319
$
(47,646)
XML 52 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Net Sales and Revenue Recognition (Tables)
 6 Months Ended
Jun. 30, 2021
Disaggregation Of Revenue [Abstract]  
Disaggregation Of Revenue [Table Text Block]
Three Months Ended June 30, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
51,799
$
35,634
$
48,207
$
135,640
Metalworking and other
87,874
87,802
43,352
219,028
139,673
123,436
91,559
354,668
Global Specialty Businesses
46,183
21,678
12,733
80,594
$
185,856
$
145,114
$
104,292
$
435,262
Timing of Revenue Recognized
Product sales at a point in time
$
177,227
$
137,838
$
101,264
$
416,329
Services transferred over time
8,629
7,276
3,028
18,933
$
185,856
$
145,114
$
104,292
$
435,262
Three Months Ended June 30, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
32,687
$
24,924
$
35,416
$
93,027
Metalworking and other
47,889
52,778
33,005
133,672
80,576
77,702
68,421
226,699
Global Specialty Businesses
32,294
15,569
11,478
59,341
$
112,870
$
93,271
$
79,899
$
286,040
Timing of Revenue Recognized
Product sales at a point in time
$
108,644
$
87,995
$
78,195
$
274,834
Services transferred over time
4,226
5,276
1,704
11,206
$
112,870
$
93,271
$
79,899
$
286,040
Six Months Ended June 30, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
98,592
$
69,908
$
97,950
$
266,450
Metalworking and other
175,952
173,342
90,315
439,609
274,544
243,250
188,265
706,059
Global Specialty Businesses
91,439
41,950
25,597
158,986
$
365,983
$
285,200
$
213,862
$
865,045
Timing of Revenue Recognized
Product sales at a point in time
$
348,821
$
269,000
$
207,663
$
825,484
Services transferred over time
17,162
16,200
6,199
39,561
$
365,983
$
285,200
$
213,862
$
865,045
Six Months Ended June 30, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
79,360
$
54,812
$
77,005
$
211,177
Metalworking and other
131,112
127,729
64,968
323,809
210,472
182,541
141,973
534,986
Global Specialty Businesses
76,525
32,174
20,916
129,615
$
286,997
$
214,715
$
162,889
$
664,601
Timing of Revenue Recognized
Product sales at a point in time
$
277,446
$
206,418
$
159,351
$
643,215
Services transferred over time
9,551
8,297
3,538
21,386
$
286,997
$
214,715
$
162,889
$
664,601
XML 53 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Leases (Tables)
 6 Months Ended
Jun. 30, 2021
Leases [Abstract]  
Schedule of Maturities of operating lease liabilities [Table Text Block]
June 30,
December 31,
2021
2020
Right of use lease assets
$
36,160
$
38,507
Other current liabilities
10,064
10,901
Long-term lease liabilities
25,668
27,070
Total operating
 
lease liabilities
$
35,732
$
37,971
Weighted average
 
remaining lease term (years)
5.8
6.0
Weighted average
 
discount rate
4.26%
4.20%
Schedule of Company's future minimum rental commitments under operating leases [Table Text Block]
June 30,
2021
For the remainder of 2021
$
6,052
For the year ended December 31, 2022
9,400
For the year ended December 31, 2023
7,234
For the year ended December 31, 2024
5,355
For the year ended December 31, 2025
4,260
For the year ended December 31, 2026 and beyond
8,152
Total lease payments
40,453
Less: imputed interest
(4,721)
Present value of lease liabilities
$
35,732
XML 54 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Restructuring Activities (Tables)
 6 Months Ended
Jun. 30, 2021
Restructuring And Related Activities [Abstract]  
Restructuring and Related Costs [Table Text Block]
QH Program
Accrued restructuring as of December 31,
 
2020
$
8,248
Restructuring and related charges
1,473
Cash payments
(4,214)
Currency translation adjustments
 
(229)
Accrued restructuring as of June 30, 2021
$
5,278
XML 55 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Share Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2021
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of share-based compensation expense in its Consolidated Statements of Income [Table Text Block]
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Stock options
$
332
$
353
$
640
$
785
Non-vested stock awards and restricted stock units
1,290
1,259
2,686
2,523
Non-elective and elective 401(k) matching contribution in
 
stock
—
1,162
1,553
1,162
Director stock ownership plan
216
54
419
94
Performance stock units
517
280
836
280
Annual incentive plan
—
(117)
—
2,829
Total share-based
 
compensation expense
$
2,355
$
2,991
$
6,134
$
7,673
Schedule of Black-Scholes option pricing model and the assumptions [Table Text Block]
Number of options granted
25,250
Dividend yield
0.85
%
Expected volatility
37.33
%
Risk-free interest rate
0.60
%
Expected term (years)
4.0
XML 56 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Pension and Other Post Retirement Benefits (Tables)
 6 Months Ended
Jun. 30, 2021
Pension Plans, Defined Benefit [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Schedule of components of net periodic benefit costs - pension plans [Table Text Block]
Three Months Ended June 30,
 
Six Months Ended June 30,
 
Other
Other
Postretirement
Postretirement
Pension Benefits
Benefits
Pension Benefits
Benefits
2021
2020
2021
2020
2021
2020
2021
2020
Service cost
$
316
$
1,164
$
2
$
1
$
632
$
2,338
$
3
$
3
Interest cost
1,094
1,486
10
26
2,184
3,255
21
52
Expected return on plan assets
(2,093)
(1,761)
—
—
(4,175)
(3,720)
—
—
Settlement charge
—
—
—
—
—
22,667
—
—
Actuarial loss amortization
857
615
—
16
1,712
1,662
—
31
Prior service cost amortization
3
(41)
—
—
5
(81)
—
—
Net periodic benefit cost
$
177
$
1,463
$
12
$
43
$
358
$
26,121
$
24
$
86
XML 57 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Other Income (Expense) (Tables)
 6 Months Ended
Jun. 30, 2021
Other Income and Expenses [Abstract]  
Schedule of other expense, net [Table Text Block]
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Income from third party license fees
$
373
$
208
$
712
$
512
Foreign exchange losses, net
(838)
(2,004)
(2,316)
(1,183)
Gain (loss) on disposals of property,
 
plant, equipment and other
assets, net
(54)
(83)
5,356
(81)
Non-income tax refunds and other related credits
14,295
832
14,392
2,131
Pension and postretirement benefit income (costs),
 
non-service components
129
(341)
253
(23,866)
Other non-operating income, net
105
395
300
319
Total other
 
income (expense), net
$
14,010
$
(993)
$
18,697
$
(22,168)
XML 58 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share (Tables)
 6 Months Ended
Jun. 30, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Three Months Ended
 
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Basic earnings (loss) per common share
 
 
 
Net income (loss) attributable to Quaker Chemical Corporation
$
 
33,570
$
(7,735)
$
 
72,185
$
(36,116)
Less: (income) loss allocated to participating securities
 
(134)
 
37
 
(287)
 
146
Net income (loss) available to common shareholders
$
 
33,436
$
(7,698)
$
 
71,898
$
(35,970)
Basic weighted average common shares outstanding
17,802,366
17,697,496
17,793,915
17,685,010
Basic earnings (loss) per common share
$
1.88
$
(0.43)
$
4.04
$
(2.03)
Diluted earnings (loss) per common share
Net income (loss) attributable to Quaker Chemical Corporation
$
33,570
$
(7,735)
$
 
72,185
$
(36,116)
Less: (income) loss allocated to participating securities
(134)
 
37
 
(287)
 
146
Net income (loss) available to common shareholders
$
33,436
$
(7,698)
$
71,898
$
(35,970)
Basic weighted average common shares outstanding
17,802,366
17,697,496
17,793,915
17,685,010
Effect of dilutive securities
47,155
—
52,095
—
Diluted weighted average common shares outstanding
17,849,521
17,697,496
17,846,010
17,685,010
Diluted earnings (loss) per common share
$
1.88
$
(0.43)
$
4.03
$
(2.03)
XML 59 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Restricted Cash (Tables)
 6 Months Ended
Jun. 30, 2021
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]  
Schedule Of Cash And Cash Equivalents [Table Text Block]
June 30,
 
December 31,
2021
2020
2020
2019
Cash and cash equivalents
$
145,610
$
322,497
$
181,833
$
123,524
Restricted cash included in other current assets
—
85
62
353
Restricted cash included in other assets
—
19,173
—
19,678
Cash, cash equivalents and restricted cash
$
145,610
$
341,755
$
181,895
$
143,555
XML 60 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill and Intangible Assets (Tables)
 6 Months Ended
Jun. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill [Table Text Block]
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2020
$
213,242
$
140,162
$
158,090
$
119,718
 
$
631,212
Goodwill additions
1,208
2,626
1,308
128
5,270
Currency translation and other adjustments
 
614
(2,633)
1,127
(2,141)
(3,033)
Balance as of June 30, 2021
$
215,064
$
140,155
$
160,525
$
117,705
 
$
633,449
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Gross Carrying
Accumulated
Amount
Amortization
2021
2020
2021
2020
Customer lists and rights to sell
$
858,025
 
$
839,551
 
$
127,883
 
$
99,806
Trademarks, formulations and product
 
technology
 
168,004
 
 
166,448
 
 
34,932
 
 
30,483
Other
 
6,390
 
 
6,372
 
 
5,909
 
 
5,824
Total definite
 
-lived intangible assets
$
1,032,419
 
$
1,012,371
 
$
168,724
 
$
136,113
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
For the year ended December 31, 2021
$
59,214
For the year ended December 31, 2022
59,564
For the year ended December 31, 2023
59,394
For the year ended December 31, 2024
58,750
For the year ended December 31, 2025
58,037
For the year ended December 31, 2026
57,740
XML 61 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Debt (Tables)
 6 Months Ended
Jun. 30, 2021
Debt [Abstract]  
Schedule of Debt [Table Text Block]
As of June 30, 2021
As of December 31, 2020
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.59%
$
189,503
1.65%
$
160,000
U.S. Term Loan
1.59%
555,000
1.65%
570,000
EURO Term Loan
1.50%
148,115
1.50%
157,062
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
2,165
Various
2,072
Total debt
$
904,783
$
899,134
Less: debt issuance costs
(9,550)
(11,099)
Less: short-term and current portion of long-term debts
(48,079)
(38,967)
Total long
 
-term debt
$
847,154
$
849,068
Interest Income And Interest Expense Disclosure [Table Text Block]
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Interest expense
$
4,813
$
5,951
$
9,463
$
13,663
Amortization of debt issuance costs
1,188
1,188
2,375
2,375
Total
$
6,001
$
7,139
$
11,838
$
16,038
XML 62 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Equity (Tables)
 6 Months Ended
Jun. 30, 2021
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
 
Translation
Pension
Available-for
 
-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at March 31, 2021
$
(28,334)
$
(22,175)
$
317
$
(3,036)
$
(53,228)
Other comprehensive income (loss) before
 
reclassifications
16,157
(260)
341
586
16,824
Amounts reclassified from AOCI
—
852
2
—
854
Related tax amounts
—
(195)
(64)
(134)
(393)
Balance at June 30, 2021
$
(12,177)
$
(21,778)
$
596
$
(2,584)
$
(35,943)
Balance at March 31, 2020
$
(99,187)
$
(17,576)
$
(460)
$
(4,301)
$
(121,524)
Other comprehensive income (loss) before
reclassifications
10,550
(336)
2,128
(144)
12,198
Amounts reclassified from AOCI
—
600
(93)
—
507
Related tax amounts
—
(51)
(427)
33
(445)
Balance at June 30, 2020
$
(88,637)
$
(17,363)
$
1,148
$
(4,412)
$
(109,264)
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
 
Translation
Pension
Available-for
 
-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at December 31, 2020
$
(2,875)
$
(23,467)
$
3,342
$
(3,598)
$
(26,598)
Other comprehensive (loss) income before
reclassifications
(9,302)
521
(404)
1,316
(7,869)
Amounts reclassified from AOCI
—
1,714
(3,083)
—
(1,369)
Related tax amounts
—
(546)
741
(302)
(107)
Balance at June 30, 2021
$
(12,177)
$
(21,778)
$
596
$
(2,584)
$
(35,943)
Balance at December 31, 2019
$
(44,568)
$
(34,533)
$
1,251
$
(320)
$
(78,170)
Other comprehensive (loss) income before
 
reclassifications
(44,069)
492
(8)
(5,315)
(48,900)
Amounts reclassified from AOCI
—
24,966
(125)
—
24,841
Related tax amounts
—
(8,288)
30
1,223
(7,035)
Balance at June 30, 2020
$
(88,637)
$
(17,363)
$
1,148
$
(4,412)
$
(109,264)
Schedule of Stockholders Equity [Table Text Block]
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at March 31, 2021
$
17,875
$
908,748
$
455,493
$
(53,228)
$
565
$
1,329,453
Net income
—
—
33,570
—
30
33,600
Amounts reported in other comprehensive
 
income
—
—
—
17,285
8
17,293
Dividends ($
0.395
 
per share)
—
—
(7,062)
—
—
(7,062)
Share issuance and equity-based
compensation plans
3
2,114
—
—
—
2,117
Balance at June 30, 2021
$
17,878
$
910,862
$
482,001
$
(35,943)
$
603
$
1,375,401
Balance at March 31, 2020
$
17,752
$
888,533
$
376,853
$
(121,524)
$
418
$
1,162,032
Net (loss) income
—
—
(7,735)
—
13
(7,722)
Amounts reported in other comprehensive
 
income
—
—
—
12,260
1
12,261
Dividends ($
0.385
 
per share)
—
—
(6,853)
—
—
(6,853)
Share issuance and equity-based
compensation plans
48
7,575
—
—
—
7,623
Balance at June 30, 2020
$
17,800
$
896,108
$
362,265
$
(109,264)
$
432
$
1,167,341
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at December 31, 2020
$
17,851
$
905,171
$
423,940
$
(26,598)
$
550
$
1,320,914
Net income
—
—
72,185
—
47
72,232
Amounts reported in other comprehensive
 
(loss) income
—
—
—
(9,345)
6
(9,339)
Dividends ($
0.790
 
per share)
—
—
(14,124)
—
—
(14,124)
Share issuance and equity-based
compensation plans
27
5,691
—
—
—
5,718
Balance at June 30, 2021
$
17,878
$
910,862
$
482,001
$
(35,943)
$
603
$
1,375,401
Balance at December 31, 2019
$
17,735
$
888,218
$
412,979
$
(78,170)
$
1,604
$
1,242,366
Cumulative effect of an accounting change
—
—
(911)
—
—
(911)
Balance at January 1, 2020
17,735
888,218
412,068
(78,170)
1,604
1,241,455
Net (loss) income
—
—
(36,116)
—
50
(36,066)
Amounts reported in other comprehensive
 
loss
—
—
—
(31,094)
(131)
(31,225)
Dividends ($
0.770
0 per share)
—
—
(13,687)
—
—
(13,687)
Acquisition of noncontrolling interest
—
(707)
—
—
(340)
(1,047)
Distributions to noncontrolling affiliate
shareholders
—
—
—
—
(751)
(751)
Share issuance and equity-based
compensation plans
65
8,597
—
—
—
8,662
Balance at June 30, 2020
$
17,800
$
896,108
$
362,265
$
(109,264)
$
432
$
1,167,341
XML 63 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Table)
 6 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Fair Value
 
Measurements at June 30, 2021
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
$
2,137
$
—
$
2,137
$
—
Total
$
2,137
$
—
$
2,137
$
—
Fair Value
 
Measurements at December 31, 2020
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
1,961
$
—
$
1,961
$
—
Total
$
1,961
$
—
$
1,961
$
—
XML 64 R41.htm IDEA: XBRL DOCUMENT v3.21.2
Hedging Activities (Tables)
 6 Months Ended
Jun. 30, 2021
General Discussion Of Derivative Instruments And Hedging Activities [Abstract]  
Scheudule of fair values of the Company''s derivative instruments, Level 2 measurements [Table Text Block]
Fair Value
Condensed Consolidated
June 30,
 
December 31,
Balance Sheet Location
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
Other non-current liabilities
$
3,356
$
4,672
$
3,356
$
4,672
June 30,
 
December 31,
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
2,584
$
3,598
$
2,584
$
3,598
Three Months Ended
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Amount and location of expense reclassified
from AOCI into expense (effective portion)
Interest expense, net
$
(659)
$
(483)
$
(1,302)
$
(465)
XML 65 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Basis of Presentation and Description of Business (Details)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2021
USD ($)
Countries
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
Segments
Countries
Jun. 30, 2020
USD ($)
Basis of Presentation and Description of Business [Abstract]        
Number Of Countries In Which Entity Operates | Countries 25   25  
Number Of Reportable Segments | Segments     4  
Subsidiaries [Member] | Argentina [Member]        
Currency conversion impacts of hyper-inflationary accounting | $ $ 0.1 $ 0.1 $ 0.3 $ 0.1
Assets Total [Member] | Subsidiaries [Member] | Argentina [Member] | Geographic Concentration Risk [Member]        
Concentration Risk, Percentage 1.00% 1.00% 1.00% 1.00%
Sales Revenue Net [Member] | Subsidiaries [Member] | Argentina [Member] | Geographic Concentration Risk [Member]        
Concentration Risk, Percentage 1.00% 1.00% 1.00% 1.00%
XML 66 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Business Acquisitions - Other Acquisitions - Narrative (Details)
€ in Millions, £ in Millions, kr in Millions, R in Millions
 1 Months Ended 3 Months Ended 6 Months Ended
Dec. 22, 2020
USD ($)
Feb. 28, 2021
EUR (€)
Feb. 28, 2021
USD ($)
May 31, 2020
DKK (kr)
May 31, 2020
USD ($)
Mar. 31, 2020
USD ($)
Mar. 31, 2020
ZAR (R)
Oct. 31, 2019
GBP (£)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
DKK (kr)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
GBP (£)
Jun. 30, 2021
EUR (€)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Business Acquisition [Line Items]                              
Payments related to acquisitions, net of cash acquired                           $ 29,424,000 $ 3,132,000
Goodwill, Acquired During Period                           $ 5,270,000  
Tin Plating Solutions [Member]                              
Business Acquisition [Line Items]                              
Intangible assets     $ 19,600,000                        
Payments related to acquisitions, net of cash acquired     25,000,000                        
Goodwill, Acquired During Period     5,000,000.0                        
Business Combination, Measurement Period                         1 year 1 year  
Tin Plating Solutions [Member] | Customer lists and rights to sell [Member]                              
Business Acquisition [Line Items]                              
Intangible assets     $ 18,300,000                        
Intangible Assets, Amortizable Life   19 years 19 years                        
Tin Plating Solutions [Member] | Licensed Trademark [Member]                              
Business Acquisition [Line Items]                              
Intangible assets     $ 400,000                        
Intangible Assets, Amortizable Life   3 years 3 years                        
Tin Plating Solutions [Member] | Product technology [Member]                              
Business Acquisition [Line Items]                              
Intangible assets     $ 900,000                        
Intangible Assets, Amortizable Life   14 years 14 years                        
Grindaix GmbH [Member]                              
Business Acquisition [Line Items]                              
Payments related to acquisitions, net of cash acquired   € 1.4 $ 1,700,000                        
Business Acquisition, Percentage of Voting Interests Acquired     38.00%                        
Coral Chemical Company (Coral) [Member]                              
Business Acquisition [Line Items]                              
Intangible assets $ 29,800,000                            
Payments related to acquisitions, net of cash acquired                 $ 54,100,000            
Cash Paid for Acquisitions 53,921,000                            
Total Assets Purchased 58,142,000                            
Business Combination, Measurement Period                         1 year 1 year  
Post Closing Adjustment $ (134,000)               $ 100,000            
Tel Nordic ApS[Member]                              
Business Acquisition [Line Items]                              
Intangible assets                     $ 2,400,000       $ 2,400,000
Intangible Assets, Amortizable Life                   17 years 17 years        
Payments related to acquisitions, net of cash acquired       kr 20.0 $ 2,900,000                    
Goodwill, Acquired During Period                     $ 500,000        
Business Combination, Measurement Period                         1 year 1 year  
Post Closing Adjustment                   kr 0.4 $ 100,000        
South Africa Equity Affiliate [Member]                              
Business Acquisition [Line Items]                              
Payments related to acquisitions, net of cash acquired           $ 1,000,000.0 R 16.7                
Business Acquisition, Percentage of Voting Interests Acquired           49.00% 49.00%         49.00%      
Adjustments To Additional Paid In Capital Other           $ 700,000                  
Norman Hay [Member]                              
Business Acquisition [Line Items]                              
Payments related to acquisitions, net of cash acquired | £               £ 80.0              
Post Closing Adjustment | £                       £ 2.5      
Chemical maskants product line [Member] | Global Specialty Businesses [Member]                              
Business Acquisition [Line Items]                              
Asset Acquisition, Consideration Transferred                         € 2.3 $ 2,800,000  
XML 67 R44.htm IDEA: XBRL DOCUMENT v3.21.2
Business Acquisitions - Preliminary Estimated Fair Values of Coral Net Assets Acquired (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 22, 2020
Jun. 30, 2021
Dec. 31, 2020
Business Acquisition [Line Items]      
Goodwill   $ 633,449 $ 631,212
Coral Chemical Company (Coral) [Member]      
Business Acquisition [Line Items]      
Cash and cash equivalents $ 958    
Accounts receivable, net 8,473    
Inventories, net 4,527    
Prepaid expenses and other assets 181    
Propery, plant & equipment 11,119    
Intangible assets 29,800    
Goodwill 3,084    
Total Assets Purchased 58,142    
Long-term debt included current portions 739    
Accounts payable, accrued expenses and other accrued liabilities 3,482    
Business Acquisition, Purchase Price Allocation, Liabilities Assumed 4,221    
Total fair value of consideration transferred 53,921    
Less: estimated purchase price settlement (134) $ 100  
Less: cash Acquired 958    
Net cash paid 53,097    
Coral Chemical Company (Coral) [Member] | As initially Reported [Member]      
Business Acquisition [Line Items]      
Cash and cash equivalents 958    
Accounts receivable, net 8,473    
Inventories, net 4,527    
Prepaid expenses and other assets 181    
Propery, plant & equipment 10,467    
Intangible assets 30,300    
Goodwill 2,814    
Total Assets Purchased 57,720    
Long-term debt included current portions 183    
Accounts payable, accrued expenses and other accrued liabilities 3,482    
Business Acquisition, Purchase Price Allocation, Liabilities Assumed 3,665    
Total fair value of consideration transferred 54,055    
Less: estimated purchase price settlement 0    
Less: cash Acquired 958    
Net cash paid 53,097    
Coral Chemical Company (Coral) [Member] | Measurement period adjustments [Member]      
Business Acquisition [Line Items]      
Cash and cash equivalents 0    
Accounts receivable, net 0    
Inventories, net 0    
Prepaid expenses and other assets 0    
Propery, plant & equipment 652    
Intangible assets (500)    
Goodwill 270    
Total Assets Purchased 422    
Long-term debt included current portions 556    
Accounts payable, accrued expenses and other accrued liabilities 0    
Business Acquisition, Purchase Price Allocation, Liabilities Assumed 556    
Total fair value of consideration transferred (134)    
Less: estimated purchase price settlement (134)    
Less: cash Acquired 0    
Net cash paid $ 0    
XML 68 R45.htm IDEA: XBRL DOCUMENT v3.21.2
Business Acquisitions - Coral - Narrative (Details)
 6 Months Ended
Jun. 30, 2021
Coral Chemical Company (Coral) [Member]  
Business Acquisition [Line Items]  
Measurement period 1 year
XML 69 R46.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments - Narrative (Details)
 6 Months Ended
Jun. 30, 2021
Segments
Business Segment Disclosures [Abstract]  
Number of reportable segments 4
XML 70 R47.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments - Performance of reportable segments (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2021
Jun. 30, 2020
Segment Reporting Information [Line Items]          
Net sales $ 435,262 $ 286,040   $ 865,045 $ 664,601
Combination and other acquisition-related expenses (6,658) (7,995)   (12,473) (15,873)
Restructuring charges (298) (486)   (1,473) (2,202)
Fair value step up of acquired inventory sold 0 (226)   (801) (226)
Indefinite-lived intangible asset impairment 0 0 $ (38,000) 0 (38,000)
Non-operating and administrative expenses (43,077) (32,045)   (84,069) (70,496)
Depreciation of corporate assets and amortization (15,640) (13,438)   (31,088) (27,485)
Operating income (loss) 38,816 2,238   83,710 (10,206)
Other income (expense), net 14,010 (993)   18,697 (22,168)
Interest Income Expense Net (5,618) (6,811)   (11,088) (15,272)
Income (loss) before taxes and equity in net income of associated companies 47,208 (5,566)   91,319 (47,646)
Americas [Member]          
Segment Reporting Information [Line Items]          
Net sales 185,856 112,870   365,983 286,997
EMEA [Member]          
Segment Reporting Information [Line Items]          
Net sales 145,114 93,271   285,200 214,715
Asia Pacific [Member]          
Segment Reporting Information [Line Items]          
Net sales 104,292 79,899   213,862 162,889
Operating Segments [Member]          
Segment Reporting Information [Line Items]          
Net sales 354,668 226,699   706,059 534,986
Segment operating earnings 104,489 56,428   213,614 144,076
Operating Segments [Member] | Global Specialty Businesses [Member]          
Segment Reporting Information [Line Items]          
Net sales 80,594 59,341   158,986 129,615
Segment operating earnings 24,209 16,393   48,378 36,953
Operating Segments [Member] | Americas [Member]          
Segment Reporting Information [Line Items]          
Net sales 139,673 80,576   274,544 210,472
Segment operating earnings 33,648 10,303   65,882 39,491
Operating Segments [Member] | Americas [Member] | Global Specialty Businesses [Member]          
Segment Reporting Information [Line Items]          
Net sales 46,183 32,294   91,439 76,525
Operating Segments [Member] | EMEA [Member]          
Segment Reporting Information [Line Items]          
Net sales 123,436 77,702   243,250 182,541
Segment operating earnings 23,405 10,471   48,649 28,830
Operating Segments [Member] | EMEA [Member] | Global Specialty Businesses [Member]          
Segment Reporting Information [Line Items]          
Net sales 21,678 15,569   41,950 32,174
Operating Segments [Member] | Asia Pacific [Member]          
Segment Reporting Information [Line Items]          
Net sales 91,559 68,421   188,265 141,973
Segment operating earnings 23,227 19,261   50,705 38,802
Operating Segments [Member] | Asia Pacific [Member] | Global Specialty Businesses [Member]          
Segment Reporting Information [Line Items]          
Net sales 12,733 11,478   25,597 20,916
Intersegment Elimination [Member] | Global Specialty Businesses [Member]          
Segment Reporting Information [Line Items]          
Net sales 2,100 1,000   4,100 2,300
Intersegment Elimination [Member] | Americas [Member]          
Segment Reporting Information [Line Items]          
Net sales 2,400 2,400   5,700 5,300
Intersegment Elimination [Member] | EMEA [Member]          
Segment Reporting Information [Line Items]          
Net sales 6,300 5,300   15,100 10,800
Intersegment Elimination [Member] | Asia Pacific [Member]          
Segment Reporting Information [Line Items]          
Net sales $ 400 $ 100   $ 500 $ 300
XML 71 R48.htm IDEA: XBRL DOCUMENT v3.21.2
Net Sales and Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Revenues [Abstract]          
Net Reporting Amount $ 16.7 $ 6.2 $ 34.5 $ 18.7  
Deferred Revenue $ 4.3   $ 4.3   $ 4.0
Customer Concentration Risk [Member] | Sales Revenue Net [Member] | Top Five Customers [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage         10.00%
Customer Concentration Risk [Member] | Sales Revenue Net [Member] | Largest customer [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage         3.00%
XML 72 R49.htm IDEA: XBRL DOCUMENT v3.21.2
Net Sales and Revenue Recognition (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Product Information [Line Items]        
Net sales $ 435,262 $ 286,040 $ 865,045 $ 664,601
Transferred At Point In Time [Member]        
Product Information [Line Items]        
Net sales 416,329 274,834 825,484 643,215
Transferred Over Time [Member]        
Product Information [Line Items]        
Net sales 18,933 11,206 39,561 21,386
Americas [Member]        
Product Information [Line Items]        
Net sales 185,856 112,870 365,983 286,997
Americas [Member] | Transferred At Point In Time [Member]        
Product Information [Line Items]        
Net sales 177,227 108,644 348,821 277,446
Americas [Member] | Transferred Over Time [Member]        
Product Information [Line Items]        
Net sales 8,629 4,226 17,162 9,551
EMEA [Member]        
Product Information [Line Items]        
Net sales 145,114 93,271 285,200 214,715
EMEA [Member] | Transferred At Point In Time [Member]        
Product Information [Line Items]        
Net sales 137,838 87,995 269,000 206,418
EMEA [Member] | Transferred Over Time [Member]        
Product Information [Line Items]        
Net sales 7,276 5,276 16,200 8,297
Asia Pacific [Member]        
Product Information [Line Items]        
Net sales 104,292 79,899 213,862 162,889
Asia Pacific [Member] | Transferred At Point In Time [Member]        
Product Information [Line Items]        
Net sales 101,264 78,195 207,663 159,351
Asia Pacific [Member] | Transferred Over Time [Member]        
Product Information [Line Items]        
Net sales 3,028 1,704 6,199 3,538
Operating Segments [Member]        
Product Information [Line Items]        
Net sales 354,668 226,699 706,059 534,986
Operating Segments [Member] | Metals [Member]        
Product Information [Line Items]        
Net sales 135,640 93,027 266,450 211,177
Operating Segments [Member] | Metalworking [Member]        
Product Information [Line Items]        
Net sales 219,028 133,672 439,609 323,809
Operating Segments [Member] | Global Specialty Businesses [Member]        
Product Information [Line Items]        
Net sales 80,594 59,341 158,986 129,615
Operating Segments [Member] | Americas [Member]        
Product Information [Line Items]        
Net sales 139,673 80,576 274,544 210,472
Operating Segments [Member] | Americas [Member] | Metals [Member]        
Product Information [Line Items]        
Net sales 51,799 32,687 98,592 79,360
Operating Segments [Member] | Americas [Member] | Metalworking [Member]        
Product Information [Line Items]        
Net sales 87,874 47,889 175,952 131,112
Operating Segments [Member] | Americas [Member] | Global Specialty Businesses [Member]        
Product Information [Line Items]        
Net sales 46,183 32,294 91,439 76,525
Operating Segments [Member] | EMEA [Member]        
Product Information [Line Items]        
Net sales 123,436 77,702 243,250 182,541
Operating Segments [Member] | EMEA [Member] | Metals [Member]        
Product Information [Line Items]        
Net sales 35,634 24,924 69,908 54,812
Operating Segments [Member] | EMEA [Member] | Metalworking [Member]        
Product Information [Line Items]        
Net sales 87,802 52,778 173,342 127,729
Operating Segments [Member] | EMEA [Member] | Global Specialty Businesses [Member]        
Product Information [Line Items]        
Net sales 21,678 15,569 41,950 32,174
Operating Segments [Member] | Asia Pacific [Member]        
Product Information [Line Items]        
Net sales 91,559 68,421 188,265 141,973
Operating Segments [Member] | Asia Pacific [Member] | Metals [Member]        
Product Information [Line Items]        
Net sales 48,207 35,416 97,950 77,005
Operating Segments [Member] | Asia Pacific [Member] | Metalworking [Member]        
Product Information [Line Items]        
Net sales 43,352 33,005 90,315 64,968
Operating Segments [Member] | Asia Pacific [Member] | Global Specialty Businesses [Member]        
Product Information [Line Items]        
Net sales $ 12,733 $ 11,478 $ 25,597 $ 20,916
XML 73 R50.htm IDEA: XBRL DOCUMENT v3.21.2
Leases - Narrative (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Lessee, Lease, Description [Line Items]        
Operating Lease Cost $ 3,600,000 $ 3,500,000 $ 7,200,000 $ 6,900,000
Short Term Lease Cost 200,000 400,000 500,000 900,000
Variable Lease Cost 0 0 0 0
Sublease Income $ 0 $ 0 0 0
Operating Lease Payments     7,100,000 $ 6,800,000
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability     $ 3,900,000  
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Total assets   Total assets  
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] Total liabilities   Total liabilities  
Land [Member] | Maximum [Member]        
Lessee, Lease, Description [Line Items]        
Lessee Operating Lease Term Of Contract 94 years   94 years  
Facilities vehicles and machinery and equipment [Member] | Maximum [Member]        
Lessee, Lease, Description [Line Items]        
Lessee Operating Lease Term Of Contract 10 years   10 years  
XML 74 R51.htm IDEA: XBRL DOCUMENT v3.21.2
Leases - Supplemental Balance Sheet Information (Details) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Lessee, Lease, Description [Abstract]    
Right of use lease assets $ 36,160 $ 38,507
Other current liabilities 10,064 10,901
Long-term lease liabilities 25,668 27,070
Total operating lease liabilities $ 35,732 $ 37,971
Weighted average remaining lease term (years) 5 years 9 months 18 days 6 years
Weighted average discount rate 426.00% 420.00%
XML 75 R52.htm IDEA: XBRL DOCUMENT v3.21.2
Leases - Maturities of Operating Lease Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Operating Lease Liabilities Payments Due [Abstract]    
For the remainder of 2021 $ 6,052  
For the year ended December 31, 2022 9,400  
For the year ended December 31, 2023 7,234  
For the year ended December 31, 2024 5,355  
For the year ended December 31, 2025 4,260  
For the year ended December 31, 2026 8,152  
Total lease payments 40,453  
Less: imputed interest (4,721)  
Present value of lease liabilities $ 35,732 $ 37,971
XML 76 R53.htm IDEA: XBRL DOCUMENT v3.21.2
Restructuring Activities - Narrative (Details)
 6 Months Ended
Jun. 30, 2021
People
Restructuring Cost and Reserve [Abstract]  
Restructuring And Related Cost Description The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain manufacturing and non-manufacturing facilities. The exact timing and total costs associated with the QH Program will depend on a number of factors and is subject to change; however, the Company currently expects reduction in headcount and site closures to continue to occur throughout 2021 and into 2022 under the QH Program and estimates that anticipated cost synergies realized from the QH Program will approximate one-times the restructuring costs incurred. Employee separation benefits will vary depending on local regulations within certain foreign countries and will include severance and other benefits.
Restructuring And Related Cost Expected Number Of Positions Eliminated 400
XML 77 R54.htm IDEA: XBRL DOCUMENT v3.21.2
Restructuring Activities (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Restructuring Reserve [Roll Forward]        
Restructuring and related charges $ 298 $ 486 $ 1,473 $ 2,202
QH Program [Member]        
Restructuring Reserve [Roll Forward]        
Accrued Restructuring, Beginning Balance     8,248  
Restructuring and related charges     1,473  
Cash Payments     (4,214)  
Currency Translation Adjustments     (229)  
Accrued Restructuring, Ending Balance $ 5,278   $ 5,278  
XML 78 R55.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation - Narrative (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Share Based Compensation [Line Items]        
Share-based Compensation Expense $ 2,355,000 $ 2,991,000 $ 6,134,000 $ 7,673,000
Option Award Vesting Period     3 years  
Risk-free Interest Rate     0.60%  
Expected Term (Years)     4 years  
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross     25,250  
Employee Stock Option [Member]        
Share Based Compensation [Line Items]        
Unrecognized Compensation Expense, Options 2,400,000   $ 2,400,000  
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1     2 years 3 months 18 days  
Restricted Stock LTIP [Member]        
Share Based Compensation [Line Items]        
Option Award Vesting Period     3 years  
Nonvested Stock Awards Granted     17,692  
Unrecognized Share-based Compensation Expense, Nonvested Stock Award 6,300,000   $ 6,300,000  
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1     1 year 10 months 24 days  
Annual Incentive Plan [Member]        
Share Based Compensation [Line Items]        
Share-based Compensation Expense 0 (117,000) $ 0 2,829,000
Restricted Stock Units (RSUs) LTIP Plan [Member]        
Share Based Compensation [Line Items]        
Nonvested Stock Awards Granted     2,791  
Unrecognized Share-based Compensation Expense, Nonvested Stock Award 1,100,000   $ 1,100,000  
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1     2 years 1 month 6 days  
Combination And Other Acquisition-Related [Member]        
Share Based Compensation [Line Items]        
Share-based Compensation Expense 200,000 300,000 $ 500,000 800,000
Performance Stock Units [Member]        
Share Based Compensation [Line Items]        
Share-based Compensation Expense 517,000 280,000 $ 836,000 280,000
Option Award Vesting Period     3 years  
Vesting Shares Target Lower Percent     0.00%  
Vesting Shares Target Upper Percent     200.00%  
Risk-free Interest Rate     0.29%  
Expected Term (Years)     3 years  
Unrecognized Share-based Compensation Expense, Nonvested Stock Award 4,200,000   $ 4,200,000  
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1     2 years 3 months 18 days  
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross     14,698  
Defined Contribution Plan [Member]        
Share Based Compensation [Line Items]        
Defined Contribution Plan Employer Matching Contribution Percent Of Match     50.00%  
Defined Contribution Plan, Employer Matching Contribution, Percent     6.00%  
Defined contribution plan employer matching contribution percent maximum     3.00%  
Defined contribution plan employer non-elective nondiscretionary contributions percent     3.00%  
Defined Contribution Plan Employer Discretionary Contribution Amount $ 0 $ 1,200,000 $ 1,500,000 $ 1,200,000
XML 79 R56.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation - Expense Table (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense $ 2,355 $ 2,991 $ 6,134 $ 7,673
Stock Options [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense 332 353 640 785
Non-vested stock awards and restricted stock units [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense 1,290 1,259 2,686 2,523
Non-elective and elective 401(k) matching contribution in stock [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense 0 1,162 1,553 1,162
Director stock ownership plan [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense 216 54 419 94
Performance Stock Units [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense 517 280 836 280
Annual Incentive Plan [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense $ 0 $ (117) $ 0 $ 2,829
XML 80 R57.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation - Black-Scholes option pricing model (Details)
 6 Months Ended
Jun. 30, 2021
shares
Share-Based Compensation Arrangement By Share-Based Payment Award Fair Value Assumptions And Methodology [Abstract]  
Options Granted 25,250
Dividend Yield 0.85%
Expected Volatility 37.33%
Risk-free Interest Rate 0.60%
Expected Term (Years) 4 years
XML 81 R58.htm IDEA: XBRL DOCUMENT v3.21.2
Pension and Other Postretirement Benefits - Net Periodic Benefit Cost and Changes in Other Comprehensive Income (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Pension Plans, Defined Benefit [Member]        
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]        
Service Cost $ 316 $ 1,164 $ 632 $ 2,338
Interest Cost 1,094 1,486 2,184 3,255
Expected Return on Plan Assets (2,093) (1,761) (4,175) (3,720)
Settlement Loss 0 0 0 22,667
Actuarial Loss Amortization 857 615 1,712 1,662
Prior Service (Credit) Cost Amortization 3 (41) 5 (81)
Net Periodic Benefit Cost 177 1,463 358 26,121
Other Postretirement Benefit Plans Defined Benefit [Member]        
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]        
Service Cost 2 1 3 3
Interest Cost 10 26 21 52
Expected Return on Plan Assets 0 0 0 0
Settlement Loss 0 0 0 0
Actuarial Loss Amortization 0 16 0 31
Prior Service (Credit) Cost Amortization 0 0 0 0
Net Periodic Benefit Cost $ 12 $ 43 $ 24 $ 86
XML 82 R59.htm IDEA: XBRL DOCUMENT v3.21.2
Pension and Other Postretirement Benefits - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Sep. 30, 2020
Jun. 30, 2021
Pension Plans, Defined Benefit [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Defined Benefit Plan, Contributions by Employer   $ 2.1
Defined Benefit Plan Effect Of Settlements And Curtailments On Accumulated Benefit Obligation $ 22.7  
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year   6.0
Other Postretirement Benefit Plans Defined Benefit [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Defined Benefit Plan, Contributions by Employer   0.1
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year   $ 1.0
Defined benefit plan settlement [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Defined Benefit Plan, Contributions by Employer $ 1.8  
XML 83 R60.htm IDEA: XBRL DOCUMENT v3.21.2
Other Income (Expense) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Other Income and Expenses [Abstract]        
Income from third party license fees $ 373 $ 208 $ 712 $ 512
Foreign exchange gains (losses), net (838) (2,004) (2,316) (1,183)
Gain (loss) on fixed asset disposals, net (54) (83) 5,356 (81)
Non-income tax refunds and other related credits 14,295 832 14,392 2,131
Pension and post retirement benefit costs, non-service components 129 (341) 253 (23,866)
Other Operating Income Expense Net 105 395 300 319
Total other income (expense), net $ 14,010 $ (993) 18,697 (22,168)
Narrative [Abstract]        
Pension Settlement Charge       $ 22,700
Certain indirect tax credits     $ 13,300  
XML 84 R61.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Defered Tax Liabilties, Net $ 6.5   $ 6.5   $ 5.9
Unrecognized Tax Benefits 24.0   24.0    
Unrecognized Tax Benefits, Income Tax Penalties Accrued 3.6   3.6   3.9
Unrecognized Tax Benefits, Interest on Income Taxes Accrued 3.2   3.2   $ 3.0
Unrecognized Tax Benefits, Income Tax Penalties Expense (0.1) $ 0.6 0.2 $ 0.5  
Unrecognized Tax Benefits, Interest on Income Taxes Expense $ 0.2 $ 0.6 0.2 0.6  
Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations     $ 0.8 $ 1.5  
XML 85 R62.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes - Uncertain Tax Positions - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Uncertain Tax Positions [Abstract]            
Effective Income Tax Rate, Continuing Operations 32.20% 57.90% 28.40% (20.70%)    
Unrecognized Tax Benefits, Interest on Income Taxes Expense $ 0.2 $ 0.6 $ 0.2 $ 0.6    
Accrued Interest 3.2   3.2     $ 3.0
Accrued Penalties 3.6   3.6     3.9
Unrecognized Tax Benefits, Income Tax Penalties Expense (0.1) $ 0.6 0.2 0.5    
Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations     0.8 $ 1.5    
Unrecognized Tax Benefits 24.0   24.0      
Income Tax Examination [Line Items]            
Deferred Tax Liabilities 6.5   6.5     $ 5.9
Unrecognized Tax Benefits Period Increase     $ 1.8      
Forecast [Member]            
Income Tax Examination [Line Items]            
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound         $ 1.5  
Italy [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination Description     As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except 2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP proceedings which the Company has accepted.      
Germany [Member]            
Income Tax Examination [Line Items]            
Unrecognized Tax Benefits Reserve 0.9   $ 0.9      
Liability For Uncertain Tax Positions Noncurrent 0.8   0.8      
Germany [Member] | Houghton [Member]            
Income Tax Examination [Line Items]            
Indemnification assets 0.8   $ 0.8      
Internal Revenue Service (IRS) [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2017      
Foreign Tax Authority [Member] | The Netherlands [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2015      
Foreign Tax Authority [Member] | United Kingdom [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2016      
Foreign Tax Authority [Member] | Brazil [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2011      
Foreign Tax Authority [Member] | China [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2015      
Foreign Tax Authority [Member] | Italy [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2006      
Income Tax Examination Liability Refund Adjustment from Settlement with Taxing Authority 2.6   $ 2.6      
Foreign Tax Authority [Member] | Italy [Member] | Maximum [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2015      
Foreign Tax Authority [Member] | Italy [Member] | Minimum [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2007      
Foreign Tax Authority [Member] | Italy [Member] | Houghton [Member]            
Income Tax Examination [Line Items]            
Unrecognized Tax Benefits Reserve 5.6   $ 5.6      
Indemnification assets 5.6   $ 5.6      
Foreign Tax Authority [Member] | Italy [Member] | Houghton [Member] | Maximum [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2018      
Foreign Tax Authority [Member] | Italy [Member] | Houghton [Member] | Minimum [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2014      
Foreign Tax Authority [Member] | Mexico [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2016      
Foreign Tax Authority [Member] | India [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2019      
Foreign Tax Authority [Member] | Germany [Member] | Houghton [Member] | Maximum [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2017      
Foreign Tax Authority [Member] | Germany [Member] | Houghton [Member] | Minimum [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2015      
Foreign Tax Authority [Member] | Netherlands and Spain [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination Liability Refund Adjustment from Settlement with Taxing Authority $ (1.6)   $ (1.6)      
State and Local Jurisdiction [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2011      
State and Local Jurisdiction [Member] | Canada [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2017      
XML 86 R63.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share - Basic (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Earnings Per Share [Abstract]        
Net income (loss) attributable to Quaker Chemical Corporation $ 33,570 $ (7,735) $ 72,185 $ (36,116)
Less: Income Allocated to Participating Securities (134) 37 (287) 146
Net income (loss) available to common shareholders $ 33,436 $ (7,698) $ 71,898 $ (35,970)
Basic weighted average common shares outstanding 17,802,366 17,697,496 17,793,915 17,685,010
Basic earnings per common share $ 1.88 $ (0.43) $ 4.04 $ (2.03)
XML 87 R64.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share - Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Earnings Per Share [Abstract]        
Net income (loss) attributable to Quaker Chemical Corporation $ 33,570 $ (7,735) $ 72,185 $ (36,116)
Less: income allocated to participating securities (134) 37 (287) 146
Net income (loss) available to common shareholders $ 33,436 $ (7,698) $ 71,898 $ (35,970)
Basic weighted average common shares outstanding 17,802,366 17,697,496 17,793,915 17,685,010
Effect of Dilutive Securities 47,155 0 52,095 0
Diluted weighted average common shares outstanding 17,849,521 17,697,496 17,846,010 17,685,010
Diluted earnings per common share $ 1.88 $ (0.43) $ 4.03 $ (2.03)
XML 88 R65.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share - Antidilutive Shares (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Business Acquisition [Line Items]    
Antidilutive Shares 6,793 2,952
XML 89 R66.htm IDEA: XBRL DOCUMENT v3.21.2
Restricted Cash (Details) - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]        
Cash and cash equivalents $ 145,610 $ 322,497 $ 181,833 $ 123,524
Restricted cash included in other current assets 0 85 62 353
Restricted cash included in other assets 0 19,173 0 19,678
Cash cash equivalents restricted cash and restricted cash equivalents $ 145,610 341,755 181,895 $ 143,555
Loss Contingency, Settlement Agreement, Terms Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an original total value of $35.0 million.      
Proceeds Of Settlement And Release Agreements     $ 35,000  
Payments Of Settlement and Release Agreements   500    
Interest Income Other   $ 100    
XML 90 R67.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill and Other Intangible Assets - Goodwill Assets (Details)
$ in Thousands
 6 Months Ended
Jun. 30, 2021
USD ($)
Goodwill Roll Forward  
Goodwill, Beginning Balance $ 631,212
Goodwill Additions 5,270
Goodwill, Translation Adjustments (3,033)
Goodwill, Ending Balance 633,449
Operating Segments [Member] | Global Specialty Businesses [Member]  
Goodwill Roll Forward  
Goodwill, Beginning Balance 119,718
Goodwill Additions 128
Goodwill, Translation Adjustments (2,141)
Goodwill, Ending Balance 117,705
Operating Segments [Member] | Americas [Member]  
Goodwill Roll Forward  
Goodwill, Beginning Balance 213,242
Goodwill Additions 1,208
Goodwill, Translation Adjustments 614
Goodwill, Ending Balance 215,064
Operating Segments [Member] | EMEA [Member]  
Goodwill Roll Forward  
Goodwill, Beginning Balance 140,162
Goodwill Additions 2,626
Goodwill, Translation Adjustments (2,633)
Goodwill, Ending Balance 140,155
Operating Segments [Member] | Asia Pacific [Member]  
Goodwill Roll Forward  
Goodwill, Beginning Balance 158,090
Goodwill Additions 1,308
Goodwill, Translation Adjustments 1,127
Goodwill, Ending Balance $ 160,525
XML 91 R68.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill and Other Intangible Assets - Intangible Assets (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Finite Lived Intangible Assets Gross [Abstract]          
Finite Lived Customer Lists, Gross $ 858,025   $ 858,025   $ 839,551
Other Finite Lived Intangible Assets, Gross 6,390   6,390   6,372
Amortization 15,000 $ 13,700 29,800 $ 27,700  
Finite-Lived Intangible Assets [Line Items]          
Finite Lived Intangible Assets Accumulated Amortization 168,724   168,724   136,113
Total 1,032,419   1,032,419   1,012,371
Customer lists and rights to sell [Member]          
Finite-Lived Intangible Assets [Line Items]          
Finite Lived Intangible Assets Accumulated Amortization 127,883   127,883   99,806
Trademarks Formulations And Product Technology [Member]          
Finite-Lived Intangible Assets [Line Items]          
Finite Lived Intangible Assets Accumulated Amortization 34,932   34,932   30,483
Total 168,004   168,004   166,448
Other Intangible Assets [Member]          
Finite-Lived Intangible Assets [Line Items]          
Finite Lived Intangible Assets Accumulated Amortization $ 5,909   $ 5,909   $ 5,824
XML 92 R69.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)
$ in Thousands
Jun. 30, 2021
USD ($)
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]  
For the year ended December 31, 2021 $ 59,214
For the Year ended December 31, 2022 59,564
For the Year ended December 31, 2023 59,394
For the Year ended December 31, 2024 58,750
For the Year ended December 31, 2025 58,037
For the Year ended December 31, 2026 $ 57,740
XML 93 R70.htm IDEA: XBRL DOCUMENT v3.21.2
Intangible Assets - Indefinite Lived (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]              
Indefinite lived intangible assets $ 205,100       $ 205,100   $ 205,100
Indefinite-lived intangible asset impairment 0   $ 0 $ 38,000 0 $ 38,000  
Houghton Combination [Member]              
Finite-Lived Intangible Assets [Line Items]              
Indefinite Lived Trademarks $ 204,000       $ 204,000   $ 204,000
Indefinite-lived intangible asset impairment   $ 38,000          
XML 94 R71.htm IDEA: XBRL DOCUMENT v3.21.2
Debt - Table (Details) - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Debt Instrument [Line Items]    
Total debt $ 904,783 $ 899,134
Less: debt issuance costs (9,550) (11,099)
Less: short-term and current portion of long-term debts (48,079) (38,967)
Total long-term debt $ 847,154 $ 849,068
Revolver [Member]    
Debt Instrument [Line Items]    
Debt Instrument Interest Rate Stated Percentage 159.00% 165.00%
Total debt $ 189,503 $ 160,000
U.S. Term Loan [Member]    
Debt Instrument [Line Items]    
Debt Instrument Interest Rate Stated Percentage 159.00% 165.00%
Total debt $ 555,000 $ 570,000
EURO Term Loan [Member]    
Debt Instrument [Line Items]    
Debt Instrument Interest Rate Stated Percentage 150.00% 150.00%
Total debt $ 148,115 $ 157,062
Industrial development bonds [Member]    
Debt Instrument [Line Items]    
Debt Instrument Interest Rate Stated Percentage 526.00% 526.00%
Total debt $ 10,000 $ 10,000
Bank lines of credit and other debt obligations [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Interest Rate Terms Various Various
Total debt $ 2,165 $ 2,072
XML 95 R72.htm IDEA: XBRL DOCUMENT v3.21.2
Debt - Debt related expenses included within Interest expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Debt related expenses included within Interest expense:        
Interest Expense, Debt $ 4,813 $ 5,951 $ 9,463 $ 13,663
Amortization of debt issuance costs 1,188 1,188 2,375 2,375
Total $ 6,001 $ 7,139 $ 11,838 $ 16,038
XML 96 R73.htm IDEA: XBRL DOCUMENT v3.21.2
Debt - Narrative (Details) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Nov. 30, 2019
Debt Instrument [Line Items]      
Letters Of Credit Outstanding Amount $ 4.0    
Initial consolidated net debt to consolidated EBITDA ratio 4.25    
Consolidated adjusted EBITDA to interest expense ratio 3.0    
Maximum annual cash dividends restriction based on covenants $ 50.0    
Percentage of cash dividends of consolidated adjusted EBITDA 20.00%    
Debt Issuance Costs, Current, Net $ 9.6 $ 11.1  
Deferred Finance Costs Noncurrent Gross 23.7    
Line of Credit Facility, Remaining Borrowing Capacity $ 300.0    
Line of Credit Facility, Covenant Compliance As of June 30, 2021 and December 31, 2020, the Company was in compliance with all of the Credit Facility covenants.    
Line of Credit Facility, Covenant Terms The Credit Facility is subject to certain financial and other covenants. The Company’s initial consolidated net debt to consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit Facility.    
Other off balance sheet arrangements In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s only other off-balance sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees outstanding as of June 30, 2021 were approximately $7 million.    
Other Assets [Member]      
Debt Instrument [Line Items]      
Debt Issuance Costs, Current, Net $ 5.1 5.9  
Maximum [Member]      
Debt Instrument [Line Items]      
Net debt to consolidated adjusted EBITDA ratio 4.00    
Minimum [Member]      
Debt Instrument [Line Items]      
Net debt to consolidated adjusted EBITDA ratio 2.0    
Interest Rate Swap [Member]      
Debt Instrument [Line Items]      
Derivative Liability Notional Amount     $ 170.0
New Credit facility [Member]      
Debt Instrument [Line Items]      
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate 1.60%    
U.S. Term Loan [Member]      
Debt Instrument [Line Items]      
Line of Credit Facility, Current Borrowing Capacity $ 600.0    
EURO Term Loan [Member]      
Debt Instrument [Line Items]      
Line of Credit Facility, Current Borrowing Capacity $ 150.0    
Term loan [Member]      
Debt Instrument [Line Items]      
Percentage of term loan principal amortization year one and two 5.00%    
Percentage of term loan principal amortization year three 7.50%    
Percentage of term loan principal amortization year four and five 10.00%    
Percentage of term loan borrowings 20.00%    
Derivative Liability Notional Amount     $ 170.0
Derivative Fixed Interest Rate 3.10%    
Derivative, Basis Spread on Variable Rate     1.64%
Payments of long-term debt $ 19.1    
Deferred Finance Costs Noncurrent Gross $ 15.5    
Long Term Debt Term 5 years    
The Revolver [Member]      
Debt Instrument [Line Items]      
Debt Instrument, Unused Borrowing Capacity, Amount $ 206.0    
Deferred Finance Costs Noncurrent Gross 8.3    
Line of Credit Facility, Current Borrowing Capacity $ 400.0    
Long Term Debt Term 5 years    
The Revolver [Member] | Maximum [Member]      
Debt Instrument [Line Items]      
Line of Credit Facility, Commitment Fee Percentage 0.30%    
The Revolver [Member] | Minimum [Member]      
Debt Instrument [Line Items]      
Line of Credit Facility, Commitment Fee Percentage 0.20%    
Industrial Development Bond Due 2028 [Member]      
Debt Instrument [Line Items]      
Debt Instrument Maturity Date Description 2028    
Industrial Development Revenue Bond $ 10.0 $ 10.0  
Bank lines of credit and other debt obligations [Member]      
Debt Instrument [Line Items]      
Letters Of Credit Outstanding Amount 7.0    
Line of Credit Facility, Remaining Borrowing Capacity $ 40.0    
XML 97 R74.htm IDEA: XBRL DOCUMENT v3.21.2
Equity and Noncontrolling Interest - Changes in Equity (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Beginning Balance $ 1,329,453 $ 1,162,032 $ 1,320,914 $ 1,242,366
Net income (loss) 33,600 (7,722) 72,232 (36,066)
Amounts reported in other comprehensive income (loss) 17,293 12,261 (9,339) (31,225)
Dividends (7,062) (6,853) (14,124) (13,687)
Acquisition of noncontrolling interest       (1,047)
Distributions to noncontrolling affiliate shareholders       (751)
Share issuance and equity-based compensation plans 2,117 7,623 5,718 8,662
Ending Balance 1,375,401 1,167,341 1,375,401 1,167,341
Cumulative Effect, Period of Adoption, Adjustment [Member]        
Beginning Balance       (911)
Adjusted Balance [Member]        
Beginning Balance       1,241,455
Common Stock [Member]        
Beginning Balance 17,875 17,752 17,851 17,735
Net income (loss) 0 0 0 0
Amounts reported in other comprehensive income (loss) 0 0 0 0
Dividends 0 0 0 0
Acquisition of noncontrolling interest       0
Distributions to noncontrolling affiliate shareholders       0
Share issuance and equity-based compensation plans 3 48 27 65
Ending Balance 17,878 17,800 17,878 17,800
Common Stock [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]        
Beginning Balance       0
Common Stock [Member] | Adjusted Balance [Member]        
Beginning Balance       17,735
Capital in Excess of Par Value [Member]        
Beginning Balance 908,748 888,533 905,171 888,218
Net income (loss) 0 0 0 0
Amounts reported in other comprehensive income (loss) 0 0 0 0
Dividends 0 0 0 0
Acquisition of noncontrolling interest       (707)
Distributions to noncontrolling affiliate shareholders       0
Share issuance and equity-based compensation plans 2,114 7,575 5,691 8,597
Ending Balance 910,862 896,108 910,862 896,108
Capital in Excess of Par Value [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]        
Beginning Balance       0
Capital in Excess of Par Value [Member] | Adjusted Balance [Member]        
Beginning Balance       888,218
Retained Earnings [Member]        
Beginning Balance 455,493 376,853 423,940 412,979
Net income (loss) 33,570 (7,735) 72,185 (36,116)
Amounts reported in other comprehensive income (loss) 0 0 0 0
Dividends (7,062) (6,853) (14,124) (13,687)
Acquisition of noncontrolling interest       0
Distributions to noncontrolling affiliate shareholders       0
Share issuance and equity-based compensation plans 0 0 0 0
Ending Balance 482,001 362,265 482,001 362,265
Retained Earnings [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]        
Beginning Balance       (911)
Retained Earnings [Member] | Adjusted Balance [Member]        
Beginning Balance       412,068
Accumulated Other Comprehensive Income (Loss) [Member]        
Beginning Balance (53,228) (121,524) (26,598) (78,170)
Net income (loss) 0 0 0 0
Amounts reported in other comprehensive income (loss) 17,285 12,260 (9,345) (31,094)
Dividends 0 0 0 0
Acquisition of noncontrolling interest       0
Distributions to noncontrolling affiliate shareholders       0
Share issuance and equity-based compensation plans 0 0 0 0
Ending Balance (35,943) (109,264) (35,943) (109,264)
Accumulated Other Comprehensive Income (Loss) [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]        
Beginning Balance       0
Accumulated Other Comprehensive Income (Loss) [Member] | Adjusted Balance [Member]        
Beginning Balance       (78,170)
Noncontrolling Interest [Member]        
Beginning Balance 565 418 550 1,604
Net income (loss) 30 13 47 50
Amounts reported in other comprehensive income (loss) 8 1 6 (131)
Dividends 0 0 0 0
Acquisition of noncontrolling interest       (340)
Distributions to noncontrolling affiliate shareholders       (751)
Share issuance and equity-based compensation plans 0 0 0 0
Ending Balance $ 603 $ 432 $ 603 432
Noncontrolling Interest [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]        
Beginning Balance       0
Noncontrolling Interest [Member] | Adjusted Balance [Member]        
Beginning Balance       $ 1,604
XML 98 R75.htm IDEA: XBRL DOCUMENT v3.21.2
Equity and Noncontrolling Interest - Changes in Equity (Parentheticals) (Details) - $ / shares
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Consolidated Statement Of Changes In Equity Parentheticals [Abstract]        
Dividends declared $ 0.395 $ 0.385 $ 0.790 $ 0.770
XML 99 R76.htm IDEA: XBRL DOCUMENT v3.21.2
Equity and Noncontrolling Interest - AOCI Reclassifications (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance $ (53,228) $ (121,524) $ (26,598) $ (78,170)
Other Comprehensive (Loss) Income, before Reclassifications, before Tax 16,824 12,198 (7,869) (48,900)
Amounts Reclassed from AOCI 854 507 (1,369) 24,841
Related Tax Amounts (393) (445) (107) (7,035)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance (35,943) (109,264) (35,943) (109,264)
Accumulated Translation Adjustment [Member]        
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance (28,334) (99,187) (2,875) (44,568)
Other Comprehensive (Loss) Income, before Reclassifications, before Tax 16,157 10,550 (9,302) (44,069)
Amounts Reclassed from AOCI 0 0 0 0
Related Tax Amounts 0 0 0 0
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance (12,177) (88,637) (12,177) (88,637)
Accumulated Defined Benefit Plans Adjustment [Member]        
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance (22,175) (17,576) (23,467) (34,533)
Other Comprehensive (Loss) Income, before Reclassifications, before Tax (260) (336) 521 492
Amounts Reclassed from AOCI 852 600 1,714 24,966
Related Tax Amounts (195) (51) (546) (8,288)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance (21,778) (17,363) (21,778) (17,363)
Accumulated Net Unrealized Investment Gain (Loss) [Member]        
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance 317 (460) 3,342 1,251
Other Comprehensive (Loss) Income, before Reclassifications, before Tax 341 2,128 (404) (8)
Amounts Reclassed from AOCI 2 (93) (3,083) (125)
Related Tax Amounts (64) (427) 741 30
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance 596 1,148 596 1,148
Derivative Instruments        
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance (3,036) (4,301) (3,598) (320)
Other Comprehensive (Loss) Income, before Reclassifications, before Tax 586 (144) 1,316 (5,315)
Amounts Reclassed from AOCI 0 0 0 0
Related Tax Amounts (134) 33 (302) 1,223
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance $ (2,584) $ (4,412) $ (2,584) $ (4,412)
XML 100 R77.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value - Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance $ 2,137 $ 1,961
Assets Fair Value Disclosure 2,137 1,961
Level 1 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance 0 0
Assets Fair Value Disclosure 0 0
Level 2 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance 2,137 1,961
Assets Fair Value Disclosure 2,137 1,961
Level 3 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance 0 0
Assets Fair Value Disclosure $ 0 $ 0
XML 101 R78.htm IDEA: XBRL DOCUMENT v3.21.2
Hedging Activities - Narrative (Details) - Interest Rate Swap [Member] - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2021
Nov. 30, 2019
Derivatives, Fair Value [Line Items]    
Derivative Liability Notional Amount   $ 170
Derivative, Term of Contract 3 years  
XML 102 R79.htm IDEA: XBRL DOCUMENT v3.21.2
Hedging Activities - Table (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Derivative Instruments Gain Loss [Line Items]          
Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net     $ 2,584,000   $ 3,598,000
Interest Rate Cash Flow Hedge Liability At Fair Value $ 3,356,000   3,356,000   4,672,000
Interest Expense [Member]          
Derivative Instruments Gain Loss [Line Items]          
Derivative Instruments Gain Loss Reclassified From Accumulated OCI Into Income Effective Portion Net (659,000) $ (483,000) (1,302,000) $ (465,000)  
Other Noncurrent Liabilities [Member]          
Derivative Instruments Gain Loss [Line Items]          
Interest Rate Cash Flow Hedge Liability At Fair Value $ 3,356,000   $ 3,356,000   $ 4,672,000
XML 103 R80.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Narrative (Details)
$ in Thousands, R$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2021
BRL (R$)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Loss Contingencies [Line Items]            
Loss Contingency Accrual At Carrying Value $ 100     $ 100   $ 100
Interest Income Other         $ 100  
Income Tax Expense (Benefit) 15,218 $ 3,222   25,907 $ (9,848)  
ACP [Member] | Maximum [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss 1,000     1,000    
ACP [Member] | Minimum [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss 100     100    
SB Decking [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss 400     400    
Houghton Combination [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss 6,000     6,000   $ 6,000
Houghton environmental matters [Member] | Maximum [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss 6,500     6,500    
Houghton environmental matters [Member] | Minimum [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss 5,500     5,500    
Foreign Consumption Tax [Member]            
Loss Contingencies [Line Items]            
Loss Contingency Accrual At Carrying Value 1,800     1,800    
Other Assets Miscellaneous Current 1,100     1,100    
Income Tax Reconciliation Tax Settlements Foreign       11,000    
Foreign Consumption Tax [Member] | Houghton [Member]            
Loss Contingencies [Line Items]            
Indemnification assets 22,000     22,000    
Foreign Consumption Tax [Member] | Maximum [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss 40,000     40,000    
Foreign Consumption Tax [Member] | Minimum [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss $ 0     0    
Brazilian Indirect Taxes [Member]            
Loss Contingencies [Line Items]            
Gain (Loss) Related To Litigation Settlement     R$ 67 13,300    
Interest Income Other       4,900    
Income Tax Expense (Benefit)       $ (8,400)    
EXCEL 104 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�AD(G>P12BAB@-06&^^08)^(!GB M0T5\>* 6 6@M[Q5*45EA'8Y45F_0,"B>!!)R(@$']I )]F)>,G_EAA[ MJ!9T$&&"65WX#EJ,EFM--:(2@:5?+4#H\S6"F;&2]P>:&_"96+NNJGN\@2TY M9:F.4=$,F8X<5B.!,_[]0U E+Z0)5"\ ,Q"+AN *S8&3P[U#1 2--H9;&6H& M]R5WP1I"CS//L;Q5A6K6%&P(*H0]2T_9AZUFGUOT7#%21/G 9=(!!J\C=3:> M RDU;POU#P[ M/=1Y\WX^8UVF73H<-(IS5$_3^L$@B%U,D\!H+"*)<#)N)V1&NY(0T[C;.[?& M4D!BCP=U G>L,@"F/5RARMX7288 \I37AGWILXP)QZ=PPOER$MN./4G!)6J M%:IN3# ^T=F^ 2#*[0Z>:]FNXW8[4*B'L!FX"L,],6I03T*06T+9=9C2:!9L M%N)X*?*%4JEJY5XV_$TX)&L?8C3\0,HTLAQ=EREGKJI M'G2J/:,JVM&,U U1A<>M+Z=T0 31AZF2C[/7$T3'X< C&RU%+1LI9KIA-YD< M'$U=5!9B5[1L4+T8U>-);1A5BZDQ5C02"T8$FF8S%'.V7W3&Y8T:EUXQ",,N MC.W0D?,C*=S07+6V9^ TQ]?#)@R?*+$.TXU[['Y8 $C1#\3\D1=V3]G">D$4 MC0>77867=9'3H,A?9\SI3=KDTB#G;N+2&2:M0>JH%AS-?Y[)!1$4[R/L%/%\ M&+KU\O9R/HZP/JX&)!I'B8\5)O9[[$B_%M'&HVGYD\%99 1[!8[I?E+L9PP< MQC($5#>[1UL(\;'T:2*E\;M?Y7M*;:25E>+7H*=4@PH"=[+G;8=7/HDZFNRD MV:%7[L7D(P<"K_A33DAK3/K>,3X=OQ9=IH\D>_'TJ>F=]!5F,'IG@Z/+[-7) M+/'3A+ [QN'6=3?D('Q&]K%?U!+ P04 " "J M0@533 CJ"7,' "S$P &0 'AL+W=OC#8IE6\GDYAMJ-!Q M[$MR6%GY4.B$Q[">Q#*0SN5082?SZ?1D4FCC1I?G\NXF7)[[*EGCZ":H6!6% M#OLKLGYW,9J-#B\^FO4F\8O)Y7FIUW1+Z9?R)N!ITDK)34$N&N]4H-7%:#%[ M>S6;\@'9\5]#N]C[K=B5I?>?^>%]?C&:LD5D*4LL0N//EJ[)6I8$.[XT0D>M M3C[8_WV0_DZG:VT\F3YN+T>E(Y;32E4T?_>[OU#CTBN5EWD;YO]K5 M>T_>C%16Q>2+YC L*(RK_^J[!HC>@=/I-P[,FP-SL;M6)%9^KY.^/ ]^IP+O MAC3^(:[*:1AG'$?E-@6L&IQ+EU8A9,*<]8OZHB MCL:HGMUX:S)#\?GY),$"EC/)&FU7M;;Y-[2=J)^\2YNH?G YY??/3V!Y:_[\ M8/[5?%#@/RHW5L?3(S6?SF<#\HY;.(Y%WO'_#8Y?%\N8 I+KMP'U+UOU+T7] MRT'U_UZI19;YRB7CUDK@WJM?F[\_TUU25]9GGW][#/^GR'_HWB*J*E*NC%-I M@_?J7SY15,FK:X\X.5[#KP@#-D8^'ZLED8,$*G6HG=8 .^3: M983B2QNU)D=!6[OG%2K9'^SV0<+!N< :?G&&%VZ!(;"ZI:P*)L%AV?##7;;1 M;BT&%R8*A>4F9M;'"MXJQX3""HS+;)779JQ@J0-^5D46"NI+L;.SK$*LM$OL M9*RRC0J5;;0%6E=6G 2.CC+ #8)5H&REU4J;T GDV+/UG:[21\-'CU0T=ZJH MRY.X/!6*B]KB4K "=J=6@1'SNSR%JFZEDO>O*"N5?-IB_^V09PH,Y>M77V:K .;FE=F_K$JAJ4QHWS M;2QU1A>CDNLJ;&ET^?,C'J*7!BU99% (P0%^]%/4R1^Z#@$[7U#:>*"W5[N- M09QSRHPD4"$%@2(C_N]1"%>^"BAGHR(=&"9>*!LPT^4(*!3Z@( Q[O M;MI _E7^!!ZJ&#!(BT"Y3CJU :TXCXI %3&)W;<_BG.!*0Q[&:.NCRVZO=;H MI;$&E6!B!T>.LB-WK]O9E?::\.,)-OX*Y Z=E^-C_)NV.K0, M"P_Z@ Q#&15+L-'Q3-YBK6DL?ZK^T+):N \BAGC]=^"+]BM&MI/ MW'&NFXI]*G<,*\+(A+;&)]XI'G\ M.+(.@TEJSS[(6G\_9SD3N03"(2^X1N,0QJ#KO\(03MCK5H@CN\Q0[JU M89I82.D=JF56DD<94> MA-G:^V]0<<09)+ZX'%+>=?.Q>\=KG65@/'$ MB RK>7Q*7,B$OS6^BD"KN2*T5[&O>(61S77(557R30Q06:':9J+H=7PND^[& MP7'P.V%B)H:L]AAKD6]H=<=J6TT==2D'ONMN42O]>:0".-:LZ*B-O$P8.B;% MQ-0,'P\M[PR0HO-5$E_X:&_4X).'T0K#9\1\(-=Q18L):O11CV6&+]2:5] MVWZ16M3?8;KM]>>LGW2 >1%IO<+1Z?@UKA"A_D)4/R1?RE>9I4]P5WYN<%NB MP!NPOO*XA#BC[0TMGF0HDJ2<7)O]^1DM4$2 +L1>*1]]U]=[P[S@]* MWYD]HH6'6C9F$>RM;<\F$U/NL>;F5+78T,E6Z9I;$O5N8EJ-O/*@6DY8%$TG M-1=-L)S[O;5>SE5GI6APK<%T=Z<<%DM@L@10HFE M=18X_>[Q J5TAHC&C\%F,+ITP*?KH_7//G:*9<,-7BCYCZCL?A$4 52XY9VT M7]7A#QSBR9R]4DGCOW#H=?-I &5GK*H',#&H1=/_^<.0AR> (GH%P 8 \[Q[ M1Y[E)V[Y'_+-Q+-R7QBR8?3G)2#O55OC[UB;PK7JK%[ [\U%5;/\1/B-A)D1X(K]J;! M/[OF%)(H!!:Q^ U[R1APXNTE_R-@^'9%>W!IL3;?W_"1CCY2[R-]Q<<-M4[5 M202U!3164/%@!5LN--QSV:%Q!PUU'#<&K:'2)"J:5+[YO,,M/EA8257>?7_I M!MYT[KKXS+2\Q$5 ;6I0WV.PO$9N.HW4318^88GU!C4P%CX7UJB%JERFH_[S M/CZ!\^I?*D.'I+K@1-;+6)W !3=[X$T%I5L@Q4#1>;UW,,L*^O[Z2\%B]G&0 MS\M2=>Y8DU/2=:$689HGHUXO73;W9$5I08E*PXSEXWDOK36V7%2 #S2:#"DY M#LKN*8HAH7$1CQBW7FN:8MH^AM!*3BEP@#@*TVD.TXQ!'(=Q/"._EC<[X6@- M=JCNDHC2D$71";!96)#PNU+504@)+"SB%%@>01)&10JWRG)Y1+:=+O-C8T$TI>PJT>RHW[5V-]0JW?>AX[D5#6]* M!$E7B"ZT!+)L"GDR^YG0EC^Z;(942:7N\.74#$=)F!9LS$XO]=2EX!LAJ2,< MSM"8]MK3:>8=IB%C\:!9$CE1H>:^>[(TC+*,BB5)3R!+PAGI75&+G3TI_F,^ MH-6"@J$<6=F7XY%)#^^_/=J7U=@;KH*.NF[]A?K':_A:H.<)+I0F;N\2(C=_U3O7[UKKG>";EKBEJ#1:9X%H/N7I!>L:OWTWBA+ M;X%?[NGQ1>T4Z'RKE#T*SL'XG"__ U!+ P04 " "J0@53K7]C1.4$ #) M"0 &0 'AL+W=OXL3;![;;KX^EDD]+N^7P>VXW=FOC,[VR/_ZQ\V)J$KV$]C[M@ MS3([;;NYY%S/M\;UD[.3O'89SD[\D#K7V\L <=AN3;B[L)V_.9V(R6'A@UMO M$BW,STYV9FVO;/IS=QGP;7Y$6;JM[:/S/02[.IVW/&_YR]B;>LX$R M67C_B5[>+$\GG C9SK:)$ P^OM@7MNL("&E\'C$GQY#D>-\^H+_.N6,N"Q/M M"]_][99IOW M3W,[ZO C#G)TD)GW/E!F^=(D2A7SJ[ M&"*NQ A7=HU:IPC3:[/H;)R=S!/BTZYY.V)=[+'D=[ TO/5]VD1XU2_M\J'_ M''D=R1,MO?#; MG>GO?HG8[3L?$M4!XE@7!M%@6<#T2T@^F0Y,C!;K]3'7"Z[M;8*+SK>?_OE6 MY1ZG>[T)UCZH'ERYVX<+6 R;BW$TJ"KTP^]9[_ OOJ'(14K% :JHI57((L%),E!U%+W"W@/#HS MOS2M6[D6&L'*L@%=LP*CB[IF4I<@"L$:C/5;YQ,$I$UVB5:*E=<$T%\>F MP@,S8+7[-5@3>GP^T$(IIHN:1.%,<=($@>J:P%&EHA%[(4@'7D+61D!1HU.# MT5FM^$,5<*.4%8@&&0HH.>I6@L*-*-]C&LB"2=Z T$PUB@*HJ@:E65.J48'X MOWP$+UA1-U!JE+S&RF$NHD#)"\:QJMB_"]?G1F?8].SS@(?QY M<-'1ZM-@.Y.PL:::Z;*>P;1B35/B4TA,6I&!RI#QP>)D#FT: K$@M(-ONS%A MC=E,94,(1:W);727F*&XL5+E9KB$/"J0AI*4LL1*Q1<-R09 M]D>#W%Y:O)*QR%ENTDT7G)2@:2)AE&"\)D-66$&$>'\,[?K6;RU,\1R,L]PY M0@-*IVJH%:L$1QB.2F*4][F&!X>1X(SE61%(B?8V#4HOL%^;BG1C0M?V\+BB6DAF=OQ'+180NQJUV>XD1?5 M-D9/8E"#Y#/5[<>XPC1H]#!PJ3&?)W2&*-'0$OZI"SW[UMD_OW>]XB"O\T=$ M1.BA3_N;]KAZ_$XYWU_/7[?O/W+>8KNZ/D)G5^C*GU7E!,+^PV'_DOPN7]8+ MG_#JS^8&O[5LH WX_\K[='BA ,>OM[-_ 5!+ P04 " "J0@53TK,!.^X$ M "7# &0 'AL+W=O>>^ZY=YR#N]C?#$OO$[E?M=UP.%FFM'X[G0[-TJ_JX4U<^PXK\]BOZH37 M?C$=UKVO9^70JIT*QLQT58=N?3GP;[PXG M?/(P<1$6RY0GID<'ZWKA+WWZ=7W>XVVZLS(+*]\-(7:D]_/#R3%_>Z+R_K+A MM^#OAD=CDB.YCO$FOWR8'4Y8!N1;WZ1LH<;CUI_ZMLV& .//K=_-_.SS\U/@W($5#V!/Q%Z#/VVZ-T0R M2@03?(\]N0M>%GOR"7OOPE O%KU?U"727^8[ OXXOAY2#\E\W.-&[=RHXD;] M=S>%6W+E[Q,Y:6-S\_%++.^W?K7LO?^,:0*>_(XG'Y/C(=33\[H)\]"0JYCJEIP6S?F>?.AF&/8!TCCS6!G(-T1S6CF'@=34 M2(6!LE2P"@.>IQ0;]^9*#-VB:"JF):S9BMI*E0<31$DJM2"".\J$Q5E'324) M%Y(J:8CC5&L')XH:8\D/;;P&LLNU;T+=ID_D9#. A&$ -&4HMQ*68 "&!*VD M))91[3(Z;C6UVN21TI3S,L<4%4YD[( LC"!7897!QOF_]?\7"#OOXVS3)#*, M19)(3=8Q=(F$CB2TIVRQJJ@0(PF(3]KBA<-V88@;*H4CE[Z_#0UL0%?=,/=] M#^OQ%MP4,Y8:;(*ARA YLF*I0S OCF*_#MC7U($4U-@S#TMY M&8A*013J.0$@G\(0702 ,F,J!R*8>6$$E^'^?VH"SJ*ZLO*,HXYEL3O$K#,\ M80Q5^LDFP"N-C0)/U+\2Q#$JN8:"4?[,%:(T2!1H#P)6N$5S,9I4#"'J_1) MRX 9%%M!(J $5T$0*"&;&90&GJTL?(%B5L!R2:W)@5BL,J5?K0*);F@%+T2@ MLXU>6(4FECU;H%+V61WPBG*@0M?(,-'>D&80I U_<1Q[M?!5&P%D*$T&@59M M><: ZLTUG6%QBL[XI!8DEG&""Y0[.I]!)T&OE_@$V*P%SE#%6+8"FN#H?,@L M/A%:JI+2?5JH#-5"YZ[ \-IY'1,T5(9+_'/P?=Z ]7F,Z>$E.]C]%SGZ&U!+ P04 M" "J0@53D.'Z;S,# "L!P &0 'AL+W=O;0;1 ?/LE5V&FV!O@3O[ M8@W>DX76CW[S>S.-F">$+2Z=1^ T/>$UMJT'(AK_'#"CP:17?+D^HO\:?"=? M%MSBM6Z_B,9MIM$X@@97O&O=9[W[#0_^!()+W=HPPNX@RR)8=M9I>5 F!E*H M?N;/ASB&E"\XO@:M F"]-SL M!LDE"Q\>^*)%^W&2. +U5\GR ##O ;(? %1PJY7;6/A%-=A\KY\0F8%1=F0T MSTX"_M&I$>0LAHQEZ0F\?/ P#WCY:0^_7BVL,U0$WTY@%@-F$3"+'V#>T]MH MNA9!K^"6N\X()\@&[>BU&.Z$6D/K[4(K^$*T_?77$&1XP&<'\U8O'[^]%>[3 MEBDZ&*+S"9%6>2.>-!PK<6G06WD%>Q6G%_&(=,:C<=TQ3%K.J\-,%2^%&J_7/#HU\PZ>LC*MJ#%D=LYK!@W:\?1$#,E7& M=9[Y11U?U"E\"<\$&^!/)+1&*$=CJ$;L]44QRJKW?F3O3V2L'#)6GIVQ:RVW M7.U_LK#J*'?HWY60G00?!^*_U%(*1YV'HM9159O_9_7<5)ZF-*0R9(]Z#% ^ MB(-OI<'HJK]Y!U7,RFR0V",W@/ZUO2J"#"[B@K%S1'.HXRPOSA$MH(SSLCQ' MM(0BSJJS"%3 50,+W&N:QG%*'O;ETQ?9EN_[#!0L+LH<;M#:2Q!RV_DB$8KJ M$:V##T5<9^E'N*.=K^(GWG8AR:]+]5B,;U53\J*#2C3K\$]8JH1.N;Z9#J?# M5W35=^#_Q/M_[):;M5"6"*Q(E8UJJ@+3_PW]QNEMZ,<+[:B[A^6&OE,T7H#N M5UJ[X\8;&#[HV;]02P,$% @ JD(%4\L__\-G @ 504 !D !X;"]W M;W)K&ULC53=3]LP$/]73M$>0*I(FJ;0H;926S:Q M24A=8=O#Q(.;7!L/?V2V0^&_W]E)LZ)!Q4OBC_M]W-GG\4Z;!ULB.GB20ME) M5#I77<:QS4N4S)[I"A7M;+21S-'4;&-;&61% $D1ITER'DO&530=A[6EF8YU M[017N#1@:RF9>9ZCT+M)U(_V"RN^+9U?B*?CBFWQ%MWW:FEH%GH+-<* M#&XFT:Q_.<]\? CXP7%G#\;@,UEK_> G7XI)E'A#*#!WGH'1[Q$7*(0G(AM_ M6LZHD_3 P_&>_7/(G7)9,XL++7[RPI63:!1!@1M6"[?2NVML\QEZOEP+&[ZP M:V*'I)C7UFG9@FDNN6K^[*FMPP%@E+P!2%M &GPW0L'E%7-L.C9Z!\9'$YL? MA%0#FLQQY0_EUAG:Y81STQ5:9^KXF.RUWE,]Q[GZ5'"K[4Z@T'2@S1)^T?X!EW. M@\ W>%_.JH 5"N:P.,S_UVQ-471I[H\H9IUB%A2S=RFR \6%MH[$0K'A#I\< MS(7.'^Y?*_MQC6_7L#1Z:YBD-')3$[EY*6M!;^ *,W1&3K6$OO1B]5OCXX*I+)&N^H2WDNE:NN?7=:O=FS)I6 M^1?>/#@WE!E7%@1N")J<70PC,$T3-Q.GJ] X:^VH#<.PI'&PO=V]R:W-H M965TEMZ9 M' LA3333F'M M[F,0F*S DIF>VJ&DE;72);,TU)O [#2RW#N5(HC#%=1/!;+)C&URB_7NWT#0*6I2=Q^CC/'7[_89_.![,11]<)"NEMF[P.9]V0D<(!6;6(3!J]OB$0C@@HO%? M@]EICW2.E_TS^A\^=HIEQ0P^*?$OSVTQ[8PZD..:5<*^J,.?V,3C"69*&&_A MT.P-.Y!5QJJR<28&)9=URXZ-#N]QB!N'V/.N#_(LGYEELXE6!]!N-Z&YC@_5 M>Q,Y+EU2EE;3*B<_.UL63"/,*:X2\ MAHS?@!S %R5M8>"3S#&_]@^(7LLQ/G.$ M;SYY\(I'"W.ALNWWGZ7Q-K/70B->I1*6_'@]09E!GYFVXU+D3'C16UIB &KG M8C'P 9(D=C9-R [Z(=GA*(6O2C[LT;B8C'=@!Z9S TSF=/M)<9[]6*ND$R+J MQN/0V70,<7:PSA[LH&MZWH[@[BL?PJBPY7!;* M!UI)TM2WXW'D).U&2=^)VAT,DQLEFK8EFKZ[1.>"9=L'FE'T-C0IA1VEQHE9 MJAR%U]L6I+NAA[[)^?OJ\3:-KU6Y0NU(G"MIHYET)1&G5 $A96C/U*W-.0*[(0--M(M=!>.E* M:R7)G_P-0 M2P,$% @ JD(%4^Z@F<16 P U@< !D !X;"]W;W)K&ULC55M;]LV$/XK!VT8$D"+).K%7F<;B)L.R]!L1IQM'X)^H*5S M1$02-9*JO?WZ'BE929K8W0=11][[/4?>;"?5HRX1#>SKJM%SKS2F?1<$.B^Q MYOI"MM@09RM5S0UMU4.@6X6\<$IU%; PS(*:B\9;S-S92BUFLC.5:'"E0'=U MS=6_2ZSD;NY%WN'@5CR4QAX$BUG+'W"-YL]VI6@7C%8*46.CA6Q X7;N74;O MEJF5=P)_"=SI9S383#92/MK-=3'W0AL05I@;:X'3[S.^QZJRABB,?P:;WNC2 M*CZG#]9_<;E3+ANN\;VL_A:%*>?>U(,"M[RKS*W<_8I#/B[ 7%;:K; ;9$,/ M\DX;60_*%$$MFO[/]T,=_H\"&Q28B[MWY**\XH8O9DKN0%EILF8)EZK3IN!$ M8T%9&T5<07IFL1KJRYL"_C E*EA);> 6C5!(Q3>PQ :WPF@XN^.;"O7Y+##D MV*H'^>!DV3MA1YQD<",;4VKXT!18O-0/*. Q:G:(>LE.&ORM:RX@#GU@(8M. MV(O'*L3.7O*-*JPJWF@?KBCA!HM#ZG!_@_4&U:<3GI+14^(\Q4<\?6W:>H0K MH?-*ZDXAW'\D-EP;K/4I=^GH+CV9V)HN<=%5"'(+N:Q;V1"DVNX:NO M*B$+ MD<-FB"8G[#7\2(R^'JVM!]P[X.$.]]0-E3HJ@/?0QQEM$9^E"7T M9Y:F+XLMQ?PXGEH9]UTW!A7JOJZD$?Z4T)I,,XC(?D;2T32!V&=I"N0L9?!A MW])S126@U#K5P( !<*W17D%&-N)S.(O\21:=PP_?35G$?A[_9XD?35+BQ_Z$ MA:_Y],::JB]87G+U@*\DCOT9\[-L\NKX,C<=5X)70/VK@==2&?$?=P_N-)U M%J6C+)6-PHX8K5G&QN,X@A6U(0V*YV5^82FFQ-[(-H6SZ1O'OQ_K;(O49.*P M2S*+4&0A2QQ6J46-97[$+)C,(CO-WKJ P;.WMD8JH9THFNQWC>F?W?%T'%J7 M_5O])-Y/O!M"0-#]JG!+JN'%A*Z0ZJ=(OS&R=2_W1AJ: XXL:?"BL@+$WTII M#AOK8!SEBR]02P,$% @ JD(%4_P+E8TQ P B 8 !D !X;"]W;W)K M&ULC55-C]LV$/TK R$'&U!7'[2\PARH*6112Q%JB0=._^^0TI6O4!VT0LY)&?>O#/V1O>HZ*31IN..EN:0V-X@KT-0)Y,\39=)QX6*MNNP=V^V M:WUT4BB\-V"/7T2B:46G2H MK- *##:;Z"Y[NUMX_^#PE\"3O;+!*]EK_>07'^I-E'I"*+%R'H'3] W?H90> MB&C\,V)&4TH?>&U?T'\)VDG+GEM\I^7?HG;M)BHCJ+'A1^D^Z]-O..HI/%ZE MI0TCG ;?(HV@.EJGNS&8&'1"#3,_CW6X"BA?"LC'@#SP'A(%EC]SQ[=KHT]@ MO#>A>2-(#=%$3BC_41Z) MHR3>-:E&P-T F+\ N(1/6KG6PGM58_T\/B%R$\/\PG"7OPKX\:AN@*4QY&F> MO8+')L4LX+'_HYBK&D;1%K[<[:TS=$^^OI)F,:59A#2+%](\T/.ICQ)!-Z!# M2ASRQ*#HK7T)!89'/#O825T]??U1J5]/\=@:Q&?EA@=Q?KY!U<-0OF6-U6B,[L"UPM30<^.^@Q25IPP-4GG> +ME-.9I2>-MEM-8T$BO@^Z^(GU5 MR]4!06I+Y1QTSDI6TG7*XS1=A)EE2YJS."O9''ZEK@$S[S\'>J*UL+VV7%I? MM-Y0YR$2,7""\PL/XV")FQ9+,; Z_:_63&"0X?O:]XJAJ&S[N4'J#DCNJ M1F6P%LY"MHCS50$ER[W)5CGD<<8RN!^[C8\D)LZ@$P:I!SG8H\)&.!CSS"HZ MMG,B1;DMFF]4*:"37BORI@SY"F9L0>3R@I%N%I=+$CY-UNZR\ FFG\_V7U!+ P04 " "J0@53A #F %T# M 3"0 &0 'AL+W=O@UAK;->6MN=7"]%KSEKZ9T$U3<-D7]O*!?'E1,XH^$3.]3: M&+SULB,'NJ7Z]^Y.HN9-*!5K:*N8:$'2_E1G,IA*=D(\ M&.7G:N7XAA#EM-0&@>#KD=Y0S@T0TOCKA.E,*4W@N3RB_VAKQUIV1-$;P?]D ME:Y73NY 1?>DY_J3./Y$3_4D!J\47-DG' ??M'"@[)46S2D8&32L'=[DZ=2' MLX#0R+)\3S19+Z4X@C3>B&8$6ZJ-1G*L-8NRU1*_,HS3ZULB M6]8>%-Q1"=N:2 JS>[+C5,V7GL8$QLTK3V"; 2Q\ 2R%CZ+5M8+;MJ+59;R' MQ"9VX]/9J/U_OE):X.;Z\@A]/^+'% MCU_ W^*9J7I.0>SAG[E\9[S6MX+-M-MS3)PT;+LJ'+\^U_?6L M][6D]*+UL&5/EP;L)+6=G 334O/PSZ2!'QV9S[A0:@X=%E"*IL%#I&S/?L7+ M@K5HHJ,+T5JR7:]M,5K ;SUYP*@;O$)823C<"-D)2>Q!? =1Y":9C\(L<[,H MF:.4A6Z0)\84I6X0I'/X0)6Z@MF09PXF#Q".+2*F;YBC(U*SDG6(VAY T;*7 M3#.*M(,HGD.4P2S,LSD$9%; MFHE;9/[\U+*C/?W(BSQ2B9?9!:("O V5QF4W1(/,S?W0C=+4B&F1N7%AQ:R( MW")(K#5/7#]X\WJ\@V"16U;^(HX,SWCAQT8/%S[JXV;[?V'_*PM[N]_C6#+7 M1&76!@?3>9UQY@9) M]_EX=!^ ,DH>L7W]1Q-?\EM;AP$SSGE]3R.+5\SJB] M>;,\N^NB:=<]=YUZ9X.JH?)@Q[%"V+[5P\R:K-/$OQX&W3?WX7?A(Y$'UBK@ M=(^A_B)+')##"!X4+3H[]G9"XQ"U8HU_+50:!_R^%T*/BDDP_0>MOP)02P,$ M% @ JD(%4TQ7XIR2 @ Z04 !D !X;"]W;W)K&ULC53;;MLP#/T5P1N!J6[9SZ9( 2=MA&U"L:+OM8>B#8C.Q4%E* M);GI_GZ4[+CI+=B+3%+DX3F2Q8XBDQ10,RF$U\[$+/)JJQ@DNXT,0T=X;^_0OWCM MJ&7)#)PH\9N7MIH&HX"4L&*-L)=J^Q4Z/;G#*Y0P?B7;+C<.2-$8J^JN&!G4 M7+9?]M"=P_\4T*Z >MYM(\_RE%DVFVBU)=IE(YHSO%1?C>2X=)=R937N&MU16]"#@-\;>432."0TILD!O+27FGJ\] T\K\\O9W<-OV<"I#7D^0', M9?DBMI__9[[$3?R9;@Y0RGI*F:>4O4'I"M]8V0@@/U:/W5^V]'="KN'!DH50 MQ>W-:[=SN!,>)OC#/(4"ZB5HDB;MR;HEWBW)N&W/D$?A#-CC\9XD61X.DABM ME-(P&P]=;)2$HS1U%DW#G&;[Q^%+(4Z=?M;AB;@L"8=YOA,W]E:& MXO+\M4N/]IY?#7KMAXPAA6JD;5]B'^WGV+Q]OH_I[1 \9WK-I2$"5E@:'PWS M@.AVL+2.51O_F)?*XFCP9H6S&+1+P/V54G;GN ;]=)_] U!+ P04 " "J M0@53QKI\2_(# ","0 &0 'AL+W=OEA:. ;LO+I%@PTV:7M8[(&6:)L-);HDM8[[ZSND M'"7!9ET?>I&&Y+R_&0XG6VT>[5H(!T^-:NWY:.W++4 MIN$.EV85VXT1O Y"C8H9(7G<<-F.II.P=V>F$]TY)5MQ9\!V33#5^)>^%^W]P97,6#EEHVHK52MV#$\GPTHQ_FN>(>$$I7S&CC^OHD+H917A&[\O=#*OK]+*AB]L][QD!%5GG6[V MPNA!(]O^SY_V>3A&@.T%6/"[-Q2\O.2.3R=&;\%X;M3FB1!JD$;G9.M!N7<& M3R7*N>F-UO56*@6\K>%CZWB[D@LE8&:MSME!A;]V[1DD) )&&#V@+QDB3X*^Y+\B MG[T;^:6TE=*V,P*^S!;6&:R?KP?,IH/9-)A-?V#V'MNJ[M".7L+@PI>09G@0 M3P[F2E>/7]]+^&'%-THON(+[C:@D5VX'LT8867%$X/9JAF%)'M_Q2BYE!?/. MHC0&:N%!.Y2:<\7;2@!RHU^7HA+-0AA(:$@W@9^ T21B*4.*IB2B>:"R(B*E M/Z6TC,:T0"I'&4;92VR\KJ5O0 MX0 I@439@GAV-^;5LI1,__X9W MT7ME=UPE'#9W8[2U<,&-VJPOP4'OV0LR(IHRSSN44THJ)(D"K+J" Y/!A> MXQC!$1.!'R%=#VVO0))&9<(\9BGJ^A0J((\2K#3\ MCAF63$E*_!8LW=JOGG"X6G$DZH=]P2$%F"G8"6Y ^$OWNS[V:ER3C8WASR+!U4_(>KO&K"8EEO0KO N5 M[X9^6 Z[PU-CUD_8%_;^G7++S4IB 2NQ1%%R-L9F-/WL[Q=.;\*\76B'/13( M-3Z7A/$,>+[4VCTOO('A 3;]%U!+ P04 " "J0@53YK'@#*4# -" M&0 'AL+W=OXR#$VYQ8:;L=JAI)VUT@VW).I-:'8:>>6=FCJ, M&S'=_@ M ]JGW9TF*1Q0*M&@-$))T+B^&BVBRV7J[+W!#X%[\V8-+I*54L].N*VN1LP1 MPAI+ZQ X_;S@-=:U R(:?_>8H^%(Y_AV?4#_XF.G6%;_5_G?LX_$$2U4;_X5]9YM-1U"VQJJF=R8&C9#=+W_M\_#&(6K:5>0GYW?X,K"^2-?U6@N M9J$E2+<1EKW[LG.//W#/X)N2=FO@LZRP.O8/B.AT-UABLT(-2>3U#&ZE18W&PO?6&LME)>3F M?>4]MPA+7G-9XK%PK;$2%K[P4M3""C27<(\OJGZA@Z)Q6GR",XCR(DA90G*6 M>CEC 6,,GL8/8XI6-_!5<=F;IVGJ-SOC=-J9?GZZ_WYLRCY!-,F#*$H/4CH- M6!93 !5UNQ:\IDOU0L-B1U??PDK)RD ZCC,R[4"/A"67S^"RZ9-5=F%1^*#L MEF*I7('4JA8;[H: @1]<"]4:B(,H2]](;!K#H[+^='(Y@X)-@FF>T"HOBB!* M)O 5#:7);PMC6I_'4AEKX)P2E;(+.(^B@!7%16]JMDK;WZP+WS$J6ZU=2#O2 MNH%$?&LE-YV!@R4@2@V;$L!YD@=%-KWH.3D[QV0R#:)TXE<%92T_T<[IT,[I MR;C5B,>30YX$*_'BN$N M'%\*?P-^K0:FV#,]@TF01ZYL:5"DD2MD,,F<'"5!1HM%X]+_+S^4X+UZ1D&4 MY_TW#I)IVG^[8IQ!1JWGH*D:2>&@HR!/VOE;('P1TP_ .8_P=02P,$% @ JD(%4XKRYBX&!P HA4 !D M !X;"]W;W)K&ULS5A;;^.V$OXKA+LXL %VS:M$ M]20!G&3/.7O02[#9M@]%'QB9CM75Q97H)-M?WQE2=N2-;1C;+M 7FR+%X/;8M!^ZI7.>/%5EW9V/EMZOOIE.NWSI*MN];E:NAI5%TU;6PV-[/^U6 MK;/SL*DJIX*Q9%K9HAY=G(6YF_;BK%G[LJC=34NZ=579]N.E*YO'\Q$?;2;> M%?=+CQ/3B[.5O7>WSO^XNFGA:;J5,B\J5W=%4Y/6+ZQ M&XP)6G+7-!_PX>W\?,10(5>ZW*,$"W\/[LJ5)0H"-7[O98ZV1^+&X7@C_3_! M=K#ESG;NJBE_+N9^>3XR(S)W"[LN_;OF\7^NMR^ MJ?K-H$%5U/'?/O4X##88=F"#Z#>(H'<\*&AY;;V].&N;1]+BVR -!\'4L!N4 M*VITRJUO8;6 ??[BS>_KPG\DX_?VKG3=Y&SJ02@N3?->P&44( X(2,AW3>V7 M'7E3S]U\=_\4E-EJ)#8:78JC O^_KE\3R2@13/ C\N360AGDR>,6_C*[ZWP+ M0?#K$9EJ*U,%F>J S%O(C?FZ=*19D%F>KZMU:;V;DQ_\TK7DJJD@0988N0^. MO*WSIG)D_&W3=1/R2P":O'=/GER63?[AUWV0'S_]VBU@9DY^K"$-R^(/&%ZM MV];5^4=RZ6I8]>2_D(^;,V'TOK5U!SIB(MST*35[L$6)VGP-N4VN75L\6$P1 M,IO_!H$'F><[=;EZ_;PA>N YL RW5\XWWC;4DN+;R8.V(]^4*Y3."5A$R(5)]HD.&F$(K.J6:.^S[L MT7;5&3V MP]5;\J^OC.#BW\1H0<3@29%W+CK7VR=B>R&;]3'/P)AQ L:-.9HXEIF<#-& M<';;<$8S.2*01C X35.#0YTE88)J$W&2FF9J5](.K@Q?RC+*313%4ZK3B*-" MX_&?2L;C(ARDA?IKT#*J-0/%T%M@@C @5X%,M"8R$3BD%.N3,1$<1$7648%^NT?GDW7+G?5'7AM MZ'A!34RBL9!4)<%<2:42,:-T9N)B$H?[W-[[N_?^0;>/,X@B0$Q#\(X50W]3 MR1,R3JE)LLFI;H= YRHDNQGX?@RR4,AQ_RL(N!1R>1P4 <>E7RC!/H&:9R%B M%-5)A%/"4/;Q)'0X2XJ8:ZF!,]E?0QI.8HB&R@2$,5BJ 6ED%V5HQMC)6 M% MLR1!'/1D.&D PZ-(&RH,G"L9VB^NAA"Z;1LX9+?R?]^ RVO? M-B6(OX^ZDAO;DI]LN7;DC6UKF.\(\@J0@'>MZ_P)]12 AO2'0<8,30/22FNJ M,CDLHQ#SB0[.D"*C2DOR/?3X?11N?+[YET :*7M^9#B#7/T<9P M%?E4[C;_4X@M34P8@)[7Q4,Q=_4A+Q.3@_.W20AX57;>. M0-5SXD( ?(U=^CSH!\I%EEX%XI58N("'#FF)J^DQ;@G((]X9E$.3(-TJ(RAC M?$@IKZ#*R8A\"FZ!Q6-5'&2F&B49R"7@%Z3R%%H6+7=*-YS$3_T"N $*7HG -L!H?Z3B&)?JX"&A5*5 M,0TE"D<*>H9,L6&# %RA6<\5C&:0(D>X(H4T&?A5I3@C )=38^IXT&[C 3H/ M;/:2,))0&#\)KC1C+S=Q!:VIVA-=FX7/""^1$DV3C!]454-W8[XP;^QK3GC( M[YXZ1* 'J+S@EXWP/O&%VB("MU[;]2#:1V*NZ41359(EY5C*JB IRJ%7Z%'*3D*D\ M&7Y)A#F6)*?3&YYP. (!:I;%3SO\")'8%NF7<0B%DY$5R.XPMO;%'M12_$X[ MN##+(02[(L0<.*+>Y8-BD_'/O,[V29.*H:Z4J125A(^*XFX=FTO??"K4+A9% M60!O1:TW/=0A+)Z/#M]CX?=T<&]6N?8^ MW YV)*1 O$+;SFXO(&?QWNWY]7A["67]O@ #2[> K1 4T%^V\48P/OAF%6[A M[AKOFRH,E\X"YO@"K"^:QF\>\(#MM>S%GU!+ P04 " "J0@539I)' &0" M #O!0 &0 'AL+W=O:3 M"A$F430*"\9E,!U[WX6>CE5E!9=XH<%41<'TXQR%JB=!'&P<"[[.K7.$TW') MUGB)]KJ\T&2%'4K&"Y2&*PD:5Y-@%A_/AR[>!]QPK,W6'EPE2Z7NG/$MFP21 M$X0"4^L0&"WW>()".""2\;O%##I*E[B]WZ"?^=JIEB4S>*+$3Y[9?!(JH3Q7ZB;V-$H@+0R5A5M,BDHN&Q6]M#V82OA*'HA(6D3 M$J^[(?(J3YEET[%6-6@736ANXTOUV22.2_=3+JVF4TYY=GK&N(8;)BJ$7[&EP _CT!*)"PW3%G#> "8O ([@7$F;&_@B,\R>YHT@5^SI;&:+LGM#HYAQS'T M',.]'#V8&8/4T+:[&=!57&!::C\)SI-2D'@2M*C?J'!P'H9KPTAE6E?])+96E ^&U. M$QFU"Z#SE5)V8SB";L9/_P!02P,$% @ JD(%4_241>XI P " < !D M !X;"]W;W)K&ULK57?3]LP$/Y73A$2('4D3=J. MH;92"V,P;0*M;'M /+C)I;%P[,QVVNZ_W]EI4]!*M8>]Q#[G[KOO?O@\7"G] M; I$"^M22#,*"FNKBS T:8$E,V>J0DE_^K-[/1ZJV@HN\5Z#JOL-+E3#^"ZN-;A1 6ANKRHTQ,2BY;%:VWN3A7PSBC4'L>3>./,LK9MEX MJ-4*M-,F-+?QH7IK(L>E*\K,:OK+R#A#JM81ZGE#O#4(SNF1U5@L$E4/.N(8E$S5Y(=$6")>JK)C\?7QL MJ-5:EGS'L@-?<(D"8BB1F5ICP_W1UQ ><&UA*E3Z_+2OFH>Y73LZ/QP=HD$% ME08SMS-*\(Q9$J@\Z,MSA2F6<]20=#LP98+)%&'FA\H7E3)__UP)W2=ZD6\7 ME>$+Z=&8@929 G(:%%!0XM%<4$$L:C06-.F 6;'*P!UE1H-4\EU::TWQ@N!L MSD53GR-(.DE_0&NO,W@?_R7O)_W_V$WN+F_)6=SIG_>\\_Z'\[_DAT(COKHM M,./KUP5*QC-S50PZO2<$V*N5=GPX]*J M5N<$\QS]=(1*:8=PNHMLH]0!2<4\@I-!_\.I6WOGB5^[G22*FY-!_W3?E0A? M3*<2]<+/8,JFX]T,JO:T'?.39KKMU)LWXBO3=!T-",S)-#I[WP] -W.W$:RJ M_*R;*TN3TV\+>JI0.P7ZGRMEMX)ST#Y^XS]02P,$% @ JD(%4TJR97"/ M P O0P !D !X;"]W;W)K&ULQ5=MC]HX$/XK M5K256JE'7H#=[0J0@-!K*VV+H+U^J/K!) .Q-K%SM@-=J3_^QDY(81M2=J]2 MOX ]GF?>GDD\&>R$O%,)@";?LI2KH9-HG=^XKHH2R*CJB!PXGJR%S*C&K=RX M*I= 8PO*4C?PO$LWHXP[HX&5S>5H( J=,@YS2521953>3R 5NZ'C.WO!@FT2 M;03N:)#3#2Q!?\KG$G=N;25F&7#%!"<2UD-G[-_,? NP&O\PV*F#-3&IK(2X M,YNW\=#Q3$200J2-"8I_6YA"FAI+&,>_E5&G]FF A^N]]=4QF115,1?J9 MQ3H9.M<.B6%-BU0OQ.X-5 GUC;U(I,K^DEVEZSDD*I06607&"#+&RW_ZK2K$ M :!["A!4@. !(/!/ +H5H/O0P_4)0*\"],[UT*\ -G6WS-T6+J2:C@92[(@T MVFC-+&SU+1KKQ;AIE*66>,H0IT<3JI@B8DWF$A1P34OZ>$Q"4)%DN=WC^:10 M"%6*/ ]!4Y:J%^2",$YN69JBBAJX&L,Q1MVH Z463&8X@; M\&$[_K(%[V(9ZEH$^UI,@E:#[PK>(5WO)0F\P/^T#,GSBQ=347 M&33E-SW? MG%>9:\KR\4$M88//JE9MPS6[=2U9KN_K9V^C%=*2WQ??&UQWZO= M]ZS[W@GW[XML!9)\6).Z-.0M)Y\3%B78)IKI>_(A!TDU'GPG;?6;E)[ZUI-Y MW6Y'07_@;@^9:U4Y2J!?)] _,X$%Y$)JNDJ![.G&B/?+IC[J_Q1-KSF8RSJ8 MR]9@EL5*L9A16\8OMV!"^XI!C.4&8V"MSJ:%E,"C>Q()O@5I M+R*6Y=@8MI^2>Z3M+\;7J6TIO-/PCHD,?XQO,*:+)@I+C[YW4!*OXQ^3.#U' M*6Q4ZAXKS7YAZ:@LUW59KEO+,E8*L (?A:;I(0?GW_&\9TUOWJ?!PJ?!9H^& M'17/]W[ M5Y;0/1C',D!ZS!RLB'U;E5=I+:UG[;&=,!_()_[-U&^0AV8VM^/?#_/E8']+ MY89Q15)8HRNO&ULO5I;4]LX%/XKFNQEZ R;6+*<2Q>8@:0%RJ49:+LSN[,/ M2JP0+;:52DHI._OC5W*QPE\K Q M56KVMM62XRF-B6SR&4WT-Q,N8J+TH[AKR9F@)$R)XJB%/*_=B@E+&D<'Z=I0 M'!WPN8I80H<"R'D<$_%X0B/^<-B C>7"#;N;*K/0.CJ8D3MZ2]7GV5#HI]:* M2\ABFDC&$R#HY+!Q#-\. VP(TAU?&'V0N<_ F#+B_-X\G(>'#<]H1",Z5H8% MT?^^T3Z-(L-)Z_$U8]I8R32$^<]+[N]3X[4Q(R)IGT=_L%!-#QO=!@CIA,PC M=<,?SFAF4쟝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�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end XML 105 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 106 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 107 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 429 430 1 false 99 0 false 12 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 000200 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 2 false false R3.htm 000300 - Statement - Condensed Consolidated Statements of Comprehensive Income Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income Statements 3 false false R4.htm 000400 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 4 false false R5.htm 000450 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 5 false false R6.htm 000500 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 010110 - Disclosure - Basis of Presentation and Description of Business Sheet http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusiness Basis of Presentation and Description of Business Notes 7 false false R8.htm 010210 - Disclosure - Business Acquisitions Sheet http://www.quakerchem.com/role/BusinessAcquisitions Business Acquisitions Notes 8 false false R9.htm 010310 - Disclosure - Recently Issued Accounting Standards Sheet http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards Recently Issued Accounting Standards Notes 9 false false R10.htm 010409 - Disclosure - Business Segments Sheet http://www.quakerchem.com/role/BusinessSegments Business Segments Notes 10 false false R11.htm 010410 - Disclosure - Net Sales and Revenue Recognition Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognition Net Sales and Revenue Recognition Notes 11 false false R12.htm 010508 - Disclosure - Leases Sheet http://www.quakerchem.com/role/Leases Leases Notes 12 false false R13.htm 010640 - Disclosure - Restructuring and Related Activities Sheet http://www.quakerchem.com/role/RestructuringAndRelatedActivities Restructuring and Related Activities Notes 13 false false R14.htm 010710 - Disclosure - Share-Based Compensation Sheet http://www.quakerchem.com/role/ShareBasedCompensation Share-Based Compensation Notes 14 false false R15.htm 010750 - Disclosure - Pension and Postretirement Benefits Sheet http://www.quakerchem.com/role/PensionAndPostretirementBenefits Pension and Postretirement Benefits Notes 15 false false R16.htm 010810 - Disclosure - Other Income (Expense) Sheet http://www.quakerchem.com/role/OtherIncomeExpense Other Income (Expense) Notes 16 false false R17.htm 010910 - Disclosure - Income Taxes and Uncertain Income Tax Positions Sheet http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions Income Taxes and Uncertain Income Tax Positions Notes 17 false false R18.htm 011010 - Disclosure - Earnings Per Share Sheet http://www.quakerchem.com/role/EarningsPerShare Earnings Per Share Notes 18 false false R19.htm 011118 - Disclosure - Restricted Cash Sheet http://www.quakerchem.com/role/RestrictedCash Restricted Cash Notes 19 false false R20.htm 011510 - Disclosure - Goodwill and Intangible Assets Sheet http://www.quakerchem.com/role/GoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 20 false false R21.htm 011910 - Disclosure - Debt Sheet http://www.quakerchem.com/role/Debt Debt Notes 21 false false R22.htm 012210 - Disclosure - Equity Sheet http://www.quakerchem.com/role/Equity Equity Notes 22 false false R23.htm 012410 - Disclosure - Fair Value Measurements Sheet http://www.quakerchem.com/role/FairValueMeasurements Fair Value Measurements Notes 23 false false R24.htm 012415 - Disclosure - Hedging Activities Sheet http://www.quakerchem.com/role/HedgingActivities Hedging Activities Notes 24 false false R25.htm 012510 - Disclosure - Commitments and Contingencies Sheet http://www.quakerchem.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 25 false false R26.htm 020001 - Disclosure - Basis of Presentation and Description of Business (Policies) Sheet http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies Basis of Presentation and Description of Business (Policies) Policies http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards 26 false false R27.htm 030303 - Disclosure - Business Acquisitions (Tables) Sheet http://www.quakerchem.com/role/BusinessAcquisitionsTables Business Acquisitions (Tables) Tables http://www.quakerchem.com/role/BusinessAcquisitions 27 false false R28.htm 030410 - Disclosure - Business Segments (Tables) Sheet http://www.quakerchem.com/role/BusinessSegmentsTables Business Segments (Tables) Tables http://www.quakerchem.com/role/BusinessSegments 28 false false R29.htm 030510 - Disclosure - Net Sales and Revenue Recognition (Tables) Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables Net Sales and Revenue Recognition (Tables) Tables http://www.quakerchem.com/role/NetSalesAndRevenueRecognition 29 false false R30.htm 030609 - Disclosure - Leases (Tables) Sheet http://www.quakerchem.com/role/LeasesTables Leases (Tables) Tables http://www.quakerchem.com/role/Leases 30 false false R31.htm 030610 - Disclosure - Restructuring Activities (Tables) Sheet http://www.quakerchem.com/role/RestructuringActivitiesTables Restructuring Activities (Tables) Tables 31 false false R32.htm 030710 - Disclosure - Share Based Compensation (Tables) Sheet http://www.quakerchem.com/role/ShareBasedCompensationTables Share Based Compensation (Tables) Tables 32 false false R33.htm 030750 - Disclosure - Pension and Other Post Retirement Benefits (Tables) Sheet http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables Pension and Other Post Retirement Benefits (Tables) Tables 33 false false R34.htm 030810 - Disclosure - Other Income (Expense) (Tables) Sheet http://www.quakerchem.com/role/OtherIncomeExpenseTables Other Income (Expense) (Tables) Tables http://www.quakerchem.com/role/OtherIncomeExpense 34 false false R35.htm 031010 - Disclosure - Earnings Per Share (Tables) Sheet http://www.quakerchem.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.quakerchem.com/role/EarningsPerShare 35 false false R36.htm 031110 - Disclosure - Restricted Cash (Tables) Sheet http://www.quakerchem.com/role/RestrictedCashTables Restricted Cash (Tables) Tables http://www.quakerchem.com/role/RestrictedCash 36 false false R37.htm 031510 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.quakerchem.com/role/GoodwillAndIntangibleAssets 37 false false R38.htm 031750 - Disclosure - Debt (Tables) Sheet http://www.quakerchem.com/role/DebtTables Debt (Tables) Tables http://www.quakerchem.com/role/Debt 38 false false R39.htm 032211 - Disclosure - Equity (Tables) Sheet http://www.quakerchem.com/role/EquityTables Equity (Tables) Tables http://www.quakerchem.com/role/Equity 39 false false R40.htm 032410 - Disclosure - Fair Value Measurements (Table) Sheet http://www.quakerchem.com/role/FairValueMeasurementsTable Fair Value Measurements (Table) Tables http://www.quakerchem.com/role/FairValueMeasurements 40 false false R41.htm 032411 - Disclosure - Hedging Activities (Tables) Sheet http://www.quakerchem.com/role/HedgingActivitiesTables Hedging Activities (Tables) Tables http://www.quakerchem.com/role/HedgingActivities 41 false false R42.htm 040010 - Disclosure - Basis of Presentation and Description of Business (Details) Sheet http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails Basis of Presentation and Description of Business (Details) Details http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies 42 false false R43.htm 040214 - Disclosure - Business Acquisitions - Other Acquisitions - Narrative (Details) Sheet http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails Business Acquisitions - Other Acquisitions - Narrative (Details) Details 43 false false R44.htm 040215 - Disclosure - Business Acquisitions - Preliminary Estimated Fair Values of Coral Net Assets Acquired (Details) Sheet http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails Business Acquisitions - Preliminary Estimated Fair Values of Coral Net Assets Acquired (Details) Details 44 false false R45.htm 040216 - Disclosure - Business Acquisitions - Coral - Narrative (Details) Sheet http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails Business Acquisitions - Coral - Narrative (Details) Details 45 false false R46.htm 040314 - Disclosure - Business Segments - Narrative (Details) Sheet http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails Business Segments - Narrative (Details) Details 46 false false R47.htm 040315 - Disclosure - Business Segments - Performance of reportable segments (Details) Sheet http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails Business Segments - Performance of reportable segments (Details) Details 47 false false R48.htm 040410 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details) Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails Net Sales and Revenue Recognition - Narrative (Details) Details 48 false false R49.htm 040412 - Disclosure - Net Sales and Revenue Recognition (Details) Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails Net Sales and Revenue Recognition (Details) Details http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables 49 false false R50.htm 040415 - Disclosure - Leases - Narrative (Details) Sheet http://www.quakerchem.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 50 false false R51.htm 040416 - Disclosure - Leases - Supplemental Balance Sheet Information (Details) Sheet http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails Leases - Supplemental Balance Sheet Information (Details) Details 51 false false R52.htm 040417 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details) Sheet http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails Leases - Maturities of Operating Lease Liabilities (Details) Details 52 false false R53.htm 040640 - Disclosure - Restructuring Activities - Narrative (Details) Sheet http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails Restructuring Activities - Narrative (Details) Details 53 false false R54.htm 040650 - Disclosure - Restructuring Activities (Details) Sheet http://www.quakerchem.com/role/RestructuringActivitiesDetails Restructuring Activities (Details) Details http://www.quakerchem.com/role/RestructuringActivitiesTables 54 false false R55.htm 040710 - Disclosure - Share-Based Compensation - Narrative (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails Share-Based Compensation - Narrative (Details) Details 55 false false R56.htm 040720 - Disclosure - Share-Based Compensation - Expense Table (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails Share-Based Compensation - Expense Table (Details) Details 56 false false R57.htm 040760 - Disclosure - Share-Based Compensation - Black-Scholes option pricing model (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails Share-Based Compensation - Black-Scholes option pricing model (Details) Details 57 false false R58.htm 040815 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost and Changes in Other Comprehensive Income (Details) Sheet http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails Pension and Other Postretirement Benefits - Net Periodic Benefit Cost and Changes in Other Comprehensive Income (Details) Details 58 false false R59.htm 040860 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details) Sheet http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails Pension and Other Postretirement Benefits - Narrative (Details) Details 59 false false R60.htm 040900 - Disclosure - Other Income (Expense) (Details) Sheet http://www.quakerchem.com/role/OtherIncomeExpenseDetails Other Income (Expense) (Details) Details http://www.quakerchem.com/role/OtherIncomeExpenseTables 60 false false R61.htm 040960 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 61 false false R62.htm 040970 - Disclosure - Income Taxes - Uncertain Tax Positions - Narrative (Details) Sheet http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails Income Taxes - Uncertain Tax Positions - Narrative (Details) Details 62 false false R63.htm 041010 - Disclosure - Earnings Per Share - Basic (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareBasicDetails Earnings Per Share - Basic (Details) Details 63 false false R64.htm 041020 - Disclosure - Earnings Per Share - Diluted (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareDilutedDetails Earnings Per Share - Diluted (Details) Details 64 false false R65.htm 041030 - Disclosure - Earnings Per Share - Antidilutive Shares (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails Earnings Per Share - Antidilutive Shares (Details) Details 65 false false R66.htm 041110 - Disclosure - Restricted Cash (Details) Sheet http://www.quakerchem.com/role/RestrictedCashDetails Restricted Cash (Details) Details http://www.quakerchem.com/role/RestrictedCashTables 66 false false R67.htm 041510 - Disclosure - Goodwill and Other Intangible Assets - Goodwill Assets (Details) Sheet http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails Goodwill and Other Intangible Assets - Goodwill Assets (Details) Details 67 false false R68.htm 041520 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets (Details) Sheet http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails Goodwill and Other Intangible Assets - Intangible Assets (Details) Details 68 false false R69.htm 041540 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) Sheet http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) Details 69 false false R70.htm 041550 - Disclosure - Intangible Assets - Indefinite Lived (Details) Sheet http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails Intangible Assets - Indefinite Lived (Details) Details 70 false false R71.htm 041910 - Disclosure - Debt - Table (Details) Sheet http://www.quakerchem.com/role/DebtTableDetails Debt - Table (Details) Details 71 false false R72.htm 041950 - Disclosure - Debt - Debt related expenses included within Interest expense (Details) Sheet http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails Debt - Debt related expenses included within Interest expense (Details) Details 72 false false R73.htm 041960 - Disclosure - Debt - Narrative (Details) Sheet http://www.quakerchem.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 73 false false R74.htm 042211 - Disclosure - Equity and Noncontrolling Interest - Changes in Equity (Details) Sheet http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails Equity and Noncontrolling Interest - Changes in Equity (Details) Details 74 false false R75.htm 042212 - Disclosure - Equity and Noncontrolling Interest - Changes in Equity (Parentheticals) (Details) Sheet http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityParentheticalsDetails Equity and Noncontrolling Interest - Changes in Equity (Parentheticals) (Details) Details 75 false false R76.htm 042220 - Disclosure - Equity and Noncontrolling Interest - AOCI Reclassifications (Details) Sheet http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails Equity and Noncontrolling Interest - AOCI Reclassifications (Details) Details 76 false false R77.htm 042410 - Disclosure - Fair Value - Assets (Details) Sheet http://www.quakerchem.com/role/FairValueAssetsDetails Fair Value - Assets (Details) Details 77 false false R78.htm 042504 - Disclosure - Hedging Activities - Narrative (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails Hedging Activities - Narrative (Details) Details 78 false false R79.htm 042505 - Disclosure - Hedging Activities - Table (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesTableDetails Hedging Activities - Table (Details) Details 79 false false R80.htm 042510 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 80 false false All Reports Book All Reports kwr20210630.htm exhibit101.htm exhibit102.htm exhibit103.htm exhibit104.htm exhibit105.htm exhibit106.htm exhibit311.htm exhibit312.htm exhibit321.htm exhibit322.htm kwr-20210630.xsd kwr-20210630_cal.xml kwr-20210630_def.xml kwr-20210630_lab.xml kwr-20210630_pre.xml http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/srt/2020-01-31 true true JSON 110 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kwr20210630.htm": { "axisCustom": 0, "axisStandard": 27, "contextCount": 429, "dts": { "calculationLink": { "local": [ "kwr-20210630_cal.xml" ] }, "definitionLink": { "local": [ "kwr-20210630_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "kwr20210630.htm" ] }, "labelLink": { "local": [ "kwr-20210630_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "kwr-20210630_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml" ] }, "schema": { "local": [ "kwr-20210630.xsd" ], "remote": [ "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd" ] } }, "elementCount": 954, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 5, "http://xbrl.sec.gov/dei/2020-01-31": 6, "total": 11 }, "keyCustom": 29, "keyStandard": 401, "memberCustom": 33, "memberStandard": 65, "nsprefix": "kwr", "nsuri": "http://www.quakerchem.com/20210630", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010409 - Disclosure - Business Segments", "role": "http://www.quakerchem.com/role/BusinessSegments", "shortName": "Business Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010410 - Disclosure - Net Sales and Revenue Recognition", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognition", "shortName": "Net Sales and Revenue Recognition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010508 - Disclosure - Leases", "role": "http://www.quakerchem.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010640 - Disclosure - Restructuring and Related Activities", "role": "http://www.quakerchem.com/role/RestructuringAndRelatedActivities", "shortName": "Restructuring and Related Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010710 - Disclosure - Share-Based Compensation", "role": "http://www.quakerchem.com/role/ShareBasedCompensation", "shortName": "Share-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010750 - Disclosure - Pension and Postretirement Benefits", "role": "http://www.quakerchem.com/role/PensionAndPostretirementBenefits", "shortName": "Pension and Postretirement Benefits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010810 - Disclosure - Other Income (Expense)", "role": "http://www.quakerchem.com/role/OtherIncomeExpense", "shortName": "Other Income (Expense)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010910 - Disclosure - Income Taxes and Uncertain Income Tax Positions", "role": "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions", "shortName": "Income Taxes and Uncertain Income Tax Positions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011010 - Disclosure - Earnings Per Share", "role": "http://www.quakerchem.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011118 - Disclosure - Restricted Cash", "role": "http://www.quakerchem.com/role/RestrictedCash", "shortName": "Restricted Cash", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000200 - Statement - Condensed Consolidated Statements of Operations", "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011510 - Disclosure - Goodwill and Intangible Assets", "role": "http://www.quakerchem.com/role/GoodwillAndIntangibleAssets", "shortName": "Goodwill and Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011910 - Disclosure - Debt", "role": "http://www.quakerchem.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012210 - Disclosure - Equity", "role": "http://www.quakerchem.com/role/Equity", "shortName": "Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012410 - Disclosure - Fair Value Measurements", "role": "http://www.quakerchem.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012415 - Disclosure - Hedging Activities", "role": "http://www.quakerchem.com/role/HedgingActivities", "shortName": "Hedging Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012510 - Disclosure - Commitments and Contingencies", "role": "http://www.quakerchem.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020001 - Disclosure - Basis of Presentation and Description of Business (Policies)", "role": "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies", "shortName": "Basis of Presentation and Description of Business (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030303 - Disclosure - Business Acquisitions (Tables)", "role": "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "shortName": "Business Acquisitions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030410 - Disclosure - Business Segments (Tables)", "role": "http://www.quakerchem.com/role/BusinessSegmentsTables", "shortName": "Business Segments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030510 - Disclosure - Net Sales and Revenue Recognition (Tables)", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables", "shortName": "Net Sales and Revenue Recognition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000300 - Statement - Condensed Consolidated Statements of Comprehensive Income", "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome", "shortName": "Condensed Consolidated Statements of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030609 - Disclosure - Leases (Tables)", "role": "http://www.quakerchem.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030610 - Disclosure - Restructuring Activities (Tables)", "role": "http://www.quakerchem.com/role/RestructuringActivitiesTables", "shortName": "Restructuring Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030710 - Disclosure - Share Based Compensation (Tables)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationTables", "shortName": "Share Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030750 - Disclosure - Pension and Other Post Retirement Benefits (Tables)", "role": "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "shortName": "Pension and Other Post Retirement Benefits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030810 - Disclosure - Other Income (Expense) (Tables)", "role": "http://www.quakerchem.com/role/OtherIncomeExpenseTables", "shortName": "Other Income (Expense) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031010 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.quakerchem.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031110 - Disclosure - Restricted Cash (Tables)", "role": "http://www.quakerchem.com/role/RestrictedCashTables", "shortName": "Restricted Cash (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031510 - Disclosure - Goodwill and Intangible Assets (Tables)", "role": "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables", "shortName": "Goodwill and Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031750 - Disclosure - Debt (Tables)", "role": "http://www.quakerchem.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032211 - Disclosure - Equity (Tables)", "role": "http://www.quakerchem.com/role/EquityTables", "shortName": "Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000400 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032410 - Disclosure - Fair Value Measurements (Table)", "role": "http://www.quakerchem.com/role/FairValueMeasurementsTable", "shortName": "Fair Value Measurements (Table)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032411 - Disclosure - Hedging Activities (Tables)", "role": "http://www.quakerchem.com/role/HedgingActivitiesTables", "shortName": "Hedging Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfCountriesInWhichEntityOperates", "reportCount": 1, "unitRef": "Countries", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040010 - Disclosure - Basis of Presentation and Description of Business (Details)", "role": "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "shortName": "Basis of Presentation and Description of Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362_srt_ConsolidatedEntitiesAxis_srt_SubsidiariesMember_srt_StatementGeographicalAxis_country_AR", "decimals": "-5", "lang": "en-US", "name": "us-gaap:AmountRecognizedInIncomeDueToInflationaryAccounting", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040214 - Disclosure - Business Acquisitions - Other Acquisitions - Narrative (Details)", "role": "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "shortName": "Business Acquisitions - Other Acquisitions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Feb28_2021_Entity_0000081362_us-gaap_BusinessAcquisitionAxis_kwr_TinplatingsolutionsMember", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040215 - Disclosure - Business Acquisitions - Preliminary Estimated Fair Values of Coral Net Assets Acquired (Details)", "role": "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "shortName": "Business Acquisitions - Preliminary Estimated Fair Values of Coral Net Assets Acquired (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Dec22_2020_Entity_0000081362_us-gaap_BusinessAcquisitionAxis_kwr_CoralChemicalCompanyMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362_us-gaap_BusinessAcquisitionAxis_kwr_CoralChemicalCompanyMember", "decimals": null, "first": true, "lang": "en-US", "name": "kwr:BusinessCombinationMeasurementPeriod", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040216 - Disclosure - Business Acquisitions - Coral - Narrative (Details)", "role": "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "shortName": "Business Acquisitions - Coral - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R46": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unitRef": "Segments", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040314 - Disclosure - Business Segments - Narrative (Details)", "role": "http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails", "shortName": "Business Segments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R47": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040315 - Disclosure - Business Segments - Performance of reportable segments (Details)", "role": "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "shortName": "Business Segments - Performance of reportable segments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "kwr:FairValueStepUpOfInventorySold", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "kwr:Netreportingamount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040410 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details)", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails", "shortName": "Net Sales and Revenue Recognition - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "kwr:Netreportingamount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040412 - Disclosure - Net Sales and Revenue Recognition (Details)", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails", "shortName": "Net Sales and Revenue Recognition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362_us-gaap_TimingOfTransferOfGoodOrServiceAxis_us-gaap_TransferredAtPointInTimeMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "myUSDPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000450 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "myUSDPerShare", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040415 - Disclosure - Leases - Narrative (Details)", "role": "http://www.quakerchem.com/role/LeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040416 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)", "role": "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails", "shortName": "Leases - Supplemental Balance Sheet Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:LeaseCostTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OperatingLeaseLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040417 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)", "role": "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails", "shortName": "Leases - Maturities of Operating Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040640 - Disclosure - Restructuring Activities - Narrative (Details)", "role": "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails", "shortName": "Restructuring Activities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040650 - Disclosure - Restructuring Activities (Details)", "role": "http://www.quakerchem.com/role/RestructuringActivitiesDetails", "shortName": "Restructuring Activities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362_us-gaap_RestructuringPlanAxis_kwr_QhProgramMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040710 - Disclosure - Share-Based Compensation - Narrative (Details)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "shortName": "Share-Based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember", "decimals": null, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040720 - Disclosure - Share-Based Compensation - Expense Table (Details)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails", "shortName": "Share-Based Compensation - Expense Table (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362_us-gaap_AwardTypeAxis_kwr_StockOptionsCompensationExpenseMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040760 - Disclosure - Share-Based Compensation - Black-Scholes option pricing model (Details)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "shortName": "Share-Based Compensation - Black-Scholes option pricing model (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "4", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040815 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost and Changes in Other Comprehensive Income (Details)", "role": "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails", "shortName": "Pension and Other Postretirement Benefits - Net Periodic Benefit Cost and Changes in Other Comprehensive Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040860 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details)", "role": "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "shortName": "Pension and Other Postretirement Benefits - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000500 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040900 - Disclosure - Other Income (Expense) (Details)", "role": "http://www.quakerchem.com/role/OtherIncomeExpenseDetails", "shortName": "Other Income (Expense) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxLiabilities", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040960 - Disclosure - Income Taxes - Narrative (Details)", "role": "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R62": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "5", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040970 - Disclosure - Income Taxes - Uncertain Tax Positions - Narrative (Details)", "role": "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails", "shortName": "Income Taxes - Uncertain Tax Positions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "5", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041010 - Disclosure - Earnings Per Share - Basic (Details)", "role": "http://www.quakerchem.com/role/EarningsPerShareBasicDetails", "shortName": "Earnings Per Share - Basic (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041020 - Disclosure - Earnings Per Share - Diluted (Details)", "role": "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails", "shortName": "Earnings Per Share - Diluted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041030 - Disclosure - Earnings Per Share - Antidilutive Shares (Details)", "role": "http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails", "shortName": "Earnings Per Share - Antidilutive Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041110 - Disclosure - Restricted Cash (Details)", "role": "http://www.quakerchem.com/role/RestrictedCashDetails", "shortName": "Restricted Cash (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2020_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041510 - Disclosure - Goodwill and Other Intangible Assets - Goodwill Assets (Details)", "role": "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails", "shortName": "Goodwill and Other Intangible Assets - Goodwill Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedCustomerListsGross", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041520 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets (Details)", "role": "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails", "shortName": "Goodwill and Other Intangible Assets - Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:FiniteLivedCustomerListsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041540 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)", "role": "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails", "shortName": "Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010110 - Disclosure - Basis of Presentation and Description of Business", "role": "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusiness", "shortName": "Basis of Presentation and Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041550 - Disclosure - Intangible Assets - Indefinite Lived (Details)", "role": "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails", "shortName": "Intangible Assets - Indefinite Lived (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-5", "lang": "en-US", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeaseObligations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041910 - Disclosure - Debt - Table (Details)", "role": "http://www.quakerchem.com/role/DebtTableDetails", "shortName": "Debt - Table (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeaseObligations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041950 - Disclosure - Debt - Debt related expenses included within Interest expense (Details)", "role": "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails", "shortName": "Debt - Debt related expenses included within Interest expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LettersOfCreditOutstandingAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041960 - Disclosure - Debt - Narrative (Details)", "role": "http://www.quakerchem.com/role/DebtNarrativeDetails", "shortName": "Debt - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LettersOfCreditOutstandingAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042211 - Disclosure - Equity and Noncontrolling Interest - Changes in Equity (Details)", "role": "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails", "shortName": "Equity and Noncontrolling Interest - Changes in Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Apr01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "myUSDPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042212 - Disclosure - Equity and Noncontrolling Interest - Changes in Equity (Parentheticals) (Details)", "role": "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityParentheticalsDetails", "shortName": "Equity and Noncontrolling Interest - Changes in Equity (Parentheticals) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R76": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042220 - Disclosure - Equity and Noncontrolling Interest - AOCI Reclassifications (Details)", "role": "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails", "shortName": "Equity and Noncontrolling Interest - AOCI Reclassifications (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashSurrenderValueFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042410 - Disclosure - Fair Value - Assets (Details)", "role": "http://www.quakerchem.com/role/FairValueAssetsDetails", "shortName": "Fair Value - Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashSurrenderValueFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Nov30_2019_Entity_0000081362_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeLiabilityNotionalAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042504 - Disclosure - Hedging Activities - Narrative (Details)", "role": "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "shortName": "Hedging Activities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember", "decimals": null, "lang": "en-US", "name": "us-gaap:DerivativeTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042505 - Disclosure - Hedging Activities - Table (Details)", "role": "http://www.quakerchem.com/role/HedgingActivitiesTableDetails", "shortName": "Hedging Activities - Table (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010210 - Disclosure - Business Acquisitions", "role": "http://www.quakerchem.com/role/BusinessAcquisitions", "shortName": "Business Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042510 - Disclosure - Commitments and Contingencies - Narrative (Details)", "role": "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:LossContingencyAccrualAtCarryingValue", "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-5", "lang": "en-US", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010310 - Disclosure - Recently Issued Accounting Standards", "role": "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards", "shortName": "Recently Issued Accounting Standards", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210630.htm", "contextRef": "FROM_Jan01_2021_TO_Jun30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 99, "tag": { "country_AR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Argentina [Member]" } } }, "localname": "AR", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "country_BR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BR", "terseLabel": "Brazil [Member]" } } }, "localname": "BR", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ca", "terseLabel": "Canada [Member]" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_CN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CN", "terseLabel": "China [Member]" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_DE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DE", "terseLabel": "Germany [Member]" } } }, "localname": "DE", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_ES": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ES", "terseLabel": "Spain [Member]" } } }, "localname": "ES", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_FR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FR", "terseLabel": "France [Member]" } } }, "localname": "FR", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_GB": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GB", "terseLabel": "United Kingdom [Member]" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_IN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IN", "terseLabel": "India [Member]" } } }, "localname": "IN", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_IT": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IT", "terseLabel": "Italy [Member]" } } }, "localname": "IT", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_MX": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MX", "terseLabel": "Mexico [Member]" } } }, "localname": "MX", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_NL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NL", "terseLabel": "The Netherlands [Member]" } } }, "localname": "NL", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "United States [Member]", "terseLabel": "Domestic plan [Member]", "verboseLabel": "U.S. [Member]" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current fiscal year end date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r824", "r826", "r827" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document period end date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r825" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document quarterly report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r828" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r822" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated By Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r829" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity central index key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity common stock shares outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity current reporting status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r829" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r829" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity filer category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r830" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity public float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r829" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity registrant name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r829" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r829" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r829" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity voluntary filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity well known seasoned issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r821" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12(b) Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r823" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "kwr_AcpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AC Products, Inc. Subsidiary involved in groundwater contamination litigation", "label": "Acp [Member]", "terseLabel": "ACP [Member]" } } }, "localname": "AcpMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_AcquisitionRelatedFairValueAdjustments": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-cash adjustments to the fair value of acquisition-related contingent consideration liabilities or non-cash gains from the revaluation of an existing equity interest as the result of a business combination .", "label": "Acquisition-related fair value adjustments related to inventory", "negatedLabel": "Acquisition-related fair value adjustments related to inventory" } } }, "localname": "AcquisitionRelatedFairValueAdjustments", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_AsbestosClaimsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Numerous lawsuits alleging injury due to exposure to asbestos.", "label": "Asbestos claims [Member]" } } }, "localname": "AsbestosClaimsMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_AssetAcquisitionConsiderationTransferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.", "label": "Asset Acquisition, Consideration Transferred" } } }, "localname": "AssetAcquisitionConsiderationTransferred", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesAssetsFixedIncomeRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in fixed income common stock.", "label": "Available For Sale Securities Assets Fixed Income Registered Investment Companies Fair Value Disclosure", "terseLabel": "Fixed Income Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsFixedIncomeRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesAssetsInternationalDevelopedAndEmergingMarketsRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in international developed and emerging markets common stock.", "label": "Available For Sale Securities Assets International Developed And Emerging Markets Registered Investment Companies Fair Value Disclosure", "terseLabel": "International Developed And Emerging Markets Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsInternationalDevelopedAndEmergingMarketsRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesAssetsLargeCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in large capitalization common stock.", "label": "Available For Sale Securities Assets Large Capitalization Registered Investment Companies Fair Value Disclosure", "terseLabel": "Large Capitalization Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsLargeCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesAssetsMidCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in mid capitalization common stock.", "label": "Available For Sale Securities Assets Mid Capitalization Registered Investment Companies Fair Value Disclosure", "terseLabel": "Mid Capitalization Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsMidCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesAssetsSmallCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in small capitalization common stock.", "label": "Available For Sale Securities Assets Small Capitalization Registered Investment Companies Fair Value Disclosure", "terseLabel": "Small Capitalization Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsSmallCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_BankLinesOfCreditAndOtherDebtObligationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bank lines of credit and other debt obligations.", "label": "Bank lines of credit and other debt obligations [Member]" } } }, "localname": "BankLinesOfCreditAndOtherDebtObligationsMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "kwr_BrazilianIndirectTaxesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legal claim in regards to certain Brazilian non-income (indirect) taxes.", "label": "Brazilian Indirect Taxes [Member]" } } }, "localname": "BrazilianIndirectTaxesMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_BusinessAcquisitionAcquireeIndiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Quaker Chemical India Private Limited business combination completed during the year.", "label": "Business Acquisition Acquiree India [Member]", "terseLabel": "India [Member]" } } }, "localname": "BusinessAcquisitionAcquireeIndiaMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_BusinessAcquisitionContingentConsiderationActualCashPayment": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 49.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid to former stockholders to settle hold-back contingent consideration liability.", "label": "Business Acquisition Contingent Consideration Actual Cash Payment", "negatedLabel": "Payment of acquisition-related liabilities", "terseLabel": "Contingent Consideration Paid" } } }, "localname": "BusinessAcquisitionContingentConsiderationActualCashPayment", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfCompanyInSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity interest issued or issuable of the total company shares issued in business acquisition.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Percentage Of Company in Shares Issued" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfCompanyInSharesIssued", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails" ], "xbrltype": "percentItemType" }, "kwr_BusinessCombinationMeasurementPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The measurement period post acquisition during which the company may record adjustments to the estimated fair value of asset acquired and liabilities assumed.", "label": "Business Combination, Measurement Period", "terseLabel": "Measurement period" } } }, "localname": "BusinessCombinationMeasurementPeriod", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "kwr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, accrued expenses and other accrued liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts payable, accrued expenses and other accrued liabilities", "terseLabel": "Accounts payable, accrued expenses and other accrued liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherAccruedLiabilities", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "kwr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebtIncludedCurrentPortions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long-term debt included current portions", "terseLabel": "Long-term debt included current portions" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebtIncludedCurrentPortions", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Businesscombinationindemnificationassetsrelatedtoformerownership": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Indemnification assets associated with business combinations", "label": "Business Combination Indemnification Assets Related to Former Ownership" } } }, "localname": "Businesscombinationindemnificationassetsrelatedtoformerownership", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_CapitalExpendituresReductionInAccrualButNoCashImpact": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of reduction in capital expenditure accruals which did not have any impact on cash.", "label": "Capital Expenditures Reduction In Accrual But No Cash Impact", "negatedLabel": "Change in accrued purchases of property, plant and equipment, net" } } }, "localname": "CapitalExpendituresReductionInAccrualButNoCashImpact", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_CashSurrenderValueCompanyOwnedLifeInsuranceDeferredCompensationAssetsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of company owned life insurance in deferred compensation assets.", "label": "Cash Surrender Value Company Owned Life Insurance Deferred Compensation Assets Fair Value Disclosure", "terseLabel": "Company Owned Life Insurance - Deferred Compensation Assets" } } }, "localname": "CashSurrenderValueCompanyOwnedLifeInsuranceDeferredCompensationAssetsFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_CeoTransitionCosts": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expense recognized for the Company's former CEO's supplemental retirement plan, which relates to the former CEO's retirement.", "label": "CEO transition costs", "negatedTerseLabel": "CEO transition charges" } } }, "localname": "CeoTransitionCosts", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kwr_ChemicalMaskantsProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 acquisition Chemical maskants product line.", "label": "Chemical maskants product line [Member]" } } }, "localname": "ChemicalMaskantsProductLineMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_CombinationAndNormanHayMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Combination and Norman Hay business acquisition that was completed during the period.", "label": "Combination And Norman Hay [Member]" } } }, "localname": "CombinationAndNormanHayMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_CombinationAndOtherAcquisitionRelatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Combination And Other Acquisition-Related [Member]" } } }, "localname": "CombinationAndOtherAcquisitionRelatedMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_CombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The August 1, 2019 business acquisition and Combination with Houghton International", "label": "Combination [Member]" } } }, "localname": "CombinationMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Combinationrelatedexpensesnetofpayements": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities, net of payments.", "label": "Combination and other acquisition-related expenses, net of payments" } } }, "localname": "Combinationrelatedexpensesnetofpayements", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_CommingledFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about pooled institutional investments, including primarily investment trusts", "label": "Commingled funds measured at NAV [Member]" } } }, "localname": "CommingledFundsMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_CompanyStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Describes amounts and percentages of the Entity's common stock as part of the Entity's Pension and Postretirement Benefit Plans.", "label": "Company Stock [Member]" } } }, "localname": "CompanyStockMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ConsolidatedAdjustedEbitdaToInterestExpenseRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company's consolidated adjusted EBITDA to interest expense ratio as part of debt convenants.", "label": "Consolidated adjusted EBITDA to interest expense ratio" } } }, "localname": "ConsolidatedAdjustedEbitdaToInterestExpenseRatio", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "kwr_ConsolidatedStatementOfChangesInEquityParentheticalsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statement Of Changes In Equity Parentheticals [Abstract]" } } }, "localname": "ConsolidatedStatementOfChangesInEquityParentheticalsAbstract", "nsuri": "http://www.quakerchem.com/20210630", "xbrltype": "stringItemType" }, "kwr_CoralChemicalCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business acquisition of Coral, a privately held, U.S.-based provider of metal finishing fluid solutions.", "label": "Coral Chemical Company (Coral) [Member]" } } }, "localname": "CoralChemicalCompanyMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables" ], "xbrltype": "domainItemType" }, "kwr_Debtinstrumentmaturityyear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year that debt instrument matures and is to be fully repaid.", "label": "Debt Instrument Maturity Year" } } }, "localname": "Debtinstrumentmaturityyear", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "gYearItemType" }, "kwr_DeferredTaxAssetsAcquiredDisallowedInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Acquired Disallowed Interest.", "label": "Deferred Tax Assets, Acquired Disallowed Interest" } } }, "localname": "DeferredTaxAssetsAcquiredDisallowedInterest", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DeferredTaxAssetsOperatingLossCarryforwardsForeignExpirationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Operating Loss Carryforwards Foreign Expiration Period.", "label": "Deferred Tax Assets Operating Loss Carryforwards Foreign Expiration Period" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeignExpirationPeriod", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "durationItemType" }, "kwr_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocalBasedOnReversalOfDeferredTaxLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Operating Loss Carryforwards State And Local Based On Reversal Of Deferred Tax Liabilities.", "label": "Deferred Tax Assets Operating Loss Carryforwards State And Local Based On Reversal Of Deferred Tax Liabilities" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocalBasedOnReversalOfDeferredTaxLiabilities", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocalExpirationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Operating Loss Carryforwards State And Local Expiration Period.", "label": "Deferred Tax Assets Operating Loss Carryforwards State And Local Expiration Period" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocalExpirationPeriod", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "durationItemType" }, "kwr_DeferredTaxAssetsPartialValuationAllowanceNetExpectedFutureBenefit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Partial Valuation Allowance, Net Expected Future Benefit.", "label": "Deferred Tax Assets, Partial Valuation Allowance, Net Expected Future Benefit" } } }, "localname": "DeferredTaxAssetsPartialValuationAllowanceNetExpectedFutureBenefit", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DeferredTaxAssetsTaxCreditCarryforwardsForeignExpectedToExpire": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Tax Credit Carryforwards Foreign Expected To Expire.", "label": "Deferred Tax Assets Tax Credit Carryforwards Foreign Expected To Expire" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeignExpectedToExpire", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DeferredTaxAssetsTaxCreditCarryforwardsForeignExpectedToExpireNextFiveYears": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Tax Credit Carryforwards Foreign Expected To Expire Next Five Years.", "label": "Deferred Tax Assets Tax Credit Carryforwards Foreign Expected To Expire Next Five Years" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeignExpectedToExpireNextFiveYears", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DefinedBenefitPlanAmortizationOfGainsLossesWithSettlementLoss": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 15.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amortization of actuarial loss including plan settlement losses", "label": "Defined Benefit Plan, Amortization of Gains (Losses) with Settlement Loss", "terseLabel": "Actuarial Loss" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLossesWithSettlementLoss", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DefinedBenefitPlanForeignCurrencyExchangeRateChangesOtherComprehensiveIncomeLoss": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 18.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from foreign currency exchange rate changes for an obligation of a foreign operation whose functional currency is not the reporting currency.", "label": "Defined Benefit Plan Foreign Currency Exchange Rate Changes, Other Comprehensive Income Loss", "negatedLabel": "Foreign Currency Exchange Rate Changes", "terseLabel": "Effect of exchange rates on amounts Included in AOCI" } } }, "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesOtherComprehensiveIncomeLoss", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DefinedContributionPlanEmployerNonElectiveNondiscretionaryContributionsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nonelective contributions funds the entity choose to direct toward their eligible workers defined contribution plan if employees make their own contributions, after employees have completed one year of service.", "label": "Defined contribution plan employer non-elective nondiscretionary contributions percent" } } }, "localname": "DefinedContributionPlanEmployerNonElectiveNondiscretionaryContributionsPercent", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_DefinedContributionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Contribution Plan [Member]" } } }, "localname": "DefinedContributionPlanMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Definedbenefitplanpremiumrefund": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Refund Related to Overpayment of Premium Refund", "label": "Defined Benefit Plan Premium Refund" } } }, "localname": "Definedbenefitplanpremiumrefund", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DefinedbenefitplansettlementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined benefit plan settlement [Member]" } } }, "localname": "DefinedbenefitplansettlementMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Definedcontributionplanemployermatchingcontributionpercentmaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of emplyee compensation that is contributed to the plan, with a maximum matching contribution made by the employer.", "label": "Defined contribution plan employer matching contribution percent maximum" } } }, "localname": "Definedcontributionplanemployermatchingcontributionpercentmaximum", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_DirectorRetainerAnnualFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total annual director retainer fee.", "label": "Director Retainer Annual Fee", "terseLabel": "Total annual director retainer fee" } } }, "localname": "DirectorRetainerAnnualFee", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DirectorStockOwnershipCashRetainer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the director retainer fee in company stock and cash.", "label": "Director Stock Ownership Cash Retainer", "terseLabel": "Director Stock Ownership Plan Terms" } } }, "localname": "DirectorStockOwnershipCashRetainer", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_DirectorStockOwnershipPercentageThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Director Stock ownership percentage threshold", "label": "Director Stock ownership Percentage Threshold" } } }, "localname": "DirectorStockOwnershipPercentageThreshold", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_DirectorsStockOwnershipPlanCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the company's board of director's stock plan.", "label": "Directors Stock Ownership Plan Compensation Expense [Member]", "terseLabel": "Director stock ownership plan [Member]" } } }, "localname": "DirectorsStockOwnershipPlanCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails" ], "xbrltype": "domainItemType" }, "kwr_Directorstockownershipplanpercentagecash": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Director Stock Ownership Plan paid in Cash", "label": "Director Stock Ownership Plan Percentage Cash" } } }, "localname": "Directorstockownershipplanpercentagecash", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_Directorstockownershipplanpercentagestock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Director Stock Ownership Plan paid in Cash", "label": "Director Stock Ownership Plan Percentage Stock" } } }, "localname": "Directorstockownershipplanpercentagestock", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_Directorstockownershipplanpercentagetotal": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Director Stock Ownership Plan paid in Total", "label": "Director Stock Ownership Plan Percentage Total" } } }, "localname": "Directorstockownershipplanpercentagetotal", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments held in diversified investment funds or registered investments measured at NAV.", "label": "Diversified investment fund - registered investment companies measured at NAV [Member]" } } }, "localname": "DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.quakerchem.com/20210630", "xbrltype": "stringItemType" }, "kwr_EffectOfTaxRateChange": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effect on EPS of tax rate change in current period.", "label": "Effect Of Tax Rate Change" } } }, "localname": "EffectOfTaxRateChange", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_EffectofpriorservicecostChargeperdilutedshare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the effect on diluted earnings per share due to a prior service cost related to pension during the period.", "label": "Effect Of Prior Service Cost Charge Per Diluted Share" } } }, "localname": "EffectofpriorservicecostChargeperdilutedshare", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "kwr_Effectofrestructuringcostsperdilutedshare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the effect on diluted earnings per share due to restructuring costs during the period.", "label": "Effect Of Restructuring Costs Per Diluted Share" } } }, "localname": "Effectofrestructuringcostsperdilutedshare", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "kwr_EmployeeStockPurchasePlanCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity basedcompensation cost recognized during the period in selling, general and administrative expense for the employee stock purchase plan.", "label": "Employee Stock Purchase Plan Compensation Expense [Member]" } } }, "localname": "EmployeeStockPurchasePlanCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInNextYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of Tax Loss Carryforward Expiring in Next Year", "label": "Expiration In Next Year [Member]" } } }, "localname": "ExpirationInNextYearMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within eight years of the balance sheet date.", "label": "Expiration In Year Eight [Member]" } } }, "localname": "ExpirationInYearEightMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within five years of the balance sheet date.", "label": "Expiration In Year Five [Member]" } } }, "localname": "ExpirationInYearFiveMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within four years of the balance sheet date.", "label": "Expiration In Year Four [Member]" } } }, "localname": "ExpirationInYearFourMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within nine years of the balance sheet date.", "label": "Expiration In Year Nine [Member]" } } }, "localname": "ExpirationInYearNineMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within seven years of the balance sheet date.", "label": "Expiration In Year Seven [Member]" } } }, "localname": "ExpirationInYearSevenMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within six years of the balance sheet date.", "label": "Expiration In Year Six [Member]" } } }, "localname": "ExpirationInYearSixMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within ten years of the balance sheet date.", "label": "Expiration In Year Ten [Member]" } } }, "localname": "ExpirationInYearTenMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiration In Year Three [Member]" } } }, "localname": "ExpirationInYearThreeMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within two years of the balance sheet date.", "label": "Expiration In Year Two [Member]" } } }, "localname": "ExpirationInYearTwoMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationinfifteenyearsmemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within Fifteen years of the balance sheet date.", "label": "Expiration In Fifteen Years [Member]" } } }, "localname": "ExpirationinfifteenyearsmemberMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationintwentyyearsmemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within twenty years of the balance sheet date.", "label": "Expiration In Twenty Years [Member]" } } }, "localname": "ExpirationintwentyyearsmemberMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_FacilitiesVehiclesAndMachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating leases for certain facilities, vehicles and machinery and equipment.", "label": "Facilities vehicles and machinery and equipment [Member]" } } }, "localname": "FacilitiesVehiclesAndMachineryAndEquipmentMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_FairValueStepUpOfInventorySold": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value step up of inventory sold relates to expenses associated with selling inventory from acquired businesses which was adjusted to fair value as part of purchase accounting.", "label": "Fair value step up of acquired inventory sold", "negatedLabel": "Fair value step up of acquired inventory sold" } } }, "localname": "FairValueStepUpOfInventorySold", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_FederalIncomeTaxExpenseForeign": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of federal income tax expense payable to non-domestic authorities.", "label": "Fededral income tax expense foreign" } } }, "localname": "FederalIncomeTaxExpenseForeign", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite Lived Intangible Assets Accumulated Amortization [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "kwr_FiniteLivedTrademarksFormulationsAndProductTechnologyGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the trademarks formulations and product technology.", "label": "Finite Lived Trademarks Formulations And Product Technology Gross", "terseLabel": "Trademarks, Formulations And Product Technology" } } }, "localname": "FiniteLivedTrademarksFormulationsAndProductTechnologyGross", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_ForeignconsumptiontaxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Consumption Tax Matter", "label": "Foreign Consumption Tax [Member]" } } }, "localname": "ForeignconsumptiontaxMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_GainOnDispositionOfAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (loss) on disposition of assets" } } }, "localname": "GainOnDispositionOfAssets", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "kwr_GlobalSpecialtyBusinessesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Global Specialty Businesses.", "label": "Global Specialty Businesses [Member]" } } }, "localname": "GlobalSpecialtyBusinessesMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_GrindaixGmbhMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acqusition of Grindaix-GmbH, a privately held, German-based, high-tech provider of coolant control and delivery systems.", "label": "Grindaix GmbH [Member]" } } }, "localname": "GrindaixGmbhMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_HoughtonCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hougton, a business combination.", "label": "Houghton Combination [Member]", "terseLabel": "Houghton Combination [Member]" } } }, "localname": "HoughtonCombinationMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "domainItemType" }, "kwr_HoughtonEnvironmentalMattersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Houghton environmental matters.", "label": "Houghton environmental matters [Member]" } } }, "localname": "HoughtonEnvironmentalMattersMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_HoughtonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination of Houghton.", "label": "Houghton [Member]" } } }, "localname": "HoughtonMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_IncludingGlobalSpecialtyBusinessesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Segment including Global Specialty Businesses.", "label": "Including Global Specialty Businesses [Member]" } } }, "localname": "IncludingGlobalSpecialtyBusinessesMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 15.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income Loss From Continuing Operations Before Noncontrolling Interests and Income Loss From Equity Method Investments", "label": "Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments", "totalLabel": "Income (loss) before equity in net income of associated companies" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kwr_IncreaseDecreaseInDeferredCompensationAndOtherNet": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future and other certain items.", "label": "Increase Decrease In Deferred Compensation And Other Net", "terseLabel": "Deferred compensation, deferred taxes and other, net" } } }, "localname": "IncreaseDecreaseInDeferredCompensationAndOtherNet", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_Increasedecreaseinaccruednoncurrentincometaxespayable": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Increase decrease in accrued non current income taxes payable", "negatedTerseLabel": "Non-current income taxes payable" } } }, "localname": "Increasedecreaseinaccruednoncurrentincometaxespayable", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_IndustrialDevelopmentBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Industrial development bonds.", "label": "Industrial development bonds [Member]" } } }, "localname": "IndustrialDevelopmentBondsMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "kwr_Industrialdevelopmentrevenuebond": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents an Industrial Development Revenue Bond used to fund the expansion of the company's Middletown, Ohio manufacturing facility.", "label": "Industrial Development Revenue Bond" } } }, "localname": "Industrialdevelopmentrevenuebond", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_InitialConsolidatedNetDebtToConsolidatedEbitdaRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company's initial consolidated net debt to consolidated adjusted EBITDA ratio range.", "label": "Initial consolidated net debt to consolidated EBITDA ratio" } } }, "localname": "InitialConsolidatedNetDebtToConsolidatedEbitdaRatio", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "kwr_Insurancesolvencyrecovery": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income associated with a cash receipt from an insolvent insurance carrier for previously submitted claims by an inative subsiary of the Company.", "label": "Insurance solvency recovery" } } }, "localname": "Insurancesolvencyrecovery", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "kwr_KoreaHoughtonCoporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Korea Houghton company business combinations that was completed during the period.", "label": "Korea Houghton Coporation [Member]" } } }, "localname": "KoreaHoughtonCoporationMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Kwr_lineofcreditremainingborrowingcapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Remaining borrowing Capacity, net of letters of credit", "label": "Line of Credit Remaining borrowing Capacity, net of letters of credit" } } }, "localname": "Kwr_lineofcreditremainingborrowingcapacity", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_LargestCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from the entity's largest customer is to net revenues.", "label": "Largest customer [Member]" } } }, "localname": "LargestCustomerMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_LegacyQuakerUsPensionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Legacy Quaker U.S. Pension Plan [Member]" } } }, "localname": "LegacyQuakerUsPensionPlanMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Lineofcreditfacilityinitiationdatedescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility Initiation Date Description.", "label": "Line Of Credit Facility Initiation Date Description" } } }, "localname": "Lineofcreditfacilityinitiationdatedescription", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_LossCarryforwardExpirationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the expirations of tax loss carryforwards.", "label": "Loss Carryforward Expiration [Axis]" } } }, "localname": "LossCarryforwardExpirationAxis", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_LossCarryforwardExpirationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identifies the period in which available tax loss carryforwards expire.", "label": "Loss Carryforward Expiration [Domain]" } } }, "localname": "LossCarryforwardExpirationDomain", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_LossContingencyRangeOfOperationWellP2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated range of time that Well P-2 will operate", "label": "Loss Contingency Range Of Operation Well P 2", "terseLabel": "P-2 well operation range estimate" } } }, "localname": "LossContingencyRangeOfOperationWellP2", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_LossContingencyRangeOfOperationWellP3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated range of time that Well P-3 will operate", "label": "Loss Contingency Range Of Operation Well P 3", "terseLabel": "P-3 well operation range estimate" } } }, "localname": "LossContingencyRangeOfOperationWellP3", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_LossOnDispositionOfAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Loss on Disposition of Assets" } } }, "localname": "LossOnDispositionOfAssets", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "kwr_MatchingStockContribution401KPlanCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the non-elective and elective 401 (k) match stock contribution plan.", "label": "Matching Stock Contribution 401 K Plan Compensation Expense [Member]", "terseLabel": "Non-elective and elective 401(k) matching contribution in stock [Member]" } } }, "localname": "MatchingStockContribution401KPlanCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails" ], "xbrltype": "domainItemType" }, "kwr_MaximumAnnualCashDividendsRestrictionBasedOnCovenants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of maximum cash dividends that can be paid annually per convenants.", "label": "Maximum annual cash dividends restriction based on covenants" } } }, "localname": "MaximumAnnualCashDividendsRestrictionBasedOnCovenants", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_MetalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Metals product line.", "label": "Metals [Member]" } } }, "localname": "MetalsMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_MetalworkingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Metals product line.", "label": "Metalworking [Member]" } } }, "localname": "MetalworkingMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_MetalworkingnorthamericamemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Metalworking North America business combination completed during the year.", "label": "Metalworking North America [Member]" } } }, "localname": "MetalworkingnorthamericamemberMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_MiningNorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Minining North America business combination completed during the year.", "label": "Mining North America [Member]" } } }, "localname": "MiningNorthAmericaMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_MiningnorthamericatrademarksformulationsandproducttechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mining North America Trademarks Formulations And Product Technology [Member]" } } }, "localname": "MiningnorthamericatrademarksformulationsandproducttechnologyMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_NarrativeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Narrative [Abstract]" } } }, "localname": "NarrativeAbstract", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "stringItemType" }, "kwr_NetDebtToConsolidatedAdjustedEbitdaRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company's consolidated net debt to consolidated adjusted EBITDA ratio range.", "label": "Net debt to consolidated adjusted EBITDA ratio" } } }, "localname": "NetDebtToConsolidatedAdjustedEbitdaRatio", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "kwr_NetherlandsAndSpainMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Netherlands and Spain [Member]" } } }, "localname": "NetherlandsAndSpainMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Netreportingamount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as revenue under net reporting arrangements", "label": "Net Reporting Amount", "terseLabel": "Revenue Recognized Under Net Reporting Arrangements" } } }, "localname": "Netreportingamount", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_NonoperatingCharges": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of non-operating charges recurring against earnings in the period, which are not directly related to or being allocated to a specific segment.", "label": "Nonoperating Charges", "negatedTerseLabel": "Non-operating and administrative expenses" } } }, "localname": "NonoperatingCharges", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_NonvestedStockAwardsCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for nonvested stock and restricted stock unit awards.", "label": "Nonvested Stock Awards Compensation Expense [Member]", "terseLabel": "Non-vested stock awards and restricted stock units [Member]" } } }, "localname": "NonvestedStockAwardsCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails" ], "xbrltype": "domainItemType" }, "kwr_NormanHayMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business acquisition of Norman Hay.", "label": "Norman Hay [Member]" } } }, "localname": "NormanHayMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_OffsetInTaxLiabilitiesThroughPurchaseAccounting": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offset In Tax Liabilities Through Purchase Accounting.", "label": "Offset In Tax Liabilities Through Purchase Accounting" } } }, "localname": "OffsetInTaxLiabilitiesThroughPurchaseAccounting", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OldCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Syndicated multicurrency, unsecured revolving credit facility with a group of lenders.", "label": "Previous Credit Facility [Member]", "terseLabel": "Previous Credit Facility [Member]" } } }, "localname": "OldCreditFacilityMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_OneJurisdictionExposurePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of exposure represented by one jurisdiction relating to possible contingency related to unasserted claims.", "label": "One Jurisdiction Exposure Percentage", "terseLabel": "Percentage of potential exposure represented by one jurisdiction" } } }, "localname": "OneJurisdictionExposurePercentage", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_OperatingIncomeLossSegmentReporting": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues before amortization and non-operating charges.", "label": "Operating Income Loss Segment Reporting", "terseLabel": "Operating Earnings, Excluding Indirect Operating Expenses", "verboseLabel": "Segment operating earnings" } } }, "localname": "OperatingIncomeLossSegmentReporting", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OperatingLossCarryforwardsForeignPartialValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Loss Carryforwards, Foreign, Partial Valuation Allowance.", "label": "Operating Loss Carryforwards, Foreign, Partial Valuation Allowance" } } }, "localname": "OperatingLossCarryforwardsForeignPartialValuationAllowance", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OperatingLossCarryforwardsStatePartialValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Loss Carryforwards, State, Partial Valuation Allowance.", "label": "Operating Loss Carryforwards, State, Partial Valuation Allowance" } } }, "localname": "OperatingLossCarryforwardsStatePartialValuationAllowance", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OtherLiabilitiesCurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line item in the statement of financial position in which the fair value amounts of the derivative instruments are included.", "label": "Other Liabilities Current [Member]" } } }, "localname": "OtherLiabilitiesCurrentMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Othercomprehensiveincomelossplancurtailments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other Comprehensive Income Loss Plan Curtailments" } } }, "localname": "Othercomprehensiveincomelossplancurtailments", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Othercomprehensiveincomelossplansettlement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other comprehensive income loss plan settlement" } } }, "localname": "Othercomprehensiveincomelossplansettlement", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Pensionandpostretirementbenefitcostsnonservicecomponents": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other income related to non-service pension cost components", "label": "Pension and post retirement benefit costs, non-service components", "negatedTerseLabel": "Pension and post retirement benefit costs nonservice components" } } }, "localname": "Pensionandpostretirementbenefitcostsnonservicecomponents", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "kwr_PercentageOfCashDividendsOfConsolidatedAdjustedEbitda": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of cash dividends of consolidated adjusted EBITDA.", "label": "Percentage of cash dividends of consolidated adjusted EBITDA" } } }, "localname": "PercentageOfCashDividendsOfConsolidatedAdjustedEbitda", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfDefenseAndIndemnityCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of defense and indemnity costs incurred by or on behalf of the subsidiary.", "label": "Percentage of defense and indemnity costs" } } }, "localname": "PercentageOfDefenseAndIndemnityCosts", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanBorrowings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of term loan borrowings.", "label": "Percentage of term loan borrowings" } } }, "localname": "PercentageOfTermLoanBorrowings", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanPrincipalAmortizationYearFourAndFive": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of term loans quarterly principal amortization during their respective five-year maturities, for years four and five.", "label": "Percentage of term loan principal amortization year four and five" } } }, "localname": "PercentageOfTermLoanPrincipalAmortizationYearFourAndFive", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanPrincipalAmortizationYearOneAndTwo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of term loans quarterly principal amortization during their respective five-year maturities, for year one and two.", "label": "Percentage of term loan principal amortization year one and two" } } }, "localname": "PercentageOfTermLoanPrincipalAmortizationYearOneAndTwo", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanPrincipalAmortizationYearThree": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of term loans quarterly principal amortization during their respective five-year maturities, for year three.", "label": "Percentage of term loan principal amortization year three" } } }, "localname": "PercentageOfTermLoanPrincipalAmortizationYearThree", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanPrincipalAmortizationYearTwo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of term loans quarterly principal amortization during their respective five-year maturities, for year two.", "label": "Percentage of term loan principal amortization year two" } } }, "localname": "PercentageOfTermLoanPrincipalAmortizationYearTwo", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PeriodOfProjectedClaimsOfSubusidiary": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of total projected claims liability of the subsidiary.", "label": "Period Of Projected Claims Of Subusidiary" } } }, "localname": "PeriodOfProjectedClaimsOfSubusidiary", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "kwr_PooledSeparateAccountPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pooled Separate account Description", "label": "Pooled Separate account percentage" } } }, "localname": "PooledSeparateAccountPercentage", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_PriorPeriodReclassifications": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of balance sheet reclassifications made to prior period financial statements in order to conform to current year presentation.", "label": "Prior Period Reclassifications" } } }, "localname": "PriorPeriodReclassifications", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_ProceedsFromNonIncomeTaxRefunds": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash received during the period as refunds for the overpayment of non-income taxes.", "label": "Proceeds From Non Income Tax Refunds", "terseLabel": "Non-income tax refunds and other related credits" } } }, "localname": "ProceedsFromNonIncomeTaxRefunds", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "kwr_PublicOfferingDollarAmountSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate dollar amount of securities that may be sold in a public offering.", "label": "Public Offering Dollar Amount Securities" } } }, "localname": "PublicOfferingDollarAmountSecurities", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_QhProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Companys management approved and the Company initiated a global restructuring plan (the QH Program) as part of its plan to realize certain cost synergies associated with the Combination.", "label": "QH Program [Member]" } } }, "localname": "QhProgramMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "domainItemType" }, "kwr_SbDeckingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inactive Subsidiary involved in asbestos litigation", "label": "Sb Decking [Member]", "terseLabel": "SB Decking [Member]" } } }, "localname": "SbDeckingMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ScheduleOfDeferredTaxAssetsAndLiabilitiesBalanceSheetClassificationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the classification on the balance sheet of deferred income tax assets and liabilities", "label": "Schedule Of Deferred Tax Assets And Liabilities Balance Sheet Classification [Table Text Block]" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesBalanceSheetClassificationTableTextBlock", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "kwr_ShareBasedCompensationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation [Line Items]" } } }, "localname": "ShareBasedCompensationLineItems", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuanceExpectedTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Estimated period over which the equity-based payment award remains in effect once approved.", "label": "Share Based Goods And Nonemployee Services Transaction Shares Approved For Issuance Expected Term", "terseLabel": "Director Stock Ownership Plan Life" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuanceExpectedTerm", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_ShareRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share repurchase program authorized by the Board of Directors of the Company. Shares may be purchased from the open market or in private negotiated transactions.", "label": "Share Repurchase Program [Member]", "terseLabel": "2015 Share Repurchase [Member]" } } }, "localname": "ShareRepurchaseProgramMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumNumberOfSharesPercentagePerEmployee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the maximum number of shares to be held per employee as a percentage of outstanding common stock.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Maximum Number Of Shares Percentage Per Employee", "terseLabel": "ESPP: Maximum Ownership of Outstanding Shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumNumberOfSharesPercentagePerEmployee", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_SignificanceThresholdInPercentageForReportingDispositionsOfABusiness": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of significance threshold for reporting dispositions of a business, as required by significance test in SEC Regulation.", "label": "Significance threshold in percentage for reporting dispositions of a business" } } }, "localname": "SignificanceThresholdInPercentageForReportingDispositionsOfABusiness", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_SouthAfricaEquityAffiliateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "South Africa Equity Affiliate [Member]" } } }, "localname": "SouthAfricaEquityAffiliateMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_StockOptionsCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the stock options plan.", "label": "Stock Options Compensation Expense [Member]", "terseLabel": "Stock Options [Member]" } } }, "localname": "StockOptionsCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails" ], "xbrltype": "domainItemType" }, "kwr_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityInstallmentsPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax installment paid related to accumulated foreign earnings liabilities, US Tax reforms.", "label": "Tax Cuts And Jobs Act Of 2017 Transition Tax For Accumulated Foreign Earnings Liability Installments Paid" } } }, "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityInstallmentsPaid", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityRemainingInstallments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax installment remining to be paid, related to accumulated foreign earnings liabilities, US Tax reforms.", "label": "Tax Cuts And Jobs Act Of 2017 Transition Tax For Accumulated Foreign Earnings Liability Remaining Installments" } } }, "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityRemainingInstallments", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Taxcutsandjobsactof2017accountingearningsofforeignsubsidiary": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Tax Cuts And Jobs Act Of 2017 Accounting Earnings Of Foreign Subsidiary" } } }, "localname": "Taxcutsandjobsactof2017accountingearningsofforeignsubsidiary", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_TelnordicMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tel Nordic ApS[Member]" } } }, "localname": "TelnordicMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A type of credit facility.", "label": "Term loan [Member]" } } }, "localname": "TermLoanMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TinplatingsolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisition of a tin-plating solutions business for the steel end market.", "label": "Tin Plating Solutions [Member]" } } }, "localname": "TinplatingsolutionsMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TopFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from the entity's top five customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk Top Five [Member]", "terseLabel": "Top Five Customers [Member]" } } }, "localname": "TopFiveMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TotalRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveLossOrIncome": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total recognized in net periodic benefit cost and other comprehensive loss or income", "label": "Total Recognized In Net Periodic Benefit Cost And Other Comprehensive Loss Or Income", "totalLabel": "Total Recognized In Net Periodic Benefit Cost And Other Comprehensive Loss Or (Income)" } } }, "localname": "TotalRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveLossOrIncome", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_TrademarksFormulationsandproducttechnologymemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trademarks Formulations And Product Technology [Member]" } } }, "localname": "TrademarksFormulationsandproducttechnologymemberMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "kwr_TrademarksandformulationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trademarks and Formulations [Member]" } } }, "localname": "TrademarksandformulationsMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TwentyTwentyOneAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Twenty Twenty One Acquisition.", "label": "Twenty Twenty One Acquisition [Member]", "terseLabel": "2021 Acquisitions [Member]" } } }, "localname": "TwentyTwentyOneAcquisitionMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_USTaxReformAct": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A decription of the Tax Cuts and Jobs Act (U.S. Tax Reform) tax legislation as enacted by the U.S. government on December 22,2017 and its effetcs on the Company's earnings.", "label": "U.S. Tax Reform Act" } } }, "localname": "USTaxReformAct", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_UncertainTaxPositions": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-cash adjustment for the non-deferred portion of the change in liability for uncertain tax positions", "label": "Uncertain Tax Positions", "terseLabel": "Uncertain tax positions (non-deferred portion)" } } }, "localname": "UncertainTaxPositions", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_UnrecognizedTaxBenefitsIfRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of potential unrecognized tax benefits.", "label": "Unrecognized Tax Benefits If Recognized" } } }, "localname": "UnrecognizedTaxBenefitsIfRecognized", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_UnrecognizedTaxBenefitsIncomeTaxPenaltiesIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Income for penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits Tax Penalties Income" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesIncome", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_UnrecognizedTaxBenefitsInterestIncomeOnIncomeTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income for an overpayment of income taxes.", "label": "Unrecognized Tax Benefits Interest Income On Income Taxes" } } }, "localname": "UnrecognizedTaxBenefitsInterestIncomeOnIncomeTaxes", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_UnrecognizedTaxBenefitsReserve": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount unrecognized tax benefit reserve.", "label": "Unrecognized Tax Benefits Reserve" } } }, "localname": "UnrecognizedTaxBenefitsReserve", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_ValuationAllowanceAmountRelatedToBusinessCombination": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Valuation Allowance, Amount Related To Business Combination", "label": "Valuation Allowance, Amount Related To Business Combination", "terseLabel": "Valuation allowance, amount Related To Business Combination" } } }, "localname": "ValuationAllowanceAmountRelatedToBusinessCombination", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Valuationallowanceamountotherforeigndeferredtaxasset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Valuation allowance amount Other Foreign Deferred Tax Asset" } } }, "localname": "Valuationallowanceamountotherforeigndeferredtaxasset", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Valuationallowanceamountstatedeferredtaxasset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Valuation Allowance Amount State Deferred tax asset" } } }, "localname": "Valuationallowanceamountstatedeferredtaxasset", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_VatAssessmentThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assessment amount for VAT related matters", "label": "Vat Assessment Three [Member]", "terseLabel": "VAT Assessment Three [Member]" } } }, "localname": "VatAssessmentThreeMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_VatSettlementOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Charge taken for settlement with two jurisdictions related to VAT disputes", "label": "Vat Settlement One [Member]", "terseLabel": "VAT Settlement One [Member]" } } }, "localname": "VatSettlementOneMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_VatSettlementTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Charge taken for settlement with third jurisdictions related to VAT disputes", "label": "Vat Settlement Two [Member]", "terseLabel": "VAT Settlement Two [Member]" } } }, "localname": "VatSettlementTwoMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_VatTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total charge taken for VAT related matters.", "label": "Vat Total [Member]", "terseLabel": "VAT, Total [Member]" } } }, "localname": "VatTotalMember", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Vestingsharestargetlowerpercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting Shares Target Lower Percent" } } }, "localname": "Vestingsharestargetlowerpercent", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_Vestingsharestargetupperpercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting Shares Target Upper Percent" } } }, "localname": "Vestingsharestargetupperpercent", "nsuri": "http://www.quakerchem.com/20210630", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "srt_AmericasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Americas [Member]" } } }, "localname": "AmericasMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails", "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r624", "r625", "r632", "r633", "r820" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r624", "r625", "r632", "r633" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r208", "r227", "r228", "r229", "r230", "r232", "r234", "r238" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r208", "r227", "r228", "r229", "r230", "r232", "r234", "r238" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Operating Lease Maturities [Table Text Block]" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": { "auth_ref": [ "r150", "r161", "r259", "r524", "r525", "r526", "r573", "r574" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]", "terseLabel": "Adjusted Balance [Member]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r150", "r161", "r259", "r524", "r525", "r526", "r573", "r574" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r150", "r161", "r259", "r524", "r525", "r526", "r573", "r574" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r150", "r161", "r259", "r524", "r525", "r526", "r573", "r574" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r245", "r381", "r385", "r794" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r487", "r497", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r791", "r795" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/LeasesNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r487", "r497", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r791", "r795" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r245", "r381", "r385", "r794" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r240", "r381", "r383", "r735", "r790", "r792" ], "lang": { "en-us": { "role": { "label": "Products and Services [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r240", "r381", "r383", "r735", "r790", "r792" ], "lang": { "en-us": { "role": { "label": "Products and Services [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r421", "r487", "r497", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r791", "r795" ], "lang": { "en-us": { "role": { "label": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/LeasesNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r421", "r487", "r497", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r791", "r795" ], "lang": { "en-us": { "role": { "label": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/LeasesNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r146", "r147", "r148", "r149", "r153", "r154", "r159", "r160", "r161", "r163", "r164", "r166", "r167", "r191" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Adjustment [Member]", "terseLabel": "Measurement period adjustments [Member]" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r146", "r147", "r148", "r149", "r153", "r154", "r159", "r160", "r161", "r163", "r164", "r165", "r166", "r167", "r191", "r262", "r263", "r528", "r574", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807" ], "lang": { "en-us": { "role": { "label": "Restatement [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r146", "r147", "r148", "r149", "r153", "r154", "r159", "r160", "r161", "r163", "r164", "r165", "r166", "r167", "r191", "r262", "r263", "r528", "r574", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807" ], "lang": { "en-us": { "role": { "label": "Restatement [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r146", "r148", "r149", "r153", "r154", "r159", "r160", "r161", "r163", "r164", "r166", "r167", "r191", "r262", "r263", "r528", "r574", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807" ], "lang": { "en-us": { "role": { "label": "As initially Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r241", "r242", "r381", "r384", "r793", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818" ], "lang": { "en-us": { "role": { "label": "Segment Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails", "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails", "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "domainItemType" }, "srt_SouthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "South America [Member]" } } }, "localname": "SouthAmericaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r241", "r242", "r381", "r384", "r793", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails", "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails", "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r335", "r492", "r724" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r450", "r719", "r720", "r721" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [Member]", "terseLabel": "Argentina [Member]" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201613Member": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.", "label": "Accounting Standards Update 2016-13 [Member]", "terseLabel": "ASU 2016-13 [Member]" } } }, "localname": "AccountingStandardsUpdate201613Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201811Member": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2018-11 Leases (Topic 842): Targeted Improvements.", "label": "Accounting Standards Update 2018-11 [Member]" } } }, "localname": "AccountingStandardsUpdate201811Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r153", "r154", "r155", "r157", "r256", "r257", "r258", "r259", "r262", "r263", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r528", "r573", "r574", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807" ], "lang": { "en-us": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible Enumeration]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "extensibleListItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable", "terseLabel": "Accounts and Other Payables" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r9", "r28", "r247", "r248" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r753", "r780" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.", "label": "Accrued Liabilities" } } }, "localname": "AccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r13", "r14", "r48" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 27.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued compensation" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r73", "r78", "r81", "r631" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r41", "r310" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment", "negatedTerseLabel": "Less: Accumulated Depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "auth_ref": [ "r68", "r78", "r81", "r630" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.", "label": "Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]", "terseLabel": "Derivative Instruments" } } }, "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r69", "r70", "r71", "r78", "r81" ], "lang": { "en-us": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "Accumulated Net Unrealized Investment Gain (Loss) [Member]" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r31", "r76", "r77", "r78", "r773", "r803", "r807" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 44.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss", "periodEndLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance", "periodStartLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r680", "r681", "r682", "r683", "r684", "r686" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r75", "r78", "r81", "r146", "r147", "r149", "r631", "r798", "r799" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income (Loss) [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r66", "r78", "r81", "r631", "r681", "r682", "r683", "r684", "r686" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Translation Adjustment [Member]" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Intangible Assets, Amortizable Life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r29" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 42.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Capital in excess of par value" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r146", "r147", "r149", "r524", "r525", "r526" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Capital in Excess of Par Value [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r127", "r299" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r153", "r154", "r155", "r157", "r256", "r257", "r258", "r259", "r262", "r263", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r528", "r571", "r572", "r573", "r574", "r737", "r738", "r739", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Adjustments For New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Adjustments To Additional Paid In Capital Other" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation": { "auth_ref": [ "r352", "r357", "r533" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from a tax benefit associated with share-based compensation plan other than an employee stock ownership plan (ESOP). Includes, but is not limited to, excess tax benefit.", "label": "Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation", "terseLabel": "Excess tax benefit from stock option exercises" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r500", "r517", "r530" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share Based Compensation Expense", "terseLabel": "Share-based Compensation Expense", "verboseLabel": "Total share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r249", "r267", "r270", "r271" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance For Doubtful Accounts Receivable", "periodEndLabel": "Balance at End of Period", "periodStartLabel": "Balance at Beginning of Period", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r97", "r127", "r692" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_InterestAndDebtExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmountRecognizedInIncomeDueToInflationaryAccounting": { "auth_ref": [ "r688" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount that will be recognized through the income statement (as well as the impact on the other financial statements) as part of highly inflationary accounting.", "label": "Amount Recognized In Income Due To Inflationary Accounting", "verboseLabel": "Currency conversion impacts of hyper-inflationary accounting" } } }, "localname": "AmountRecognizedInIncomeDueToInflationaryAccounting", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "terseLabel": "Antidilutive Shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r139", "r216", "r229", "r236", "r254", "r624", "r632", "r673", "r746", "r769" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total assets", "terseLabel": "Segment assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsAndLiabilitiesLesseeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Abstract]" } } }, "localname": "AssetsAndLiabilitiesLesseeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r10", "r11", "r62", "r139", "r254", "r624", "r632", "r673" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total current assets", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r662" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Fair Value Disclosure" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date.", "label": "Assets Total [Member]", "terseLabel": "Assets Total [Member]" } } }, "localname": "AssetsTotalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r501", "r519" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r642", "r645" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis Of Accounting Policy [Policy Text Block]" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r480", "r493" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r480", "r493", "r597", "r598" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when the business acquisition agreement was executed, in CCYY-MM-DD format.", "label": "Business Acquisition, Date of Acquisition Agreement" } } }, "localname": "BusinessAcquisitionDateOfAcquisitionAgreement1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r614" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionNameOfAcquiredEntity": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Name of the acquired entity.", "label": "Business Acquisition Name Of Acquired Entity" } } }, "localname": "BusinessAcquisitionNameOfAcquiredEntity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of Voting Interests Acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r595", "r596" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Schedule of unaudited Pro Forma [Text Block]" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r591" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination Acquisition Related Costs", "negatedLabel": "Combination and other acquisition-related expenses", "negatedTerseLabel": "Combination-related expenses", "terseLabel": "Combination, integration and other acquisition-related expenses" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r610", "r611", "r612" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Total consideration paid", "terseLabel": "Purchase price", "totalLabel": "Total fair value of consideration transferred", "verboseLabel": "Total fair value of consideration transferred", "zeroTerseLabel": "Total consideration paid for Coral", "zeroVerboseLabel": "Cash Paid for Acquisitions" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r610", "r611" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Fair value of common stock issued as consideration", "terseLabel": "Shares issued related to the Combination", "verboseLabel": "Less: Fair value of common stock issued as consideration" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r126", "r615" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "negatedTerseLabel": "Change in Fair Value Estimate", "terseLabel": "Change in Fair Value Estimate" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r616" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business acquisitions disclosure [Text Block]" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate": { "auth_ref": [ "r601" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of indemnification assets (amounts to be reimbursed if and when certain assumed liabilities are paid) recognized at the acquisition date of a business combination.", "label": "Business Combination Indemnification Assets Amount As Of Acquisition Date", "terseLabel": "Indemnification assets" } } }, "localname": "BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsDescription": { "auth_ref": [ "r600" ], "lang": { "en-us": { "role": { "documentation": "For indemnification assets recognized in connection with a business combination, this element represents a description of such assets.", "label": "Business Combination Indemnification Assets Description" } } }, "localname": "BusinessCombinationIndemnificationAssetsDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueHigh": { "auth_ref": [ "r602" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For indemnification assets recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the indemnification benefit which may be realized.", "label": "Business Combination Indemnification Assets Range Of Outcomes Value High" } } }, "localname": "BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueHigh", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueLow": { "auth_ref": [ "r602" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the indemnification benefit which may be realized.", "label": "Business Combination Indemnification Assets Range Of Outcomes Value Low" } } }, "localname": "BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueLow", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": { "auth_ref": [ "r605" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred", "terseLabel": "Post Closing Adjustment", "verboseLabel": "Less: estimated purchase price settlement" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r603" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total Assets Purchased" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r603" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "negatedTerseLabel": "Cash Acquired", "terseLabel": "Cash Acquired", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r603" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r603" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables", "terseLabel": "Accounts receivable, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r603" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "terseLabel": "Deferred tax liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r603" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r599", "r603" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r603" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Acquisition, Purchase Price Allocation, Liabilities Assumed", "negatedTotalLabel": "Total Liabilities Assumed", "terseLabel": "Total Liabilities Assumed", "totalLabel": "Total Liabilities Assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r599", "r603" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Net", "terseLabel": "Cash Paid for Acquisitions", "totalLabel": "Business Acquisition, Cost of Acquired Entity, Purchase Price" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r599", "r603" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Propery, plant & equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": { "auth_ref": [ "r594" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.", "label": "Equity Method Investment Realized Gain (Loss) On Revaluation", "negatedLabel": "Non cash gain from purchase of equity affiliate", "terseLabel": "Gain on Revaluation of Existing Equity Interest in Step Purchase" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Acquisitions [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r131", "r132", "r133" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Change in accrued purchases of property, plant and equipment, net" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r105" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash Acquired From Acquisition", "negatedTerseLabel": "Cash Acquired", "terseLabel": "Less: cash Acquired", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r7", "r38", "r129" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.quakerchem.com/role/RestrictedCashDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at begining of period" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.", "label": "Cash And Cash Equivalents Disclosure [Text Block]" } } }, "localname": "CashAndCashEquivalentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCash" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r121", "r129", "r134" ], "calculation": { "http://www.quakerchem.com/role/RestrictedCashDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash cash equivalents restricted cash and restricted cash equivalents", "periodEndLabel": "Cash, Cash Equivalents and Restricted Cash at the end of the period", "periodStartLabel": "Cash, Cash Equivalents and Restricted Cash at the beginning of the period", "totalLabel": "Cash cash equivalents restricted cash and restricted cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r121", "r678" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash And Cash Equivalents Period Increase Decrease", "terseLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash", "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashSurrenderValueFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).", "label": "Cash Surrender Value Fair Value Disclosure", "terseLabel": "Company Owned Life Insurance" } } }, "localname": "CashSurrenderValueFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r359", "r360", "r361", "r362" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r55", "r334", "r754", "r778" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 39.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r331", "r332", "r333", "r345" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Dividends declared" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityParentheticalsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r146", "r147" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r27" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 41.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2021 -17,878,137 shares; 2020 - 17,850,616 shares", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Common Stock Voting Rights" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r84", "r86", "r87", "r94", "r760", "r787" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive income attributable to Quaker Chemical Corporation", "totalLabel": "Comprehensive income (loss) attributable to Quaker Chemical Corporation" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r84", "r86", "r93", "r620", "r621", "r636", "r759", "r786" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 13.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest", "negatedLabel": "Less: (income) loss attributable to noncontrolling interest", "terseLabel": "Less: comprehensive income attributable to noncontrolling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r84", "r86", "r92", "r619", "r636", "r758", "r785" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 12.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive income", "totalLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive income (loss) [Policy Text Block]" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r200", "r201", "r245", "r670", "r671" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r200", "r201", "r245", "r670", "r671", "r809" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk By Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r200", "r201", "r245", "r670", "r671", "r809" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentsOffBalanceSheetRisk": { "auth_ref": [ "r672", "r767" ], "lang": { "en-us": { "role": { "documentation": "Description of financial instruments, excluding certain derivatives, with off-balance sheet credit risk (for example, standby letters of credit or financial guarantees), including (1) information about the (shared) activity, region or economic characteristic that identifies the concentration, (2) the face or contract amount of the instrument, (3) the nature and terms of the instrument, including the market risk, cash requirements and accounting policies for it, (4) the maximum amount of loss due to credit risk that would be incurred if the counterparties failed completely to perform according to the terms of the contracts, and any security or collateral that proved to be of no value, (5) the entity's policy of requiring collateral or other security to support financial instruments subject to credit risk, information about access to collateral or other security, and a brief description of the security supporting those financial instruments, and (6) the policy of entering into and a brief description of master netting arrangements to mitigate the credit risk, and the extent to which such arrangements would reduce the maximum amount of loss due to credit risk.", "label": "Concentration Risk Credit Risk Financial Instruments Off Balance Sheet Risk", "terseLabel": "Other off balance sheet arrangements" } } }, "localname": "ConcentrationRiskCreditRiskFinancialInstrumentsOffBalanceSheetRisk", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r200", "r201", "r245", "r670", "r671" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Reclassification Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r197", "r200", "r201", "r202", "r670", "r672" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r200", "r201", "r245", "r670", "r671" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateBondSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).", "label": "Industrial Development Bond Due 2028 [Member]" } } }, "localname": "CorporateBondSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r99", "r735" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of goods sold", "terseLabel": "Cost of goods sold (excluding amortization expense - See Note 14)" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": { "auth_ref": [ "r264", "r265", "r266", "r268", "r269", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r284" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.", "label": "Credit Loss Financial Instrument [Policy Text Block]" } } }, "localname": "CreditLossFinancialInstrumentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r198", "r245" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerListsMember": { "auth_ref": [ "r607" ], "lang": { "en-us": { "role": { "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.", "label": "Customer lists and rights to sell [Member]" } } }, "localname": "CustomerListsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r608" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtAndCapitalLeaseObligations": { "auth_ref": [ "r752", "r781" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term and long-term debt and lease obligation.", "label": "Debt and Capital Lease Obligations", "terseLabel": "Total debt", "totalLabel": "Debt And Capital Lease Obligations", "verboseLabel": "Credit facilities" } } }, "localname": "DebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r46" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Short-term borrowings and current portion of long-term debt", "negatedTerseLabel": "Current portion of long-term debt" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt [Text Block]" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.", "label": "Debt Instrument, Description of Variable Rate Basis" } } }, "localname": "DebtInstrumentDescriptionOfVariableRateBasis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r50", "r691" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument, Interest Rate During Period" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument Interest Rate Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateTerms": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.", "label": "Debt Instrument, Interest Rate Terms" } } }, "localname": "DebtInstrumentInterestRateTerms", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r51", "r666" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Line Of Credit Maturity Date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument Maturity Date Description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r53", "r141", "r353", "r354", "r355", "r356", "r690", "r691", "r693", "r765" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": { "auth_ref": [ "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.", "label": "Debt Instrument, Unused Borrowing Capacity, Amount" } } }, "localname": "DebtInstrumentUnusedBorrowingCapacityAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt, Weighted Average Interest Rate" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "auth_ref": [ "r550" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound" } } }, "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsCurrentNet": { "auth_ref": [ "r61", "r692" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Current, Net" } } }, "localname": "DeferredFinanceCostsCurrentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r42", "r692" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Cost Capitalized to Term loans and Long Term Debt", "negatedLabel": "Less: debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNoncurrentGross": { "auth_ref": [ "r42", "r692" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Deferred Finance Costs Noncurrent Gross" } } }, "localname": "DeferredFinanceCostsNoncurrentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r541", "r543" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Tax Assets Net Noncurrent", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r127", "r140", "r568", "r580", "r581", "r582" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred income taxes", "negatedTerseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r24", "r25", "r559", "r748", "r768" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r541", "r543" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 35.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities Net", "terseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueRevenueRecognized1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.", "label": "Deferred Revenue Revenue Recognized 1", "negativeTerseLabel": "Deferred Revenue Revenue Recognized" } } }, "localname": "DeferredRevenueRevenueRecognized1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r562" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "terseLabel": "Deferred Tax Assets, Net", "totalLabel": "Total deferred tax assets, net" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetCurrent": { "auth_ref": [ "r541", "r542", "r543", "r544", "r560" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards classified as current.", "label": "Current deferred tax assets" } } }, "localname": "DeferredTaxAssetsNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "auth_ref": [ "r566", "r567" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "auth_ref": [ "r566", "r567" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax": { "auth_ref": [ "r564", "r566", "r567" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible alternative minimum tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax", "terseLabel": "Alternative minimum tax carryforward" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": { "auth_ref": [ "r564", "r566", "r567" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign", "terseLabel": "Foreign tax credit and other credits" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r543", "r562" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities", "terseLabel": "Defered Tax Liabilties, Net", "totalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesCurrent": { "auth_ref": [ "r541", "r543", "r544", "r566", "r567" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 30.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as current.", "label": "Current deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": { "auth_ref": [ "r430" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.", "label": "Defined Benefit Plan, Accumulated Benefit Obligation", "terseLabel": "Accumulated Benefit Obligation" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligationIncreaseDecreaseForSettlementAndCurtailment": { "auth_ref": [ "r454" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of (increase) decrease in accumulated benefit obligation of defined benefit plan from effects of settlement and curtailment.", "label": "Defined Benefit Plan Effect Of Settlements And Curtailments On Accumulated Benefit Obligation" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligationIncreaseDecreaseForSettlementAndCurtailment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": { "auth_ref": [ "r74", "r78", "r442" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), before Tax", "negatedTotalLabel": "Accumulated Other Comprehensive Loss", "terseLabel": "Gross AOCI", "totalLabel": "Accumulated Other Comprehensive Loss (\"AOCI\")" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r397", "r437", "r468", "r474", "r475" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 8.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gains (Losses)", "negatedLabel": "Actuarial Loss Amortization", "terseLabel": "Actuarial Loss Amortization" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r397", "r438", "r469", "r474", "r475" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 9.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "negatedLabel": "Prior Service (Credit) Cost Amortization", "terseLabel": "Prior Service (Credit) Cost Amortization" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation": { "auth_ref": [ "r397", "r439", "r470" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 13.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transition asset (obligation) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Transition Obligations (Assets)", "terseLabel": "Transition Asset Amortization" } } }, "localname": "DefinedBenefitPlanAmortizationOfTransitionAssetObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountOfEmployerAndRelatedPartySecuritiesIncludedInPlanAssets": { "auth_ref": [ "r450", "r474" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of employer security in which defined benefit plan asset is invested. Includes, but is not limited to, security issued or managed by related party of employer.", "label": "Defined Benefit Plan, Amount of Employer and Related Party Securities Included in Plan Assets", "terseLabel": "Value of Employer Securities Included in Plan Assets" } } }, "localname": "DefinedBenefitPlanAmountOfEmployerAndRelatedPartySecuritiesIncludedInPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForRemeasurementDueToSettlement": { "auth_ref": [ "r401" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from remeasurement due to settlement. Excludes decrease to benefit obligation for settlement payment.", "label": "Defined Benefit Plan Benefit Obligation Increase Decrease For Remeasurement Due To Settlement", "terseLabel": "Pension Settlement Charge" } } }, "localname": "DefinedBenefitPlanBenefitObligationIncreaseDecreaseForRemeasurementDueToSettlement", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement": { "auth_ref": [ "r401" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment, which decreases benefit obligation of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract. Excludes decreases to benefit obligation for remeasurement due to settlement.", "label": "Defined Benefit Plan Benefit Obligation Payment For Settlement" } } }, "localname": "DefinedBenefitPlanBenefitObligationPaymentForSettlement", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationPeriodIncreaseDecrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan Benefit Obligation Period Increase (Decrease)" } } }, "localname": "DefinedBenefitPlanBenefitObligationPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "auth_ref": [ "r421", "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r450", "r474" ], "lang": { "en-us": { "role": { "documentation": "Information by defined benefit plan asset investment.", "label": "Defined Benefit Plan, Asset Categories [Axis]" } } }, "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r413", "r422", "r424", "r472", "r474", "r475" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Contributions by Employer", "terseLabel": "Employer Contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod": { "auth_ref": [ "r453" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost of providing special or contractual termination benefits payable from defined benefit plan.", "label": "Defined Benefit Plan Cost Of Providing Special Or Contractual Termination Benefit Recognized During Period", "terseLabel": "Defined Benefit Plan, Termination" } } }, "localname": "DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDescriptionOfNatureOfEventResultingInSpecialOrContractualTerminationBenefitsRecognizedDuringPeriod": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "documentation": "Description of nature of event resulting in defined benefit plan providing special or contractual termination benefits.", "label": "Defined Benefit Plan Description Of Nature Of Event Resulting In Special Or Contractual Termination Benefits Recognized During Period" } } }, "localname": "DefinedBenefitPlanDescriptionOfNatureOfEventResultingInSpecialOrContractualTerminationBenefitsRecognizedDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": { "auth_ref": [ "r422", "r474" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan Equity Securities [Member]" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": { "auth_ref": [ "r472", "r475" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.", "label": "Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r397", "r436", "r467", "r474", "r475" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return on Plan Assets", "negatedLabel": "Expected Return on Plan Assets", "terseLabel": "Expected Return on Plan Assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExplanationOfSignificantChangeInBenefitObligationOrPlanAssetsNotApparentFromOtherRequiredDisclosures": { "auth_ref": [ "r454", "r477" ], "lang": { "en-us": { "role": { "documentation": "Description of reason for changes in benefit obligation and plan assets of defined benefit plan.", "label": "Defined Benefit Plan Explanation Of Significant Change In Benefit Obligation Or Plan Assets Not Apparent From Other Required Disclosures" } } }, "localname": "DefinedBenefitPlanExplanationOfSignificantChangeInBenefitObligationOrPlanAssetsNotApparentFromOtherRequiredDisclosures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r397", "r402", "r435", "r466", "r474", "r475" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest Cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r433", "r464", "r474", "r475" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 10.0, "parentTag": "kwr_TotalRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveLossOrIncome", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost", "terseLabel": "Net Periodic Benefit Cost", "totalLabel": "Net Periodic Benefit Cost", "verboseLabel": "Pension and postretirement benefit costs, non-service components" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanOtherCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of defined benefit plan cost (credit), classified as other.", "label": "Defined Benefit Plan Other Costs", "terseLabel": "Prior Service Cost Charge" } } }, "localname": "DefinedBenefitPlanOtherCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryPercentage": { "auth_ref": [ "r422", "r474" ], "lang": { "en-us": { "role": { "documentation": "Percentage of investment to total investment within defined benefit plan asset category.", "label": "Defined Benefit Plan Additional Disclosures About Plan Assets" } } }, "localname": "DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": { "auth_ref": [ "r398", "r440", "r471" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 7.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.", "label": "Defined Benefit Plan, Recognized Net Gain (Loss) Due to Curtailments", "terseLabel": "Curtailment Charge" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "auth_ref": [ "r398", "r440", "r471" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 6.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.", "label": "Defined Benefit Plan, Recognized Net Gain (Loss) Due to Settlements", "negatedTerseLabel": "Settlement Loss" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r400", "r434", "r465", "r474", "r475" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service Cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlansGeneralInformation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of defined benefit pension and other postretirement plans.", "label": "Defined Benefit Plans General Information", "terseLabel": "Defined Benefit Plans Investment Description" } } }, "localname": "DefinedBenefitPlansGeneralInformation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r478" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Defined Contribution Plan, Cost Recognized", "terseLabel": "Total Contribution Amount" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.", "label": "Defined Contribution Plan Employer Discretionary Contribution Amount" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent", "terseLabel": "Non-elective Match Percentage" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches of the employee's percentage contribution matched.", "label": "Defined Contribution Plan Employer Matching Contribution Percent Of Match" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeAmountOfHedgedItem": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of hedged item in hedging relationship. Excludes hedged asset or liability.", "label": "Derivative Amount Of Hedged Item" } } }, "localname": "DerivativeAmountOfHedgedItem", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeBasisSpreadOnVariableRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.", "label": "Derivative, Basis Spread on Variable Rate" } } }, "localname": "DerivativeBasisSpreadOnVariableRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract Type [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": { "auth_ref": [ "r63", "r64", "r65", "r656" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Amount Not Offset Against Collateral", "terseLabel": "Interest Rate Swaps, Liability" } } }, "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Derivative Fixed Interest Rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r643", "r644", "r650", "r653" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument Risk [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r661" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments And Hedging Activities Disclosure [Text Block]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r641", "r643", "r650", "r653", "r654", "r657", "r659" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments Gain Loss By Hedging Relationship By Income Statement Location By Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments Gain Loss [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r648", "r652" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments Gain Loss Reclassified From Accumulated OCI Into Income Effective Portion Net" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet": { "auth_ref": [ "r649", "r658" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.", "label": "Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net" } } }, "localname": "DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityNotionalAmount": { "auth_ref": [ "r638", "r639", "r640" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payments on the derivative liability.", "label": "Derivative Liability Notional Amount" } } }, "localname": "DerivativeLiabilityNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeRemainingMaturity1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative Remaining Maturity 1" } } }, "localname": "DerivativeRemainingMaturity1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativeTermOfContract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative, Term of Contract" } } }, "localname": "DerivativeTermOfContract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativeVariableInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.", "label": "Derivative Variable Interest Rate" } } }, "localname": "DerivativeVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of defined contribution pension and other postretirement plans.", "label": "Description of Defined Contribution Pension and Other Postretirement Plans", "terseLabel": "Description of Defined Contribution Plan" } } }, "localname": "DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases": { "auth_ref": [ "r694", "r695" ], "lang": { "en-us": { "role": { "documentation": "A general description of the nature of the existing leasing arrangements of a lessee for all operating leases including, but not limited to: (1) rental escalation clauses; (2) renewal or purchase options; (3) guarantees or indemnities, if any, (4) restrictions imposed by lease arrangements; (5) unusual provisions or conditions; (6) contingent rentals, if any; and (7) lease expiration dates.", "label": "Operating Lease Terms" } } }, "localname": "DescriptionOfLesseeLeasingArrangementsOperatingLeases", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disaggregation Of Revenue [Abstract]" } } }, "localname": "DisaggregationOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue [Table Text Block]" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure of Compensation Related Costs, Share-based Payments [Text Block]" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationChangesToPlanOfSale": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Description of the facts and circumstances leading to the decision to change the plan to sell the disposal group, including discontinued operation, and its effect on the results of operations of the period and any prior periods presented.", "label": "Disposal Group Including Discontinued Operation Changes To Plan Of Sale" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationChangesToPlanOfSale", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent": { "auth_ref": [ "r0", "r1", "r4", "r307", "r315" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current", "terseLabel": "Intangible Assets Reclassified as Held for Sale" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCash": { "auth_ref": [ "r357", "r764" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.", "label": "Cash dividends" } } }, "localname": "DividendsCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r357", "r764" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends Common Stock", "negatedLabel": "Dividends common stock", "negatedTerseLabel": "Dividends" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r14", "r48" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 26.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Dividends payable" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Country [Member]" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DomesticLineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, inside the reporting entity's home country.", "label": "Domestic Line of Credit [Member]", "terseLabel": "U.S. Term Loan [Member]" } } }, "localname": "DomesticLineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails", "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Per share data:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r95", "r159", "r160", "r161", "r162", "r163", "r172", "r175", "r183", "r186", "r187", "r191", "r192", "r761", "r788" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net income (loss) attributable to Quaker Chemical Corporation common shareholders - basic", "terseLabel": "Basic earnings per common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EarningsPerShareBasicDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r95", "r159", "r160", "r161", "r162", "r163", "r175", "r183", "r186", "r187", "r191", "r192", "r761", "r788" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Net income (loss) attributable to Quaker Chemical Corporation common shareholders - diluted", "terseLabel": "Diluted earnings per common share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r188", "r189", "r190", "r193" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r678" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 53.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of foreign exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate, Continuing Operations" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r546", "r583" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r546", "r583" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1", "terseLabel": "Weighted Average Remaining Life, Nonvested Stock Awards" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r518" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options", "terseLabel": "Unrecognized Share-based Compensation Expense, Nonvested Stock Award" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r518" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options", "terseLabel": "Unrecognized Compensation Expense, Options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Stock Options [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity Class Of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r146", "r147", "r149", "r154", "r164", "r167", "r196", "r259", "r352", "r357", "r524", "r525", "r526", "r573", "r574", "r680", "r681", "r682", "r683", "r684", "r686", "r798", "r799", "r800" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment Ownership Percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r39", "r217", "r252" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Investments in associated companies", "terseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities": { "auth_ref": [ "r531" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 47.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.", "label": "Excess tax benefit from stock option exercises" } } }, "localname": "ExcessTaxBenefitFromShareBasedCompensationFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r662", "r663", "r664", "r669" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [TableTextBlock]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r662", "r663" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r474", "r663", "r725", "r726", "r727" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value By Fair Value Hierarchy Level [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r668" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r422", "r424", "r429", "r474", "r663", "r725" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r422", "r424", "r429", "r474", "r663", "r726" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r474", "r663", "r727" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r662", "r663" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r667", "r669" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r474", "r725", "r726", "r727" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Measurements Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r642", "r646", "r657" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r702" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease Liability Current" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r702" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Long-term lease liabilities" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedCustomerListsGross": { "auth_ref": [ "r298" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of an asset comprised of customer information, acquired in a business combination or other transaction, having a finite beneficial life.", "label": "Finite Lived Customer Lists, Gross" } } }, "localname": "FiniteLivedCustomerListsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r298" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Accumulated Amortization", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Next Twelve Months", "terseLabel": "For the Year ended December 31, 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "For the year ended December 31, 2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Five", "terseLabel": "For the Year ended December 31, 2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Four", "terseLabel": "For the Year ended December 31, 2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Three", "terseLabel": "For the Year ended December 31, 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Two", "terseLabel": "For the Year ended December 31, 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r293", "r295", "r298", "r302", "r736", "r743" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r298", "r743" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Gross", "terseLabel": "Total", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGrossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite Lived Intangible Assets Gross [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsGrossAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails", "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r293", "r297" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedTrademarksGross": { "auth_ref": [ "r298" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a specified period of time.", "label": "Finite Lived Trademarks, Gross" } } }, "localname": "FiniteLivedTrademarksGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FixedIncomeSecuritiesMember": { "auth_ref": [ "r422", "r474" ], "lang": { "en-us": { "role": { "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.", "label": "Fixed Income Securities [Member]" } } }, "localname": "FixedIncomeSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainBeforeTax": { "auth_ref": [ "r676", "r677" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain recognized in the income statement.", "label": "Foreign Currency Transaction Gain, before Tax" } } }, "localname": "ForeignCurrencyTransactionGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossRealized": { "auth_ref": [ "r676", "r677" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), Realized", "terseLabel": "Foreign exchange gains (losses), net" } } }, "localname": "ForeignCurrencyTransactionGainLossRealized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionLossBeforeTax": { "auth_ref": [ "r676", "r677" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.", "label": "Foreign Currency Transaction Loss Before Tax" } } }, "localname": "ForeignCurrencyTransactionLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of transaction giving rise to foreign currency transaction gain (loss), including but not limited to, nature of the transaction, the foreign currency involved, the accounting for the transaction.", "label": "Foreign Currency Transactions Description" } } }, "localname": "ForeignCurrencyTransactionsDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignLineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, outside the reporting entity's home country.", "label": "Foreign Line of Credit [Member]", "terseLabel": "EURO Term Loan [Member]" } } }, "localname": "ForeignLineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r479", "r483", "r496" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "Foreign [Member]" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r127", "r306", "r313" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Assets", "terseLabel": "Gain (loss) on fixed asset disposals, net" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfOtherAssets": { "auth_ref": [ "r127" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of other assets.", "label": "Gain Loss On Sale Of Other Assets" } } }, "localname": "GainLossOnSaleOfOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r127" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain on disposal of property, plant and equipment", "negatedLabel": "(Gain) loss on disposal of property, plant, equipment and other assets" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r334" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain (Loss) Related To Litigation Settlement" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralDiscussionOfDerivativeInstrumentsAndHedgingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "General Discussion Of Derivative Instruments And Hedging Activities [Abstract]" } } }, "localname": "GeneralDiscussionOfDerivativeInstrumentsAndHedgingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pension and Other Postretirement Benefits [Abstract]" } } }, "localname": "GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r285", "r286", "r745" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Goodwill, Ending Balance", "periodStartLabel": "Goodwill, Beginning Balance", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r287" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Goodwill Additions" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill And Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill And Intangible Assets Disclosure [Text Block]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r135", "r290" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill And Intangible Assets, Goodwill, Policy [Policy Text Block]" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r288" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Translation Adjustments" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPeriodIncreaseDecrease": { "auth_ref": [ "r290" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Period Increase Decrease" } } }, "localname": "GoodwillPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r289", "r590" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Purchase Accounting Adjustments", "terseLabel": "Goodwill Reductions" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill Roll Forward" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r98", "r139", "r216", "r228", "r232", "r235", "r238", "r254", "r673" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "auth_ref": [ "r127", "r303" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Indefinite-lived intangible asset impairment", "negatedLabel": "Indefinite-lived intangible asset impairment" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [ "r127", "r305", "r312" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).", "label": "Impairment of Long-Lived Assets Held-for-use", "negatedTerseLabel": "Impairment of Long-Lived Assets Held-for-use" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r143", "r216", "r228", "r232", "r235", "r238" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 13.0, "parentTag": "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (loss) before taxes and equity in net income of associated companies", "totalLabel": "Income (loss) before taxes and equity in net income of associated companies" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r89", "r127", "r213", "r252", "r755", "r782" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 16.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Equity in net income of associated companies", "verboseLabel": "Total equity in net income of associated companies" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "auth_ref": [ "r127" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.", "label": "Equity in net (income) loss of associated companies, net of dividends", "negatedLabel": "Equity in undistributed earnings of associated companies, net of dividends" } } }, "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r551" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxCreditsAndAdjustments": { "auth_ref": [ "r128" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A credit or adjustment for government or taxing authority authorized decrease in taxes owed as a result of meeting certain tax policy conditions.", "label": "Income Tax Credits and Adjustments", "terseLabel": "Certain indirect tax credits" } } }, "localname": "IncomeTaxCreditsAndAdjustments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Taxes on Income and Uncertain Tax Positions [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r547", "r558", "r563", "r578", "r584", "r586", "r587", "r589" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Taxes on Income [Text Block]" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationDescription": { "auth_ref": [ "r549" ], "lang": { "en-us": { "role": { "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.", "label": "Income Tax Examination Description" } } }, "localname": "IncomeTaxExaminationDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority.", "label": "Income Tax Examination Liability Refund Adjustment from Settlement with Taxing Authority" } } }, "localname": "IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExaminationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Examination [Line Items]" } } }, "localname": "IncomeTaxExaminationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationTable": { "auth_ref": [ "r552" ], "lang": { "en-us": { "role": { "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.", "label": "Income Tax Examination [Table]" } } }, "localname": "IncomeTaxExaminationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationYearUnderExamination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year being audited in the income tax examination, in CCYY format.", "label": "Income Tax Examination, Year under Examination" } } }, "localname": "IncomeTaxExaminationYearUnderExamination", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "gYearListItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r140", "r166", "r167", "r214", "r545", "r579", "r585", "r789" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 14.0, "parentTag": "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Taxes on income (loss) before equity in net income of associated companies", "terseLabel": "Income Tax Expense (Benefit)", "totalLabel": "Income Tax Expense (Benefit), Total" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r540", "r546" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Income Tax Reconciliation Change In Enacted Tax Rate", "terseLabel": "Transition Tax", "verboseLabel": "U.S. Tax Reform Charges" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxSettlementsForeign": { "auth_ref": [ "r546" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax settlement.", "label": "Income Tax Reconciliation Tax Settlements Foreign" } } }, "localname": "IncomeTaxReconciliationTaxSettlementsForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Uncertain Tax Positions [Abstract]" } } }, "localname": "IncomeTaxUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r123", "r130" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes, net of refunds" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r126" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued liabilities", "negatedLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r126" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Accounts receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r126" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Estimated taxes on income" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r126" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase Decrease In Inventories", "negatedLabel": "Inventories", "terseLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r126" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "negatedLabel": "Prepaid expenses and other current assets", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInRestrictedCash": { "auth_ref": [ "r107", "r110" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 34.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities.", "label": "Change in restricted cash, net", "negatedLabel": "Change in restricted cash, net" } } }, "localname": "IncreaseDecreaseInRestrictedCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInRestructuringReserve": { "auth_ref": [ "r126" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations.", "label": "Change in restructuring liabilities" } } }, "localname": "IncreaseDecreaseInRestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "auth_ref": [ "r550" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase reasonably possible in the next twelve months for the unrecognized tax benefit.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Lower Bound" } } }, "localname": "IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r176", "r177", "r178", "r187" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "order": 5.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Effect of Dilutive Securities" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r301" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite Lived Intangible Assets Excluding Goodwill", "terseLabel": "Indefinite lived intangible assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Indefinite Lived Intangible Assets Excluding Goodwill [Abstract]" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedTrademarks": { "auth_ref": [ "r301" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit.", "label": "Indefinite Lived Trademarks" } } }, "localname": "IndefiniteLivedTrademarks", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r292", "r296" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpense": { "auth_ref": [ "r689" ], "calculation": { "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.", "label": "Interest and Debt Expense", "totalLabel": "Total" } } }, "localname": "InterestAndDebtExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "InterestAndDebtExpenseAbstract", "terseLabel": "Debt related expenses included within Interest expense:" } } }, "localname": "InterestAndDebtExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r103", "r350" ], "calculation": { "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_InterestAndDebtExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseMember": { "auth_ref": [ "r652" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing interest expense.", "label": "Interest Expense [Member]" } } }, "localname": "InterestExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.", "label": "Interest Income And Interest Expense Disclosure [Table Text Block]" } } }, "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r762" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income Expense Net", "negatedLabel": "Interest Income Expense Net", "terseLabel": "Interest expense, net", "verboseLabel": "Interest Income Expense Net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income Other" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r117", "r122", "r130" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue": { "auth_ref": [ "r644" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all interest rate derivative liabilities designated as cash flow hedging instruments.", "label": "Interest Rate Cash Flow Hedge Liability At Fair Value" } } }, "localname": "InterestRateCashFlowHedgeLiabilityAtFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InternalRevenueServiceIRSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.", "label": "Internal Revenue Service (IRS) [Member]" } } }, "localname": "InternalRevenueServiceIRSMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r208", "r227", "r228", "r229", "r230", "r232", "r234", "r238" ], "lang": { "en-us": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Elimination [Member]", "terseLabel": "Intersegment Sales Elimination [Member]" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoodsAndWorkInProcess": { "auth_ref": [ "r58" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.", "label": "Work-in-process and finished goods" } } }, "localname": "InventoryFinishedGoodsAndWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r8", "r60" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories, net", "totalLabel": "Inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventories" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryRawMaterialsAndSupplies": { "auth_ref": [ "r59" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.", "label": "Raw materials and supplies" } } }, "localname": "InventoryRawMaterialsAndSupplies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Operating Leases, Rent Expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r716" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Schedule of Maturities of operating lease liabilities [Table Text Block]" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r699" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.", "label": "Leases Disclosure [TextBlock]" } } }, "localname": "LeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r707" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r705" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee Leases [Policy Text Block]" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r717" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of Company's future minimum rental commitments under operating leases [Table Text Block]" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r717" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee Operating Lease Liability Payments Due", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r717" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due After Year Five", "terseLabel": "For the year ended December 31, 2026 and beyond" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r717" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months", "terseLabel": "For the year ended December 31, 2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r717" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Five", "terseLabel": "For the year ended December 31, 2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r717" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Four", "terseLabel": "For the year ended December 31, 2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r717" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Three", "terseLabel": "For the year ended December 31, 2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r717" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Two", "terseLabel": "For the year ended December 31, 2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r717" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee Operating Lease Liability Payments Remainder Of Fiscal Year", "terseLabel": "For the remainder of 2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r717" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee Operating Lease Liability Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [ "r706" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee Operating Lease Term Of Contract" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters Of Credit Outstanding Amount" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r47", "r139", "r230", "r254", "r625", "r632", "r633", "r673" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 38.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Total liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r34", "r139", "r254", "r673", "r751", "r776" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Total liabilities and equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r49", "r139", "r254", "r625", "r632", "r633", "r673" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 32.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Total current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r54" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability For Uncertain Tax Positions Noncurrent", "terseLabel": "Uncertain Tax Positions (Includes Interest and Penalties)" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityCovenantCompliance": { "auth_ref": [ "r19", "r21" ], "lang": { "en-us": { "role": { "documentation": "Identification of whether the entity has been in compliance with any credit facility debt covenants during the period.", "label": "Line of Credit Facility, Covenant Compliance" } } }, "localname": "LineOfCreditFacilityCovenantCompliance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCovenantTerms": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Description of the conditions for borrowing under the credit facility including the nature of any restrictions.", "label": "Line of Credit Facility, Covenant Terms" } } }, "localname": "LineOfCreditFacilityCovenantTerms", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": { "auth_ref": [ "r44" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Current Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityCurrentBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": { "auth_ref": [ "r142" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of the credit facility.", "label": "Line of Credit Facility, Increase (Decrease), Net" } } }, "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityInitiationDate1": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility first became available, in CCYY-MM-DD format.", "label": "Line Of Credit Facility Initiation Date 1" } } }, "localname": "LineOfCreditFacilityInitiationDate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDescription": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Description of the interest rate for the amounts borrowed under the credit facility, including the terms and the method for determining the interest rate (for example, fixed or variable, LIBOR plus a percentage, increasing rate, timing of interest rate resets, remarketing provisions).", "label": "Line Of Credit Facility Interest Rate Description" } } }, "localname": "LineOfCreditFacilityInterestRateDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r44" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line Of Credit Facility Maximum Borrowing Capacity", "terseLabel": "Total debt", "totalLabel": "Debt And Capital Lease Obligations", "verboseLabel": "Credit facilities" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r44" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Revolver [Member]", "terseLabel": "Line of Credit, Current Facility [Member]", "verboseLabel": "New Credit facility [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.", "label": "Long-lived Assets by Geographic Areas [Table Text Block]", "verboseLabel": "Schedule of reportable segments' long-lived assets, including certain identifiable assets [Table Text Block]" } } }, "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r22" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-term Debt and Capital Lease Obligations", "terseLabel": "Total long-term debt", "totalLabel": "Long Term Debt And Capital Lease Obligations" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtByMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt By Maturity Abstract" } } }, "localname": "LongTermDebtByMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r145", "r348" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Next Twelve Months", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r145", "r348" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Five", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r145", "r348" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Four", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r145", "r348" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Three", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r145", "r348" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Two", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r53" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 33.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtPercentageBearingVariableInterestRate": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.", "label": "Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate" } } }, "localname": "LongTermDebtPercentageBearingVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LongTermDebtTerm": { "auth_ref": [ "r666" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Long Term Debt Term" } } }, "localname": "LongTermDebtTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r53", "r349" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r334", "r335", "r336", "r339", "r340", "r341", "r344", "r346", "r347" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingencies by Nature of Contingency [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r334", "r335", "r336", "r339", "r340", "r341", "r344", "r346", "r347" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r334" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual At Carrying Value", "terseLabel": "Unrelated Environmental Liability Accruals" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualPayments": { "auth_ref": [ "r334" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow reducing loss contingency liability.", "label": "Payments Of Settlement and Release Agreements" } } }, "localname": "LossContingencyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyEstimateOfPossibleLoss": { "auth_ref": [ "r338", "r343", "r346" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.", "label": "Loss Contingency, Estimate of Possible Loss" } } }, "localname": "LossContingencyEstimateOfPossibleLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyLossInPeriod": { "auth_ref": [ "r334" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.", "label": "Non-Income Tax Contingency Charge", "negatedTerseLabel": "Non-income tax contingency charge" } } }, "localname": "LossContingencyLossInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyManagementsAssessmentAndProcess": { "auth_ref": [ "r338", "r343" ], "lang": { "en-us": { "role": { "documentation": "Describes management's process to evaluate the contingency matter and to estimate the impact on the financial statements and ongoing operations, such as added credit risk or loss of customers, including pertinent information to adequately disclose the matter and significant assumptions underlying the estimates.", "label": "Loss Contingency Actions Taken By Defendant" } } }, "localname": "LossContingencyManagementsAssessmentAndProcess", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r334", "r335", "r336", "r339", "r340", "r341", "r344", "r346", "r347" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyReceivableProceeds": { "auth_ref": [ "r118", "r347" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the collection of receivables related to a loss contingency.", "label": "Proceeds Of Settlement And Release Agreements" } } }, "localname": "LossContingencyReceivableProceeds", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencySettlementAgreementTerms": { "auth_ref": [ "r334", "r337", "r342" ], "lang": { "en-us": { "role": { "documentation": "Description of the terms of a settlement agreement which resolved the legal matter, including the nature of the consideration, timing of payment, and the nature of rights obtained or lost (for example, but not limited to, patent, trademark, copyright, license and franchise rights).", "label": "Loss Contingency, Settlement Agreement, Terms" } } }, "localname": "LossContingencySettlementAgreementTerms", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r57", "r139", "r254", "r673", "r750", "r775" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 46.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r357" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedLabel": "Distributions to noncontrolling affiliate shareholders" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromRedemptions": { "auth_ref": [ "r357", "r622", "r623" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).", "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests", "negatedLabel": "Acquisition of noncontrolling interest", "terseLabel": "Acquisition of noncontrolling interest" } } }, "localname": "MinorityInterestDecreaseFromRedemptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r121" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 52.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net cash provided (used in) by financing activities", "totalLabel": "Net cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r121" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 35.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net cash (used in) provided by investing activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r121", "r125", "r128" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 28.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net cash provided by operating activities", "totalLabel": "Net cash (used in) provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r5", "r82", "r85", "r90", "r128", "r139", "r153", "r159", "r160", "r161", "r162", "r166", "r167", "r180", "r216", "r228", "r232", "r235", "r238", "r254", "r673", "r756", "r783" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.quakerchem.com/role/EarningsPerShareBasicDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 }, "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income (loss) attributable to Quaker Chemical Corporation", "terseLabel": "Net income", "totalLabel": "Net income (loss) attributable to Quaker Chemical Corporation" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EarningsPerShareBasicDetails", "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r82", "r85", "r166", "r167", "r627", "r635" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 18.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Less: Net income attributable to noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r159", "r160", "r161", "r162", "r172", "r173", "r182", "r187", "r216", "r228", "r232", "r235", "r238" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareBasicDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "NetIncomeLossAvailableToCommonStockholdersBasic", "totalLabel": "Net income (loss) available to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareBasicDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r174", "r182", "r187" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "NetIncomeLossAvailableToCommonStockholdersDiluted", "totalLabel": "Net income (loss) available to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleDescription": { "auth_ref": [ "r151", "r161", "r168", "r170", "r194", "r195" ], "lang": { "en-us": { "role": { "documentation": "Disclosure related to a new accounting pronouncement or a change in accounting principle, including the nature and reason for the change and the effect of the change on prior periods and the current period.", "label": "New Accounting Pronouncement Or Change In Accounting Principle Description" } } }, "localname": "NewAccountingPronouncementOrChangeInAccountingPrincipleDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements And Changes In Accounting Principles [Abstract]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r151", "r152", "r155", "r156", "r169", "r170", "r171", "r260", "r261", "r387", "r388", "r389", "r390", "r527", "r575", "r576", "r577", "r740", "r741", "r742", "r802", "r803", "r804", "r805", "r807" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements Or Change In Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r150", "r153", "r154", "r155", "r157", "r158", "r161", "r191", "r256", "r257", "r258", "r259", "r262", "r263", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r528", "r571", "r572", "r573", "r574", "r737", "r738", "r739", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non Domestic [Member]" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation": { "auth_ref": [ "r358", "r629" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.", "label": "Noncontrolling Interest Decrease From Deconsolidation", "negatedLabel": "Disposition of noncontrolling interest", "terseLabel": "Disposition of Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestDecreaseFromDeconsolidation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r146", "r147", "r149", "r357", "r617" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r102" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Other income (expense), net", "negatedLabel": "Other expense, net", "terseLabel": "Total other income (expense), net", "totalLabel": "Other Income (Expense), Net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of countries in which the entity operates as of balance sheet date.", "label": "Number Of Countries In Which Entity Operates" } } }, "localname": "NumberOfCountriesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number Of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenseMember": { "auth_ref": [ "r652" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.", "label": "Operating Expense [Member]" } } }, "localname": "OperatingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r216", "r228", "r232", "r235", "r238" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating income (loss)", "terseLabel": "Operating income for reportable segments", "totalLabel": "Operating income (loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r708", "r718" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease Cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Liabilities Payments Due [Abstract]" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r702" ], "calculation": { "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating lease liabilities", "terseLabel": "Present value of lease liabilities", "totalLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails", "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r702" ], "calculation": { "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current", "terseLabel": "Short-term lease liabilities", "verboseLabel": "Other current liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r702" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 34.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails": { "order": 4.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liaiblity noncurrent", "terseLabel": "Long-term lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r703" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease liability.", "label": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "extensibleListItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r704", "r712" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease Payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r701" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use lease assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r703" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "extensibleListItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r715", "r718" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease Weighted Average Discount Rate Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r714", "r718" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term (years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r696", "r697" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due Next Year", "terseLabel": "For the year ended 2019" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r696", "r697" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due in Five Years", "terseLabel": "For the year ended 2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r696", "r697" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due in Four Years", "terseLabel": "For the year ended 2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r696", "r697" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due in Three Years", "terseLabel": "For the year ended 2021" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r696", "r697" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due in Two Years", "terseLabel": "For the year ended 2020" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r696", "r697" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due Therafter", "terseLabel": "For the year ended 2024 and beyond" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r564" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.", "label": "Operating Loss Carryforwards, Limitations on Use" } } }, "localname": "OperatingLossCarryforwardsLimitationsOnUse", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r561" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Operating Loss Carryforwards, Valuation Allowance" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r227", "r228", "r229", "r230", "r232", "r238" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of Presentation and Description of Business [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r6", "r637" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Basis of Presentation and Description of Business [Text Block]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r642", "r657" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsMiscellaneousCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.", "label": "Other Assets Miscellaneous Current" } } }, "localname": "OtherAssetsMiscellaneousCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r42" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other non-current assets", "totalLabel": "Total other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plans [Abstract]" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r72", "r76", "r441" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Net gain (loss) arising during the period, other", "negatedLabel": "Net gain (loss) arising during the period, other" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r67", "r76", "r674", "r675", "r679" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "terseLabel": "Currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r76", "r79", "r80", "r441" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 14.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax", "terseLabel": "Prior service credit (cost)", "totalLabel": "Total Recognized in Other Comprehensive (Income) Loss", "verboseLabel": "Recognition of amortization in net periodic benefit cost Prior service credit (cost)" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": { "auth_ref": [ "r76", "r79", "r80", "r441" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 6.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service (Cost) Credit, Net of Tax", "negatedTerseLabel": "Amortization of prior service cost", "terseLabel": "Amortization of prior service gain" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r78", "r680", "r682", "r686" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive (Loss) Income, before Reclassifications, before Tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r83", "r86", "r88", "r91", "r352", "r680", "r685", "r686", "r757", "r784" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 11.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Amounts reported in other comprehensive income (loss)", "totalLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r74", "r76" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 8.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Defined Benefit Retirement Plans", "negatedLabel": "Defined benefit retirement plans" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": { "auth_ref": [ "r72", "r76", "r441" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 12.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Unamortized Gain (Loss) Arising During Period, before Tax", "negatedLabel": "Net Loss (Gain) Arising During The Period", "terseLabel": "Net Loss (Gain) Arising During The Period" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax": { "auth_ref": [ "r76", "r79", "r80", "r441" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails": { "order": 19.0, "parentTag": "kwr_TotalRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveLossOrIncome", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net period benefit cost (credit) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Tax", "terseLabel": "Total Recognized in Other Comprehensive Income (Loss)", "totalLabel": "Total Recognized in Other Comprehensive (Income) Loss" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": { "auth_ref": [ "r76", "r79", "r80", "r441" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net (Gain) Loss, Net of Tax", "negatedTerseLabel": "Amortization of actuarial loss", "terseLabel": "Amortization of actuarial loss" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax": { "auth_ref": [ "r76", "r79", "r80", "r441" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 7.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Transition (Asset) Obligation, Net of Tax", "terseLabel": "Amortization of Initial Net Asset" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "auth_ref": [ "r619", "r620", "r630" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "terseLabel": "Related Tax Amounts" } } }, "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r68", "r76", "r660" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 9.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Current period change in fair value of derivatives" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r69", "r76" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 10.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "Unrealized gain (loss) on available-for-sale securities" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherDebtSecuritiesMember": { "auth_ref": [ "r251", "r283", "r422", "r668" ], "lang": { "en-us": { "role": { "documentation": "Investments in debt securities classified as other.", "label": "Other Debt Securities [Member]" } } }, "localname": "OtherDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherDepreciationAndAmortization": { "auth_ref": [ "r100", "r127", "r308" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.", "label": "Other Depreciation And Amortization", "negatedLabel": "Depreciation of corporate assets and amortization", "terseLabel": "Depreciation" } } }, "localname": "OtherDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherFiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r298" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of finite-lived intangible assets classified as other.", "label": "Other Finite Lived Intangible Assets, Gross" } } }, "localname": "OtherFiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "auth_ref": [ "r392", "r535" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.", "label": "Other Income and Other Expense Disclosure [Text Block]" } } }, "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpense" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherIncomeMember": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other revenue.", "label": "Other Income [Member]" } } }, "localname": "OtherIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r12", "r13", "r48" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 31.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other accrued liabilities", "terseLabel": "Other Current Liabilities", "totalLabel": "Accrued Liabilities, Current, Total" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r54" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 37.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other non-current liabilities", "totalLabel": "Total" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r22", "r749", "r771" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long Term Debt", "terseLabel": "Other debt obligations (including capital leases)" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncome": { "auth_ref": [ "r128" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income or gain included in net income that result in no cash inflow (outflow), classified as other.", "label": "OtherNoncashIncome", "negatedLabel": "Gain on inactive subsidiary litigation and settlement reserve", "terseLabel": "Gain on inactive subsidiary litigation and settlement reserve" } } }, "localname": "OtherNoncashIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Noncash Investing And Financing Items [Abstract]" } } }, "localname": "OtherNoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingExpense": { "auth_ref": [ "r104" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to nonoperating activities, classified as other.", "label": "Other Nonoperating Expense", "negatedLabel": "Other non-operating expense" } } }, "localname": "OtherNonoperatingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r96" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other non-operating income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income Expense Net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r394", "r395", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r421", "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r446", "r447", "r450", "r453", "r459", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r478", "r479", "r480", "r481", "r482", "r483" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefit Plans Defined Benefit [Member]", "terseLabel": "Domestic Other Postretirement Benefits [Member]" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherRestrictedAssetsCurrent": { "auth_ref": [ "r61" ], "calculation": { "http://www.quakerchem.com/role/RestrictedCashDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets that are pledged or subject to withdrawal restrictions, classified as other.", "label": "OtherRestrictedAssetsCurrent", "terseLabel": "Restricted cash included in other current assets" } } }, "localname": "OtherRestrictedAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r101" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of selling, general and administrative expense classified as other.", "label": "Other Selling General And Administrative Expense" } } }, "localname": "OtherSellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PatentedTechnologyMember": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law.", "label": "Product technology [Member]" } } }, "localname": "PatentedTechnologyMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForLegalSettlements": { "auth_ref": [ "r124" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.", "label": "Insurance settlement realized", "negatedLabel": "Insurance settlement realized", "terseLabel": "Payments Made, Restricted Cash" } } }, "localname": "PaymentsForLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r113" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 46.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments For Repurchase Of Common Stock", "negatedLabel": "Payments for repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": { "auth_ref": [ "r113" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 48.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.", "label": "Payments To Acquire Additional Interest In Subsidiaries", "negatedLabel": "Purchase of noncontrolling interest in affiliates, net" } } }, "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r118", "r319" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Cash Payments", "negatedLabel": "Cash Payments", "terseLabel": "Restructuring, Cash Payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails", "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r116" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 43.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Financing-related debt issuance costs", "negatedLabel": "Financing-related debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r113" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 44.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Dividends paid", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsMinorityInterest": { "auth_ref": [ "r113" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 51.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.", "label": "Distributions to noncontrolling shareholders", "negatedTerseLabel": "Distributions to noncontrolling affiliate shareholders" } } }, "localname": "PaymentsOfDividendsMinorityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r108", "r613" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments To Acquire Businesses Gross", "negatedTerseLabel": "Gross Cash Paid for Acquisition", "terseLabel": "Cash transferred to Houghton shareholders", "totalLabel": "Net cash paid", "verboseLabel": "Net cash paid" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r108" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 31.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments related to acquisitions, net of cash acquired", "negatedLabel": "Payments related to acquisitions, net of cash acquired", "terseLabel": "Net cash paid for Coral", "totalLabel": "Net cash paid for Coral", "verboseLabel": "Net cash paid for Coral" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r109" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 30.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Investments in property, plant and equipment", "negatedLabel": "Investments in property, plant and equipment", "terseLabel": "Capital Expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitContributions": { "auth_ref": [ "r124" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.", "label": "Pension and other postretirement benefits contributions", "negatedLabel": "Pension and other postretirement benefits" } } }, "localname": "PensionAndOtherPostretirementBenefitContributions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitExpense": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.", "label": "Pension And Other Postretirement Benefit Expense", "negatedLabel": "Pension And Other Postretirement Benefit Expense" } } }, "localname": "PensionAndOtherPostretirementBenefitExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r421", "r423", "r429", "r448", "r451", "r452", "r453", "r455", "r456", "r474", "r476", "r477", "r478", "r498" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Pension And Other Postretirement Benefits Disclosure [Text Block]" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefits" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "auth_ref": [ "r20", "r395", "r396", "r419", "r474" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 29.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.", "label": "Accrued pension and postretirement benefits", "negatedLabel": "Current Liabilities", "terseLabel": "Current Liabilities" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r23", "r395", "r396", "r419", "r474" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 36.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Accrued Pension and Postretirement Benefits, Non-current", "negatedLabel": "Non-current Liabilities", "terseLabel": "Non-current accrued pension and post-retirment benefits" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r393", "r395", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r421", "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r446", "r447", "r450", "r453", "r459", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r478", "r479", "r493", "r494", "r495", "r496" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plans, Defined Benefit [Member]", "terseLabel": "Total Pension Plans [Member]" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Stock Units [Member]", "terseLabel": "Performance Stock Units [Member]" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanAssetCategoriesDomain": { "auth_ref": [ "r421", "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r450", "r474" ], "lang": { "en-us": { "role": { "documentation": "Defined benefit plan asset investment.", "label": "Plan Asset Categories [Domain]" } } }, "localname": "PlanAssetCategoriesDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock Par Or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r10", "r36", "r37" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromInsuranceSettlementInvestingActivities": { "auth_ref": [ "r107", "r120" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 33.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow for proceeds from settlement of insurance claim, classified as investing activities. Excludes insurance settlement classified as operating activities.", "label": "Insurance settlement interest earned" } } }, "localname": "ProceedsFromInsuranceSettlementInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r111" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 50.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r112" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 39.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from long-term debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r111" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 45.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Stock options exercised, other" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "auth_ref": [ "r144" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 41.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Borrowings on revolving credit facilities, net" } } }, "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfOtherDebt": { "auth_ref": [ "r144" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 42.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) for debt classified as other.", "label": "Repayments on other debt, net" } } }, "localname": "ProceedsFromRepaymentsOfOtherDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": { "auth_ref": [ "r144" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 38.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Net decrease in short-term borrowings" } } }, "localname": "ProceedsFromRepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r106" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 32.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from disposition of assets" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r5", "r82", "r85", "r119", "r139", "r153", "r166", "r167", "r216", "r228", "r232", "r235", "r238", "r254", "r619", "r626", "r628", "r635", "r636", "r673", "r763" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 17.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAdditionalDisclosures": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional information disclosed pertaining to property, plant and equipment.", "label": "Property Plant And Equipment Additional Disclosures" } } }, "localname": "PropertyPlantAndEquipmentAdditionalDisclosures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r41", "r311" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r40", "r309" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, Plant and Equipment, at Cost", "totalLabel": "Property, Plant and Equipment, Gross, Total" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r16", "r17", "r311", "r777" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Net property, plant and equipment", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, Plant and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r16", "r309" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RealEstateHeldforsale": { "auth_ref": [ "r779" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of investments in land and buildings held for sale, excluding real estate considered to be inventory of the entity.", "label": "Real Estate Held for sale" } } }, "localname": "RealEstateHeldforsale", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r78", "r81", "r680", "r684", "r686" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "terseLabel": "Amounts Reclassed from AOCI" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r228", "r232" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Schedule of information about the performance of the Company's reportable segments, operating earnings [Table Text Block]" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r230", "r232" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.", "label": "Reconciliation of capital expenditures and depreciation for identifiable assets [Table Text Block]" } } }, "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r115" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 37.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "RepaymentsOfLongTermDebt", "terseLabel": "Payments of term loan debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": { "auth_ref": [ "r114" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 40.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.", "label": "Payments of long-term debt", "negatedLabel": "Payments of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r134", "r744", "r772" ], "calculation": { "http://www.quakerchem.com/role/RestrictedCashDetails": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash included in other assets" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock LTIP [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) LTIP Plan [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring And Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesCompletionDate": { "auth_ref": [ "r317", "r326" ], "lang": { "en-us": { "role": { "documentation": "Date the exit and disposal activities were completed or are expected to be completed, in CCYY-MM-DD format.", "label": "Restructuring and Related Activities, Completion Date" } } }, "localname": "RestructuringAndRelatedActivitiesCompletionDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDescription": { "auth_ref": [ "r317", "r326" ], "lang": { "en-us": { "role": { "documentation": "Description of a specific restructuring plan and related activities including the facts and circumstances leading to the restructuring or decision to exit an activity, and the expected completion date. This concept and related items would be utilized for each plan if multiple exit plans have been implemented in the period.", "label": "Restructuring and Related Activities, Description" } } }, "localname": "RestructuringAndRelatedActivitiesDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring And Related Activities Disclosure [Text Block]" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringAndRelatedActivitiesInitiationDate": { "auth_ref": [ "r317", "r326" ], "lang": { "en-us": { "role": { "documentation": "Date the restructuring activities were initiated or are expected to be initiated, in CCYY-MM-DD format.", "label": "Restructuring and Related Activities, Initiation Date" } } }, "localname": "RestructuringAndRelatedActivitiesInitiationDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_RestructuringAndRelatedCostDescription": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Information pertinent to an understanding of the specified type of restructuring cost, including the facts and circumstances leading to the expected activity, discussion of the level and quantity of personnel to be terminated, and the expected completion date.", "label": "Restructuring And Related Cost Description" } } }, "localname": "RestructuringAndRelatedCostDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expected cost remaining for the specified restructuring cost.", "label": "Restructuring And Related Cost Expected Cost Remaining" } } }, "localname": "RestructuringAndRelatedCostExpectedCostRemaining1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The expected number of positions to be eliminated as a result of restructuring activities.", "label": "Restructuring And Related Cost Expected Number Of Positions Eliminated" } } }, "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r127", "r318", "r323", "r328" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring and related charges", "negatedLabel": "Restructuring and related charges", "negatedTerseLabel": "Restructuring charges", "verboseLabel": "Restructuring Charges (Credits)" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring Cost and Reserve [Abstract]" } } }, "localname": "RestructuringCostsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r319", "r324" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Accrued restructuring", "periodEndLabel": "Accrued Restructuring, Ending Balance", "periodStartLabel": "Accrued Restructuring, Beginning Balance", "terseLabel": "Accrued Restructuring" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring Reserve [Abstract]" } } }, "localname": "RestructuringReserveAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r318", "r327" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 28.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "periodEndLabel": "Accrued Restructuring, Ending Balance", "periodStartLabel": "Accrued Restructuring, Beginning Balance", "terseLabel": "Accrued restructuring" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveTranslationAdjustment": { "auth_ref": [ "r319", "r327" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.", "label": "Currency Translation Adjustments", "negatedLabel": "Currency Translation Adjustments" } } }, "localname": "RestructuringReserveTranslationAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Depreciation, depletion, amortization, and accretion related to oil and gas producing activities.", "label": "Results of Operations, Depreciation, Depletion, Amortization and Accretion", "terseLabel": "Depreciation and amortization" } } }, "localname": "ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r30", "r357", "r528", "r774", "r802", "r807" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 43.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained earnings", "terseLabel": "Adjustment to prior period earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r146", "r147", "r149", "r154", "r164", "r167", "r259", "r524", "r525", "r526", "r573", "r574", "r798", "r800" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanNameAxis": { "auth_ref": [ "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r421", "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r445", "r446", "r447", "r450", "r453", "r459", "r460", "r461", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r497" ], "lang": { "en-us": { "role": { "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Axis]" } } }, "localname": "RetirementPlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanNameDomain": { "auth_ref": [ "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r421", "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r445", "r446", "r447", "r450", "r453", "r459", "r460", "r461", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r497" ], "lang": { "en-us": { "role": { "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Domain]" } } }, "localname": "RetirementPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r421", "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r445", "r446", "r447", "r450", "r453", "r460", "r461", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r479", "r483", "r496" ], "lang": { "en-us": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r421", "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r445", "r446", "r447", "r450", "r453", "r460", "r461", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r479", "r483", "r496" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r393", "r394", "r395", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r421", "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r446", "r447", "r450", "r453", "r459", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r478", "r479", "r480", "r481", "r482", "r483", "r493", "r494", "r495", "r496" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r393", "r394", "r395", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r421", "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r446", "r447", "r450", "r453", "r459", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r478", "r479", "r480", "r481", "r482", "r483", "r493", "r494", "r495", "r496" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue From Contract With Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r207", "r208", "r227", "r233", "r234", "r240", "r241", "r245", "r380", "r381", "r735" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue From Contract With Customer Excluding Assessed Tax", "terseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r207", "r208", "r227", "r233", "r234", "r240", "r241", "r245", "r380", "r381", "r735" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue From Contract With Customer Including Assessed Tax", "terseLabel": "Income from third party license fees" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r136", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r391" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue recognition [Policy Text Block]", "terseLabel": "Revenue From Contract With Customer [Policy Text Block]" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r382", "r391" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue From Contract With Customer [TextBlock]" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognition" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r136", "r137" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition [Policy Text Block]" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "The Revolver [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r713", "r718" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r200", "r245" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Sales Revenue Net [Member]", "terseLabel": "Sales Revenue Net [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": { "auth_ref": [ "r460", "r461", "r474" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Schedule of Information for pension plans with an accumulated benefit obligation in excess of plan assets [Table Text Block]" } } }, "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r78", "r685", "r686" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.", "label": "Schedule of compan's pension plan target asset allocation and pension plan investments measured at fair value on a recurring basis [Table Text Block]" } } }, "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income (loss) expected to be recognized as components of net periodic benefit cost over the next fiscal year, including the net gain (loss), net prior service cost or credit, and net transition asset or obligation.", "label": "Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year [Table Text Block]" } } }, "localname": "ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.", "label": "Scheudule of funded status of Company'ds plans' reconciled with amounts reported in the Consolidated Balance Sheets [Table Text Block]" } } }, "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.", "label": "Schedule of other changes recognized in other comprehensive income - pension plans [Table Text Block]" } } }, "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "auth_ref": [ "r443" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.", "label": "Schedule of Weighted-average assumptions used to determine benefit obligations [Table Text Block]" } } }, "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": { "auth_ref": [ "r460", "r474" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]" } } }, "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r597", "r598" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r597", "r598" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of fair value of consideration transferred in the Combination [Table Text Block]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule Of Cash And Cash Equivalents [Table Text Block]" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r647" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Scheudule of fair values of the Company''s derivative instruments, Level 2 measurements [Table Text Block]" } } }, "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "Schedule of share-based compensation expense in its Consolidated Statements of Income [Table Text Block]" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r569" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schecule of taxes on income before equity in net income of associated companies [Table Text Block]" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of total deferred tax assets and liabilities [Table Text Block]" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r458", "r459", "r462", "r463", "r474" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostAndChangesInOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r187" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock": { "auth_ref": [ "r449" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of a one-percentage-point increase and the effect of a one-percentage-point decrease in the assumed health care cost trend rates on the aggregate of the service and interest cost components of net periodic postretirement health care benefit costs and the accumulated postretirement benefit obligation for health care benefits.", "label": "Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block]" } } }, "localname": "ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.", "label": "Schedule of changes in the fair value of the plans' Level 3 investments [Table Text Block]" } } }, "localname": "ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r500", "r516", "r530" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r500", "r516", "r530" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Schedule of The compensation expense recorded on each award during the year [Table Text Block]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.", "label": "Schedule of Expected Benefit Payments [Table Text Block]" } } }, "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r293", "r297", "r736" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails", "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r293", "r297" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r698" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the assumed health care cost trend rates for the next year used to measure the expected cost of benefits covered by the plans, including the ultimate trend rate(s) and when that rate is expected to be achieved.", "label": "Schedule of Assumed health care cost trend rates [Table Text Block]" } } }, "localname": "ScheduleOfHealthCareCostTrendRatesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of components of earnings before income taxes [Table Text Block]" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r348" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of components of net periodic benefit costs - pension plans [Table Text Block]" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule of other expense, net [Table Text Block]" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfProductInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of product information that are included in the discussion of the nature of an entity's operations.", "label": "Schedule of Product Information [Table Text Block]" } } }, "localname": "ScheduleOfProductInformationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r604" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of estimated fair values of net assets acquired [Table Text Block]" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r321", "r322", "r325" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r321", "r322", "r325" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r216", "r219", "r231", "r290" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r216", "r219", "r231", "r290" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of information about the performance of the Company's reportable segments, sales and total assets [Table Text Block]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of activity of nonvested restricted stock units granted under the Company's LTIP plan [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Schedule of summary of the Company's outstanding stock options [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r505", "r507", "r509" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of Stock option activity under all plans [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r510" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Black-Scholes option pricing model and the assumptions [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of activity of nonvested restricted stock awards granted under the Company's LTIP plan [Table Text Block]" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.", "label": "Schedule of Stockholders Equity [Table Text Block]" } } }, "localname": "ScheduleOfStockholdersEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r557", "r570" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r203", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r227", "r228", "r229", "r230", "r232", "r233", "r234", "r235", "r236", "r238", "r245", "r790" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segment Domain" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r203", "r205", "r206", "r216", "r220", "r232", "r236", "r237", "r238", "r239", "r240", "r244", "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingMeasurementDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Segment Disclosures [Abstract]" } } }, "localname": "SegmentReportingMeasurementDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r135", "r221", "r222", "r223", "r224", "r225", "r226", "r241" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segments [Policy Text Block]" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r101" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Other Acquisitions [Member]" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r126" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation [Abstract]" } } }, "localname": "ShareBasedCompensationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period 1", "terseLabel": "Option Award Vesting Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Equity Award Vesting Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Discount rate from fair value on purchase date that participants pay for shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date", "terseLabel": "ESPP: Discount from Market Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period", "terseLabel": "Nonvested Stock Awards Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement By Share-Based Payment Award Fair Value Assumptions And Methodology [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate", "terseLabel": "Dividend Yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate", "terseLabel": "Expected Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate", "terseLabel": "Risk-free Interest Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r508" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share Based Compensation Arrangement By Share Based PaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "terseLabel": "Exercised Options, Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross", "terseLabel": "Options Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r499", "r504" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of shares (or other type of equity) that have been approved for issuance in the equity-based payment transaction.", "label": "Share Based Goods And Nonemployee Services Transaction Shares Approved For Issuance", "terseLabel": "Director Stock Ownership Plan Maximum Number of Shares Authorized Under Plan" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r511", "r529" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1", "terseLabel": "Expected Term (Years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent", "terseLabel": "ESPP: Purchase Price Percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares Issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r18", "r747", "r770" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short Term Borrowings", "negatedLabel": "Less: short-term and current portion of long-term debts", "terseLabel": "Short-term Debt (including capital leases)" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r709", "r718" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short Term Lease Cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r2", "r203", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r227", "r228", "r229", "r230", "r232", "r233", "r234", "r235", "r236", "r238", "r245", "r290", "r316", "r320", "r329", "r790" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Statement, Business Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGoodwillAssetsDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r56", "r146", "r147", "r149", "r154", "r164", "r167", "r196", "r259", "r352", "r357", "r524", "r525", "r526", "r573", "r574", "r680", "r681", "r682", "r683", "r684", "r686", "r798", "r799", "r800" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement, Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestAOCIReclassificationsDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails", "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Changes in Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r146", "r147", "r149", "r196", "r735" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockCompensationPlanMember": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.", "label": "Annual Incentive Plan [Member]" } } }, "localname": "StockCompensationPlanMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Share based compensation plans", "verboseLabel": "Share issuance and equity-based compensation plans" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": { "auth_ref": [ "r26", "r27", "r352", "r357", "r532" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.", "label": "Stock Issued During Period Shares Employee Stock Ownership Plan", "terseLabel": "Shares issued for ESPP" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period Shares Other", "terseLabel": "Shares issued for Options exercise and Other activity" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r26", "r27", "r352", "r357" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Stock Issued During Period Shares Share Based Compensation", "terseLabel": "Shares issued for equity based comp plans" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan": { "auth_ref": [ "r26", "r27", "r352", "r357", "r532" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).", "label": "Shares issued for employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r26", "r27", "r352", "r357" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock offering, net of related expenses" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r56", "r352", "r357" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Shares issued upon exercise of stock options and other" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program Authorized Amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program Remaining Authorize" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r26", "r27", "r352", "r357" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased And Retired During Period Shares" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r26", "r27", "r352", "r357" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Repurchases of common stock", "negatedLabel": "Repurchases of common stock" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r27", "r32", "r33", "r139", "r250", "r254", "r673" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 45.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Total Quaker shareholders equity", "totalLabel": "Total Quaker shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r139", "r146", "r147", "r149", "r154", "r164", "r254", "r259", "r357", "r524", "r525", "r526", "r573", "r574", "r617", "r618", "r634", "r673", "r680", "r681", "r686", "r799", "r800" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 47.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Total equity", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r138", "r357", "r363" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Equity [Text Block]" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/Equity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubleaseIncome": { "auth_ref": [ "r711", "r718" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sublease income excluding finance and operating lease expense.", "label": "Sublease Income" } } }, "localname": "SubleaseIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventDescription": { "auth_ref": [ "r722" ], "lang": { "en-us": { "role": { "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.", "label": "Subsequent Event Description" } } }, "localname": "SubsequentEventDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r687", "r723" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r687", "r723" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r687", "r723" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsDate": { "auth_ref": [ "r722" ], "lang": { "en-us": { "role": { "documentation": "Date the event occurred after the balance sheet date but before financial statements are issues or available to be issued, in CCYY-MM-DD format.", "label": "Subsequent Events Date" } } }, "localname": "SubsequentEventsDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "auth_ref": [ "r561" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.", "label": "Schedule of changes in the Company's deferred tax asset valuation allowance [Table Text Block]" } } }, "localname": "SummaryOfValuationAllowanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalEmployeeRetirementPlanDefinedBenefitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide limited group of employees with supplemental retirement benefits, in addition to other pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Supplemental Employee Retirement Plans, Defined Benefit [Member]", "terseLabel": "Supplemental Retirement Benefits Plan [Member]" } } }, "localname": "SupplementalEmployeeRetirementPlanDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": { "auth_ref": [ "r536", "r538" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.", "label": "Tax Adjustments, Settlements, and Unusual Provisions" } } }, "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardDescription": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "A description of the origin, nature, and characteristics of the tax credit carryforward.", "label": "TaxCreditCarryforwardDescription" } } }, "localname": "TaxCreditCarryforwardDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability": { "auth_ref": [ "r589" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax liability from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.", "label": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability" } } }, "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "auth_ref": [ "r381", "r386" ], "lang": { "en-us": { "role": { "documentation": "Information by timing of transfer of good or service to customer.", "label": "Timing Of Transfer Of Good Or Service [Axis]" } } }, "localname": "TimingOfTransferOfGoodOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "auth_ref": [ "r381", "r386" ], "lang": { "en-us": { "role": { "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.", "label": "Timing Of Transfer Of Good Or Service Domain" } } }, "localname": "TimingOfTransferOfGoodOrServiceDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "verboseLabel": "Licensed Trademark [Member]" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsOtherAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredAtPointInTimeMember": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred at point in time.", "label": "Transferred At Point In Time [Member]" } } }, "localname": "TransferredAtPointInTimeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredOverTimeMember": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred over time.", "label": "Transferred Over Time [Member]" } } }, "localname": "TransferredOverTimeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r153", "r154", "r155", "r157", "r256", "r257", "r258", "r259", "r262", "r263", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r528", "r571", "r572", "r573", "r574", "r737", "r738", "r739", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Type Of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": { "auth_ref": [ "r181", "r184", "r185" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareBasicDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.", "label": "UndistributedEarningsAllocatedToParticipatingSecurities", "negatedLabel": "Less: Income Allocated to Participating Securities" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareBasicDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": { "auth_ref": [ "r179", "r181", "r184", "r185" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.", "label": "Undistributed Earnings Allocated To Participating Securities Diluted", "negatedLabel": "Less: income allocated to participating securities" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r537", "r588", "r766", "r808" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.", "label": "Undistributed Earnings of Foreign Subsidiaries" } } }, "localname": "UndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss": { "auth_ref": [ "r647" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.", "label": "Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net" } } }, "localname": "UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r539", "r553" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance", "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r554" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits, Decreases Resulting from Settlements with Taxing Authorities", "terseLabel": "Decrease in Unrecognized Tax Benefits Due to Settlements" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued": { "auth_ref": [ "r548" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of statutory penalties accrued for a tax position claimed or expected to be claimed by the entity, in its tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties Accrued", "terseLabel": "Accrued Penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense": { "auth_ref": [ "r548" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties Expense" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": { "auth_ref": [ "r548" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense accrued for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued", "terseLabel": "Accrued Interest" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": { "auth_ref": [ "r548" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "auth_ref": [ "r553" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.", "label": "Unrecognized Tax Benefits Period Increase" } } }, "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r555" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations", "negatedTerseLabel": "Decrease in Unrecognized Tax Benefits Due to Lapse of Statute of Limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r556" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesUncertainTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r710", "r718" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease Cost" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r174", "r187" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "WeightedAverageNumberOfDilutedSharesOutstanding", "totalLabel": "Diluted weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r172", "r187" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "order": 4.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "WeightedAverageNumberOfSharesOutstandingBasic", "terseLabel": "Basic weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareBasicDetails", "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 12 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "21B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080549-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693" }, "r171": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "60", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2740-109256" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "65", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2793-109256" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "66", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2814-109256" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r193": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e725-108305" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e765-108305" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r246": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL82887624-210437" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "30", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647444&loc=SL120269210-210444" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "30", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647444&loc=SL120254536-210444" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "8A", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121648281&loc=SL120267834-210445" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL120267845-210446" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919260-210447" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919272-210447" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL120267966-210447" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL120267969-210447" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121614247&loc=SL120267897-210452" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "13A", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121565518&loc=SL120267917-210453" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121565518&loc=SL120269220-210453" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL120267853-210455" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "3C", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL120267859-210455" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3D", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL120267862-210455" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r304": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(a))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r333": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r345": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r351": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r363": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r391": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r392": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "http://asc.fasb.org/topic&trid=49130413" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(m)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(s)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r498": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11374-113907" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "40", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "740", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120384995&loc=d3e23524-113945" }, "r534": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r535": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "720", "URI": "http://asc.fasb.org/topic&trid=2122503" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28511-109314" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28200-109314" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28446-109314" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32059-109318" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31928-109318" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31958-109318" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1),(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r589": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4),(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464" }, "r6": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=SL65897772-128472" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479" }, "r616": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4616395-111683" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r637": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226006-175313" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624186-113959" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1),(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993" }, "r661": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121549808&loc=d3e36991-112694" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 1)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717" }, "r699": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "840", "URI": "http://asc.fasb.org/topic&trid=2208923" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918631-209977" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.13,16)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(f))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r821": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r822": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r823": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r824": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r825": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r826": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r827": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r828": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r829": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r830": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" } }, "version": "2.1" } ZIP 111 0000081362-21-000013-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000081362-21-000013-xbrl.zip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�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�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�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